coumarin has been researched along with warfarin in 3240 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1075 (33.18) | 18.7374 |
| 1990's | 274 (8.46) | 18.2507 |
| 2000's | 549 (16.94) | 29.6817 |
| 2010's | 1090 (33.64) | 24.3611 |
| 2020's | 252 (7.78) | 2.80 |
| Authors | Studies |
|---|---|
| Gubernator, K; Kansy, M; Senner, F | 1 |
| Andersson, K; Borg, P; Frostell-Karlsson, A; Hämäläinen, M; Karlsson, R; Remaeus, A; Roos, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Hadjipavlou-Litina, DJ; Kontogiorgis, CA | 2 |
| Jolivette, LJ; Ward, KW | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Andersson, PO; Karlsson, BC; Näslund, I; Nicholls, IA; Rosengren, AM | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Kojo, A; Kraul, H; Pelkonen, O; Rautio, A; Salmela, E | 1 |
| Fry, JR; Hammond, AH | 1 |
| Morioka, M; Nagai, K; Nohara, C; Saito, T; Sato, T; Susaki, K; Suzuki, K; Takebayashi, Y | 1 |
| Egan, DA; O'Kennedy, R | 1 |
| Fentem, JH; Fry, JR | 3 |
| Dullemond-Westland, AC; Merkus, HM; van Heusden, AM | 1 |
| Brubaker, R; Coots, MC; Glueck, HI; Kant, KS; Penn, I; Tonne, VA | 1 |
| Knight, CG; Murphy, G; Willenbrock, F | 1 |
| Morris, DL; Ward, JB | 1 |
| Crawford, ED; Fair, WR; Glode, LM; Gomella, LG; Marshall, ME; Mohler, JL; Zippe, CD | 1 |
| Gaudin, H; Lake, BG; Price, RJ; Walters, DG | 1 |
| Lake, BG; Osborne, DJ; Price, RJ; Walters, DG | 1 |
| Allard, AS; Hynning, PA; Neilson, AH; Remberger, M | 1 |
| Grainger, DJ; Hesketh, TR; Metcalfe, JC; Weissberg, PL | 1 |
| Benesch, L; Wittstamm, FJ | 1 |
| Bär, FW; de Swart, JB; van der Veen, FH; van Ommen, V; van Oppen, J; Wellens, HJ | 1 |
| Boeri, G; Girolami, A; Sartori, MT | 1 |
| Cholerton, S; Gonzalez, FJ; Idle, JR; Idle, ME; Vas, A | 1 |
| Bogers, JW; Huikeshoven, FJ; Lotgering, FK | 1 |
| Ayhan, A; Kişnişci, HA; Nazli, N; Ozmen, F; Yapar, EG; Yüce, K | 1 |
| Girolami, A; Lazzaro, AR; Ruzza, G; Viero, ML | 1 |
| Apps, R; Dietrichs, E; Trott, JR | 1 |
| Fentem, JH; Fry, JR; Thomas, NW | 1 |
| Hickey, MJ; Hurley, JV; Knight, KR; Lepore, DA; O'Brien, BM | 1 |
| Butler, K; Fried, A; Marshall, ME | 1 |
| Hussain, AS; Johnson, RD; Ritschel, WA; Vachharajani, NN | 1 |
| Heinrichs, C; Kühnel, L; Neugebauer, J; Wache, I | 1 |
| Bichler, J; Birg, A; Lill, H; Schramm, W; Spannagl, M | 1 |
| Aonuma, S; Nagao, M; Nakayasu, M; Shima, H; Sugimura, T | 2 |
| Thornes, RD; Wall, PG | 1 |
| Fentem, JH; Fry, JR; Hammond, AH | 1 |
| Girolami, A; Sartori, MT; Simioni, P | 1 |
| Bouchier-Hayes, DJ; Creagh, TA; Leahy, AL; McNamara, E | 1 |
| Kohda, T; Oishi, M; Yamagoe, S | 1 |
| Elgart, ML; Goldberg, SL; Kessler, CM; Orthner, CL; Yalisove, BL | 1 |
| Ellbrück, D; Rasche, H; Seifried, E; Wankmüller, H | 1 |
| Ellbrück, D; Seifried, E; Wankmüller, H | 1 |
| Fentem, JH; Fry, JR; Whiting, DA | 1 |
| Honkakoski, P; Lang, MA; Mäenpää, J; Pelkonen, O; Syngelmä, T | 1 |
| Lake, BG; Peters, MM; van Bladeren, PJ; van Ommen, B; Walters, DG | 1 |
| Conrath, U; Jeblick, W; Kauss, H | 1 |
| Kessler, CM | 1 |
| Baumgartner, G; Stuhlmeier, K; Theyer, G; Zlabinger, GJ | 1 |
| Anderson, KE; Goeger, DE | 1 |
| Cox, D; Egan, D; Moran, E; O'Kennedy, R; Prosser, E; Thornes, RD | 1 |
| Hennig, FW; Herrmann, R; Manegold, C; Matthiessen, W; Maurer, B | 1 |
| Amato, R; Dexeus, FH; Dozier, N; Fitz, K; Logothetis, CJ; Reuben, JM; Sella, A | 1 |
| Gitel, SN; Martinowitz, U; Mazar, AL; Rakocz, M; Ramot, B; Taicher, S; Varon, D | 1 |
| Anderson, DR; Levine, MN | 1 |
| Cansunar, E; Richardson, AJ; Stewart, CS; Wallace, G | 1 |
| Piller, NB | 1 |
| Diehm, C; Müller-Bühl, U; Richter, GM; Schiffl, R; Weiss, T; Wilhelm, C | 1 |
| Imanishi, H; Matsumoto, K; Ohta, T; Sasaki, YF; Shirasu, Y; Tutikawa, K; Watanabe, M | 1 |
| Avigdor, S; Barnea, ER | 1 |
| Elson, EL; Qian, H | 1 |
| Aalders, JG; Bouma, J; Kragt, H | 1 |
| Ballard, JO; Patrick, SD; Wallin, R | 1 |
| Cappellato, MG; Girolami, A; Lazzaro, AR; Simioni, P | 1 |
| Faulstich, H; Rinnerthaler, G; Small, JV; Zobeley, S | 1 |
| Heinrichs, C; Karge, M; Kühnel, L; Stigge, V | 1 |
| Gangolli, SD; Lake, BG; Walters, DG | 1 |
| Chambers, M; McKernan, M; Thornes, RD | 1 |
| Bachmann, F; Grimaudo, V; Gueissaz, F; Hauert, J; Kruithof, EK; Sarraj, A | 1 |
| Kitchens, CS; Moreb, J | 1 |
| Appleby, EC; Conning, DM; Evans, JG; Lake, BG | 1 |
| Caldwell, A; Fitzsimons, EJ; McQuaker, G; Morrison, M | 1 |
| Badalament, RA; Barkley, C; Drago, JR; Metz, EN; Nesbitt, J | 1 |
| Coe, SA; Khazanchi, RK; Knight, KR; McCann, JJ; O'Brien, BM; Pederson, WC | 1 |
| Browne, H; Corrigan, T; Daly, L; Daly, P; Edwards, G; Keane, F; Lynch, G; O'Loughlin, S; Tanner, A; Thornes, D | 1 |
| Casley-Smith, JR; Jamal, S | 1 |
| Gänger, KH; Nachbur, BH; Ris, HB; Zurbrügg, H | 1 |
| Butler, K; Cantrell, J; Marshall, ME; Mendelsohn, L; Wiseman, C | 1 |
| Gallicchio, VS; Harmon, C; Hulette, BC; Marshall, ME | 1 |
| Lindberg, RL; Negishi, M | 1 |
| Butler, K; Marshall, ME; Metcalfe, M; Tate, M | 1 |
| Davenport, Y; Tseng, A; Venook, AP | 1 |
| Fischer, J; Haanen, C; Verbruggen, B; Wessels, H | 1 |
| Cibull, M; Eichhorn, T; Jennings, CD; Marshall, ME; Rhoades, J; Riley, LK; Thompson, J | 1 |
| Brown, S; Conley, D; Hollingsworth, P; Marshall, ME; Thompson, JS | 1 |
| Beamand, JA; Evans, JG; Gray, TJ; Hue, KL; Lake, BG; Lewis, DF | 1 |
| Kessler, CM; Strickland, DK | 1 |
| Kirsten, E; Kun, E; Kurian, P; Milo, GE | 1 |
| Fullilove, S; Hardesty, B; Kramer, G; Tipper, J; Wollny, E | 1 |
| Butler, K; Cantrell, J; Harvey, J; Macdonald, J; Marshall, ME; Mendelsohn, L | 1 |
| Wallin, R | 1 |
| Buki, K; Hakam, A; Jakobovits, EB; Kirsten, E; Kun, E; Lee, WM; McLick, J; Tseng, A | 1 |
| Loeliger, EA | 1 |
| De Long, MJ; Prochaska, HJ; Talalay, P | 1 |
| Burkel, WE; Graham, LM; Lindblad, B; Sell, R; Stanley, JC; Wakefield, TW; Wright, SW | 1 |
| Banson, B; Berman, JA; Celoria, GM; Friedmann, P; Rhee, SW; Steingart, RH | 1 |
| Kriessmann, A | 1 |
| Agrawala, P; Hussain, SA; Kappes, JK; Kraeling, M; Ritschel, WA | 1 |
| Monhart, V; Sobota, J | 1 |
| Park, BK | 1 |
| Braun, B; Hellstern, P; Kiehl, R; Scheffler, P; Wenzel, E | 1 |
| Juvonen, RO; Lang, MA; Shkumatov, VM | 1 |
| Akhrem, AA; Chashchin, VL; Iuvonen, RO; Lang, MA; Shkumatov, VM | 1 |
| Cornwall, J; Phillipson, OT | 2 |
| Hussain, SA; Ritschel, WA | 1 |
| Dimayuga, ML; Klopman, G | 1 |
| Lie, JT | 1 |
| Barkhaus, JK; Ritschel, WA | 1 |
| Bodey, GP; Dreizen, S; Keating, MJ; McCredie, KB | 1 |
| Ehringer, H; Kretschmer, G; Minar, E; Polterauer, P; Schemper, M; Wagner, O; Wenzl, E | 1 |
| Ernstoff, MS; Kirkwood, JM | 1 |
| Butler, K; Cantrell, J; Macdonald, JS; Marshall, ME; Mendelsohn, L; Riley, L; Taylor, R; Wiseman, C | 1 |
| Canzler, E; Hundsdörfer, S; Zipprich, K | 1 |
| Diehl, H; Schröder, U | 1 |
| Lang, SJ; Mulder, DG | 1 |
| Rosen, T; Stone, MS | 1 |
| Clodius, L; Piller, NB | 1 |
| Duveau, D | 1 |
| Karnik, R; Lechner, K; Niessner, H; Pabinger, I; Slany, J | 1 |
| Burke, MD; Mayer, RT; Rawlins, MD; Rettie, AE; Williams, FM | 1 |
| Chambers, J; Melville, GN; Mills, J; Pascoe, KO | 1 |
| Creedon, KA; Suttie, JW | 1 |
| Broekmans, AW; Loeliger, EA; Nienhuis, AM; Teepe, RG; Vermeer, BJ | 1 |
| Langvad, E; Pedersen, L; Rose, C | 1 |
| Pawlow, I; Pawlow, V | 1 |
| Schardein, JL | 1 |
| Conney, AH; Kappas, A | 1 |
| Hermann, G; Schwartz, IS; Slater, G | 1 |
| Cappellato, MG; Girolami, A; Ruzza, G; Vicarioto, MA | 1 |
| Lefkovits, H | 1 |
| Hirose, S; Naganuma, M; Nakajima, K; Nakayama, Y; Someya, T | 1 |
| Huyke, R; Stürzebecher, J; Vogel, G | 1 |
| Bonetti, S; Brattsten, LB; Evans, CK; Zalkow, LH | 1 |
| Harter, ML; Jung, V; Song, PS | 1 |
| Alcorn, GJ; Ritschel, GB; Ritschel, WA | 1 |
| Fuhrmann, GF; Heide, M; Legrum, W; Netter, KJ | 1 |
| Kada, T; Moriya, M; Ohta, T; Shirasu, Y; Watanabe, K | 1 |
| Colebunders, R; De Schepper, A; Schutyser, G; Verselder, R | 1 |
| Ritschel, WA | 1 |
| Lake, BG | 2 |
| April, ME; Brandt, ME; Brandt, RB; Thomson, C | 1 |
| Easton, AC; Faragher, EB; Thomson, JM | 1 |
| Hardt, T; Ritschel, WA | 1 |
| Hardt, TJ; Ritschel, WA | 4 |
| Kamataki, T; Kato, R; Maeda, K; Nagai, T; Yamazoe, Y | 1 |
| Hess, R; Laven, R | 1 |
| Numata, M | 1 |
| Abell, M; Buck, D; Davis, TS; DeMuth, RJ; Kress, D; Miller, SH | 1 |
| Gaffney, RM | 1 |
| Broekmans, AW; Mulder, CJ | 1 |
| Lake, BG; Lewis, DF | 2 |
| Bruin, P; Meeuwsen, EA; Pennings, AJ; van Andel, MV; Worst, JG | 1 |
| Albainy-Jenei, S; Benefield, C; Kervin, K; Khazaeli, MB; Marshall, ME; Umerani, A; Zhao, Q | 1 |
| Pittman, K; Selby, P | 1 |
| Lourdes Zatón, AM; Ochoa de Aspuru, E | 1 |
| Jensen, A; Schuster, C; Zygmunt, M | 1 |
| Béréziat, JC; Frei, E; Geneste, O; Lang, MA; Raffalli, F; Schmezer, P | 1 |
| Fernandez-Salguero, P; Gonzalez, FJ | 1 |
| Bracken, W; Bullock, P; Draper, A; Parkinson, A; Pearce, R; Podval, J; Thomas, P; Veltman, J | 1 |
| Bassett, ML; Dahlstrom, JE | 1 |
| Beamand, JA; Esclangon, F; Lake, BG; Price, RJ; Sauer, MJ; Walters, DG | 1 |
| Ali, JA; Maxwell, A; Orphanides, G | 1 |
| Du, J; Xu, J | 1 |
| Petrylak, D; Yagoda, A | 1 |
| Hale, WE; Marks, RG; Padgett, PD; Stewart, RB | 1 |
| Balestra, B | 1 |
| Banga, JD; Mali, WP; Rienks, R; Tetteroo, E; van Kester, JA | 1 |
| Casley-Smith, JR | 2 |
| Harris, JE | 1 |
| Florijn, RJ; Raap, AK; Slats, J; Tanke, HJ | 1 |
| LaFollette, JW; Sanders, RA; Watkins, JB | 1 |
| Driomina, ES; Gashev, SB; Reznitchenko, AV; Sharov, VS; Vladimirov, YA | 1 |
| Arvela, P; Bäckstrom, M; Pelkonen, O; Rautio, A; Sotaniemi, EA | 1 |
| Beamand, JA; Lake, BG; Price, RJ; Steensma, A; Walters, DG | 1 |
| Griffin, JP | 1 |
| Beer, JH; Rihs, F; Sturzenegger, M | 1 |
| De Kruijff, B; Keller, RC; Silvius, JR | 1 |
| Güray, T; Iscan, M; Pelkonen, O; Rautio, A; Rostami, H | 1 |
| Kostian, ML; Lehtimäki, J; Mäkelä, S; Poutanen, M; Santti, R; Vihko, R | 1 |
| Beamand, JA; Esclangon, F; Lake, BG; Price, RJ; Renwick, AB; Walters, DG; Wield, PT | 1 |
| Brenner, S; Tamir, A; Wolf, R | 1 |
| Jansson, I; Schenkman, JB; Voznesensky, AI | 1 |
| Juvonen, R; Mäenpää, J; Pelkonen, O; Raunio, H; Rautio, A | 1 |
| Hardesty, B; Kramer, G; Kudlicki, W; Odom, OW | 1 |
| Cabane, J; Hervé, R; Housset, B; Imbert, JC; Robert, A; Wattiaux, MJ | 1 |
| Bader, R; Hawkins, P; Hirsh, J; Keller, F; Mannucci, PM; Pelzer, H; Peng, M; Solleder, EM; Teijidor, LM; Tripodi, A | 1 |
| Arvela, P; Mustajoki, P; Mustajoki, S; Pelkonen, O; Rautio, A | 1 |
| Hoffmann, A; Merkel, U; Sigusch, H | 1 |
| Azizova, O; Driomina, E; Polnikov, I; Sharov, V; Vladimirov, Y | 1 |
| Bartsch, H; Kirby, GM; Lang, MA; Pelkonen, P; Wild, CP | 1 |
| Coon, MJ; Ding, X; Peng, HM | 1 |
| Baranowska-Kortylewicz, J; Berman, RM; Bump, E; Kassis, AI; Makrigiorgos, GM; Sahu, SK | 1 |
| Hughes, GR | 1 |
| Knees, U; Macdonald, E; Ohly, A; Pontz, BF; Stiegler, H | 1 |
| Grizzle, WE; Myers, RB; Parker, M | 1 |
| Kager, M; Maucher, A; von Angerer, E | 2 |
| Böhmig, GA; Menzel, JE; Nöhammer, C; Zlabinger, GJ | 1 |
| Kahn, J; Preis, P; Tseng, A; Waldman, F | 1 |
| Deasy, B; Dempsey, E; Egan, DA; O'Kennedy, R; Smyth, MR | 1 |
| Hakkola, J; Mäenpää, J; Pelkonen, O; Raunio, H; Rautio, A | 1 |
| Breslin, B; Browne, H; Browne, HY; Corrigan, T; Daly, L; Daly, P; Edwards, G; Gaffney, E; Lynch, G; Thornes, RD | 1 |
| Marshall, ME; Mohler, JL; Thompson, IM; Williams, BT | 1 |
| Bueschen, A; Butler, K; Edmonds, K; Markiewicz, M; Marshall, ME; Mohler, JL; Ryles, M; Urban, D; Weiss, L; Williams, B | 1 |
| Foukaraki, E; Haugland, RP; Iatridou, H; Katerinopoulos, HE; Kuhn, MA; Marcus, EM | 1 |
| Belloc, F; Bourson, J; Boutorine, AS; Bulychev, NV; Garestier, T; Koshkin, AA; Lebedev, AV; Mergny, JL; Rougée, M; Valeur, B | 1 |
| Landmann, C | 1 |
| Fernyhough, L; Fry, JR; Hammond, AH; Kell, SW; Thomas, NW | 1 |
| Marques, AD; Marques, GS | 1 |
| del Rio, L; Lafoz, E; Monreal, M; Olive, A; Vedia, C | 1 |
| Heston, WD; Huryk, R; Perez, G; Russo, P; Warner, JA | 1 |
| Houston, P; Kodadek, T | 1 |
| Evans, JG; Lake, BG; Lewis, DF; Price, RJ | 1 |
| Maucher, A; von Angerer, E | 1 |
| Schulze, H; Sommerfeld, HJ | 1 |
| Fitos, I; Simoncsits, A; Visy, J | 1 |
| Casley-Smith, JR; Wang, CT; Zi-hai, C | 1 |
| Casley-Smith, J; Casley-Smith, JR; Jamal, S | 1 |
| Evans, JG; Lake, BG | 1 |
| Choisy, H; Fay, R; Lamiable, D; Millart, H; Trenque, T; Vistelle, R | 1 |
| Casley-Smith, JR; Morgan, RG; Piller, NB | 1 |
| Iwasaki, M; Juvonen, RO; Lindberg, RL; Negishi, M | 1 |
| Bauer, KA; Birkner, B; Linnau, Y; Rosenberg, RD; Schramm, W; Schwarz, HP; Spannagl, M | 1 |
| Bauer, KA | 2 |
| Debruyne, FM; Doesburg, W; vd Meijden, AP; Witjes, JA | 1 |
| Ao, X; Lehrer, SS | 1 |
| Alhava, E; Gynther, J; Järvinen, T; Juvonen, RO; Kinonen, T; Pasanen, M; Poso, A | 1 |
| Cunningham, MT; Olson, JD | 1 |
| Desnos, M; Lecuru, F; Taurelle, R | 1 |
| Boda, Z; Pósán, E; Rigó, J; Shahak, A; Szücs, G | 1 |
| Boman, K; Jansson, JH; Nilsson, T; Norberg, B; Westman, G | 1 |
| Einhäupl, KM; Masuhr, F | 1 |
| Aznar, J; Casaña, P; Curats, R; Fernández, MA; Jorquera, JI; Montoro, JM | 1 |
| Courtellemont, P; Krasteva, M; Moulon, C; Peguet-Navarro, J; Redziniak, G; Schmitt, D | 2 |
| Legrum, W; Runkel, M; Tegtmeier, M | 1 |
| Mykkänen, H; Pasanen, M; Pelkonen, O; Rauma, AL; Rautio, A; Törrönen, R | 1 |
| Flamm, J; Ludwig, H; Micksche, M; Sagaster, P | 1 |
| Fry, JR; Jack, KR; Kho, K; Thomas, NW | 1 |
| Chiang, CH; Chiou, GC; Liu, SX; Yao, QS | 1 |
| Balestrieri, C; Camussi, G; Giovane, A; Iorio, EL; Quagliuolo, L; Servillo, L | 1 |
| Ardekian, L; Blinder, D; Martinowitz, U; Peleg, M; Taicher, S | 1 |
| Aubrun, JC; Carlton, BD; Simon, GS | 1 |
| Mischke, R | 1 |
| El-Hayek, R; Ikemoto, N | 1 |
| Fahrig, R; Steinkamp-Zucht, A | 1 |
| Binkley, SN; Ring, BJ; VandenBranden, M; Wrighton, SA | 1 |
| Ding, X; Gonzalez, FJ; Liu, C; Zhuo, X | 1 |
| Bogan, DP; Killard, AJ; O'Kennedy, R | 1 |
| Johansen, JD; Menné, T; Rastogi, SC | 1 |
| Heyn, H; Stevens, JC; White, RB | 1 |
| Kharasch, ED; Spracklin, DK; Thummel, KE | 1 |
| Kapetanovic, IM; Kupferberg, HJ; McNeilly, PJ; Strong, JM; Torchin, CD | 1 |
| Chang, TS; Fu, KD; Gan, JL; Huang, WY | 1 |
| Cottrell, S; Lake, BG; Oliver, K; Powell, CJ | 1 |
| Grasso, P; Lake, BG | 1 |
| Igloi, GL | 1 |
| Bogan, DP; O'Kennedy, R | 1 |
| Biour, M; Gersberg, M; Guédès, Y; Lamiable, D; Leutenegger, E; Ratanasavanh, D; Riché, C | 1 |
| Cataldi, A; Cerreta, G; Derwish, A; Donini, I; Occhionorelli, S; Schettino, A; Vettorello, G | 1 |
| Beamand, JA; Lake, BG; Mistry, H; Price, RJ; Renwick, AB; Wield, PT | 1 |
| Bisht, KS; Biswas, G; Gupta, S; Jain, SC; Jha, A; Parmar, VS; Raj, HG; Sharma, SK; Singh, A; Singh, S | 1 |
| Chiou, GC; Kapingu, MC; Liu, SX; Wang, MS | 1 |
| Ghosh, P; Markin, RS; Sorrell, MF | 1 |
| Haas, N; Henz, BM; Hermes, B | 1 |
| Dick, B; Jacobi, FK | 1 |
| Brockmeier, J; Eichinger, S; Eichler, HG; Kyrle, PA; Lechner, K; Speiser, W; Weltermann, A | 1 |
| Draper, AJ; Madan, A; Parkinson, A | 1 |
| Breeze, AL; Ladbury, JE; O'Brien, R; Pauptit, RA; Poyser, JP; Singh, OM; Skarzynski, T; Tsai, FT; Tucker, A; Weston, S; Wigley, DB; Wonacott, AJ | 1 |
| Fondevila, CG; Frontroth, J; Lazzari, MA; Meschengieser, SS; Santarelli, MT | 1 |
| Becker, MC; Beurton, I; Bresson-Hadni, S; Carbillet, JP; Hrusovsky, S; Koch, S; Miguet, JP; Monnot, B; Vanlemmens, C | 1 |
| Boda, Z; Bódi, A; Csapó, K; Hegedús, I; Medgyesi, F; Pfliegler, G; Voith, L | 1 |
| Guengerich, FP; Shimada, T; Yamazaki, H | 1 |
| Bogan, DP; Deasy, B; O'Kennedy, R; Smyth, MR | 1 |
| Jarema, MA; Lee, JS; Street, JC | 1 |
| de la Campa, AG; Fenoll, A; García, E; Muñoz, R | 1 |
| Patten, CJ; Smith, T; Tan, Y; Yang, CS | 1 |
| Inoue, K; Mimura, M; Nakamura, S; Oda, H; Ohmori, S; Shimada, T; Yamazaki, H | 1 |
| van den Besselaar, AM | 1 |
| Beckley-Kartey, SA; Capel, M; Hotchkiss, SA | 1 |
| Lindsey, EM | 1 |
| Darroudi, F; Knasmüller, S; Nagao, M; Parzefall, W; Sanyal, R | 1 |
| Beaune, P; Brazier, JL; Buronfosse, T; Désage, M; Guitton, J; Lepape, A | 1 |
| Anderson, LM; Jones, AB; Liao, AM; Liu, Y; Smith, TJ; Yang, CS | 1 |
| Friesen, MJ; Murphy, SE; Patten, CJ; Smith, TJ; Tynes, RE; Yang, CS | 1 |
| Kugler, J; Loprinzi, CL; Sloan, J | 1 |
| Ding, X; Gu, J; Lipinskas, TW; Walker, DM; Walker, VE | 1 |
| Pasanen, M; Pelkonen, O; Rannala, Z; Rautio, A; Sotaniemi, EA; Tooming, A | 1 |
| Jörger, U; Ludwig, MM; Stumpe, KO; Vahlensieck, M | 1 |
| Jones, BC; Smith, DA; Tyman, CA | 1 |
| Koenigs, LL; Peter, RM; Rettie, AE; Thompson, SJ; Trager, WF | 1 |
| Cholerton, S; Hadidi, H; Idle, JR; Zahlsen, K | 1 |
| Bondoc, FY; Hong, JY; Huang, WQ; Lee, M; Wang, YY; Yang, CS | 1 |
| Fournier, B; Hooper, DC | 2 |
| Inoue, K; Kamataki, T; Kodama, T; Nagashima, K; Nakamura, K; Shimada, N; Shimizu, T; Yokoi, T | 1 |
| Haan, J; Kamphuisen, PW; Rosekrans, PC; Van Der Meer, FJ | 1 |
| Bourian, M; Legrum, W; Runkel, M; Tegtmeier, M | 1 |
| Ebert, RF; Echaves, SA; Gottfried, EL; Ng, VL; Stead, AG; Valdes-Camin, R | 1 |
| Gustafsson, J; Hellmold, H; Magnusson, M; Pelto-Huikko, M; Rylander, T; Warner, M | 1 |
| Beutler, JJ; van de Ven, PJ | 1 |
| Bantle, JA; Fort, DJ; Hull, MA; Propst, T; Stover, EL | 1 |
| Fuhr, U | 1 |
| Brezniak, DV; Fenton, JW; Hassouna, HI; Ofosu, FA | 1 |
| Siegers, CP; Steffen, B; Weber, US | 1 |
| Aymard, G; Comets, E; Diquet, B; Legrand, M; Mentré, F | 1 |
| Lü, HQ; Niggemann, B; Schmitz, U; Zänker, KS | 1 |
| Schipper, JP | 1 |
| Arora, A; Nair, MG; Strasburg, GM | 1 |
| Baloğlu, H; Başak, M; Doğan, B; Harmanyeri, Y; Taşkapan, O | 1 |
| Desel, H; Gundert-Remy, U; Kahl, GF; Kahl, R; Meineke, I | 1 |
| Maxwell, A; Smith, CV | 1 |
| Chang, NC; Chang, YL; Chen, YL; Teng, CM; Tzeng, CC; Wang, TC | 1 |
| Dedieu, F; Duverger, JP; Laemmel, E; Leutenegger, E; Pons, C; Stücker, O | 1 |
| Funae, Y; Funayama, M; Green, C; Inoue, K; Kamataki, T; Kimura, K; Kinoshita, M; Kodama, T; Nagashima, K; Nunoya, K; Yokoi, T | 1 |
| Demedts, M; Van Haecke, P; Vansteenkiste, J | 1 |
| Baxter, PJ; Hankins, DC; Kharasch, ED; Thummel, KE | 1 |
| Ding, X; Gu, J; He, W; Lipinskas, TW; Su, T | 1 |
| Born, SL; Caudill, D; Fix, AS; Lehman-McKeeman, LD | 2 |
| Anderson, KE; Goeger, DE; Hsie, AW | 2 |
| Boets, EP; Breedveld, FC; Chaar, CG; Keunen, JE; Ronday, K | 1 |
| Brunsvik, A; Cholerton, S; Hadidi, H; Idle, JR; Irshaid, Y; Vågbø, CB; Zahlsen, K | 1 |
| Duffy, CF; O'Kennedy, R | 1 |
| Gonsorcík, J; Jonás, P; Jurgová, T; Kristian, P; Kucinský, R; Lazúr, J; Tokarcíková, A; Tomasch, J | 1 |
| Agnelli, G; Hull, RD; Hyers, TM; Morris, TA; Samama, M; Tapson, V; Weg, JG | 1 |
| Ito, A; Kitada, S; Kojima, K; Ogishima, T; Shimokata, K | 1 |
| Bruynzeel, DP; Kunkeler, AC; Weijland, JW | 1 |
| Kugler, JW; Levitt, R; Loprinzi, CL; Michalak, JC; Mowat, RB; Novotny, P; Quella, SK; Rooke, TW; Sloan, JA; Stella, PJ; Tschetter, LK; Windschitl, H | 1 |
| Ganz, PA | 1 |
| Adamczyk, M; Fishpaugh, JR; Mattingly, PG | 1 |
| Shimada, T; Tanaka, M; Yamazaki, H | 1 |
| Witte, CL | 1 |
| Alcaide, A; Alcoba, C; Azcona, JM; Burgos, A; Garrido, J; Lorente, C; Moreno, E; Murillo, E; Olsina-Kissler, J; Olsina-Pavia, J; Samaniego, E; Serra, M | 1 |
| Andersen, KE; Bruze, M; Frosch, PJ; Giménez Arnau, E; Johansen, JD; Lepoittevin, JP; Menné, T; Mutterer, V; Rastogi, SC; White, IR | 1 |
| Shimada, T; Yamazaki, H | 1 |
| Gopalakrishnan, R; Lu, J; Morse, MA; Murphy, SE; Sabourin, CL; Stoner, GD; Weghorst, CM | 1 |
| Gelboin, HV; Gonzalez, FJ; Krausz, KW; Sai, Y; Yang, TJ | 1 |
| Lake, BG; Lovell, DP; Price, RJ; van Iersel, M; Walters, DG | 1 |
| Ghali, JK | 1 |
| Mack, P; Yang, EB; Zhang, K; Zhao, YN | 1 |
| Liao, Y; Wang, B | 1 |
| Dickins, M; Eddershaw, PJ; Goldfarb, PS; Lake, BG; Lewis, DF; Tarbit, MH | 1 |
| Beeg, T; Hattenbach, LO; Kreuz, W; Zubcov, A | 1 |
| Barja-Fidalgo, C; da Silva, AC; de Moura, RS; Fierro, IM; Lopes, Cda S | 1 |
| Agundez, I; Arreba, E; Carrera, S; Castrodeza, J; Fernandez, L; Gonzalez-Fajardo, JA; Gutiérrez, V; Mateo, AM; Perez, JL; Vaquero, C | 1 |
| Bourian, M; Freudenstein, J; Krisp, A; Legrum, W; Runkel, M; Tegtmeier, M | 1 |
| Chen, KC; Chen, SH; Lien, HM | 1 |
| Bartsch, H; Hergenhahn, M; Weninger, A; Yang, Q | 1 |
| Muller, S; Rocca, S; Stébé, MJ | 1 |
| al-Nawas, B; Belz, GG; Bockisch, A; Grötz, KA; Henneicke-von Zepelin, HH; Kohnen, R; Kutzner, J; Naser-Hijazi, B; Wagner, W; Wüstenberg, P | 1 |
| Grobbee, DE; Kardinaal, AF; Kruijssen, DA; Princen, HM; van de Vijver, LP; van Duyvenvoorde, W; van Poppel, G | 1 |
| Hellemons, BS; Knottnerus, JA; Langenberg, M; Lemmens, T; Lodder, J; Schouten, HJ; van Ree, JW; Vermeer, F | 1 |
| Alder, S | 1 |
| Aben, KK; de Man, RA; Penning-van Beest, FJ; Stricker, BH; van Meegen, E; Wilson, JH | 1 |
| Soucek, P | 1 |
| Aillaud, MF; Denson, KW; Droullé, C; Houbouyan-Reveillard, LL; Johnston, M; Kitchen, S; Lindahl, TL; Marren, M; Martinuzzo, ME; Tripodi, A; van den Besselaar, AM; Vergnes, C | 1 |
| Hankins, DC; Kharasch, ED; Taraday, JK | 1 |
| Hardesty, B; Kramer, G; Ramachandiran, V; Willms, C | 1 |
| Bharathi, S; Mishra, AK | 1 |
| Inoue, K; Shimada, T; Yamazaki, H | 1 |
| Clement, DL | 1 |
| O'Rourke, ME | 1 |
| Bleich, S; Degner, D; Kropp, S; Rüther, E; Scheschonka, A | 1 |
| Eggers, CH; Kimmel, BJ; Knight, SW; Samuels, DS | 1 |
| Jiwajinda, S; Ohigashi, H; Santisopasri, V | 1 |
| Burt, ET; Essmann, M; Larsen, B; Zhang, X | 1 |
| Bezerra, GA; Ferreira, AA; Leal, LK; Matos, FJ; Viana, GS | 1 |
| James, PR | 1 |
| Stiefelhagen, P | 1 |
| Karaivanova, M; Konstantinov, S; Kostova, I; Manolov, I; Netzeva, T | 1 |
| Franke, A | 1 |
| Forberg, E; Jimenez-Boj, E; Krinninger, B; Svolba, G; Watzke, HH | 1 |
| Clark, SL; Porter, TF; West, FG | 1 |
| Bishara, J; Blance, SJ; Maxwell, A; Preston, ZA; Smyth, MS; Williams, NL | 1 |
| Campiglia, AD; Mallik, S; Peterson, R; Roy, BC | 1 |
| Dive, G; Doucet, C; Masereel, B; Pirotte, B; Pochet, L; Reboud-Ravaux, M; Wouters, J | 1 |
| Keating, GJ; Killard, AJ; O'Kennedy, R | 1 |
| Concannon, S; Ramachandran, VN; Smyth, WF | 1 |
| Bailey, SR; Baim, DS; Cleman, MW; Deutsch, E; Diver, DJ; Fitzgerald, PJ; Hayase, M; Kuntz, RE; Leon, MB; Metz, JA; Moses, JW; Oesterle, SN; Oshima, A; Overlie, PA; Pepine, CJ; Safian, RD; Shani, J; Simonton, CA; Smalling, RW; Teirstein, PS; Yeung, AC; Yock, PG; Zidar, JP | 1 |
| Airault, M; Benedetti, Y; Bonnefoy, A; Chatreaux, F; Demassey, J; Dupuis-Hamelin, C; Ferroud, D; Haesslein, JL; Iltis, A; Khider, J; Klich, M; Lachaud, S; Lassaigne, P; Laurin, P; Musicki, B; Periers, AM; Pierre, C; Tessot, N; Vicat, P | 1 |
| Ball, HW; Manson, MM; McLellan, LI; Shepherd, AG | 1 |
| Born, SL; Caudill, D; Lehman-McKeeman, LD; Smith, BJ | 1 |
| Lisgarten, J; Mberu, EK; Mwangi, JW; Oketch-Rabah, HA | 1 |
| Gjerstad, E; Gosink, L; Janc, JW; Kar, H; Loftus, SM; Sheppeck, JE; Wheatley, JB; Zubiria, AR | 1 |
| Brechmann, J; Unterberg, C | 1 |
| Charitos, C; Kokotos, G; Tzougraki, C | 1 |
| Anderson, DR; Ansell, J; Bussey, H; Dalen, J; Deykin, D; Hirsh, J; Poller, L | 1 |
| Hamulyák, K; Lindhout, T; Nijziel, M; van 't Veer, C; van Oerle, R; van Pampus, E | 1 |
| Juvonen, R; Pelkonen, O; Taavitsainen, P | 1 |
| Barratt, MD; Castell, JV; Langowski, JJ; Miranda, MA | 1 |
| Cloak, CC; Lin, KM; Nuccio, I; Pechnick, RN; Poland, RE; Wan, YJ | 1 |
| Heilmann, J; Quadri-Spinelli, T; Rali, T; Sticher, O | 1 |
| El-Bindary, AA | 1 |
| Alhaique, F; Cabral, LM; dos Santos, TC | 1 |
| Api, AM; Ford, RA; Hawkins, DR; Mayo, BC | 1 |
| Bharat, V; Mohanty, B | 1 |
| Higuchi, T; Kikuchi, K; Nagano, T; Takakusa, H; Urano, Y | 1 |
| Abilov, ZA; Ahmad, VU; Burasheva, GS; Miftakhova, AF; Zahid, M | 1 |
| Bestmann, L; Bühler, D; Maly, FE; Oldenburg, J; Züger, M | 1 |
| Chen, H; Walsh, CT | 1 |
| Bertina, RM; Sturk, A; van Dam, W; van den Besselaar, AM | 1 |
| Bu, HZ; Knuth, K; Magis, L; Teitelbaum, P | 1 |
| Carmella, SG; Hecht, SS; Johnson, LM; Losey, LM; Murphy, SE | 1 |
| Cai, H; Guengerich, FP; Hanna, IH; Nakamura, K; Nishimura, Y; Williams, KM | 1 |
| Finch, RA; Fort, DJ; Rogers, RL; Stover, EL | 1 |
| Kaniwa, N; Murayama, N; Nakajima, Y; Ohno, Y; Ozawa, S; Sai, K; Sawada , J | 1 |
| Bonnefoy, A; Chatreaux, F; Ferreira, A; Klich, M; Loyau, V; Mauvais, P; Murer, M; Schio, L | 1 |
| Aygün Kocabaş, N; Cholerton, S; Cok, I; Karakaya, AE; Sardaş, S | 1 |
| Lacey, M; Nejaty, H; Whitehead, SA | 1 |
| Karaivanova, M; Kostova, I; Manolov, I | 1 |
| Antoch, G; Hansen, O; Pourhassan, S; Stock, W | 1 |
| Api, AM | 1 |
| Fraedrich, G; Klein-Weigel, P | 1 |
| Karaivanova, M; Konstantinov, S; Kostova, I; Manolov, I; Nicolova, I | 1 |
| de Zeeuw, RA; Ensing, K; Janssen, MJ | 1 |
| Anziano, DJ; Carter, JD; Hill, KW; Husar, GM; Kropp, E; Leuck, M; McGee, DP; Pieken, W; Sebesta, DP; Taunton-Rigby, J; Vagle, K | 1 |
| Herman, P; Lakowicz, JR; Lin, HJ; Maliwal, BP | 1 |
| Corrie, JE; Webb, MR | 1 |
| Himmelreich, G; Loew, A; Riess, H | 1 |
| Izaguirre, R; Salazar, E | 1 |
| Dayanandan, P; Kaufman, PB | 1 |
| Buurma, H; Egberts, AC; Leufkens, HG; Rahimtoola, H; Tijssen, CC | 1 |
| Murphy, SE; von Weymarn, LB | 2 |
| Hu, Y; Ling, H; Peng, F | 1 |
| Guengerich, FP; Martin, MV; Nakamura, K | 1 |
| Elizalde-Galvan, P; García-Mondragón, MJ; Jiménez-Orozco, FA; León-Cedeño, F; López-González, JS; Mandoki, JJ; Mendoza-Patiño, N; Molina-Guarneros, JA; Nieto-Rodriguez, A; Velasco-Velázquez, MA | 1 |
| Kikut-Ligaj, D; Radecka, H; Radecki, J; Szymańska, I | 1 |
| Ikemoto, N; Yamamoto, T | 1 |
| Ikemoto, N; Rodriguez, J; Yamamoto, T | 1 |
| Bayerl, C; Harenberg, J; Hoffmann, U; Huhle, G; Winkler, M | 1 |
| Davey, MH; Fréchet, JM; Svec, F; Yu, C | 1 |
| Deligeorgiev, TG; Foukaraki, E; Katerinopoulos, HE; Liepouri, F | 1 |
| Apiyasawat, S; Jacobs, LE; Kotler, MN; Wongpraparut, N | 1 |
| Domenici, E; Gevi, M | 1 |
| Coulter, KR; Doseff, A; Knoell, DL; Marsh, CB; Sweeney, P; Wang, Y; Wewers, MD | 1 |
| Ikenaga, T; Kitamura, Y; Ohta, M; Watanabe, M | 1 |
| Fujita, K; Kamataki, T; Nakayama, K; Nohmi, T; Tsuruma, K; Yamada, M; Yamazaki, Y | 1 |
| Ickx, BE | 1 |
| Chauhan, N; Clerici, M; Jespersen, J; Keown, M; Meeuwisse-Braun, J; Poller, L; Tripodi, A; van den Besselaar, AM | 1 |
| Blinder, D; Manor, Y; Martinowitz, U; Taicher, S | 1 |
| Choudhary, MI; Khalid, A; Sultani, SZ | 1 |
| Bae, K; Huong, DT; Jo, YS; Kim, YH; Lee, MK | 1 |
| Adcock, DM; Johnston, M | 1 |
| Hoermann, L; Jeltsch, JM; Lamour, V; Moras, D; Oudet, P | 1 |
| Graatsma, HH; Stricker, BH; Visser, LE | 1 |
| Chilvers, KF; James, AL; Perry, JD; Reed, RH | 1 |
| Houbouyan-Réveillard, LL; van den Besselaar, AM | 1 |
| Altorjay, I; Palatka, K; Tornai, I; Udvardy, M | 1 |
| Keener, WK; Miller, AR; Roberto, FF; Watwood, ME | 1 |
| Afri, M; Frimer, AA; Gottlieb, HE | 1 |
| Chiba, K; Kobayashi, K; Shimada, N; Urashima, K | 1 |
| Araki, S; Citterio, D; Hisamoto, D; Ikeda, T; Kitamura, Y; Komatsu, H; Kubota, T; Nakagawa, J; Oka, K; Saito, N; Suzuki, K; Suzuki, Y | 1 |
| Born, SL; Caudill, D; Fliter, KL; Purdon, MP | 1 |
| Baumann, G; Mendler, G; Stiegler, H | 1 |
| Matsuda, T; Mizutani, M | 1 |
| Everett, SA; Moody, CJ; Naylor, MA; Newman, RG; Patel, KB; Stratford, MR; Swann, E; Tian, N; Vojnovic, B; Wardman, P | 1 |
| Hazem, A; Zaha, AA | 1 |
| Ariyoshi, N; Daigo, S; Fujieda, M; Ikeda, K; Kamataki, T; Koizumi, W; Nagayama, S; Nishioka, Y; Saigenji, K; Takahashi, Y; Tanabe, S; Yamazaki, H | 1 |
| Budzinsky, B; Cooper, WE; Pérez-Mellado, V; Vitt, LJ | 1 |
| Beckurts, KT; Brachtendorf, L; Fuhr, U; Hölscher, AH; Jetter, A | 1 |
| Kovac, B; Novak, I | 1 |
| Deligeorgiev, TG; Katerinopoulos, HE; Liepouri, F; Savakis, C; Veneti, Z | 1 |
| Buia, R; Pârvu, AE; Pârvu, M; Pleşca-Manea, L; Puia, M; Taămaş, M | 1 |
| Borchardt, RT; Tang, F | 1 |
| Borchardt, RT; Ouyang, H; Siahaan, TJ; Tang, F | 1 |
| Al-Delaime, T; Al-Lawati, AA; Valliathu, J; Venkitraman, M | 1 |
| Boursier, V | 1 |
| Aengevaeren, WR; Brouwer, MA; Hertzberger, DP; Luijten, HE; Uijen, GJ; van Boven, AJ; van den Bergh, PJ; Veen, G; Verheugt, FW; Vromans, RP | 1 |
| Carlton, PS; Gopalakrishnan, R; Gupta, A; Morse, MA; Stoner, GD | 1 |
| Escobar, MA | 1 |
| Han, XM; Huang, SL; Xu, P; Zhou, HH; Zhu, RH | 1 |
| Asp, V; Bernal Ruiz, ML; Ingelman-Sundberg, M; Ledesma, M; McLellan, RA; Oscarson, M; Rautio, A; Sinues, B | 1 |
| Kisiel, W; Michalska, K | 1 |
| Jun, JY; Kang, KH; Kim, YC; Ko, EK; Lee, HS; Oh, H; Oh, MH; Park, SU | 1 |
| Al-Shaboury, S; Al-Tamrah, AS; Belal, F | 1 |
| Carré, MC; Chaubet, F; Even, P; Letourneur, D; Viriot, ML | 1 |
| Api, AM; Born, SL; Ford, RA; Hawkins, DR; Lefever, FR | 1 |
| Ashley, DL; Brown, CR; Calafat, AM; Chiang, JM; Polzin, GM; Stanfill, SB; Watson, CH | 1 |
| Anzellotti, D; Huner, NP; Ibrahim, RK; NDong, C; Sarhan, F | 1 |
| Knijff-Dutmer, EA; Schut, GA; van de Laar, MA | 1 |
| Hak, E; Hoes, AW; Rutten, FH; Stalman, WA; Verheij, TJ | 1 |
| Alabouvette, C; Cachinero-Díaz, JM; Jiménez-Díaz, RM; Landa, BB; Lemanceau, P | 1 |
| Chauhan, N; Jespersen, J; Keown, M; Poller, L; Shiach, C; Tripodi, A; van den Besselaar, AM | 2 |
| Craighead, HG; Foquet, M; Korlach, J; Levene, MJ; Turner, SW; Webb, WW | 1 |
| Bais, HP; Ravishankar, GA; Sudha, G; Suresh, B | 1 |
| Chang, FR; Chen, CY; Khalil, AT; Lee, YH; Liaw, CC; Ramesh, P; Wu, YC; Yuan, SS | 1 |
| Hull, RD; Pineo, G | 1 |
| Rüfer, A; Wuillemin, WA | 1 |
| Mohr, A; Steiner, T; Weber, MA | 1 |
| Lee, KH; Morris-Natschke, SL; Suzuki, M; Xie, L; Yu, D | 1 |
| Ghoshal, SK; Mohan, D; Rastogi, RC; Saharo, PD; Sharma, N; Sharma, VK | 1 |
| Gage, BF; Yusen, RD | 1 |
| de Miranda, JA; Guilardi, S; Machado, AE; Nicodem, DE; Severino, D | 1 |
| Burian, M; Freudenstein, J; Henneicke-von Zepelin, HH; Legrum, W; Naser-Hijazi, B; Tegtmeier, M | 1 |
| Chander, SK; Ireson, CR; Parish, D; Potter, BV; Purohit, A; Reed, MJ; Woo, LW | 1 |
| Chander, SK; Leese, MP; Potter, BV; Purohit, A; Raobaikady, B; Reed, MJ; Woo, LW | 1 |
| Chen, LX; Jiao, CX; Niu, CG; Shen, GL; Yu, RQ | 1 |
| Abenavoli, MR; Badiani, M; Fuggi, A; Sidari, M; Sorgonà, A | 1 |
| Hadjipavlou-Litina, D; Kontogiorgis, C | 1 |
| Becker, EW; Henneicke-von Zepelin, HH; Naser-Hijazi, B; Schmeck-Lindenau, HJ; Schnitker, J | 1 |
| Lunte, CE; O'Kennedy, R; Smyth, MR; Ward, EM | 1 |
| Agbaria, RA; Billiot, FH; Chatman, T; Morris, K; Tarus, J; Warner, IM; Williams, AA | 1 |
| Abbate, R; Antonucci, E; Gensini, GF; Poli, D; Prisco, D | 1 |
| Berthou, F; Dréano, Y; Le Gal, A; Lucas, D | 1 |
| Cashman, JR; Fandrick, K; MacDougall, JM; Serafin, SV; Zhang, X | 1 |
| Curry, SM; Daston, GP; Fliter, KL; Lehman-McKeeman, LD; Morrall, SW; Vassallo, JD | 1 |
| Baudry, J; Berenbaum, MR; Li, W; Pan, L; Schuler, MA | 1 |
| COVERT, DF | 1 |
| TOOHEY, M | 3 |
| BECK, DF; SCARRONE, LA; WRIGHT, IS | 1 |
| LACHARME, J; MENTZER, C; NETIEN, G; VERCIER, P | 1 |
| DE NICOLA, P | 5 |
| PAMPURIK, E | 1 |
| VERHAGEN, H; WIERSEMA, MU | 2 |
| KLOSA, J | 14 |
| GRUBER, CM; LEE, KS; RIEDERS, F | 1 |
| HYDEN, M; KUBIK, MM; WRIGHT, HP | 1 |
| LOSSE, H | 1 |
| COLLI, A; CORONA, GL | 2 |
| MEYER, OO; ROTTER, R | 3 |
| BEAUMONT, JL; CHEVALIER, H; COBLENTZ, B; LENEGRE, J; MAURICE, P | 2 |
| BEAUMONT, JL; LENEGRE, J; MAURICE, P; ROGOWSKY, M | 1 |
| RICHIER, JL; RICHIER-CHEVREL, ME | 1 |
| SCHLACHMAN, M | 1 |
| DE VETTEN, AL | 2 |
| VAN BUSKIRK, WC | 1 |
| VUILLEUMIER, P | 2 |
| SOULIER, JP; SOULLARD, J | 1 |
| POPOVIC, B | 1 |
| DOERNER, AA; RUSSEK, AS; RUSSEK, HI; WHITE, LG; ZOHMAN, BL | 2 |
| LINDEMAYR, W | 1 |
| ZILLIACUS, H | 1 |
| VON BRUCHHAUSEN, F | 1 |
| VERSTRAETE, M | 1 |
| BJERKELUND, CJ | 1 |
| BRUCKNEROVA, O | 1 |
| KOLLER, F | 1 |
| COLLI, A | 1 |
| OWENS, FM | 1 |
| DUYZINGS, AJ | 1 |
| KOLLAR, K | 1 |
| FLUCKIGER, P; KOLLER, F; LOELIGER, A | 1 |
| SHICK, RM | 1 |
| BOLT, RJ | 1 |
| BRODIE, BB; BURNS, JJ; SIMSON, G; WEINER, M; YALE, EK | 1 |
| GATE, J; GERMAIN, D; VAYRE, J | 1 |
| IZAR, G | 1 |
| HELLEM, AJ | 1 |
| CATALDI, R; OPPEZZI, CA | 1 |
| MCGREEVY, EJ; MCGREEVY, JV | 1 |
| SCHWAN, W | 1 |
| THYGESEN, P | 1 |
| HAGER, H; MATIS, P | 1 |
| SWAIN, T | 1 |
| SAPEIKA, N | 1 |
| HAYDEN, M; KUBIK, MM; WRIGHT, HP | 1 |
| PROCHAZKA, Z | 2 |
| BANNON, WG; BARKER, NW; OWEN, CA | 1 |
| LAKSHINA, LK; ZILOVA, AN | 1 |
| HUNTER, RB; TUDHOPE, GR | 1 |
| BLANC, MR; BOREL-MILHET, MF; CROIZAT, P; FAVRE-GILLY, MJ; FROMENT, R; ITHIER, S | 1 |
| MEITUS, ML; WASSERMAN, P | 1 |
| BUTTO, M; FRANCESCON, M | 1 |
| GOINARD, P; PEGULLO, J | 1 |
| HALSE, T | 1 |
| CRAMER, P | 1 |
| SCHWENZER, AW | 2 |
| DELLA SANTA, R | 1 |
| POLLITZER, RS | 1 |
| MAYALL, R | 2 |
| WEINER, M | 2 |
| DEL NUNZIO, RF; RICHTER, IH; SWILLER, SL | 1 |
| DALGAARD, OZ | 2 |
| POSTHUMA, AE | 1 |
| DENTON, CR; FITZPATRICK, TB; LERNER, AB | 1 |
| BRODIE, BB; BURNS, JJ; SIMSON, G; WEINER, M | 1 |
| SWEDBERG, B | 1 |
| IZARN, P | 2 |
| KONIG, FE | 1 |
| TAGER, M | 1 |
| BRODIE, BB; BURNS, JJ; SIMSON, G; STEELE, JM; WEINER, M | 1 |
| BOYER, FR; FUNK, EH; KELLER, EA; VANDER VEER, JB | 1 |
| LESPAGNOL, C; MERCIER, J; SESTIER, MR | 1 |
| SILIATO, F | 1 |
| CHUBATY, W; JACQUES, LB; LEPP, E | 1 |
| DIENSTBIER, Z; HERMANSKY, F; PUDLAK, P | 1 |
| MAIER, HC; OTT, RH; ROSE, OA | 1 |
| BROUSTET, P | 1 |
| SCHIAVINA, GP | 3 |
| RAPP, WF | 1 |
| BERMAN, L; EGAN, R; MILCH, E | 1 |
| SHAPIRO, S | 4 |
| MENTZER, C; MEUNIER, P; MORAUX, J | 2 |
| CHRIST, M; KELLER, M | 1 |
| ABRAMOV, AL; KALLNER, G | 1 |
| HAGAN, EC; RADOMSKI, JL | 1 |
| WESSLER, S | 1 |
| GYENEI, M; KOVACS, E | 1 |
| CONWAY, H; JOSLIN, D; STARK, RB | 1 |
| PREZIOSI, P | 1 |
| STEPHAN, E | 1 |
| JURGENS, R | 2 |
| JAKOB, H; KOLLER, F | 1 |
| BONNET, DD; GROSS, B | 1 |
| LUND, E | 3 |
| HAMMERL, H; HOLLER, G; WEINMANN, O; ZEMANN, J | 1 |
| BORGSTROM, S | 1 |
| DAM, H; SØNDERGAARD, E | 1 |
| WICKE, G | 2 |
| AVELLANEDA, M; CASTRO, CM; STRITZLER, G | 2 |
| KNAKE, HJ; VILMAR, E | 1 |
| VAN KALMTHOUT, JM | 2 |
| COSGRIFF, SW | 1 |
| FERSTL, A; LACHNIT, V | 1 |
| ALTMANN, O; HORN, Z; KOVACS, E | 1 |
| SCHELLENBERG, W | 1 |
| FERRER, J; GARCIA TURIELLA, R; GASPARY, FV; TUERO, PR | 1 |
| BARKER, NW; GIFFORD, RW; MANN, FD; WOLFF, JM | 1 |
| COOGAN, TJ; DAVIS, JA; PETERSEN, ES | 1 |
| MULLERTZ, S | 1 |
| RAEVSKAIA, GA | 1 |
| AFANAS'EVA, LM | 1 |
| BAL, AK; SHARMA, AK | 1 |
| BAYER, I; PARTILLA, H | 1 |
| IGLAUER, A; MENDELSOHN, SN | 1 |
| MATIS, P | 2 |
| FABRE, R | 1 |
| HARTERT, H; HARTERT, I | 1 |
| KOPP, A; KRANZ, H | 1 |
| CELICE, J; JEANSON, F; PLAS, F | 1 |
| LACHAINE, G | 1 |
| ALAGILLE, D | 1 |
| GAGLIO, M; MAZZONE, O | 1 |
| GAGLIO, M; LOMBARDO, G | 1 |
| GAGLIO, M; LOMBARDO, G; MAZZONE, O | 1 |
| LASCH, HG; LINKE, A | 1 |
| KOZONIS, MC; SMITH, DS | 1 |
| CAZZOLA, D | 1 |
| MONTIGEL, C; PULVER, R | 2 |
| DE JONGH, DK; KOK, K | 1 |
| DIENSTBIER, Z; LIBANSKY, J; POLAK, B | 4 |
| GREGORY, PO | 1 |
| PIRKEY, WP | 1 |
| NIKOLIC, B | 1 |
| HENRIQUES, MC | 1 |
| PLICHET, A | 1 |
| ANDERSEN, AH | 1 |
| KRAUS, HH | 1 |
| THIES, HA | 7 |
| FUNKE, A; JACOB, J | 1 |
| ROSTI, P | 2 |
| KELLER, M; MERZ, WR | 1 |
| ISLER, O; JURGENS, R; RUEGG, R; STUDER, A | 1 |
| GAGLIARDI, L | 4 |
| MANTERO, O; RANDAZZO, A | 1 |
| DONZELOT, E; KAUFMANN, H | 1 |
| BEAUMONT, JL; GELE, P | 1 |
| EFIMOVA, GM; IASAKOVA, OI; KUSHELEVSKII, BP | 1 |
| EGOROVA, LI; LIUTROVNIK, BV | 1 |
| OWREN, PA | 2 |
| KOCH, H | 1 |
| GOODWIN, RH; POLLOCK, BM | 1 |
| PUCHNER, R | 1 |
| CHRIST, MA | 1 |
| SERRI, F | 1 |
| DIEFENBACH, AE; DRUMM, A; FISHER, MM; FRANKEL, GJ; GRIFFITH, RW; WILENSKY, ND | 1 |
| HILDEN, T; MUNCK, O | 3 |
| KISTNER, RW; SMITH, GV | 1 |
| JEWELL, P; PILKINGTON, T; ROBINSON, B | 1 |
| KAUTZSCH, E | 1 |
| GRIGNOLI, A; STEFANI, G | 1 |
| COLLI, A; DE NICOLA, P; ROSTI, P | 1 |
| DALY, I; RIORDAN, DJ | 1 |
| ALDEHOFF, P; WEIDENBACH, H | 1 |
| KARIYONE, T; MATSUNO, T | 1 |
| LUTHY, F | 1 |
| KRANZ, H | 2 |
| THOMPSON, CE | 1 |
| DEUTSCH, E; HUEBER, EF; MAYER, E; WOHLRAB, K | 1 |
| ALLEN, WH | 1 |
| RAINIE, RC | 1 |
| ARAKAWA, K; UKITA, T | 1 |
| ARAKAWA, K | 1 |
| IVANOVIC, N; JOHNSON, JF; OLWIN, JH; SEEGERS, WH | 1 |
| HERRMANN, O; OVERMAN, RS; WRIGHT, IS | 1 |
| KONIG, FE; REICH, T; STEINBRUCHEL, M | 1 |
| FRIEDMAN, IA; OLWIN, JH | 1 |
| LANGE, PF; TERVEER, J | 1 |
| VERHAGEN, H | 1 |
| GOETZE, I; PERLICK, E | 1 |
| DOTTI, F; LEONI, R | 1 |
| BIRCHER, J | 1 |
| REIST, A | 1 |
| FRIES, K | 1 |
| GIULINI, R | 1 |
| HUNTER, RB; WALKER, W | 1 |
| REPPEL, L | 2 |
| LAUBE, W | 1 |
| SAVITT, LE | 1 |
| CLATANOFF, DV; MEYER, OO; TRIGGS, PO | 1 |
| DEWS, SC; MARSHALL, IH | 1 |
| MALCHIODI, C; TATTONI, G | 1 |
| MULLERTZ, S; STORM, O | 1 |
| PERLICK, E | 1 |
| SCHIAVINA, P | 1 |
| DEKKER, E; GROEN, J | 1 |
| PALEY, SS; ROSENBAUM, L | 1 |
| STAMM, H | 1 |
| ARIEFF, AJ; PYZIK, SW | 1 |
| SIDORINA, FI | 1 |
| PASCHEN, HW | 1 |
| D'ESHOUGUES, JR; PASQUET, P; RAYNAUD, R | 1 |
| DUVE, W | 1 |
| DUQUENOIS, P; GREIB, E | 1 |
| BURT, CC | 1 |
| DONALD, AC; TUDHOPE, GR | 1 |
| ASTRUP, T; MULLERTZ, S | 1 |
| BOURGAIN, R; HERZIG, L; SYMONS, C; TODD, M; WRIGHT, IS | 1 |
| BARKER, NW; MANN, FD; REITEMEIER, J | 1 |
| FELDMAN, L; FORMAN, IM; GOLDSTEIN, SE; SCHAEFER, GL | 1 |
| BEGTRUP, H | 2 |
| BORTOLOTTI, GC; FACCHINI, G | 1 |
| CHATTERJEA, JB; SALOMON, L | 1 |
| CHALMERS, JN; DIXON, MF; POLACK, W | 1 |
| DONALD, AC; HUNTER, RB; TUDHOPE, GR; WALKER, W; WHITTON, I | 1 |
| TELLE, HJ | 1 |
| MAYER, AM | 1 |
| GIPPERICH, G | 1 |
| AEPPLI, H; PULVER, R | 1 |
| BIRCHER, J; KAUFMANN, P | 1 |
| BENTLEY, WB | 1 |
| HORITA, A; LOOMIS, TA | 1 |
| DAM, H; GEILL, T; LUND, E; SØNDERGAARD, E | 2 |
| HULTEN, O | 1 |
| BELLER, FK | 3 |
| COUPERUS, M | 1 |
| CONN, HL; WOOD, JC | 1 |
| BOURGAIN, R; HERZIG, L; TODD, M; WRIGHT, IS | 1 |
| MANCHESTER, B; RABKIN, B | 1 |
| FROMMEYER, WB | 1 |
| MARKS, J; TRUSCOTT, BM; WITHYCOMBE, JF | 1 |
| HULE, V | 1 |
| VAN WIEN, A; VEROFT, R | 1 |
| McGUIRE, WP | 1 |
| BURKS, JW; GEORGE, WM | 1 |
| DYGGVE, H; LUND, E | 1 |
| LEO, LS; LIDMAN, B | 1 |
| ZAŁOGA, K | 1 |
| RODAS, JM; ROTHFELD, B; THALER, WJ; WILLIAMS, CH | 1 |
| CINGOLANI, E; SCHIAVELLO, A; SEBASTIANI, C | 1 |
| SALVI, F | 3 |
| EISENSTADT, HB; ELSTER, BB | 1 |
| SERT, AS | 1 |
| MERSKEY, C; SAPEIKA, N | 1 |
| DOUGLAS, AS | 2 |
| HUNTER, RB; SHEPHERD, DM | 1 |
| CAPORALE, G; MUSAJO, L; RODIGHIERO, G | 1 |
| KUSCHINSKY, G | 1 |
| KARSTILA, P; PIRILA, V | 1 |
| MENTASTI, P; SALVI, F | 3 |
| KANOF, NB | 1 |
| KLABUSAY, L; KROUTIL, M; LENFELD, J | 1 |
| SCHMIDT-ELMENDORFF, H | 1 |
| FETZER, E | 1 |
| GUTIERREZ FERNANDEZ, J | 1 |
| DUCCI, H; NOGUERA, H | 1 |
| ABRAHAMS, OL; STEIN, HB | 2 |
| ACAR, J; CHICHE, P; JALLUT, H | 1 |
| MATERNE, M | 1 |
| JANOT, MM; LE MEN, J; PLOUVIER, V; POURRAT, H | 1 |
| VON BRANDIS, HJ | 1 |
| HEICHMANN, J | 1 |
| LERNER, AB | 1 |
| ZACCARIA, A | 1 |
| LANGER, H | 1 |
| CLOWARD, RB; YUHL, ET | 1 |
| TRONNBERG, G | 1 |
| CASTRO, C; STRITZLER, G | 1 |
| CHRISTIANSEN, JV | 1 |
| KAPPELER, R | 1 |
| DAM, H; GREEN, JP; SONDERGAARD, E | 1 |
| ECKSTEIN, M; KOCWA, A | 1 |
| ALKJAERSIG, N; JOHNSON, SA; SEEGERS, WH | 1 |
| BRAMBEL, CE | 1 |
| BRUNTON, L; LOWENSTEIN, L; SHAPIRO, L | 1 |
| DIRNBERGER, P; WITTE, S | 1 |
| EICHBAUM, F; ROSENFELD, G; SPANOUDIS, S | 1 |
| NIJENHUIS, WT | 1 |
| PRZYBOROWSKI, T | 1 |
| BEAUMONT, JL | 1 |
| BOURGAIN, R; WRIGHT, IS | 1 |
| BARKHAN, P | 1 |
| IVERSEN, T | 1 |
| MEIXNER, H | 3 |
| BURKS, JW; GEORGE, W | 1 |
| RICCI, M | 1 |
| MARTIUS, C; NITZ-LITZOW, D | 1 |
| PRIOR, IA | 1 |
| MORRIS, LE; WESSLER, S | 1 |
| RASSLER, R | 2 |
| RICCI, M; SALVI, F | 1 |
| POLLOCK, BE | 1 |
| GOLDBLUM, RW; OLSEN, CJ; PIPER, WN | 1 |
| BLICKENSTAFF, DD; FITZPATRICK, TB; HOPKINS, CE; SWIFT, S | 1 |
| SARTORI, C | 2 |
| LOPES CARDOZO, E | 1 |
| WRIGHT, IS | 3 |
| DUFF, IF; GAMBLE, JR; HODGSON, PE; POLHEMUS, JA; WILLIS, PW; WILSON, WS | 1 |
| BOULWARE, JM; FEICHTMEIR, TV; PERKINS, HA; SPAET, TH; THAYER, WW | 1 |
| FULLERTON, HW; MANSON, DI | 1 |
| HANSEN, AT; STORM, O | 1 |
| ALEKSANDROW, D; ASKANAS, Z; OSINSKI, T; WIECLAWEK, B; WYSZNACKA, W | 1 |
| BRODMAN, HR; LITTMAN, JK | 1 |
| MACRAE, LD | 1 |
| CASTRO, CM; STRITZLER, G | 1 |
| MEAD, JA; SMITH, JN; WILLIAMS, RT | 4 |
| ASKEY, JM; CHERRY, CB | 1 |
| FUCIK, K; HAIS, IM; KAKAC, B; KNOBLOCH, E; PROCHAZKA, Z | 2 |
| CLERC-BORY, M; MENTZER, C | 1 |
| BROSSEAU, C; MAROIS, A | 1 |
| DE DOMINICIS, E; ROLANDI, L | 1 |
| DEBERDT, R; VANDENBROUCKE, J; VERSTRAETE, M | 1 |
| MUSAJO, L | 1 |
| KELLY, EW; PINKUS, H | 1 |
| DE ROSNAY, CD | 1 |
| ZEMLIANOI, AG | 1 |
| HUNKA, R; SZINNYAI, M; TREIT, S; VARJASI, F | 2 |
| CORDEIRO, A; CRESPO, FF | 1 |
| GOOSSENS, N; RICHTER, F; WALCHER, A | 1 |
| COTTAFAVI, M | 1 |
| KRAFT, E; MAKOWSKY, L | 1 |
| MANNA, GK | 1 |
| SZIRMAI, E | 3 |
| JOHNSON, SA; SEEGERS, WH | 1 |
| CAPORALE, G; RODIGHIERO, G | 2 |
| ANTONELLO, C; RODIGHIERO, G | 2 |
| BANCHETTI, A | 1 |
| AL'PERN, PM; LOGINOVA, FI; MALOVA, MV | 1 |
| NAEYE, RL | 1 |
| MENTZER, C | 1 |
| OBE, G | 1 |
| MURI, JW | 1 |
| BERNASCONI, P; RAYNAUD, R | 1 |
| Duquenois, P; Gazet Du Chatelier, G; Greib, E | 1 |
| PARTILLA, H; STOCKINGER, L | 1 |
| VERGANI, G | 1 |
| ROSENTHAL, RL | 2 |
| GATTONI, L; SAITA, G | 1 |
| STROBEL, E | 1 |
| KNOBEL, P | 1 |
| HOFMANN, P | 1 |
| CINGOLANI, E | 2 |
| LINDAHL, O | 1 |
| CLATANOFF, DV; MEYER, OO | 1 |
| KRUESI, OR; SCHILLING, FJ | 1 |
| JURGENS, J | 2 |
| MONTAGNE, F | 1 |
| CASTRONOVA, E; HYMAN, C; NELSON, TE | 1 |
| BUIS, R | 1 |
| MENNIG, H | 1 |
| CONNELL, WF; MAYER, GA | 2 |
| ABU-SHADY, H; DIGANGI, FE; SOINE, TO | 1 |
| KUSHELEVSKII, BP | 1 |
| HERBST, L; KAISER, E | 1 |
| DEUTSCH, E; GIEBISCH, G; MULLER, A; SCHEUBA, G; THALER, H | 1 |
| PRATT, G | 1 |
| AFANAS'EV, GG | 1 |
| CURTIS, AC; HARRELL, ER; SHELDON, SA | 1 |
| CORCILIUS, F | 1 |
| DEBENEDETTI, V; RAVERA, M | 2 |
| GUERIN, M; LACOUR, F; OBERLING, C | 1 |
| PERELMAN, AJ; SHOSHKES, M | 1 |
| SODERBERG, U; WACHTMEISTER, CA | 1 |
| STERNE, J | 1 |
| FERRIMAN, D | 1 |
| BOGGERO, C; RONCALLO, E | 1 |
| BIANCO, S; CROLLE, G | 1 |
| BOWING, G; THEDERING, F | 1 |
| HERZ, A | 1 |
| RAVINA, A | 1 |
| FREEMAN, DJ; MEYER, OO | 1 |
| CATALANO, V; NAVAZIO, F | 1 |
| ELLIOTT, JA | 1 |
| JAMAIN, B; LEROUX, M | 1 |
| MORAUX, J | 1 |
| SOULIER, JP | 2 |
| JORDAL, R | 1 |
| VERTES, B | 1 |
| DA RE, P; DE LORENZI, F | 1 |
| THOYER-ROZAT, J; VASSY, S | 1 |
| BENARD, H; BOYER, J; GALISTIN, P; TISSIER, M | 1 |
| HAZLETON, LW; MURER, HK; THIESSEN, R; TUSING, TW; ZEITLIN, BR | 1 |
| FORSTER, F; ROSE, WM | 1 |
| PERCESEPE, E | 1 |
| DUCCI, H; KATZ, R; ROESCHMANN, W; TORIELLO, L | 1 |
| FERGUSON, JH; FRESH, JW; LEWIS, JH; SPAUGH, E; ZUCKER, MB | 1 |
| SCHUHMACHERS-BRENDLER, R | 1 |
| CALDWELL, MJ; JOHNSON, SA; PRIEST, EM | 2 |
| HUNTER, GA; LANDER, H | 1 |
| DE NICOLA, P; GORI, E | 1 |
| NANNINGA, HS | 1 |
| FRESENIUS, P | 1 |
| ALTENBURG, E | 1 |
| HANSEN, A | 1 |
| IMDAHL, H | 1 |
| KEIL, WE | 1 |
| TELLER, H | 1 |
| DUFF, IF; GAMBLE, JR; GRIFFIN, DR; HODGSON, PE; POLHEMUS, JA; WILLIS, PW; WILSON, WS | 1 |
| CORNBLEET, T; HOIT, L | 1 |
| BELIAEVA, EL | 1 |
| DEUTSCH, E; KAISER, E; LEEB, H | 1 |
| NILSSON, IM | 1 |
| CORRAL ALMONTE, J; MENENDEZ, C; NUNEZ RAMOS, C | 1 |
| MCELFRESH, AE; OZGE, A | 1 |
| GOOSSENS, N; HOFFMANN, K | 1 |
| CINGOLANI, E; GAUDIANO, A | 1 |
| VANDENBROUCKE, J; VERSTRAETE, M | 1 |
| BIRKINSHAW, JH; CHAPLEN, P; FINDLAY, WP | 1 |
| MOLLISON, AW; NEILSON, JM | 1 |
| MOON, RY; NEILL, EC; VANDER VEER, JB | 1 |
| BEAUCHAMP, C; PAVILLARD, J | 1 |
| CLOSGES, J; NORPOTH, L | 1 |
| BEVILACQUA, M; COLLI, A | 1 |
| DE NICOLA, P; FUMAROLA, D | 1 |
| BAER, S; KRAVITZ, C; MARKSON, V; YARROW, MW | 2 |
| CHARTIER, Y; DAVID, A; JOHNSON, R | 2 |
| RAVERA, M | 1 |
| ESTES, JE; FAIRBAIRN, JF | 1 |
| FRIES, K; KONIG, FE; REICH, T | 2 |
| MULLER, K | 1 |
| Poncelet, P | 1 |
| BOHME, H; SEVERIN, T | 3 |
| CLARK, PA; VERSTRAETE, M; WRIGHT, IS | 1 |
| FISHER, LM; LOWENTHAL, J | 1 |
| MENTASTI, P | 1 |
| RADHAKISHUN, KS; TEN BOKKEL HUININK, SA; VERMEULEN, HJ | 1 |
| KRANEPUHL, F | 1 |
| ALEXANDER, F; ARSCOTT, PM; KOPPEL, JL; OLWIN, JH | 1 |
| DERECHIN, M | 1 |
| CARRILLO, P; CASTILLO, F; McCOOK, J; MILANES, B; PEREZ, M; TOLEDO, F; UGUET, E | 1 |
| ALESSANDRI, M; FERRETTI, R; SABAH, D | 1 |
| BUSER, P | 1 |
| ENSOR, RE; PETERS, HR | 1 |
| LEDINGHAM, GA; VAN SUMERE, CF; VAN SUMERE-DE PRETER, C; VINING, LC | 1 |
| GRIFFIN, AC; O'NEAL, MA | 1 |
| KNIEPKAMP, G | 1 |
| GUGGENBUHL-SCHMITTER, H | 1 |
| CIFERRI, FE; SHAPIRO, S | 1 |
| FREMONT, RE; JAGENDORF, B | 1 |
| NICHOLSON, JH | 1 |
| HATHWAY, DE | 1 |
| MASSARANI, E | 2 |
| HORSFALL, WR | 1 |
| PRIOR, I | 1 |
| FURIAN, R | 1 |
| BICKOFF, EM; BOOTH, AN; DEEDS, F; LIVINGSTON, AL; LYMAN, RL; THOMPSON, CR | 1 |
| KOSCH, L | 1 |
| DELAGE, JM; DROUIN, G; ROBERGE, R | 1 |
| GUIDO, JJ; PARANO, JR; PERRETTA, A; RASCOVAN, S; SANSUSTE, A | 1 |
| BLUMBERG, H; DAYTON, HB; GORDON, SM | 1 |
| DALSGAARD-NIELSEN, T; SKINHOJ, E | 1 |
| DE CAROLIS, D | 1 |
| GOODMAN, DH | 1 |
| DEUTSCH, E; HUEBER, EF; MAYER, E; TOLK, R | 1 |
| KELLER, R | 1 |
| OTTESTAD, E; SVENDSEN, AB | 1 |
| GUIDOT, J; KERRIN, HF; WILHELM, SK | 1 |
| GODCHAUX, R; PARIS, J; VANLERENBERGHE, J | 1 |
| McKAY, DG; SHAPIRO, SS | 1 |
| CLAVEL, B; PERRAULT, M | 1 |
| FOWLKS, WL; GRIFFITH, DG; OGINSKY, EL | 1 |
| CASTRO, CM; DE SOLDATI, L; GRILLI, H | 1 |
| DANIELS, F; FITZPATRICK, TB; HOPKINS, CE | 1 |
| JOSEPHSON, AM; LICHTMAN, AM; LISKER, R; SHAPIRO, CM | 1 |
| CRAMER, W; POHLHAUS, E | 1 |
| DEZELIC, M; KOSAK, R; STERN, P | 1 |
| WASCHKE, G | 1 |
| MARTIN, P | 1 |
| SUTHERLAND, GK | 1 |
| BRAYMER, HD; PETRAKIS, PL; SHETLAR, MR; WENDER, SH; YANG, CH | 1 |
| STRAULI, P; UEBELHART, R | 1 |
| BECKER, SW | 1 |
| PAULI, HG; PRIEST, EM | 1 |
| CANNAVA, A | 1 |
| ANTONELLO, C; CAPORALE, G; MUSAJO, L; RODIGHIERO, G | 1 |
| ANTONELLO, C; CAPORALE, G | 1 |
| BERGAMASCO, C; RODIGHIERO, G | 1 |
| FORNASARI, E; RODIGHIERO, G | 1 |
| AUGUSTIN, E | 1 |
| SCHRICKER, KT; WITTE, S | 1 |
| DUE, G | 1 |
| ADAMIS, D; BECKER, R; LAVELLE, SM; SISE, HS | 1 |
| FERRARI, A; SIDERI, G; VERGANI, G | 1 |
| JANOK, J; MAJEROVA, Z; MASEK, J; TICHY, V; VALENTINOVA, I | 1 |
| SISE, HS | 1 |
| BIANCO, S; CIANCAGLINI, L; CROLLE, G | 1 |
| LOELIGER, A | 2 |
| DEIMEL, H | 1 |
| BARTELS, CC; EVANS, JA; RULLO, FR | 1 |
| CROLLE, G; RAVERA, M | 1 |
| MEYER, OO | 2 |
| JAMRA, M; VERRASTRO, T; ZINDEL, M | 1 |
| TRUMBLE, EA | 1 |
| JOHNSON, SA; KOPPEL, JL; OLWIN, JH; SEEGERS, WH | 1 |
| HORDER, MH | 2 |
| MAUCK, HP; PORTER, RR; RICHARDSON, D | 1 |
| LEVAI, M | 1 |
| DOUGLAS, AS; MAIR, K | 1 |
| BELLIS, DM | 1 |
| BERNHARD, RA | 1 |
| NORD, FF; SHIMAZONO, H | 1 |
| EJRUP, B | 1 |
| WIRECKI, M | 1 |
| PRINO, G | 1 |
| CANDURA, MD | 1 |
| BARKER, NW; DANFORD, HG; JUERGENS, JL | 1 |
| FAUCON, G; JOURDAN, F | 1 |
| PEYMAN, MA | 1 |
| GIFFORD, RW; SHEPS, SG | 1 |
| BACHMANN, F; KAUFMANN, G; STREULI, F; WEGMANN, T | 1 |
| PRINO, G; RICCI, A; SANTAMARIA, L | 1 |
| KAWASE, Y | 1 |
| KETTENBORG, HK; LOELIGER, EA; PLANTEN, O | 1 |
| KETTENBORG, HK; LOELIGER, EA | 1 |
| CAPORALE, G; CINGOLANI, E | 1 |
| GUGGISBERG, W; MONTIGEL, C | 1 |
| MANSTEIN, B | 1 |
| AERICHIDE, N; DAVID, P; DESROCHERS, Y | 1 |
| BLYBERG, M; SVENDSEN, AB | 1 |
| SCHAFER, R | 1 |
| ELLIOTT, DW; WILLIAMS, RD | 1 |
| CLARK, PA; WRIGHT, IS | 1 |
| BENDA, L; DEUTSCH, E; ZISCHKA, W | 1 |
| GORZ, HJ; HASKINS, FA | 2 |
| NOUR-ELDIN, F; WILKINSON, JF | 1 |
| HAAG-BERRURIER, M | 1 |
| FITZPATRICK, TB; PATHAK, MA | 3 |
| HOPKINS, CE | 1 |
| COCHRAN, WN; POLLITZER, RS; STROM, CH | 1 |
| RADNOT, M; WALLNER, E | 1 |
| DILLON, MT | 1 |
| DANIELS, F; FITZPATRICK, TB; HOPKINS, CE; PATHAK, MA | 1 |
| RADHAKISHUN, KS; TEN BOKKEL HUININK, S; VERMEULEN, HJ | 1 |
| ADAMI, E; MARAZZI UBERTI, E; TURBA, C | 1 |
| BRAFIELD, AJ | 1 |
| BOOTH, AN; DEEDS, F; EMERSON, OH; JONES, FT; MASRI, MS; ROBBINS, DJ | 1 |
| ABDELAL, H; EL-HAWARY, MF; EL-MOFTY, A; EL-MOFTY, AM | 3 |
| SHIMAZONO, H | 1 |
| BIANCHI, A; DE SCHAEPDRYVER, AF; DE VLEESCHHOUWER, GR; PREZIOSI, P | 1 |
| GOLD, H; LILLEY, GW | 1 |
| NEUMANN, J | 1 |
| MASSART, L; TEUCHY, H; VAN SUMERE, CF | 1 |
| ARKLESS, HA; KUSHNER, B | 1 |
| CONN, EE; KOSUGE, T | 2 |
| GREIG, HB | 1 |
| GREIF, S | 1 |
| HARRISON, CE; SPITTEL, JA; WAUGH, JM | 1 |
| CARTER, JR; CONNOR, WE; HOAK, JC; WARNER, ED | 1 |
| LECONTE DES FLORIS, R; RICHON, J | 1 |
| GORZ, HJ; HASKINS, FA; SCHAEFFER, GW | 1 |
| JAPIKSE, JE; KETTENBOURG, HK | 1 |
| ERDELYI, A; FEDINA, L; FOLDI, M; KELLNER, M; KOVACH, AG | 1 |
| LOWENTHAL, J; MACFARLANE, JA; MCDONALD, KM | 1 |
| CHENKIN, T; DAYTON, PG; WEINER, M | 1 |
| FELSON, B; WEINSTEIN, AS; WIOT, JF | 1 |
| ARORA, RB; KRISHNASWAMY, NR; SESHADRI, TR | 1 |
| BROWN, SA; TOWERS, GH; WRIGHT, D | 1 |
| CLETON, FJ | 1 |
| WENDT, H; WEYGAND, F | 1 |
| ARORA, RB; MATHUR, CN; SETH, SD | 1 |
| BROWN, SA | 2 |
| CHENKIN, T; DAYTON, PG; TARCAN, Y; WEINER, M | 1 |
| AUERBACH, R; FEDER, W | 1 |
| GOLLUB, S; LIKOFF, W; ULIN, AW | 1 |
| HELLEMANS, J | 1 |
| HOLEMANS, R; VERSTRAETE, M | 1 |
| GRUNDNER, HG; HARTERT, H; SCHULT, A | 1 |
| SOSSOUNTZOV, I | 1 |
| BELLIS, DM; STOKER, JR | 2 |
| LEWIS, AE; TAT, RJ | 1 |
| da RAPOSO, JS; RIBEIRO, AP; SALES NETO, M; TOSTES, LR | 1 |
| den BRABANDER, AS; LOELIGER, EA; MATTERN, MJ | 1 |
| NEEL, JL | 1 |
| SULMA, T; WIERZCHOWSKA, K | 1 |
| STOECKLI, A | 1 |
| SEIDE, MJ | 1 |
| ALEXANDER, B | 1 |
| BREWER, SS | 1 |
| DELAHAYE, JP; FROMENT, A; PLAUCHU, G | 1 |
| DELBOY, C | 1 |
| de VRIES, S; KLUFT, O; WIEBERDINK, J | 1 |
| GOODMAN, JR; REILLY, EB; WARNER, GF | 1 |
| HELLEMANS, J; VERMYLEN, C; VERSTRAETE, M; VORLAT, M | 1 |
| CHAKRABORTI, DP; CHAUDHURI, M; SHARMA, AK | 1 |
| AGGELER, PM; LEONG, LS; O'REILLY, RA | 2 |
| KNYPL, JS | 1 |
| BARRUCAND, D; CHERRIER, F; FAIVRE, G; GILGENKRANTZ, JM; TENETTE, C | 1 |
| BORCHGREVINK, CF; POOL, JG | 1 |
| HEMKER, HC; HENSEN, A; LOELIGER, EA; MATTERN, MJ | 1 |
| CHIAVARELLI, S; CIRIACI, E; GATTA, F; LANDIVITTORY, R | 1 |
| DADAK, V; RAJDOVSKY, G | 1 |
| GIBELLI, A; MOREO, GC | 1 |
| AGGELER, PM; HOAG, MS; KROPATKIN, ML; LEONG, LS; O'REILLY, RA | 1 |
| LEVY, CC; WEINSTEIN, GD | 2 |
| ANAND, KK; CHOPRA, IC; JAMWAL, KS; SETHI, OP | 1 |
| BAUGH, CW | 1 |
| JAWAD, FH; SOINE, TO | 1 |
| KRATZ, F; STAUDINGER, H | 1 |
| LEVY, CC | 1 |
| CASCIO, G; PALAZZOADRIANO, M | 1 |
| BARRETT, JL; MADER, IJ; NALBANDIAN, RM; PEARCE, JF; RUPP, EC | 1 |
| HOERDER, MH; MANRIQUE, R | 1 |
| LEMMICH, J; NIELSEN, BE | 1 |
| MAYER, GA | 1 |
| CALDINI, O; FERRETTI, GF; SELLERI, R | 1 |
| MARTON, P; PETER, M | 1 |
| HOCKERTS, T; MULKE, G | 1 |
| LEIKEP, K; SADEK, J | 1 |
| UPPLEGGER, H | 1 |
| BONIVER, G; DRAGO, E; GAVINI, R | 1 |
| THEDERING, F | 1 |
| JORGENSEN, G | 2 |
| BENEDETTI-VALENTINI, S | 1 |
| KOOY, HJ; VAN ASSEN, FJ | 1 |
| LOPEZ, M | 1 |
| KAPPELER, R; KOLLER, F | 1 |
| KNOBEL, P; SAUDAN, Y | 1 |
| LEEMING, J; SCHULZE, BV | 1 |
| KRESBACH, E; SAILER, S | 2 |
| DE LA CUESTA ALMONACID, L | 1 |
| GARB, S | 1 |
| GREEN, P | 1 |
| BIGLIARDI, P | 1 |
| CUSTER, HR; MUSTARD, RL | 1 |
| MILLIKAN, CH; SHICK, RM; SIEKERT, RG | 1 |
| MADSEN, ET | 1 |
| PARADOWSKI, K | 1 |
| CRAMER, W | 1 |
| BERSCH, HW; DOPP, W | 1 |
| DUSINSKY, G; GRUNTOVA, Z | 1 |
| STAHL, H | 1 |
| HORWITZ, M; SOUGIN-MIBASHAN, R | 1 |
| GRIFFITHS, FE | 1 |
| FRISCH, P | 1 |
| ADAMIS, D; KIMBALL, DM; SISE, HS | 1 |
| COLPRON, G; LONG, LA; MARION, P | 1 |
| KRESBACH, H | 1 |
| KNORR, W; MATIS, P | 1 |
| HOLUBOVA, E; MACOVA, S; MATOUSKOVA, H; TRCKA, V | 1 |
| HRABANE, J; KARASEK, F; MANGAKIS, N; NEUMANN, J; POKORNY, J; REINIS, Z; TRAVNICEK, T; VANECEK, R | 1 |
| CERMAK, L; GREGOR, O; HYNIE, J; POKORNY, J | 1 |
| REINIS, Z | 2 |
| HERLES, F; JAROSOVA, V | 1 |
| BURESOVA, A; GROSSMANN, V; HAIS, IM; HOLUBOVA, E; KREJCI, F; LEDVINOVA, Z; MICHALEC, C; SLAVIK, K; TRCKA, V; VAICENBACHEROVA, V; WENKE, M | 1 |
| PROCHAZKA, Z; TRCKA, V | 1 |
| HERAUD, G | 1 |
| BIANCHI, M; CRAVAREZZA, F | 1 |
| MAGNANI, B | 2 |
| BEHL, PN | 1 |
| VENKATESWARAN, CH | 1 |
| AVELLANEDA, M | 1 |
| MALAGAMBA, G | 1 |
| GAROFALO, E | 1 |
| MOESCHLIN, S; SCHORNO, H | 1 |
| PAOLAGGI, J; PARAF, A | 1 |
| SOERGEL, W | 1 |
| ROTTGER, H | 2 |
| BECHER, K; HOEPKER, W | 1 |
| KNYPL, JS; SZOPA, JS | 1 |
| ADLER, M; BOJSZKO, I; KOVACS, E; PARADI, Z | 1 |
| KOSUGE, T | 1 |
| GILLO, L; LA BARRE, J | 1 |
| RAPAPORT, SI | 1 |
| Albericio, F; Alsina, J | 1 |
| Craig, S; Davidson, SJ; Gray, E; Iampietro, R; Lawrie, AS; Leeming, D; Mackie, IJ; Purdy, G; Rigsby, P | 1 |
| Lee, TH | 1 |
| Chang, TK; Waxman, DJ | 1 |
| Hayashida, N; Okazaki, M; Taguchi, G; Ubukata, T; Yamamoto, H | 1 |
| Givel, M | 1 |
| Nampoori, VP; Nedumpara, RJ; Paul, B; Radhakrishnan, P; Santhi, A | 1 |
| Alhenc-Gelas, M; Corazza, F; Demulder, A; Ferster, A; Loop, M | 1 |
| Geller, JC | 1 |
| Chakrabarty, D; Chakraborty, A; Hazra, P; Sarkar, N | 1 |
| Fouda, HG; Khojasteh-Bakht, SC; Prakash, C; Rossulek, MI | 1 |
| BADIN, J; MENTZER, C; MEUNIER, P; MORAUX, J | 1 |
| GLOOR, F; SIGG, B | 1 |
| KRATKY, J; POKORNY, A; SAJNER, J | 1 |
| BHAVSAR, MD; DESAI, RD | 1 |
| ALLEN, GW; HULL, E | 1 |
| MARTINI, V | 1 |
| MERZ, WR | 1 |
| OLIVIER, C | 1 |
| COLLENTINE, GE; QUICK, AJ | 1 |
| JOHOW, R | 1 |
| LABOREY, F; LAVOLLAY, J | 2 |
| REIFF, M; WIESMANN, R | 1 |
| BASSEN, FA; MICHAEL, SR; SCHAEFER, L; VURAL, IL | 1 |
| ILLINGWORTH, DG | 1 |
| DUMAS, A | 1 |
| BEDFORD, PD | 1 |
| OLEESKY, S; STANBURY, SW | 1 |
| ZWIAUER, A | 1 |
| HOLTEN, C | 1 |
| BARKER, NW; HURN, M; MANN, FD | 1 |
| BORNSCHEIN, H; DEUTSCH, E; ZWIAUER, A | 1 |
| MOE, AE; STAFNE, WA | 1 |
| GROSSMANN, V; KASALICKY, B | 1 |
| FRANCOVA-KLIMOVA, V; HOLUBOVA, E; TRCKA, V | 1 |
| BARKER, NW; HANSON, HH; MANN, FD | 2 |
| LEVINE, HJ; RYAN, HE | 1 |
| STARE, FJ; VAN ITALLIE, TB | 1 |
| HOUGIE, C | 1 |
| GRIPE, RP | 1 |
| HOLYOKE, JB; WHEELWRIGHT, HJ | 1 |
| GILCHRIST, AR; TULLOCH, JA | 1 |
| BRONSTEIN, MR; WITKIND, E | 1 |
| PAPP, C; SMITH, KS | 1 |
| HOLUBOVA, E; HORAKOVA, Z; MACOVA, S; TRCKA, V | 1 |
| AXELROD, M; KLEINFELD, M | 1 |
| GRUBER, CM; RIEDERS, F | 1 |
| COLLENTINE, GE; HUSSEY, CV; QUICK, AJ | 1 |
| GOLDAMMER, HG | 1 |
| GRUBER, CM; LASZICZENKO, T; LEE, KS | 1 |
| BROWN, A; DOUGLAS, AS | 1 |
| GRUNING, W | 1 |
| HENDERSON, RR; SACHS, JJ | 1 |
| HOLMES, RW; LOVE, J | 1 |
| FIL'KOVA, EM; GORINSHTEIN, ML; KASATKIN, EV; MERKUL', VE | 1 |
| SCOTT, M | 1 |
| SZPILCZYNSKI, S | 1 |
| HALLEN, LG | 1 |
| BEAUMONT, JL; GERBAUX, A; IENEGRE, J | 1 |
| AAS, K; OWREN, PA | 1 |
| FIELD, JB | 1 |
| HARTENBACH, W | 1 |
| JOHNSON, AT | 1 |
| KRIEGER, VI; ROSE, WM | 1 |
| BURKE, GE; SCARONE, LA; WRIGHT, IS | 1 |
| BERMAN, H; MAINELLA, FS | 1 |
| de GENNES, L | 1 |
| DELLA SANTA, R; FALLER, R | 1 |
| HABIF, DV; JARETZKI, A; REHBEIN, A | 1 |
| DELGADO, A; MENDEZ, L; ZAJARIAS, S | 1 |
| FANTL, P; NELSON, JF | 1 |
| PETERSEN, O | 1 |
| EZELL, HK; GAZES, PC; GOLDBERG, LI; HANNA, CB; LEARY, JS; PRYSTOWSKY, RP; WALTON, RP | 1 |
| MORPURGO, F | 1 |
| NICHELE, G; PIANTONI, D | 1 |
| BARNARD, RD; SCHWARTZ, M | 1 |
| DEL NUNZIO, R; RICHTER, IH; SWILLER, SL | 1 |
| CHRIST, MA; MERZ, WR | 1 |
| CONWAY, H; DOCKTOR, JP; JOSLIN, D; STARK, RB | 1 |
| SYNER, JC | 1 |
| HUSSEY, CV; KASER, M; QUICK, AJ | 1 |
| STRAGNELL, R | 1 |
| MANSELL, RV | 1 |
| COSTANTINI, A; TINTORI, M | 2 |
| MARNAY, C | 1 |
| GRAILLOT, G | 1 |
| BAYER-HOLLER, I; PARTILLA, H; STOCKINGER, L | 1 |
| BENEDEK, A; ROSENTHAL, RL; WEAVER, JC | 1 |
| DUCKERT, F; HU-WANG, H; KOLLER, F; LOELIGER, A | 1 |
| LINKE, A | 1 |
| ARNOLDS, P; ERLEMANN, E | 1 |
| ALCALA, F; LANG, H; OBE, G | 1 |
| PUNDEL, JP | 1 |
| TWYMAN, JB | 1 |
| GOODWIN, RH; KAVANAGH, F | 2 |
| BOCCHIA, M; GIACONI, G | 1 |
| SVENDSEN, AB | 1 |
| KENIGOWA, M; LITWIN, F | 1 |
| BRUERA, EF; DE ROSA, J; GARCIA TUIRELLA, R | 1 |
| WAINSTEIN, I | 1 |
| STEIN, HB; WALLACE, BV | 1 |
| BERVOETS, WP; DAMM, A | 1 |
| OSTEN, W | 1 |
| BLOOM, D; GOLDFEDER, A; WEINER, M | 1 |
| ANDREAE, WA | 1 |
| LOPES CARDOZO, E; MOLENAAR, M | 1 |
| BONPARIS, A; FABRE, A | 1 |
| ROBIN, V | 1 |
| Griffin, KR; Liao, Y; Wang, B; Yang, W; Zych, LA | 1 |
| Itin, P; Wernli, M | 1 |
| Pivonka, D | 1 |
| Khan, N; Sharma, S; Sultana, S | 1 |
| Hirsh, J; O'Donnell, M | 1 |
| Rosendaal, FR; Torn, M; van der Meer, FJ | 1 |
| Baker, JR; Moore, MR; Nishijo, M; Satarug, S; Ujjin, P; Vanavanitkun, Y | 1 |
| Choudhary, MI; Iqbal, S; Khan, KM; Lodhi, MA; Maharvi, GM; Perveen, S; Rahman, AU; Ullah, Z | 1 |
| Chen, CH; Chen, HH; Lee, MT; Liao, CH; Tsai, CH; Yang, WP; Yen, CK | 1 |
| Dénes, M; Farsang, C; Kiss, T; Lengyel, M | 1 |
| Klein, J; Klimek, M; Verbrugge, SJ | 1 |
| Arrhenius, T; Chen, M; Cheng, JF; Ishikawa, A; Kashiwagi, H; Kozono, T; Nadzan, AM; Ono, Y; Sato, H; Tith, S; Wallace, D | 1 |
| Andreatta, D; Berg, MA; Coleman, RS; Murphy, CJ; Somoza, MM | 1 |
| Davda, J; Labhasetwar, V; Lee, VH; Qaddoumi, MG; Ueda, H; Yang, J | 1 |
| Obach, RS; Walsky, RL | 1 |
| Asp, T; Borg, S; Bowra, S; Holm, PB | 1 |
| Bae, S; Hur, GM; Lee, CJ; Lee, JH; Lim, JH; Park Js, Js; Park, YC; Seok, JH | 1 |
| Aguilar-Cazares, D; Lopez-Gonzalez, JS; Mandoki, JJ; Molina-Guarneros, JA; Morales-Fuentes, J; Prado-Garcia, H | 1 |
| Gericke, KH; Niesner, R; Roth, W | 1 |
| Joseph, CC; Malima, RC; Ndoile, MM; Nkunya, MH | 1 |
| Callaghan, R; Campbell, J; Kerr, ID; Linton, KJ; Rothnie, A; Storm, J | 1 |
| Ding, X; He, XY; Hong, JY; Hu, WY; Lu, AY; Shen, J | 1 |
| Bischoff, L; Brun, MP; Garbay, C | 1 |
| Ageno, W; Dentali, F | 1 |
| Kostova, I; Manolov, I; Radulova, M | 1 |
| Born, SL; Daston, GP; Hicks, SM; Vassallo, JD | 1 |
| Warkentin, TE | 3 |
| Karger, BL; Moskovets, E; Pashkova, A | 1 |
| Pantazopoulos, K; Zakynthinos, E | 1 |
| Dejaegere, AP; Schechner, M; Sirockin, F; Stote, RH | 1 |
| Cameron, J; Grober, RD; Mason, MD; Pohlers, G; Ray, K | 1 |
| Chandra, R; Dwarakanath, BS; Koshy, L; Mathew, TL; Raj, HG | 1 |
| Kemp, K; Stierle, AA; Stierle, DB | 1 |
| Brouwers, JR; Knijff-Dutmer, EA; Postma, MJ; van de Laar, MA; van der Palen, J | 1 |
| Chen, S; Cho, M; Karlsberg, K; Yuan, YC; Zhou, D | 1 |
| Philip, F; Scarlata, S | 1 |
| Caldarera, CM; Facchini, A; Fattori, M; Fiumana, E; Flamigni, F; Pegg, AE; Pignatti, C; Stefanelli, C; Tantini, B | 1 |
| Amemura-Maekawa, J; Chang, B; Hayakawa, Y; Kura, F; Moribayashi, A; Sugie, H; Wada, A; Watanabe, H | 1 |
| Hecht, SM; Jones, SH; Ma, J | 1 |
| BURT, CC; KUBIK, M; WRIGHT, HP | 1 |
| DAVE, LD; SHAH, NM | 1 |
| BATTLE, WD; CAPPS, RT | 1 |
| MAO, YD; PARKS, LM | 1 |
| GROSSMANN, V; HAIS, IM; KASALICKY, B | 2 |
| D'AGOSTINO, L; SEMERARO, S | 1 |
| SHAPIRO, S; WEINER, M | 1 |
| LASSNER, J | 1 |
| Andersen, NT; Christensen, TD; Hansen, OK; Hasenkam, JM; Hjortdal, VE; Maegaard, M | 1 |
| Bae, H; Kim, HS | 1 |
| Matsuzaki, F; Wariishi, H | 1 |
| Ding, K; Sun, J; Zhao, D | 1 |
| Allikian, MJ; Bhole, D; Tower, J | 1 |
| Itani, T; Kanho, H; Kawahara, N; Kuroyanagi, M; Masuda, K; Nakane, T; Takase, Y; Yaoya, S | 1 |
| Azebaze, AG; Bodo, B; Fomum, ZT; Meyer, M; Nkengfack, AE; Ouahouo, BM | 1 |
| Corrie, JE; Munasinghe, VR; Reid, GP; Webb, MR | 1 |
| Arsuaga, J; Breier, AM; Brown, PO; Cozzarelli, NR; Khodursky, AB; Peter, BJ | 1 |
| Battaglia, F; Fadda, G; Masucci, L; Plotti, G; Posteraro, B; Romano, L; Sanguinetti, M; Zanetti, S | 1 |
| Ansell, J; Bergqvist, D | 1 |
| Abenavoli, MR; Albano, S; Cacco, G; Sorgonà, A | 1 |
| Börm, W; Hassepass, U; Kast, E; Mohr, K; Richter, HP | 1 |
| Lewis, DF | 1 |
| Alink, GM; Boersma, MG; Martena, MJ; Rietjens, IM; Spiegelenberg, W | 1 |
| Cho, HJ; Choi, SZ; Chung, SH; Kang, HC; Lee, JH; Lee, KR; Lee, SO; Park, SH; Yang, EY | 1 |
| Chen, Z; Lin, L | 1 |
| Calcutt, MW; Guengerich, FP; Kim, KH; Yun, CH | 1 |
| Beeching, JR; Buschmann, H; Gómez-Vásquez, R; Reilly, K; Tohme, J | 1 |
| Adam, BS; Pentz, R; Siegers, CP; Strubelt, O; Tegtmeier, M | 1 |
| Antônio, MA; Bighetti, AE; Carvalho, JE; Foglio, MA; Kohn, LK; Possenti, A; Rehder, VL; Vilela, L | 1 |
| Antonenko, YN; Bendig, J; Geissler, D; Hagen, V; Keller, S; Krylova, OO; Pohl, P; Schmidt, R; Wiesner, B | 1 |
| Baker, RI; Bowden, C; Gent, M; Julian, JA; Kakkar, AK; Lee, AY; Levine, MN; Prins, M; Rickles, FR | 1 |
| Diamond, SL; Ellman, JA; Gosalia, DN; Salisbury, CM | 1 |
| Gaytant, MA; Jansen, J; Stuyt, PM | 1 |
| Baumgartner, RW; Gandjour, J; Georgiadis, D; Zeindler, J | 1 |
| Diamond, SL; Ellman, JA; Gosalia, DN; Maly, DJ; Salisbury, CM | 1 |
| Ekman, S; Fransson-Steen, R; Hagbjörk, AL; Löfgren, S; Terelius, Y | 1 |
| Borra, MT; Denu, JM; Smith, BC | 1 |
| Abdo, G; Pournaras, CJ; Stangos, AN; Zaninetti, M | 1 |
| But, PP; Cheng, CL; Han, QB; He, ZD; Jiang, RW; Qiao, CF; Shaw, PC; Xu, HX | 1 |
| Andreev, V; Chen, HS; Giese, R; Karger, BL; Moskovets, E; Pashkova, A; Rejtar, T; Zang, X | 1 |
| Gawley, RE; Shanmugasundaram, M; Tarkka, RM; Thorne, JB | 1 |
| Lippard, SJ; Won, AC; Woodroofe, CC | 1 |
| Carvalho, DC; Garrido, SS; Marchetto, R; Scatigno, AC; Trovatti, E | 1 |
| Andersen, KE; Arnau, EG; Bruze, M; Frosch, PJ; Goossens, A; Johansen, JD; Lepoittevin, JP; Menné, T; Pirker, C; Rastogi, SC; Svedman, C; Uter, W; White, IR | 1 |
| Andersen, KE; Arnau, EG; Brinkmeier, T; Bruze, M; Frosch, PJ; Goossens, A; Johansen, JD; Lepoittevin, JP; Menne, T; Pirker, C; Rastogi, SC; Svedman, C; Uter, W; White, IR | 1 |
| De Smet, PA; Hofman, A; Stricker, BH; Trienekens, PH; van Duijn, CM; Visser, LE; Vulto, AG | 1 |
| DiGiovanni, J; Kleiner, HE; Mammen, JS; Strickland, PT; Sutter, TR | 1 |
| Baldrich, E; O'Sullivan, CK | 1 |
| Lu, C; Lumyong, S; Shen, Y; Taechowisan, T | 1 |
| Jain, SK; Kumar, A; Parmar, VS; Prasad, AK; Raj, HG; Rastogi, RC; Sharma, SK; Singh, BK; Tyagi, R; Watterson, AC | 1 |
| Dong, Y; Feng, SS | 1 |
| Andreatta, D; Berg, MA; Coleman, RS; Ernsting, NP; Kovalenko, SA; Murphy, CJ; Pérez Lustres, JL | 1 |
| Gottesdiener, KM; Kari, PP; Marbury, T; Miller, JL; Mistry, GC; Rodrigues, AD; Simpson, RC; Wagner, JA; Winchell, GA | 1 |
| Greinacher, A; Krahn, EL; Lubenow, N; Magnani, HN; Sloane, DA; Warkentin, TE; Wessel, A | 1 |
| Appling, DR; Garofalo, C; Kramer, G | 1 |
| Funae, Y; Imaida, K; Kamataki, T; Masumura, K; Miyazaki, M; Nohmi, T; Saoo, K; Takeuchi, H; Yamazaki, H; Yokohira, M | 1 |
| Boissier, C; Chesné, C; Corlu, A; Heresbach, D; Jugdé, F; Rougier-Larzat, N; Semana, G | 1 |
| Elinos-Báez, CM; León, F; Santos, E | 1 |
| Gopal, M; Khan, IA; Kulkarni, MV; Shahabuddin, MS; Sun, CM | 1 |
| Kong, L; Liu, R; Shi, Y; Sun, Q | 1 |
| Farinola, N; Piller, N | 1 |
| Callaghan, R; Kerr, ID; McMahon, R; Rothnie, A; Storm, J; Taylor, A | 1 |
| Bushell, KN; Clark, JD; Huang, N; Murphy, EA; Pan, N; Ramarao, MK; Shen, MW; Wang, Y; Williams, C | 1 |
| Chakrabarty, D; Chakraborty, A; Hazra, P; Sarkar, N; Seth, D | 1 |
| Fuhr, U; Kober, S; Mutschler, E; Spahn-Langguth, H; Zaigler, M | 1 |
| Anwald, B; Fuss, C; Gepdiremen, A; Haberl, M; Klein, K; Meyer, UA; Weil, R; Wojnowski, L; Zanger, UM | 1 |
| Harburn, JJ; Rath, NP; Spilling, CD | 1 |
| Carotti, A; Carrupt, PA; Catto, M; Favre, E; Novaroli, L; Reist, M | 1 |
| Ghisalberti, EL; Ridsdill-Smith, TJ; Wang, SF | 1 |
| Galeffi, C; Nicoletti, M; Palazzino, G; Rakotondramanana, DA; Ramanitrahasimbola, D; Randriantsoa, A; Rasoanaivo, P; Ratsimamanga, S | 1 |
| Griffin, KJ; Hsu, MH; Johnson, EF; Stout, CD; Yano, JK | 1 |
| Cui, H; D'Agostino, J; Ding, X; Gu, J; Su, T; Swiatek, PJ; Yang, W; Zhang, QY; Zhang, X; Zhuo, X | 1 |
| Cieślik, T; Cieślik-Bielewska, A; Pelc, R | 1 |
| Jiang, Z; Qiu, Z; Wang, X; Xie, Q | 1 |
| Ito, Y; Lake, BG; Lewis, DF | 1 |
| Fu, SK; Hu, KL; Jiang, XG; Lu, W; Tan, YZ; Zhang, Y | 1 |
| Bailly, F; Cotelle, P; Mbemba, G; Mouscadet, JF; Queffelec, C | 1 |
| Carlton, BD; Daston, GP; Felter, SP; Vassallo, JD | 1 |
| Chohan, ZH; Gulnaz, F; Rehman, SU; Supuran, CT | 1 |
| Guengerich, FP; Kim, D; Wu, ZL | 1 |
| Guengerich, FP; Podust, LM; Wu, ZL | 1 |
| Hossain, MA; Mihara, H; Ueno, A | 1 |
| Brittebo, EB; Carlsson, C; Franzén, A; Hermansson, V; Lang, M | 1 |
| Greaves, M | 1 |
| Lengyel, M | 2 |
| Bevans, CG; Fregin, A; Hünerberg, M; Müller, CR; Oldenburg, J; Rost, S | 1 |
| Alcaide, C; Cano, E; Fraiz, N; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Vilar, S; Yánez, M | 1 |
| Lüftl, M; Schuler, G; Simon, M | 1 |
| Aladağ, H; Göksel, V; Kabakci, T; Karaca, M | 1 |
| Brenna, E; Fronza, G; Fuganti, C; Gatti, FG; Grande, V; Guillou, C; Reniero, F; Serra, F; Serra, S | 1 |
| Chen, B; Chen, Y; Fan, G; Wang, J; Wu, H; Wu, Y; Xie, Y; Yan, C | 1 |
| Ali, AM; Asmah Susidarti, R; Ee Cheng Lian, G; Ismail, HB; Kulip, J; Rahmani, M; Sukari, MA; Waterman, PG; Yun Hin, TY | 1 |
| Liu, PX; Zhou, ZW | 1 |
| Li, W; Xiao, YQ; Zhang, C | 1 |
| Danilov, EO; Rodgers, MA; Velate, S | 1 |
| Campbell, CT; Kleiner, HE; Prince, M; Robertson, TA; Wells, AJ | 1 |
| Dumas, AM; Fillion, E; Kuropatwa, BA; Malhotra, NR; Sitler, TC | 1 |
| Garino, C; Kraus, JL; Laras, Y; Moret, V; Pietrancosta, N; Quéléver, G; Rolland, A | 1 |
| Charlier, C; Frédérick, R; Masereel, B; Pochet, L; Robert, S; Wouters, J | 1 |
| Allan, RK; Mok, D; Ratajczak, T; Ward, BK | 1 |
| Bourgeois, P; Dondon, R; Fery-Forgues, S | 1 |
| Das, K; Jain, B; Patel, HS | 1 |
| Barroso, VM; Canuto, KM; Costa, MF; Leal, LK; Pitombeira, M; Silveira, ER; Viana, GS | 1 |
| Maurer, K; Moeller, KD; Roth, K; Tesfu, E | 1 |
| Angelillo-Scherrer, A; Borradori, L; Masouyé, I; Sanchez-Politta, S | 1 |
| Bogyo, M; Brömme, D; Choe, Y; Craik, CS; Ellman, JA; Greenbaum, DC; Lecaille, F; Leonetti, F | 1 |
| Jakucs, J; Pocsay, G | 1 |
| Berberan-Santos, MN; Brites, MJ; Fedorov, A; Gigante, B; Nascimento, S; Santos, C | 1 |
| Bonner, WD; Thimann, KV | 2 |
| Abenavoli, MR; Badiani, M; Cacco, G; Ciaffi, M; Marabottini, R; Paolacci, AR; Sorgonà, A | 1 |
| Anzenbacher, P; Anzenbacherová, E; Masek, V; Veinlichová, A | 1 |
| Constantin, T; Dankó, K; Fekete, G; Kovács, G; Ponyi, A; Varga, E | 1 |
| Chen, W; Lou, L; Tang, W; Zhao, W | 1 |
| Buliková, A; Chlupová, G; Gumulec, J; Kissová, J; Matýsková, M; Penka, M; Slechtová, M; Smejkal, P | 1 |
| Castelain, M; Chabeau, G; Floc'h, F; Gard, A; Goujon, C; Maliverney, C; Nicolas, JF; Valeyrie, M; Vocanson, M | 1 |
| Cui, J; Qian, X; Wang, J | 1 |
| Belvís, R; Bravo, Y; Castellanos, M; Cocho, D; Egido, J; Geffner, D; Gich, I; Gil-Núñez, A; Marta, J; Martí-Fàbregas, J; Martí-Vilalta, JL; Millán, M; Navarro, R; Obach, V; Palomeras, E; Rodríguez-Campello, A | 1 |
| Fritschi, J; Hentrich, DP; Müller, PR; Wuillemin, WA | 1 |
| Bracco, F; Collina, S; Martino, E; Ramaiola, I; Urbano, M | 1 |
| Sas, G | 1 |
| Dawane, BS; Dhole, NA; Gacche, RN; Gond, DS | 1 |
| Lee, S; Shin, WS; Sivakumar, K; Wang, Q; Xie, F | 1 |
| Mohan, D; Sahare, PD; Sharma, VK | 1 |
| Bayry, J; Christophe, O; Dasgupta, S; Delignat, S; Friboulet, A; Hoebeke, J; Kaveri, SV; Kazatchkine, MD; Lacroix-Desmazes, S; Nagaraja, V; Reinbolt, J; Saenko, E; Wootla, B | 1 |
| Bhattacharyya, K; Ghosh, S; Mondal, SK; Roy, D; Sahu, K; Sen, P | 1 |
| Arakawa, H; Dan-oh, Y; Hara, K; Kasada, C; Shinpo, A; Suga, S; Sugihara, H; Wang, ZS | 1 |
| Laria, D; Pantano, DA; Skaf, MS; Sonoda, MT | 1 |
| Barbier, P; Bourgarel-Rey, V; Carre, M; Combes, S; Finet, JP; Gilli, R; Grégoire, C; Peyrot, V; Rappl, C | 1 |
| Furukawa, K; Kashimura, Y; Nakashima, H; Torimitsu, K | 1 |
| Belyayev, MA; Cournoyer, JJ; Lin, C; O'Connor, PB | 1 |
| Harayama, T | 1 |
| Deng, H; Deng, Q; Zhang, Z; Zhao, S; Zhou, L | 1 |
| Häser, K; Schwab, W; Wenk, HH | 1 |
| Grigoriadis, N; Karagianidou, C; Tsilchorozidou, T; Vagropoulos, I | 1 |
| Aoki, K; Horie, T; Kashiwagura, Y; Ozawa, N; Sato, H; Tateno, C; Yoshizato, K | 1 |
| Aslan, V; Entok, E | 1 |
| Krasnoslobodtsev, AV; Smirnov, SN | 2 |
| Brozic, P; Gobec, S; Rizner, TL; Smuc, T | 1 |
| Hoflack, JC; Kienhuis, AS; Kleinjans, JC; Moonen, EJ; Stierum, RH; van Delft, JH; van Ommen, B; Wortelboer, HM | 1 |
| Ahmed, V; Liu, Y; Silvestro, C; Taylor, SD | 1 |
| El-Khatib, RM; Nassr, LA | 1 |
| Budzisz, E; Krajewska, U; Kwiecień, RA; Lorenz, IP; Mayer, P; Małecka, M; Paneth, P; Rózalski, M | 1 |
| Gage, BF | 1 |
| Barone, V; Improta, R; Santoro, F | 1 |
| Baggio, CH; Dalsenter, PR; Freitas, CS; Graça, C; Marques, MC | 1 |
| Blount, JW; Dixon, RA; Tian, L | 1 |
| Bardón, A; Cravero, R; González Sierra, M; Luna, L; Popich, S; Vera, N | 1 |
| Altomare, C; Carotti, A; Catto, M; De Marco, A; Gnerre, C; Jenner, P; Rose, S; Summo, L; Testa, B | 1 |
| Iancov, I; Michailova, A; Mitov, I; Neychev, H; Nikolova, N; Stefanova, T; Zlabinger, GJ | 1 |
| Cui, JR; Ran, FX; Wang, RQ; Wu, J; Xu, B; Yang, XW | 1 |
| Chen, CS; Ding, X; Fang, C; Gu, J; Kannan, K; Waxman, DJ; Wei, Y; Xie, F; Yang, W | 1 |
| Fujieda, M; Kamataki, T; Kiyotani, K; Peamkrasatam, S; Sriwatanakul, K; Yamazaki, H; Yoovathaworn, K | 1 |
| Higashi, E; Katoh, M; Nakajima, M; Tokudome, S; Yokoi, T | 1 |
| Jiang, X; Lu, W; She, Z; Wan, J | 1 |
| Borisov, SM; Karasyov, AA; Krause, C; Vasylevska, AS | 1 |
| de Jager, LS; Diachenko, GW; Perfetti, GA | 1 |
| Kamande, MW; Locascio, LE; Lowry, M; Ross, D; Warner, IM | 1 |
| Baker, N; Greenway, GM; Wheatley, RA; Wiles, C | 1 |
| Féau, C; Kerth, P; Klein, E; Lebeau, L | 1 |
| Cacace, A; Dickey, J; Esposito, K; Hermsmeier, M; Johnson, SR; Lawrence, M; Loughney, D; Padmanabha, R; Pike, K; Poss, M; Tebben, A; Vaccaro, W; Wong, V | 1 |
| Farinola, N; Piller, NB | 1 |
| Blaskovich, M; Curini, M; Epifano, F; Genovese, S; Hamilton, A; Sebti, SM | 1 |
| Hüttel, W; Müller, M | 1 |
| de Boer, A; Kramer, MH; Schalekamp, T; van Geest-Daalderop, JH; van Holten-Verzantvoort, AT | 1 |
| Rath, W; Richter, ON | 1 |
| Blagg, BS; Huang, YT | 1 |
| Brodmann, M; Pilger, E; Seinost, G | 1 |
| Feilmeier, BJ; Herberg, JT; McCroskey, MC; Miller, JR; Tomilo, M | 1 |
| Neychev, HO; Nikolova, NJ; Stefanova, TH; Toshkova, RA | 1 |
| Cho, CH; Choi, SY; Keum, DY; Kwon, KY; Lee, JH; Park, NH | 1 |
| Herings, RM; Koerselman, J; Penning-van Beest, FJ | 1 |
| Barbosa, LC; Barros, EC; Campos, MR; Guedes, RN; Moreira, MD; Picanço, MC | 1 |
| Hadjipavlou-Litina, D; Kontogiorgis, CA | 1 |
| Aparício Garcia Cortez, D; Brenzan, MA; Nakamura, CV; Prado Dias Filho, B; Ueda-Nakamura, T; Young, MC | 1 |
| Ashton, M; Asimus, S; Elsherbiny, D; Hai, TN; Huong, NV; Jansson, B; Petzold, MG; Simonsson, US | 1 |
| Dong, KS; Kumagai, S; Li, JY; Manabe, N; Tulayakul, P | 1 |
| Inamdar, SR; Mannekutla, JR; Mulimani, BG | 1 |
| Baggio, CH; Cipriani, TR; da Silva-Santos, JE; de Souza, LM; Freitas, CS; Graça, C; Marques, MC; Pontarolo, R; Rattmann, YD; Rieck, L; Sassaki, GL | 1 |
| Gao, L; Li, D; Li, X; Li, Z; Wang, Y; Xu, J | 1 |
| Casas, JS; Castellano, EE; Couce, MD; Crespo, O; Ellena, J; Laguna, A; Sanchez, A; Sordo, J; Taboada, C | 1 |
| Grau, E; Jiménez, D; Lobo, JL; Madridano, O; Monreal, M; Naufall, D; Teresa Orue, M | 1 |
| Marchetti, M; Piccolo, O; Ulgheri, F | 1 |
| Cornelissen, JJ; Debets, MF; Dirks, AT; Nolte, RJ; Rutjes, FP; van Berkel, SS; van Delft, FL | 1 |
| Isik, E; Oksuz, S; Sabudak, T | 1 |
| Chuang, MC; Huang, CC; Lin, CH; Lin, P; Lin, PH | 1 |
| Menzella, HG; Myles, DC; Shaw, SJ; Smith, AB; Xian, M | 1 |
| Dong, JH; Guo, YJ; Jin, F; Pang, R; Tao, JY; Zhang, SL; Zhao, L | 1 |
| Daniilides, K; Gennimata, D; Gikas, E; Kazanis, M; Malli, D; Panderi, I; Vavagiannis, A | 1 |
| Copley, MJ; Couch, JF; Naghski, J | 1 |
| Bauer, T; Hechenberger, M; Jaunzeme, I; Jirgensons, A; Kauss, V; Noeske, T; Parsons, CG; Renner, S; Schneider, G; Starchenkovs, I; Trifanova, D; Weil, T | 1 |
| Kar, A; Panda, S | 1 |
| Dowdy, JC; Sayre, RM | 1 |
| Hadjipavlou-Litina, D; Kontogiorgis, CA; Luo, Y; Xu, Y | 1 |
| Herijgers, P; Verhamme, P | 1 |
| Pearson, DA | 1 |
| Kuo, PY; Lin, SL; Yang, DY | 1 |
| Moore, JF; Pellin, MJ; Veryovkin, IV; Zinovev, AV | 1 |
| Michno, N; Murphy, SE; Schlicht, KE; Scott, EE; Smith, BD | 1 |
| Biersack, HJ; Brockmann, H; Bucerius, J; Ezziddin, S; Palmedo, H | 1 |
| Atichartpongkul, S; Fuangthong, M; Mongkolsuk, S; Rangkadilok, N; Sallabhan, R; Satayavivad, J; Sriprang, R | 1 |
| Asdaq, SM; Kalkhambkar, RG; Kamanavalli, CM; Kulkarni, GM; Premkumar, N; Sun, CM | 1 |
| Broo, KS; Larsson, J; Viljanen, J | 1 |
| Chang, YH; Das, AR; De Clercq, E; Hong, SC; Hwu, JR; Neyts, J; Singha, R; Vliegen, I | 1 |
| Floc'h, F; Gard, A; Hennino, A; Nicolas, JF; Rozières, A; Valeyrie, M; Vocanson, M | 1 |
| Chovancova, J; Kois, P; Lac, J; Lácová, M; Puchala, A; Rasala, D; Solcanyova, E | 1 |
| Castner, EW; Shirota, H; Wishart, JF | 1 |
| Chittepu, P; Seela, F; Sirivolu, VR | 1 |
| Ashton, M; Asimus, S; Hai, TN; Van Huong, N | 1 |
| Agren, H; Chandra Jha, P; Wang, Y | 1 |
| Barbera, M; Bisi, A; Caputo, A; Carrara, M; Gobbi, S; Rampa, A; Zampiron, A | 1 |
| CHATTERJEE, A; MITRA, SS | 1 |
| MENTZER, C; MOLHO, D | 1 |
| GIANELLA, CV; KAULLA, KN | 1 |
| STERRETT, FS | 1 |
| Lee, DY; Liu-Chen, LY; Ma, Z; Xu, W | 1 |
| Alam, MS; Khan, R; Shawl, AS; Tantray, M; Tantry, M | 1 |
| Rychlik, M | 1 |
| Guan, H; Tang, H; Zhou, H; Zhu, L | 1 |
| Brenner, B; Kalina, U; Knaub, S; Nagy, A; Ostermann, H; Pabinger, I | 1 |
| Bahn, KN; Gang, HI; Ha, YL; Hah, CK; Kim, YS | 1 |
| Arakawa, T; Kita, Y; Koyama, AH | 1 |
| Guzow, K; Legowska, A; Lesner, A; Rolka, K; Wiczk, W; Wysocka, M | 1 |
| Ariyoshi, T; Imato, T; Maki, T; Makihara, K; Nakajima, H; Nakano, K; Seto, D; Soh, N | 1 |
| Oldenburg, J; Pötzsch, B; Seidel, H; Watzka, M | 1 |
| Asmis, L; Brand, B; Oldenburg, J; Speich, R; Ulrich, S | 1 |
| Misra, A; Surti, N | 1 |
| Crowther, MA; Warkentin, TE | 1 |
| Aoyama, H; Fujimoto, H; Hashimoto, Y; Kobayashi, H; Noguchi-Yachide, T | 1 |
| Acharya, H; Coutinho, E; Malde, A; Manvar, A; Mishra, A; Shah, A; Upadhyay, K; Verma, J; Virsodia, V | 1 |
| Bharadwaj, PK; Ray, D | 1 |
| Abrahim, D; Da Silva, LJ; Ishii-Iwamoto, EL; Kern, KA; Pergo, EM; Soares da Silva, PC; Voll, E | 1 |
| Giouvalakis, N; Raikos, N; Theodoridis, GA; Tsoukali-Papadopoulou, H; Zacharis, CK | 1 |
| Marinova, M; Müller-Reible, C; Oldenburg, J; Watzka, M | 1 |
| Frederich, N; Habib Jiwan, JL; Hofkens, J; Jonas, AM; Muls, B; Nysten, B | 1 |
| Brooker, NL; Kuzimichev, Y; Laas, J; Pavlis, R | 1 |
| Behr, W; Ehret, W; Harwix, S; Murmann, K; Schlimok, G; Schulze, R; V Scheidt, W; Wittwer, H | 1 |
| Alexandra, JF; Gouin-Thibault, I; Loriot, MA; Pautas, E; Siguret, V | 1 |
| Glick, GD; Maglott, EJ | 1 |
| Hayashi, Y; Hirota, S; Kimura, T; Kiso, Y; Noguchi, M; Prakash, H; Skwarczynski, M | 1 |
| Hirode, M; Imazawa, T; Kiyosawa, N; Miyagishima, T; Mizukawa, Y; Nagao, T; Omura, K; Ono, A; Shimizu, T; Uehara, T; Urushidani, T | 1 |
| Costa, Rde J; Diniz, A; Jordão, BQ; Mantovani, MS | 1 |
| Bhasikuttan, AC; Kumbhakar, M; Nath, S; Pal, H; Singh, PK | 1 |
| Imfeld, T; Mutzbauer, TS | 1 |
| Huang, ST; Ting, KN; Wang, KL | 1 |
| Cusido, J; Katritzky, AR; Narindoshvili, T | 1 |
| Ding, J; Liu, Y; Shi, D; Sun, J | 1 |
| Greinacher, A; Koster, A; Lincoff, AM; Warkentin, TE | 1 |
| Arakawa, T; Hirano, A; Shiraki, K | 1 |
| Cestari, SH; Di Stasi, LC; Luchini, AC; Pellizzon, CH; Rodrigues-Orsi, P; Seito, LN; Witaicenis, A | 1 |
| Abyan, M; Fery-Forgues, S; Lamere, JF | 1 |
| Arai, Y; Ishikawa, T; Kodama, N; Kumamoto, T; Nakamura, T; Oda, M; Tsuchiya, S; Ueno, K; Yano, S | 1 |
| Berenbaum, MR; Niu, G; Rupasinghe, SG; Schuler, MA; Wen, Z; Zeng, RS | 1 |
| Douketis, JD; Jamula, E; Schulman, S | 1 |
| Castrodeza, J; González-Fajardo, JA; Martin-Pedrosa, M; Tamames, S; Vaquero-Puerta, C | 1 |
| Adamo, L; Conticello, C; De Maria, R; Giannone, I; Gulisano, M; Musumeci, T; Pignatello, R; Puglisi, G; Vicari, L | 1 |
| de Boer, A; Maitland-van der Zee, AH; Schalekamp, T | 1 |
| Giurleo, JT; Pronchik, J; Talaga, DS | 1 |
| Chung, WY; Lee, HK; Lim, SY; Park, HG; Park, MS | 1 |
| Farag, NA; Mohamed, SR; Soliman, GA | 1 |
| Baba, N; Izumi, M; Kawazu, K; Nakajima, S; Takaishi, K | 1 |
| Achari, G; Ghosh, JP; Langford, CH | 1 |
| Melegh, B; Sipeky, C | 1 |
| Liu, Z; Luo, XL; Zhou, XX | 1 |
| Chen, JR; Kuo, PY; Wong, JB; Yang, DY | 1 |
| Boersma, MG; Punt, A; Rietjens, IM; Zaleska, M | 1 |
| KUBIK, M; REINIS, Z | 1 |
| CASPANI, R | 1 |
| CHENEY, G | 1 |
| BOYD, J; ROBERTSON, A | 1 |
| DRAPER, AJ | 1 |
| Basiaga, SB; Hage, DS; Joseph, KS; Moser, AC; Schiel, JE | 1 |
| Ahlawat, DS; Mohan, D; Sharma, AK; Singh, RD | 1 |
| SMITH, WK | 1 |
| Blagg, BS; Burlison, JA; Donnelly, AC; Holzbeierlein, J; Mays, JR; Nelson, JT; Vielhauer, G | 1 |
| Halpern, BP; Stephenson, D | 1 |
| Kishor, M; Ramachary, DB; Reddy, YV | 1 |
| Cooperwood, JS; Khan, MO; Musa, MA | 1 |
| Badia, A; Clos, MV; Colombo, L; Martínez-Otero, A; Pera, M; Ruiz-Molina, D; Salmona, M | 1 |
| Chung, A; Johnson, JV; Katritzky, AR; Narindoshvili, T; Yoshioka, M | 1 |
| Bhasikuttan, AC; Kumbhakar, M; Mohanty, J; Mukherjee, T; Nath, S; Pal, H; Sarkar, SK; Singh, PK | 1 |
| Kajita, Y; Kurahashi, T; Matsubara, S | 1 |
| Chan, HY; Chen, KH; Fang, JM; Liao, JH | 1 |
| Attanasi, OA; Begala, M; Berretta, S; Corda, M; Fadda, MB; Fais, A; Filippone, P; Meli, G; Podda, G; Tocco, G | 1 |
| Akita, K; Fujii, M; Hirata, T; Hongo, D; Kuroyanagi, M; Ogawa, K; Yanaka, N | 1 |
| Berg, JZ; Murphy, SE; Schlicht, KE | 1 |
| Katerinopoulos, HE; Pergantis, SA; Roussakis, E | 1 |
| Mahavorasirikul, W; Na-Bangchang, C; Na-Bangchang, K; Reungweerayut, R; Satarug, S; Tassaneeyakul, W | 1 |
| Li, F; Sun, XY | 1 |
| Bertolucci, SK; Braga, FC; de Aquino Ribeiro, JA; de Oliveira, AB; Pereira, AB; Pinto, JE | 1 |
| Heinze, K; Hempel, K | 1 |
| Li, WH; Yang, S | 1 |
| Kemkes-Matthes, B | 1 |
| Azzousi, AR; Ballereau, C; de la Taille, A; Descazeaud, A; Devonec, M; Dumonceau, O; Fourmarier, M; Haillot, O; Lukacs, B; Robert, G; Saussine, C | 1 |
| Badami, PS; Kulkarni, A; Patil, SA | 1 |
| Coffigny, H; Hanedanian, M; Louit, G; Pin, S; Renault, JP; Taran, F | 1 |
| Berndl, S; Herzig, N; Kele, P; Lachmann, D; Li, X; Wagenknecht, HA; Wolfbeis, OS | 1 |
| Wang, DX; Wang, YS; Xu, HY; Yang, JH | 1 |
| Afantitis, A; Detsi, A; Hadjipavlou-Litina, DJ; Igglessi-Markopoulou, O; Kontogiorgis, C; Koufaki, M; Melagraki, G | 1 |
| Büller, HR; Ettema, HB; Mulder, MC; Nurmohamed, MT; Verheyen, CC | 1 |
| Kawai, K; Osada, H; Saito, A; Sudo, T | 1 |
| Aengevaeren, WR; Brouwer, MA; Kievit, PC; van den Bergh, PJ; Veen, G; Verheugt, FW | 1 |
| Kolev, T; Koleva, BB; Mayer-Figge, H; Nikolova, R; Sheldrick, WS; Spiteller, M | 1 |
| Poller, L | 1 |
| Christensen, TD; Jensen, C; Larsen, TB; Maegaard, M; Sørensen, B | 1 |
| Conemans, JM; Coremans, AM; Hermans, MH; Ouwehand, ME; Péquériaux, NC; Schmeits, PC; van Geest-Daalderop, JH | 1 |
| Allard, JF; Babin, J; Lepage, M; Morris, D; Pelletier, M; Zhao, Y | 1 |
| Jayawardana, MA; Satarasinghe, RL | 1 |
| Abbas, ME; Li, K; Li, W; Liu, S; Luo, W; Tang, H; Zhou, W; Zhu, L | 1 |
| Apostolakos, P; Galatis, B; Livanos, P | 1 |
| Abe, H; Furukawa, K; Hibino, K; Ito, Y; Sako, Y; Tsuneda, S | 1 |
| Fujita, T; Kanehiro, M; Mino, T; Sakamoto, M | 1 |
| Corrie, JE; Ferenczi, MA; Hild, G; Siththanandan, VB; Webb, MR; West, TG | 1 |
| Baudoin, C; Féron, C; Koyama, S; Novotny, MV; Soini, HA; Wiesler, D | 1 |
| Herek, JL; Kuipers, L; Milder, MT; van der Walle, P | 1 |
| Barbosa-Filho, JM; de Barros Viana, GS; de Brito, EM; de Moura, RR; de Sousa, FC; Leal, LK; Lucetti, DL; Macedo, DS; Monteiro, VS; Patrocínio, MC; Pereira, EC; Vasconcelos, SM | 1 |
| Gupta, R; Mishra, P; Mittal, A | 1 |
| Bdzoch, J; Bugar, I; Janek, M; Link, G; Palszegi, T; Szöcs, V; Velic, D; Zitnan, M | 1 |
| Cornelissen, JJ; Dirks, AT; Nolte, RJ | 1 |
| Chang, SK; Choi, MG; Kim, YH; Namgoong, JE | 1 |
| Boorsma, A; Dejong, CH; Gottschalk, R; Kienhuis, AS; Kleinjans, JC; Stierum, RH; van de Poll, MC; van Delft, JH; van Herwijnen, M | 1 |
| Humphreys, WG; Shu, YZ; Zhao, W; Zheng, J; Zhu, M; Zhuo, X | 1 |
| Rutjes, FP; van Berkel, SS; van Delft, FL; van der Lee, B | 1 |
| Banton, M; Bus, J; Carlson, G; Cruzan, G; Gingell, R | 1 |
| Chen, D; Fan, G; Jiang, Y; Wang, J; Wu, Y; Zhou, T | 1 |
| Liebman, JF; Matos, MA; Miranda, MS; Morais, VM; Sousa, CC | 1 |
| Cho, M; Choi, JH; Choi, K; Park, B; Park, EK | 1 |
| Floege, J; Krüger, T | 1 |
| Corda, M; Delogu, G; Era, B; Fadda, MB; Fais, A; Matos, MJ; Picciau, C; Podda, G; Quezada, E; Santana, L | 1 |
| Jiang, X; Ren, Y; Wang, R; Yin, J | 1 |
| Al-Kady, AS; Ebeid, el-ZM; Gaber, M; Hussein, MM | 1 |
| Rockson, SG | 1 |
| Gopalakrishnan, S; Manojkumar, P; Ravi, TK | 1 |
| Pari, L; Rajarajeswari, N | 1 |
| Chang, SK; Han, MS; Jang, HH; Kim, MH; Yi, S | 1 |
| Hörl, WH | 1 |
| Hobley, J; Lear, MJ; MacAry, PA; Ngai, MH; Song, HY; Song, ZY | 1 |
| Aureli, F; Coni, E; Lungarini, S | 1 |
| Chen, J; Fang, C; Liu, S; Wu, W; Yu, N; Zhang, Q | 1 |
| Bonner, D; Burns, A; Connelly, L; Herz, E; Marchincin, T; Switalski, S; Wiesner, U | 1 |
| Alves, CF; Alves, VB; Clemente-Napimoga, JT; Cunha, FQ; Dal-Secco, D; de Assis, IP; Napimoga, MH; Rehder, VL; Uber-Bucek, E | 1 |
| Achari, G; Berlinguette, CP; Ghosh, JP; Langford, CH; Sui, R | 1 |
| Brunet, SM; Paige, MF; Steer, RP; Sugunan, SK; Tripathy, U | 1 |
| Avila, M; Escarpa, A; Ríos, A; Zougagh, M | 1 |
| Evale, BG; Hanagodimath, SM; Manohara, SR | 1 |
| Fujishima, SH; Hamachi, I; Nonaka, H; Ojida, A; Tsukiji, S; Uchinomiya, SH | 1 |
| Germann, R; Kalina, U; Knaub, S; Ostermann, H; Pabinger, I; Tiede, A | 1 |
| An, M; Haig, TJ; Pratley, JE; Seal, AN; Wu, H | 1 |
| Dai, CL; Liang, XL; Liao, ZG; Wang, GF; Zhang, XH; Zhao, GW | 1 |
| Kumbhakar, M; Nath, S; Pal, H; Satpati, AK | 1 |
| Laur, LM; Maddox, CE; Tian, L | 1 |
| Hosamani, KM; Keri, RS; Reddy, HR; Shingalapur, RV | 1 |
| Brydegaard, M; Guan, Z; Svanberg, S; Wellenreuther, M | 1 |
| Conemans, JM; Hermans, MH; Péquériaux, NC; Poodt, J; van Geest-Daalderop, JH | 1 |
| Brard, L; Kim, KK; Lange, TS; Singh, RK | 1 |
| Bayona, JM; Fernandez-Alvarez, M; Garcia-Jares, C; Jover, E; Llompart, M; Lores, M | 1 |
| Clive, DL; Stoffman, EJ | 1 |
| Dix, AV; Tor, Y; Xie, Y | 1 |
| Jagdale, AR; Kim, MJ; Kim, SJ; Kim, Y; Lee, KM; Swamy, KM; Yoo, KH; Yoon, J | 1 |
| Li, XL; Li, Y; Liu, KC; Wang, SF; Wang, XM; Yang, YP; Zhao, YL | 1 |
| Delatour, T; Punt, A; Rietjens, IM; Schilter, B; Scholz, G; van Bladeren, PJ | 1 |
| Denat, F; Diaz-Fernandez, YA; Pallavicini, P; Pasotti, L; Sok, N | 1 |
| Chen, L; Fan, D; Qiu, Y; Xia, Y; Yu, T; Zhang, H; Zhang, P; Zhao, Y | 1 |
| Dosche, C; Féau, C; Kerth, P; Klein, E; Lebeau, L | 1 |
| Abraham, K; Heinemeyer, G; Lampen, A; Lindtner, O; Wöhrlin, F | 1 |
| Innocenti, A; Parkkila, S; Scozzafava, A; Supuran, CT; Temperini, C | 1 |
| Donovalová, J; Flasík, R; Gáplovský, A; Stankovicová, H | 1 |
| Grzywna, E; Krupa, M; Moskała, M; Składzień, T | 1 |
| Satchi-Fainaro, R; Segal, E; Shabat, D; Weinstain, R | 1 |
| Giesen, DJ; Kondakova, ME; Lenhart, WC; Madaras, M; Rajeswaran, M; Ren, X | 1 |
| Crispim, SP; De Vries, JH; Geelen, A; Le Donne, C; Leclercq, C; Ocke, MC; Raffo, A; Sette, S; Siebelink, E; van't Veer, P | 1 |
| Aoyama, C; Funatsu, T; Mizuno, J; Noguchi, M; Saeki, A; Shirasaki, Y; Shoji, S; Tsunoda, M | 1 |
| Ahn, T; Jung, HC; Kim, D; Kim, DH; Pan, JG; Park, SH; Yun, CH | 1 |
| Chen, RY; Gong, T; Liu, P; Wang, DX; Yang, Y; Yu, DQ | 1 |
| Ismail, R; Ong, CE; Tan, EL; Tiong, KH; Yiap, BC | 1 |
| Allignol, A; Beyersmann, J; Schumacher, M | 1 |
| Hsiung, PA; Lin, HM; Shyu, SG; Wang, WK | 1 |
| Jin, Z; Ma, QJ; Mao, GJ; Shen, GL; Yu, RQ; Zhang, XB; Zhao, XH | 1 |
| Chen, K; Guo, Y; Qi, H; Su, Z; Yang, XF; Zhao, M | 1 |
| Lu, Y; Luan, JW; Yang, XW; Zhang, BG; Zhang, CY; Zheng, QT | 1 |
| Albertazzi, L; Bizzarri, R; Nifosì, R; Signore, G | 1 |
| Atmaca, M; Deniz Obay, B; Ketani, A; Murat Bilgin, H; Ozekinci, S; Taşdemir, E | 1 |
| Chen, B; Lin, W; Long, L; Tan, W; Yuan, L | 1 |
| ALLEN, EV | 1 |
| FALK, OP | 1 |
| SCHIFFLER, RJ | 1 |
| BARKER, NW; PARKER, RL | 1 |
| BRAMBEL, CE; MacLEAN, AL | 2 |
| CLEMENTS, JL | 1 |
| DEUTSCH, E | 1 |
| BERNE, CJ; PETIT, DW | 1 |
| LECOCQ, J | 1 |
| KADISH, AH | 1 |
| ATWOOD, SS | 1 |
| FANTL, P; NANCE, MH | 1 |
| de la BARREDA, P; FERNANDEZ DE MOLINA, A; GRANDE COVIAN, F | 1 |
| VARANGOT, J; VASSY, S | 3 |
| ALLEN, EV; HINES, EA | 1 |
| THORSEN, G | 1 |
| BARAC, G | 1 |
| De BEER, EJ | 1 |
| NELSON, CM; WASHINGTON, TB | 1 |
| CHIAVACCI, LV; PUTNAM, TJ | 1 |
| BLANCHAER, MC; STEFANINI, M | 1 |
| CORNMAN, I | 1 |
| HORNING, EC; HORNING, MG | 1 |
| AUDUS, LJ; QUASTEL, JH | 1 |
| LUPTON, AM | 1 |
| RIGDON, RH; VARNADOE, NB | 1 |
| Ashani, Y; Goldsmith, M; Gupta, RD; Leader, H; Silman, I; Sussman, JL; Tawfik, DS | 1 |
| MARRIAN, DH; RUSSELL, PB | 1 |
| ANGEVINE, DM; THUERER, GR | 1 |
| Born, SL; Kaetzel, RS; Lehman-McKeeman, LD; Lewis, CL; Reed, DJ; Vassallo, JD | 1 |
| de Leeuw, PW; Hamulyak, K; Kroon, AA; Leiner, T; Rennenberg, RJ; Schurgers, LJ; Ten Cate, H; van Varik, BJ; Vermeer, C | 1 |
| Hosamani, KM; Hugar, MH; Keri, RS; Shingalapur, RV | 1 |
| Chung, SJ; Jeong, MS; Kim, TI; Kim, Y | 1 |
| Booth-Genthe, CL; Grimm, SW; Harris, JJ; Linnenbach, AJ; Liu, R; Luzietti, RA; Zhou, D | 1 |
| Du, J; Li, G; Ma, W; Peng, X; Song, B; Wang, X; Wang, Z; Xu, Q | 1 |
| Bhatia, G; Khanna, AK; Kumar, A; Rosaiah, JN; Sashidhara, KV | 1 |
| Guan, J; Li, SP; Qian, ZM; Xu, J; Zhao, WM | 1 |
| Gerding, H; Loukopoulos, V; Meier, C | 1 |
| Hadi, AH; Ketuly, KA | 1 |
| Abdelhafez, OM; Amin, KM; Batran, RZ; Maher, TJ; Nada, SA; Sethumadhavan, S | 1 |
| Fuchsbergerová, M; Milatová, E; Remková, A | 1 |
| Froudakis, GE; Katerinopoulos, HE; Klontzas, E; Tsikalas, GK; Voutsadaki, S | 1 |
| Li, N; Tong, A; Xiang, Y | 1 |
| Chen, YC; Han, B; Li, JL; Wu, L; Zhou, SL | 1 |
| Mascareñas, JL; Sánchez, MI; Vázquez, ME; Vázquez, O | 1 |
| Bardos, J; Cano, C; Golding, BT; Griffin, RJ; Hardcastle, IR; Parveen, N; Payne, SL; Peacock, M; Rodriguez-Aristegui, S | 1 |
| Borak, JB; Falvey, DE | 1 |
| Jadhav, VB; Kulkarni, MV; Nayak, SK; Row, TN | 1 |
| Bhatia, G; Khanna, AK; Kumar, A; Kumar, M; Sashidhara, KV; Sonkar, R | 1 |
| Chan, MK; Fekner, T; Li, X | 1 |
| Adfa, M; Koketsu, M; Komura, K; Yoshimura, T | 1 |
| Ahmed, F; Siddesha, JM; Urooj, A; Vishwanath, BS | 1 |
| Huang, WH; Li, J; Li, SP; Lv, GP; Yang, FQ | 1 |
| Chang, YW; Silas, JA; Ugaz, VM | 1 |
| Artigas, D; Loza-Alvarez, P; Palero, J; Santos, SI | 1 |
| Ehrenschwender, T; Kele, P; Varga, BR; Wagenknecht, HA | 1 |
| Ben Hadda, T; Dongre, R; Meshram, J; Parvez, A; Sheik, J; Tiwari, V; Youssoufi, MH | 1 |
| Seitz, CS; Trautmann, A | 1 |
| Bizzarri, B; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Granese, A; Rivanera, D; Scaltrito, MM; Secci, D; Sisto, F; Zicari, A | 1 |
| Mladenović, M; Solujić, S; Sukdolak, S; Vuković, N | 1 |
| Chen, IS; Cheng, MJ; Chiang, CC; Huang, HY; Peng, CF | 1 |
| Hanaoka, K; Nagano, T; Sasakura, K; Takakura, H; Terai, T; Tsuboi, T; Ueno, T; Urano, Y | 1 |
| Chen, YJ; Gao, K; Li, Y; Qiang, Y; Zhao, J | 1 |
| Bao, C; Huang, Q; Li, C; Li, F; Lin, Q; Liu, Z; Zhu, L | 1 |
| Chowdhury, PK; Kumar, V; Mishra, RK; Upadhyay, KK | 1 |
| Govindaraju, T; Maity, D | 3 |
| Huang, ST; Lee, YH; Lin, CM; Teng, CJ; Wang, KL; Wu, JY | 1 |
| Choi, W; Kim, J; Lee, CW | 1 |
| Ghanadzadeh, A; Moghadam, M; Tajalli, H; Zakerhamidi, MS | 1 |
| Cai, Y; Chen, R; Lu, X; Lu, Y; Wei, Q | 1 |
| Das, M; Sahoo, SK | 1 |
| Jiao, J; Liao, Q; Xiang, H | 1 |
| Bai, LS; Chen, J; Liu, HF; Liu, JX; Liu, XH; Qi, XB; Song, BA; Yang, Y; Zhu, HL | 1 |
| Bagrel, D; Bana, E; Kirsch, G; Valente, S; Viry, E | 1 |
| Abad, C; Casañola-Martín, GM; Le-Thi-Thu, H; Marrero-Ponce, Y; Parmar, VS; Rescigno, A; Saso, L; Torrens, F | 1 |
| Balasubramanian, N; Cook, G; Mandal, T; Singh, RK; Srivastava, DK | 1 |
| Bencetić-Mihaljević, V; Dragojević, S; Elenkov, IJ; Gabelica-Marković, V; Ilijas, M; Klonkay, AC; Lerman, L; Malnar, I; Mesić, M; Ralić, J; Sucić, AF; Sunjić, V | 1 |
| Das, TM; Kumar, KK; Kumar, RM; Subramanian, V | 1 |
| Groothuis, GM; Merema, MT; van Midwoud, PM; Verpoorte, E | 1 |
| Baskin, JM; Beatty, KE; Bertozzi, CR; Fisk, JD; Hangauer, MJ; Lu, YY; Smart, BP; Szychowski, J; Tirrell, DA | 1 |
| Bhattacharyya, SS; Boujedaini, N; Khuda-Bukhsh, AR; Paul, S | 1 |
| Feng, L; Hu, L; Li, Y; Wang, J; Wang, Y; Zhang, P | 1 |
| Abraham, K; Fry, H; Preiss-Weigert, A; Woehrlin, F | 1 |
| Lin, W; Song, J; Yuan, L | 1 |
| Chawla, S; Khan, MS; Khan, ZH; Qaiser, D; Singh, RD | 1 |
| Coutinho, EC; Denish, K; Desai, B; Dholariya, K; Loriya, R; Manvar, A; Parecha, A; Patel, G; Shah, A; Shaikh, MS; Upadhyay, K; Virsdoia, V; Vora, V | 1 |
| Kumar, A; Kumar, M; Puri, A; Sashidhara, KV; Srivastava, A | 1 |
| Bevans, CG; Geisen, C; Müller, CR; Oldenburg, J; Rost, S; Seifried, E; Sittinger, K; Spohn, G; Watzka, M | 1 |
| Creaven, BS; Czeglédi, E; Devereux, M; Enyedy, ÉA; Foltyn-Arfa Kia, A; Karcz, D; Kellett, A; McClean, S; Nagy, NV; Noble, A; Rockenbauer, A; Szabó-Plánka, T; Walsh, M | 1 |
| Hori, Y; Kikuchi, K; Mizukami, S; Watanabe, S | 1 |
| Ananthakirshnan, R; Atta, S; Jana, A; Narayana Dhuleep, PS | 1 |
| GLEY, P; MENTZER, C | 1 |
| QUICK, AJ | 2 |
| DECAUX, F | 1 |
| HYMAN, C | 1 |
| LUCIA, SP | 1 |
| ALEXANDER, MM; MAIER, HM | 1 |
| KOSSOVE, AA | 1 |
| BILLET, D; MENTZER, C | 1 |
| KAUFMANN, J; SMITH, E | 1 |
| FACQUET, J; KISCH, R; SASSIER, R | 1 |
| NICHOL, ES; PAGE, SW | 1 |
| BASU, UP; DHAR, SP | 1 |
| NORMANT, H; PAUL, R | 1 |
| AGGELER, PM | 1 |
| DUNLOP, AP; JAQUES, LB | 1 |
| ALLEN, AW | 1 |
| BERRETA, JA; COSSIO, P | 1 |
| MEYER, OO; THILL, CJ | 2 |
| BOSE, AN | 1 |
| COTLOVE, E; VORZIMER, JJ | 1 |
| Becker, A; Becker, C; Brenner, C; Franz, WM; Huber, B; Ostermann, H; Steinbeck, G | 1 |
| Abenavoli, MR; Lupini, A; Miller, AJ; Sorgonà, A | 1 |
| Codognoto, L; de Oliveira, HP; Marcolan, M; Martins, PA; Pedrosa, VA; Rodrigues, MR | 1 |
| An, R; Li, Y; Wang, X; You, L | 1 |
| Hoshino, T; Li, W; Liu, G; Shen, J; Tang, Y | 1 |
| Florijn, KW; Haringsma, J; Kuipers, EJ; Veldt, BJ | 1 |
| de Kleijn, DP; de Vries, JP; Derksen, WJ; Moll, FL; Pasterkamp, G; Peeters, W; Tersteeg, C; van der Wal, AC; Vink, A | 1 |
| Liu, T; Méndez, C; Rohr, J; Salas, JA; Shepherd, MD | 1 |
| Li, F; Liang, W; Sun, X; Wang, Y | 1 |
| Kim, HJ; Kwon, H; Lee, K | 1 |
| He, S; Huang, S; Lu, Y; Wei, F; Zeng, X; Zhao, L | 1 |
| Fleita, DH; Mohareb, RM; Sakka, OK | 1 |
| Kerkines, IS; Petsalakis, ID; Rebek, J; Theodorakopoulos, G | 1 |
| Ghosh, HN; Nibbering, ET; Verma, S | 1 |
| Shi, Y; Zhou, CH | 1 |
| El-Agrody, AM; Khattab, ES; Mohamed, HM; Motlaq, SS; Sabry, NM | 1 |
| Gobec, S; Hribar, G; Kocbek, P; Rižner, TL; Starčević, S | 1 |
| Makris, M; Van Veen, JJ | 1 |
| Aziz, A; Cha, TS; Chen, CF; Loh, SH; Yee, W | 1 |
| Aswal, VK; Dey, S; Gangully, R; Kumbhakar, M; Nath, S; Pal, H; Satpati, AK; Singh, PK | 1 |
| Bartsch, RA; Kim, HJ; Kim, JS; Kim, JW; Ko, KC; Kwon, PS; Lee, JY; Wu, JS | 1 |
| Abraham, K; Götz, M; Gundert-Remy, U; Lampen, A; Luch, A; Mielke, H; Vieth, B | 1 |
| Altucci, L; Botta, G; Carafa, V; Mai, A; Nebbioso, A; Rotili, D; Tarantino, D | 1 |
| Delogu, G; Ferino, G; Picciau, C; Podda, G; Quezada, E; Uriarte, E; Viña, D | 1 |
| Fang, Y; Li, JY; Liu, K; Yao, C; Zhao, TC; Zhou, Y | 1 |
| Jung, HS; Kang, C; Kim, GH; Kim, JS; Ko, KC; Lee, AR; Lee, JY; Na, YC | 1 |
| Conti, F; Cristalli, G; Giuliani, C; Maggi, F; Papa, F; Sagratini, G; Vittori, S | 1 |
| Hatanaka, Y; Kato, K; Kishi, H; Masuda, S; Tomohiro, T | 1 |
| Aguirre-Pranzoni, C; Ardanaz, CE; Bisogno, FR; Kurina-Sanz, M; Orden, AA; Tonn, CE | 1 |
| Chen, JJ; Li, KT; Yang, DY | 1 |
| Abd El Galil, KH; Futamura, Y; Koito, A; Najimudin, N; Ong, EB; Osada, H; Saito, A; Watanabe, N | 1 |
| Campos, FR; de Francisco, TM; Gasparetto, JC; Pontarolo, R | 1 |
| De Clercq, E; Hwu, JR; Leyssen, P; Lin, SY; Neyts, J; Tsay, SC | 1 |
| Anzenbacher, P; Palacios, MA | 1 |
| El-Zahab, B; Ganea, GM; Kolic, PE; Warner, IM | 1 |
| Albertazzi, L; Amir, RJ; Hawker, CJ; Kang, T; Khan, A; Willis, J | 1 |
| Miller, RH; Wang, C; Wang, Y; Wu, C; Zhu, J | 1 |
| Ghosh, M; Manna, P; Sil, PC | 1 |
| Adlakha, P; Bavishi, A; Bhavsar, D; Parekh, S; Parmar, M; Radadiya, A; Savant, M; Shah, A; Thakrar, S; Upadhyay, K; Vala, H | 1 |
| Jerković, I; Marijanović, Z; Staver, MM | 1 |
| Ast, S; Flehr, R; Holdt, HJ; Klamroth, T; Müller, H; Walz, B | 1 |
| Kikuchi, K; Mizukami, S; Sadhu, KK; Watanabe, S | 1 |
| Hirai, T; Shiraishi, Y; Sumiya, S | 2 |
| Iwasaki, S; Maeda, H; Shinohara, Y; Tsukamoto, K | 1 |
| Gonzalez-Velasquez, FJ; Moss, MA; Murphy, BP; Soto-Ortega, DD; Wang, Q; Wilson, KA; Xie, F | 1 |
| Abraham, K; Lampen, A; Pfister, M; Wöhrlin, F | 1 |
| Bhattacharyya, K; Das, AK; Mondal, T; Sen Mojumdar, S | 1 |
| Cheng, Y; Dong, Y; Jiang, X; Li, J; Song, F; Zhu, C | 1 |
| Kanazawa, T; Okada, H; Takashima, Y; Taki, H; Tanaka, K | 1 |
| Dawn, S; Dewal, MB; Krause, JA; Paderes, MC; Pellechia, PJ; Shimizu, LS; Smith, MD; Sobransingh, D; Wibowo, AC | 1 |
| Ho, D; Lomize, AL; Lugo, MR; Merrill, AR; Pogozheva, ID; Schwan, AL; Singh, SP | 1 |
| Bulut, M; Durmuş, M; Esenpınar, AA | 1 |
| Bettis, SE; Brennaman, MK; Concepcion, JJ; Forbes, MD; Hampton, SD; Lebedeva, NV; Meyer, TJ; Miller, SA; Moran, AM; Papanikolas, JM; Paul, JJ; Westlake, BC | 1 |
| Lin, HH; Wang, MQ; Yu, XQ; Zhang, DW; Zhang, J; Zhang, Y | 1 |
| Ahamed, BN; Ghosh, P | 1 |
| Geibel-Zehender, A; Gohlke-Bärwolf, C; Kruck, I; Regitz-Zagrosek, V; Schaefer, C; Seeland, U | 1 |
| Chamseddine, N; Djaffar-Jureidini, I; Hakime, N; Keleshian, S; Naoufal, R; Zahed, L | 1 |
| Guru, BR; Hali, M; McPharlin, CM; Panyam, J; Toti, US; Whittum-Hudson, JA; Wykes, SM | 1 |
| Badami, PS; Kulkarni, AD; Naik, VH; Patil, SA; Unki, SN | 1 |
| Chen, YG; Hua, Y; Li, XY; Li, Y; Liu, JP; Wang, JH; Wang, LQ; Wang, YY; Wu, MM | 1 |
| Chen, YD; Kong, LY; Wang, T; Wang, XB; Zhou, X | 1 |
| Brustad, E; Chapman, E; Charbon, G; Jacobs-Wagner, C; Løbner-Olesen, A; Schultz, PG; Scott, KA; Wang, J | 1 |
| Matos, MJ; Santana, L; Uriarte, E; Vazquez-Rodriguez, S; Viña, D | 1 |
| Liu, W; Wang, P; Wu, J; Zhang, H; Zhuang, X | 1 |
| Liu, W; Ma, J; Sheng, R; Wang, P; Wu, J; Zhang, H; Zhuang, X | 1 |
| Chang, SY; Chao, YK; Chao, YS; Hsieh, HP; Kao, CL; Ke, YY; Lee, CN; Lin, PH; Shiao, HY; Su, CT | 1 |
| Mohanty, C; Parhi, P; Sahoo, SK | 1 |
| Arshad, A; Bagley, MC; Lam, CK; Mohamad, S; Osman, H; Zahariluddin, AS | 1 |
| Pohnert, G; Ross, C; Welling, M | 1 |
| Bhatia, G; Khanna, AK; Kumar, M; Modukuri, RK; Rai, S; Sashidhara, KV; Shukla, R; Sonkar, R | 1 |
| Aguilera, JA; Konigsfeld, KM; Milligan, JR; Perry, CC; Tang, VJ | 1 |
| Alizadeh, BH; Ardestani, SK; Dehghan, G; Emami, S; Foroumadi, A; Khoobi, M; Ramazani, A; Safavi, M; Shafiee, A | 1 |
| Bhatia, SN; Chen, AA; Golub, TR; Ong, LL; Schwartz, RE; Thomas, DK | 1 |
| Goody, RS; Itzen, A; Sun, H; Triola, G; Waldmann, H; Wu, YW; Yi, L | 1 |
| Cheng, Y; Guo, J; Lin, A; Shi, Y; Zhu, C; Zhu, X | 1 |
| Balzarini, J; Cetina, M; Clercq, ED; Makuc, D; Mintas, M; Muratović, S; Nagl, A; Plavec, J; Završnik, D | 1 |
| Govender, P; Govender, T; Kruger, HG; Maguire, GE; Pietersen, LK | 1 |
| Huang, XY; Shan, ZJ; Su, L; Zhai, HL; Zhang, XY | 1 |
| Miao, C; Shi, Y | 1 |
| Braunbeck, T; Broschard, TH; Huebler, N; Strecker, R; Weigt, S | 1 |
| Das, D; Guha, S; Hauli, I; Lohar, S; Mukhopadhyay, SK | 1 |
| Lee, B; Scopelliti, R; Severin, K | 1 |
| Cole, EL; Johnson, JR; Lampkins, AJ; Lee, JJ; O'Neil, EJ; Smith, BA; Smith, BD | 1 |
| Abraham, R; Basavarajaswamy, G; Giles, D; Mathew, V; Sandhya, B | 1 |
| Capelo, JL; Lodeiro, C; Nuñez, C; Oliveira, E; Rodríguez-González, B | 1 |
| Murayama, N; Nakanishi, Y; Uehara, S; Uno, Y; Yamazaki, H; Zeldin, DC | 1 |
| Bereczky, Z; Boda, Z; Olah, Z; Szarvas, M | 1 |
| Han, JH; Jung, HS; Kang, C; Kim, JS; Kim, ZH | 1 |
| Cornish, VW; Jing, C | 1 |
| Barboni, L; Caprioli, G; Maggi, F; Papa, F; Ricciutelli, M; Sagratini, G; Vittori, S | 1 |
| Chen, M; Guo, W; Li, JF; Liu, J; Lv, X; Sun, YQ | 1 |
| Bai, D; Cheng, J; Hou, F; Huang, L; Li, Z; Liu, H; Shi, Y; Xi, P; Xie, G; Xie, K; Zeng, Z | 1 |
| Berntorp, K; Hlebowicz, J; Lindstedt, S; Nilsson, J; Wickenberg, J | 1 |
| Cam, G; Crémault, A; Gatault, P; Kwetcheu, AT; Laruelle, E; Le Cacheux, P; Queffeulou, G; Renaudineau, E; Rioux-Leclercq, N; Siohan, P; Vigneau, C | 1 |
| Delaporte, E; Rodrigues, AD | 1 |
| Bonvini, P; Cozza, G; Gianoncelli, A; Meggio, F; Moro, S; Pasquale, R; Pinna, LA; Rosolen, A; Zagotto, G; Zorzi, E | 1 |
| Grote, JG; Navarathne, D; Ner, Y; Sotzing, GA | 1 |
| Geng, RX; Ji, QG; Shi, Y; Zhou, CH; Zhou, XD | 1 |
| Gelb, MH; Hui, R; Spáčil, Z; Tureček, F | 1 |
| Hirai, T; Manabe, K; Shiraishi, Y; Sumiya, S | 1 |
| Guo, W; Liu, J; Liu, Y; Lv, X; Sun, YQ; Wang, P; Zhao, Y | 1 |
| Chiang, PH; Hsu, FL; Huang, CH; Huang, YS; Huang, ZY; Liao, JH; Lin, MH; Wu, SH; Wu, TH | 1 |
| Ampasavate, C; Anuchapreeda, S; Iangcharoen, P; Kasinrerk, W; Limtrakul, P; Punfa, W; Yodkeeree, S | 1 |
| Cohen, JD; Liu, DS; Slavoff, SA; Ting, AY | 1 |
| Di Stasi, LC; Felisbino, SL; Gálvez, J; Garrido-Mesa, N; Hiruma-Lima, CA; Luchini, AC; Utrilla, P; Witaicenis, A | 1 |
| Chen, ZZ; Deng, SP; Huang, JG; Huang, Y; Li, J; Li, LQ; Li, S; Su, XJ; Wu, Q; Yang, RY | 1 |
| Garza, J; Ramírez, JZ; Vargas, R | 1 |
| Carta, F; Maresca, A; Scozzafava, A; Supuran, CT | 1 |
| Fernandes, A; Guo, W; Hensenne, P; Jonas, AM; Mathy, B; Nysten, B; Riant, O | 1 |
| Alexander, J; Fotland, TØ; Husøy, T; Paulsen, JE; Sanner, T | 1 |
| Anish, C; Bagchi, T; Jinturkar, KA; Kumar, MK; Misra, AR; Panda, AK | 1 |
| Bao, C; Cheng, S; Fan, G; Huang, Q; Li, B; Lin, Q; Zhu, L | 1 |
| Li, J; Li, X; Wang, S | 1 |
| Geister, L; Jüni, P; Kalesan, B; Mattle, HP; Meier, B; Mono, ML; Nedeltchev, K; Praz, F; Räber, L; Wahl, A; Windecker, S | 1 |
| Bain, CP; Humphries, WH; Kemp, ML; Murthy, N; Payne, CK; Reddie, KG | 1 |
| Dilnawaz, F; Jagannathan, NR; Mewar, S; Sahoo, SK; Sharma, U; Singh, A | 1 |
| Menezes, AH; Vogel, TW | 1 |
| Arbelbide, J; Argibay, PF; Belloso, WH; Garfi, LG; Redal, MA; Scibona, P | 1 |
| Bonneau, A; Maresca, A; Supuran, CT; Winum, JY | 1 |
| Cao, D; Wang, L; Ye, D | 1 |
| Chen, S; Hong, J; Hong, Y; Li, Z; Liu, T; Zeng, S; Zheng, M | 1 |
| Bourbon, P; Ferraudi, G; Helquist, P; Peng, Q; Stauffacher, C; Wiest, O | 2 |
| Banerjee, A; Das, D; Guha, S; Hauli, I; Lohar, S; Matalobos, JS; Mukherjee, SK; Sahana, A | 1 |
| Lapalikar, GV; Oakeshott, JG; Russell, RJ; Scott, C; Taylor, MC; Warden, AC | 1 |
| Bi, K; Cui, S; Jia, Y; Liang, K; Qian, Z; Zhang, Q | 1 |
| Guo, H; James, TD; Ji, S; Shao, J; Wu, W; Zhao, J | 1 |
| Kido, J; Nakata, G; Pu, YJ; Sasabe, H; Satoh, F; Yokoyama, D | 1 |
| Capelo, JL; Lima, JC; Lodeiro, C; Oliveira, E | 1 |
| de Graaf, IA; Groothuis, GM; Koenderink, JB; Russel, FG; Siissalo, S; van den Broek, PH; van den Heuvel, JJ; Wittgen, HG | 1 |
| Almqvist, F; Bengtsson, C; Chorell, E; Cusumano, CK; Edvinsson, S; Hultgren, SJ; Johansson, LB; Pinkner, JS; Rosenbaum, E | 1 |
| Brée, F; Obach, R; Peraire, C; Solà, J; Ventura, V | 1 |
| Chung, JW; Lee, K; Neikirk, C; Nelson, CM; Priestley, RD | 1 |
| Liu, X; Pan, J; Spring, DR; Xu, Z | 1 |
| Hwang, KC; Kundu, P | 1 |
| de Cuendias, A; Gayet, F; Haddleton, DM; Mackenzie, SR; O'Connell, MA; Shirley, IM; Unwin, PR | 1 |
| Cheng, Y; Fu, Y; Xing, Z; Zhou, J; Zhu, C | 1 |
| Alici, B; Arslan, O; Cakir, U; Cetinkaya, E; Demir, D; Ergün, A; Gençer, N; Karatas, MO | 1 |
| Atta, S; Ikbal, M; Kumar, A; Pradeep Singh, ND | 1 |
| Kiuchi, F; Narukawa, Y; Oshima, N; Takeda, T | 1 |
| Garrard, I; Głowniak, K; Mroczek, T; Skalicka-Woźniak, K | 1 |
| Colucci, G; Meierhofer, S; Steiner, S | 1 |
| Mostard, GJ; Thijssen, AY | 1 |
| Beyersmann, J; Di Termini, S; Hieke, S; Schumacher, M | 1 |
| Chen, Y; He, W; Liu, Z; Lu, Y; Wang, X; Yang, Z | 1 |
| Chen, X; Liu, X; Wu, L; Zhang, Q; Zhu, J | 1 |
| Hao, BX; Lee, HC; Yu, PL; Yue, J; Zhang, L; Zhang, LH; Zhang, ZH; Zhao, YJ | 1 |
| Chen, X; Li, H; Li, Y; Liu, Y; Yang, J; Zhang, D; Zhang, F; Zhang, S; Zhou, W | 1 |
| Barth, A; Baumann, A; Dekowski, B; Eichhorst, J; Eisenhardt, D; Eremina, N; Hagen, V; Keller, S; Marter, K; Schaal, J; Vargas, C; Wiesner, B | 1 |
| Carrier, M; Dao, V; Kovacs, MJ; Lazo-Langner, A; Lee, AY; Louzada, ML; Meyer, G; Ramsay, TO; Rodger, MA; Wells, PS; Zhang, J | 1 |
| Gao, H; Wei, B; Yang, R; Yu, W | 1 |
| Scott, EE; Stephens, ES; Walsh, AA | 1 |
| Chongchivivat, A; Dakanali, M; Do, TH; Guizzunti, G; Haidekker, MA; Horn, A; Jarusreni, T; Lichlyter, D; Theodorakis, EA | 1 |
| Grúz, J; Hedbavny, J; Klejdus, B; Kováčik, J; Stork, F | 1 |
| Rahnasto-Rilla, M; Raunio, H | 1 |
| Kim, JC; Seo, SR | 1 |
| Ng, DY; Wang, T; Weil, T; Wu, Y | 1 |
| Das, N; Kumar, P; Moorthy, NS; Shrivastava, SK; Shukla, S; Srivastava, RS; Trivedi, P | 1 |
| Blahová, J; Svobodová, Z | 1 |
| Alves, PB; Andrade, MS; Bezerra, DP; Blank, AF; Carvalho, AA; Costa, EV; da Silva, TB; de Jesus, AM; de Jesus, JR; de Moraes, MO; dos Anjos, CS; Gomes, WF; Moraes, VR; Nogueira, PC; Pessoa, C; Pinheiro, ML; Prata, AP; Ribeiro, SS; Sampaio, TS; Santos, AD; Silva-Mann, R | 1 |
| He, Z; Huang, R; Liang, M; Liu, R; Qi, W; Su, R; Wang, M | 1 |
| Murphy, SE; Retzlaff, C; von Weymarn, LB | 1 |
| Ferlazzo, A; Lannazzo, D; Lanza, M; Milone, C; Piperno, A; Pistone, A; Romeo, G; Romeo, R | 1 |
| Han, JH; Heo, KJ; Jung, HS; Kang, C; Kim, JS; Lee, JH; Pradhan, T | 1 |
| Laurenti, M; López-Cabarcos, E; Rubio-Retama, J; Ruiz-Cabello, J; Serrano-Ruiz, D | 1 |
| Baba, R; Hori, Y; Kikuchi, K; Mizukami, S | 1 |
| Gai, F; Hou, W; Huo, Q; Li, X; Li, Y; Liu, Y; Xu, D; Yang, X; Zhang, L; Zhao, X; Zhou, T | 1 |
| Alouane, A; Aujard, I; Dubruille, S; Gautier, A; Jullien, L; Labruère, R; Le Saux, T; Pelupessy, P; Schmidt, F | 1 |
| Aparecida de Oliveira Pinto, M; Brumano, L; Castro, HC; da Penha Henriques do Amaral, M; da Santos da Silva, LS; de Sá Martins Muller, C; Fabri, RL; Moreira Dias, LO; Scio, E; Soares e Silva, LS; Stringheta, PC | 1 |
| Aldwayyan, AS; Alsalhi, MS; Ibnaouf, KH; Masilamani, V; Prasad, S | 1 |
| Azerang, P; Rezayan, AH; Sardari, S; Sarvary, A | 1 |
| Borrmann, A; Dommerholt, J; Lemke, EA; Milles, S; Plass, T; Schultz, C; van Delft, FL; van Hest, JC; Verkade, JM; Wiessler, M | 1 |
| De Malsche, W; Lynen, F; Majeed, B; Van Hoof, C; Zhang, L | 1 |
| Gebhardt, P; Haidasz, E; Hanthorn, JJ; Pratt, DA | 1 |
| Molleti, N; Ray, SK; Singh, PK; Singh, VK | 1 |
| Chen, T; Lee, LW; Lin, MH; Lin, PY; Ou, KL; Sheu, SY; Su, CL; Yeh, KS | 1 |
| Avinash, MB; Govindaraju, T; Schmuck, C; Verheggen, E | 1 |
| Chen, L; Lei, S; Liu, J; Wang, M; Wu, F; Zhao, L; Zhao, Z | 1 |
| Prabu, SL; Suriyaprakash, TN; Thiyagarajan, S | 1 |
| Du, L; Li, M; Li, W; Sun, W; Yu, X | 1 |
| Balijepalli, A; Chien, M; Hellner, B; Ju, J; Kasianowicz, JJ; Kumar, S; Li, Z; Reiner, JE; Robertson, JW; Russo, JJ; Tao, C | 1 |
| Bhattacharya, K; Creaven, BS; Duffy, B; Jaiswal, S; Laffir, F; McHale, P; Sullivan, M; Walsh, M | 1 |
| Kalle, AM; Kumar, CS; Kumar, GP; Kumar, KR; Mulakayala, C; Mulakayala, N; Oruganti, S; Pal, M; Rambabu, D; Rao, MV | 1 |
| Desai, KG; Olsen, KF; Reinhold, SE; Schwendeman, SP; Zhang, L | 1 |
| Chen, NH; Li, CJ; Shi, J; Yang, JZ; Yuan, YH; Zhang, DM | 1 |
| Brown, PJ; Brun, YV; Cava, F; de Pedro, MA; Hall, E; Hughes, HV; Kuru, E; Tekkam, S; VanNieuwenhze, MS | 1 |
| Badisa, VL; Latinwo, LM; Musa, MA; Owens, MA; Patterson, TA | 1 |
| Cao, S; Gao, H; Jiang, X; Pang, Z; Xi, Z; Yang, Z; Zhang, S | 1 |
| Legoabe, LJ; Petzer, A; Petzer, JP | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Xia, H; Yao, L | 1 |
| Abrahamsen, B; Bunch, L; Gonzalez-Franquesa, A; Huynh, TH; Jensen, AA; Madsen, KK | 1 |
| Chen, HY; Chien, MW; Lai, CC; Li, LJ; Liu, CW; Su, CY | 1 |
| Jin, L; Kan, Y; Li, H; Wen, Z; Yin, B | 1 |
| Kumar, P; Patel, KK; Thakkar, HP | 1 |
| Gutjahr, G; Kapfhammer, HP; Lafer, I; Reininghaus, B; Reininghaus, EZ; Schmidt, H; Schmidt, SM; Stepan, V | 1 |
| Altman, RB; Au, NT; Borgiani, P; Botton, MR; Carlquist, JF; Cavallari, LH; Chowbay, B; Ciccacci, C; Danese, E; Fava, C; Guidi, GC; Horne, BD; Huang, M; Johnson, JA; Khalifa, SI; Kringen, MK; Langaee, T; Lee, MT; Loriot, MA; Lubitz, SA; Minuz, P; Montagnana, M; Mushiroda, T; Nakamura, Y; Pengo, V; Pirmohamed, M; Rettie, AE; Sagreiya, H; Scott, SA; Shahin, MH; Siguret, V; Stricker, BH; Suarez-Kurtz, G; Suriapranata, IM; Taljaard, M; Teichert, M; Zambon, CF; Zhang, JE; Zhang, X; Zhao, L | 1 |
| Bhusal, RP; Cho, P; Chong, CK; Kim, HS; Kim, SY; Lee, B; Park, B; Park, H; Song, HO; Yu, K | 1 |
| Hu, W; Jiang, H; Li, J; Xia, H; Zhang, Q; Zou, G | 1 |
| Bast, A; Bekers, O; Drent, M; Verschakelen, JA; Wijnen, PA | 1 |
| Balastrier, M; Beattie, KD; Carroll, AR; Choomuenwai, V; Davis, RA; Levrier, C; Martin, F | 1 |
| Bibila Mayaya Bisseyou, Y; Bouhmaida, N; Ghermani, N; Guillot, B; Jelsch, C; Lecomte, C; Lugan, N | 1 |
| Dunckley, T; Gokhale, V; Hulme, C; Medda, F; Smith, B | 1 |
| Brandenburg, V; Floege, J; Krüger, T; Marx, N; Schlieper, G | 1 |
| Abdalla, MM; Abdelhafez, OM; Ali, HI; Amin, KM; Batran, RZ | 1 |
| Ali, Z; Kumar, DA; Kumar, JA; Raju, BC; Saidachary, G; Sridhar, B; Tiwari, AK | 1 |
| Chen, DD; Miao, F; Qin, BF; Wang, Y; Yang, R; Yang, XJ; Zhou, L | 1 |
| Chen, CT; Lin, YC | 1 |
| Carotti, A; Catto, M; Cellamare, S; Leonetti, F; Nicolotti, O; Pesce, P; Pisani, L; Stefanachi, A | 1 |
| Hayashida, Y; Hidaka, Y; Lhieochaiphant, S; Morinaga, O; Sakamoto, A; Shoyama, Y; Tung, NH; Uto, T | 1 |
| Chao, J; Chu, Y; Huo, F; Jin, S; Wang, L; Yan, X; Yang, Y; Yin, C; Zhang, Y; Zheng, A; Zhi, P | 1 |
| Fang, H; Hou, X; Li, M; Wang, B; Yang, X | 1 |
| Chang, J; Gu, Z; He, B; Li, Y; Wang, G | 1 |
| Hou, JT; Li, K; Wu, MY; Yu, KK; Yu, XQ | 1 |
| Bellare, JR; Datta, A; De, D; Narayanan, J; Sajjan, M | 1 |
| Baskaran, N; Karthikeyan, S; Manoharan, S; Prabhakar, MM | 1 |
| Avula, SR; Bathula, SR; Palnati, GR; Sashidhara, KV; Sharma, K | 1 |
| Cen, J; Chen, J; Chen, Y; Guo, Z; He, W; He, Y; Jiao, Y; Qiu, L; Yang, Z; Zhu, C | 1 |
| Abou-Seri, SM; Amin, KM; Awadallah, FM; Eissa, AA; Hassan, GS | 1 |
| Abenavoli, MR; Araniti, F; Lupini, A; Sunseri, F | 1 |
| Caduff Good, A; Geisen, C; Henz, S; Krähenbühl, S; Nobel, D | 1 |
| Borbas, KE; Ilchenko, NO; Pershagen, E; Szíjjártó, C | 1 |
| Basu, A; Chudayeu, M; Costa, PR; de Moraes, Pde F; Kaushik-Basu, N; Leão, RA; Nichols, DB; Talele, TT | 1 |
| Andrade, MF; Azzolini, AE; Emery, FS; Figueiredo-Rinhel, AS; Kabeya, LM; Lucisano-Valim, YM; Paris, MR; Pupo, MT; Santos, EO | 1 |
| Wu, J | 1 |
| Jessurun, NT; van Puijenbroek, EP | 1 |
| Hatanaka, Y; Maruyama, N; Morimoto, S; Tomohiro, T | 1 |
| Hutadilok-Towatana, N; Panthong, K; Rukachaisirikul, V; Srisud, Y; Tewtrakul, S; Voravuthikunchai, SP | 1 |
| Hu, XJ; Kong, LY; Wang, XB | 1 |
| Hirano, T | 1 |
| Berka, K; Otyepka, M; Paloncýová, M | 1 |
| Müllers, KC; Pinto, JF; Wahl, MA | 2 |
| Bertolucci, SK; Braga, FC; Oliveira, AB; Pereira, AB; Pinto, JE | 1 |
| Ezeh, VC; Harrop, TC | 1 |
| Lu, Y; Zhai, X | 1 |
| Jiang, TY; Lv, HX; Zhang, YL; Zhang, ZH; Zhou, JP | 1 |
| Garfunkel, E; Lai, J; Lee, KB; Shah, BP | 1 |
| Schulman, S | 1 |
| Bhuniya, S; Han, JH; Jeon, HM; Kang, C; Kim, JS; Lee, JH; Maiti, S; Park, N | 1 |
| Chung, JW; Neikirk, C; Priestley, RD | 1 |
| Fontenla, JA; Friedman, C; Gonzalez-Franco, RM; Matos, MJ; Santana, L; Tatonetti, NP; Uriarte, E; Vilar, S; Viña, D | 1 |
| Cheng, Q; Guengerich, FP | 1 |
| Bari, SB; Deshmukh, PK; Donda, ST; Firke, SD; Patil, DA; Patil, PO | 1 |
| Cappendijk, SL; Miksys, S; Perry, WM; Tyndale, RF; Zhao, B | 1 |
| Garg, V; Gust, D; Kodis, G; Liddell, PA; Moore, AL; Moore, TA; Terazono, Y | 1 |
| Bag, S; Foster, M; Ghosh, S; LeVine, H; Schifone, C; Sood, A; Török, B; Török, M; Tulsan, R; Zhou, W | 1 |
| Abo-Dya, NE; Asiri, A; Avan, I; Basak, AK; Biswas, S; Katritzky, AR | 1 |
| Artur, Y; Berdeaux, O; Chevalier, J; Heydel, JM; Jakob, I; Le Bon, AM; Ménétrier, F; Sicard, G; Thiebaud, N; Veloso Da Silva, S | 1 |
| Hu, W; Li, J; Xu, Y; Zhang, Q; Zou, G | 1 |
| Chattopadhyay, AP; Fröhlich, R; Ghosh, K; Kar, D; Khuda-Bukhsh, AR; Samadder, A | 1 |
| Deb, R; Dube, D; Nahar, R; Parakh, R; Saxena, R; Singh, TP; Verma, IC | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, M; Jiang, X; Kang, T; Liu, Z; Miao, D; Pang, Z; Song, Q; Tu, Y; Yao, L | 1 |
| Chao, J; Huo, F; Li, Y; Liu, D; Martínez-Máñez, R; Nie, Z; Yang, Y; Yin, C; Zheng, A | 1 |
| Jin, X; Sun, G; Wu, X; Zhou, X | 1 |
| Ahn, J; Moon, MK; Um, MY; Youl Ha, T | 1 |
| Borges, F; Kachler, S; Klotz, KN; Matos, MJ; Santana, L; Uriarte, E; Vazquez-Rodriguez, S | 1 |
| Avula, B; Khan, IA; Nanayakkara, NP; Wang, YH; Zhao, J | 1 |
| Chen, H; Chen, J; Gao, X; Gu, G; Hu, Q; Jiang, X; Kang, T; Liu, Z; Pang, Z; Song, Q; Tu, Y; Yao, L | 1 |
| Alquézar, JB; Arteaga, JF; Barrero, AF; Burón, PA; Coloma, AG; Díaz, CE; Herrador del Pino, MM; Portero, AG | 1 |
| Kerr, R; Ogden, G; Sime, G | 1 |
| Cai, BC; Li, L; Li, WD; Lu, TL; Yin, FZ | 1 |
| Chockalingam, S; Dhandapani, RK; Panchamoorthy, R; Thada, R | 1 |
| Kong, LY; Li, JY; Wang, XB; Xie, SS; Yang, L | 1 |
| Guo, M; Hou, J; Lu, Y; Rong, WT; Wang, DF; Wang, Y; Xu, Q; Yu, SQ | 1 |
| Al-Kady, AS; Ebeid, el-ZM; El-Shekheby, HA; Hamza, SM; Mangood, AH | 1 |
| Cao, J; Chae, WS; He, Y; Jung, H; Kang, C; Kim, JS; Lee, JH; Park, N; Peng, X; Suh, M; Yang, Z | 1 |
| Lin, CH; Yang, DY | 1 |
| Hussein, GM; Liu, J; Matsuda, H; Matsuo, K; Nakamura, S; Yoshikawa, M; Zhuang, Y | 1 |
| Kang, YJ; Kim, CH; Kim, SJ; Kim, SS; Lim, SM; Park, SH; Sim, YB; Suh, HW | 1 |
| Schmollngruber, M; Schröder, C; Steinhauser, O | 1 |
| Khan, MS; Khan, ZH; Qaiser, D; Singh, RD | 1 |
| Aun, R; Belczak, SQ; Beserra, J; Campos, W; Nering, G; Sincos, IR | 1 |
| Fang, Y; Gu, Y; Wang, Y; Wu, F; Zhao, H; Zhao, Y; Zou, Q | 1 |
| Fardim, P; Heinze, T; Kotiaho, A; Niemi, M; Wondraczek, H | 1 |
| Li, Y; Liu, H; Liu, J; Wang, C; Yao, J; Zhou, Z | 1 |
| Duan, YT; Qin, YJ; Qiu, HY; Sang, YL; Wang, PF; Wang, YT; Wang, ZC; Wen, Q; Yang, YA; Zhang, X; Zhu, HL | 1 |
| Amaro, M; Brezovský, J; Chaloupková, R; Damborský, J; Hof, M; Kováčová, S; Maier, L; Paruch, K; Sýkora, J | 1 |
| Chen, S; Heinis, C; Lee, B; Scopelliti, R; Severin, K | 1 |
| Chai, T; Fu, HY; Gao, PF; Guo, YL; Huang, GH; Liao, H; Yan, B | 1 |
| Chen, N; Hu, J; Kong, L; Liu, G; Song, X; Sun, M; Sun, Y; Wang, D; Wang, Y; Wu, D | 1 |
| Caballero, J; Cassels, BK; García-Beltrán, O; Mena, N; Nuñez, MT; Vargas, V; Yañez, O | 1 |
| Bai, H; Qian, J; Sun, Q; Tian, H; Zhang, W | 1 |
| Oliveira, G; Pinto, JF; Wahl, MA | 2 |
| Ha, Y; Kim, BY; Kim, YK; Park, HR | 1 |
| Das, P; Reddy, CB; Saroach, RP; Sharma, D; Shil, AK | 1 |
| Dai, X; Liu, K; Su, H; Wu, L; Yu, Y; Zou, X | 1 |
| Dai, J; Kim, JC | 1 |
| Chen, H; Gu, Y; Li, S; Li, X; Wang, K; Yao, Y; Zhao, J; Zhou, L | 1 |
| Akimoto, I; Motegi, K; Nishizono, N; Oda, K; Wada, K; Yamaguchi, Y; Yoshimura, T | 1 |
| Pouyfung, P; Prasopthum, A; Rongnoparut, P; Sarapusit, S; Srisook, E | 2 |
| Geng, Y; Gu, Z; He, B; Lai, Y; Li, S; Luo, S; Pan, S | 1 |
| Hayen, H; Krieger, S; Schmitz, OJ | 1 |
| Fang, CW; Liu, SJ; Pan, L; Wu, WL; Xiang, JR; Yu, NJ | 1 |
| Chen, D; Gan, Y; Xia, D; Yu, H; Zhu, C; Zhu, Q | 1 |
| Dankesreiter, S; Fehl, C; König, B; Schroll, P | 1 |
| Aillard, P; Banwell, MG; Cervi, A; Chai, CL; Hazeri, N; Petit, L; Willis, AC | 1 |
| Ge, JF; Liu, XD; Lu, JM; Sun, R; Xu, Y; Xu, YJ | 1 |
| Alipour, M; Foroumadi, A; Ghandi, M; Khoobi, M; Moradi, A; Nadri, H; Razavi, SF; Sakhteman, A; Shafiee, A | 1 |
| Choi, S; Connelly, S; Kelly, JW; Kim, B; Myung, N; Park, SJ; Wilson, IA | 1 |
| Taddei, P; Tozzi, S; Zanna, N | 1 |
| Liu, ZQ; Xi, GL | 4 |
| Hatanaka, Y; Inoguchi, H; Masuda, S; Tomohiro, T | 1 |
| Chaicham, A; Sahasithiwat, S; Tomapatanaget, B; Tuntulani, T | 1 |
| Bazzicalupi, C; Caltagirone, C; Cao, Z; Chen, Q; Di Natale, C; Garau, A; Lippolis, V; Liu, H; Lundström, I; Lvova, L; Mostallino, MC; Nieddu, M; Paolesse, R; Prodi, L; Sgarzi, M; Zaccheroni, N | 1 |
| Ma, X; Qu, DH; Tian, H; Zhang, Q | 1 |
| Buckup, T; Krauter, CM; Möhring, J; Motzkus, M; Pernpointner, M | 1 |
| Chanu, MB; Mahendra, M; Puttaraju, KB; Rai, K; Rasal, VP; Shivashankar, K; Venkata Vivek, PN | 1 |
| Khoshroo, A; Mazloum-Ardakani, M | 1 |
| Cserép, GB; Herner, A; Kele, P; Wolfbeis, OS | 1 |
| Cao, YC; Liang, XL; Liao, ZG; Luo, Y; Zhang, J; Zhao, GW; Zhao, LJ; Zhu, ML | 1 |
| An, Y; Chen, FM; Gao, LN; Jin, Y; Lei, M; Li, B; Lu, H; Yang, H | 1 |
| Das, AK; Goswami, S; Maity, S | 1 |
| Bourgaud, F; Dugrand, A; Duval, T; Froelicher, Y; Hehn, A; Olry, A | 1 |
| Kariyappa, AK; Nagamallu, R | 1 |
| Cao, Z; Chen, Z; Dai, J; Di, Z; Feng, J; Feng, Y; Hao, P; He, X; He, Y; Hong, W; Hu, J; Hu, Y; Huang, K; Huang, W; Jiang, D; Kong, Y; Li, T; Li, W; Li, X; Li, Y; Li, Z; Liu, H; Pan, B; Shen, Z; Sheng, J; Wang, B; Wu, Y; Xing, X; Xu, X; Yang, W; Yang, X; Yu, Y; Yuan, B; Zhang, B; Zhao, G; Zhao, W | 1 |
| Chen, PT; Cheng, TJ; Cheng, WC; Fang, JM; Fu, WC; Huang, LY; Huang, SH; Huang, WF; Wong, CH; Wu, WS | 1 |
| Gevorgyan, V; Gulevich, AV; Wang, Y | 1 |
| Gütschow, M; Mertens, MD | 1 |
| Bagrel, D; Bana, E; Cerella, C; Chaimbault, P; Dicato, M; Diederich, M; Kirsch, G; Sibille, E; Valente, S | 1 |
| Du, F; Gong, A; Long, L; Meng, S; Wang, L; Zhang, C; Zhou, L | 1 |
| Girish, V; Gurupadaswamy, HD; Khanum, SA; Lakshmi Ranganatha, V; Meghashri, S; Rekha, ND; Zameer, F | 1 |
| Chung, SJ; Kang, HJ; Kim, JH; Sumranjit, J | 1 |
| Guíñez, RF; Matos, MJ; Maya, JD; Olea-Azar, C; Santana, L; Uriarte, E; Vazquez-Rodriguez, S | 1 |
| Cao, YC; Liang, XL; Liao, ZG; Yang, M; Zhao, GW; Zhao, LJ; Zhu, ML | 1 |
| Hou, JT; Li, CY; Li, K; Wu, MY; Yu, XQ | 1 |
| Bhaskara Rao, K; Choudhary, D; Khedgikar, V; Kumar, M; Modukuri, RK; Sashidhara, KV; Trivedi, R | 1 |
| Adamo, C; Ciofini, I; Netti, PA; Rega, N; Savarese, M | 2 |
| Fang, Y; Han, G; Li, H; Wan, L; Wang, H; Wu, C; Zhang, A; Zhang, Z | 1 |
| Mercer, DK; Miller, L; O Neil, DA; Robertson, J; Smith, S; Stewart, CS; Wright, K | 1 |
| Avlonitis, N; Calogeropoulou, T; Heropoulos, GA; Prousis, KC | 1 |
| Chen, CS; Chen, S; Cheng, H; Li, ZY; Liu, LH; Qin, SY; Rong, L; Zhang, XZ | 1 |
| Belov, VN; Bierwagen, J; Bottanelli, F; Hell, SW; Nizamov, S; Schill, H | 1 |
| Blackwell, HE; McInnis, CE | 1 |
| Reinhold, SE; Schwendeman, SP | 1 |
| Creaven, BS; Dömötör, O; Enyedy, EA; Karcz, D; Tuccinardi, T; Walsh, M | 1 |
| Aguiló, E; Andermark, V; Arcau, J; Cetina, M; Gandioso, A; Lima, JC; Moro, A; Ott, I; Rissanen, K; Rodríguez, L | 1 |
| Abdel Gawad, NM; Abdel Rahman, DE; Amin, KM; El Ashry, MK | 1 |
| Drábiková, K; Harmatha, J; Jančinová, V; Nosál', R; Perečko, T; Smidrkal, J | 1 |
| Chen, J; Gao, W; Hua, C; Li, Q; Wang, Z | 1 |
| Jiang, Z; Miao, JY; Xiao, Y; Xu, Y; Zhang, TT; Zhao, BX | 1 |
| Han, C; Lin, Z; Liu, B; Shen, Y; Wang, C; Zhou, X; Zhu, Z | 1 |
| Choi, HE; Choi, HY; El-Gamal, MI; Jang, HL; Lee, KT; Oh, CH | 1 |
| Inamdar, SR; Panicker, CY; Patil, SK; Wari, MN | 1 |
| He, HZ; Pan, XY; Wang, C; Wang, T; Zhou, N | 1 |
| Alouini, MA; Berthelot, T; Déléris, G; Fery-Forgues, S; Moustoifa, el-F; Rubio-Albenque, S | 1 |
| Chen, H; Li, S; Li, X; Lv, M; Yao, Y; Zhao, L | 1 |
| Chamsaz, EA; Joy, A; Maddipatla, MV; Sun, S | 1 |
| Ding, Z; Han, X; Hou, X; Li, R; Li, Z; Liu, H; Luo, H; Wu, F; Yan, G; Zhang, W; Zhou, M | 1 |
| Ciuffo Gladys, M; Garro Hugo, A; Manzur Jimena, M; Pungitore Carlos, R; Tonn Carlos, E | 1 |
| Aliaga, ME; Cassels, BK; García-Beltrán, O; Martínez, NP; Mena, N; Núñez, MT; Pavez, P; Pérez, C | 1 |
| Feng, SS; Leong, DT; Tan, GR | 1 |
| Davydov, DR; Halpert, JR; Jang, HH; Lee, GY; Yun, CH | 1 |
| Guo, J; Raghupathi, KR; Thayumanavan, S; Wang, F; Zhuang, J | 1 |
| Blagg, BS; Brown, D; Gu, W; Holzbeierlein, J; Khandelwal, A; Kusuma, BR; Liu, W; Vielhauer, G | 1 |
| Chang, ST; Lin, CY; Yeh, TF | 1 |
| Lee, YH; Lee, YS; Nam, SO; Park, DH; Ryu, JH | 1 |
| Che, Y; Feng, Y; Liu, X; Niu, S; Ren, F; Yuan, Y | 1 |
| Arsikin, K; Harhaji-Trajković, L; Ilić, DR; Jevtić, VV; Klisurić, O; Radić, GP; Ristić, B; Sukdolak, S; Trajković, V; Trifunović, SR; Vuković, N | 1 |
| Feng, L; Gong, S; Jiang, X; Pang, Z; Yu, Y; Zhong, Y | 1 |
| Basaran, I; Cakir, U; Hopa, E; Sinan, S; Turan, Y | 1 |
| Li, J; Yang, GF; Yang, SH; Yang, WC; Zhang, CF | 1 |
| Jung, D; Kim, JS; Lee, JH; Maiti, S | 1 |
| Goerge, T; Jeskowiak, A; Magnolo, N | 1 |
| Firdouse, A; Khanum, SA; Lakshmi Ranganatha, V; Prabhakar, BT; Thirusangu, P; Vijay Avin, BR | 1 |
| Wang, KW; Wang, SW; Wei, JG; Wu, B | 1 |
| Gütschow, M; Hinz, S; Mertens, MD; Müller, CE | 1 |
| Prariyachatigul, C; Promsuwan, P; Sriphana, U; Suthiwong, J; Thongsri, Y; Yenjai, C | 1 |
| Aljuffali, IA; Fang, JY; Hung, YY; Leu, YL; Pan, TL; Wang, PW | 1 |
| Barman, N; Sahu, K; Singha, D | 1 |
| Bi, X; Cao, J; Chen, G; Gao, W; Li, Q; Xia, X; Zhang, X; Zhao, Y | 1 |
| Caballero, J; Cassels, BK; Galdámez, A; García-Beltrán, O; Mena, N; Nuñez, MT; Yañez, O | 1 |
| He, G; Huang, W; Li, B; Peng, C; Song, X; Wu, F; Zeng, S; Zheng, Y | 1 |
| Chan, WH; Lee, AW; Leung, KC; You, QH; Zhu, XM | 1 |
| Chen, GR; He, XP; Li, J; Liu, G; Sheng, Y; Shi, DT; Tang, Y; Wei, XL; Xie, J; Zang, Y | 1 |
| Chen, K; Cui, D; Jiang, N; Wang, J; Wang, R; Xiao, H; Yin, G | 1 |
| Chao, YC; Cheng, KM; Huang, WH; Kuo, C | 1 |
| Bondock, S; Nasr, T; Youns, M | 1 |
| van Dam, NM | 1 |
| Borges, F; Fontenla, JA; González Franco, RM; Janeiro, P; Matos, MJ; Santana, L; Tatonetti, NP; Uriarte, E; Vilar, S; Viña, D | 1 |
| Chang, CI; Hsu, BD; Hu, WC; Kuo, YH; Lin, WY; Shen, CP; Sung, PJ; Wang, WH; Wu, JB | 1 |
| Bajorath, J; Furtmann, N; Gütschow, M; Horn, M; Mareš, M; Mertens, MD; Schmitz, J | 1 |
| Bouzin, C; Draoui, N; Feron, O; Riant, O; Schicke, O; Seront, E; Sonveaux, P | 1 |
| Geisen, R; Mayer, LS; Schmidt-Heydt, M; Stoll, DA | 1 |
| Estrada-Soto, S; Hidalgo-Figueroa, S; Ibarra-Barajas, M; Navarrete-Vázquez, G; Rios, MY; Sánchez-Recillas, A | 1 |
| Dai, X; Miao, JY; Tian, J; Wang, PC; Wang, SQ; Wu, QH; Xu, Y; Zhao, BX | 1 |
| Lee, HK; Lee, YH; Ling, XY; Liu, T; Miao, YE; Phang, IY; Wei, J | 1 |
| Bruns, RE; Passari, LM; Scarminio, IS | 1 |
| García-Morales, V; Matos, MJ; Santana, L; Tatonetti, NP; Uriarte, E; Vilar, S; Viña, D | 1 |
| Cui, Y; Gao, J; Liu, M; Qian, G; Tan, Y; Yang, Y; Yu, J | 1 |
| Ballazhi, L; Dräger, G; Huwiler, A; Imeri, F; Jashari, A; Mikhova, B; Popovski, E; Shabani, A | 1 |
| Briesen, H; Gajewska, M; Schramm, KW; Urani, C; Worth, A | 1 |
| Bantu, R; Holagunda, UD; Kumar, CG; Nagarapu, L; Pombala, S; Sridhar, B; Yadagiri, B | 1 |
| Fang, X; Lv, L; Wang, B; Wang, Z; Wu, L; Xin, H; Xu, Q; Zhao, Y | 1 |
| Bi, FZ; Jiang, Z; Miao, JY; Xiao, Y; Xu, Y; Zhao, BX | 1 |
| Kang, MK; Kim, JC | 1 |
| Chang, JX; Liu, WH; Liu, Y; Wang, SB | 1 |
| Delogu, GL; Quezada, E; Serra, S; Tatonetti, NP; Uriarte, E; Vilar, S; Viña, D | 1 |
| Han, L; Qu, J; Qu, Q; Wu, LX; Zhan, M; Zhang, W; Zhang, YW; Zhou, HH | 1 |
| Deng, X; Guan, S; Huang, G; Liu, Y; Song, B; Wang, Z; Xiong, Y; Xu, L; Xu, S; Zhang, S | 1 |
| Chen, H; Li, CJ; Li, Y; Ma, J; Shi, J; Tang, J; Wang, C; Yang, JZ; Zhang, DM | 1 |
| Chen, KC; Cheng, CH; Lee, WT; Lin, CW; Lin, MH; Wang, YF; Xiao, CQ | 1 |
| Arivazhagan, M; Kavitha, R; Subhasini, VP | 1 |
| Erastov, AA; Kostanyan, AE; Shishilov, ON | 1 |
| Jiang, C; Qian, J; Sun, Q; Tian, H; Zhang, R; Zhang, W | 1 |
| Chen, H; Gu, Y; Li, S; Li, X; Lv, M; Tan, G; Wang, K; Yao, Y | 1 |
| Duan, YW; En, D; Guo, Y; Li, CW; Li, J; Peng, MJ; Suzenet, F; Yang, XF; Yin, B | 1 |
| Haque, MM; Liu, S; Peng, X; Sun, H; Wang, Y | 1 |
| Lin, W; Tan, L; Yuan, L; Zheng, K; Zhu, S | 1 |
| Chen, YY; Dong, ZQ; He, X; Li, J; Liu, XH; Pan, ZX; Shi, JB; Song, BA; Tang, WJ | 1 |
| Carlson, JC; Giedt, RJ; Kohler, RH; Meimetis, LG; Weissleder, R | 1 |
| Mohanraj, R; Sivasankar, S | 1 |
| Fan, L; Li, TR; Qin, JC; Wang, BD; Yang, ZY | 1 |
| Du, J; Wang, F; Zhang, C; Zhu, Y | 1 |
| Hammers, MD; Pluth, MD | 1 |
| Bansal, G; Bansal, Y; Sandhu, S; Silakari, O | 1 |
| Feng, LM; Guo, DA; Ji, S; Liu, CF; Qian, Y; Qiao, X; Wang, Q; Ye, M | 1 |
| Bi, K; He, J; Li, Q; Wu, X; Xu, H | 1 |
| Nagesh, N; Raju, G; Reddy, ChR; Reddy, MD; Srinivas, R | 1 |
| Inafuku, M; Iwasaki, H; Nugara, RN; Oku, H; Takara, K | 1 |
| Cole, JM; Liu, X; Mao, D; Xu, Z | 1 |
| Chiba, M; Ishii, Y; Yamada, H; Yamamiya, I; Yoshisue, K | 1 |
| Cao, Z; Li, J; Rinkevicius, Z | 1 |
| Borjigidai, A; Cui, J; Cui, X; Kang, F; Pang, ZR | 1 |
| Han, ET; Han, JH; Huong, DT; Kim, JY; Lee, WJ; Park, H; Shin, HJ; Yeo, SJ | 1 |
| Han, J; Huang, W; Huang, X; Li, Z; Qian, H; Sun, L; Zhang, C | 1 |
| Borges, F; Fonseca, A; Kachler, S; Klotz, KN; Matos, MJ; Santana, L; Tatonetti, NP; Uriarte, E; Vilar, S | 1 |
| Banasiewicz, M; Deperasińska, I; Gryko, DT; Kozankiewicz, B; Morawska, K; Tasior, M; Vakuliuk, O | 1 |
| Chen, W; Huang, L; Huang, W; Loo, JS; Pei, W; Wang, C; Yan, Q; Yao, C; Zhang, Q; Zhou, Y; Zhu, J | 1 |
| Mandi, P; Nantasenamat, C; Pingaew, R; Prachayasittikul, S; Prachayasittikul, V; Ruchirawat, S; Saekee, A | 1 |
| Peng, DY; Sun, Q; Yang, GF; Yang, SG; Yang, WC; Zhu, XL | 1 |
| Hamulakova, S; Hrabinova, M; Imrich, J; Janovec, L; Korabecny, J; Kristian, P; Kuca, K; Spilovska, K | 1 |
| Braga, PA; das G F da Silva, MF; de Freitas, SD; Fernandes, JB; Forim, MR; Severino, VG; Venâncio, T; Vieira, PC | 1 |
| Bendicho, C; Cabaleiro, N; de la Calle, I; Lavilla, I | 1 |
| Leung, EY; Meads, C; Tirlapur, SA | 1 |
| Hirai, T; Nakamura, M; Shiraishi, Y; Yamamoto, K | 1 |
| Chen, R; Ding, W; Jia, L; Ma, T; Wang, Y; Xie, J; Xu, J; Zhu, T; Zhu, W | 1 |
| Cheng, H; Jia, HZ; Li, SY; Liu, LH; Qiu, WX; Rong, L; Zhang, XZ | 1 |
| Chen, YL; Guan, Z; He, YH; Song, J; Xue, Y; Yang, DC; Yuan, Y | 1 |
| Davis, RA; Poulsen, SA; Supuran, CT; Vullo, D | 1 |
| Ram Reddy, A; Sheshashena Reddy, T | 1 |
| Chattopadhyay, SK; Kundu, I; Maitra, R | 1 |
| Bagai, I; Becker, DF; Ragsdale, SW; Spencer, AL; Zuiderweg, ER | 1 |
| Fan, W; Fu, S; Tong, X; Yan, Q; Zhao, Y | 1 |
| Kim, G; Kwon, Y; Ryu, JH; Yoon, J; Zhou, X | 1 |
| Badami, PS; Halasangi, BM; Patil, SA; Prabhakara, CT; Toragalmath, SS | 1 |
| de Boer, OJ; de Winter, RJ; Kers, J; Li, X; Niessen, HW; Ploegmakers, HJ; Tijssen, JG; van der Wal, AC; Vink, A | 1 |
| Das, S; Dhar, SK; Govindaraju, T; Kumar, M; Kundu, TK; Narayanaswamy, N; Pati, SK; Samanta, PK; Sharma, R | 1 |
| Hatamjafari, F; Vahabi, V | 1 |
| Cerqueira, NM; Esteves, AP; Francisco, CS; Oliveira-Campos, AM; Rodrigues, LR | 1 |
| Chen, J; Duan, JA; Liu, P; Qian, DW; Xu, Y; Zhou, B | 1 |
| Chen, XP; Miao, JY; Yuan, Q; Zhang, JY; Zhang, YR; Zhao, BX | 1 |
| Morel, FL; Ranocchiari, M; Rummelt, SM; van Bokhoven, JA; Xu, X | 1 |
| Choi, DY; Choi, HS; Choi, K; Chong, CK; Hong, NN; Huong, DT; Kim, HS; Li, CY; Mallik, SK; Park, H; Sung, HW; Yeo, SJ; Yu, K | 1 |
| Bai, DC; Chen, CY; Cui, YM; Dou, W; Li, PX; Liu, W; Liu, WS; Ru, JX; Shen, R; Zhang, KM | 1 |
| Baker, D; Deerinck, TJ; Drennan, CL; Ellisman, MH; Goldman, PJ; Liu, DS; Nivón, LG; Phipps, WS; Richardson, D; Richter, F; Ting, AY; Yao, JZ; Ye, AZ | 1 |
| Chen, Y; Clouthier, CM; Keillor, JW; Lachance, H; Strmiskova, M; Tsao, K | 1 |
| Akoudad, S; Darweesh, SK; Hofman, A; Ikram, MA; Koudstaal, PJ; Leening, MJ; Stricker, BH; van der Lugt, A; Vernooij, MW | 1 |
| Kim, J | 1 |
| Chen, X; Han, C; Hu, B; Miao, Q; Shen, Y; Wang, C; Zhu, Z | 1 |
| Botton, MR; Suarez-Kurtz, G | 1 |
| Glass, TE; Hettie, KS | 1 |
| Chamsaz, EA; Joy, A; Leipzig, ND; Maddipatla, MV; McCormick, AM; Shi, S; Yokoyama, H | 1 |
| Chen, XY; Chen, Y; Feng, P; Guo, YL; Huang, YQ; Liu, MM; Yang, G | 1 |
| Dou, X; Feng, C; Ji, W; Liu, G; Xu, M | 1 |
| Fang, JG; Fang, R; Peng, Y; Wang, YW; Yang, YL; Zhang, BX; Zhang, FM | 1 |
| Astruc, D; Igartua, ME; Li, N; Moya, S; Rapakousiou, A; Ruiz, J; Salmon, L; Zhao, P | 1 |
| Alexandru, T; Amaral, L; Boni, M; Dinache, A; Nastasa, V; Pascu, A; Pascu, ML; Radu, E; Staicu, A; Stoicu, A | 1 |
| Hashimoto, T; Hayashita, T; Katano, K; Kobayashi, H | 1 |
| Dong, C; Hong, Y; Jia, Y; Lou, X; Min, X; Tang, BZ; Xia, F; Xu, X; Zhao, Z; Zhuang, Y | 1 |
| Choo, YM; Kim, HJ; Lim, SY; Mahamad, UA; Yap, AC | 1 |
| Chen, Z; Li, J; Li, M; Mu, Y; Shan, A; Xue, B; Zhang, W | 1 |
| Callan, JF; Fowley, C; McCaughan, B; McEwan, C; McHale, AP; Nomikou, N | 1 |
| Fu, G; Li, H; Liu, S; Lu, J; Mu, Y; Qian, S; Wan, Y | 1 |
| Aquino, RP; Benayache, F; Benayache, S; Kerbab, K; Mekhelfi, T; Mencherini, T; Picerno, P; Rastrelli, L; Sansone, F; Zaiter, L | 1 |
| Janani, M; Razavi, SM | 1 |
| Husain, MA; Ishqi, HM; Rehman, SU; Sarwar, T; Tabish, M | 1 |
| Oliphant, CS; Reaves, AB; Richardson, AM; Sands, CW; Self, TH | 1 |
| Detsi, A; Hadjipavlou-Litina, D; Hamilakis, S; Kavetsou, E; Kontogiorgis, C; Liargkova, T; Roussaki, M; Zelianaios, K | 1 |
| Jafari, M; Kuramada, S; Lopez, TE; Pham, A; Schriner, SE; Truong, S | 1 |
| Fukuhara, K; Hishikawa, K; Ieda, N; Kitamura, K; Miyata, N; Nakagawa, H; Suzuki, T | 1 |
| Dai, X; Xu, Y; Zhao, BX | 1 |
| He, L; Lin, W; Wei, H; Xu, Q | 1 |
| Devlin, JR; Morrow, JR; Sander, SA; Siters, KE | 1 |
| Basukriadi, A; Wilkins, RM | 1 |
| Cadwallader, KR; Lorjaroenphon, Y | 1 |
| De Marco, S; de Nijs, M; Jekel, A; Lopez, P; Mol, HG; van Sisseren, M | 1 |
| Daroji, VK; Hillemane, V; Jayashree, BS; Nayak, Y; Unnikrishnan, MK | 1 |
| Bansal, G; Bansal, Y; Kaur, M; Kohli, S; Sandhu, S | 1 |
| Gonzalez-Covarrubias, V; Jaramillo-Villafuerte, K; Sánchez-Girón, F; Soberón, X; Villegas-Torres, B | 1 |
| Li, Q; Shuai, Y; Wang, F; Wang, H; Wei, W; Yan, K; Yang, D | 1 |
| Cole, JM; Cui, J; Liu, X; Mao, D; Qiao, Q; Xu, Z; Yin, W; Zhao, M | 1 |
| Hroboňová, K; Májek, P; Poláček, R; Sádecká, J | 1 |
| Chen, J; English, BP; Grimm, JB; Lavis, LD; Lionnet, T; Macklin, JJ; Normanno, D; Patel, R; Revyakin, A; Singer, RH; Slaughter, JP; Zhang, Z | 1 |
| Autore, G; Bruno, M; Formisano, C; Jemia, MB; Marzocco, S; Rosselli, S; Senatore, F | 1 |
| Liang, Q; Shen, YH; Xu, WH; Zhao, P | 1 |
| Capelo, JL; Cavaleiro, JA; Faustino, MA; Lodeiro, C; Menezes, JC; Neves, Mda G; Oliveira, E; Santos, CI; Santos, HM | 1 |
| Duan, YW; Guo, Y; Li, H; Li, Z; Yang, XF; Zhong, Y | 1 |
| Deng, J; Mao, L; Wang, Y; Yu, P | 1 |
| Madany, MM; Saleh, AM | 1 |
| Chai, YD; Gong, YK; Huang, PF; Nakashima, K; Zhang, J; Zhao, J | 1 |
| Alijanpour, SO; Asghari, S; Chaichi, MJ; Shadlou, S | 1 |
| Ali, F; Chattopadhyay, S; Das, A; Reddy G, U; Taye, N | 1 |
| Jia, L; Jiang, Z; Pang, Y; Yang, J; Yang, X; Yu, S | 1 |
| Daunert, S; Joel, S; Pasini, P; Raut, N | 1 |
| Byun, KM; Choi, JM; Han, J; Han, JH; Jung, HS; Jung, JH; Kang, C; Kim, JH; Kim, JS; Kweon, HS; Lee, JH | 1 |
| Gutiérrez-Barranquero, JA; McCarthy, RR; O'Gara, F; Reen, FJ | 1 |
| Armitage, BA; Brotherton, WL; Pham, HH; Schmidt, BF; Szent-Gyorgyi, C; Waggoner, AS; Zanotti, KJ | 1 |
| Chattopadhyay, P; Dhara, K; Lohar, S; Mandal, SK; Mukherjee, M; Pal, S; Sen, B | 1 |
| Hadjipavlou-Litina, DJ; Kallitsakis, MG; Litinas, KE; Marco-Contelles, J; Soriano, E; Yañez, M | 1 |
| Dana, J; Debnath, T; Ghosh, HN; Lobo, H; Maity, P; Shankarling, GS | 1 |
| Yue, J; Zhang, L; Zhang, LH | 1 |
| Agarrabeitia, AR; Bañuelos, J; de la Moya, S; Duran-Sampedro, G; Esnal, I; García-Moreno, I; López-Arbeloa, I; Macías, MA; Ortiz, MJ; Peña-Cabrera, E | 1 |
| Helbig, H; Konrad, J; Oberacher-Velten, I; Vogt, R | 1 |
| Campos, FR; Cerqueira, LB; de Francisco, TM; Gasparetto, JC; Peccinini, RG; Pontarolo, R | 1 |
| Cao, AC; Guo, ZF; Lu, ZL; Yue, P; Zhai, YG; Zhang, Y | 1 |
| Huang, J; Tong, X; Wang, J; Zhang, J; Zhang, L | 1 |
| Baerson, SR; Ren, Y; Su, YJ; Wang, J; Wang, RL; Xia, QQ; Zeng, RS; Zheng, SC | 1 |
| Hou, JT; Li, K; Liao, YX; Liu, YH; Ran, YZ; Yang, J; Yu, KK; Yu, XQ; Zhou, XD | 1 |
| Bailey, A; Callis, R; De Savi, C; Degorce, SL; Ducray, R; Lamont, G; MacFaul, P; Martin, S; Maudet, M; Morgentin, R; Norman, RA; Peru, A; Pink, JH; Plé, PA; Roberts, B; Scott, JS | 1 |
| Antonchick, AP; Golz, C; Potowski, M; Strohmann, C; Waldmann, H | 1 |
| Barbosa-Filho, JM; de Araujo Leite, JC; de Castro, TM; de Siqueira-Junior, JP; Marques-Santos, LF | 1 |
| Hatanaka, Y; Masuda, S; Morimoto, S; Tomohiro, T; Yamaguchi, S | 1 |
| Barocelli, E; Carotti, A; Giorgio, C; Hadjipavlou-Litina, D; Karalaki, F; Kontogiorgis, C; Mangiatordi, GF; Nicolotti, O; Patsilinakos, A; Tognolini, M | 1 |
| Chen, CT; Huang, TL; Wang, MC | 1 |
| Jiang, N; Kong, LY; Lan, JS; Li, ZR; Wang, KD; Wang, X; Xie, SS; Yu, W | 1 |
| Cao, L; Li, G; Li, X; Shen, L; Si, J; Wang, J; Zhang, L; Zhu, J | 1 |
| Karami, R; Khaksarinejad, R; Mohsenifar, A; Rahmani-Cherati, T; Tabatabaei, M | 1 |
| Barcellini-Couget, S; Beaudouin, R; Brochot, C; Desousa, G; Pery, AR; Rahmani, R; Teng, S | 1 |
| Li, P; Wang, L; Yang, S; Yang, W | 1 |
| Hara, D; Komatsu, H; Nishimoto, S; Son, A; Tanabe, K | 1 |
| Alan, Y; Glass, TE; Tran, TM | 1 |
| Hu, Y; Long, L; Wang, J; Xiao, X | 1 |
| Chen, C; Liu, W; Xu, C | 2 |
| Datta, S; Halder, M; Hossaini, Z; Khalilzadeh, MA; Mousa, SA; Rajabi, M | 1 |
| Guo, D; Han, X; Ling, Y; Luo, J; Shi, C; Wang, L; Xu, G | 1 |
| Bakthadoss, M; Kannan, D; Malathi, P; Manikandan, V; Sivakumar, N | 1 |
| Huang, Y; Jiang, Q; Liu, M; Lu, Z; Tan, Y | 1 |
| Chen, YD; Li, ZX; Liu, XW; Shen, YM; Zhang, SB; Zhong, X | 1 |
| Ji, W; Ji, Y; Jin, Q; Tang, X; Tong, Q | 1 |
| Fedorova, M; Ni, Z; Vemula, V | 1 |
| Chen, Z; Duan, L; Qian, J; Qu, H; Sun, D; Sun, Q; Tian, H; Zhang, W | 1 |
| Li, H; Xu, C; Yin, B | 1 |
| Kandavelu, P; Rose, J; Sun, X; Wang, BC; Yan, Y; Yuan, Q; Zhang, H; Zhou, D | 1 |
| Fan, J; Mu, H; Peng, X; Wang, J; Zhu, H | 1 |
| Badami, PS; Kinnal, SM; Kulkarni, AD; Manjunatha, M; Naik, VH; Patil, SA; Prabhakara, CT | 1 |
| Arshad, S; Ashraf, M; Chattha, FA; Kousar, S; Munawar, MA; Nisa, M | 1 |
| He, L; Lin, W; Liu, Y; Tang, Y; Wei, H; Xu, Q | 1 |
| Liu, H; Shen, JZ; Zhang, HX | 1 |
| Durić, K; Kovac Besovic, EE; Muratovic, S; Niksic, H; Sofic, E | 1 |
| Abellán-Flos, M; Supuran, CT; Tanç, M; Vincent, SP | 1 |
| Mishra, PK; Saha, T; Talukdar, P | 1 |
| Matsuta, E; Nakatani, K | 1 |
| Behara, KK; Gangopadhyay, M; Ghosh, SK; Karwa, S; Singh, ND; Singh, T | 1 |
| Murayama, S; Tobita, S; Yoshihara, T | 1 |
| Arai, Y; El-Kabbani, O; Endo, S; Gouda, H; Hara, A; Hu, D; Ikari, A; Matsunaga, T; Miura, T; Miyagi, N; Nishinaka, T; Oguri, H; Terada, T; Toyooka, N; Xia, S | 1 |
| Patil, R; Sawant, S | 1 |
| Iino, R; Noji, H; Obayashi, Y | 1 |
| Altomare, CD; Carotti, A; Carrupt, PA; Catto, M; Denora, N; Farina, R; Gadaleta, D; Mendez-Alvarez, E; Muncipinto, G; Nicolotti, O; Nurisso, A; Passos, CS; Pisani, L; Soto-Otero, R | 1 |
| MegallyAbdo, NY; Mohareb, RM | 1 |
| Ayano, E; Hiruta, Y; Kanazawa, H; Wang, J; Yamada, A | 1 |
| Al-Amiery, AA; Al-Majedy, YK; Kadhum, AA; Mohamad, AB | 1 |
| Gong, R; Guo, Z; Jiang, Y; Wan, X | 1 |
| He, L; Lin, W; Liu, Y; Wei, H; Xie, Y; Xu, Q; Zhu, S | 1 |
| Álvares-Ribeiro, L; Bessa, A; Loureiro, JA; Madeira, PP; Rodrigues, AE; Zaslavsky, BY | 1 |
| Duan, C; Jia, H; Meng, Q; Succar, P; Zhang, R; Zhang, Z; Zhao, L | 1 |
| Adams, DJ; Draper, ER; McDonald, TO | 1 |
| Gasparetto, JC; Leonart, LP; Pontarolo, R | 1 |
| Banik, D; Kuchlyan, J; Kundu, N; Roy, A; Sarkar, N | 2 |
| Bekhradnia, A; Domehri, E; Khosravi, M | 1 |
| Costa, SP; Fonseca, AS; Gonçalves, MS; Soares, AM | 1 |
| Duan, X; Li, L; Ma, XK; Peterson, EC; Ruan, T | 1 |
| Hoda, N; Jameel, E; Kumar, J; Umar, T | 1 |
| Aylott, JW; Beeby, A; Boyle, RW; Chan, WC; Chauhan, VM; Giuntini, F; Jones, DR; Lavado, AS; Zen, AA | 1 |
| Adolf, D; Jacob, D; Köckerling, F; Roessing, C; Schug-Pass, C | 1 |
| Gao, C; Li, X; Liu, M; Lu, W; Peng, C; Shen, Q; Su, B; Wei, X; Xie, C; Xie, Z | 1 |
| Li, YJ; Wang, CY; Wang, HS; Yao, GY; Ye, MY | 1 |
| Brückner, C; Chen, J; Lei, Y; Parisi, J; Srinivasan, G; Yao, X | 1 |
| Gilmour, R; Metternich, JB | 2 |
| Cao, XJ; Chen, MY; Dai, X; Du, ZF; Hu, SW; Miao, JY; Zhang, T; Zhao, BX | 1 |
| Harms, H; Kleinsteuber, S; Popp, D; Schrader, S; Sträuber, H | 1 |
| Huang, RY; Li, G; Li, X; Wang, M; Zeng, X; Zhao, J; Zhao, Y | 1 |
| Hirai, T; Nakamura, M; Shiraishi, Y | 1 |
| Qin, JC; Yang, ZY | 1 |
| Huang, ZS; Tan, JH; Tian, YG; Yan, JW | 1 |
| Barco, G; de la Fuente Revenga, M; Fernández-Sáez, N; García-Orue, I; Herrera-Arozamena, C; Rivara, S; Rodríguez-Franco, MI; Sugden, D | 1 |
| Li, X; Son, YA | 1 |
| Long, L; Wang, J; Xiao, X | 1 |
| Chilingirova, N; Dimitrova-Karamfilova, A; Goranova, T; Kaneva, R; Mitev, V; Nachev, G; Tzveova, R | 1 |
| Ghosh, S; Koley, S | 1 |
| Jadhav, PD; Reaney, MJ; Sammynaiken, R; Shen, J | 1 |
| Ashraf, S; Iftikhar, J; Iqbal, J; Muddassar, M; Saeed, A; Zaib, S; Zhang, KY | 1 |
| Manidhar, DM; Subramanyam, R; Suresh Reddy, C; Yeggoni, DP | 1 |
| Doria, F; Freccero, M; Ladame, S; Spalluto, V; Zuffo, M | 1 |
| Furuta, T; Narumi, T; Nomura, W; Takano, H; Tamamura, H | 1 |
| Ajees, AA; Das, S; Kamath, PR; Pai, KS; Sunil, D | 1 |
| Al-Masoudi, NA; Al-Salihi, NJ; Marich, YA; Markus, T | 1 |
| Borges, F; Estrada, M; Laguna, R; Matos, MJ; Rodríguez-Enríquez, F; Rodríguez-Franco, MI; Santana, L; Uriarte, E; Viña, D | 1 |
| Chen, J; Hu, M; Li, Q; Liu, Z; Lu, L; Peng, X; Shi, J; Wang, Y; Xie, C; Yan, T; Zhou, F; Zhu, L | 1 |
| Chang, HH; Chang, JY; Chang, KM; Chen, HH; Chen, IL; Chen, YL; Chen, YT; Huang, CH; Kuo, CC; Shih, C; Tzeng, CC; Wang, TC; Yang, SC | 1 |
| Cuong, NM; Ha, VT; Huong, TT; Khanh, PN; Kim, YH; Son, NT; Tai, BH; Tai, NV | 1 |
| Basavaraja, J; Inamdar, SR; Suresh Kumar, HM; Wari, MN | 1 |
| Bharathi, MV; Chhabra, M; Paira, P | 1 |
| Kesharwani, RK; Kotamraju, S; Santosh, K; Toopurani, MK; Vaarla, K; Vedula, RR | 1 |
| Bourgaud, F; Costantino, G; Dugrand-Judek, A; Froelicher, Y; Hehn, A; Ollitrault, P; Olry, A | 1 |
| Küçükbay, FZ; Küçükbay, H; Supuran, CT; Tanc, M | 1 |
| Han, GI; Kang, C; Kim, JS; Kim, TW; Lee, H; Lee, YH; Verwilst, P; Wi, Y; Yang, Z | 1 |
| Ding, XQ; Gong, HL; Hou, RC; Jiang, Y | 1 |
| Avila Ferrer, FJ; Cerezo, J; Prampolini, G; Santoro, F | 1 |
| Carta, F; Cozzi, A; Di Cesare Mannelli, L; Ghelardini, C; Micheli, L; Supuran, CT | 1 |
| Clemens, S; Weber, M | 1 |
| Gobrogge, CA; Kong, VA; Walker, RA | 1 |
| Kariyappa, AK; Nagamallu, R; Ningappa, MB; Srinivasan, B | 1 |
| Chen, K; Ge, Z; Huang, Y; Ji, Q; Liao, F; Liu, X; Wu, H; Yang, X; Yuan, L | 1 |
| Abel, S; Böttcher, C; Chutia, R; Müller, J; Scheel, D; Schmidt, S; Strehmel, N; Ziegler, J | 1 |
| Carta, M; Feng, S; Mulle, C; Müller, R; Nadler, A; Schultz, C; Stein, F; Yushchenko, DA | 1 |
| Hirano, K; Kobayashi, T | 1 |
| Dang, X; Gao, Y; Guo, Y; Sun, Y; Tang, C; Tang, M; Wang, K; Zhou, Z | 1 |
| Chaplin, BP; Guo, L; Jing, Y | 1 |
| Aparin, IO; Chistov, AA; Farzan, VM; Formanovsky, AA; Korshun, VA; Podkolzin, AT; Shipulin, GA; Ustinov, AV; Veselova, OA; Zatsepin, TS | 1 |
| Alıcı, B; Çetinkaya, E; Günal, S; Karataş, MO; Olgundeniz, B; Özdemir, İ | 1 |
| Choi, JS; Kim, O; Lee, JH; Min, BS; Nguyen, PH; Woo, MH; Zhao, BT | 1 |
| Kalam Khan, FA; Kulkarni, AA; Lohar, KS; Pachpinde, AM; Patil, RH; Sangshetti, JN; Shinde, DB | 1 |
| Alexander, SA; Barzegar Amiri Olia, M; Schiesser, CH; Zavras, A | 1 |
| Fujii, W; Hori, H; Kitagawa, Y; Ozaki, K; Tanaka, Y | 2 |
| de Sousa, G; Pery, A; Rahmani, R; Salle-Siri, R; Teng, S | 1 |
| Feng, C; Ji, W; Li, Z; Liu, G | 1 |
| Callaghan, C; Dash, S; Lee, BR; Liu, J; Maddox, M; Mandava, SH; Peralta, D; Tarr, MA | 1 |
| Chapple, C; Ferruzzi, MG; Jacobi, JL; Janle, EM; Kirchmaier, AL; Laurentz, SM; Li, X; McCabe, GP; Menze, AK; Yang, B | 1 |
| Asiago, J; Berhow, M; Cooke, J; Devaiah, SP; Hayford, D; Kiser, S; Lin, Z; Loftis, P; Mallampalli, VK; McIntosh, CA; Owens, DK; Pike, LM; Sarkar, TR; Sibhatu, MB; Strong, CL; Wamucho, A; Williams, BE | 1 |
| Bhakoo, K; Connell, J; Hsu, BY; Li, X; Lythgoe, M; Ng, M; Roberts, T; Seifalian, AM; Tan, A; Wang, J; Wong, SY; Zhang, Y | 1 |
| Christiansen, O; Godtliebsen, IH; Hansen, MB; König, C | 1 |
| Lee, Y; Poudel, S | 1 |
| Jiang, N; Kong, LY; Lan, JS; Li, F; Wang, J; Wang, X; Wang, ZM; Wu, JJ; Xie, SS | 1 |
| Berckmans, P; Covaci, A; Hollanders, K; Maho, W; Peers, B; Remy, S; Verstraelen, S; Witters, H | 1 |
| Liu, S; Sun, M; Wang, S; Wu, L; Yan, Y; Yang, L; Yu, H; Zhang, K; Zhang, Y; Zhao, J | 1 |
| He, D; Li, J; Li, X; Peng, Z; Wang, G | 1 |
| Lee, J; Lim, B | 1 |
| Li, J; Li, YQ; Mu, L; Yamato, T; Zeng, X | 1 |
| Chen, GL; Li, W; Sun, CS; Yu, JG; Yu, R; Zheng, K | 1 |
| Alvarez-Idaboy, JR; Galano, A; Mazzone, G; Russo, N | 1 |
| Jockusch, S; Pemberton, BC; Selvakumar, S; Sibi, MP; Sivaguru, J; Vallavoju, N | 1 |
| Blagg, BS; Byrd, KM; Cohen, MS; Holzbeierlein, J; Liu, W; Motiwala, HF; Sanchez, J; Subramanian, C | 1 |
| Chen, P; Li, R; Pan, J; Sun, YQ; Yang, GP; Zhou, YS | 1 |
| Cao, L; Gao, L; Li, GZ; Li, XJ; Lv, N; Si, JY; Wang, JC | 1 |
| Bradley, M; Ladyman, MK; Lilienkampf, A; Walton, JG | 1 |
| Chen, W; Jiang, H; Jiang, J; Sun, X; Wang, Q; Zhang, Z | 1 |
| Akay, S; Kayan, B; Yang, Y | 1 |
| Ge, J; Li, Q; Liu, W; Niu, G; Wang, P; Wu, J; Zhang, H; Zhou, B | 1 |
| Hou, MQ; Liu, J; Zhang, MZ; Zhang, RR; Zhang, WH; Zhang, Y; Zhou, F | 1 |
| Bu, ZW; Guo, SQ; Wang, QL; Wang, WB; Zhu, YS | 1 |
| Cong, W; Hou, GG; Li, HJ; Liu, WS; Sun, JF; Wang, C; Zhao, F | 1 |
| Chen, Y; Gao, C; Jiang, Y; Li, W; Li, X; Zhang, B | 1 |
| Law, CS; Losic, D; Nemati, M; Santos, A | 1 |
| Abdul Majid, N; Fadaeinasab, M; Iman, V; Karimian, H; Mohan, S; Mohd Ali, H; Mohd Hashim, N; Nordin, N; Othman, R; Ramli, N | 1 |
| Derksen, DJ; Gorobets, E; Keay, BA; Parvez, M | 1 |
| Dai, X; Du, ZF; Miao, JY; Wang, LH; Zhao, BX | 1 |
| Dandriyal, J; Jaitak, V; Kumar, M; Singla, R | 1 |
| Huang, C; Li, J; Lou, K; Qian, R; Tang, Y; Tong, H; Wang, R; Wang, W | 1 |
| Cheng, AX; Gao, S; Lou, HX; Xu, RX; Zhao, Y | 1 |
| Bajorath, J; Blaut, M; Braune, A; Furtmann, N; Gütschow, M; Häußler, D; Mangold, M; Stirnberg, M | 1 |
| Brazil, NT; Faber, K; Medeiros-Neves, B; Panatieri, LF; Rott, MB; Teixeira, HF; von Poser, GL; Zorzi, GK | 1 |
| Bettoschi, A; Caltagirone, C; Ceglie, A; Cuomo, F; Lopez, F; Meli, V; Murgia, S; Tamburro, M | 1 |
| Chen, YF; Dang, YP; Li, YQ; Zhao, L | 1 |
| Guo, C; Liang, Z; Mou, Y; Tian, Y; Xu, H | 1 |
| Ding, AX; He, L; Lin, L; Liu, FT; Lu, ZL; Ma, SF; Wang, HL | 1 |
| Barcellini-Couget, S; Brochot, C; De Sousa, G; Pery, ARR; Rahmani, R; Tebby, C; Teng, S | 1 |
| Agostini-Costa, TD; Alonso, AM; da Silva, DB; da Silva, JP; Fonseca, MC; Gomes, IS; Montanari Junior, I; Pereira, AM; Pereira, RC; Vaz, AP; Vieira, RF | 1 |
| Gul, S; Imran, S; Ismail, NH; Khan, KM; Perveen, S; Salar, U; Taha, M; Wadood, A | 1 |
| Bain, D; Barman, MK; Paramanik, B; Patra, A | 1 |
| Burgueño-Tapia, E; Cornejo-Garrido, J; Domínguez-Mendoza, EA; Ordaz-Pichardo, C | 1 |
| Ghalayani, P; Imeni, V; Koohestanimobarhan, S; Nourmohammadian, F; Salami, S; Yaghmaei, S | 1 |
| Afonso, C; Bailly, L; Hubert-Roux, M; Lizzul-Jurse, A; Renard, PY; Sabot, C | 1 |
| Jeyaveeran, JC; Parthasarathy, K; Praveen, C; Prince, AA | 1 |
| Erastov, AA; Kostanyan, AE | 2 |
| Bayraktutan, T; Onganer, Y | 1 |
| Feng, Y; Fischer, M; Han, Y; Ma, F; Withers, SG; Yang, GY | 1 |
| Brommesson, C; Gao, H; Hu, J; Hu, Z; Tian, Y; Uvdal, K; Wang, H; Zhang, Q; Zhang, X; Zhao, M | 1 |
| Bevan, CL; Ladame, S; Metcalf, GA; Patel, H; Rama, N; Shibakawa, A; Sita-Lumsden, A; Zivi, A | 1 |
| Kanzaki, S; Kunihiro, Y; Nishimura, S; Ohtsuki, T; Sisido, M; Watanabe, K | 1 |
| Bajorath, J; Furtmann, N; Hameed, A; Ibrar, A; Iqbal, J; Khan, I; Saeed, A; Tehseen, Y | 1 |
| Capo, X; Martorell, M; Pons, A; Sureda, A; Tejada, S; Tur, JA | 1 |
| Devaraj, NK; Wu, H | 1 |
| Chen, S; Hou, P; Liu, L; Wang, J; Zhang, Q | 1 |
| Bhatt, V; Kumar, N; Sharma, S; Sharma, U; Singh, B | 1 |
| Bandyopadhyay, S; Dirda, ND; Kanold, PO; Kao, JP; Katz, EJ; Muralidharan, S; Tang, CM | 1 |
| Harkiss, AH; Sutherland, A | 1 |
| Chen, PR; Fan, X; Ge, Y; Li, J; Lin, F; Lin, Z; Ngai, WS; Wang, J; Yang, Y; Zhang, G; Zhao, J; Zheng, S | 1 |
| García, CB; López, I; Ribate, MP; Sangüesa, E; Vancraenendonck, Y; Zuriaga, E | 1 |
| Ali, A; Cantrell, CL; Jones, AM | 1 |
| Kapoor, M; Roy, SS | 1 |
| Cardoso, EO; Conte, FL; Conti, BJ; Golim, MA; Hernandes, RT; Oliveira, LP; Santiago, KB; Sforcin, JM | 1 |
| Cheng, J; Cheng, Y; Duan, J; Li, P; Li, R | 1 |
| Mao, W; Wang, Y; Xia, L; Xie, H | 1 |
| Cipolat Mis, T; Del Giudice, R; Nicolì, F; Schiano di Visconte, M | 1 |
| Berthod, A; Faure, K; Fumat, N | 1 |
| Chen, YZ; Liu, XL; Niu, LY; Yang, QZ; Yang, Y | 1 |
| Chen, J; Ding, W; Li, S; Yu, Y | 1 |
| Feng, F; Liu, T; Nie, B; Ren, Z; Xu, X; Yao, M; Yuan, F; Zhang, F; Zhang, Y; Zhou, W | 1 |
| He, SD; Jia, L; Jiang, Z; Yan, CC; Yang, XT; Yu, SH; Zhou, YY | 1 |
| Baker, JR; Cannon, J; Choi, SK; Gam, K; Isham, D; Mukherjee, J; Payne, M; Tang, S; Wong, PT; Yanik, SA | 1 |
| Angelova, VT; Buyukliev, R; Dimitrov, I; Djukic, M; Momekov, G; Saso, L; Shivachev, B; Valcheva, V; Vassilev, NG | 1 |
| Li, CR; Li, SL; Yang, ZY | 1 |
| Cano, M; Gandioso, A; Marchán, V; Massaguer, A | 1 |
| Hirasawa, N; Hiratsuka, M; Hosono, H; Kumondai, M; Maekawa, M; Mano, N; Oda, A; Yamaguchi, H | 1 |
| Escobedo, JO; Huo, F; Li, X; Salamanca, J; Strongin, RM; Wen, Y; Yi, T; Yin, C; Yue, Y | 1 |
| Elshemy, HAH; Zaki, MA | 1 |
| Amesty, Á; Anaissi-Afonso, L; Estévez-Braun, A; Hueso-Falcón, I; Lorenzo-Castrillejo, I; Machín, F | 1 |
| Brand, AR; de Borst, GJ | 1 |
| Bahulayan, D; Muhammed Ajmal, C; Soumya, TV | 1 |
| Burley, GA; Chung, CH; Humphreys, LD; Mosley, JE; Sadler, JC | 1 |
| Chen, Z; Fan, X; Qian, J; Sun, Q; Yao, Y; Zhang, W | 1 |
| Belluti, F; Bisi, A; Cappadone, C; Di Martino, RMC; Farruggia, G; Gobbi, S; Iotti, S; Malucelli, E; Meluzzi, A; Rampa, A; Sargenti, A | 1 |
| Abdel-Latif, MS; Aly, TAA; Elmeleigy, KM; Khattab, MS; Mohamed, SM | 1 |
| Cannon, J; Choi, SK; Corbin, K; Krummel, MF; Mukherjee, J; Nip, AJ; Roberts, EW; Tang, S; Wong, PT | 1 |
| A, AH; Ali, F; Chattopadhyay, S; Das, A; Kushwaha, S; Taye, N | 1 |
| Bu, M; Cao, T; Guo, M; Hu, L; Li, H; Yang, BB; Zeng, C | 1 |
| Fang, J; Fu, ZH; Han, X; Peng, Y; Shao, Y; Wang, YW; Zhang, ZH | 1 |
| Adobes-Vidal, M; Helm, M; Schmid, K | 1 |
| Ge, J; Li, Y; Liu, W; Niu, G; Wang, M; Wang, P; Wu, J; Xiao, H; Zhang, H; Zhang, P | 1 |
| Ghiasvand, N; Hosseinzadeh, L; Iranshahi, M; Jelodarian, Z; Rashidi, M; Shokoohinia, Y | 1 |
| Costa, SPG; Gonçalves, MST; Santos, FC; Soares, AMS | 1 |
| Alexandre, M; Bertrand, V; De Pauw-Gillet, MC; Grauwels, M; Jellali, R; Jérôme, C; Rosière, N | 1 |
| Abenavoli, MR; Araniti, F; Chambery, A; D'Abrosca, B; Esposito, A; Fiorentino, A; Lupini, A; Russo, R; Scognamiglio, M; Sunseri, F | 1 |
| Chandra, S; Kanode, R; Sharma, S | 1 |
| Abdizadeh, R; Abdizadeh, T; Abnous, K; Ghodsi, R; Hadizadeh, F; Kalani, MR; Khashyarmanesh, BZ; Tayarani-Najaran, Z | 1 |
| Blanchard, HS; Gobrogge, CA; Walker, RA | 1 |
| Abou-Zied, OK; Ghasemi, A; Karimi-Jafari, MH; Khammari, A; Khoobi, M; Saboury, AA; Yousefinejad, S | 1 |
| Kang, H; Lee, SW; Yeo, WS; Yun, H | 1 |
| Baldus, S; Dechend, R; Fliser, D; Floege, J; Hetzel, G; Keller, T; Mahfoud, F; Massberg, S; Remppis, A; Schlieper, G; Schwenger, V; Weinreich, T | 1 |
| Gao, Z; Li, Z; Shao, X; Wang, D; Xu, Z; Yuan, P | 1 |
| Harms, H; Kleinsteuber, S; Plugge, CM; Popp, D; Sträuber, H | 1 |
| Captain, B; Garcia-Amorós, J; Nonell, S; Raymo, FM; Thapaliya, ER | 1 |
| Liao, YC; Thirumalaivasan, N; Wei, LF; Wu, SP | 1 |
| Aisa, HA; Mamat, N; Niu, C; Pang, GX | 1 |
| Kadyrova, RA; Khomenko, TM; Korchagina, DV; Orshanskaya, IR; Salakhutdinov, NF; Sannikova, VA; Volcho, KP; Zarubaev, VV | 1 |
| Allan, C; Hanna, JR; Hulme, AN; Lawrence, C; Meyer, O; Wilson, ND | 1 |
| Kobayashi, D; Nishizono, N; Oda, K; Wada, K; Yamaguchi, Y; Yoshimura, T | 1 |
| Cilibrizzi, A; Collins, J; Fedorova, M; Leatherbarrow, R; Vilar, R; Woscholski, R | 1 |
| Abdul Salam, AA; Joseph, MM; Kamath, PR; Sunil, D; T T, S | 1 |
| Al-Horani, RA; Obaidullah, AJ | 1 |
| Cheng, F; Gong, YC; Li, YP; Li, ZL; Pan, X; Tao, L; Xiong, XY | 1 |
| Chen, Z; Li, B; Liu, P; Wu, H; Wu, S; Xie, X; Zeng, F | 1 |
| Ge, J; Li, Y; Liu, W; Wang, M; Wang, P; Wu, J; Zhang, H | 1 |
| Yang, XF; Zhang, J; Zhang, X; Zhang, Y | 1 |
| Altomare, CD; Catto, M; Cellamare, S; De Palma, A; Farina, R; Pisani, L | 1 |
| Beutler, JA; da Cunha, MG; de Alencar, SM; Franchin, M; Franco, GCN; Fukada, SY; Ikegaki, M; Ramos-Junior, ES; Rosalen, PL; Taira, TM | 1 |
| Alarcón-Enos, JE; Aqueveque-Muñoz, PM; Céspedes-Acuña, CL; Vargas-Soto, FA | 1 |
| Hanaoka, K; Komatsu, T; Sakamoto, S; Ueno, T; Urano, Y | 1 |
| Hamulakova, S; Janovec, L; Jun, D; Kuca, K; Soukup, O | 1 |
| Almodôvar, VAS; Cerqueira, AFR; Neves, MGPMS; Tomé, AC | 1 |
| Fatakdawala, H; Fereidouni, F; Gorpas, D; Ma, D; Marcu, L | 1 |
| Bavari, S; Cheng, H; Gharaibeh, D; Kenny, T; Peet, NP; Retterer, C; Rong, L; Schafer, A; Soloveva, V; Zamani, R | 1 |
| B Manjappa, K; Lin, JM; Yang, DY | 1 |
| Dong, R; Fan, Z; Luo, K; Wang, Y; Wu, F; Yan, Z; Zhang, D; Zhang, J; Zhang, R | 1 |
| Fichte, MAH; Heckel, A; Weyel, XMM | 1 |
| Baron, GV; De Malsche, W; Desmet, G; Futagami, S; Hara, T; Ottevaere, H | 1 |
| Karnik, KS; Nikalje, APG; Sarkate, AP; Seijas, JA; Tiwari, SV; Vazquez-Tato, MP | 1 |
| Mazur, AK | 1 |
| Kumar Sahoo, S; Parhi, P; Suklabaidya, S | 1 |
| Cai, P; Kong, LY; Li, F; Liu, QH; Wang, J; Wang, XB; Wu, JJ; Yang, HL; Yang, XL | 1 |
| Ding, H; Li, J; Li, X; Li, Z; Liu, Y; Yin, S; Zhang, L | 1 |
| Kebeish, R; Saleh, AM | 1 |
| Khan, S; Malla, AM; Naseem, I; Zafar, A | 1 |
| Bedi, PMS; Gupta, MK; Nepali, K; Saxena, AK; Sharma, S; Singh, H; Singh, JV | 1 |
| Kharkar, PS; Warrier, S | 1 |
| Abbas, Q; Channar, PA; Hassan, M; Larik, FA; Mahesar, PA; Raza, H; Saeed, A; Seo, SY | 1 |
| Bae, S; Han, K; Hong, JI; Kim, SK; Lee, DN; Shin, IS | 1 |
| Bize, C; de Medina, P; Epifano, F; Fiorito, S; Genovese, S; Rives, A; Taddeo, VA | 1 |
| Li, L; Li, Y; Liu, Y; Ma, S; Qu, J; Su, F; Wang, R; Yu, S; Zhao, Z | 1 |
| Kim, JH | 1 |
| Li, J; Liu, C; Lv, N; Sun, M | 1 |
| Gruber-Khadjawi, M; Gutmann, A; Nidetzky, B; Schiller, M | 1 |
| Ahn, KH; Chang, YT; Jun, YW; Kim, HR; Kim, JJ; Reo, YJ; Sarkar, S; Singha, S | 1 |
| Kasaian, J; Mohammadi, A | 1 |
| Ding, Y; Lan, JS; Li, XD; Liang, HF; Liao, Y; Lu, YJ; Zeng, RF; Zhang, T | 1 |
| Balusamy, SR; Kandaswamy, N; Periyathambi, D; Perumalsamy, H; Raveendiran, N; Sankarapandian, K | 1 |
| Yamaguchi, Y | 1 |
| Bu, ZW; Guo, JM; Jin, SJ; Wang, QL; Zhu, YS | 1 |
| Fan, J; Jiao, X; Li, Y; Liang, M; Tang, B; Wang, X; Xie, X | 1 |
| Batran, RZ; Dawood, DH; El-Seginy, SA; Gugnani, KS; Maher, TJ; Rondon-Ortiz, AN | 1 |
| Badisa, VL; Joseph, MY; Latinwo, LM; Musa, MA | 1 |
| Chu, SJ; Han, HW; Han, LJ; Lu, GH; Qi, JL; Sun, WX; Wang, XM; Yang, RW; Yang, YH; Zheng, CS | 1 |
| Alamry, KA; Asiri, AM; Sun, M; Wang, S; Yang, R; Yang, S; Yu, H; Zhang, K; Zheng, J | 1 |
| Cerqueira, LB; de Francisco, TMG; Gasparetto, JC; Leonart, LP; Pontarolo, R; Pontes, FLD | 1 |
| Abenavoli, MR; Araniti, F; Lupini, A; Mauceri, A; Princi, MP; Sorgonà, A; Sunseri, F; Varanini, Z | 1 |
| Ahern, CA; Brauchi, SE; Cabezas-Bratesco, D; Carnevale, V; Galpin, JD; Islas, L; Kasimova, MA; Ladron-de-Guevara, E; Steinberg, X; Villa, F | 1 |
| Hu, Y; Shen, Y; Tu, X; Wang, GX; Wu, X | 1 |
| Feng, LS; Hu, XL; Liu, ML; Xu, Z; Zhang, GD | 1 |
| Chen, X; Feng, L; Guan, J; Jin, X; Wu, M; Xu, Y; Yang, X | 1 |
| Albiero, LR; Andrade, MF; Azzolini, AECS; Bortot, LO; Caliri, A; Carvalho, CA; Dos Santos, GB; Emery, FS; Figueiredo-Rinhel, ASG; Kabeya, LM; Lucisano-Valim, YM; Pupo, MT; Santos, EOL | 1 |
| Bosch, M; Bresolí-Obach, R; Contreras, S; Galindo, A; Gandioso, A; Marchán, V; Nin-Hill, A; Nonell, S; Palau, M; Rovira, A; Rovira, C | 1 |
| Enyedy, ÉA; Maciejewska, D; Ostrowska, K; Pósa, V; Żołek, T | 1 |
| Chinje, E; Cuff, S; Jaffar, M; Knox, R; Lewis, RD; Weeks, I | 1 |
| Dai, X; Gao, YD; Miao, JY; Ning, JY; Su, L; Wei, Q; Zhao, BX | 1 |
| Agarwal, D; Awasthi, SK; Dixit, AK; Gupta, RD; Kumar, S; Yadav, N | 1 |
| Bachari, K; Bouhenna, MM; Luyten, W; Mameri, N; Pérez, MV; Silva, AMS; Talhi, O | 1 |
| Baral, R; Basu, A; Bhattacharjee, A; Bhattacharya, S; Bhuniya, A; Hajra, S; Patra, AR; Roy, SS; Sk, UH | 1 |
| Gutiérrez-Barranquero, JA; O Gara, F; Parages, ML; Reen, FJ | 1 |
| Huang, Q; Jiang, N; Li, Q; Liang, N; Liu, J; Xie, SS | 1 |
| Devarajegowda, HC; Hosamani, KM; Joshi, SD; Kurjogi, MM; Mangasuli, SN | 1 |
| Akbarzadeh, T; Edraki, N; Karimpour-Razkenari, E; Khanavi, M; Mahdavi, M; Saeedi, M; Sameem, B; Vafadarnejad, F | 1 |
| Chen, QJ; Ni, JC; Shi, JT; Tan, QW | 1 |
| Chen, Y; Dong, M; Feng, M; Guo, Y; Jiang, S; Kuerban, K; Li, J; Wang, Q; Ye, L | 1 |
| Bracher, F; Müller, C; Stöckelhuber, M; Vetter, F | 1 |
| Afifi, M; Imran, S; Khan, KM; Rahim, F; Shah, SAA; Sultan, S; Taha, M | 1 |
| De Moliner, F; Knox, K; McLaughlin, PJ; Oparka, K; Reinders, A; Vendrell, M; Ward, JM | 1 |
| Lahouidak, S; Ríos, A; Salghi, R; Zougagh, M | 1 |
| Adnan Ali Shah, S; Afifi, M; Hadiani Ismail, N; Imran, S; Mohammed Khan, K; Rahim, F; Sultan, S; Taha, M | 1 |
| Achar, G; Budagumpi, S; Chen, XR; Lan, A; Małecki, JG; Pan, SH; Patil, SA; Shahini, CR | 1 |
| Naidu, VGM; Rama Krishna, B; Ramakrishna, S; Thummuri, D; Venkata Mallavadhani, U | 1 |
| Bednarikova, Z; Gazova, Z; Hamulakova, S; Holztragerova, M; Hsu, WT; Ulicna, K; Wang, SS; Wu, JW | 1 |
| Bi, ZM; Duan, L; Lai, CJ; Liu, EH; Wang, ZY; Zhuang, B | 1 |
| Hedberg, C; Kindahl, T; Moodie, LWK; Shukla, L | 1 |
| Avecilla, F; Kongot, M; Kumar, A; Kumar, R; Kurjogi, MM; Netalkar, SP; Reddy, DS | 1 |
| Kumar, S; Pathak, DP; Sharma, V | 1 |
| Di, H; Duan, Z; Jahufer, Z; Luo, K; Stewart, A; Wang, Y; Wu, F; Yan, Z; Zhang, J | 1 |
| Adegawa, S; Endo, H; Kasubuchi, M; Sato, R; Shii, F; Tsuneto, K; Yamagishi, T | 1 |
| Carney, IJ; Chekroun, B; Hambley, TW; Kolanowski, JL; Lim, Z; New, EJ; Torrisi, AG | 1 |
| Chand, K; Hiremathad, A; Keri, RS | 1 |
| Dai, Y; Lin, S; Ma, X; Wang, K; Xia, F; Zhang, X; Zhu, S | 1 |
| Cheng, Y; Miao, W; Wang, F; Wang, H | 1 |
| Endl, E; Feineis, S; Groll, J; Hüttmann, G; Lutz, J; Rahmanzadeh, R; Rudnitzki, F | 1 |
| Abe-Yoshizumi, R; Anderson, T; Aso, H; Bramley, A; Chang, W; Chen, Y; Du, Q; Forsyth, A; Gao, S; Gao, X; George, ES; Haake, S; Hackney, AC; Hayashi, T; He, J; Hu, J; Inoue, K; Ito, M; Itsiopoulos, C; Jiang, J; Kandori, H; Katto, S; Kiku, Y; Kitazawa, H; Kobayashi, H; Lane, AR; Lassemillante, AM; Li, B; Li, C; Li, G; Li, J; Li, Q; Li, T; Li, X; Liu, J; Liu, X; Liu, Z; Marshall, S; Marx, W; Mayr, HL; Nagasawa, Y; Niu, M; Nochi, T; Ohtani, H; Reddy, AJ; Rose, MT; Sato, H; Sato, Y; Suo, H; Taguchi, T; Tahara, S; Tahara, T; Takada, N; Takeuchi, S; Tanaka, K; Tang, L; Tatucu-Babet, OA; Thomas, CJ; Tierney, AC; Trakman, GL; Umino, T; Urakawa, M; Wang, Q; Watanabe, K; Xia, H; Yan, H; Yang, Q; Ye, R; Yoshimura, K; Yu, A; Zhan, Y; Zhang, Y; Zhang, Z; Zhao, P; Zhao, X; Zhou, X; Zhuang, T | 1 |
| Abdel-Megied, AM; Awad, M; Hammad, MA; Omar, MA | 1 |
| Gupta, S; Kumar, A; Palanati, GR; Sashidhara, KV; Siddiqi, MI; Sikka, K; Singh, LR; Upadhyay, A; Yadav, PN | 1 |
| Hu, Y; Zhang, BJ; Zhang, L; Zhang, XY | 1 |
| Abbas Bukhari, SN; Abdolahi, Z; Abdollahi, M; Ameri, A; Ayazgok, B; Baeeri, M; Emami, S; Forootanfar, H; Foroumadi, A; Ganjali, MR; Jafari, M; Jalili-Baleh, L; Khoobi, M; Küçükkılınç, TT; Nadri, H; Rahimifard, M | 1 |
| Ali, Z; Ilhan, M; Khan, IA; Küpeli Akkol, E | 1 |
| Huang, XY; Liu, WM; Ma, QG; Sang, ZP; Wang, F; Wei, RR; Yang, M; Yu, Q | 1 |
| Azevedo, L; da Silva, MC; Daguer, H; do Carmo, MAV; Escher, GB; Granato, D; Marques, MB; Molognoni, L; Prado-Silva, LD; Rosso, ND; Sant'Ana, AS; Santos, JS | 1 |
| Khan, S; Naseem, I; Zafar, A | 1 |
| Biavatti, MW; Faqueti, LG; Sandjo, LP | 1 |
| Marco, MP; Reverter, JC; Salvador, JP; Tassies, D | 1 |
| Koppal, VV; Kusanur, RA; Melavanki, RM; Patil, NR | 1 |
| Ben Jannet, H; Chekir, S; Dargère, D; Debbabi, M; Gharbi, R; Laprévote, O; Regazzetti, A | 1 |
| Ao, Y; Gai, F; Han, Z; Huo, Q; Jin, L; Li, L; Liu, Y; Yu, Y | 1 |
| Chen, X; Chen, Y; Chu, Y; Wang, Z; Zhang, J; Zhang, Y | 1 |
| Ge, J; Li, Q; Liu, W; Qi, S; Ren, H; Wang, P; Wu, J; Zhang, H | 1 |
| Hamulakova, S; Hrabinova, M; Janockova, J; Janovec, L; Jun, D; Kuca, K; Sepsova, V; Soukup, O | 1 |
| Ibrar, A; Khan, I; Saeed, F; Shehzadi, SA | 1 |
| Höglinger, D; Nadler, A; Stephan, M; Wagner, N | 1 |
| Bao, X; Chen, X; Jin, Y; Ju, X; Li, L; Li, W; Liang, G; Qian, J; Wu, W; Xiao, Z; Zheng, S; Zhu, W | 1 |
| Nieszala, M; Smith, EA; Stafford, A; Wijesooriya, CS; Zimmerman, JR | 1 |
| Li, T; Lin, S; Liu, M; Mo, R; Shen, S; Wang, L; Xu, X; Yan, Z | 1 |
| He, Y; Jia, X; Liu, H; Niu, C; Sun, Y | 1 |
| Chu, MJ; Gong, JX; Liu, H; Lv, XH; Ma, QW; Ren, ZL; Wang, JC; Wang, W | 1 |
| Hagiwara, S; Itagaki, H; Miyazaki, H; Shinoda, S; Takahashi, H; Yamashita, K | 1 |
| Huang, XL; Liang, H; Qin, QP; Shi, BB; Tan, MX; Wang, SL; Wang, ZF; Wei, QM; Zou, BQ | 1 |
| Jiang, CS; Song, JL; Zhang, H; Zhang, L; Zhang, QQ; Zhang, YY | 1 |
| Gao, Q; Qi, H; Sun, LL; Sun, XY; Wang, GX; Wang, K; Wei, NN | 1 |
| Chen, X; Hu, H; Huang, S; Li, M; Ma, Y; Ni, J; Shu, X; Wang, Y; Wu, L; Zhao, W; Zhou, Q | 1 |
| Knox, K; Oparka, K; Paterlini, A; Thomson, S | 1 |
| Groundwater, PW; Hibbs, DE; Luo, JL; Mamidi, RR; Perry, JD; Váradi, L; Wang, M | 1 |
| Gupta, S; Monpara, J; Vavia, P; Velga, D; Verma, T | 1 |
| Konop, M; Koszelewski, D; Ostaszewski, R; Ufnal, M; Zaorska, E | 1 |
| Asthana, S; Delogu, F; Era, B; Fais, A; Kumar, A; Matos, MJ; Medda, R; Santana, L; Sogos, V; Uriarte, E | 1 |
| He, H; Hou, Y; Li, Y; Wang, C; Wei, D; Zhang, T | 1 |
| Jiao, Q; Liu, Q; Xu, C; Xu, Y; Yang, Y; Zheng, D; Zhu, H | 1 |
| An, R; Guo, C; Hou, Z; Li, JT; Mou, YH; Yu, HN | 1 |
| Hou, JT; Hu, Q; Li, W; Qin, C; Zeng, L | 1 |
| Gan, ZY; Liang, FP; Meng, T; Peng, LT; Qin, QP; Tan, MX; Wang, K; Wang, ZR; Zou, HH | 1 |
| Chen, Y; Ge, JF; Sun, R; Wei, XR; Xu, YJ | 1 |
| Bruns, RE; Marcheafave, GG; Passari, LMZG; Scarminio, IS | 1 |
| Budzisz, E; Kasperkiewicz, K; Ponczek, MB | 1 |
| Barros-Aguirre, D; Bates, RH; Fang, C; Fernandez-Menendez, R; Fisher, S; Gomez, JE; Guijarro-Lopez, L; Hubbard, BK; Hung, DT; Lee, KK; Lopez-Roman, EM; Nietupski, R; Peng, Z; Serrano-Wu, MH; Yin, Y | 1 |
| Ahmed, W; Guha, S; Nagaraja, V; Udupa, S | 1 |
| Borges, F; Fernandes, C; Fonseca, A; Garrido, J; Martins, C; Matos, MJ; Nunes, R; Otero-Espinar, FJ; Remião, F; Sarmento, B; Silva, R; Uriarte, E | 1 |
| Che, J; Shi, G; Tang, J; Wang, Y; Zhao, H | 1 |
| Altomare, CD; Carrieri, A; Cellamare, S; Colabufo, NA; Niso, M; Pisani, L; Rullo, M | 1 |
| Feng, H; Han, Q; Liu, J; Meng, Q; Wang, YL; Xu, ZP; Zhang, R; Zhang, Z | 1 |
| Dong, B; Kong, X; Lin, W; Song, W; Wang, C; Zhang, N | 1 |
| Anil, SM; Balaji, KS; Jayarama, S; Kiran, KR; Lingaraju, GS; Sadashiva, MP | 1 |
| Ju, H; Lei, J; Ma, F; Wang, Q; Xu, H; Zhang, L; Zhou, J | 1 |
| Kuang, GC; Li, H; Wang, H; Wu, J; Wu, Y; Yin, JF | 1 |
| Cotlet, M; Eagleton, AM; Higashiya, S; Seeley, JP; Welch, JT | 1 |
| Armario-Hita, JC; Borrego, L; Carrascosa, JM; Córdoba, S; de Frutos, JO; Fernández-Redondo, V; García-Bravo, B; García-Gavín, J; Gatica-Ortega, ME; Giménez-Arnau, AM; González-Pérez, R; Heras-Mendoza, F; Hervella-Garcés, M; Mercader, P; Pastor-NIeto, MA; Ruiz-González, I; Sánchez-Pedreño, P; Sánchez-Pérez, J; Sanz-Sánchez, T; Silvestre, JF; Zaragoza, V | 1 |
| Hu, C; Li, J; Yan, L | 1 |
| Bräse, S; Fiebich, BL; Gargouri, B; Hurrle, T; Jauch, H; Keil, A; Mohr, F; Saliba, SW; van der Stelt, M; Volz, N | 1 |
| Ahinko, M; Jokinen, E; Niinivehmas, S; Pentikäinen, OT | 1 |
| Bai, H; Chen, S; Chen, W; Ma, X; Qu, P; Wei, X; Xu, M; Zhu, D | 1 |
| Altman, R; Beltrán, L; Berg, RL; Borgiani, P; Borobia, AM; Bourgeois, S; Burmester, JK; Caldwell, MD; Cañadas-Garre, M; Carcas, AJ; Cavallari, LH; Cen, HJ; Ciccacci, C; Danese, E; Dávila-Fajardo, C; de Boer, A; Deloukas, P; Denny, JC; Dillon, C; Drozda, K; Fava, C; Genç, E; Giontella, A; Gong, IY; Gonzalez-Conejero, R; Gwak, HS; Haug, KBF; Hirai, K; Huang, M; Isaza, C; Itoh, K; Jiménez-Varo, E; Johnson, JA; Khalifa, SI; Kim, RB; Kringen, MK; Krishnamoorthy, R; Kutala, VK; Langaee, T; Lee, KE; Lee, MTM; Lesauskaite, V; Limdi, NA; Loriot, MA; Lubitz, SA; Maitland-van der Zee, AH; Mazzaccara, C; Minuz, P; Mittal, B; Montagnana, M; Mushiroda, T; Nakamura, Y; Özer, M; Paldi, A; Pathare, A; Pengo, V; Perini, J; Pirmohamed, M; Raimondi, S; Ramirez, AH; Rathore, SS; Rivers, C; Rodrigues Botton, M; Roldan, V; Sacchetti, L; Sagreiya, H; Scott, S; Shahin, MHA; Shendre, A; Siguret, V; Suarez-Kurtz, G; Suriapranata, IM; Tagetti, A; Taljaard, M; Tan, SL; Tatarunas, V; Tong, HY; Verhoef, TI; Zambon, CF; Zhang, JE; Zhang, Y; Zhao, LZ; Zhou, HH | 1 |
| Kong, L; Liu, G; Tian, X; Tian, Y; Wu, Z; Xu, H; Zhang, H; Zhang, R; Zhang, Z; Zhou, H; Zhu, X | 1 |
| Peng, Q; Qin, S; Wei, P; Zhang, L; Zhang, R; Zhou, Y; Zhu, C; Zhu, M | 1 |
| Li, J; Xie, Y; Yan, L | 1 |
| Chen, Y; Gao, Y; Tao, Y; Wang, X; Wu, H; Yu, D | 1 |
| Dutta, R; Ghosh, M; Pyne, A; Sarkar, N | 1 |
| Han, J; Liu, R; Ni, L; Qiu, Y; Tang, X; Wang, Y; Zhu, Z | 1 |
| Chu, CC; Ou, JY; Shih, YC; Wang, BY | 1 |
| Andronov, VA; Chagarovskiy, AO; Ivanova, OA; Levina, II; Trushkov, IV; Voskressensky, LG | 1 |
| Chiba, J; Hayashi, R; Hotta, Y; Kaneko, T; Morimoto, S; Tomohiro, T; Yamamoto, A | 1 |
| Chang, KH; Chen, CM; Chiu, YJ; Huang, CC; Lee, SY; Lee-Chen, GJ; Lin, W; Yang, SM | 1 |
| Burkina, V; Rasmussen, MK; Zamaratskaia, G; Zlabek, V | 1 |
| Barbera, C; Beninatto, R; Borsato, G; De Lucchi, O; Elvassore, N; Galesso, D; Guarise, C; Luni, C; Martewicz, S; Pavan, M; Serena, E | 1 |
| Chu, MP; Jia, C; Wang, JL; Xu, K | 1 |
| Alavijeh, MS; Azizian, H; Balalaie, S; Ghalehshahi, HG; Sohbati, HR | 1 |
| Creaven, B; Karcz, D; Matwijczuk, A; Starzak, K; Wybraniec, S | 1 |
| Jiang, Y; Lyu, HN; Tu, PF; Wang, K; Wei, NN | 1 |
| Li, H; Li, Z; Wu, B; Yang, J; Yang, XF; Zhang, J | 1 |
| Abd El-Karim, SS; Abdelghany, TM; El Kerdawy, AM; Syam, YM | 1 |
| Jung, JH; Kim, SH; Kim, YH; Koo, J; Koo, JI; Park, JE; Shim, BS; Shin, EA | 1 |
| Bachurin, SO; Hu, YC; Huang, WC; Hwu, JR; Lin, SY; Shieh, FK; Tan, KT; Tsay, SC; Ustyugov, A | 1 |
| Feng, G; Feng, S; Liu, D | 1 |
| Alvala, M; Alvala, R; Ghouse, MS; Goud, NS; Pranay, J; Qureshi, IA; Talla, V; Vishnu, J | 1 |
| Dai, H; Ge, S; Huang, M; Li, Y; Ling, Y; Liu, J; Meng, C; Ming, G; Qian, J; Shi, Y; Wang, S; Yao, Y; Zhang, T; Zhang, Y | 1 |
| Liu, Y; Sun, B; Tian, H; Wang, H; Wu, X; Yang, S | 1 |
| Cacchio, A; De Blasis, E; Di Carlo, G; Vincenza, C | 1 |
| Li, Q; Ran, C; Shi, Q; Song, Y; Sun, Z; Wang, H; Wang, R; Xu, C; Zeng, R | 1 |
| Feng, Y; Jiang, Y; Liu, W; Qiu, F; Song, X; Tang, X; Wang, Y; Yang, Y; Zhang, G | 1 |
| Baranczak, A; McClure, RA; Rabalski, AJ; Vasudevan, A; Williams, JD | 1 |
| Amano, R; Morimoto, J; Ono, T; Sando, S | 1 |
| Khan, ZA; Naqvi, SAR; Sajid, MA; Shahzad, SA; Usman, M | 1 |
| Abreu, P; Carrier, M; Feugère, G; Heissler, J; Lee, AYY; Woodruff, S | 1 |
| Mikstacka, R; Piekuś-Słomka, N; Ronowicz, J; Sobiak, S | 1 |
| Chen, D; Fan, H; Gao, Z; Ji, K; Li, X; Liang, H; Liu, P; Liu, Y; Wang, X; Wu, J; Zhao, F | 1 |
| Kokot, B; Majaron, H; Novak, M; Pajk, S; Štrancar, J | 1 |
| Cellier-Rastit, M; James, AL; Orenga, S; Perry, JD; Robinson, SN; Stanforth, SP; Turnbull, G | 1 |
| Brabec, V; Bresolí-Obach, R; Galindo, A; Gandioso, A; Hally, C; Kasparkova, J; Kostrhunova, H; Marchán, V; Markova, L; Nonell, S; Novohradsky, V; Rovira, A; Ruiz, J; Svitelova, M; Vigueras, G | 1 |
| Aminah, NS; Kristanti, AN; Phuwapraisirisan, P; Ramadhan, R; Takaya, Y; Thant, TM | 1 |
| Beutler, JA; Miski, M; Ransom, TT; Tosun, F | 1 |
| Bak, JM; Lee, HI | 1 |
| He, C; He, M; Li, L; Liang, X; Luan, S; Lv, C; Song, X; Wu, Q; Yin, L; Yin, Z; Yuan, Z; Zhang, W; Zou, Y | 1 |
| Huang, C; Kong, L; Sui, Z; Wang, N; Zeng, Z; Zhao, Y | 1 |
| Cheng, W; Ding, Y; Sun, Y; Xie, Y; Yang, Z; Zhang, MZ; Zhang, W | 1 |
| Abdullah, M; Bhakat, M; Kumar, R; Mohanty, TK; Mondal, S; Singh, A; Yadav, SK | 1 |
| Jiao, X; Li, Y; Tang, B; Wang, X; Xiao, Y; Xie, X; Zhang, J; Zhao, Z | 1 |
| Alvala, M; Angeli, A; Mohammed, A; Narella, SG; Shaik, MG; Supuran, CT | 1 |
| Chen, LL; Chu, SS; Dai, M; Peng, HS; Wu, X; Xie, J; Zhang, L | 1 |
| Sinkeldam, RW; Tor, Y | 1 |
| Álvarez-Fernández, A; Busoms, S; Flis, P; Luís-Villarroya, A; Perez Martín, L; Poschenrieder, C; Salt, DE; Terés, J; Tolrà, R | 1 |
| Ghosh, AK; Lee, DS | 1 |
| Guo, C; Hou, Z; Mou, Y; Yang, X; Yu, H | 1 |
| Cho, JW; Hyun, JY; Kim, HB; Park, CW; Park, SH; Shin, I | 1 |
| Arrowsmith, RL; Botchway, SW; Cortezon-Tamarit, F; Ge, H; James, TD; Mirabello, V; Pascu, SI; Sedgwick, AC; Wang, HC | 1 |
| Gao, HW; Hu, J; Hu, Z; Liu, T; Lu, S; Uvdal, K; Zhang, X | 1 |
| Fang, JM; Hsu, TW; Hung, WC; Lee, WL | 1 |
| Liu, G; Liu, L; Pei, C; Wang, C; Wang, H; Wang, Y; Zhang, H; Zhu, L | 1 |
| Amano, T; Kitazawa, T; Sugiyama, S; Teraoka, H; Uno, Y | 2 |
| Chen, H; Chen, X; Liu, Q; Lu, A; Riaz, MK; Wong, KH; Yang, Z; Zhang, G; Zhang, X | 1 |
| Api, AM; Belmonte, F; Belsito, D; Biserta, S; Botelho, D; Bruze, M; Burton, GA; Buschmann, J; Cancellieri, MA; Dagli, ML; Date, M; Dekant, W; Deodhar, C; Fryer, AD; Gadhia, S; Jones, L; Joshi, K; Lapczynski, A; Lavelle, M; Liebler, DC; Na, M; O'Brien, D; Patel, A; Penning, TM; Ritacco, G; Rodriguez-Ropero, F; Romine, J; Sadekar, N; Salvito, D; Schultz, TW; Sipes, IG; Sullivan, G; Thakkar, Y; Tokura, Y; Tsang, S | 1 |
| Chao, J; Huo, F; Xie, X; Yin, C; Zhang, Y | 1 |
| Beesley, A; Beyer, SF; Conrath, U; Langenbach, CJG; Rohmann, PFW; Schultheiss, H | 1 |
| Araya, H; Fujimoto, Y; Hira, K; Niazi, S; Prashantha Kumar, BR; Sajeli Begum, A; Santhosh Kumar, S | 1 |
| Ahangar, N; Akbarzadeh, T; Masihi, PH; Mohammadi-Khanaposhtani, M; Saeedi, M; Shakiba, A; Sobhani, S | 1 |
| Dai, L; Jin, L; Tan, X; Wang, Q; Wang, W; Zhao, C | 1 |
| Chen, Y; Hou, L; Jiang, X; Lu, Z; Pan, Y; Shangguan, M; Xu, P; Zou, W | 1 |
| Hu, X; Mang, D; Sasaki, T; Zhang, S; Zhang, Y | 1 |
| Sawaya, ACHF; Ueno, VA | 1 |
| Chalansonnet, V; Lowe, J; Orenga, S; Perry, JD; Robinson, SN; Stanforth, SP; Sykes, HE; Truong, TV | 1 |
| Arnold, N; Dube, M; Fobofou, SA; Fotso, GW; Mogue Kamdem, L; Ndjie Ebene, A; Tchaleu Ngadjui, B | 1 |
| Han, L; Lu, J; Lv, C; Niu, X; Qin, R; Zhao, Y | 1 |
| Chen, C; Kong, L; Li, L; Luo, J; Wang, S; Zhang, Y; Zhu, D; Zhu, T | 1 |
| Duan, C; Guo, L; Guo, X; Huang, L; Li, M; Liu, J; Mao, T; Sheng, Y; Sun, S; Wang, Z; Yi, Y; Zhang, H; Zhang, J; Zhang, Y | 1 |
| Debruille, K; Quirino, JP; Smith, JA | 1 |
| Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL | 1 |
| Agarwal, M; Gupta, R; Jain, Y; Kumari, M | 1 |
| Bai, R; Chen, Y; Gu, J; Han, J; Su, J; Xie, Y; Yang, K; Yu, S; Yuan, S; Zhang, C; Zhou, T | 1 |
| Chen, H; Ding, F; He, X; Li, Y; Shen, J; Yang, P; Zhang, L | 1 |
| Andres-Mach, M; Bryda, J; Szewczyk, A; Zagaja, M | 1 |
| Hou, X; Sun, Y; Wang, D; Wang, J; Zhang, X; Zhao, Y | 1 |
| Biswas, G; Dhara, D; Dhara, S; Kapat, K; Maiti, S; Samanta, P | 1 |
| Hu, X; Lin, W; Wang, J; Zhang, J; Zhuang, C | 1 |
| Guo, JW; Huang, LH; Huang, MJ; Liu, HM; Wu, ZH; You, YZ; Zhao, JW | 1 |
| Barreto, GE; Bibak, B; Keshavarzi, Z; Sahebkar, A; Sathyapalan, T; Shakeri, F | 1 |
| Chaudhari, HK; Jadhav, BS; Kenny, RS; Mali, SN; Mandewale, MC; Yamgar, RS | 1 |
| Asgari, MS; Biglar, M; Faramarzi, MA; Hajimiri, MH; Hamedifar, H; Kiani, M; Larijani, B; Mahdavi, M; Mohammadi-Khanaposhtani, M; Pourbagher, R; Rahimi, R; Ranjbar, PR; Zabihi, E | 1 |
| Avecilla, F; Kongot, M; Kumar Singhal, N; Kumar, A; Maurya, N; Patel, R; Reddy, DS; Singh, V | 1 |
| Anil Kumar, GN; Joshi, SD; Khanapurmath, N; Kulkarni, MV | 1 |
| Angerani, S; Chang, D; Feng, S; Lindberg, E; Riezman, H; Winssinger, N | 1 |
| Bhai, S; Chatterjee, PB; Ganguly, B; Haldar, S; Nair, RR; Raju, M; Raval, IH | 1 |
| An, L; Chen, R; Li, Y; Liu, Y; Luo, Q; Wang, G; Wang, H; Xue, Y; Zhang, L | 1 |
| Diederich, MF; Menezes, JCJMDS | 1 |
| Das, A; Hananya, N; Press, O; Sagi, I; Satchi-Fainaro, R; Scomparin, A; Shabat, D | 1 |
| Benelli, G; Maggi, F; Pavela, R | 1 |
| Bordy, M; Gao, J; Hasserodt, J; Hori, Y; Kikuchi, K; Shimomura, T | 1 |
| Kumar, A; Prusty, JS | 1 |
| Cui, X; Li, C; Li, M; Li, N; Li, Y; Sun, Y; Tian, Y; Wang, T; Wu, Y; Zhang, D; Zhu, J | 1 |
| Abu Hafsa, SH; Elghandour, MMMY; Hassan, AA; Kanth Reddy, PR; Monroy, JC; Salem, AZM | 1 |
| Akdemir, A; Angeli, A; Ozturk, D; Sonmez, F; Supuran, CT; Zengin Kurt, B | 1 |
| Agrawala, PK; Devi, SC; Dwarakanath, BS; Manda, K; Parmar, VS; Prasad, AK; Shrivastava, A; Venkateswaran, K | 1 |
| Guerrero, MF; López, JL; Olaya, MDP; Vergel, NE; Viña, MD | 1 |
| Ahsan Halim, S; Al-Harrasi, A; Csuk, R; Ibrar, A; Khan, A; Khan, I; Mehsud, S; Saeed, A | 1 |
| Ieda, N; Kawaguchi, M; Nakagawa, H; Ohta, Y; Osada, S; Wakita, H | 1 |
| Chen, YJ; Cui, J; Ling, JJ; Ping, FF; Wei, B; Xu, JJ; Zhou, J | 1 |
| Cai, Y; Li, C; Luo, X; Pang, M; Xiao, Z; Zhou, X | 1 |
| Xu, Y; Zhang, G; Zhou, HF | 1 |
| Friedman, SH; Kover, K; Sarode, BR | 1 |
| de Paula, H; de S Barcelos, I; de S Borges, W; Francisco, CS; Javarini, CL; Lacerda, V; Morais, PAB; Neto, ÁC | 1 |
| Araujo, GC; Caruso, ÍP; Cornélio, ML; Di Stasi, LC; Fossey, MC; Moraes, FR; Piva, HMR; Souza, FP; Tanimoto, A; Witaicenis, A | 1 |
| Lei, K; Li, GY; Li, J; Li, XJ; Liu, H; Liu, RM; Quan, ZS; Wang, SB; Wang, XK; Wei, LC | 1 |
| Aoki, H; Furuta, T; Sasaki, H; Shiraishi, Y; Suzuki, AZ; Watahiki, R | 1 |
| Nauen, R; Zaworra, M | 1 |
| Chen, L; Deng, D; Lan, T; Pei, H; Tang, M; Xue, L; Yang, Z; Ye, H; Zheng, S; Zhu, J | 1 |
| Bachari, K; Berry, A; Caldefie-Chézet, F; Decombat, C; Delort, L; Ramdani, LH; Silva, A; Talhi, O; Vasson, MP; Vermerie, M | 1 |
| da Cunha, MG; de Cássia Orlandi Sardi, J; Franchin, M; Freires, IA; Rosalen, PL | 1 |
| Cheng, S; Dong, W; Pan, X; Shi, M; Su, T; Zhang, C; Zhao, W | 1 |
| Cai, G; Chen, J; Guo, J; Kong, L; Ren, Y; Song, D; Wan, C; Yu, W; Zhang, W; Zhu, J | 1 |
| Alıcı, B; Ateş, B; Balcıoğlu, S; Olgun Karataş, M; Özdemir, İ | 1 |
| Danis, O; Mutlu, O; Sariyer, E; Topuzogullari, M; Turgut-Balik, D; Yakarsonmez, S; Yuce-Dursun, B | 1 |
| Han, M; Li, W; Li, X; Xu, W; Yang, Y; Zhou, T | 1 |
| Alamsetti, SK; Gries, G; Gries, R; Munoz, A; Renyard, A | 1 |
| Fei, Y; Ju, Z; Li, J; Liu, A; Niu, H; Shu, P; Wei, X; Xu, Z; Yu, M; Zhu, H; Zou, S | 1 |
| Udhayakumari, D | 1 |
| Alhazza, IM; Alwasel, SH; Hudecova, L; Jomová, K; Lauro, P; Simunkova, M; Valko, M | 1 |
| Kostanyan, A; Martynova, M | 1 |
| Ansari, MF; Battini, N; Geng, RX; Hu, CF; Li, S; Lv, JS; Sui, YF; Zhang, PL; Zhou, CH | 1 |
| Arabshahi, HJ; Dyrkheeva, NS; Lavrik, OI; Mamontova, EM; Reynisson, J; Salakhutdinov, NF; Volcho, KP; Zakharenko, AL; Zakharova, OD | 1 |
| Altomare, CD; Carrieri, A; Catto, M; de Candia, M; Pisani, L; Rullo, M | 1 |
| Baltazar, MT; Lee, MY; Li, H; Moxon, TE; Nicol, B; Pendlington, R; Pickles, J; Piechota, P; Sorrell, I | 1 |
| Jia, Q; Li, N; Li, Y; Wang, Z; Yin, W; Zhao, N; Zhuang, J | 1 |
| Cindrić, M; Hranjec, M; Liekens, S; Mašek, T; Perin, N; Starčević, K; Vervaeke, P | 1 |
| Wang, Y; Xu, L; Zhang, B; Zhang, W; Zhou, Y; Zhu, Y | 1 |
| Gong, L; Li, M; Lu, C; Lu, P; Wang, Y; Zhu, L | 1 |
| Bai, MJ; Chen, XB; Duan, SY; Li, Y; Wang, XQ; Yang, XD; Yang, ZX; Ye, PT | 1 |
| Dong, J; Gao, J; Wang, Y; Zhang, W | 1 |
| Akiyama, H; Hazama, Y; Hiyama, M; Koga, N; Kurata, M; Qiu, XP; Usukura, J; Winnik, FM | 1 |
| Ding, C; Fu, J; Wang, C; Zhou, S | 1 |
| Deng, M; Jiang, X; Li, H; Liang, S; Lü, M; Qi, X; Wu, J; Yang, Y; Zhou, X | 1 |
| Xie, Y; Yan, L; Zhang, S | 1 |
| Hu, X; Li, Y; Liu, S; Song, C; Wang, Z; Yao, C | 1 |
| Ait-Yahiatène, E; Buriez, O; Ebene, DH; Grimaud, L; Guille-Collignon, M; Labbé, E; Le Saux, T; Lemaître, F; Liu, X; Pan, N; Pandard, J | 1 |
| Wang, H; Wang, P; Yu, S; Zhang, R | 1 |
| Barbosa, JMC; Câmara, VRF; Capelini, C; Carvalho, SA; Couto, TB; da Silva, EF; de Castro, SL; Junior, PAS; Lourenço, MCS; Low, JN; Murta, SMF; Salomão, K; Villar, JDF; Wardell, JL | 1 |
| Jaitak, V; Kaur, K; Sharma, P; Singh, S; Singla, R; Thakur, A | 1 |
| Pai, RV; Vavia, PR | 1 |
| Awasthi, SK; Pandey, M; Sharma, B; Sharma, K; Yadav, P | 1 |
| Choudhary, K; Jin, JO; Joshi, J; Patel, PK; Singh, AK; Yadav, D | 1 |
| Herrera Ibatá, DM; Matos, MJ; Uriarte, E; Viña, D | 1 |
| Bashir, A; Noreen, A; Safdar, Z; Sohail, R | 1 |
| Hernández-Pérez, E; Jiménez-Ferrer, E; Nicasio-Torres, P; Serrano-Román, J | 1 |
| Golubović, M; Veselinović, AM; Zivkovic, M; Zlatanovic, M; Zlatanovic, N | 1 |
| Arbeloa, T; Bañuelos, J; Bautista-Hernández, CI; Becerra-González, JG; Enríquez-Palacios, E; López-Arbeloa, I; Peña-Cabrera, E | 1 |
| Javaid, A; Jokinen, EM; Juvonen, RO; Lehtonen, M; Pentikäinen, OT; Raunio, H | 1 |
| Ahmad, Z; Al-Qawasmeh, RA; Al-Tel, TH; Hersi, F; Jaber, AM; Omar, HA; Zaher, DM | 1 |
| Babin, J; Boudier, A; Durand, A; Forero Ramirez, LM; Gaucher, C; Nouvel, C; Six, JL | 1 |
| Ciulla, M; di Profio, P; Epifano, F; Fiorito, S; Genovese, S; Palumbo, L; Scotti, L | 1 |
| Doctor, N; Kayan, B; Parker, G; Smith, M; Vang, K; Yang, Y | 1 |
| Kato, SI; Maruyama, R; Nakamura, Y; Shiozaki, S; Tobita, S; Yamamoto, K; Yoshihara, T | 1 |
| Cordeiro, MNDS; Luan, F; Wang, T; Wang, Y; Zhao, C; Zhuang, X | 1 |
| Liu, S; Peng, T; Sun, Y; Wang, G; Wang, L; Wang, T; Wen, X; Zhang, S | 1 |
| Ding, J; Gao, W; Huang, H; Liu, Z; Shao, F; Wang, C; Wang, Q; Wang, Y; Zhou, X | 1 |
| Budzisz, E; Guga, P; Kasperkiewicz, K; Owczarek, J; Ponczek, MB | 1 |
| Li, L; Li, Y; Liu, H; Luo, W; Ma, J; Wang, C; Wang, J; Wang, PG; Xie, S; Yue, K | 1 |
| Feng, D; Yang, P; Yang, Y; Zhang, A | 1 |
| Bian, Y; Leng, X; Li, Y; Tu, Z; Wang, W; Wang, Z; Wei, Z; Zheng, L | 1 |
| Baltazar, MT; Cable, S; Carmichael, PL; Cubberley, R; Cull, T; Delagrange, M; Dent, MP; Hatherell, S; Houghton, J; Kukic, P; Lee, MY; Li, H; Malcomber, S; Middleton, AM; Moxon, TE; Nathanail, AV; Nicol, B; Pendlington, R; Reynolds, G; Reynolds, J; Westmoreland, C; White, A | 1 |
| Dekić, BR; Dekić, VS; Ilić, SM; Radulović, NS; Randjelović, PJ; Stojanović, NM; Stojiljković, NI | 1 |
| Ge, X; Liu, C; Liu, X; Liu, Z; Shang, W; Tian, L; Wang, Q; You, J; Yuan, XA; Zhang, L; Zhang, Y | 1 |
| Sivrikaya Ozak, S; Yılmaz, Y | 1 |
| Butterworth, S; Detsi, A; Garzon Sanz, M; Gkionis, L; Kalospyros, A; Kavetsou, E; Manousakis, D; Tirella, A | 1 |
| Cheng, X; Ding, W; Liu, H; Liu, J; Rong, X; Wang, C; Wu, C; Xing, J | 1 |
| Amdouni, Y; Anghel, N; Boubaker, G; Desiatkina, O; Furrer, J; Hemphill, A; Mösching, M; Păunescu, E | 1 |
| Fakhri, S; Farzaei, MH; Kazemi-Afrakoti, S; Majnooni, MB; Mojarrab, M; Shokoohinia, Y | 1 |
| Araya, H; Begum Ahil, S; Fujimoto, Y; Hira, K; Kulkarni, OP; Kumar, SS | 1 |
| Hanke, S; Heiker, JT; Pippel, J; Pirotte, B; Reboud-Ravaux, M; Sträter, N; Tindall, CA; Ulbricht, D | 1 |
| Bujalska-Zadrożny, M; Głuch-Lutwin, M; Jeleniewicz, P; Karczyńska, U; Leśniak, A; Mordyl, B; Ostrowska, K; Sacharczuk, M; Siwek, A; Trzaskowski, B | 1 |
| Bode, JW; Broguiere, N; Lüchtefeld, I; Lutolf, MP; Mazunin, D; Rizzo, R; Trachsel, L; Zenobi-Wong, M | 1 |
| Han, BH; Jarussophon, S; Kaewchangwat, N; Niamnont, N; Prateepchinda, S; Suttisintong, K; Thanayupong, E; Unger, O; Yata, T | 1 |
| Bartz, U; Breidenbach, J; Gütschow, M | 1 |
| Lei, Y; Li, S; Niu, T; Shi, H; Wu, X; Zhang, X | 1 |
| Cartaya, A; Goudreau, C; Gupta, A; Kalyanram, P; Ma, H; Marshall, S; Nangia, S; Stadler, I; Zimmermann, T | 1 |
| Aydin, Z; Guo, M; Wei, Y; Yan, B | 1 |
| Berry, A; Berthon, JY; Caldefie-Chezet, F; Chalard, P; Cholet, J; Danton, O; Decombat, C; Delort, L; Felgines, C; Fraisse, D; Gainche, M; Ogeron, C; Priam, J; Ranouille, E; Ripoche, I; Saunier, E; Senejoux, F; Tourette, A; Troin, Y; Vareille-Delarbre, M; Vermerie, M | 1 |
| Bączek, K; Kosakowska, O; Przybył, JL; Szymborska-Sandhu, I; Węglarz, Z | 1 |
| Ceranowicz, P; Cieszkowski, J; Gałązka, K; Kuśnierz-Cabala, B; Maduzia, D; Warzecha, Z | 1 |
| Kanazawa, H; Maekawa, Y; Nagase, K; Okada, Y; Okamoto, N | 1 |
| Jachak, SM; Kumar, G; Siva Krishna, V; Sriram, D | 1 |
| Bai, R; Gu, J; Guo, J; Jiang, X; Lv, Y; Mi, Z; Shi, Y; Xie, Y; Yao, C; Zhang, C; Zhou, T | 1 |
| He, H; Jiang, FL; Liang, C; Liu, XY; Liu, Y; Ma, XZ; Tian, M | 1 |
| Banerjee, S; Bhattacharyya, A; Hussain, A; Sarkar, T | 1 |
| Jhunjhunwala, S; Nandi, D; Ray, S; Thakur, S | 1 |
| Alam, MA; Alnufaie, R; Alsup, N; Andrew Chambers, S; Gilmore, D; Raj Kc, H; Whitt, J | 1 |
| Dandriyal, J; Jaitak, V; Kaur, K | 1 |
| Annunziata, F; Dallavalle, S; Pinna, C; Pinto, A; Tamborini, L | 1 |
| Alıcı, B; Ateş, B; Balcıoğlu, S; Çakır, Ü; Gürses, C; Karataş, MO; Noma, SAA | 1 |
| Aktar, S; Caruso, F; Davis, M; Gahn, C; Hefter Feuss, E; Roman-Holba, S; Rossi, M; Wen, K | 1 |
| Belagali, SL; Bhat, M; Kumbar, VM; Mamatha, SV | 1 |
| Kang, MK; Kang, YH; Kim, DY; Kim, SI; Kim, YH; Lee, EJ; Na, W; Oh, H; Oh, SY | 1 |
| Li, J; Tan, R; Wang, L; Zhao, S; Zhong, X | 1 |
| Hong, K; Jeong, SK; Lee, BZ; Lee, IS; Lee, S; Pham, CH; Yoo, HM | 1 |
| Al-Abdullah, ES; Alkahtani, HM; Alshibl, HM; Awad, GEA; Bari, A; Haiba, ME; Ibrahim, BMM; Mahmoud, AH; Villinger, A | 1 |
| An, Z; Li, K; Miao, J; Su, L; Yue, Q; Zhao, B; Zhao, L; Zhao, Z | 1 |
| Chatterjee, S; Dey, S; Hira, SK; Mondal, S; Nayek, HP; Patra, N | 1 |
| Bogojevic, SS; Crochet, A; Nikodinovic-Runic, J; Pavic, A; Sovari, SN; Vojnovic, S; Zobi, F | 1 |
| He, L; Liu, R; Lu, Z; Ma, S; Sun, X; Yu, Q | 1 |
| Jian, X; Kong, L; Li, L; Li, S; Luo, J; Wang, Z; Zhao, Y | 1 |
| Supuran, CT | 1 |
| Arora, S; Attri, S; Bhagat, K; Kaur Gulati, H; Kaur, P; Kumar, N; Mohinder Singh Bedi, P; Sharma, S; Singh, A; Singh, H; Vir Singh, J | 1 |
| Ahn, KH; Ban, C; Cho, SW; Dai, M; Jeon, J; Jin, Y; Joo, J; Jun, YW; Jung, YL; Kim, HR; Kim, S; Reo, YJ; Roh, H; Sarkar, S; Singha, S; Yang, YJ | 1 |
| Adhav, PB; Chabukswar, A; Chabukswar, VV; Dallavalle, S; Diwate, BB; Gawali, SS; Jagdale, SC; Kodam, KM; Pawar, DS; Tapase, SR | 1 |
| Delavari, S; Hamrang, V; Keyvan Rad, J; Mahdavian, AR; Ziadzade, S | 1 |
| Bai, Y; Chen, G; Hou, Z; Li, J; Li, M; Li, Z; Luo, L; Luo, X; Qu, D; Su, S; Wang, Y; Xue, X; Ye, Z; Zhang, X | 1 |
| Biglar, M; Faramarzi, MA; Hajimiri, MH; Hamedifar, H; Kiani, M; Larijani, B; Mahdavi, M; Mohammadi-Khanaposhtani, M; Mollazadeh, M; Valizadeh, Y; Zonouzi, A | 1 |
| Shen, W; Zhang, D; Zheng, J; Zhou, Z | 1 |
| Dai, SY; Yang, D | 1 |
| Go, Y; Heo, M; Kim, YH; Kim, YS; Li, HX; Li, W; Yang, SY | 1 |
| Al-Warhi, T; Eldehna, WM; Elkaeed, EB; Sabt, A | 1 |
| Alonso-Pena, M; Besada, P; Costas-Lago, MC; Fontenla, JÁ; Moro, S; Quezada, E; Rodríguez-Enríquez, F; Sturlese, M; Terán, C; Torres-Terán, I; Viña, D | 1 |
| Basu, G; Ganguly, S; Ghosh, D; Govindaraju, T; Narayanaswamy, N | 1 |
| Danduga, RCSR; Kola, PK; Konidala, SK; Kotra, V | 1 |
| Alvala, M; Angeli, A; Argulwar, OS; Arifuddin, M; Soman, J; Sridhar Goud, N; Supuran, CT; Thacker, PS | 1 |
| Iikuni, S; Kaneko, S; Ono, M; Sakai, S; Shimizu, Y; Shirakawa, H; Watanabe, H | 1 |
| Qin, HL; Rakesh, KP; Ravindar, L; Zhang, ZW | 1 |
| Blanc, M; Cormier, B; Cousin, X; Hyötyläinen, T; Keiter, SH; Krauss, M; Scherbak, N | 1 |
| Bakos, É; Kele, P; Magyar, C; Német, O; Németh, K; Özvegy-Laczka, C; Patik, I; Tusnády, GE | 1 |
| Classen, T; Fejzagić, AV; Greb, J; Hogenkamp, F; Myllek, S; Pietruszka, J | 1 |
| Chung, B; Lee, J; Lee, WH; Oh, DC; Oh, KB; Park, JS; Shin, J; Suh, Y | 1 |
| Akbar, I; Alarifi, S; Ali, D; Chidambaram, SK; Radhakrishnan, S | 1 |
| Baune, M; Hayen, H; Kang, K; Kraemer, SM; Schenkeveld, WDC; Weber, G | 1 |
| Hsu, SH; Pieterse, CMJ; Stassen, MJJ; Stringlis, IA | 1 |
| Chen, SY; Li, K; Liu, YH; Pan, SL; Shi, L; Yu, KK; Yu, XQ | 1 |
| Ali, M; Dutta, A; Islam, ASM; Katarkar, A; Maiti, D; Sasmal, M | 1 |
| Cuffaro, D; Nuti, E; Rossello, A | 1 |
| Di Bussolo, V; Di Pietro, S; Iacopini, D; Lessi, F; Moscardini, A; Signore, G | 1 |
| Hina, S; Kamiya, Y; Kobayashi, Y; Miura, T; Murayama, N; Shimizu, M; Yamazaki, H | 1 |
| Bogdał, D; Janus, Ł; Piątkowski, M; Radwan-Pragłowska, J | 1 |
| Fan, Z; Li, M; Li, X; Ma, B; Wang, J; Zhang, H; Zhang, W | 1 |
| Chen, SW; Li, WB; Qiao, XP; Wang, S; Wang, ZX | 1 |
| Jakubowicz-Gil, J; Langner, E; Maciejczyk, A; Rzeski, W; Skalicka-Woźniak, K; Sumorek-Wiadro, J; Zając, A | 1 |
| Di Bello, DT; Franco-Ulloa, S; Groot, H; Hurtado, JJ; Macías, MA; Mestizo, PD; Miscione, GP; Narváez, DM; Pinzón-Ulloa, JA; Suescun, L | 1 |
| Borbas, KE; Demeyere, E; Kiraev, SR; Kovacs, D; Mathieu, E; Siemens, F | 1 |
| Bezold, D; Dürr, T; Esser, B; Haas, T; Häner, M; Jessen, HJ; Ma, J; Popp, C; Qiu, D; Richert, S; Ripp, A; Wassy, D | 1 |
| Barberon, M; Conejero, G; Dubos, C; Gao, F; Gaymard, F; Hecker, A; Hem, S; Izquierdo, E; Lefebvre-Legendre, L; Robe, K; Rofidal, V; Rouhier, N; Sylvestre-Gonon, E | 1 |
| Alghamdi, S; Faidah, H; Khurram, M; Rehman, SU; Shesha, NT | 1 |
| Banerjee, P; Mondal, A; Nag, S | 1 |
| Li, K; Li, MJ; Wang, N; Wei, X; Yu, KK; Yu, XQ | 1 |
| Cui, H; Ding, XY; Duan, LX; Huang, GY; Liu, Z; Lu, XY; Wu, JJ; Zhang, LD; Zhang, RR; Zhang, SJ | 1 |
| Cai, Y; Chen, Y; Liao, X; Ma, S; Qin, Q; Xu, G; Yang, Z; Zhan, J; Zhong, Y | 1 |
| Chen, HM; Kohsiek, M; Nasseri, SA; Rahfeld, P; Wardman, JF; Withers, SG | 1 |
| Hou, JT; Wang, B; Wang, S; Yu, KK; Zhu, L | 1 |
| Di Stasi, LC | 1 |
| Cimpean, A; Costache, M; Curti, F; Gebaur, A; Golgovici, F; Iovu, H; Necula, MG; Negrescu, AM; Nica, C | 1 |
| Ji, CB; Li, JL; Peng, YY; Sun, JC; Wang, XH; Zeng, XP | 1 |
| Alvala, M; Bharath, RD; Ghouse, MS; Goud, NS; Kumar, P; Nagaraju, C | 1 |
| Kongot, M; Kumar, A; Reddy, DS | 1 |
| Bruning, N; Dötsch, L; Hennes, E; Lampe, P; Pulvermacher, LM; Sievers, S; Waldmann, H; Ziegler, S | 1 |
| Božić Nedeljković, BD; Božić, BD; Duletić-Laušević, SN; Gašić, UM; Lunić, TM; Mandić, MR; Oalđe, MM; Sabovljević, AD; Sabovljević, MS | 1 |
| Chansaenpak, K; Chudapongse, N; Kamkaew, A; Lai, RY; Pewklang, T; Wet-Osot, S | 1 |
| Alcaro, S; Angeli, A; Angius, R; Cottiglia, F; Deplano, S; Distinto, S; Maccioni, E; Meleddu, R; Onali, A; Ortuso, F; Sanna, E; Secci, D; Supuran, CT | 1 |
| Fan, J; Hu, L; Li, H; Song, Y; Sun, Y; Zhang, R; Zheng, T | 1 |
| Dholaria, P; Kapadiya, K | 1 |
| Chinta, BS; Hoye, TR; Lee, D | 1 |
| Bizzarri, R; Di Bussolo, V; Di Pietro, S; Iacopini, D; Moscardini, A; Pineschi, M; Signore, G | 1 |
| Upadhyay, HC | 1 |
| Ge, JF; Ma, W; Sun, R; Xu, B; Xu, YJ | 1 |
| Ansari, MHSH; Azad, R; Bhandari, SV; Burra, PVLS; Dodamani, S; Dofe, VS; Jalalpure, SS; Kamble, DD; Karnik, KS; Lokwani, DK; Sangshetti, JN; Sarkate, AP; Tiwari, SV | 1 |
| Chen, L; Jiang, H; Liu, H; Liu, J; Wang, B; Wang, Y; Wang, Z | 1 |
| Abed, SA; Kassim, H; Salleh, WMNHW; Taher, M; Tawang, A | 1 |
| Demir, S; Tekin, A | 1 |
| Abdel Rahman, DE; Abdelrasheed Allam, H; Amin, KM; El-Zoheiry, HH | 1 |
| Danis, O; Kocer, S; Sariyer, E; Turgut-Balik, D | 1 |
| Abbasi, SW; Ahmad, F; Aroosh, A; Hameed, S; Islam, A; Kalsoom, S; Khatoon, S; Naseer, MM; Yasinzai, M | 1 |
| de la Mare, JA; Dingle, LMK; Edkins, AL; Hoppe, HC; Khanye, SD; Laming, D; Mbaba, M; Swart, T; Zulu, AI | 1 |
| Chuenchid, A; Phutdhawong, W; Phutdhawong, WS; Sirirak, J; Taechowisan, T | 1 |
| Bhattarai, N; Kumbhar, AA; Pokharel, YR; Yadav, PN | 1 |
| Abul Qais, F; Mohapatra, S; Patro, R; Rath, B; Sharma, T | 1 |
| Boyle, JJ; Ge, Y; Long, NJ; Mason, JC; Walter, ERH | 1 |
| Hussain, A; Kumar, A; Sahoo, S; Sarkar, T | 1 |
| Caldwell, ST; Cvetko, F; Hartley, RC; McCarron, JG; Murphy, MP; O'Byrne, SN; Wilson, C | 1 |
| Ishida, H; Itoh, T; Ohashi, N; Yoshikawa, C | 1 |
| Roh, EJ | 1 |
| Chu, A; Forli, S; Johnson, KA; Kelly, JW; Morgan, GJ; Nair, R; Petrassi, HM; Santos-Martins, D; Wilson, IA; Yan, NL | 1 |
| Alvarez de Cienfuegos, L; Lupiañez, JA; Martinez, A; Medina-O'Donnell, M; Parra, A; Reyes-Zurita, FJ; Rivas, F; Vega-Granados, K | 1 |
| Peng, D; Shan, C; Shi, Y; Wu, H; Wu, J; Zhang, S; Zhao, L | 1 |
| Liu, H; Luck, RL; Steenwinkel, TE; Vohs, T; Wan, S; Werner, T; Xia, S; Zhang, Y | 1 |
| Ali, F; Anand, R; Das, A; Gaded, V; Hoskere Ashoka, A; Malvi, H; Mariam, J | 1 |
| Endo, H; Kasubuchi, M; Mang, D; Sasaki, K; Sato, R; Shii, F; Toyama, T; Tsuneto, K | 1 |
| Bakker, AT; Bevan, CL; Bock, N; Clements, JA; De Vita, E; Engelsberger, E; Kryza, T; Lovell, S; Maneiro, M; Neodo, A; Tanaka, RJ; Tate, EW; Williams, ED; Xu, C; Zhang, L | 1 |
| Fernandes, CC; Qian, X; Städler, B; Westensee, IN | 1 |
| Cristina da Costa Araldi, I; Danesi, CC; de Andrade Fortes, T; de Freitas Bauermann, L; de Souza Vencato, M; Dornelles, GL; Emanuelli Mello, CB; Gindri, AL; Machado, AK; Maciel, RM; Melazzo de Andrade, C; Piber de Souza, T; Sorraila de Oliveira, J | 1 |
| Ansari, MF; Cheng, Y; Hu, C; Hu, Y; Pan, G; Yadav Bheemanaboina, RR; Yu, C; Zhang, J; Zhou, C | 1 |
| Aragaw, WW; Chui, WK; Dartois, V; Dick, T; Gengenbacher, M; Jackson, CJ; Lee, BM; Yang, X; Zimmerman, MD | 1 |
| Ge, JF; Qiu, LH; Sun, R; Wang, YN; Xu, YJ; Zhang, XQ | 1 |
| Duan, C; Jiao, Y; Ma, C; Zuo, Y | 1 |
| Arion, VB; Babak, MV; Büchel, GE; Darvasiova, D; Hammerstad, M; Popovic-Bijelic, A; Rapta, P; Shova, S; Spengler, G; Stepanenko, I | 1 |
| Chen, CY; Feng, N; Li, BQ; Li, XK; Li, ZY; Lin, Y; Ma, AJ; Tan, LF; Zhang, XZ | 1 |
| O'Shea, P; Teevan-Hanman, C | 1 |
| Arenz, C; Kornhuber, J; Mohamed, ZH; Rhein, C; Schmid, B; Tripal, P | 1 |
| Ekpo, OE; Joubert, J; Malan, SF; Mzezewa, SC; Omoruyi, SI; Zondagh, LS | 1 |
| Huang, W; Li, J; Liu, X; Mo, T; Shi, S; Tu, P; Wang, J; Wang, X; Xu, X; Yan, Y | 1 |
| Araniti, F; Bruno, L; Cabeiras-Freijanes, L; Lucini, L; Madeo, ML; Minervino, M; Miras-Moreno, B; Muto, A; Sofo, A; Talarico, E | 1 |
| Al Adhami, T; Alharthy, RD; Hussain, D; Imran, A; Iqbal, J; Miraz Rahman, K; Shafiq, Z; Tariq Shehzad, M | 1 |
| Miao, J; Ren, H; Wei, Q; Yao, W; Zhang, J; Zhao, B | 1 |
| Cutrín, E; Laguna, R; Otero, F; Quezada, E; Rodríguez-Enríquez, F; Uriarte, E; Viña, D | 1 |
| Byun, HS; Hur, GM; Ju, E; Lee, J; Lee, SR; Na, M; Park, KA; Piao, X; Quan, KT; Sohn, KC | 1 |
| Faccio, G; Ihssen, J; Sirec, T; Spitz, U; Yao, C | 1 |
| Alavi, SJ; Bafghi, MH; Orafai, H; Sadeghian, H; Zebarjadi, A | 1 |
| Lai, C; Liang, Y; Lin, W; Zhao, Y; Zou, X | 1 |
| Cai, J; Deng, S; Jiang, Y; Lei, Q; Shen, J | 1 |
| Ciszkowicz, E; Creaven, B; Jenkins, H; Kamiński, D; Karcz, D; Lecka-Szlachta, K; Matwijczuk, A; Miłoś, A; Radomski, P; Ślusarczyk, L; Starzak, K | 1 |
| Dandekar, P; Dobhal, A; Jain, R; Srivastav, A | 1 |
| Javed, T; Khalid, N; Khalid, S; Raja, SA; Rehman, KU; Riaz, S | 1 |
| Hou, J; Li, J; Liu, L; Ma, J; Si, W; Wang, Y; Xu, Y; Zhang, Z | 1 |
| Gardner, ZS; Jonnalagadda, S; Jonnalagadda, SK; Mani, C; Mereddy, VR; Nelson, GL; Palle, H; Ronayne, CT; Rumbley, J; Schumacher, TJ; Solano, LN | 1 |
| Alasmary, FA; Almutairi, TM; Nocentini, A; Osman, SM; Petreni, A; Supuran, CT | 1 |
| Grzelakowska, A; Modrzejewska, J; Podsiadły, R; Szala, M; Zakłos-Szyda, M; Zielonka, J | 1 |
| Matos, MJ | 1 |
| Chen, J; Hu, Y; Liu, GL; Liu, L; Lu, JF; Shan, LP; Xue, MY | 1 |
| Banothu, J; G, AC; Gondru, R; Li, Y | 1 |
| Aptula, A; Baltazar, MT; Cubberley, R; Gilmour, N; Maxwell, G; Przybylak, K; Reynolds, G; Reynolds, J; Spriggs, S; Windebank, S | 1 |
| Amooru, GD; Aramati, BMR; Dubey, S; Gajula, NN; Kallubai, M; Kandrakonda, YR; Shaik, JB; Subramanyam, R | 1 |
| Ben Khemis, I; Ben Lamine, A | 1 |
| Apweiler, M; Bräse, S; Fiebich, BL; Gräßle, S; Hurrle, T; Saliba, SW; Streyczek, J | 1 |
| Matos, MJ; Santana, L; Uriarte, E | 1 |
| Hu, S; Li, Q; Luo, M; Shen, P; Su, Z; Wang, J; Wu, Z | 1 |
| Achar, RR; Al-Rejaie, SS; Dharmashekara, C; Elgorban, AM; Flores-Holguín, N; Frau, J; Glossman-Mitnik, D; Gowda, MV; Kameshwar, VH; Kollur, SP; Ortega-Castro, J; Shivamallu, C; Shreevatsa, B; Swamy, VH; Syed, A; Thimmulappa, RK | 1 |
| Chen, D; Gong, W; He, Q; Jiang, L; Jiang, M; Jin, Z; Qin, S; Yu, Z; Zhu, Y | 1 |
| Dong, J; Fan, C; Lu, G; Pu, S; Tu, Y | 1 |
| Dard, C; Francisco Hilário, F; Leforestier, B; Lespinasse, MA; Maubon, D; Milet, A; Molina, MC; Pereira de Freitas, R; Pérès, B; Traoré, MDM; Wong, YS | 1 |
| Alanazi, MM; Amran, SI; Biswas, S; Chander, S; Das, B; Hadda, TB; Hasan, AH; Jamalis, J; Murugesan, S; Pratama, MRF; Shakya, S | 1 |
| Ahmad, R; Azizan, KA; Baharum, SN; Goh, KJ; Goh, YK; Ong, CE | 1 |
| Chen, Y; Cheng, X; Liu, H; Lv, X; Maraswami, M; Xia, D | 1 |
| Aldabaldetrecu, M; Benavides, A; Guerrero, J; Gutiérrez, D; Mascayano, C; Modak, B; Olguín, A; Valenzuela, B | 1 |
| Li, X; Ma, H; Shi, W; Zhao, Y | 1 |
| Moraes, MLL; Silva, HDT; Silva, SA | 1 |
| Chu, A; Johnson, KA; Kelly, JW; Morgan, GJ; Nair, R; Wilson, IA; Yan, NL | 1 |
| Aguilar, LF; Borges, F; Celik, I; Delogu, G; González, C; Matos, MJ; Mella, J; Mellado, M; Uriarte, E; Viña, D | 1 |
| Ahmad, I; Boulaamane, Y; Britel, MR; Das, N; Maurady, A; Patel, H | 1 |
| Liu, H; Luck, RL; Qiu, X; Sun, L; Yan, Q; Zhang, Y | 1 |
| Bashir, MK; Fakri Mustafa, Y; Khudhayer Oglah, M; Riyadh Khalil, R; Tareq Mohammed, E | 1 |
| He, Y; Jiang, X; Liao, L; Qiao, F; Wang, Z; Xiao, Y; Zhang, Y; Zhao, Y | 1 |
| Abid, M; Abid, S; Allouche, N; Ammar, H; Baaziz, I; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Ramazani, A; Tlili, N; Zarei, A | 1 |
| Fang, Y; Guo, R; Hang, S; Sheng, R; Wang, Y; Wu, W | 1 |
| Bharate, SB; Gairola, S; Nuthakki, VK; Sharma, A; Singh, B | 1 |
| Chu, H; Li, Y; Mu, Y; Pan, Y; Sun, J; Wang, L; Wang, X | 1 |
| Kim, H; Kim, JH; Lee, Y; Maeng, HJ; Oh, Y; Paek, SM; Yoon, JH | 1 |
| Feng, XF; Mei, YF; Pan, J; Wang, YS; Xia-Hou, ZR; Yang, JH; Yang, T; Zhang, YY | 1 |
| Bugarin, A; Feldman, MR; Kandathil, V; Patil, SA; Sobha, A; Somappa, SB | 1 |
| Han, L; Huang, S; Jia, C; Mao, D; Rasool, A; Wang, M; Yan, M; Yang, P | 1 |
| Koleva, AI; Koleva, IZ; Lozanova, V; Lyapchev, R; Madzharova, I; Morgenstern, B; Nikolova, RD; Petkova-Yankova, N; Petrov, PY; Simeonova, KB; Subev, K | 1 |
| Das, S; Kulkarni, S; Liang, C; Mishra, PK; Ratre, P; Thareja, S | 1 |
| Hong, S; Jeong, J; Kim, M | 1 |
| Kumar, A; Kumar, S | 1 |
| Creaven, BS; Georgieva, I; Kavanagh, K; Mujahid, M; Rosair, G; Trendafilova, N; Walsh, M | 1 |
| Gouda, MAS; Ismail, MF; Mahmoud, NFH; Marzouk, MI; Salem, MAI | 1 |
| Abdel-Aziem, A; Elsharabasy, SA; Sayed, MT | 1 |
| Çelik Onar, H; Ece, A; Erçağ, E; Gülçin, İ; Özden, EM; Taslak, HD | 1 |
| Beesley, A; Beyer, SF; Bredenbruch, S; Conrath, U; Gätgens, J; Habash, SS; Langenbach, CJG; Levecque, S; Oldiges, M; Schleker, ASS; Schultheiss, H; Wanders, V | 1 |
| Chen, D; Chen, FM; Li, YL; Nie, XM; Xu, XL; Zhang, F | 1 |
146 review(s) available for coumarin and warfarin
| Article | Year |
|---|---|
[The pathophysiology, clinical picture and treatment of coumarin-induced necrosis].
Topics: Administration, Oral; Coumarins; Humans; Incidence; Necrosis; Recurrence; Risk Factors; Skin Diseases; Time Factors | 1991 |
The pharmacology of aspirin, heparin, coumarin, and thrombolytic agents. Implications for therapeutic use in cardiopulmonary disease.
Topics: Aspirin; Coumarins; Fibrinolytic Agents; Heparin; Humans; Thromboembolism; Thrombolytic Therapy; Thrombosis | 1991 |
The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds.
Topics: Animals; Coumarins; Humans | 1990 |
Side-effects of antithrombotic therapy.
Topics: Administration, Oral; Adult; Animals; Anticoagulants; Coumarins; Drug Eruptions; Drug Hypersensitivity; Female; Fibrinolytic Agents; Hemorrhagic Disorders; Heparin; Humans; Male; Osteoporosis; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Factors; Thrombocytopenia; Thrombolytic Therapy; Vitamin K | 1990 |
Macrophage and tissue changes in the developmental phases of secondary lymphoedema and during conservative therapy with benzopyrone.
Topics: Animals; Cell Count; Coumarins; Humans; Lymphedema; Macrophages | 1990 |
Coumarin necrosis of the penis.
Topics: Coumarins; Humans; Male; Middle Aged; Necrosis; Penis; Protein C Deficiency; Pulmonary Embolism | 1989 |
Protein C and protein S clinical perspectives.
Topics: Blood Coagulation Disorders; Coumarins; Deficiency Diseases; Glycoproteins; Humans; Protein C; Protein C Deficiency; Protein S | 1987 |
Warfarin: metabolism and mode of action.
Topics: Animals; Coumarins; Cytochrome P-450 Enzyme System; Protein Binding; Stereoisomerism; Tissue Distribution; Warfarin | 1988 |
Current status of drugs as teratogens in man.
Topics: Abnormalities, Drug-Induced; Anti-Bacterial Agents; Anticonvulsants; Antineoplastic Agents; Coumarins; Diethylstilbestrol; Ethanol; Female; Humans; Lithium; Lithium Carbonate; Penicillamine; Pregnancy; Risk; Teratogens | 1985 |
Interindividual differences in the metabolism of xenobiotics.
Topics: Aflatoxin B1; Aflatoxins; Antipyrine; Benzopyrenes; Biotransformation; Carcinogens; Coumarins; Desipramine; Diet; Dihydroxydihydrobenzopyrenes; Hexobarbital; Humans; Liver; Microsomes, Liver; Pharmaceutical Preparations; Smoking; Steroids; Zoxazolamine | 1985 |
The management of renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Coumarins; Genetic Therapy; Humans; Immunotherapy; Interferons; Interleukin-2; Kidney Neoplasms; Killer Cells, Lymphokine-Activated; Neoplasm Staging; Tumor Necrosis Factor-alpha | 1994 |
The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.
Topics: Animals; Carcinogens; Cattle; Chromosome Mapping; Chromosomes, Human, Pair 19; Coumarins; Cricetinae; Cytochrome P-450 Enzyme System; Gene Expression Regulation, Enzymologic; Humans; Liver; Mice; Multigene Family; Neoplasms; Phenotype; Rabbits; Rats; Species Specificity; Steroid Hydroxylases; Substrate Specificity | 1995 |
Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; Coumarins; Doxorubicin; Drug Administration Schedule; Drug Resistance; Fluorouracil; Humans; Intercalating Agents; Male; Methotrexate; Neoplasm Staging; Polyamines; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Somatostatin | 1993 |
[Skin necrosis: a paradoxical complication of anticoagulation].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Necrosis; Skin; Thrombosis | 1995 |
Interaction of dietary factors with oral anticoagulants: review and applications.
Topics: Administration, Oral; Alcoholic Beverages; Allium; Anticoagulants; Beverages; Caffeine; Coumarins; Dietary Fats; Food-Drug Interactions; Humans; Peptide Hydrolases; Silicones; Vitamin K; Vitamins | 1995 |
Anticoagulants and skin necrosis.
Topics: Administration, Oral; Anticoagulants; Coumarins; Heparin; Humans; Necrosis; Protein C Deficiency; Protein S Deficiency; Skin; Vitamin K Deficiency | 1994 |
Species differences in the metabolism and hepatotoxicity of coumarin.
Topics: Animals; Chemical and Drug Induced Liver Injury; Coumarins; Humans; In Vitro Techniques; Liver Diseases; Species Specificity | 1993 |
The antiphospholipid syndrome: ten years on.
Topics: Anticoagulants; Antiphospholipid Syndrome; Coumarins; Humans | 1993 |
Regulation of coumarin 7-hydroxylation in man.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Liver; Liver Diseases; Mice; Mixed Function Oxygenases; Prodrugs; Umbelliferones | 1994 |
Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma; Coumarins; Humans; Male; Middle Aged; Prostatic Neoplasms | 1994 |
An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin.
Topics: Adult; Aged; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Cimetidine; Coumarins; Drug Therapy, Combination; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Survival Analysis; Treatment Outcome; Umbelliferones | 1994 |
[Immunotherapy of prostate cancer].
Topics: Antibodies, Monoclonal; Coumarins; Humans; Immunotherapy; Immunotherapy, Active; Immunotherapy, Adoptive; Male; Prostatic Neoplasms; Suramin | 1993 |
Management of patients with hereditary defects predisposing to thrombosis including pregnant women.
Topics: Abnormalities, Drug-Induced; Anticoagulants; Antithrombin III; Antithrombin III Deficiency; Blood Proteins; Coumarins; Disease Susceptibility; Drug Eruptions; Factor V Deficiency; Female; Fibrinolytic Agents; Genetic Predisposition to Disease; Humans; Infant, Newborn; Male; Necrosis; Pregnancy; Pregnancy Complications, Hematologic; Prevalence; Protein C; Protein S Deficiency; Puerperal Disorders; Purpura; Recurrence; Risk; Thrombolytic Therapy; Thrombosis; Warfarin | 1995 |
Coumarin-induced hepatic necrosis.
Topics: Aged; Antineoplastic Agents; Biopsy; Chemical and Drug Induced Liver Injury; Coumarins; Humans; Liver; Male; Necrosis; Prostatic Neoplasms | 1997 |
[Acute cytolytic hepatitis caused by coumarin. 2 cases].
Topics: Acute Disease; Adult; Anticoagulants; Chemical and Drug Induced Liver Injury; Coumarins; Female; Humans; Middle Aged; Venous Insufficiency | 1997 |
Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.
Topics: Age Factors; Animals; Beverages; Calcium Channel Blockers; Citrus; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Flavonoids; Food-Drug Interactions; Furocoumarins; Herb-Drug Interactions; Humans; Intestine, Small; Male; Mixed Function Oxygenases; Risk Assessment; Sex Factors | 1998 |
Thrombin and antithrombotics.
Topics: Blood Coagulation; Blood Coagulation Factors; Coumarins; Enzyme Activation; Factor VIII; Fibrinolytic Agents; Heparin; Hirudins; Humans; Prothrombin; Thrombin; Thromboplastin; Vitamin K | 1998 |
A case of coumarin necrosis with penile and pedal involvement.
Topics: Adenocarcinoma; Anticoagulants; Coumarins; Foot Dermatoses; Humans; Lung Neoplasms; Male; Middle Aged; Necrosis; Penile Diseases; Pulmonary Embolism; Skin Diseases | 1998 |
Antithrombotic therapy for venous thromboembolic disease.
Topics: Coumarins; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombolytic Therapy | 1998 |
Contemporary issues in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Anticoagulants; Aspirin; Community Health Services; Coumarins; Heart Failure; Humans; Hypertension; Myocardial Ischemia; Stroke Volume; United States; Ventricular Dysfunction, Left | 1999 |
Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
Topics: Animals; Carcinogens; Cosmetics; Coumarins; Cricetinae; Food Contamination; Humans; Intestinal Absorption; Mice; Mutagenicity Tests; Rats; Risk Assessment; Toxicity Tests | 1999 |
Management of venous edema: insights from an international task force.
Topics: Anticoagulants; Bandages; Calcium Dobesilate; Cardiovascular Agents; Chronic Disease; Controlled Clinical Trials as Topic; Coumarins; Diosmin; Edema; Femoral Vein; Hemostatics; Humans; Leg; Placebos; Rutin; Saphenous Vein; Sclerotherapy; Vasodilator Agents; Venous Insufficiency; Venous Thrombosis | 2000 |
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Coumarins; Drug Interactions; Food; Heart Valve Prosthesis; Humans; Myocardial Infarction; Thromboembolism; Venous Thrombosis; Warfarin | 2001 |
[Heart disease, anticoagulants and pregnancy].
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Coumarins; Female; Fetus; Gestational Age; Heart Valve Prosthesis; Heparin; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Factors; Thromboembolism; Time Factors; Warfarin | 2001 |
Cutaneous reactions to anticoagulants. Recognition and management.
Topics: Anticoagulants; Coumarins; Fibrinolytic Agents; Heparin; Hirudins; Humans; Skin Diseases | 2001 |
Preoperative stop or continue? New antithrombotic and anticoagulants.
Topics: Anticoagulants; Coumarins; Fibrinolytic Agents; Hemorrhage; Heparin; Hirudins; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Preoperative Care; Purinergic P2 Receptor Antagonists; Risk Factors; Thrombosis; Thromboxane A2 | 2001 |
[Acute gastrointestinal bleeding in patients with antithrombotic therapy].
Topics: Acute Disease; Anticoagulants; Aspirin; Coumarins; Deamino Arginine Vasopressin; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Hemostatics; Heparin; Humans; Thrombolytic Therapy; Ticlopidine | 2002 |
[Lymphedema: which drug therapy?].
Topics: Anticoagulants; Breast Neoplasms; Coumarins; Diuretics; Female; Flavonoids; Humans; Lymphedema | 2002 |
Coumarin therapy in thrombosis.
Topics: Anticoagulants; Coumarins; Humans; International Normalized Ratio; Thrombosis; Warfarin | 2003 |
Recent progress in the development of coumarin derivatives as potent anti-HIV agents.
Topics: Anti-HIV Agents; Coumarins; Drug Design; HIV; Humans; Solubility; Structure-Activity Relationship | 2003 |
Outpatient treatment of acute venous thromboembolic disease.
Topics: Acute Disease; Ambulatory Care; Anticoagulants; Coumarins; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Home Care Services; Humans; Injections, Subcutaneous; Pulmonary Embolism; Recurrence; Venous Thrombosis | 2003 |
Solid-phase synthesis of C-terminal modified peptides.
Topics: Alcohols; Aldehydes; Amides; Anilides; Chemistry, Organic; Coumarins; Hydrazines; Hydroxamic Acids; Ketones; Models, Chemical; Organic Chemistry Phenomena; Peptide Biosynthesis; Peptides; Protein Structure, Tertiary | 2003 |
Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review.
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Costs and Cost Analysis; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Risk Factors; Vitamin K; Warfarin; Withholding Treatment | 2004 |
An overview of the heparin-induced thrombocytopenia syndrome.
Topics: Antibodies; Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Heparitin Sulfate; Humans; Immunoglobulin G; Models, Biological; Monocytes; Phenotype; Platelet Activation; Platelet Factor 4; Thrombin; Thrombocytopenia; Thrombosis | 2004 |
Current options in the prevention of thromboembolic disease.
Topics: Administration, Oral; Anticoagulants; Coumarins; Fondaparinux; Heparin; Humans; Injections, Subcutaneous; Polysaccharides; Thrombocytopenia; Thromboembolism | 2004 |
Molecular mechanisms of toxicity of important food-borne phytotoxins.
Topics: Alkaloids; Alkenes; Aristolochic Acids; beta Carotene; Coumarins; Enzymes; Ephedra; Food; Glycosides; Humans; Hypericum; Kava; Lactones; Plants, Toxic; Polymorphism, Genetic; Synephrine | 2005 |
[Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke | 2005 |
Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema.
Topics: Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Flavonoids; Humans; Lymphedema; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Single Nucleotide | 2005 |
A safety assessment of coumarin taking into account species-specificity of toxicokinetics.
Topics: Animals; Anticoagulants; Coumarins; Dogs; Environmental Exposure; Humans; Mice; Primates; Rats; Risk Assessment; Species Specificity; Toxicity Tests | 2006 |
[Triplex antithrombotic therapy after coronary-stent implantation (that is absent from recommendation)].
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Coumarins; Drug Therapy, Combination; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Secondary Prevention; Stents; Ticlopidine | 2005 |
[Progress in study of chemical constituents and anti-tumor activities of Cnidium monnieri].
Topics: Antineoplastic Agents, Phytogenic; Cnidium; Coumarins; Drugs, Chinese Herbal; Furocoumarins; Molecular Structure | 2005 |
[The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
Topics: Anticoagulants; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Postoperative Hemorrhage; Preoperative Care; Risk Factors; Thromboembolism; Vitamin K; Warfarin | 2006 |
[Old burdens and new perspectives of the long-term anticoagulant therapy].
Topics: Anticoagulants; Azetidines; Benzylamines; Coumarins; Drug Administration Schedule; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Neoplasms; Patient Compliance; Thromboembolism; Thrombolytic Therapy; Thrombosis | 2006 |
[Synthetic studies on aromatic heterocyclic compounds].
Topics: Alkaloids; Amines; Chemistry, Organic; Coumarins; Heterocyclic Compounds; Organic Chemistry Phenomena; Oxygen; Palladium | 2006 |
Think of HIT.
Topics: Contraindications; Coumarins; Heparin; Humans; Practice Guidelines as Topic; Thrombin; Thrombocytopenia | 2006 |
Pharmacogenetics-based coumarin therapy.
Topics: Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C9; Genotype; Humans; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Single Nucleotide; Vitamin K Epoxide Reductases | 2006 |
CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients?
Topics: Animals; Chemical and Drug Induced Liver Injury; Coumarins; Humans; Liver Diseases; Lymphedema; Pharmacogenetics; Polymorphism, Genetic | 2007 |
[Thromboembolic diseases in pregnancy].
Topics: Algorithms; Anticoagulants; Aspirin; Contraindications; Coumarins; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2007 |
Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
Topics: Anticoagulants; Bone and Bones; Bone Density; Coumarins; Humans; Nutritional Requirements; Osteocalcin; Osteoporosis; Risk Factors; Time Factors; Vitamin K; Vitamin K Deficiency | 2007 |
[New insight in therapeutic anticoagulation by Coumarin derivatives].
Topics: Anticoagulants; Coumarins; Drug Hypersensitivity; Humans; Mixed Function Oxygenases; Vitamin K; Vitamin K Epoxide Reductases | 2008 |
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents.
Topics: Anticoagulants; Coumarins; Disease Management; Hemorrhage; Heparin; Humans; Risk | 2008 |
The vitamin K cycle.
Topics: Animals; Blood Coagulation; Calcium; Carbon-Carbon Ligases; Coumarins; Homeostasis; Humans; Mixed Function Oxygenases; Osteoporosis; Vitamin K; Vitamin K 1; Vitamin K 2; Vitamin K Epoxide Reductases | 2008 |
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
Topics: Anticoagulants; Coumarins; Defibrillators, Implantable; Hematoma; Heparin; Humans; Pacemaker, Artificial; Perioperative Care; Practice Guidelines as Topic; Prosthesis Implantation; Thromboembolism | 2008 |
[Advance in the study of compounds inducing the expression of heme oxygenase-1].
Topics: Animals; Antineoplastic Agents; Antioxidants; Coumarins; Drugs, Chinese Herbal; Enzyme Induction; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Humans; Lovastatin; Nitric Oxide; Peptide Hormones; Probucol; Signal Transduction; Transcription Factors | 2008 |
A review of coumarin derivatives in pharmacotherapy of breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Coumarins; Enzyme Inhibitors; Estrogens; Humans; Selective Estrogen Receptor Modulators | 2008 |
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review.
Topics: Anticoagulants; Blood Loss, Surgical; Coumarins; Heparin, Low-Molecular-Weight; Humans; Laser Therapy; Male; Platelet Aggregation Inhibitors; Prostatectomy; Prostatic Hyperplasia; Risk Factors; Treatment Outcome | 2009 |
Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
Topics: Adenocarcinoma; Adenoma; Animals; Bronchioles; Carcinogens; Cell Proliferation; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Endpoint Determination; Enzyme Inhibitors; Epithelial Cells; Humans; Inhalation Exposure; Isoenzymes; Lung Neoplasms; Mice; Mice, Knockout; Mutagenicity Tests; Naphthalenes; Rats; Structure-Activity Relationship; Styrene | 2009 |
In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: implications for risk assessment.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Biotransformation; Carcinogens; Computational Biology; Coumarins; Expert Systems; Humans; Models, Biological; Mutagens; Plants, Edible; Plants, Medicinal; Risk Assessment; Species Specificity | 2010 |
Toxicology and risk assessment of coumarin: focus on human data.
Topics: Animals; Biotransformation; Chemical and Drug Induced Liver Injury; Coumarins; Edema; Flavoring Agents; Humans; Liver Neoplasms; Lymphedema; Plants, Medicinal; Risk Assessment; Species Specificity; Toxicity Tests; Venous Insufficiency | 2010 |
The complex clinical picture of side effects to anticoagulation.
Topics: Anaphylaxis; Anticoagulants; Coumarins; Drug Eruptions; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Hypersensitivity, Delayed; Polysaccharides; Thrombin; Thrombocytopenia; Vitamin K | 2010 |
Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Chromones; Coumarins; Female; Flavonoids; Humans; Letrozole; Nitriles; Receptors, Estrogen; Sulfonamides; Triazoles | 2010 |
Coumarin-induced intramural hematoma of the duodenum: case report and review of the literature.
Topics: Aged; Anticoagulants; Coumarins; Duodenum; Gastrointestinal Hemorrhage; Hematemesis; Hematoma; Humans; Male; Melena | 2011 |
Cardiovascular diseases in pregnancy.
Topics: Anticoagulants; Cardiomyopathies; Coumarins; Cross-Sectional Studies; Dose-Response Relationship, Drug; Endocarditis; Female; Germany; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hypertension; Incidence; Infant, Newborn; Male; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prenatal Care | 2011 |
Natural history and management of cervical spine disease in chondrodysplasia punctata and coumarin embryopathy.
Topics: Adult; Cervical Vertebrae; Chondrodysplasia Punctata; Coumarins; Disease Management; Female; Fetal Diseases; Humans; Male; Pregnancy; Radiography; Spinal Diseases | 2012 |
CYP2A6: genetics, structure, regulation, and function.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Mice; Models, Molecular; Multigene Family; Neoplasms; Nicotine; Nicotinic Agonists; Polymorphism, Genetic; Smoking; Substrate Specificity | 2012 |
Physicochemical strategies for inhibition of amyloid fibril formation: an overview of recent advances.
Topics: Amyloid; Chelating Agents; Cold Temperature; Coumarins; Humans; Hydrostatic Pressure; Lasers; Nanoparticles; Nucleic Acids; Peptides; Small Molecule Libraries; Trehalose | 2012 |
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Algorithms; Alleles; Aryl Hydrocarbon Hydroxylases; Cohort Studies; Coumarins; Cross-Sectional Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Ethnicity; Humans; International Normalized Ratio; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Publication Bias; Sex Factors; Vitamin K Epoxide Reductases | 2012 |
Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?
Topics: Alzheimer Disease; Animals; Anthraquinones; Biomedical Research; Carbolines; Catechin; Chromosomes, Human, Pair 21; Coumarins; Down Syndrome; Drug Design; Dyrk Kinases; Humans; Mice; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; tau Proteins | 2012 |
Sailing between Scylla and Charybdis: oral long-term anticoagulation in dialysis patients.
Topics: Anticoagulants; Coumarins; Humans; Kidney Failure, Chronic; Risk Assessment | 2013 |
Development of functional molecules for elucidation of the physiological roles of several nuclear receptors and their endogenous ligands.
Topics: Coumarins; Fluorescent Dyes; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Ligands; Protein Binding; Receptors, Cytoplasmic and Nuclear; Receptors, Progesterone; Receptors, Thyroid Hormone; Thiazolidinediones | 2013 |
New anticoagulants in atrial fibrillation management.
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Coumarins; Dabigatran; Female; Hematology; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Renal Insufficiency; Sex Factors; Warfarin | 2013 |
A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
Topics: Alzheimer Disease; Coumarins; Depression; Drug Design; Humans; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2013 |
Bioactive natural compounds from the mangrove endophytic fungi.
Topics: Alkaloids; Animals; Apoptosis; Biological Products; Chromones; Coumarins; Fungi; Humans; Peptides; Polyketides; Terpenes | 2014 |
Sweet potato (Ipomoea batatas [L.] Lam)--a valuable medicinal food: a review.
Topics: Animals; Anthocyanins; Antineoplastic Agents; Antioxidants; Cardiovascular Agents; Coumarins; Disease Models, Animal; Humans; Hypoglycemic Agents; Ipomoea batatas; Nutritive Value; Phenols; Phytochemicals; Plants, Medicinal; Quinic Acid; Triterpenes | 2014 |
Coumarin hybrids as novel therapeutic agents.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Cell Survival; Coumarins; Drug Design; Drug Resistance, Multiple, Bacterial; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding | 2014 |
The management of secondary lower limb lymphoedema in cancer patients: a systematic review.
Topics: Coumarins; Disease Management; Humans; Lower Extremity; Lymphedema; Neoplasms; Palliative Medicine; Quality of Life; Stockings, Compression | 2015 |
Pharmacogenetics of coumarin anticoagulants in Brazilians.
Topics: Anticoagulants; Brazil; Coumarins; Ethnicity; Humans; Pharmacogenetics; Polymorphism, Genetic | 2015 |
Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
Topics: Acenocoumarol; Animals; Anticoagulants; Clinical Trials as Topic; Coumarins; Fever; Hemorrhage; Humans; International Normalized Ratio; Phenprocoumon; Rats; Risk Factors; Treatment Outcome; Vitamin K; Warfarin | 2015 |
Coumarin: a promising scaffold for anticancer agents.
Topics: Animals; Antineoplastic Agents; Biological Products; Coumarins; Humans; Neoplasms; Signal Transduction; Structure-Activity Relationship | 2015 |
Coumarin: A Privileged Scaffold for the Design and Development of Antineurodegenerative Agents.
Topics: Coumarins; Drug Design; Neurodegenerative Diseases; Neuroprotective Agents; Structure-Activity Relationship | 2016 |
The essential role of coumarin secretion for Fe acquisition from alkaline soil.
Topics: Arabidopsis; Coumarins; Gas Chromatography-Mass Spectrometry; Iron; Metabolomics; Soil | 2016 |
Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients.
Topics: Anticoagulants; Coumarins; Cytochrome P450 Family 4; Hemorrhage; Humans; International Normalized Ratio; Polymorphism, Genetic | 2016 |
Current Progresses and Trends in the Development of Progesterone Receptor Modulators.
Topics: Boranes; Coumarins; Heterocyclic Compounds, Fused-Ring; Hormone Replacement Therapy; Humans; Hydrocarbons, Alicyclic; Indoles; Ligands; Protein Binding; Receptors, Progesterone; Steroids; Vitamin D | 2016 |
Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Topics: Animals; Antineoplastic Agents; Coumarins; Humans | 2016 |
Developments of Anticoagulants and New Agents with Anti-Coagulant Effects in Deep Vein Thrombosis.
Topics: Anticoagulants; Coumarins; Factor Xa; Factor Xa Inhibitors; Humans; Triazoles; Venous Thrombosis | 2017 |
Coumarin and Derivates as Lipid Lowering Agents.
Topics: Coumarins; Humans; Hypolipidemic Agents; Oxidative Stress; Phenols | 2017 |
Inverse Electron-Demand Diels-Alder Bioorthogonal Reactions.
Topics: Animals; Coumarins; Cycloaddition Reaction; DNA; Electrons; Humans; Microscopy, Fluorescence; Polysaccharides; Positron Emission Tomography Computed Tomography; Tetrazoles | 2016 |
Recent advances in the synthesis and application of fluorescent α-amino acids.
Topics: Amino Acids; Chemistry Techniques, Synthetic; Coumarins; Flavones; Fluorescent Dyes; Optical Imaging; Polycyclic Aromatic Hydrocarbons; Spectrometry, Fluorescence | 2016 |
Can pharmacogenetics help patients under chronic treatment with coumarin anticoagulants?
Topics: Anticoagulants; Coumarins; Dose-Response Relationship, Drug; Genotype; Humans; Pharmacogenetics; Vitamin K | 2016 |
Evidence for periprocedural antiplatelet therapy, heparinization and bridging of coumarin therapy in carotid revascularization.
Topics: Angioplasty; Anticoagulants; Carotid Stenosis; Coumarins; Endarterectomy, Carotid; Heparin; Humans; Intracranial Embolism; Patient Selection; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stents; Thromboembolism; Time Factors; Treatment Outcome | 2017 |
[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].
Topics: Anticoagulants; Atrial Fibrillation; Contraindications, Drug; Coumarins; Germany; Humans; Nephrology; Prospective Studies; Renal Insufficiency, Chronic; Societies, Medical; Stroke | 2017 |
Coumarin-Tetrapyrrolic Macrocycle Conjugates: Synthesis and Applications.
Topics: Alkylation; Coumarins; Indoles; Isoindoles; Molecular Structure; Porphyrins; Pyrroles | 2017 |
Biological activities of farnesiferol C: a review.
Topics: Coumarins; Ferula; Molecular Structure; Plant Roots; Sesquiterpenes | 2018 |
Synthesis of Furanocoumarin, Benzofuran and Coumarin Derivatives Possessing an Inhibitory Effect on Human CYP, and Elucidation of the Inhibitory Mechanism.
Topics: Benzofurans; Citrus paradisi; Coumarins; Cytochrome P-450 CYP3A Inhibitors; Fruit and Vegetable Juices; Furocoumarins; Humans; Structure-Activity Relationship | 2017 |
Recent Developments of Coumarin Hybrids as Anti-fungal Agents.
Topics: Antifungal Agents; Coumarins; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Coumarin: a novel player in microbial quorum sensing and biofilm formation inhibition.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Physiological Phenomena; Biofilms; Coumarins; Humans; Quorum Sensing | 2018 |
Recent Advances in Cyclodextrin-Based Light-Responsive Supramolecular Systems.
Topics: Anthracenes; Azo Compounds; Coumarins; Cyclodextrins; Gels; Light; Liposomes; Micelles; Nanostructures | 2018 |
Topics: Adaptive Immunity; Amines; Animals; Antigen Presentation; Carbon Dioxide; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cattle; Cell Separation; Cholesterol; Contrast Media; Coumarins; Cytokines; Dendritic Cells; Dimerization; Dynamic Light Scattering; Endoglin; Female; Gadolinium DTPA; gamma-Cyclodextrins; Heterografts; Humans; Hydrophobic and Hydrophilic Interactions; Immune Tolerance; Immunity, Innate; Inducible T-Cell Co-Stimulator Protein; Leukocytes, Mononuclear; Light; Liver Neoplasms; Magnetic Resonance Imaging; Microscopy, Electron, Transmission; Olive Oil; Parturition; Phenotype; Polyethylene Glycols; Polymers; Polyphenols; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors; Spectrometry, Fluorescence; Water | 2017 |
Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery.
Topics: Aldehyde Reductase; Alkaline Phosphatase; Cholinesterases; Coumarins; Drug Design; Enzymes; Glucosidases; Humans; Molecular Docking Simulation; Monoamine Oxidase | 2018 |
Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coumarins; Cytochrome P-450 CYP2C9; Cytochrome P450 Family 4; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Vitamin K Epoxide Reductases | 2019 |
5-Endo-dig cyclizations in organic syntheses.
Topics: Benzofurans; Catalysis; Chemistry Techniques, Synthetic; Coumarins; Cyclization; Indoles; Molecular Structure | 2020 |
Hybrid
Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Coumarins; Curcumin; Humans; Oleanolic Acid; Resveratrol; Stilbenes; Structure-Activity Relationship | 2019 |
A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade.
Topics: Coumarins; Diterpenes; DNA Topoisomerases; Fatty Acids; Flavonoids; Heterocyclic Compounds; Humans; Lignans; Organometallic Compounds; Polyphenols; Quinones; Topoisomerase Inhibitors | 2019 |
RIFM fragrance ingredient safety assessment, coumarin, CAS Registry Number 91-64-5.
Topics: Animals; Cell Line; Consumer Product Safety; Coumarins; Endpoint Determination; Humans; No-Observed-Adverse-Effect Level; Odorants; Perfume; Risk Assessment; Salmonella typhimurium | 2019 |
Coumarins as potential supportive medication for the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Brain; Coumarins; Disease Models, Animal; Epilepsy; Humans; Seizures | 2019 |
A review of the pharmacological and therapeutic effects of auraptene.
Topics: Aegle; Anti-Inflammatory Agents; Apoptosis; Cell Proliferation; Citrus; Coumarins; Humans; Inflammation; Signal Transduction | 2019 |
Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.
Topics: Antineoplastic Agents, Phytogenic; Biological Products; Chalcones; Coumarins; Dimerization; DNA Topoisomerases; Humans; Molecular Structure; Neoplasms; Resveratrol; Topoisomerase Inhibitors | 2019 |
Coumarins: antifungal effectiveness and future therapeutic scope.
Topics: Animals; Antifungal Agents; Coumarins; Drug Resistance, Multiple, Fungal; Humans; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship | 2020 |
Therapeutic potential of coumarin bearing metal complexes: Where are we headed?
Topics: Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cell Survival; Coordination Complexes; Coumarins; Drug Resistance, Microbial; Fungi; Humans; Metals | 2020 |
Detection of toxic fluoride ion via chromogenic and fluorogenic sensing. A comprehensive review of the year 2015-2019.
Topics: Boron Compounds; Chemistry Techniques, Analytical; Colorimetry; Coumarins; Electrons; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Fluorides; Fluorine; History, 21st Century; Hydrazones; Hydrogen Bonding; Ions; Photochemistry; Quantum Dots; Schiff Bases; Spectrometry, Fluorescence | 2020 |
The Application of the Combination of Monte Carlo Optimization Method based QSAR Modeling and Molecular Docking in Drug Design and Development.
Topics: Coumarins; Drug Design; HIV Integrase; Humans; Molecular Docking Simulation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Software | 2020 |
Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.
Topics: Animals; Cardiovascular Diseases; Coumarins; Factor Xa Inhibitors; Humans; Vitamin K | 2020 |
Coumarin-containing hybrids and their antibacterial activities.
Topics: Anti-Bacterial Agents; Coumarins; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2020 |
Isofraxidin: Synthesis, Biosynthesis, Isolation, Pharmacokinetic and Pharmacological Properties.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Cardiotonic Agents; Coumarins; Eleutherococcus; Fraxinus; Humans; Matrix Metalloproteinases; Neuroprotective Agents; NF-kappa B; Solvents; Tumor Necrosis Factor-alpha | 2020 |
Coumarin as a structural component of substrates and probes for serine and cysteine proteases.
Topics: Catalytic Domain; Coumarins; Cysteine Proteases; Fluorescence; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Serine; Serine Proteases; Substrate Specificity | 2020 |
An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities.
Topics: Chemistry, Pharmaceutical; Coumarins; Humans; Structure-Activity Relationship; Tissue Scaffolds | 2020 |
Coumarin carbonic anhydrase inhibitors from natural sources.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Humans; Molecular Structure; Neoplasms | 2020 |
Approaches for the synthesis of o-nitrobenzyl and coumarin linkers for use in photocleavable biomaterials and bioconjugates and their biomedical applications.
Topics: Biocompatible Materials; Coumarins | 2020 |
Recent advancements of coumarin-based anticancer agents: An up-to-date review.
Topics: Antineoplastic Agents; Coumarins; Humans; Molecular Structure; Structure-Activity Relationship | 2020 |
Antibacterial activities with the structure-activity relationship of coumarin derivatives.
Topics: Anti-Bacterial Agents; Coumarins; Drug Resistance, Bacterial; Drug Resistance, Multiple; Structure-Activity Relationship | 2020 |
Coumarin Communication Along the Microbiome-Root-Shoot Axis.
Topics: Communication; Coumarins; Microbiota; Plant Roots; Rhizosphere; Soil Microbiology | 2021 |
Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.
Topics: Animals; Antitubercular Agents; Coumarins; Drug Design; Humans; Isoniazid; Mycobacterium tuberculosis; Peptides, Cyclic; Pharmaceutical Preparations; Pore Forming Cytotoxic Proteins; Tuberculosis, Multidrug-Resistant | 2020 |
Coumarin Derivatives in Inflammatory Bowel Disease.
Topics: Animals; Biological Products; Coumarins; Humans; Inflammatory Bowel Diseases; Protective Agents | 2021 |
Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity.
Topics: Animals; Antitubercular Agents; Coumarins; Drug Design; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2021 |
Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance.
Topics: Anti-Bacterial Agents; Coumarins; Drug Resistance; Humans; Structure-Activity Relationship; Triazoles | 2021 |
The phytochemistry and biological diversity of Ferulago genus (Apiaceae): a systematic review.
Topics: Apiaceae; Biodiversity; Coumarins; Ethnopharmacology; Oils, Volatile; Phytochemicals; Phytotherapy; Plant Extracts; Sesquiterpenes | 2021 |
Anticancer Potential of Coumarin and its Derivatives.
Topics: Anti-Infective Agents; Antineoplastic Agents; Coumarins; Humans; Neoplasms | 2021 |
Binding site comparison for coumarin inhibitors and amine/amino acid activators of human carbonic anhydrases.
Topics: Amines; Amino Acids; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Humans; Molecular Structure | 2021 |
Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Benzimidazoles; Chemistry, Pharmaceutical; Coumarins; Drug Development; Humans; Molecular Structure | 2022 |
3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade.
Topics: Chemistry, Pharmaceutical; Coumarins; Humans | 2021 |
Recent Developments of Coumarin-based Hybrids in Drug Discovery.
Topics: Antineoplastic Agents; Coumarins; Drug Design; Drug Discovery; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2022 |
Recent advances in fluorescent probes for lipid droplets.
Topics: Animals; Cell Line; Coumarins; Flavones; Fluorescent Dyes; Humans; Lipid Droplets; Microscopy, Fluorescence; Naphthalimides; Polycyclic Aromatic Hydrocarbons | 2022 |
Daphnetin, a Coumarin in Genus Stellera Chamaejasme Linn: Chemistry, Bioactivity and Therapeutic Potential.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Coumarins; Umbelliferones | 2022 |
Comprehensive Review on Medicinal Applications of Coumarin-Derived Imine-Metal Complexes.
Topics: Antioxidants; Coordination Complexes; Coumarins; Imines | 2022 |
Medicinal chemistry aspects and synthetic strategies of coumarin as aromatase inhibitors: an overview.
Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Chemistry, Pharmaceutical; Coumarins; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent | 2022 |
Visible-Light-Active Coumarin- and Quinolinone-Based Photocatalysts and Their Applications in Chemical Transformations.
Topics: Coumarins; Quinolones | 2023 |
58 trial(s) available for coumarin and warfarin
| Article | Year |
|---|---|
Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma.
Topics: Adult; Aged; Carcinoma; Coumarins; Drug Evaluation; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms | 1992 |
Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Coumarins; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Radiography | 1991 |
Phase II trial of coumarin and cimetidine in advanced renal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cimetidine; Coumarins; Drug Evaluation; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pleural Neoplasms; Survival Rate | 1990 |
Side-effects of antithrombotic therapy.
Topics: Administration, Oral; Adult; Animals; Anticoagulants; Coumarins; Drug Eruptions; Drug Hypersensitivity; Female; Fibrinolytic Agents; Hemorrhagic Disorders; Heparin; Humans; Male; Osteoporosis; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Factors; Thrombocytopenia; Thrombolytic Therapy; Vitamin K | 1990 |
Prevention of early recurrence of high risk malignant melanoma by coumarin. Irish Melanoma Group.
Topics: Adult; Combined Modality Therapy; Coumarins; Female; Humans; Male; Melanoma; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Random Allocation; Skin Neoplasms | 1989 |
The effects of 5,6 benzo-[a]-pyrone (coumarin) and DEC on filaritic lymphoedema and elephantiasis in India. Preliminary results.
Topics: Analysis of Variance; Coumarins; Diethylcarbamazine; Double-Blind Method; Elephantiasis, Filarial; Filariasis; Humans; India; Lymphedema; Randomized Controlled Trials as Topic; Regression Analysis | 1989 |
Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Coumarins; Female; Femoral Artery; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Popliteal Artery; Random Allocation; Risk; Saphenous Vein | 1986 |
The significance of coumarin anticoagulation in laser assisted percutaneous transluminal angioplasty of femoropopliteal arterial obstructions.
Topics: Administration, Oral; Aged; Angioplasty, Balloon, Laser-Assisted; Anticoagulants; Arterial Occlusive Diseases; Coumarins; Female; Femoral Artery; Humans; Male; Middle Aged; Popliteal Artery; Prospective Studies; Risk Factors; Thrombosis | 1995 |
Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers.
Topics: Adult; Analysis of Variance; Beverages; Citrus; Coumarins; Female; Humans; Hydroxylation; Male; Reference Values | 1994 |
Treatment with coumarin to prevent or delay recurrence of malignant melanoma.
Topics: Chemotherapy, Adjuvant; Coumarins; Double-Blind Method; Female; Humans; Life Tables; Male; Melanoma; Neoplasm Recurrence, Local; Prospective Studies | 1994 |
Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
Topics: Adult; Aged; Aged, 80 and over; Contraindications; Coumarins; Dalteparin; Female; Fractures, Spontaneous; Hemorrhage; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Patient Compliance; Pulmonary Embolism; Recurrence; Spinal Fractures; Thromboembolism | 1994 |
Treatment of filarial lymphoedema and elephantiasis with 5,6-benzo-alpha-pyrone (coumarin).
Topics: Coumarins; Double-Blind Method; Elephantiasis, Filarial; Female; Filariasis; Humans; Lymphedema; Male; Middle Aged; Treatment Outcome | 1993 |
Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-alpha-pyrone (coumarin), and the effects of diethylcarbamazine (DEC).
Topics: Adult; Aged; Coumarins; Diethylcarbamazine; Double-Blind Method; Drug Therapy, Combination; Elephantiasis, Filarial; Female; Humans; Lymphedema; Male; Middle Aged | 1993 |
Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone.
Topics: Arm; Chronic Disease; Coumarins; Double-Blind Method; Female; Follow-Up Studies; Humans; Leg; Lymphedema; Male; Middle Aged; Skin Temperature | 1993 |
Anticoagulant therapy in pregnancy. Report of 54 cases.
Topics: Adult; Anticoagulants; Chi-Square Distribution; Coumarins; Female; Fetus; Heart Valve Prosthesis; Hemorrhage; Heparin; Humans; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies | 1996 |
Coumarin 7-hydroxylation in long-term adherents of a strict uncooked vegan diet.
Topics: Adult; Aged; Anticoagulants; Coumarins; Diet, Vegetarian; Eating; Female; Humans; Hydroxylation; Male; Middle Aged; Nutritional Status | 1996 |
Randomised study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cimetidine; Coumarins; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Prospective Studies; Recombinant Proteins | 1995 |
Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect.
Topics: Administration, Oral; Administration, Topical; Anticoagulants; Arm; Combined Modality Therapy; Coumarins; Humans; Hydroxyethylrutoside; Leg; Lymphedema; Physical Therapy Modalities; Treatment Outcome | 1996 |
The use of 5,6 benzo-[alpha]-pyrone (coumarin) and heating by microwaves in the treatment of chronic lymphedema of the legs.
Topics: Administration, Oral; Adult; Anticoagulants; Bandages; Chronic Disease; Combined Modality Therapy; Coumarins; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Leg; Lymphedema; Male; Microwaves; Treatment Outcome | 1996 |
Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment.
Topics: Administration, Oral; Adult; Anticoagulants; Biomarkers; Bleeding Time; Blood Coagulation Factors; Coumarins; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Evaluation; Hemostasis; Humans; Necrosis; Skin | 1997 |
Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.
Topics: Anticoagulants; Aspirin; Coumarins; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thromboembolism; Time Factors | 1997 |
[Coumarin combined with low-dose acetylsalicylic acid in the prevention of thromboembolic complications in patients with mitral and aortic valve prostheses].
Topics: Adolescent; Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Coumarins; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Thromboembolism | 1997 |
Single-dose disulfiram does not inhibit CYP2A6 activity.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Coumarins; Cross-Over Studies; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disulfiram; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Male; Mixed Function Oxygenases; Umbelliferones | 1998 |
Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chronic Disease; Combined Modality Therapy; Coumarins; Cross-Over Studies; Double-Blind Method; Female; Humans; Lymphedema; Mastectomy; Middle Aged; Postoperative Complications; Radiotherapy; Transaminases; Treatment Failure | 1999 |
Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer.
Topics: Arm; Breast Neoplasms; Combined Modality Therapy; Coumarins; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lymphedema; Middle Aged; Treatment Outcome | 1999 |
Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Coumarins; Enoxaparin; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Phlebography; Thrombophlebitis; Time Factors | 1999 |
Naringenin and interindividual variability in interaction of coumarin with grapefruit juice.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Beverages; Citrus; Coumarins; Cross-Over Studies; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Flavanones; Flavonoids; Genotype; Humans; Kinetics; Male; Mixed Function Oxygenases; Scopoletin; Umbelliferones | 1999 |
[Prospective double-blind study of prophylaxis of radioxerostomia with Coumarin/Troxerutine in patients with head and neck cancer].
Topics: Adult; Aged; Coumarins; Double-Blind Method; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Hydroxyethylrutoside; Male; Middle Aged; Mouth Mucosa; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Salivation; Treatment Outcome; Xerostomia | 1999 |
Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Survival Analysis; Thromboembolism; Treatment Outcome | 1999 |
Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
Topics: Administration, Oral; Adult; Analysis of Variance; Anticoagulants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Coumarins; Cross-Over Studies; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Female; Humans; Male; Methoxsalen; Mixed Function Oxygenases; Molecular Probes; Umbelliferones | 2000 |
A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
Topics: Administration, Oral; Adult; Aged; Algorithms; Anticoagulants; Blood Coagulation; Case Management; Coumarins; Drug Administration Schedule; Female; Heart Valve Prosthesis; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Patient Acceptance of Health Care; Patient Compliance; Patient Education as Topic; Prospective Studies; Self Administration; Self Care; Thromboembolism | 2000 |
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Coumarins; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Stents; Ticlopidine; Treatment Outcome; Ultrasonography, Interventional | 2000 |
The in vivo dermal absorption and metabolism of [4-14C] coumarin by rats and by human volunteers under simulated conditions of use in fragrances.
Topics: Administration, Topical; Adult; Animals; Biotransformation; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Coumarins; Humans; Male; Middle Aged; Perfume; Rats; Skin Absorption; Solutions | 2001 |
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
Topics: Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Disease-Free Survival; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Treatment Outcome | 2002 |
Single copy of variant CYP2A6 alleles does not confer susceptibility to liver dysfunction in patients treated with coumarin.
Topics: Adult; Aged; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Chemical and Drug Induced Liver Injury; Coumarins; Cytochrome P-450 CYP2A6; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genotype; Humans; Hydroxyethylrutoside; Liver Diseases; Liver Function Tests; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Prospective Studies; Smoking; Venous Insufficiency | 2003 |
Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Anticoagulants; Aspartate Aminotransferases; Coumarins; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Humans; Hydroxyethylrutoside; Liver; Male; Middle Aged | 2003 |
Oral anticoagulation therapy in children: successfully controlled by self-management.
Topics: Administration, Oral; Adolescent; Anticoagulants; Child; Child, Preschool; Coumarins; Female; Heart Defects, Congenital; Humans; Infant; Male; Patient Compliance; Self Administration; Thrombosis; Treatment Outcome | 2004 |
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Coumarins; Dalteparin; Female; Heparin, Low-Molecular-Weight; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Survival Analysis; Thromboembolism; Treatment Outcome | 2005 |
The effect of ketoconazole on the pharmacokinetics of a selective alpha 1A-adrenoceptor antagonist.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Antagonists; Adult; Area Under Curve; Carbon Radioisotopes; Coumarins; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fomepizole; Half-Life; Humans; Ketoconazole; Male; Microsomes, Liver; Pyrazoles; Pyrimidinones; Quinidine; Receptors, Adrenergic, alpha-1; Sulfaphenazole; Theophylline | 2005 |
Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial.
Topics: Aged; Anticoagulants; Aspirin; Cerebral Arterial Diseases; Cerebrovascular Disorders; Constriction, Pathologic; Coumarins; Female; Humans; Male; Middle Cerebral Artery; Platelet Aggregation Inhibitors; Treatment Outcome | 2006 |
In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cotinine; Coumarins; Cytochrome P-450 CYP2A6; Drug Combinations; Female; Gene Frequency; Genotype; Humans; Hydroxyethylrutoside; Male; Middle Aged; Mixed Function Oxygenases; Nicotine; Nicotinic Agonists; Phenotype; Polymethacrylic Acids; Polymorphism, Genetic; Polyvinyls; Thailand; Tobacco Use Cessation Devices; Umbelliferones | 2006 |
Low molecular weight heparin treatment in pregnant women with a mechanical heart valve prosthesis.
Topics: Adult; Coumarins; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydrocephalus; Nadroparin; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Thrombosis; Treatment Outcome | 2007 |
Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Caffeine; Chlorzoxazone; Coumarins; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Male; Mephenytoin; Metoprolol; Midazolam; Middle Aged | 2007 |
The effect of feeding piglets with the diet containing green tea extracts or coumarin on in vitro metabolism of aflatoxin B1 by their tissues.
Topics: Aflatoxin B1; Animal Feed; Animals; Antioxidants; Camellia sinensis; Coumarins; Diet; DNA Adducts; Female; Gene Expression Regulation; Glutathione Transferase; Intestinal Mucosa; Liver; Phytotherapy; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity; Swine | 2007 |
Artemisinin and CYP2A6 activity in healthy subjects.
Topics: Adult; Antimalarials; Area Under Curve; Artemisinins; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Coumarins; Cross-Over Studies; Cytochrome P-450 CYP2A6; Enzyme Induction; Humans; Male; Mixed Function Oxygenases; Nicotine; Tandem Mass Spectrometry; Umbelliferones; Vietnam | 2008 |
Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Coumarins; Drug Combinations; Emergencies; Europe; Factor IX; Factor VII; Factor X; Female; Hemorrhage; Hemostatics; Humans; International Normalized Ratio; Israel; Male; Middle Aged; Prospective Studies; Prothrombin; Pulmonary Embolism; Vitamin K | 2008 |
Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.
Topics: Anticoagulants; Coumarins; Enoxaparin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Postthrombotic Syndrome; Prospective Studies; Recurrence; Thromboembolism; Time Factors; Venous Thrombosis | 2008 |
Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome.
Topics: Aged; Anticoagulants; Aspirin; Coronary Occlusion; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Myocardial Infarction; Recurrence; Thrombolytic Therapy; Treatment Outcome | 2009 |
Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.
Topics: Aged; Anticoagulants; Antidotes; Atrial Fibrillation; Blood Coagulation Factors; Coumarins; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Emergency Medical Services; Factor IX; Factor VII; Factor X; Female; Home Infusion Therapy; Humans; Male; Prothrombin; Time Factors; Treatment Outcome; Venous Thrombosis | 2010 |
Relative bioavailability of coumarin from cinnamon and cinnamon-containing foods compared to isolated coumarin: a four-way crossover study in human volunteers.
Topics: Adult; Beverages; Capsules; Cinnamomum aromaticum; Coumarins; Cross-Over Studies; Female; Food; Glucuronides; Humans; Intestinal Absorption; Kinetics; Male; Middle Aged; Plant Bark; Powders; Risk Assessment; Spices; Umbelliferones | 2011 |
Pharmacogenetics of coumarin dosing: prevalence of CYP2C9 and VKORC1 polymorphisms in the Lebanese population.
Topics: Adolescent; Adult; Alleles; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C9; Female; Gene Frequency; Humans; International Normalized Ratio; Lebanon; Male; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Genetic; Prevalence; Vitamin K Epoxide Reductases | 2011 |
Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance.
Topics: Adult; Aged; Blood Glucose; Capillaries; Capsules; Cinnamomum aromaticum; Cinnamomum zeylanicum; Coumarins; Cross-Over Studies; Female; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Phytotherapy; Plant Preparations; Postprandial Period; Veins | 2012 |
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.
Topics: Anticoagulants; Cohort Studies; Coumarins; Decision Support Techniques; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Models, Statistical; Neoplasms; Proportional Hazards Models; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Secondary Prevention; Sensitivity and Specificity; Venous Thromboembolism | 2012 |
Randomised trial of a clinical dosing algorithm to start anticoagulation with phenprocoumon.
Topics: Aged; Algorithms; Anticoagulants; Confidence Intervals; Coumarins; Drug Dosage Calculations; Female; Genotype; Humans; International Normalized Ratio; Male; Middle Aged; Phenprocoumon; Polypharmacy | 2013 |
Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial.
Topics: Biomechanical Phenomena; Brazil; Cardiovascular Agents; Chronic Disease; Coumarins; Diosmin; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Foot Joints; Hesperidin; Humans; Hydroxyethylrutoside; Male; para-Aminobenzoates; Plethysmography; Quality of Life; Range of Motion, Articular; Recovery of Function; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venous Insufficiency | 2014 |
Effect of a mixture of diosmin, coumarin glycosides, and triterpenes on bleeding, thrombosis, and pain after stapled anopexy: a prospective, randomized, placebo-controlled clinical trial.
Topics: Acetaminophen; Adult; Aged; Blood Loss, Surgical; Coumarins; Demography; Digestive System Surgical Procedures; Diosmin; Female; Glycosides; Hemorrhoids; Humans; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Placebos; Prospective Studies; Surgical Stapling; Thrombosis; Triterpenes | 2017 |
Effectiveness and safety of a mixture of diosmin, coumarin and arbutin (Linfadren
Topics: Adult; Aged; Arbutin; Child; Combined Modality Therapy; Coumarins; Diosmin; Drug Combinations; Edema; Female; Hand; Hand Injuries; Humans; Male; Middle Aged; Patient Satisfaction; Physical Therapy Modalities; Postoperative Complications | 2019 |
Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study.
Topics: Aged; Coumarins; Dalteparin; Disease-Free Survival; Female; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Survival Rate; Thrombosis; Venous Thromboembolism | 2019 |
3037 other study(ies) available for coumarin and warfarin
| Article | Year |
|---|---|
Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.
Topics: Absorption; Adsorption; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Permeability; Pharmacokinetics; Spectrophotometry, Ultraviolet | 1998 |
Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.
Topics: Binding Sites; Biosensing Techniques; Digitoxin; Drug Stability; Humans; Molecular Weight; Naproxen; Orosomucoid; Pharmaceutical Preparations; Protein Binding; Quinine; Rifampin; Ritonavir; Serum Albumin; Solvents; Warfarin | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Azo Compounds; Carrageenan; Coumarins; Edema; Hindlimb; Inflammation; Molecular Structure; Rats; Structure-Activity Relationship | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Synthesis and antiinflammatory activity of coumarin derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Coumarins; Cyclooxygenase Inhibitors; Edema; Female; Free Radical Scavengers; Immunologic Factors; Lipoxygenase Inhibitors; Male; Mannich Bases; Rats; Rats, Inbred F344; Structure-Activity Relationship; Superoxides | 2005 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Synthetic human serum albumin Sudlow I binding site mimics.
Topics: Anticoagulants; Binding Sites; Binding, Competitive; Chromatography, High Pressure Liquid; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Magnetic Resonance Spectroscopy; Molecular Dynamics Simulation; Molecular Imprinting; Molecular Mimicry; Polymethacrylic Acids; Radioligand Assay; Serum Albumin; Warfarin | 2010 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Genetic Variation; Humans; Hydroxylation; Kinetics; Male; Middle Aged; Mixed Function Oxygenases; Reference Values; Reproducibility of Results; Umbelliferones | 1992 |
Effect of serum-free medium on cytochrome P450-dependent metabolism and toxicity in rat cultured hepatocytes.
Topics: 1-Propanol; Animals; Benzopyrans; Cells, Cultured; Coumarins; Culture Media, Serum-Free; Cytochrome P-450 Enzyme System; Glutathione; Liver; Male; Propanols; Rats; Rats, Wistar | 1992 |
A new isocoumarin antibiotic, Y-05460M-A.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibiotics, Antineoplastic; Bacillus; Bacteria; Chromones; Coumarins; Drug Screening Assays, Antitumor; Leukemia P388; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Soil Microbiology | 1992 |
Rapid and sensitive determination of coumarin and 7-hydroxycoumarin and its glucuronide conjugate in urine and plasma by high-performance liquid chromatography.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Coumarins; Glucuronates; Humans; Hydrolysis; Umbelliferones | 1992 |
Metabolism of coumarin by rat, gerbil and human liver microsomes.
Topics: Adolescent; Adult; Aged; Animals; Chromatography, High Pressure Liquid; Coumarins; Female; Gerbillinae; Humans; In Vitro Techniques; Liver; Male; Microsomes, Liver; Rats; Rats, Inbred Strains; Species Specificity; Xenobiotics | 1992 |
Pregnancy and protein C deficiency.
Topics: Adult; Coumarins; Female; Fetal Death; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematologic; Protein C Deficiency; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1992 |
Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis.
Topics: Blood Proteins; Coumarins; Female; Glycoproteins; Humans; Kidney Failure, Chronic; Middle Aged; Necrosis; Peritoneal Dialysis, Continuous Ambulatory; Protein C Deficiency; Protein S; Skin; Skin Diseases | 1992 |
A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Topics: Amino Acid Sequence; Chromatography, High Pressure Liquid; Coumarins; Extracellular Matrix; Humans; Metalloendopeptidases; Molecular Sequence Data; Oligopeptides; Sensitivity and Specificity; Substrate Specificity | 1992 |
Coumarin inhibits micronuclei formation induced by benzo(a)pyrene in male but not female ICR mice.
Topics: Animals; Benzo(a)pyrene; Bone Marrow; Coumarins; Drug Administration Schedule; Drug Tolerance; Female; Kinetics; Male; Mice; Mice, Inbred ICR; Micronuclei, Chromosome-Defective; Micronucleus Tests; Sex Characteristics | 1992 |
Metabolism of [3-14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans.
Topics: Acetaldehyde; Adolescent; Adult; Animals; Aroclors; Child; Chlorodiphenyl (54% Chlorine); Coumarins; Cricetinae; Female; Gerbillinae; Humans; Hydroxylation; Male; Mesocricetus; Microsomes, Liver; Middle Aged; Phenylacetates; Rats; Rats, Inbred Strains; Species Specificity | 1992 |
Identification of o-hydroxyphenylacetaldehyde as a major metabolite of coumarin in rat hepatic microsomes.
Topics: Acetaldehyde; Animals; Aroclors; Chlorodiphenyl (54% Chlorine); Chromatography, High Pressure Liquid; Coumarins; Male; Mass Spectrometry; Microsomes, Liver; NADP; Rats; Rats, Inbred Strains | 1992 |
Role of sulfate concentration in dechlorination of 3,4,5-trichlorocatechol by stable enrichment cultures grown with coumarin and flavanone glycones and aglycones.
Topics: Anaerobiosis; Biodegradation, Environmental; Catechols; Coumarins; Flavonoids; Mass Spectrometry; Molecular Structure; Soil Microbiology; Sulfates; Water Microbiology | 1992 |
Hexamethylenebisacetamide selectively inhibits the proliferation of human and rat vascular smooth-muscle cells.
Topics: Acetamides; Animals; Cell Division; Cells, Cultured; Coumarins; DNA Replication; Endothelium, Vascular; Fibroblasts; Hematinics; Humans; Kinetics; Muscle, Smooth, Vascular; Quinazolines; Quinazolinones; Rats; Thymidine | 1992 |
[Reliable Quick value management by self determination].
Topics: Coumarins; Heart Valve Prosthesis; Humans; Postoperative Complications; Prothrombin Time; Risk Factors; Self Care; Thromboembolism | 1992 |
Complications after intracoronary stent implantation: three cases.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Dipyridamole; Drug Administration Schedule; Electrocardiography; Exercise Test; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Premedication; Recurrence; Stents | 1992 |
The poor reliability of factor X chromogenic assays in coumarin treated patients.
Topics: Chromogenic Compounds; Coumarins; Factor X; Humans; Reproducibility of Results | 1992 |
Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine.
Topics: Administration, Oral; Chromatography, Thin Layer; Coumarins; Female; Fluorescence; Humans; Male; Spectrometry, Fluorescence; Umbelliferones | 1992 |
Complications of anticoagulant therapy in ovulatory women.
Topics: Adult; Contraceptive Agents, Female; Corpus Luteum; Coumarins; Female; Hemoperitoneum; Humans; Ovulation; Uterine Hemorrhage | 1991 |
Pregnancy and its complications after cardiac valve replacement.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Coumarins; Female; Fetal Death; Heart Valve Prosthesis; Heparin; Humans; Infant Mortality; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Thromboembolism | 1991 |
Laser nephelometer evaluation of factor IX.
Topics: Antigen-Antibody Complex; Coumarins; Factor IX; Hemophilia A; Immune Sera; Kinetics; Lasers; Liver Cirrhosis; Nephelometry and Turbidimetry; Reference Values | 1990 |
A study of branching in the projection from the inferior olive to the x and lateral c1 zones of the cat cerebellum using a combined electrophysiological and retrograde fluorescent double-labelling technique.
Topics: Animals; Axonal Transport; Brain Stem; Cats; Cerebellum; Coumarins; Electric Stimulation; Fluorescent Dyes; Forelimb; Nerve Fibers; Olivary Nucleus; Rhodamines; Skin | 1991 |
Species differences in the hepatotoxicity of coumarin: a comparison of rat and Mongolian gerbil.
Topics: Animals; Coumarins; Gerbillinae; Injections, Intraperitoneal; Liver; Male; Organ Size; Rats; Rats, Inbred Strains; Species Specificity | 1992 |
Combined coumarin and omental transfer treatments for canine proximal obstructive lymphoedema.
Topics: Animals; Collagen; Combined Modality Therapy; Coumarins; Dogs; Endopeptidases; Extracellular Space; Lymphedema; Omentum; Skin | 1991 |
Interspecies scaling of the pharmacokinetic parameters of coumarin among six different mammalian species.
Topics: Animals; Body Weight; Coumarins; Dogs; Half-Life; Haplorhini; Humans; Liver; Liver Circulation; Metabolic Clearance Rate; Organ Size; Rabbits; Rats; Sheep; Species Specificity; Tissue Distribution | 1991 |
[Combined arterial bypass operation and coumarin therapy--a concept for long-term management and its conditions].
Topics: Adult; Aorta, Abdominal; Aortic Aneurysm; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Combined Modality Therapy; Coumarins; Humans; Ischemia; Leg; Long-Term Care; Male; Middle Aged | 1991 |
Development of a chromogenic substrate assay for the determination of hirudin in plasma.
Topics: Calibration; Chromogenic Compounds; Coumarins; Disseminated Intravascular Coagulation; Heparin; Hexadimethrine Bromide; Hirudins; Humans; Oligopeptides; Predictive Value of Tests; Recombinant Proteins; Thrombin | 1991 |
Loss of amplified genes by poly(ADP-ribose) polymerase inhibitors.
Topics: 3T3 Cells; Aminobenzoates; Animals; Benzamides; Benzoates; Benzoic Acid; Cell Differentiation; Cell Transformation, Neoplastic; Coumarins; Gene Amplification; Humans; Luminol; meta-Aminobenzoates; Mice; Middle Aged; Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogenes; Tumor Cells, Cultured | 1991 |
Control of blow fly strike in sheep by coumarin.
Topics: Animals; Coumarins; Diptera; Female; Gangrene; Insecticides; Larva; Male; Myiasis; Scrotum; Sheep; Sheep Diseases; Triazines | 1991 |
Maintenance of monooxygenase activities and detection of cytochrome P-450-mediated cytotoxicity in Mongolian gerbil hepatocyte cultures.
Topics: Animals; Benzopyrans; Cell Death; Cells, Cultured; Coumarins; Cytochrome P-450 Enzyme System; Gerbillinae; Liver; Male; Mixed Function Oxygenases; Phenobarbital | 1991 |
The biological inertia of coumarin-induced pre-factors (so called PIVKAs)
Topics: Biomarkers; Coumarins; Humans; Protein Precursors; Prothrombin; Prothrombin Time | 1991 |
Local beneficial effect of coumarin in experimental peritonitis.
Topics: Animals; Anti-Bacterial Agents; Coumarins; Drug Therapy, Combination; Male; Peritonitis; Rats; Rats, Inbred Strains; Sepsis | 1991 |
Poly(ADP-ribose) polymerase inhibitors suppress UV-induced human immunodeficiency virus type 1 gene expression at the posttranscriptional level.
Topics: Benzamides; beta-Galactosidase; Blotting, Northern; Chloramphenicol O-Acetyltransferase; Coumarins; Gene Expression; Genes, tat; Genes, Viral; HeLa Cells; HIV-1; Humans; Kinetics; Niacinamide; Plasmids; Poly(ADP-ribose) Polymerase Inhibitors; Restriction Mapping; Transcription, Genetic; Transfection; Ultraviolet Rays | 1991 |
Skin necrosis following prolonged administration of coumarin in a patient with inherited protein S deficiency.
Topics: Adult; Blood Proteins; Coumarins; Glycoproteins; Humans; Male; Necrosis; Protein S; Skin; Time Factors | 1991 |
[The clinical course of coumarin-induced necrosis].
Topics: Adult; Coumarins; Drug Hypersensitivity; Drug Therapy, Combination; Female; Heparin; Humans; Middle Aged; Necrosis; Obesity; Phenprocoumon; Pulmonary Embolism; Risk Factors; Skin Diseases; Thrombophlebitis; Time Factors | 1991 |
O-hydroxyphenylacetaldehyde: a major novel metabolite of coumarin formed by rat, gerbil and human liver microsomes.
Topics: Acetaldehyde; Animals; Chromatography, High Pressure Liquid; Coumarins; Cytosol; Gerbillinae; Humans; Kinetics; Liver; Male; Mass Spectrometry; Microsomes, Liver; NAD; Rats; Rats, Inbred Strains; Species Specificity | 1991 |
Comparative studies on coumarin and testosterone metabolism in mouse and human livers. Differential inhibitions by the anti-P450Coh antibody and metyrapone.
Topics: Animals; Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Humans; Metyrapone; Mice; Mice, Inbred DBA; Microsomes, Liver; Mixed Function Oxygenases; Pyrazoles; Steroid Hydroxylases; Testosterone | 1991 |
Effect of inducers of cytochrome P-450 on the metabolism of [3-14C]coumarin by rat hepatic microsomes.
Topics: Animals; Coumarins; Cytochrome P-450 Enzyme System; Enzyme Activation; Glutathione; Isoenzymes; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Inbred Strains | 1991 |
Effect of cimetidine on the metabolism of coumarin by rat, gerbil and human liver microsomes.
Topics: Animals; Cimetidine; Coumarins; Drug Interactions; Gerbillinae; Humans; Male; Microsomes, Liver; Models, Biological; Phenobarbital; Rats; Rats, Inbred Strains; Umbelliferones | 1991 |
The protein kinase inhibitor, K-252a, decreases elicitor-induced Ca2+ uptake and K+ release, and increases coumarin synthesis in parsley cells.
Topics: Biological Transport; Calcium; Carbazoles; Cells, Cultured; Coumarins; Indole Alkaloids; Plants; Potassium; Protein Kinase C | 1991 |
Synergistic effect of coumarin (1,2 benzopyrone) and endotoxin in the induction of human interleukin-1.
Topics: 4-Hydroxycoumarins; Biological Assay; Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Drug Synergism; Endotoxins; Humans; In Vitro Techniques; Interleukin-1; Interleukin-6; Leukocytes, Mononuclear; Tumor Necrosis Factor-alpha; Umbelliferones | 1991 |
Coumarin-induced changes in delta-aminolaevulinic acid synthase and cytochrome P-450 in chick embryo liver.
Topics: 5-Aminolevulinate Synthetase; Aniline Hydroxylase; Animals; Aryl Hydrocarbon Hydroxylases; Benzopyrene Hydroxylase; Chick Embryo; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Induction; Heme; Liver; Microsomes; Mixed Function Oxygenases; Oxidoreductases; Oxidoreductases, N-Demethylating; Porphyrins | 1991 |
Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cimetidine; Coumarins; Drug Evaluation; Female; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Kidney Neoplasms; Lymphocyte Activation; Male; Middle Aged; Remission Induction; T-Lymphocytes, Regulatory | 1990 |
Dental extraction for patients on oral anticoagulant therapy.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Coumarins; Dental Care for Disabled; Fibrin Tissue Adhesive; Hemostatic Techniques; Heparin; Humans; Middle Aged; Oral Hemorrhage; Thromboembolism; Tooth Extraction | 1990 |
Effect of coumarin on glucose uptake by anaerobic rumen fungi in the presence and absence of Methanobrevibacter smithii.
Topics: Animals; Coumarins; Euryarchaeota; Fungi; Glucose; Rumen | 1990 |
[Thrombosis of the inferior vena cava in a 20-year-old patient with decreased protein C activity].
Topics: Adult; Coumarins; Female; Heparin; Humans; Phlebography; Protein C; Protein C Deficiency; Recurrence; Risk Factors; Thrombophlebitis; Thrombosis; Tomography, X-Ray Computed; Vena Cava, Inferior | 1990 |
Suppression of 6-TG-resistant mutations in V79 cells and recessive spot formations in mice by vanillin.
Topics: Acrolein; Animals; Benzaldehydes; Cells, Cultured; Coumarins; Drug Resistance; Ethylnitrosourea; Female; Male; Mice; Mice, Inbred C57BL; Mutagenicity Tests; Mutation; Pregnancy; Thioguanine; Ultraviolet Rays; X-Rays | 1990 |
Coordinated induction of estrogen hydroxylase and catechol-O-methyl transferase by xenobiotics in first trimester human placental explants.
Topics: Butylated Hydroxyanisole; Carcinogens; Catechol O-Methyltransferase; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Humans; Naphthols; Placenta; Pregnancy; Pregnancy Trimester, First; Steroid Hydroxylases; Xenobiotics | 1990 |
Distribution of molecular aggregation by analysis of fluctuation moments.
Topics: Biophysics; Coumarins; Mathematics; Models, Theoretical; Spectrometry, Fluorescence | 1990 |
Anticoagulants and the formation of lymphocysts after pelvic lymphadenectomy in gynecologic and oncologic operations.
Topics: Anticoagulants; Coumarins; Dextrans; Drug Therapy, Combination; Female; Heparin; Humans; Hysterectomy; Lymph Node Excision; Lymphangioma; Lymphatic Metastasis; Pelvis; Postoperative Complications; Thrombosis; Uterine Cervical Neoplasms; Uterine Neoplasms | 1986 |
Vitamin K antagonism of coumarin intoxication in the rat.
Topics: 4-Hydroxycoumarins; Animals; Blood Coagulation Factors; Coumarins; Dicumarol; Liver; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Inbred Strains; Vitamin K; Vitamin K Epoxide Reductases; Warfarin | 1986 |
Factor X antigen--factor X activity discrepancy in coumarin treated patients. No relationship with dilution curve.
Topics: Antigens; Blood Coagulation Disorders; Blood Coagulation Tests; Coumarins; Factor X; Humans | 1987 |
Coumarin-phalloidin: a new actin probe permitting triple immunofluorescence microscopy of the cytoskeleton.
Topics: Actins; Coumarins; Cytoskeleton; Fibroblasts; Humans; Microscopy, Fluorescence; Oligopeptides; Phalloidine; Staining and Labeling | 1988 |
Investigations of antithrombin III-activity in patients after myocardial infarction and a long-term coumarin therapy.
Topics: Aged; Antithrombin III; Coumarins; Female; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 1988 |
Comparison of the metabolism and disposition of [3-14C]coumarin in the rat and marmoset (Callithrix jacchus).
Topics: Animals; Callitrichinae; Coumarins; Hydroxylation; Male; Microsomes, Liver; Rats; Rats, Inbred Strains; Species Specificity | 1989 |
Necrosis of the skin induced by coumarin.
Topics: Coumarins; Humans; Necrosis; Skin | 1989 |
Necrosis of skin induced by coumarin in a patient deficient in protein S.
Topics: Coumarins; Glycoproteins; Humans; Male; Middle Aged; Necrosis; Protein S; Skin | 1989 |
Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases.
Topics: Blood Coagulation Disorders; Blood Coagulation Factors; Coumarins; Female; Glycoproteins; Humans; Intracranial Embolism and Thrombosis; Lupus Coagulation Inhibitor; Necrosis; Protein S; Skin Diseases; Syndrome | 1989 |
Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide.
Topics: Benzamides; Blotting, Southern; Cell Differentiation; Cell Line; Coumarins; Dimethyl Sulfoxide; Gene Amplification; Humans; Leukemia, Promyelocytic, Acute; Niacinamide; Nucleic Acid Hybridization; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogenes; Quinazolines; Quinazolinones; RNA, Neoplasm | 1989 |
Studies on the induction of cholangiofibrosis by coumarin in the rat.
Topics: Animals; Atrophy; Bile Ducts, Intrahepatic; Body Weight; Coumarins; Fibrosis; gamma-Glutamyltransferase; Liver Cirrhosis; Male; Microsomes, Liver; Mixed Function Oxygenases; Necrosis; Organ Size; Rats; Rats, Inbred Strains | 1989 |
Discrepant INR values: a comparison between Manchester and Thrombotest reagents using capillary and venous samples.
Topics: Animals; Blood Coagulation Tests; Brain Chemistry; Capillaries; Coumarins; False Negative Reactions; Humans; Rabbits; Reagent Kits, Diagnostic; Reference Standards; Thromboplastin; Thrombosis; Veins; Warfarin | 1989 |
Coumarin and 7-hydroxycoumarin treatment of canine obstructive lymphoedema.
Topics: Animals; Coumarins; Dogs; Endopeptidases; Hindlimb; Lymph; Lymphedema; Proteins; Skin; Umbelliferones | 1989 |
Surgical thrombectomy versus conservative treatment for deep venous thrombosis; functional comparison of long-term results.
Topics: Bandages; Combined Modality Therapy; Coumarins; Drug Therapy, Combination; Follow-Up Studies; Heparin; Humans; Phlebography; Plethysmography; Postoperative Complications; Pulmonary Embolism; Quality of Life; Retrospective Studies; Thrombophlebitis; Ultrasonography; Venous Insufficiency; Venous Pressure | 1989 |
Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Coumarins; Female; Humans; Male; Melanoma; Middle Aged; Pilot Projects | 1989 |
Toxicity of coumarin (1,2-benzopyrone) on human peripheral blood mononuclear cells and human and murine bone marrow progenitor stem cells.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Coumarins; Humans; Leukocytes, Mononuclear; Male; Mice; Stem Cells; Umbelliferones | 1989 |
Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.
Topics: Amino Acid Sequence; Amino Acids; Animals; Cell Line; Coumarins; Cytochrome P-450 Enzyme System; Mice; Molecular Sequence Data; Mutation; Steroid Hydroxylases; Substrate Specificity | 1989 |
Coumarin necrosis or Coumadin necrosis?
Topics: Coumarins; Humans; Terminology as Topic; Warfarin | 1989 |
Activity of coumarin and cimetidine in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Cimetidine; Coumarins; Drug Evaluation; Drug Therapy, Combination; Humans; Kidney Neoplasms | 1989 |
Interference of coumarin therapy with the "Heptest" owing to declining prothrombin concentrations.
Topics: Coumarins; False Positive Reactions; Heparin; Humans; Plasma; Prothrombin; Reagent Kits, Diagnostic | 1989 |
Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Coumarins; Female; Humans; Killer Cells, Natural; Lymphocytes; Male; Middle Aged; Monocytes; Neoplasms | 1989 |
Effects of coumarin (1,2-benzopyrone) on lymphocyte, natural killer cell, and monocyte functions in vitro.
Topics: Antigens; Cells, Cultured; Coumarins; Humans; Killer Cells, Natural; Lymphocytes; Macrophages; Mitogens; Monocytes | 1989 |
Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites.
Topics: Animals; Biotransformation; Coumarins; Dose-Response Relationship, Drug; Glutathione; Liver; Male; Maleates; Protein Biosynthesis; Rats; Rats, Inbred Strains | 1989 |
Inhibition of carcinogen-induced cellular transformation of human fibroblasts by drugs that interact with the poly(ADP-ribose) polymerase system. Initial evidence for the development of transformation resistance.
Topics: Acetamides; Anti-Bacterial Agents; Benzamides; Butylated Hydroxyanisole; Carcinogens; Cell Transformation, Neoplastic; Coumarins; Fibroblasts; Humans; NAD+ Nucleosidase; Poly(ADP-ribose) Polymerase Inhibitors; Quercetin | 1985 |
Interaction of the 56,000-dalton phosphoprotein phosphatase from reticulocytes with regulin and inhibitor 2.
Topics: Animals; Cobalt; Coumarins; Cytoskeletal Proteins; Fluorescence; Iron; Manganese; Phosphoprotein Phosphatases; Proteins; Rabbits; Reticulocytes; Trypsin; Zinc | 1986 |
Treatment of non-small cell lung cancer with coumarin and cimetidine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cimetidine; Coumarins; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1987 |
Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
Topics: 4-Hydroxycoumarins; Animals; Anticoagulants; Blood Coagulation; Coumarins; Immunosorbent Techniques; Ligases; Male; Microsomes, Liver; NAD(P)H Dehydrogenase (Quinone); Oxidoreductases; Quinone Reductases; Rats; Rats, Inbred Strains; Salicylates; Salicylic Acid; Vitamin K; Warfarin | 1986 |
Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly(ADP ribose) polymerase.
Topics: Animals; Cell Division; Coumarins; DNA; Fibroblasts; Gene Expression Regulation; Neoplasms, Experimental; Oncogenes; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Transformation, Genetic | 1987 |
[Fibrinolytic and anticoagulation therapy in Budd-Chiari syndrome. Review and recommendations].
Topics: Blood Coagulation Tests; Budd-Chiari Syndrome; Coumarins; Drug Therapy, Combination; Heparin; Humans; Tissue Plasminogen Activator | 1988 |
Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis.
Topics: Acrylates; Animals; Carcinogens; Cinnamates; Coumarins; Crotonates; Dicarboxylic Acids; Enzyme Induction; Glutathione Transferase; Mice; NAD(P)H Dehydrogenase (Quinone); Phenols; Phenylenediamines; Quinone Reductases; Quinones; Signal Transduction | 1988 |
Endothelial cell proliferation in vitro after incubation with anticoagulant and antiplatelet drugs.
Topics: Animals; Anticoagulants; Cell Division; Coumarins; Culture Techniques; Cyclooxygenase Inhibitors; Dipyridamole; Dogs; Endothelium, Vascular; Heparin; Molecular Weight; Platelet Aggregation Inhibitors; Thromboxane-A Synthase | 1988 |
Coumarin skin necrosis in a patient with heparin-induced thrombocytopenia--a case report.
Topics: Aorta; Aorta, Thoracic; Coumarins; Female; Femoral Artery; Heparin; Humans; Intermittent Claudication; Middle Aged; Necrosis; Skin; Thrombocytopenia | 1988 |
[Treatment of deep venous thrombosis of the lower leg].
Topics: Adult; Clothing; Coumarins; Female; Heparin; Humans; Knee Injuries; Thrombophlebitis; Time Factors | 1988 |
Effect of age on the pharmacokinetics of coumarin.
Topics: Aging; Animals; Coumarins; Dogs; Injections, Intravenous; Male | 1988 |
[An unusual complication of therapy with Pelentan--hemorrhage into the iliopsoas muscle].
Topics: Coumarins; Hemorrhage; Humans; Leg; Male; Middle Aged; Muscular Diseases; Tomography, X-Ray Computed | 1988 |
[Thromboembolism complications and coumarin necrosis in a patient with congenital antithrombin III deficiency].
Topics: Adult; Antithrombin III Deficiency; Coumarins; Female; Humans; Ischemia; Necrosis; Pedigree; Thromboembolism; Toes | 1988 |
Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Chromatography; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Hydrogen-Ion Concentration; Isoenzymes; Kinetics; Mice; Microsomes, Liver; Mixed Function Oxygenases; Molecular Weight; Phospholipids; Pyrazoles; Spectrum Analysis; Substrate Specificity | 1988 |
[Isolation and characteristics of coumarin-specific cytochrome P-450 (P-450Cho) from liver microsomes of DBA/2N mice, induced with pyrazole].
Topics: Animals; Coumarins; Cytochromes; Electrophoresis, Polyacrylamide Gel; Enzyme Induction; Hydroxylation; Mice; Mice, Inbred DBA; Microsomes, Liver; Phenobarbital; Pyrazoles; Solubility; Spectrophotometry, Ultraviolet; Substrate Specificity | 1988 |
Mediodorsal and reticular thalamic nuclei receive collateral axons from prefrontal cortex and laterodorsal tegmental nucleus in the rat.
Topics: Animals; Cell Count; Coumarins; Fluorescent Dyes; Frontal Lobe; Neural Pathways; Rats; Rats, Inbred Strains; Rhodamines; Tegmentum Mesencephali; Thalamic Nuclei | 1988 |
Quantitative analysis of axonal branching using the retrograde transport of fluorescent latex microspheres.
Topics: Animals; Axons; Biological Transport; Brain; Brain Chemistry; Coumarins; Microspheres; Rats; Rats, Inbred Strains; Rhodamines | 1988 |
Transdermal absorption and topical bioavailability of coumarin.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Biological Availability; Coumarins; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Skin; Skin Absorption | 1988 |
Computer-automated structure evaluation of flavonoids and other structurally related compounds as glyoxalase I enzyme inhibitors.
Topics: Computer Simulation; Coumarins; Flavonoids; Lactoylglutathione Lyase; Lyases; Software; Structure-Activity Relationship | 1988 |
Recurrent thromboembolism, disseminated intravascular coagulation, and coumarin-induced skin necrosis associated with protein C deficiency.
Topics: Adolescent; Blood Coagulation; Coumarins; Disseminated Intravascular Coagulation; Female; Gangrene; Humans; Myocardium; Necrosis; Protein C Deficiency; Pulmonary Embolism; Recurrence; Skin; Thromboembolism | 1988 |
A comparison of two transdermal diffusion apparatuses: a brief communication.
Topics: Animals; Coumarins; Diffusion; Equipment and Supplies; In Vitro Techniques; Models, Biological; Permeability; Rats; Skin Absorption | 1987 |
Necrotizing dermatitis in patients receiving cancer chemotherapy.
Topics: Antineoplastic Agents; Bacterial Infections; Cellulitis; Coumarins; Dermatitis; Female; Gangrene; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Necrosis; Neoplasms; Pyoderma; Skin; Thromboangiitis Obliterans | 1987 |
Coumarin plus cimetidine: yet another angle for therapy of renal cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cimetidine; Coumarins; Humans; Kidney Neoplasms; Pilot Projects | 1987 |
Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cimetidine; Coumarins; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nephrectomy; Pilot Projects; Remission Induction | 1987 |
[Teratogenic effect of coumarins].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Coumarins; Epiphyses; Female; Fetal Growth Retardation; Humans; Pregnancy; Pregnancy Complications, Hematologic; Thrombophlebitis | 1987 |
Substrate specificity of the carbon monoxide-dependent cytochrome P-450 kinetics.
Topics: Animals; Benzoflavones; Carbon Monoxide; Coumarins; Cytochrome P-450 Enzyme System; Hydrogen-Ion Concentration; Isoenzymes; Kinetics; Metyrapone; Microsomes, Liver; NADP; Substrate Specificity; Swine | 1987 |
Thromboembolic obstruction of the pulmonary artery treated by endarterectomy.
Topics: Adult; Angiography; Cardiopulmonary Bypass; Coumarins; Endarterectomy; Humans; Male; Prognosis; Pulmonary Embolism; Radionuclide Imaging | 1986 |
Acral purpura: an unusual sign of coumarin necrosis.
Topics: Coumarins; Humans; Male; Middle Aged; Necrosis; Purpura; Skin; Toes; Warfarin | 1986 |
The effect of coumarin (5,6 benzo-alpha-pyrone) on elicited members of the mononuclear system in dogs with chronic secondary lymphedema.
Topics: Animals; Chronic Disease; Coumarins; Dogs; Lymphedema; Monocytes; Phagocytosis | 1986 |
Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
Topics: Anticoagulants; Bioprosthesis; Coumarins; Drug Therapy, Combination; Heart Valve Diseases; Heart Valve Prosthesis; Hemorrhage; Heparin; Humans; Platelet Aggregation; Postoperative Complications; Prosthesis Design; Risk; Thromboembolism | 1986 |
Coumarin induced acral skin necrosis associated with hereditary protein C deficiency.
Topics: Adult; Antigen-Antibody Complex; Cesarean Section; Complement C4; Coumarins; Female; Glycoproteins; Hemorrhage; Humans; Necrosis; Pregnancy; Protein C; Puerperal Disorders; Skin Diseases; Thromboembolism; Toes | 1986 |
Major differences between lung, skin and liver in the microsomal metabolism of homologous series of resorufin and coumarin ethers.
Topics: Animals; Benzoflavones; Coumarins; Female; Lung; Metyrapone; Mice; Mice, Inbred BALB C; Microsomes; Microsomes, Liver; Oxazines; Skin; Structure-Activity Relationship | 1986 |
Preliminary investigations of the wound-healing properties of a Jamaican folk medicinal plant (Justicia pectoralis).
Topics: Animals; Coumarins; Drug Evaluation, Preclinical; Female; Jamaica; Male; Medicine, Traditional; Plants, Medicinal; Rats; Rats, Inbred Strains; Wound Healing | 1986 |
Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
Topics: Animals; Azoles; Coumarins; Cytosol; Dithiothreitol; Hypoprothrombinemias; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Tetrazoles; Vitamin K; Vitamin K 1; Vitamin K Epoxide Reductases; Warfarin | 1986 |
Recurrent coumarin-induced skin necrosis in a patient with an acquired functional protein C deficiency.
Topics: Biopsy; Blood Coagulation Factors; Coumarins; Female; Humans; Middle Aged; Necrosis; Protein C Deficiency; Prothrombin Time; Skin; Vitamin K | 1986 |
Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Coumarins; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Skin Neoplasms | 1987 |
[Chondrodystrophia punctata--historical clinical review with special reference to chondrodysplasia punctata embryopathica].
Topics: Chondrodysplasia Punctata; Coumarins; Female; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; Humans; Infant, Newborn; Pregnancy | 1985 |
Breast mass in a 69-year-old woman.
Topics: Aged; Breast Diseases; Coumarins; Fat Necrosis; Female; Humans; Mammography | 1986 |
Factor X antigen evaluation by means of a laser nephelometer in health and disease.
Topics: Adult; Antigens; Coumarins; Factor X; Factor X Deficiency; Female; Heterozygote; Homozygote; Humans; Lasers; Male; Middle Aged; Nephelometry and Turbidimetry | 1985 |
Hapten binding assay using guinea pig macrophages.
Topics: Acetaldehyde; Aldehydes; Animals; Binding, Competitive; Camphor; Coumarins; Dinitrofluorobenzene; Ethanol; Female; Guinea Pigs; Macrophages; Radioligand Assay; Receptors, Antigen; Salicylates; Styrenes; Surface-Active Agents | 1985 |
A study of the phototoxicity of lemon oil.
Topics: 5-Methoxypsoralen; Animals; Citrus; Coumarins; Furocoumarins; Guinea Pigs; Methoxsalen; Oils, Volatile; Photosensitivity Disorders; Pigmentation Disorders; Skin | 1985 |
[Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
Topics: Blood Coagulation Tests; Coumarins; Factor V; Factor XII; Glycoproteins; Humans; Kallikreins; Prekallikrein; Protein C; Thromboembolism; Thrombosis | 1984 |
Induction by carrot allelochemicals of insecticide-metabolising enzymes in the southern armyworm (Spodoptera eridania).
Topics: Animals; Body Weight; Coumarins; Cytochrome P-450 Enzyme System; Enzyme Induction; Ergosterol; Glutathione Transferase; Insecticides; Larva; Lepidoptera; Mixed Function Oxygenases; Moths; NADPH-Ferrihemoprotein Reductase; Oxidoreductases, N-Demethylating; Stigmasterol; Sulfurtransferases; Terpenes; Vegetables | 1984 |
The photobinding of 5,7-dimethoxycoumarin to adenovirus type-2 DNA. A method for in vitro mutagenesis.
Topics: Adenoviridae; Base Sequence; Coumarins; DNA Restriction Enzymes; DNA, Viral; Photochemistry | 1983 |
Therapeutic concentration of coumarin as antipyretic.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Coumarins; Endotoxins; Male; Rabbits; Time Factors | 1984 |
Vanadium inhibits oxidative drug demethylation in vivo in mice.
Topics: Acetamides; Animals; Ascorbic Acid; Breath Tests; Carbon Dioxide; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Dealkylation; Liver; Male; Mice; Oxidation-Reduction; Substrate Specificity; Vanadium | 1983 |
Anti-mutagenic effects of coumarin and umbelliferone on mutagenesis induced by 4-nitroquinoline 1-oxide or UV irradiation in E. coli.
Topics: 4-Nitroquinoline-1-oxide; Coumarins; Escherichia coli; Mutagens; Mutation; Nitroquinolines; Structure-Activity Relationship; Ultraviolet Rays; Umbelliferones | 1983 |
Hepatic haematoma, a complication during anticoagulant therapy. A case report.
Topics: Chemical and Drug Induced Liver Injury; Coumarins; Female; Hematoma; Humans; Liver; Liver Diseases; Middle Aged; Tomography, X-Ray Computed | 1984 |
Therapeutic concentration of coumarin and predicted dosage regimens.
Topics: Adult; Computers; Coumarins; Delayed-Action Preparations; Episiotomy; Female; Humans; Injections, Intravenous; Models, Biological; Umbelliferones | 1984 |
Investigations into the mechanism of coumarin-induced hepatotoxicity in the rat.
Topics: Acetylcysteine; Animals; Chemical and Drug Induced Liver Injury; Coumarins; Kinetics; Liver; Liver Diseases; Male; Microsomes, Liver; Naphthalenes; Necrosis; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1984 |
Inhibitors of glyoxalase I in vitro.
Topics: Ascorbic Acid; Coumarins; Erythrocytes; Esculin; Humans; In Vitro Techniques; Lactoylglutathione Lyase; Lyases; Tryptophan | 1983 |
The use of Vacutainer tubes for collection and storage of blood for coagulation testing.
Topics: Blood Coagulation Tests; Blood Preservation; Blood Specimen Collection; Coumarins; Factor VII; Humans; Partial Thromboplastin Time; Prothrombin Time; Temperature | 1983 |
Tissue distribution of coumarin, 7-hydroxycoumarin and their 7-hydroxy metabolites following parenteral administration of 14C-labeled compound in the DBA/lac mouse.
Topics: Animals; Coumarins; Kinetics; Male; Mice; Mice, Inbred DBA; Models, Biological; Tissue Distribution; Umbelliferones | 1983 |
Pharmacokinetics of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide in the blood and brain of gerbils following intraperitoneal administration of coumarin.
Topics: Animals; Brain; Coumarins; Esculin; Flavonoids; Gerbillinae; Injections, Intraperitoneal; Kinetics; Male; Umbelliferones | 1983 |
Dose-related pharmacokinetics of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide upon intraperitoneal administration of coumarin and 7-hydroxycoumarin in the rat.
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Half-Life; Injections, Intraperitoneal; Kinetics; Rats; Rats, Inbred Strains; Umbelliferones | 1983 |
Investigation of the dose-response relationship upon intraperitoneal administration of coumarin and 7-hydroxycoumarin on the carrageenan induced edema of the rat hind paw.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Coumarins; Dose-Response Relationship, Drug; Edema; Injections, Intraperitoneal; Rats; Rats, Inbred Strains; Umbelliferones | 1983 |
Evidence for the involvement of multiple forms of cytochrome P-450 in the occurrence of sex-related differences of drug metabolism in the rat.
Topics: Animals; Chemical Fractionation; Coumarins; Cytochrome P-450 Enzyme System; Female; Immunodiffusion; Male; Microsomes, Liver; Proteins; Rats; Rats, Inbred Strains; Sex Characteristics; Spectrophotometry | 1982 |
The effect of coumarin and 7-hydroxycoumarin on in vitro macrophage phagocytosis of latex particles.
Topics: Animals; Coumarins; In Vitro Techniques; Latex; Macrophages; Mice; Phagocytosis; Umbelliferones | 1983 |
[Elevation of the threshold in the rabbit dental pulp test with coumarin: unspecified (local) effect rather than analgesic activity?].
Topics: Analgesics; Animals; Coumarins; Dental Pulp Test; Dose-Response Relationship, Drug; Pain; Rabbits; Reaction Time; Time Factors | 1982 |
Conservative anticoagulant therapy for chronic thrombosis of deep femoral vein.
Topics: Adult; Aged; Anticoagulants; Coumarins; Dilazep; Female; Femoral Vein; Fibrinolysis; Humans; Male; Middle Aged; Platelet Adhesiveness; Thrombosis | 1982 |
Effects of 5,6 benzo-alphapyrone on traumatic edema due to crush and burn injury.
Topics: Animals; Burns; Coumarins; Edema; Hindlimb; Male; Organ Size; Rats | 1981 |
Resolution rates of artificially produced protein and amino acid oedemas and the effects of a benzopyrone.
Topics: Amino Acids; Animals; Blood Proteins; Coumarins; Edema; Male; Povidone; Rats; Rats, Inbred Strains; Time Factors | 1981 |
[Coumarin resistance and vitamin K1].
Topics: Coumarins; Drug Resistance; Food, Formulated; Humans; Netherlands; Vitamin K 1 | 1981 |
Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificity.
Topics: Amino Acid Sequence; Animals; Binding Sites; Coumarins; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Isoenzymes; Mice; Models, Molecular; Molecular Sequence Data; Rats; Steroid Hydroxylases; Substrate Specificity; Testosterone | 1995 |
Autoclavable highly cross-linked polyurethane networks in ophthalmology.
Topics: Animals; Coumarins; Cross-Linking Reagents; Cyanates; Ethylenediamines; Eye, Artificial; Isocyanates; Lenses, Intraocular; Molecular Weight; Polyurethanes; Propanolamines; Prostheses and Implants; Rabbits; Spectrophotometry, Ultraviolet; Staining and Labeling; Sterilization; Temperature; Water | 1993 |
Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitro.
Topics: Apoptosis; Cell Division; Cell Survival; Coumarins; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Prostate-Specific Antigen; Protein Biosynthesis; Proteins; RNA, Neoplasm; Time Factors; Tumor Cells, Cultured; Umbelliferones | 1994 |
Effect of the antiallergic drug disodium cromoglycate and various derivatives on alkaline phosphatase.
Topics: Alkaline Phosphatase; Animals; Benzoates; Benzoic Acid; Calcium; Cattle; Chickens; Coumarins; Cromolyn Sodium; Dicumarol; Kinetics; Protein Conformation; Structure-Activity Relationship; Viscosity | 1994 |
[Cranial sinus thrombosis in puerperium].
Topics: Adult; Anticoagulants; Coumarins; Diagnosis, Differential; Drug Administration Schedule; Female; Heparin; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Neurologic Examination; Puerperal Disorders; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed | 1995 |
Cytochrome P450 2A of nasal epithelium: regulation and role in carcinogen metabolism.
Topics: Aflatoxins; Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Carcinogens; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Diethylnitrosamine; Isoenzymes; Male; Mice; Mice, Inbred DBA; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; Nasal Mucosa; Nitrosamines; Rats; RNA, Messenger | 1995 |
Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Topics: Alkylation; Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Benzoflavones; beta-Naphthoflavone; Blotting, Western; Caffeine; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Cytochromes b5; Dexamethasone; Enzyme Induction; Female; Hydroxylation; Isoenzymes; Macaca fascicularis; Male; Microsomes, Liver; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Oxazines; Oxidation-Reduction; Phenobarbital; Sex Factors; Species Specificity; Testosterone | 1995 |
Liver failure while taking coumarin.
Topics: Aged; Animals; Coumarins; Female; Humans; Liver Failure; Rats | 1995 |
Metabolism of coumarin by precision-cut calf liver slices and calf liver microsomes.
Topics: Animals; Cattle; Coumarins; Humans; In Vitro Techniques; Liver; Macaca fascicularis; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Species Specificity | 1995 |
Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Coumarins; Cross-Linking Reagents; Dimethyl Suberimidate; DNA Gyrase; DNA Topoisomerases, Type II; Escherichia coli; Kinetics; Macromolecular Substances; Novobiocin; Peptide Fragments; Trypsin | 1995 |
[Chemical constituents of Impatiens siculi fer Hook.f].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Drugs, Chinese Herbal | 1995 |
A longitudinal evaluation of dipyridamole drug use in an ambulatory elderly population.
Topics: Aged; Aged, 80 and over; Coumarins; Dipyridamole; Drug Utilization; Female; Humans; Male; Practice Patterns, Physicians' | 1995 |
Frequency of coumarin hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Coumarins; Dose-Response Relationship, Drug; Humans; Incidence | 1995 |
Analysis of antifading reagents for fluorescence microscopy.
Topics: Coumarins; Fluorescein; Fluoresceins; Fluorescent Dyes; In Situ Hybridization, Fluorescence; Indicators and Reagents; Microscopy, Fluorescence; Rhodamines | 1995 |
Biotransformation in Egyptian spiny mouse Acomys cahirinus.
Topics: 2-Naphthylamine; Animals; Benzo(a)pyrene; Benzphetamine; Biotransformation; Coumarins; Cytochrome P-450 Enzyme System; Dinitrochlorobenzene; Epoxide Hydrolases; Epoxy Compounds; Ethacrynic Acid; Female; Fluorenes; Glucuronosyltransferase; Glutathione Transferase; Intestines; Kidney; Liver; Male; Methylation; Muridae; Naphthols; Oxazines; Oxygenases; Sex Factors | 1995 |
Coumarin derivatives enhance the chemiluminescence accompanying lipid peroxidation.
Topics: Coloring Agents; Coumarins; Free Radicals; Iron; Kinetics; Lasers; Lipid Metabolism; Liposomes; Luminescent Measurements; Piperidines; Pyrrolidines | 1995 |
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
Topics: Administration, Oral; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Capsules; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Epilepsy; Female; Humans; Injections, Intravenous; Isoenzymes; Kidney Diseases; Kidney Function Tests; Lidocaine; Liver; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged; Mixed Function Oxygenases; Peptide Fragments; Procollagen; Umbelliferones | 1995 |
Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, cynomolgus monkey and human precision-cut liver slices.
Topics: Animals; Child; Coumarins; Culture Media; Culture Techniques; Cytochrome P-450 Enzyme System; Female; Guinea Pigs; Humans; Liver; Macaca fascicularis; Male; Mice; Mice, Inbred DBA; Rats; Rats, Sprague-Dawley; Species Specificity | 1994 |
Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Topics: Administration, Oral; Adult; Antithrombin III; Aspirin; beta-Thromboglobulin; Biomarkers; Coumarins; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fibrinopeptide A; Heart Valve Prosthesis; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Peptide Hydrolases; Postoperative Complications; Thromboembolism; Ultrasonography, Doppler, Transcranial | 1995 |
Characterization of the resonance energy transfer couple coumarin-BODIPY and its possible applications in protein-lipid research.
Topics: Bacterial Proteins; Boron Compounds; Coumarins; Energy Transfer; Liposomes; Molecular Conformation; Phosphatidylcholines; Phosphatidylglycerols; Proteins; Spectrometry, Fluorescence | 1995 |
Interindividual variability of coumarin 7-hydroxylation in a Turkish population.
Topics: Adult; Age Factors; Coumarins; Female; Humans; Hydroxylation; Individuality; Male; Middle Aged; Plants, Medicinal; Polymorphism, Genetic; Sex Factors; Smoking; Turkey | 1994 |
Estrogen-specific 17 beta-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast Neoplasms; Cell Division; Coumarins; Estradiol; Estrogens, Non-Steroidal; Estrone; Flavonoids; Glycyrrhetinic Acid; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Sitosterols; Tumor Cells, Cultured | 1995 |
Comparison of the metabolism of 7-ethoxycoumarin and coumarin in precision-cut rat liver and lung slices.
Topics: Animals; Coumarins; Culture Techniques; Glucuronates; Glucuronic Acid; Isotope Labeling; Liver; Lung; Male; Rats; Rats, Sprague-Dawley; Sulfates; Umbelliferones | 1995 |
2nd Proceedings of The International Society of Coumarin Investigators (ISCI). 1,2-Benzopyrone (Coumarin): update on mechanisms of action - Treatment of renal cell carcinoma and prostate cancer - Prevention of melanoma recurrence. Hamburg, Germany, 9 Marc
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Coumarins; Humans; Kidney Neoplasms; Male; Melanoma; Prostatic Neoplasms | 1994 |
Leukocytoclastic vasculitis: another coumarin-induced hemorrhagic reaction.
Topics: Aged; Coumarins; Drug Eruptions; Hemorrhage; Humans; Male; Necrosis; Skin; Vasculitis, Leukocytoclastic, Cutaneous | 1994 |
Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzene Derivatives; Benzphetamine; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Cytochromes b5; Male; Microsomes, Liver; NADP; NADPH-Ferrihemoprotein Reductase; Osmolar Concentration; Oxidoreductases; Rabbits; Steroid Hydroxylases | 1994 |
Metabolic interactions of methoxsalen and coumarin in humans and mice.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Kinetics; Male; Methoxsalen; Mice; Mice, Inbred DBA; Microsomes, Liver; Mixed Function Oxygenases | 1994 |
Chaperone-dependent folding and activation of ribosome-bound nascent rhodanese. Analysis by fluorescence.
Topics: Chaperonins; Coumarins; Escherichia coli; Immunoglobulin G; Protein Folding; Ribosomes; Spectrometry, Fluorescence; Thiosulfate Sulfurtransferase | 1994 |
Coumarin-induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Coumarins; Family Health; Female; Humans; Necrosis; Protein S Deficiency; Skin | 1994 |
Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Topics: Animals; Brain Chemistry; Calibration; Coumarins; Evaluation Studies as Topic; Female; Heparin; Humans; Indicators and Reagents; Liver Diseases; Male; Phospholipids; Placenta; Pregnancy; Prothrombin Time; Rabbits; Recombinant Proteins; Reference Standards; Thromboplastin | 1994 |
Effects of heme arginate on cytochrome P450-mediated metabolism of drugs in patients with variegate porphyria and in healthy men.
Topics: Adult; Arginine; Caffeine; Coumarins; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Heme; Humans; Isoenzymes; Lidocaine; Male; Middle Aged; Porphyrias, Hepatic; Reference Values | 1994 |
The chemiluminescence assay of lipid peroxidation products in human blood plasma lipoproteins.
Topics: Coloring Agents; Coumarins; Ethanol; Humans; Kinetics; Lipid Peroxidation; Lipoproteins; Lipoproteins, LDL; Luminescent Measurements; Spectrophotometry; Thiobarbituric Acid Reactive Substances | 1994 |
Metabolism of nitrosamines and aflatoxin B1 by hamster liver CYP2A enzymes.
Topics: Aflatoxin B1; Animals; Blotting, Western; Coumarins; Cricetinae; Cytochrome P-450 Enzyme System; Electrophoresis, Polyacrylamide Gel; Female; Kinetics; Male; Mesocricetus; Methylcholanthrene; Microsomes, Liver; Nitrosamines; Phenobarbital; Pyrazoles; Steroid Hydroxylases | 1994 |
Structure-function analysis of CYP2A10 and CYP2A11, P450 cytochromes that differ in only eight amino acids but have strikingly different activities toward testosterone and coumarin.
Topics: Amino Acid Sequence; Animals; Aryl Hydrocarbon Hydroxylases; Base Sequence; Coumarins; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; DNA Primers; Kinetics; Microsomes; Molecular Sequence Data; Mutagenesis, Site-Directed; Nose; Polymerase Chain Reaction; Rabbits; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Structure-Activity Relationship; Substrate Specificity; Testosterone | 1994 |
A method for detection of hydroxyl radicals in the vicinity of biomolecules using radiation-induced fluorescence of coumarin.
Topics: Avidin; Cesium Radioisotopes; Coumarins; Dose-Response Relationship, Radiation; Fluorescence; Free Radicals; Gamma Rays; Histones; Humans; Hydroxides; Hydroxyl Radical; In Vitro Techniques; Methods; Polylysine; Serum Albumin; Solutions; Water | 1993 |
[Pelvic vein thrombosis in protein C deficiency after infectious mononucleosis].
Topics: Adolescent; Combined Modality Therapy; Coumarins; Drug Administration Schedule; Female; Heparin; Humans; Iliac Vein; Infectious Mononucleosis; Long-Term Care; Protein C Deficiency; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Ultrasonography | 1993 |
The effects of coumarin and suramin on the growth of malignant renal and prostatic cell lines.
Topics: Carcinoma, Renal Cell; Cell Division; Coumarins; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Suramin; Tumor Cells, Cultured | 1994 |
Antitumour activity of coumarin in prostate and mammary cancer models.
Topics: Adenocarcinoma; Animals; Coumarins; Disease Models, Animal; Female; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Rats | 1994 |
Mode of action of coumarin in immune cells.
Topics: Binding Sites; Binding, Competitive; Cell Adhesion; Cells, Cultured; Coumarins; Humans; Monocytes; Umbelliferones | 1994 |
Coumarin modulates the cell-cycle progression of an MTV-EJras cell line.
Topics: Animals; Cell Cycle; Cell Line; Cell Line, Transformed; Coumarins; Dexamethasone; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Genes, ras; Rats; Resting Phase, Cell Cycle; S Phase | 1994 |
Antibody-based approaches to coumarin analysis.
Topics: Animals; Antibodies; Antibody Specificity; Antigen-Antibody Reactions; Binding, Competitive; Chromatography, High Pressure Liquid; Coumarins; Electrochemistry; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Humans; Male; Ovalbumin; Rabbits; Serum Albumin, Bovine; Thyroglobulin; Umbelliferones | 1994 |
The development of a new family of intracellular calcium probes.
Topics: Animals; Calcium; Coumarins; Fluorescent Dyes; Mice | 1994 |
Fluorescence energy transfer as a probe for nucleic acid structures and sequences.
Topics: Aminoacridines; Base Sequence; Coumarins; DNA; Energy Transfer; Ethidium; Fluorescein; Fluoresceins; Fluorescent Dyes; Molecular Sequence Data; Nucleic Acid Conformation; Nucleic Acid Hybridization; Oligodeoxyribonucleotides; Rhodamines; Spectrometry, Fluorescence; Translocation, Genetic | 1994 |
[Successful therapy of lymphedema].
Topics: Arm; Coumarins; Humans; Leg; Lymphedema | 1994 |
Comparison of in vivo and in vitro rat hepatic toxicity of coumarin and methyl analogues, and application of quantitative morphometry to toxicity in vivo.
Topics: Animals; Coumarins; In Vitro Techniques; Liver; Male; Rats; Rats, Wistar | 1994 |
Spectroscopic studies of coumarin in micelles.
Topics: Coumarins; Membranes, Artificial; Micelles; Photochemistry; Solutions; Spectrophotometry | 1994 |
TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
Topics: Animals; Apoptosis; Body Weight; Clusterin; Coumarins; Diethylstilbestrol; Finasteride; Flutamide; Gene Expression Regulation; Genetic Markers; Glycoproteins; Male; Molecular Chaperones; Orchiectomy; Organ Size; Prostate; Rats; Rats, Sprague-Dawley; RNA, Messenger; Testosterone | 1994 |
Spectrophotometric assay for enzyme-mediated unwinding of double-stranded DNA.
Topics: Base Sequence; Coumarins; DNA Helicases; Duocarmycins; Fluorescein; Fluoresceins; In Vitro Techniques; Indoles; Leucomycins; Molecular Sequence Data; Nucleic Acid Denaturation; Oligodeoxyribonucleotides; Recombinant Proteins; Spectrometry, Fluorescence | 1994 |
Studies on the acute effects of coumarin and some coumarin derivatives in the rat.
Topics: 7-Alkoxycoumarin O-Dealkylase; Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Coumarins; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Electrochemistry; Epoxy Compounds; Ethylmorphine-N-Demethylase; Liver; Male; Microsomes, Liver; Necrosis; Rats; Rats, Sprague-Dawley; Thermodynamics | 1994 |
Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Coumarins; Drug Evaluation, Preclinical; Female; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Tamoxifen; Time Factors; Umbelliferones | 1994 |
Binding studies with recombinant human serum albumin obtained by expression of a synthetic gene in yeast. Stereoselective binding and allosteric interaction with benzodiazepine and coumarin ligands.
Topics: Benzodiazepines; Binding Sites; Carbon Radioisotopes; Chromatography, Affinity; Coumarins; Drug Interactions; Genes, Fungal; Humans; Protein Structure, Tertiary; Recombinant Proteins; Saccharomyces cerevisiae; Serum Albumin; Stereoisomerism | 1993 |
Effect of pretreatment with some mixed-function oxidase enzyme inducers on the acute hepatotoxicity of coumarin in the rat.
Topics: Alanine Transaminase; Animals; Aroclors; Aspartate Aminotransferases; Coumarins; Dose-Response Relationship, Drug; Enzyme Induction; Liver; Male; Methylcholanthrene; Mixed Function Oxygenases; Necrosis; Phenobarbital; Rats; Rats, Sprague-Dawley | 1993 |
Sensitive high-performance liquid chromatographic method for the determination of coumarin in plasma.
Topics: Calibration; Chromatography, High Pressure Liquid; Coumarins; Humans; Male; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1993 |
Evaluation of the antitumour activity of coumarin in prostate cancer models.
Topics: Animals; Antineoplastic Agents; Coumarins; Drug Administration Schedule; Drug Screening Assays, Antitumor; Lung Neoplasms; Male; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1993 |
Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.
Topics: Amino Acid Sequence; Animals; Aryl Hydrocarbon Hydroxylases; Asparagine; Base Sequence; Binding Sites; Corticosterone; Coumarins; Cytochrome P-450 Enzyme System; Desoxycorticosterone; Hydroxyprogesterones; Leucine; Mice; Mice, Inbred AKR; Molecular Sequence Data; Mutagenesis, Site-Directed; Progesterone; Spectrophotometry; Steroid Hydroxylases; Structure-Activity Relationship | 1993 |
Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate.
Topics: Aged; Coumarins; Female; Humans; Necrosis; Protein C; Protein C Deficiency; Skin | 1993 |
Coumarin-induced skin necrosis.
Topics: Aged; Coumarins; Female; Humans; Male; Middle Aged; Necrosis; Protein C; Protein C Deficiency; Skin | 1993 |
Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.
Topics: Administration, Intravesical; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Coumarins; Dipyridamole; Fibrin; Humans; Male; Random Allocation; Urinary Bladder Neoplasms; Warfarin | 1993 |
Phalloidin unzips nebulin from thin filaments in skeletal myofibrils.
Topics: Actins; Animals; Calcium; Calmodulin; Coumarins; Epitopes; Fluorescent Antibody Technique; Microscopy, Fluorescence; Muscle Proteins; Myocardium; Myofibrils; Phalloidine; Protein Binding; Rabbits; Rhodamines; Sarcomeres | 1995 |
Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Binding, Competitive; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Humans; Hydroxylation; Kinetics; Male; Mice; Mice, Inbred DBA; Microsomes, Liver; Mixed Function Oxygenases; Models, Chemical; Parasympathomimetics; Pilocarpine | 1995 |
Low interinstrument variability of the international normalized ratio with the coagamate X2/Simplastin excel system.
Topics: Anticoagulants; Blood Coagulation Tests; Calibration; Coumarins; Humans; Prothrombin Time; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 1996 |
Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report.
Topics: Aged; Anticoagulants; Coumarins; Female; Heparin; Hip Prosthesis; Humans; Necrosis; Postoperative Complications; Skin Diseases; Thrombocytopenia | 1996 |
Oral anticoagulant treatment in a medical care district--a descriptive study.
Topics: Administration, Oral; Anticoagulants; Coumarins; Female; Hemorrhage; Humans; Male; Monitoring, Ambulatory; Outcome Assessment, Health Care; Outpatient Clinics, Hospital; Primary Health Care; Rural Health Services; Sweden; Thromboembolism; Warfarin | 1995 |
[Cerebral sinus and venous thrombosis].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Intracranial Embolism and Thrombosis; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Sinus Thrombosis, Intracranial; Thrombolytic Therapy | 1996 |
A modification of the APC resistance test and its application to the study of patients on coumarin therapy.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Coumarins; Drug Resistance; Factor V Deficiency; Humans; Middle Aged; Mutation; Protein C; Thrombophlebitis | 1996 |
In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells--a screening predictive assay for contact sensitizers.
Topics: Coumarins; Dermatitis, Contact; Diazonium Compounds; Fluorescein-5-isothiocyanate; Haptens; Humans; Immunization; Langerhans Cells; Lymphocyte Activation; Phenylenediamines; Pyridines; Sodium Dodecyl Sulfate; T-Lymphocytes; Terpenes; Trinitrobenzenes | 1996 |
Metabolic and analytical interactions of grapefruit juice and 1,2-benzopyrone (coumarin) in man.
Topics: Anticoagulants; Antioxidants; Beverages; Chromatography, High Pressure Liquid; Citrus; Coumarins; Flavanones; Flavonoids; Fluorescence; Food-Drug Interactions; Humans; Male; Umbelliferones | 1996 |
Further studies on the lobar heterogeneity in response to coumarin-mediated hepatotoxicity.
Topics: Animals; Benzoflavones; beta-Naphthoflavone; Body Weight; Coumarins; Liver; Male; Mice; Necrosis; Organ Size; Random Allocation; Rats; Rats, Wistar; Species Specificity; Specimen Handling | 1996 |
Increase of ocular blood flow by some phytogenic compounds.
Topics: Acetophenones; Administration, Topical; Animals; Anticoagulants; Antioxidants; Coumarins; Eye; Flavonoids; Hesperidin; Microspheres; Mydriatics; p-Hydroxyamphetamine; Rabbits; Regional Blood Flow; Reserpine | 1996 |
In vitro sensitization of human T cells with hapten-treated Langerhans cells: a screening test for the identification of contact allergens.
Topics: Acyclic Monoterpenes; Allergens; Antigen Presentation; Cells, Cultured; Coumarins; Dermatitis, Allergic Contact; Diazonium Compounds; Epidermal Cells; Epidermis; Fluorescein-5-isothiocyanate; Haptens; Humans; Irritants; Langerhans Cells; Lymphocyte Activation; Monoterpenes; Perfume; Phenylenediamines; Pyridines; Sodium Dodecyl Sulfate; T-Lymphocytes; Terpenes; Trinitrobenzenesulfonic Acid | 1996 |
Measurement of platelet-activating factor acetylhydrolase activity by quantitative high-performance liquid chromatography determination of coumarin-derivatized 1-O-alkyl-2-sn-lysoglyceryl-3-phosphorylcholine.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Chromatography, High Pressure Liquid; Coumarins; Female; Humans; Phospholipases A; Phosphorylcholine; Pregnancy; Sensitivity and Specificity; Spectrometry, Fluorescence | 1996 |
[Oral surgical procedures during anticoagulant therapy].
Topics: Adult; Aged; Anticoagulants; Coumarins; Dental Cements; Female; Gelatin Sponge, Absorbable; Hemostasis; Hemostatic Techniques; Humans; Inflammation; Male; Middle Aged; Surgery, Oral; Tooth Extraction; Tranexamic Acid | 1996 |
Effects of coumarin following perinatal and chronic exposure in Sprague-Dawley rats and CD-1 mice.
Topics: Animal Feed; Animals; Animals, Newborn; Body Weight; Carcinogenicity Tests; Coumarins; Drug Administration Schedule; Female; Liver; Male; Mice; Mice, Inbred Strains; Rats; Rats, Sprague-Dawley | 1996 |
Evaluation of a prothrombin time optimized for the dog on plasmas with defined coagulation factor deficiency due to coumarin intoxication.
Topics: Animals; Blood Coagulation Disorders; Coumarins; Dog Diseases; Dogs; Female; Humans; Male; Pregnancy; Prothrombin Time; Reference Values; Sensitivity and Specificity; Vitamin K | 1995 |
Reciprocal control of the conformational state of the sarcoplasmic reticulum calcium channel protein by polarization and depolarization in the transverse tubule.
Topics: Animals; Calcium Channels; Calcium Channels, L-Type; Coumarins; Membrane Potentials; Models, Biological; Molecular Probes; Muscle Contraction; Muscle Proteins; Myofibrils; Protein Conformation; Rabbits; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Signal Transduction | 1996 |
Induction or suppression of SV40 amplification by genotoxic carcinogens, non-genotoxic carcinogens or tumor promoters.
Topics: Acetamides; Acetone; Anthracenes; Carcinogens; Cell Line, Transformed; Coumarins; Deoxyuridine; Dimethylformamide; Diterpenes; DNA, Viral; Mercaptopurine; Methotrexate; Mutagens; Nitroquinolines; Nucleic Acid Hybridization; Simian virus 40; Terpenes; Testosterone; Tetradecanoylphorbol Acetate; Thioacetamide; Virus Replication | 1996 |
Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Coumarins; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Kinetics; Liver; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Omeprazole; Proton-Translocating ATPases; Rabbits; Rabeprazole; Recombinant Proteins; Sulfaphenazole; Theophylline | 1996 |
Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Baculoviridae; Biotransformation; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Complementary; Enzyme Inhibitors; Fomepizole; Hempa; Humans; Immunoblotting; Male; Methoxsalen; Metyrapone; Mixed Function Oxygenases; Nitriles; Nitrophenols; Olfactory Mucosa; Pyrazoles; Rabbits; Rats; Rats, Wistar; Spodoptera; Substrate Specificity; Testosterone | 1996 |
Analysis of the glucuronidation of 7-hydroxycoumarin by HPLC.
Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Coumarins; Glucuronosyltransferase; In Vitro Techniques; Liver; Umbelliferones | 1996 |
Natural ingredients based cosmetics. Content of selected fragrance sensitizers.
Topics: 1-Propanol; Acrolein; Acyclic Monoterpenes; Aldehydes; Allergens; Cosmetics; Coumarins; Emollients; Eugenol; Hair Preparations; Humans; Monoterpenes; Perfume; Propanols; Terpenes | 1996 |
Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
Topics: Antibodies, Monoclonal; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Isoenzymes; Kinetics; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Recombinant Proteins; Troleandomycin | 1996 |
Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Topics: Anesthetics, Inhalation; Aryl Hydrocarbon Hydroxylases; Carbon Monoxide; Chlorofluorocarbons; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Halothane; Humans; In Vitro Techniques; Isoenzymes; Ketoconazole; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; Recombinant Proteins | 1996 |
Stereoselective metabolism of a new anticonvulsant drug candidate, losigamone, by human liver microsomes.
Topics: Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Furans; Gas Chromatography-Mass Spectrometry; Humans; Isoenzymes; Lamotrigine; Microsomes, Liver; Mixed Function Oxygenases; Phenytoin; Recombinant Proteins; Stereoisomerism; Triazines | 1996 |
Strain-specific enhancement or inhibition of coumarin hepatotoxicity in mice following pretreatment with two different liver enzyme-inducing agents.
Topics: Alanine Transaminase; Animals; Aroclors; Aspartate Aminotransferases; beta-Naphthoflavone; Chemical and Drug Induced Liver Injury; Chlorodiphenyl (54% Chlorine); Coumarins; Enzyme Induction; Hydroxylation; Male; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Species Specificity | 1996 |
Comparison of the hepatotoxicity of coumarin in the rat, mouse, and Syrian hamster: a dose and time response study.
Topics: Alanine Transaminase; Animals; Bilirubin; Body Weight; Coumarins; Cricetinae; DNA Replication; Dose-Response Relationship, Drug; Feeding Behavior; gamma-Glutamyltransferase; Liver; Male; Mesocricetus; Mice; Organ Size; Rats; Rats, Sprague-Dawley; Species Specificity; Time Factors | 1996 |
Substrate properties of fluorescent ribonucleotides in the terminal transferase-catalyzed labeling of DNA sequencing primers.
Topics: Coumarins; DNA Nucleotidylexotransferase; DNA Primers; Fluorescein; Fluoresceins; Fluorescent Dyes; Rhodamines; Ribonucleotides; Sequence Analysis, DNA; Substrate Specificity; Xanthenes | 1996 |
Simultaneous determination of coumarin, 7-hydroxycoumarin and 7-hydroxycoumarin glucuronide in human serum and plasma by high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Coumarins; Humans; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Umbelliferones | 1996 |
Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes.
Topics: 4-Hydroxycoumarins; Aged; Animals; Cells, Cultured; Child; Coumaric Acids; Coumarins; Dose-Response Relationship, Drug; Humans; L-Lactate Dehydrogenase; Liver; Mice; Mice, Inbred DBA; Middle Aged; Phenylacetates; Rabbits; Rats; Rats, Sprague-Dawley; Umbelliferones | 1996 |
[Contribution of a combination of alpha and beta benzopyrones, flavonoids and natural terpenes in the treatment of lymphedema of the lower limbs at the 2d stage of the surgical classification].
Topics: Adolescent; Adult; Aged; Anticoagulants; Coumarins; Drainage; Drug Therapy, Combination; Follow-Up Studies; Humans; Leg; Lymphedema; Middle Aged; Phytotherapy; Plant Extracts; Time Factors | 1996 |
Comparison of the toxicity of allyl alcohol, coumarin and menadione in precision-cut rat, guinea-pig, cynomolgus monkey and human liver slices.
Topics: 1-Propanol; Animals; Coloring Agents; Coumarins; Guinea Pigs; Humans; Liver; Macaca fascicularis; Male; Potassium; Propanols; Protein Biosynthesis; Rats; Tetrazolium Salts; Thiazoles; Toxicity Tests; Vitamin K | 1996 |
Chemoprevention of carcinogen-DNA binding: the relative role of different oxygenated substituents on 4-methylcoumarins in the inhibition of aflatoxin B1-DNA binding in vitro.
Topics: Aflatoxin B1; Animals; Carcinogens; Coumarins; DNA; Male; Microsomes, Liver; Rats; Rats, Wistar; Structure-Activity Relationship | 1996 |
Facilitation of retinal function recovery by coumarin derivatives.
Topics: Animals; Anticoagulants; Coumarins; Dark Adaptation; Disease Models, Animal; Drugs, Chinese Herbal; Electroretinography; Female; Ischemia; Rats; Retina; Retinal Artery Occlusion; Structure-Activity Relationship | 1997 |
Immunopathological events of adverse cutaneous reactions to coumarin and heparin.
Topics: Coumarins; Drug Eruptions; Female; Heparin; Humans; Middle Aged; Necrosis; Skin; Thromboembolism; Tumor Necrosis Factor-alpha | 1997 |
[Cataract surgery and anticoagulation--current status].
Topics: Anticoagulants; Aspirin; Blood Loss, Surgical; Cataract Extraction; Coumarins; Heparin; Humans; Patient Care Team; Prothrombin Time; Risk Factors; Thromboembolism | 1996 |
Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Child, Preschool; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dioxanes; Enzyme Inhibitors; Female; Furans; Humans; Hydroxylation; Kinetics; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Solvents; Umbelliferones | 1997 |
The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
Topics: Binding Sites; Coumarins; Crystallography, X-Ray; DNA Gyrase; DNA Topoisomerases, Type II; Escherichia coli; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Weight; Novobiocin; Protein Binding; Protein Conformation; Solutions; Structure-Activity Relationship; Thermodynamics | 1997 |
Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.
Topics: Antibodies; Aryl Hydrocarbon Hydroxylases; Asian People; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Japan; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; White People | 1996 |
Interspecies differences in coumarin metabolism in liver microsomes examined by capillary electrophoresis.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Electrophoresis, Capillary; Humans; Kinetics; Mammals; Microsomes, Liver; Mixed Function Oxygenases; NADP; Species Specificity; Umbelliferones | 1996 |
Study of coumarin metabolism by Chinese hamster lung fibroblasts expressing a human cytochrome P450 using H-nmr.
Topics: Animals; Cell Line; Coumarins; Cricetinae; Cricetulus; Culture Media; Cytochrome P-450 Enzyme System; Humans; Magnetic Resonance Spectroscopy; Umbelliferones; Xenobiotics | 1996 |
Molecular bases of three characteristic phenotypes of pneumococcus: optochin-sensitivity, coumarin-sensitivity, and quinolone-resistance.
Topics: Amino Acid Sequence; Base Sequence; Coumarins; DNA, Recombinant; Drug Resistance, Microbial; Genes, Bacterial; Molecular Sequence Data; Phenotype; Quinine; Quinolones; Sequence Homology, Amino Acid; Streptococcus oralis; Streptococcus pneumoniae | 1997 |
Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Baculoviridae; Binding, Competitive; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochromes b5; Electron Transport; Gene Expression; Humans; Microsomes; Mixed Function Oxygenases; NADH, NADPH Oxidoreductases; NADPH-Ferrihemoprotein Reductase; Nitroso Compounds; Rats; Transfection | 1997 |
Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
Topics: Adrenergic beta-Antagonists; Aniline Compounds; Animals; Antineoplastic Agents; Benzphetamine; Carcinogens; Coumarins; Cytochrome P-450 Enzyme System; Dogs; Erythromycin; Ethanolamines; Ethylmorphine; Guinea Pigs; Humans; Macaca fascicularis; Mephenytoin; Microsomes, Liver; Nifedipine; Oxazines; Oxidation-Reduction; Phenacetin; Phenytoin; Rats; Species Specificity | 1997 |
Field study of lyophilised plasmas for local prothrombin time calibration in The Netherlands.
Topics: Anticoagulants; Calibration; Coumarins; Drug Administration Schedule; Humans; Indicators and Reagents; Laboratories; Netherlands; Plasma; Prothrombin Time; Quality Assurance, Health Care | 1997 |
Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse.
Topics: Aged; Animals; Antineoplastic Agents; Breast; Carbon Radioisotopes; Cells, Cultured; Chromatography, High Pressure Liquid; Coumarins; Diffusion; Epidermal Cells; Epidermis; Female; Gas Chromatography-Mass Spectrometry; Humans; Isotope Labeling; Keratinocytes; Male; Mice; Mice, Inbred DBA; Middle Aged; Rats; Rats, Inbred F344; Skin Absorption; Species Specificity | 1997 |
Treatment decision making.
Topics: Anticoagulants; Blood Coagulation Tests; Coumarins; Decision Making; Dental Care for Chronically Ill; Humans; Medical History Taking; Platelet Count | 1997 |
Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens.
Topics: Acrolein; Amines; Antimutagenic Agents; Benzaldehydes; Caffeine; Carbolines; Carcinoma, Hepatocellular; Coumarins; DNA Repair; Heterocyclic Compounds; Humans; Hydrolyzable Tannins; Imidazoles; Micronucleus Tests; Mutagens; Quinolines; Tumor Cells, Cultured | 1997 |
Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil.
Topics: Alfentanil; Benzoflavones; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ditiocarb; Fentanyl; Humans; Immunoblotting; Isoenzymes; Microsomes, Liver; Saccharomyces cerevisiae; Sufentanil; Transfection | 1997 |
Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes.
Topics: Animals; Aspirin; Biotransformation; Carbon Monoxide; Coumarins; Cytochrome P-450 Enzyme System; Erythrocebus patas; Female; Isothiocyanates; Lipoxygenase; Lung; Masoprocol; Microsomes; Microsomes, Liver; Nitrosamines; Oxygenases; Prostaglandin-Endoperoxide Synthases | 1997 |
Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; CHO Cells; Chromatography, High Pressure Liquid; Coumarins; Cricetinae; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Nitrosamines; Nitroso Compounds | 1997 |
Coumarin-induced hepatotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Coumarins; Female; Humans; Liver Function Tests; Lymphedema | 1997 |
Intraperitoneal administration of coumarin causes tissue-selective depletion of cytochromes P450 and cytotoxicity in the olfactory mucosa.
Topics: Animals; Coumarins; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Liver; Male; Mice; Mice, Inbred C57BL; Nasal Mucosa; Organ Specificity; Rats; Rats, Wistar | 1997 |
Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
Topics: Adolescent; Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Child; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; gamma-Glutamyltransferase; Hepatitis A; Humans; Liver; Liver Function Tests; Male; Mixed Function Oxygenases; Transaminases; Umbelliferones | 1997 |
Intermittent edema of the upper and lower extremities and the abdominal wall caused by membranous stenosis of the superior vena cava and membranous obstruction of the inferior vena cava.
Topics: Abdominal Muscles; Adult; Anticoagulants; Arm; Bandages; Clothing; Coumarins; Edema; Humans; Leg; Male; Ultrasonography; Vena Cava, Inferior; Vena Cava, Superior; Venous Insufficiency | 1996 |
Identification of the cytochrome P450 isoforms involved in the O-demethylation of 4-nitroanisole in human liver microsomes.
Topics: Adult; Aged; Anisoles; Anti-Infective Agents; Anticoagulants; Antifungal Agents; Antimalarials; Binding, Competitive; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Humans; Isoenzymes; Ketoconazole; Kinetics; Male; Methylation; Microsomes, Liver; Middle Aged; Quinidine; Substrate Specificity; Sulfaphenazole; Theophylline | 1997 |
Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Child; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochromes b5; Enzyme Activation; Female; Humans; Kinetics; Male; Methoxsalen; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; NADP; NADPH-Ferrihemoprotein Reductase; Recombinant Proteins; Spectrophotometry; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Time Factors | 1997 |
A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Child; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxylation; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Polymorphism, Genetic; Structure-Activity Relationship | 1997 |
Rat olfactory mucosa displays a high activity in metabolizing methyl tert-butyl ether and other gasoline ethers.
Topics: Air Pollutants; Animals; Antineoplastic Agents; Biotransformation; Carbon Monoxide; Carcinogens; Chromatography, Gas; Coumarins; Ethyl Ethers; Gasoline; Male; Methyl Ethers; Mice; Microsomes, Liver; NADP; Olfactory Mucosa; Rats; Rats, Sprague-Dawley | 1997 |
Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
Topics: 4-Quinolones; Amino Acid Sequence; Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Coumarins; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Molecular Sequence Data; Mutation; Novobiocin; Phenotype; Sequence Alignment; Sequence Homology, Amino Acid; Staphylococcus aureus | 1998 |
Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes.
Topics: 1-Propanol; Caffeine; Chlorzoxazone; Coumarins; Cyclosporine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Microsomes, Liver; Mixed Function Oxygenases; Phenacetin; Phenothiazines; Precipitin Tests; Sulfaphenazole; Tolbutamide | 1998 |
Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features.
Topics: Aged; Anticoagulants; Coumarins; Drug Eruptions; Factor V; Humans; Lupus Coagulation Inhibitor; Male; Necrosis; Thrombophlebitis | 1998 |
The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human.
Topics: Anticoagulants; Beverages; Citrus; Coumarins; Cross-Over Studies; Dose-Response Relationship, Drug; Flavanones; Flavonoids; Humans; Male; Umbelliferones | 1997 |
Highly sensitive thromboplastins do not improve INR precision.
Topics: Anticoagulants; Coumarins; Humans; Indicators and Reagents; Multivariate Analysis; Prothrombin Time; Reference Values; Regression Analysis; Sensitivity and Specificity; Thromboplastin | 1998 |
Identification of CYP2A3 as a major cytochrome P450 enzyme in the female peripubertal rat breast.
Topics: Amino Acid Sequence; Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Immunohistochemistry; Mammary Glands, Animal; Mice; Mice, Inbred DBA; Mixed Function Oxygenases; Molecular Sequence Data; Polymerase Chain Reaction; Pregnancy; Rats; Rats, Sprague-Dawley | 1998 |
The spotty sign.
Topics: Aged; Angioplasty, Balloon; Anticoagulants; Coumarins; Embolism, Cholesterol; Female; Humans; Renal Artery Obstruction; Skin Diseases, Vascular | 1998 |
Evaluation of the developmental toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX.
Topics: 4-Hydroxycoumarins; Abnormalities, Drug-Induced; Animals; Biotransformation; Coumarins; Cyclophosphamide; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Umbelliferones; Xenopus | 1998 |
Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines.
Topics: Antineoplastic Agents; Caco-2 Cells; Carcinoma, Hepatocellular; Coumarins; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Leukemia, Lymphoid; Liver Neoplasms; Stomach Neoplasms; Tumor Cells, Cultured; Umbelliferones | 1998 |
Rapid and simple micromethod for the quantification of fluindione in human plasma using high-performance liquid chromatography.
Topics: Anticoagulants; Calibration; Chromatography, High Pressure Liquid; Coumarins; Humans; Light; Phenindione; Reference Standards; Reproducibility of Results; Specimen Handling; Spectrophotometry, Ultraviolet; Time Factors | 1998 |
Computer-assisted molecular design for the determination of structure-activity relationships for chemopreventive agents.
Topics: Antineoplastic Agents; Carcinoma; Cell Division; Cell Movement; Chemoprevention; Computer-Aided Design; Coumarins; Drug Design; Guanine; Guanosine Triphosphate; Humans; Molecular Structure; Point Mutation; Protein Binding; Proto-Oncogene Proteins p21(ras); Structure-Activity Relationship; Tumor Cells, Cultured; Umbelliferones; Urinary Bladder Neoplasms | 1997 |
[Consensus on antithrombotic prophylaxis of vascular events in patients with manifested atherosclerotic vascular disease].
Topics: Aged; Anticoagulants; Arteriosclerosis; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Coumarins; Humans; Ischemic Attack, Transient | 1998 |
Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system.
Topics: Amidines; Antioxidants; Coumarins; Ferric Compounds; Ferrous Compounds; Flavonoids; Hydroquinones; Lipid Peroxidation; Liposomes; Oxidants; Structure-Activity Relationship | 1998 |
Determination of 2-hydroxyphenylacetic acid (2HPAA) in urine after oral and parenteral administration of coumarin by gas-liquid chromatography with flame-ionization detection.
Topics: Administration, Oral; Chromatography, Gas; Coumarins; Drug Interactions; Flame Ionization; Humans; Infusions, Parenteral; Phenylacetates | 1998 |
Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Adenylyl Imidodiphosphate; Circular Dichroism; Coumarins; Cross-Linking Reagents; Crystallography, X-Ray; Dimethyl Suberimidate; DNA Gyrase; DNA Topoisomerases, Type II; Enzyme Stability; Glutamine; Hydrolysis; Lysine; Models, Molecular; Molecular Weight; Mutagenesis, Site-Directed; Protein Binding | 1998 |
alpha-Methylene-gamma-butyrolactones: synthesis and vasorelaxing activity assay of coumarin, naphthalene, and quinoline derivatives.
Topics: 4-Butyrolactone; Animals; Aorta, Thoracic; Coumarins; Female; Male; Naphthalenes; Platelet Aggregation Inhibitors; Quinolines; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilation; Vasodilator Agents | 1998 |
[Microcirculatory consequences of a venous striction in the rat. Effect of a coumarine-rutine association].
Topics: Animals; Anticoagulants; Blood Flow Velocity; Constriction, Pathologic; Coumarins; Drug Therapy, Combination; Erythrocytes; Male; Microcirculation; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Rutin | 1998 |
A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).
Topics: Aryl Hydrocarbon Hydroxylases; Base Sequence; Cloning, Molecular; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Gene Deletion; Genomic Library; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Molecular Sequence Data; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Substrate Specificity; Thiazoles; Thiazolidines | 1998 |
Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity.
Topics: Alleles; Anti-Infective Agents; Coumarins; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Fluoroquinolones; Mutation; Staphylococcus aureus | 1998 |
Long-term treatment with cyclosporin A and coumarin in pulmonary thromboembolic Behçet's disease.
Topics: Adult; Aneurysm; Anticoagulants; Behcet Syndrome; Coumarins; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Hemoptysis; Humans; Immunosuppressive Agents; Pulmonary Artery; Pulmonary Embolism | 1998 |
Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa.
Topics: Amitrole; Animals; Aryl Hydrocarbon Hydroxylases; Cobalt; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; DNA Probes; Enzyme Induction; Griseofulvin; Immunoblotting; Isoenzymes; Kidney; Liver; Lung; Male; Mice; Mice, Inbred C57BL; Mixed Function Oxygenases; Olfactory Mucosa; Pyrazoles; RNA, Messenger; Substrate Specificity; Thioacetamide; Tin Compounds; Xenobiotics | 1998 |
Selective Clara cell injury in mouse lung following acute administration of coumarin.
Topics: Administration, Oral; Animals; Anticoagulants; Bronchi; Carcinogens; Coumarins; Dose-Response Relationship, Drug; Epithelial Cells; Female; Hyperplasia; Liver; Lung; Male; Mice; Necrosis; Rats; Rats, Inbred F344 | 1998 |
Coumarin chemoprotection against aflatoxin B1-induced gene mutation in a mammalian cell system: a species difference in mutagen activation and protection with chick embryo and rat liver S9.
Topics: Aflatoxin B1; Animals; Antimutagenic Agents; Biotransformation; Chick Embryo; CHO Cells; Chromatography, High Pressure Liquid; Coumarins; Cricetinae; Liver; Male; Mutagens; Rats; Rats, Sprague-Dawley | 1998 |
Chorioretinopathy in primary antiphospholipid syndrome: a case report.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Choroid; Choroid Diseases; Coumarins; Female; Fluorescein Angiography; Fundus Oculi; Heparin; Humans; Retinal Diseases; Retinal Vessels; Visual Acuity; Visual Field Tests; Visual Fields | 1998 |
Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Gas Chromatography-Mass Spectrometry; Genetic Variation; Humans; Hydroxylation; Jordan; Male; Mixed Function Oxygenases; Phenylacetates; Polymorphism, Genetic; Umbelliferones | 1998 |
Determination of 7-hydroxycoumarin and its glucuronide and sulphate conjugates in liver slice incubates by capillary zone electrophoresis.
Topics: Animals; Antineoplastic Agents; Coumarins; Electrophoresis, Capillary; Liver; Mice; Mice, Inbred BALB C; Umbelliferones | 1998 |
[Retroperitoneal hematoma and femoral compression neuropathy--a complication of anticoagulation therapy after myocardial infarct].
Topics: Anticoagulants; Atrial Fibrillation; Cerebrovascular Disorders; Coumarins; Female; Hematoma; Hemorrhage; Humans; Leg; Middle Aged; Myocardial Infarction; Nerve Compression Syndromes; Retroperitoneal Space; Risk Factors | 1998 |
Cooperative formation of a substrate binding pocket by alpha- and beta-subunits of mitochondrial processing peptidase.
Topics: Amino Acid Sequence; Animals; Coumarins; Dimerization; Metalloendopeptidases; Mitochondrial Processing Peptidase; Molecular Sequence Data; Peptides; Rats; Spectrometry, Fluorescence; Substrate Specificity | 1998 |
The rôle of coumarin in patch testing.
Topics: Allergens; Cosmetics; Coumarins; Dermatitis, Allergic Contact; Female; Humans; Male; Medical Records; Patch Tests; Perfume; Retrospective Studies | 1998 |
The quality of life after breast cancer--solving the problem of lymphedema.
Topics: Breast Neoplasms; Coumarins; Female; Humans; Lymph Node Excision; Lymphedema; Postoperative Complications; Treatment Failure | 1999 |
Resin-supported labeling reagents.
Topics: Acridines; Biotin; Chromatography, High Pressure Liquid; Coumarins; Esters; Estriol; Fluorescein; Haptens; Phenytoin; Resins, Plant; Thyroxine | 1999 |
Highly sensitive high-performance liquid chromatographic assay for coumarin 7-hydroxylation and 7-ethoxycoumarin O-deethylation by human liver cytochrome P450 enzymes.
Topics: Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 Enzyme System; Humans; Isoenzymes; Kinetics; Microsomes, Liver; Sensitivity and Specificity; Spectrometry, Fluorescence | 1999 |
The placebo "arm".
Topics: Coumarins; Dose-Response Relationship, Drug; Female; Humans; Lymphedema; Placebos; Randomized Controlled Trials as Topic; Research Design | 1999 |
Identification of coumarin as the sensitizer in a patient sensitive to her own perfume but negative to the fragrance mix.
Topics: Adult; Cosmetics; Coumarins; Dermatitis, Allergic Contact; Female; Humans; Patch Tests; Perfume | 1999 |
Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
Topics: Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Cholecalciferol; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Ethanolamines; Humans; Isoenzymes; Lauric Acids; Microsomes, Liver; Mixed Function Oxygenases; Nifedipine; Omeprazole; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Paclitaxel; Prostaglandins; Recombinant Proteins; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Theophylline; Tretinoin; Warfarin; Xenobiotics | 1999 |
Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Northern; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Dimethylnitrosamine; Esophagus; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Isoenzymes; Lung; Male; Mixed Function Oxygenases; Nasal Mucosa; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution | 1999 |
An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
Topics: Animals; Anisoles; Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Catalysis; Coumarins; Cross Reactions; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Humans; Hybridomas; Mice; Mice, Inbred BALB C; Microsomes, Liver; Mixed Function Oxygenases | 1999 |
Genetic variation in the metabolism of coumarin in mouse liver.
Topics: Animals; Carbon Radioisotopes; Coumarins; Female; Genetic Variation; Genotype; Hydroxylation; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Multivariate Analysis; Protein Binding; Species Specificity | 1999 |
Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor.
Topics: Adenosine Triphosphate; Binding, Competitive; Carcinoma, Hepatocellular; Coumarins; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Esculin; Genistein; Humans; Hydroxylation; Inhibitory Concentration 50; Kinetics; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Protein Kinases; Tumor Cells, Cultured; Umbelliferones | 1999 |
Substituted coumarins as esterase-sensitive prodrug moieties with improved release rates.
Topics: Animals; Biological Availability; Coumarins; Esterases; Kinetics; Prodrugs; Swine; Time Factors | 1999 |
Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity.
Topics: Amino Acid Sequence; Animals; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Fadrozole; Furans; Humans; Mice; Mixed Function Oxygenases; Models, Molecular; Molecular Sequence Data; Structure-Activity Relationship; Substrate Specificity | 1999 |
Ophthalmic manifestation of congenital protein C deficiency.
Topics: Anticoagulants; Cataract; Consanguinity; Coumarins; Eye Diseases; Female; Humans; IgA Vasculitis; Infant, Newborn; Microphthalmos; Protein C; Protein C Deficiency; Retinal Detachment; Retinal Hemorrhage; Vitreous Hemorrhage | 1999 |
Studies on the anti-allergic activity of Mikania glomerata.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asteraceae; Coumarins; Male; Plant Extracts; Pleurisy; Rats; Rats, Wistar | 1999 |
Determination of fatty acids in vegetable oil by reversed-phase liquid chromatography with fluorescence detection.
Topics: Chromatography, Liquid; Coumarins; Fatty Acids; Plant Oils; Solvents; Spectrometry, Fluorescence; Temperature | 1999 |
Cigarette smoke induces direct DNA damage in the human B-lymphoid cell line Raji.
Topics: Acetaldehyde; Acetylcysteine; Acrolein; Aldehydes; Aryl Hydrocarbon Hydroxylases; Ascorbic Acid; B-Lymphocytes; beta-Naphthoflavone; Biotransformation; Burkitt Lymphoma; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B1; Cytochrome P-450 Enzyme System; DNA Damage; DNA Repair; DNA-Formamidopyrimidine Glycosylase; DNA, Neoplasm; Formaldehyde; Free Radical Scavengers; Gamma Rays; Humans; Mixed Function Oxygenases; N-Glycosyl Hydrolases; Oxidation-Reduction; Reactive Oxygen Species; Smoke | 1999 |
Release of a model molecule from highly concentrated fluorinated reverse emulsions. Influence of composition variables and temperature.
Topics: Alkanes; Chemistry, Pharmaceutical; Coumarins; Delayed-Action Preparations; Diffusion; Emulsions; Fluorocarbons; Gels; Heating; Kinetics; Solubility; Spectrophotometry, Ultraviolet; Surface-Active Agents; Water | 1999 |
Co-mutagenicity of coumarin (1,2-benzopyrone) with aflatoxin B1 and human liver S9 in mammalian cells.
Topics: Aflatoxin B1; Animals; Biotransformation; Cells, Cultured; CHO Cells; Coumarins; Cricetinae; Drug Synergism; Humans; Liver; Mutagenicity Tests; Mutagens | 1999 |
Oxidation of LDL and extent of peripheral atherosclerosis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cholesterol, Dietary; Coumarins; Diet, Fat-Restricted; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Odds Ratio; Risk Factors | 1999 |
Guidelines for the surgical management of breast cancer: comment.
Topics: Anticoagulants; Breast Neoplasms; Coumarins; Female; Humans; Lymphedema; Postoperative Complications; Practice Guidelines as Topic | 1999 |
Development of tolerance to Clara cell necrosis with repeat administration of coumarin.
Topics: Animals; Antineoplastic Agents; Biotransformation; Carcinogens; Coumarins; Cytochrome P-450 Enzyme System; Drug Tolerance; Epithelial Cells; Female; Lung; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Necrosis | 1999 |
Determination of serum liver tests during therapy with coumarin anticoagulants.
Topics: Anticoagulants; Cohort Studies; Coumarins; Enzymes; Humans; Liver; Liver Function Tests; Retrospective Studies | 1999 |
Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Escherichia coli; Humans; Hydroxylation; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Rats; Recombinant Proteins; Sensitivity and Specificity; Spectrometry, Fluorescence | 1999 |
Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio.
Topics: Animals; Anticoagulants; Blood Preservation; Calibration; Coumarins; Cryopreservation; Evaluation Studies as Topic; Freeze Drying; Humans; International Normalized Ratio; Plasma; Prothrombin Time; Rabbits; Reference Standards; Reproducibility of Results | 1999 |
Fluorophores at the N terminus of nascent chloramphenicol acetyltransferase peptides affect translation and movement through the ribosome.
Topics: Animals; Cattle; Chloramphenicol O-Acetyltransferase; Coumarins; Eosine Yellowish-(YS); Fluorescent Dyes; Kinetics; N-Formylmethionine; Peptide Biosynthesis; Peptides; Protein Biosynthesis; Protein Folding; Pyrenes; Ribosomes; RNA, Transfer, Met; Spectrometry, Fluorescence; Thiosulfate Sulfurtransferase; Time Factors | 2000 |
Deconvolution of the fluorescence spectra into its component Gaussians: a method to analyze the binding of coumarin to bovine serum albumin.
Topics: Coumarins; Fluorescence Polarization; Protein Binding; Serum Albumin, Bovine | 1999 |
CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians.
Topics: Aryl Hydrocarbon Hydroxylases; Asian People; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; DNA; DNA Primers; Gene Deletion; Genotype; Humans; Japan; Microsomes, Liver; Mixed Function Oxygenases; Mutation; Nicotine; Oxidation-Reduction; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; White People | 2000 |
Advances in symptom management: lymphedema.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Coumarins; Female; Humans; Lymphedema; Mastectomy; Middle Aged; Research Design | 1999 |
Electroconvulsive therapy and anticoagulation.
Topics: Aged; Anticoagulants; Coumarins; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Male; Venous Thrombosis | 2000 |
Disruption of the Borrelia burgdorferi gac gene, encoding the naturally synthesized GyrA C-terminal domain.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Borrelia burgdorferi Group; Coumarins; DNA Gyrase; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Microbial; Genes, Bacterial; Mutation; Phenotype; Plasmids; Protein Structure, Tertiary | 2000 |
Coumarin-related compounds as plant growth inhibitors from two rutaceous plants in Thailand.
Topics: Coumarins; Magnetic Resonance Spectroscopy; Molecular Structure; Plant Growth Regulators; Plants | 2000 |
Estrogen effects on Candida albicans: a potential virulence-regulating mechanism.
Topics: Candida albicans; Coumarins; DNA Primers; Estradiol; Fungal Proteins; HSP90 Heat-Shock Proteins; Humans; In Vitro Techniques; Kinetics; Membrane Transport Proteins; Phenol; RNA, Messenger; Up-Regulation | 2000 |
Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: a comparative study.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brazil; Bronchodilator Agents; Coumarins; Female; Guinea Pigs; In Vitro Techniques; Male; Mice; Plants, Medicinal; Rats; Rats, Wistar | 2000 |
Effect of pregnancy on the duration of bovine pericardial bioprostheses.
Topics: Abnormalities, Drug-Induced; Animals; Anticoagulants; Bioprosthesis; Cattle; Coumarins; Female; Heart Valve Prosthesis; Heparin; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Factors; Warfarin | 2000 |
[Good therapy control requires a standardized test. Thrombosis ABC, 13: INR instead of Quick].
Topics: Anticoagulants; Coumarins; Humans; International Normalized Ratio; Long-Term Care; Predictive Value of Tests; Prothrombin Time; Thromboembolism | 2000 |
Cytotoxic activity of cerium complexes with coumarin derivatives. Molecular modeling of the ligands.
Topics: 4-Hydroxycoumarins; Antineoplastic Agents; Cell Survival; Cerium; Coumarins; Humans; Hymecromone; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Organometallic Compounds; Spectrophotometry, Infrared; Tumor Cells, Cultured; Warfarin | 2000 |
[Prevention of embolism in atrial septal defects?].
Topics: Adult; Age Factors; Anticoagulants; Aspirin; Coumarins; Embolism; Female; Fibrinolytic Agents; Heart Septal Defects, Atrial; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Time Factors; Venous Thrombosis | 2000 |
Coumarin derivatives and breast-feeding.
Topics: Anticoagulants; Breast Feeding; Contraindications; Coumarins; Female; Humans; Molecular Structure; Pregnancy | 2000 |
Temperature-sensitive suppressor mutations of the Escherichia coli DNA gyrase B protein.
Topics: Antibiotics, Antineoplastic; Coumarins; Crystallography, X-Ray; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Enzyme Inhibitors; Escherichia coli; Glycine; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Novobiocin; Phenotype; Protein Conformation; Suppression, Genetic; Temperature; Thermodynamics; Valine | 2000 |
Synthesis and fluorescence properties of new fluorescent, polymerizable, metal-chelating lipids.
Topics: Chelating Agents; Coumarins; Fluorescent Dyes; Lipid Bilayers; Metals; Microscopy, Electron; Molecular Conformation; Nitrosamines; Rhodamines | 2000 |
Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase.
Topics: Chymotrypsin; Coumarins; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Leukocyte Elastase; Magnetic Resonance Spectroscopy; Spectrophotometry, Infrared | 2000 |
Production and characterization of anti-coumarin scFv antibodies.
Topics: Antibodies; Antibody Affinity; Coumarins; Enzyme-Linked Immunosorbent Assay; Immunoglobulin Variable Region | 1998 |
A study of the electrospray ionisation of selected coumarin derivatives and their subsequent fragmentation using an ion trap mass spectrometer.
Topics: Coumarins; Mass Spectrometry; Peptide Fragments | 2000 |
Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Coumarins; Hexoses; Microbial Sensitivity Tests | 2000 |
Regulation of rat glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B(1)-induced preneoplasia.
Topics: 4-Butyrolactone; Aflatoxin B1; Animals; Anticarcinogenic Agents; Antioxidants; Carcinogens; Catalytic Domain; Coumarins; Diet; Ellagic Acid; Enzyme Induction; Ethoxyquin; Glutamate-Cysteine Ligase; Glutathione; Inactivation, Metabolic; Liver; Liver Neoplasms, Experimental; Male; Phenobarbital; Precancerous Conditions; Rats; Rats, Inbred F344; Rats, Wistar | 2000 |
In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity.
Topics: Acetaldehyde; Adult; Animals; Anticoagulants; Antineoplastic Agents; Child, Preschool; Chromatography, Gas; Coumarins; Female; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Middle Aged; Rats; Rats, Inbred F344; Species Specificity | 2000 |
A new antiplasmodial coumarin from Toddalia asiatica roots.
Topics: Animals; Antimalarials; Coumarins; Humans; Medicine, African Traditional; Plant Extracts; Plant Roots; Plants, Medicinal; Plasmodium falciparum | 2000 |
Synthesis of a statistically exhaustive fluorescent peptide substrate library for profiling protease specificity.
Topics: Chromatography, High Pressure Liquid; Combinatorial Chemistry Techniques; Coumarins; Endopeptidases; Fluorescent Dyes; Molecular Probes; Substrate Specificity | 2000 |
[Superior vena cava thrombosis after in vitro fertilization].
Topics: Abortion, Spontaneous; Adult; Anticoagulants; Coumarins; Estradiol; Female; Fertilization in Vitro; Fibrinolytic Agents; Humans; Hydroxyprogesterones; Magnetic Resonance Imaging; Pregnancy; Streptokinase; Vena Cava, Superior; Venous Thrombosis | 2000 |
Synthesis and fluorescence properties of intramolecularly quenched fluorogenic p-nitroanilides containing coumarin or quinolinone derivatives as fluorophores.
Topics: Aniline Compounds; Coumarins; Fluorescent Dyes; Models, Chemical; Peptide Biosynthesis; Quinolones; Spectrometry, Fluorescence | 2000 |
Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Coagulation; Case-Control Studies; Cell Culture Techniques; Cells, Cultured; Coumarins; Cryopreservation; Culture Media, Serum-Free; Female; Hip Fractures; Humans; International Normalized Ratio; Leukocytes, Mononuclear; Male; Middle Aged; Plasma; Postoperative Complications; Statistics, Nonparametric; Thromboplastin | 2001 |
In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
Topics: Aryl Hydrocarbon Hydroxylases; Benzene Derivatives; Binding Sites; Chlorzoxazone; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Inhibitory Concentration 50; Isoenzymes; Kinetics; Methoxsalen; Microsomes, Liver; Mixed Function Oxygenases; Molecular Structure; Monoterpenes; Spectrophotometry; Terpenes; Tranylcypromine | 2001 |
Development of an expert system rulebase for the prospective identification of photoallergens.
Topics: Allergens; Animals; Coumarins; Expert Systems; Guinea Pigs; Ketones; Molecular Structure; Structure-Activity Relationship | 2000 |
Effect of cigarette smoking on coumarin metabolism in humans.
Topics: Administration, Oral; Adolescent; Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Mixed Function Oxygenases; Nicotine; Smoking | 2000 |
Bioactive coumarin derivatives from the fern Cyclosorus interruptus.
Topics: Anti-Infective Agents; Coumarins; Microbial Sensitivity Tests; Plant Extracts; Plants; Spectrum Analysis | 2000 |
Spectral studies on metal-ligand bonding in complexes of 1-acetyl-2-(coumariniminecarboxamide-3-yl)hydrazine.
Topics: Benzopyrans; Cobalt; Copper; Coumarins; Electron Spin Resonance Spectroscopy; Hydrazines; Ligands; Magnetic Resonance Spectroscopy; Manganese; Metals; Molecular Structure; Nickel; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Thermodynamics | 2001 |
Development of a profitable procedure for the extraction of 2-H-1-benzopyran-2-one (coumarin) from Mikania glomerata.
Topics: Costs and Cost Analysis; Coumarins; Drug Industry; Plant Extracts; Seasons; Sodium Hydroxide | 2001 |
Bleeding complication during coumarin therapy due to amiodarone and azithromycin.
Topics: Amiodarone; Anticoagulants; Atrial Fibrillation; Azithromycin; Coumarins; Drug Interactions; Fatal Outcome; Female; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Middle Aged; Postoperative Complications; Respiratory Tract Infections | 2000 |
Intramolecular fluorescence resonance energy transfer system with coumarin donor included in beta-cyclodextrin.
Topics: beta-Cyclodextrins; Chemical Phenomena; Chemistry, Physical; Circular Dichroism; Coumarins; Cyclodextrins; Fluorescent Dyes; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2001 |
Coumarins from the aerial part of Halocnemum strobilaceum.
Topics: Chenopodiaceae; Coumarins; Furocoumarins; Humans; Hymecromone; Magnetic Resonance Spectroscopy; Plant Extracts; Plants, Medicinal | 2001 |
Coagulation factor IX propeptide mutations causing coumarin hypersensitivity: identification of female alanine-10 valine heterozygotes.
Topics: Coumarins; Drug Hypersensitivity; Factor IX; Family Health; Female; Founder Effect; Hemorrhage; Heterozygote; Humans; Male; Point Mutation | 2001 |
Coumarin formation in novobiocin biosynthesis: beta-hydroxylation of the aminoacyl enzyme tyrosyl-S-NovH by a cytochrome P450 NovI.
Topics: Acylation; Adenosine Triphosphate; Bacterial Proteins; Chromatography, High Pressure Liquid; Cloning, Molecular; Coumarins; Cytochrome P-450 Enzyme System; Genes, Bacterial; Hydroxylation; Novobiocin; Protein Processing, Post-Translational; Protein Structure, Tertiary; Recombinant Proteins; Stereoisomerism; Streptomyces | 2001 |
Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubes.
Topics: Anticoagulants; Artifacts; Blood Specimen Collection; Calcium; Citrates; Coumarins; Equipment Contamination; Humans; International Normalized Ratio; Magnesium; Prothrombin Time; Rubber; Sodium Citrate; Solutions | 2001 |
High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Chlorzoxazone; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dextromethorphan; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Single-Blind Method; Specimen Handling; Spectrometry, Mass, Electrospray Ionization; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Substrate Specificity; Tolbutamide | 2001 |
Consumption of watercress fails to alter coumarin metabolism in humans.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biotransformation; Brassicaceae; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Humans; Male; Mixed Function Oxygenases; Reference Values | 2001 |
Coumarin substrates for cytochrome P450 2D6 fluorescence assays.
Topics: Amino Acid Sequence; Catalysis; Coumarins; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Enzyme Inhibitors; Fluorescent Dyes; Humans; Kinetics; Microsomes, Liver; Molecular Sequence Data; Quinidine; Recombinant Proteins; Substrate Specificity | 2001 |
Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
Topics: 2-Acetylaminofluorene; Abnormalities, Drug-Induced; Animals; beta-Naphthoflavone; Biotransformation; Chlorodiphenyl (54% Chlorine); Coumarins; Cyclophosphamide; Embryo, Mammalian; Embryo, Nonmammalian; Isoniazid; Microsomes, Liver; Phenobarbital; Rats; Toxicity Tests; Trichloroethylene; Xenopus laevis | 2001 |
Expression of CYP2A6 in tumor cells augments cellular sensitivity to tegafur.
Topics: Antimetabolites, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Cell Division; Colonic Neoplasms; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Fluorouracil; Gene Expression; Humans; Hydroxylation; Microsomes; Mixed Function Oxygenases; Tegafur; Transfection; Tumor Cells, Cultured | 2001 |
Fine Tuning of physico-chemical parameters to optimise a new series of novobiocin analogues.
Topics: Anti-Bacterial Agents; Coumarins; Microbial Sensitivity Tests; Novobiocin; Staphylococcus aureus | 2001 |
Determination of coumarin metabolism in Turkish population.
Topics: Adult; Aged; Amino Acid Substitution; Aryl Hydrocarbon Hydroxylases; Cotinine; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Female; Gene Frequency; Genotype; Humans; Isoenzymes; Male; Middle Aged; Mixed Function Oxygenases; Nicotine; Phenotype; Point Mutation; Polymorphism, Genetic; Smoking; Turkey; Umbelliferones | 2001 |
Differing effects of endocrine-disrupting chemicals on basal and FSH-stimulated progesterone production in rat granulosa-luteal cells.
Topics: Animals; Apigenin; Cells, Cultured; Colforsin; Coumarins; DDT; Estradiol; Estrogens; Female; Flavonoids; Follicle Stimulating Hormone; Genistein; Granulosa Cells; Phenols; Progesterone; Rats; Rats, Wistar | 2001 |
Synthesis, physicochemical characterization, and cytotoxic screening of new zirconium complexes with coumarin derivatives.
Topics: Antineoplastic Agents; Cell Survival; Coumarins; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Hymecromone; Ligands; Magnetic Resonance Spectroscopy; Organometallic Compounds; Spectrophotometry, Infrared; Warfarin; Zirconium | 2001 |
Ischaemic jejunal stenosis complicating portal and mesenteric vein thrombosis: a report of two cases.
Topics: Adult; Coumarins; Fibrinolytic Agents; Follow-Up Studies; Humans; Intestinal Obstruction; Ischemia; Jejunum; Laparotomy; Male; Mesenteric Vascular Occlusion; Portal Vein; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler; Venous Thrombosis | 2001 |
Lack of effect of coumarin on the formation of micronuclei in an in vivo mouse micronucleus assay.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Anticoagulants; Bone Marrow Cells; Coumarins; DNA Damage; Female; Male; Mice; Micronucleus Tests; Mitomycin | 2001 |
[Conservative therapy of acute pelvic-leg vein thrombosis].
Topics: Ambulatory Care; Anticoagulants; Bandages; Combined Modality Therapy; Coumarins; Follow-Up Studies; Heparin; Heparin, Low-Molecular-Weight; Humans; Iliac Vein; Leg; Venous Thrombosis | 2001 |
New lanthanide complexes of 4-methyl-7-hydroxycoumarin and their pharmacological activity.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Coumarins; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Guinea Pigs; Ileum; Injections, Intraperitoneal; Lanthanoid Series Elements; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Muscle Contraction; Parasympatholytics; Spectrophotometry, Infrared; Toxicity Tests | 2001 |
A fluorescent receptor assay for benzodiazepines using coumarin-labeled desethylflumazenil as ligand.
Topics: Animals; Benzodiazepines; Cattle; Chromatography, High Pressure Liquid; Coumarins; Flumazenil; Fluorescent Dyes; Ligands; Radioligand Assay; Receptors, GABA-A; Reproducibility of Results | 2001 |
Diels--Alder bioconjugation of diene-modified oligonucleotides.
Topics: Biotinylation; Coumarins; Fluorescein; Oligonucleotides; Temperature | 2001 |
Frequency-domain fluorescence microscopy with the LED as a light source.
Topics: 3T3 Cells; Animals; Coumarins; Fluorescent Dyes; Light; Mice; Microscopy, Fluorescence; Organic Chemicals | 2001 |
Fluorescent coumarin-labeled nucleotides to measure ADP release from actomyosin.
Topics: Actomyosin; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Chickens; Coumarins; Diphosphates; Fluorescent Dyes; Kinetics; Muscle, Skeletal; Muscle, Smooth; Protein Binding; Rabbits | 2001 |
[Secondary osteoporosis induced by anticoagulants?].
Topics: Administration, Oral; Adult; Anticoagulants; Bone and Bones; Bone Density; Clinical Trials as Topic; Coumarins; Double-Blind Method; Female; Fractures, Bone; Heparin; Heparin, Low-Molecular-Weight; Humans; Immobilization; Meta-Analysis as Topic; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Pregnancy; Pregnancy Complications; Prospective Studies; Renal Dialysis; Retrospective Studies; Risk Factors; Time Factors; Vitamin K | 2001 |
Analysis and significance of gravity-induced asymmetric growth in the grass leaf-sheath pulvinus.
Topics: Avena; Carbamates; Colchicine; Coumarins; Gravitropism; Gravity Sensing; Hordeum; Nitriles; Plant Epidermis; Poaceae; Pulvinus; Sucrose | 1984 |
Reduction in the intensity of abortive migraine drug use during coumarin therapy.
Topics: Anticoagulants; Aspirin; Coumarins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergotamine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Severity of Illness Index; Sumatriptan; Vasoconstrictor Agents | 2001 |
Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3.
Topics: Animals; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Esophagus; Hydroxylation; Male; Microsomes; Mixed Function Oxygenases; Rats; Rats, Inbred F344 | 2001 |
[Dominant selecting culture medium of Peucedanum decursivum by orthogonal design].
Topics: Apiaceae; Coumarins; Culture Media; Culture Techniques; Hormones | 2001 |
Random mutagenesis of human cytochrome p450 2A6 and screening with indole oxidation products.
Topics: Aryl Hydrocarbon Hydroxylases; Cell Membrane; Chromatography, High Pressure Liquid; Coloring Agents; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Escherichia coli; Humans; Indigo Carmine; Indoles; Kinetics; Mixed Function Oxygenases; Mutagenesis; Oxidation-Reduction; Spectrophotometry; Umbelliferones | 2001 |
Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin.
Topics: Adenocarcinoma; Antineoplastic Agents; Biotransformation; Cell Cycle; Cell Division; Coumarins; Cyclin D1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Umbelliferones | 2001 |
Fullerene modified supported lipid membrane as sensitive element of sensor for odorants.
Topics: 1-Octanol; Acyclic Monoterpenes; Biosensing Techniques; Carbon; Coumarins; Electrochemistry; Fullerenes; Lipid Bilayers; Membranes, Artificial; Menthol; Molecular Structure; Norisoprenoids; Odorants; Terpenes | 2001 |
T-tubule depolarization-induced local events in the ryanodine receptor, as monitored with the fluorescent conformational probe incorporated by mediation of peptide A.
Topics: Animals; Calcium; Calcium Channel Blockers; Coumarins; Fluorescent Dyes; Ionophores; Membrane Potentials; Microsomes; Models, Biological; Muscle, Skeletal; Nimodipine; Peptide Fragments; Protein Structure, Secondary; Rabbits; Ryanodine Receptor Calcium Release Channel; Spectrometry, Fluorescence; Time Factors | 2002 |
Ca2+-dependent dual functions of peptide C. The peptide corresponding to the Glu724-Pro760 region (the so-called determinant of excitation-contraction coupling) of the dihydropyridine receptor alpha 1 subunit II-III loop.
Topics: Animals; Caffeine; Calcium; Calcium Channels, L-Type; Calpain; Coumarins; Fluorescent Dyes; Microsomes; Muscle, Skeletal; Myocardium; Peptide Fragments; Polylysine; Protein Binding; Protein Structure, Secondary; Rabbits; Ryanodine; Ryanodine Receptor Calcium Release Channel | 2002 |
Monolithic porous polymer for on-chip solid-phase extraction and preconcentration prepared by photoinitiated in situ polymerization within a microfluidic device.
Topics: Biotechnology; Coumarins; Immunoassay; Ion Exchange; Light; Peptides; Polymerase Chain Reaction; Polymers; Proteins; Sequence Analysis | 2001 |
Iminocoumarin-based low affinity fluorescent Ca2+ indicators excited with visible light.
Topics: Calcium; Chelating Agents; Coumarins; Egtazic Acid; Fluorescent Dyes; Light; Molecular Structure | 2001 |
Biventricular thrombi.
Topics: Aged; Coumarins; Echocardiography; Female; Follow-Up Studies; Heart Diseases; Heparin; Humans; Sensitivity and Specificity; Thrombosis; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors.
Topics: Anti-Bacterial Agents; Binding Sites; Biotinylation; Coumarins; DNA Gyrase; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Novobiocin; Peptides, Cyclic; Radioligand Assay; Topoisomerase II Inhibitors | 2002 |
Opposing effect by cytokines on Fas-mediated apoptosis in A549 lung epithelial cells.
Topics: Apoptosis; bcl-X Protein; Blotting, Western; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cell Nucleus; Cell Survival; Coumarins; Cytokines; Cytoplasm; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; fas Receptor; Flow Cytometry; Humans; Immunohistochemistry; Inflammation; Interferon-gamma; Interleukin-1; Keratins; Lung; Microscopy, Fluorescence; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2002 |
Responses of anthocyanin-producing and non-producing cells of Glehnia littoralis to radical generators.
Topics: Amidines; Anthocyanins; Apiaceae; Cell Division; Cell Line; Coumarins; Hydrogen Peroxide; Phenylalanine Ammonia-Lyase; X-Rays | 2002 |
Construction of Salmonella typhimurium YG7108 strains, each coexpressing a form of human cytochrome P450 with NADPH-cytochrome P450 reductase.
Topics: Alkylating Agents; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diclofenac; Ethanolamines; Genetic Engineering; Humans; Midazolam; Mixed Function Oxygenases; Mutagenicity Tests; NADP; NADPH-Ferrihemoprotein Reductase; Nitrosamines; Recombinant Proteins; Salmonella typhimurium; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 2001 |
European concerted action on anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors.
Topics: Administration, Oral; Animals; Anticoagulants; Calibration; Coumarins; Europe; Humans; International Cooperation; International Normalized Ratio; Plasma; Point-of-Care Systems; Prothrombin Time; Rabbits; Reference Standards; Reference Values; Thromboplastin | 2002 |
Dental extractions in patients maintained on oral anticoagulant therapy: comparison of INR value with occurrence of postoperative bleeding.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Chi-Square Distribution; Coumarins; Curettage; Dental Caries; Female; Gelatin Sponge, Absorbable; Hemostasis, Surgical; Hemostatics; Humans; Insect Proteins; International Normalized Ratio; Male; Middle Aged; Periodontitis; Postoperative Hemorrhage; Silk; Statistics as Topic; Suture Techniques; Sutures; Tooth Extraction; Tranexamic Acid | 2001 |
A new coumarin from Murraya paniculata.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Magnetic Resonance Spectroscopy; Molecular Structure; Plant Extracts; Plant Leaves; Rutaceae | 2002 |
Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium.
Topics: Animals; Brain; Coumarins; Dose-Response Relationship, Drug; Kinetics; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Plant Extracts; Rutaceae | 2002 |
Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
Topics: Administration, Oral; Anticoagulants; Blood Coagulation; Calibration; Coumarins; Humans; International Normalized Ratio; Laboratories; Reference Standards; Reproducibility of Results | 2002 |
An open conformation of the Thermus thermophilus gyrase B ATP-binding domain.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Catalysis; Coumarins; Dimerization; DNA Gyrase; Enzyme Inhibitors; Hydrolysis; Models, Molecular; Molecular Sequence Data; Protein Conformation; Sequence Homology, Amino Acid; Thermus thermophilus; Topoisomerase II Inhibitors | 2002 |
Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Cohort Studies; Contraindications; Coumarins; Drug Interactions; Drug Prescriptions; Female; Glucocorticoids; Humans; Male; Osteoarthritis; Peptic Ulcer Hemorrhage; Retrospective Studies | 2002 |
Synthesis and evaluation of novel fluorogenic substrates for the detection of bacterial beta-galactosidase.
Topics: Bacteriological Techniques; beta-Galactosidase; Colony Count, Microbial; Coumarins; Enterobacteriaceae; Fluorescent Dyes; Galactosides; Humans; Water Microbiology | 2001 |
Field study of lyophilized calibrant plasmas for fresh plasma INR determination.
Topics: Anticoagulants; Blood Coagulation; Calibration; Coumarins; France; Freeze Drying; Humans; Indicators and Reagents; International Normalized Ratio; Laboratories; Netherlands; Plasma; Prothrombin Time; Recombinant Proteins; Reference Standards; Reproducibility of Results; Sample Size; Thromboplastin | 2002 |
A rapid fluorescence-based assay for detecting soluble methane monooxygenase.
Topics: Coumarins; Fluorescence; Magnetic Resonance Spectroscopy; Methylosinus trichosporium; Oxidation-Reduction; Oxygenases; Solubility; Spectrometry, Fluorescence; Substrate Specificity; Time Factors; Umbelliferones | 2002 |
Superoxide organic chemistry within the liposomal bilayer, part II: a correlation between location and chemistry.
Topics: Binding Sites; Coumarins; Dimyristoylphosphatidylcholine; Free Radicals; Lipid Bilayers; Liposomes; Magnetic Resonance Spectroscopy; Molecular Structure; Superoxides | 2002 |
Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Baculoviridae; Cells, Cultured; Chlorzoxazone; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dextromethorphan; Diclofenac; DNA, Complementary; Ethanolamines; Gene Expression; Humans; Insecta; Isoenzymes; Mephenytoin; Midazolam; Nitrophenols; Pharmaceutical Preparations; Phenacetin; Rats; Substrate Specificity; Testosterone; Tumor Cells, Cultured | 2002 |
Design and synthesis of Mg2+-selective fluoroionophores based on a coumarin derivative and application for Mg2+ measurement in a living cell.
Topics: Animals; Coumarins; Ionophores; Magnesium; PC12 Cells; Rats; Spectrometry, Fluorescence | 2002 |
Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation.
Topics: Animals; Cosmetics; Coumarins; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxylation; In Vitro Techniques; Lung; Male; Mice; Microsomes; Microsomes, Liver; Rats; Rats, Inbred F344 | 2002 |
Prospective study of 36 patients with 46 popliteal artery aneurysms with non-surgical treatment.
Topics: Adult; Aged; Aged, 80 and over; Aneurysm; Coumarins; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Popliteal Artery; Prospective Studies; Thrombosis; Ultrasonography, Doppler, Color | 2002 |
Liquid photocurable biodegradable copolymers: in vivo degradation of photocured poly(epsilon-caprolactone-co-trimethylene carbonate).
Topics: Absorbable Implants; Animals; Biocompatible Materials; Biodegradation, Environmental; Coumarins; Lactones; Male; Microscopy, Electron, Scanning; Molecular Structure; Polyesters; Polymers; Rats; Rats, Wistar; Skin; Surface Properties; Ultraviolet Rays | 2002 |
Modifying rates of reductive elimination of leaving groups from indolequinone prodrugs: a key factor in controlling hypoxia-selective drug release.
Topics: Coumarins; Drug Delivery Systems; Humans; Hypoxia; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Oxygen; Prodrugs; Tumor Cells, Cultured | 2002 |
Antimicrobial activity of two novel coumarin derivatives: 3-cyanonaphtho[1,2-(e)] pyran-2-one and 3-cyanocoumarin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Candida albicans; Coumarins; Escherichia coli; Microbial Sensitivity Tests; Pyrones; Staphylococcus aureus | 2002 |
A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; DNA Primers; DNA, Neoplasm; Drug Combinations; Escherichia coli; Genotype; Humans; Kinetics; Middle Aged; Mixed Function Oxygenases; Mutagenesis, Site-Directed; Oxonic Acid; Polymerase Chain Reaction; Polymorphism, Genetic; Pyridines; Recombinant Proteins; Stomach Neoplasms; Tegafur; Transfection | 2002 |
Behavioral responses to plant toxins by two omnivorous lizard species.
Topics: Animals; Behavior, Animal; Coumarins; Lizards; Male; Plants, Toxic; Quinine; Saponins; Species Specificity; Taste; Tongue | 2002 |
Cytochrome P450 enzymes contributing to demethylation of maprotiline in man.
Topics: Cells, Cultured; Chlorzoxazone; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzymes; Humans; Ketoconazole; Kinetics; Maprotiline; Mephenytoin; Microsomes, Liver; Models, Biological; Quinidine; Sulfaphenazole; Theophylline | 2002 |
Electronic structure of coumarins.
Topics: Coumarins; Electrons; Models, Chemical; Spectrophotometry; Ultraviolet Rays | 2002 |
Near-membrane iminocoumarin-based low affinity fluorescent Ca(2+) indicators.
Topics: Animals; Benzimidazoles; Benzopyrans; Binding Sites; Calcium; Cell Membrane; Coumarins; Drosophila melanogaster; Embryo, Nonmammalian; Fluorescent Dyes; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Membrane Lipids; Microscopy, Fluorescence; Spectrum Analysis; Thiazoles | 2002 |
Effects of Melilotus officinalis on acute inflammation.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents; Citrulline; Coumarins; Hydrocortisone; Inflammation; Leukocyte Count; Male; Melilotus; Nitric Oxide; Phagocytosis; Phytotherapy; Plant Extracts; Plant Structures; Rabbits; Turpentine | 2002 |
Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
Topics: Acids; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Cell Line; Coumarins; Dogs; Enkephalin, Leucine-2-Alanine; Genes, MDR; Humans; Intestinal Mucosa; Mitochondrial Proteins; Multidrug Resistance-Associated Protein 2; Opioid Peptides; Permeability; Prodrugs; Ribosomal Proteins; Saccharomyces cerevisiae Proteins | 2002 |
A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics.
Topics: Acids; Animals; Caco-2 Cells; Cell Line; Coumarins; Dogs; Enkephalin, Leucine-2-Alanine; Enzyme Stability; Genes, MDR; Humans; Liver; Male; Mitochondrial Proteins; Multidrug Resistance-Associated Protein 2; Permeability; Prodrugs; Rats; Rats, Sprague-Dawley; Ribosomal Proteins; Saccharomyces cerevisiae Proteins | 2002 |
Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation.
Topics: Administration, Oral; Adult; Anticoagulants; Coumarins; Drug Administration Schedule; Female; Heart Valve Prosthesis; Heparin; Humans; Injections, Subcutaneous; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Retrospective Studies; Risk Factors; Thrombosis; Treatment Outcome | 2002 |
Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.
Topics: Amino Acid Sequence; Animals; Aryl Hydrocarbon Hydroxylases; Catalytic Domain; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Humans; Hydrogen Bonding; Mice; Mixed Function Oxygenases; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Quantitative Structure-Activity Relationship; Rats; Sequence Homology, Amino Acid; Species Specificity; Steroid Hydroxylases; Substrate Specificity; Thermodynamics | 2002 |
Functional role of cytochrome p-450 2a3 in N-nitrosomethylbenzylamine metabolism in rat esophagus.
Topics: Animals; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Biotransformation; Carcinogens; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dimethylnitrosamine; Esophagus; Lung; Male; Mixed Function Oxygenases; Organ Culture Techniques; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2002 |
Reversal of coumarin-induced over-anticoagulation.
Topics: Anticoagulants; Coumarins; Factor VIIa; Hemorrhage; Humans; Recombinant Proteins | 2002 |
Phenotypic polymorphism of CYP2A6 activity in a Chinese population.
Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; China; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP2A6; Female; Humans; Male; Mixed Function Oxygenases; Phenotype; Polymorphism, Genetic; Umbelliferones | 2002 |
Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.
Topics: Alleles; Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Southern; Cell Line; Chlorocebus aethiops; COS Cells; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Female; Genotype; Humans; Isoenzymes; Male; Mixed Function Oxygenases; Pedigree; Phenotype; Polymerase Chain Reaction; Recombination, Genetic; Sequence Analysis, DNA; Substrate Specificity | 2002 |
A new coumarin glucoside ester from Cichorium intybus.
Topics: Asteraceae; Benzopyrans; Coumarins; Glucosides; Humans; Phytotherapy; Plant Leaves | 2002 |
Hepatoprotective and free radical scavenging activities of prenylflavonoids, coumarin, and stilbene from Morus alba.
Topics: Biphenyl Compounds; Cell Line; Chemical and Drug Induced Liver Injury; Coumarins; Flavonoids; Free Radical Scavengers; Humans; Inhibitory Concentration 50; Morus; Phytotherapy; Picrates; Plant Extracts; Plant Structures; Stilbenes | 2002 |
Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative.
Topics: Adult; Coumarins; Humans; Labetalol; Male; Pharmaceutical Preparations; Spectrometry, Fluorescence | 2002 |
Coumarin-like fluorescent molecular rotors for bioactive polymers probing.
Topics: Cell Division; Cell Line; Coumarins; Endothelium; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Molecular Probes; Polymers; Polysaccharides | 2003 |
Comparative metabolism and kinetics of coumarin in mice and rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Autoradiography; Carcinogens; Coumarins; Diet; Dose-Response Relationship, Drug; Half-Life; Mice; Mice, Inbred Strains; Phenylacetates; Rats; Rats, Inbred F344; Species Specificity; Umbelliferones | 2003 |
Concentrations of nine alkenylbenzenes, coumarin, piperonal and pulegone in Indian bidi cigarette tobacco.
Topics: Allylbenzene Derivatives; Anisoles; Benzaldehydes; Benzodioxoles; Coumarins; Cyclohexane Monoterpenes; Eugenol; Flavoring Agents; Gas Chromatography-Mass Spectrometry; India; Monoterpenes; Nicotiana | 2003 |
Daphnetin methylation by a novel O-methyltransferase is associated with cold acclimation and photosystem II excitation pressure in rye.
Topics: Amino Acid Sequence; Base Sequence; Blotting, Northern; Caffeic Acids; Cell Division; Chromatography, Thin Layer; Cold Temperature; Coumaric Acids; Coumarins; DNA, Complementary; Gene Library; Lignin; Magnetic Resonance Spectroscopy; Mass Spectrometry; Methylation; Methyltransferases; Molecular Sequence Data; Photosynthetic Reaction Center Complex Proteins; Photosystem II Protein Complex; Phylogeny; Protons; Recombinant Proteins; Secale; Sequence Homology, Amino Acid; Spectrophotometry; Temperature; Ultraviolet Rays; Umbelliferones | 2003 |
Concomitant coumarin-NSAID therapy and risk for bleeding.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Cohort Studies; Coumarins; Drug Interactions; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Outpatients; Risk Factors; Surveys and Questionnaires | 2003 |
Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cross-Sectional Studies; Evidence-Based Medicine; Female; Humans; Logistic Models; Male; Middle Aged; Practice Patterns, Physicians'; Primary Health Care; Risk Assessment; Thromboembolism | 2003 |
CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6.
Topics: Animals; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Epoxy Compounds; Humans; Hydroxylation; Kinetics; Mice; Mixed Function Oxygenases; Steroid Hydroxylases | 2003 |
Effect of fusaric acid and phytoanticipins on growth of rhizobacteria and Fusarium oxysporum.
Topics: Bacillus; Bacteria; Cell Division; Coumarins; Culture Media; Fusaric Acid; Fusarium; Genistein; Oligopeptides; Pest Control, Biological; Phylogeny; Pigments, Biological; Plants; Pseudomonas; Pseudomonas fluorescens; Rhizobium; Soil Microbiology; Tomatine | 2002 |
European Concerted Action on Anticoagulation (ECAA). An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors.
Topics: Adult; Calibration; Coumarins; Europe; Freeze Drying; Humans; Point-of-Care Systems; Prothrombin Time; Quality Control; Reagent Strips; Reference Values; Reproducibility of Results | 2003 |
Zero-mode waveguides for single-molecule analysis at high concentrations.
Topics: Biochemistry; Computer Simulation; Coumarins; Deoxycytosine Nucleotides; Diffusion; DNA; DNA-Directed DNA Polymerase; Enzymes, Immobilized; Finite Element Analysis; Fluorescence; Fluorescent Dyes; Ligands; Light; Nanotechnology; Optics and Photonics; Spectrometry, Fluorescence | 2003 |
Permeabilization and in situ adsorption studies during growth and coumarin production in hairy root cultures of Cichorium intybus L.
Topics: Adsorption; Asteraceae; Coumarins; Culture Techniques; Permeability; Plant Roots | 2001 |
Chemical constituents from the Hydrangea chinensis.
Topics: Coumarins; Hydrangea; Plant Extracts; Plant Leaves; Plant Roots; Quinazolines | 2003 |
[Anticoagulation in patients with venous thromboembolism].
Topics: Anticoagulants; Bandages; Clinical Trials as Topic; Coumarins; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Injections, Subcutaneous; Outpatients; Pulmonary Embolism; Thrombectomy; Thrombocytopenia; Thrombolytic Therapy; Time Factors; Vena Cava Filters; Venous Thrombosis | 2003 |
[Sudden onset of unilateral right-sided symptoms. Unilateral venous infarct of the left thalamus in thrombosis of the internal cerebral veins].
Topics: Angiography, Digital Subtraction; Anticoagulants; Brain Infarction; Cerebral Veins; Coumarins; Female; Follow-Up Studies; Heparin; Humans; Intracranial Thrombosis; Magnetic Resonance Angiography; Middle Aged; Prognosis; Risk Factors; Thalamus; Time Factors; Tomography, X-Ray Computed | 2003 |
Influence of solvent and substituent on excited state characteristics of laser grade coumarin dyes.
Topics: Coloring Agents; Coumarins; Light; Models, Chemical; Solvents; Spectrophotometry | 2003 |
Photophysics and spectroscopic properties of 3-benzoxazol-2-yl-chromen-2-one.
Topics: Benzoxazoles; Chromones; Coumarins; Models, Chemical; Physics; Spectrophotometry; Thermodynamics; Ultraviolet Rays | 2003 |
Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo.
Topics: Chemistry, Clinical; Chromatography, High Pressure Liquid; Coumarins; Ether; Humans; Hydrogen-Ion Concentration; Models, Chemical; Sulfonamides; Sulfonic Acids; Temperature; Time Factors | 2003 |
Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate.
Topics: 2-Methoxyestradiol; Animals; Arylsulfatases; Cell Division; Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Female; Humans; Inhibitory Concentration 50; Microsomes; Models, Chemical; Placenta; Rats; Rats, Wistar; Steryl-Sulfatase; Sulfonamides; Sulfonic Acids; Time Factors; Tumor Cells, Cultured | 2003 |
A coumarin derivative covalently immobilized on sensing membrane as a fluorescent carrier for nitrofurazone.
Topics: Coumarins; Fluorescent Dyes; Hydrogen-Ion Concentration; Membranes, Artificial; Nitrofurazone; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2003 |
Coumarin inhibits the growth of carrot (Daucus carota L. cv. Saint Valery) cells in suspension culture.
Topics: 2,4-Dichlorophenoxyacetic Acid; Amino Acids; Cell Division; Cells, Cultured; Coumarins; Daucus carota; Enzymes; Fructose; Glucose; Indoleacetic Acids; Plant Growth Regulators; Plant Proteins; Sucrose | 2003 |
Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory/antioxidant agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chromatography, Thin Layer; Coumarins; Drug Evaluation, Preclinical; Rats; Rats, Inbred F344 | 2003 |
European Concerted Action on Anticoagulation (ECAA): an assessment of a method for ISI calibration of two whole blood point-of-care PT monitor systems based on lyophilized plasmas using whole blood equivalent PT.
Topics: Blood Preservation; Calibration; Coumarins; Freeze Drying; Humans; International Normalized Ratio; Monitoring, Physiologic; Point-of-Care Systems; Prothrombin Time; Reference Standards | 2003 |
Application of capillary electrophoresis with pH-mediated sample stacking to analysis of coumarin metabolites in microsomal incubations.
Topics: Animals; Coumarins; Electrophoresis, Capillary; Haplorhini; Hydrogen-Ion Concentration; Male; Microsomes; Technology, Pharmaceutical | 2003 |
Enantioselectivity of alcohol-modified polymeric surfactants in micellar electrokinetic chromatography.
Topics: Alcohols; Benzoin; Chromatography, Micellar Electrokinetic Capillary; Coumarins; Micelles; Particle Size; Polymers; Stereoisomerism; Surface-Active Agents | 2003 |
Asymptomatic excessive coumarin anticoagulation is a risk factor for thrombotic and bleeding complications of oral anticoagulant therapy.
Topics: Administration, Oral; Anticoagulants; Coumarins; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Risk; Thrombosis; Time Factors; Vitamin K 1; Warfarin | 2003 |
Diversity of selective environmental substrates for human cytochrome P450 2A6: alkoxyethers, nicotine, coumarin, N-nitrosodiethylamine, and N-nitrosobenzylmethylamine.
Topics: Adult; Antibodies, Blocking; Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Coumarins; Cytochrome P-450 CYP2A6; Diethylnitrosamine; Dimethylnitrosamine; Environmental Pollutants; Enzyme Inhibitors; Ethers; Female; Humans; In Vitro Techniques; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Nicotine; Substrate Specificity | 2003 |
Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cotinine; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Haplorhini; Humans; In Vitro Techniques; Menthol; Microsomes, Liver; Mixed Function Oxygenases; Nicotine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Smoking; Stereoisomerism; Steroid Hydroxylases | 2003 |
Liquid chromatographic determination of the glutathione conjugate and ring-opened metabolites formed from coumarin epoxidation.
Topics: Animals; Chromatography, High Pressure Liquid; Coumarins; Epoxy Compounds; Glutathione; Magnetic Resonance Spectroscopy; Male; Microsomes, Liver; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2003 |
Molecular docking of substrates and inhibitors in the catalytic site of CYP6B1, an insect cytochrome p450 monooxygenase.
Topics: 5-Methoxypsoralen; Amino Acid Substitution; Animals; Aryl Hydrocarbon Hydroxylases; Catalytic Domain; Computer Simulation; Coumarins; Furocoumarins; Insect Proteins; Methoxsalen; Models, Molecular; Pilocarpine; Protein Binding; Structural Homology, Protein | 2003 |
Vitamin K control of the increased hypoprothrombinemic effect of dicumarol in congestive heart failure.
Topics: Coumarins; Dicumarol; Heart Failure; Humans; Sexually Transmitted Diseases; Vitamin K | 1952 |
Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
Topics: Anticoagulants; Antifibrinolytic Agents; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hemostatics; Heparin Antagonists; Humans; Naphthoquinones; Phenindione; Prothrombin; Vitamin K | 1952 |
A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
Topics: American Heart Association; Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate; Thromboembolism; United States | 1952 |
[Derivatives of hydroxy-4-coumarin inhibiting plant germination and growth].
Topics: Coumarins; Germination; Physiological Phenomena; Plants | 1952 |
[Control of anticoagulant effect of (bis-(4-oxycumarinyl)-3,3')-ethyl ester of acetic acid by determination of factor VII].
Topics: Acetates; Acetic Acid; Anticoagulants; Coumarins; Esters; Factor VII | 1952 |
[Hazards in pelentan therapy].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
[Cutaneous hemorrhage and necrosis after dicumol or dicumacyl administration in thrombosis].
Topics: Coumarins; Drug Eruptions; Necrosis; Thrombosis | 1952 |
[Tromexane derivatives in the mother milk; paradox effects on prothrombin].
Topics: Coumarins; Hemostatics; Milk, Human; Mothers; Prothrombin | 1952 |
[Four oxycumarine].
Topics: Coumarins | 1952 |
Further pharmacologic aspects of tromexan (pelantan or ethyl biscumacetate).
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
Influence of anticoagulant administration on the rate of recanalization of experimentally thrombosed veins.
Topics: Anticoagulants; Coumarins; Thrombosis; Venous Thrombosis | 1952 |
[Therapy of fresh myocardial infarction with anticoagulants].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Myocardial Infarction | 1952 |
[Chronic intoxication with dicumarol; histopathological studies in rat].
Topics: Animals; Coumarins; Dicumarol; Rats | 1952 |
Further experience with coumarin anticoagulants.
Topics: Anticoagulants; Coumarins; Humans | 1952 |
[Anticoagulant therapy of myocardial infarct; in vitro heparin tolerance test].
Topics: Anticoagulants; Coumarins; Heparin; Humans; In Vitro Techniques; Myocardial Infarction | 1952 |
[Indications and results of anticoagulant therapy in severe angina pectoris; 40 cases].
Topics: Angina Pectoris; Anticoagulants; Coumarins; Humans | 1952 |
[Complications of anticoagulant therapy; study of 450 patients].
Topics: Anticoagulants; Coumarins; Humans | 1952 |
[Anticoagulant therapy in venous thromboses].
Topics: Anticoagulants; Coumarins; Heparin; Thrombosis; Venous Thrombosis | 1952 |
The anticoagulants, a brief review.
Topics: Anticoagulants; Coumarins; Heparin | 1951 |
[Clinical studies on surgical thrombosis and embolism].
Topics: Anticoagulants; Biomedical Research; Coumarins; Embolism; Humans; Thrombosis | 1951 |
The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan.
Topics: Antifibrinolytic Agents; Coumarins; Ethyl Biscoumacetate; Hemostatics; Humans; Hypoprothrombinemias; Injections, Intravenous; Retinoids; Vitamin K; Vitamin K 1 | 1953 |
[Tromexan therapy of thrombophlebitis].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis | 1952 |
[Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1].
Topics: Antifibrinolytic Agents; Coumarins; Dicumarol; Hemostatics; Humans; Hypoprothrombinemias; Naphthoquinones; Prothrombin; Retinoids; Vitamin K; Vitamin K 1; Vitamin K 2 | 1952 |
[Comparative study on the effect of heparin and dicoumarin].
Topics: Coumarins; Dicumarol; Heparin | 1952 |
Indications for dicumarol in acute myocardial infarction.
Topics: Acute Disease; Anterior Wall Myocardial Infarction; Cardiovascular Diseases; Coumarins; Dicumarol; Myocardial Infarction | 1951 |
[Control of ascending thromboses following Moskowicz's varicose veins operation].
Topics: Anticoagulants; Coumarins; Humans; Thrombosis; Varicose Veins | 1952 |
Heparin and dicumarol in severe dysmenorrhoea; with special reference to the occurrence of intravasal aggregation of erythrocytes.
Topics: Coumarins; Dicumarol; Dysmenorrhea; Erythrocytes; Female; Heparin; Humans | 1952 |
[Studies on the furocoumarin derivatives].
Topics: Coumarins; Furans; Furocoumarins | 1952 |
[Vitamin K as an antidote to decumarol?].
Topics: Antidotes; Antifibrinolytic Agents; Coumarins; Hemostatics; Humans; Prothrombin; Vitamin K | 1952 |
The method of administering dicoumarol.
Topics: Coumarins; Dicumarol | 1953 |
[Experience with the treatment of thrombophlebitis with simultaneous application of pelentan and vitamin E].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis; Vitamin E | 1952 |
[Recent progress in anticoagulant therapy of thromboembolism].
Topics: Anticoagulants; Blood Coagulation; Coumarins; Heparin; Humans; Thromboembolism | 1952 |
[Hemorrhagic disease caused by dicumarol poisoning].
Topics: Coumarins; Dicumarol; Humans | 1952 |
The treatment of thrombophlebitis.
Topics: Coumarins; Heparin; Humans; Minnesota; Thrombophlebitis | 1952 |
[Subcutaneous hemorrhage with necrosis caused by dicumarol].
Topics: Coumarins; Dicumarol; Necrosis | 1952 |
[Experiences with pelentan therapy of acute rheumatism in adults].
Topics: Adult; Coumarins; Ethyl Biscoumacetate; Humans; Rheumatic Diseases; Rheumatic Heart Disease | 1952 |
[Progress in management of dicumarol therapy; simplification of control; vitamin KI as antidote].
Topics: Antidotes; Antifibrinolytic Agents; Coumarins; Dicumarol; Heparin Antagonists; Naphthoquinones; Prothrombin; Retinoids; Vitamin K; Vitamins | 1952 |
Hazards and pitfalls of anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Heparin | 1953 |
Myocardial infarction; comparison of results following use of dicumarol and dicumarol with heparin in the acute stage.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Heparin; Myocardial Infarction | 1953 |
The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
Topics: Coumarins; Ethyl Biscoumacetate; Regression Analysis | 1952 |
[Cutaneous gangrene of the lower limbs].
Topics: Coumarins; Gangrene; Humans; Leg; Lower Extremity | 1952 |
[Anticoagulant therapy of venous thrombosis].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Thrombosis; Venous Thrombosis | 1952 |
[Prolonged anticoagulant therapy; procedure, problems and results].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins | 1952 |
[Effect of dicumarol derivatives on flicker fusion frequency in cardiovascular patients].
Topics: Cardiovascular Diseases; Cardiovascular System; Coumarins; Diagnostic Techniques, Cardiovascular; Dicumarol; Flicker Fusion; Vision, Ocular | 1952 |
Anticoagulant therapy in acute arterial thrombosis.
Topics: Anticoagulants; Coumarins; Heparin; Humans; Thrombosis | 1953 |
[Dicumarol treatment in general practice].
Topics: Coumarins; Dicumarol; Family Practice; General Practice; Hemostatics; Prothrombin | 1952 |
[Dicumarol therapy of disseminated sclerosis].
Topics: Coumarins; Dicumarol; Humans; Multiple Sclerosis | 1952 |
[On the effect of dicumarol on capillary permeability].
Topics: Capillary Permeability; Coumarins; Dicumarol | 1951 |
The identification of coumarins and related compounds by filter-paper chromatography.
Topics: Chromatography; Chromatography, Paper; Coumarins | 1953 |
Effect of dicoumarol on the ascorbic acid content of the liver and adrenal glands.
Topics: Adrenal Glands; Ascorbic Acid; Carbohydrate Metabolism; Coumarins; Dicumarol; Liver | 1953 |
Recanalization of thrombosed arteries under anticoagulant therapy.
Topics: Anticoagulants; Arteries; Coumarins; Disease; Femoral Artery; Humans; Thrombosis | 1953 |
[Studies on anticoagulants; pelentan metabolites in human and rabbit urine].
Topics: Animals; Anticoagulants; Body Fluids; Coumarins; Ethyl Biscoumacetate; Rabbits | 1952 |
The comparative effects of menadione sodium bisulfite and vitamin K1 on the hypoprothrombinemia induced by dicumarol.
Topics: Antifibrinolytic Agents; Coumarins; Dicumarol; Hemorrhagic Disorders; Heparin Antagonists; Hypoprothrombinemias; Naphthoquinones; Vitamin K; Vitamin K 1; Vitamin K 3 | 1953 |
[Application of dicoumarin in myocardial infarctions and in thromboses of peripheral vessels].
Topics: Coumarins; Dicumarol; Humans; Myocardial Infarction; Thrombosis | 1953 |
Mode of action of tromexan.
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate | 1953 |
[Anticoagulants in the prevention and treatment of postoperative venous complications].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Phlebitis; Postoperative Complications; Thrombosis; Veins | 1953 |
Influence of long-term bishydroxycoumarin (dicumarol) therapy on liver function.
Topics: Coumarins; Dicumarol; Digestion; Leadership; Liver | 1953 |
[Variations in fibrinogenemia, prothrombin time and liquoid coagulation time during treatment with anticoagulants].
Topics: Anticoagulants; Blood Coagulation Tests; Coagulants; Coumarins; Extracellular Space; Fibrinogen; Hemostatics; Heparin; Humans; Polyanetholesulfonate; Prothrombin Time | 1952 |
[Preventive therapy of postoperative phlebitis].
Topics: Biomedical Research; Coumarins; Humans; Phlebitis; Postoperative Period | 1952 |
[Real or apparent value of tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
[Experiences in postoperative lung infarctions].
Topics: Coumarins; Humans; Infarction; Lung; Pulmonary Infarction | 1953 |
[Prophylaxis and therapy of thromboembolism].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Humans; Thromboembolism | 1953 |
[The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Ethyl Biscoumacetate; Myocardial Infarction | 1952 |
Ethyl biscoumacetate (tromexan) in coronary artery disease.
Topics: Coronary Artery Disease; Coronary Disease; Coumarins; Diuretics; Ethyl Biscoumacetate; Humans | 1953 |
[Heparin and dicoumarol in anticoagulant therapy].
Topics: Anticoagulants; Coumarins; Dicumarol; Heparin | 1952 |
Coumarin anticoagulant agents.
Topics: Anticoagulants; Coumarins; Humans | 1952 |
A study of the sedimentation rate in cases of myocardial infarction under dicumarol therapy.
Topics: Blood Sedimentation; Cardiovascular Diseases; Coumarins; Dicumarol; Hematologic Tests; Myocardial Infarction | 1952 |
[A case of dicumarol poisoning].
Topics: Blood Transfusion; Coumarins; Dicumarol | 1953 |
The effect of splenectomy on the action of dicumarol; an experimental study, with case report.
Topics: Coumarins; Dicumarol; Prothrombin Time; Spleen; Splenectomy | 1953 |
Clinical and experimental studies with 8-methoxypsoralen in vitiligo.
Topics: Coumarins; Humans; Methoxsalen; Ultraviolet Rays; Ultraviolet Therapy; Vitiligo | 1953 |
The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
Topics: Animals; Biotransformation; Coumarins; Dogs; Ethyl Biscoumacetate; Rabbits | 1953 |
[Dicumarol intoxication, its prevention and therapy].
Topics: Biomedical Research; Coumarins; Dicumarol | 1953 |
[Dicumarol therapy of migrating thrombosis].
Topics: Coumarins; Dicumarol; Thrombophlebitis; Thrombosis | 1953 |
[Treatment of venous thrombosis with dicoumarol ethyl acetate regulated daily according to Quick's control time and plasma clotting-time in the presence of one unit of heparin].
Topics: Acetates; Blood Coagulation Tests; Coumarins; Dicumarol; Heparin; Humans; Thrombophlebitis; Venous Thrombosis | 1953 |
[Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Gynecology; Heparin; Obstetrics; Thromboembolism; Thrombosis | 1953 |
The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
Topics: Blood Coagulation; Coagulase; Coumarins; Dicumarol; Phenindione; Prothrombin; Prothrombin Time | 1953 |
The control of prothrombin activity with tromexan therapy.
Topics: Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Hematologic Tests; Prothrombin; Prothrombin Time; Psychotherapy | 1953 |
Clinical evaluation of ethyl biscoumacetate (tromexan).
Topics: Coumarins; Ethyl Biscoumacetate | 1953 |
[Comparison of the effects of coumarins and benzoxazolones on the central nervous system].
Topics: Benzoxazoles; Central Nervous System; Coumarins; Humans | 1953 |
[Modification of the arterial pressure of the retina in venous thrombosis of the central retinal vein during anticoagulant therapy].
Topics: Anticoagulants; Arterial Pressure; Coumarins; Retina; Retinal Vein; Venous Thrombosis | 1953 |
Effect of phenylindanedione and dicumarol in experimental frostbite.
Topics: Coumarins; Dicumarol; Frostbite; Phenindione | 1953 |
[Coagulating activity of blood serum and problem of anticogulant therapy].
Topics: Blood Coagulation; Coumarins; Humans; Serum | 1953 |
Hemopericardium with tamponade during anticoagulant therapy of myocardial infarct; report of a case with recovery following pericardiotomy.
Topics: Anticoagulants; Coumarins; Hemorrhage; Myocardial Infarction; Pericardial Effusion; Pericardiectomy; Pericardium; Physiological Phenomena | 1953 |
[Indications in anticoagulant treatment].
Topics: Anticoagulants; Coumarins; Heparin; Humans | 1953 |
[Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
Topics: 4-Hydroxycoumarins; Coumarins; Ethyl Biscoumacetate; Female; Gynecology; Humans; Obstetrics; Thrombophlebitis; Venous Thrombosis | 1953 |
Organic rodenticides.
Topics: Animals; Coumarins; Fluoroacetates; Rodentia; Rodenticides | 1953 |
[Clinical significance of factor VII].
Topics: Blood Coagulation; Coumarins; Factor VII; Hemostatics; Heparin Antagonists; Humans; Infant, Newborn; Liver; Liver Diseases; Pregnancy; Thromboembolism; Vitamin K | 1953 |
Use of bishydroxycoumarin (dicumarol) for prevention of postoperative thromboembolism; a study of twenty-seven hundred consecutive surgical patients.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Patients; Postoperative Care; Postoperative Period; Thromboembolism | 1953 |
Warfarin sodium derivative: (coumadin sodium); an intravenous hypoprothrombinemia-inducing agent.
Topics: Coumarins; Humans; Hypoprothrombinemias; Prothrombin Time; Sodium; Warfarin | 1953 |
[The possible tautomeric forms of 4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Coumarins | 1953 |
[A new assymetrical vitamin K antagonist: 3-(alpha-naphthyl)-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Vitamin K | 1953 |
[Antivitamin K action of alpha-naphthyl-3-hydroxy-4-coumarin].
Topics: Coumarins | 1953 |
[A new possibility of tromexan detection in the milk].
Topics: Animals; Breast; Coumarins; Dairy Products; Ethyl Biscoumacetate; Milk | 1953 |
Dicumarol and myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Myocardial Infarction | 1953 |
The toxicity of 3-(acetonylbenzyl)-4-hydroxy-coumarin (warfarin) to laboratory animals.
Topics: Animals; Animals, Laboratory; Coumarins; Warfarin | 1953 |
Studies in intravascular coagulation. II. A comparison of the effect of dicumarol and heparin on clot formation in isolated venous segments.
Topics: Blood Coagulation; Coumarins; Dicumarol; Heparin; Humans; Veins | 1953 |
[Dicoumarin test in liver function test].
Topics: Coumarins; Dicumarol; Humans; Liver Function Tests | 1953 |
[The nitrification of 4-hydroxycoumarin; study on the synthesis of terramycin-like substances].
Topics: 4-Hydroxycoumarins; Coumarins; Nitrification; Oxytetracycline | 1953 |
Observations on the development of circulation in skin grafts. V. Effect of an anticoagulant (dicumarol) on homologous skin grafts.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Skin; Skin Transplantation | 1953 |
[Anticoagulants in cardiovascular diseases].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Embolism; Heparin; Thrombosis | 1953 |
[The use of tromexan in thrombophlebitis; two years of experience in the Clinique de la Source, in Lausanne].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis | 1953 |
[Therapy of myocardial infarct].
Topics: Adenosine Triphosphate; Ascorbic Acid; Bile Acids and Salts; Coumarins; Diet; Folic Acid; Heparin; Humans; Hypnotics and Sedatives; Khellin; Magnesium Sulfate; Myocardial Infarction; Purines; Quinidine; Salts; Sympathomimetics; Vitamin B Complex; Vitamin E; Vitamins | 1953 |
[Rapid cicatrization of an atonic wound after treatment with tromexan].
Topics: Cicatrix; Coumarins; Ethyl Biscoumacetate; Humans; Wounds and Injuries | 1953 |
[Experimental research on the anticoagulant marcoumar (3-(1-phenyl-propyl)-4-hydroxy-coumarin) and its antagonist konakion (synthetic vitamin K1)].
Topics: Anticoagulants; Capillaries; Cardiovascular System; Coumarins; Phenprocoumon; Prothrombin Time; Vitamin K 1 | 1953 |
[A new highly active anticoagulant with prolonged effect (marcoumar)].
Topics: Anticoagulants; Coumarins; Heparin Antagonists; Humans; Infarction; Lung; Myocardial Infarction; Phenprocoumon; Pulmonary Infarction; Thrombosis; Vitamin K | 1953 |
Susceptibility of Rattus hawaiiensis Stone to warfarin.
Topics: Coumarins; Rats; Warfarin | 1953 |
[Prolonged dicumarol therapy of coronary thrombosis and other thromboembolic diseases].
Topics: Coronary Thrombosis; Coumarins; Dicumarol; Thromboembolism | 1953 |
[Heparin tolerance test and prothrombin time in the control of anticoagulant therapy of coronary infarction].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Infarction; Myocardial Infarction; Prothrombin Time | 1953 |
Further investigations on getting patients up from bed early and on dicumarol treatment as a prophylactic for post-operative thrombosis.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Postoperative Care; Postoperative Period; Thrombosis | 1953 |
Comparison of the anticoagulant action of 3-(alpha-p-chlorphenyl-beta-acetylethyl)-4-hydroxycoumarin (coumachlor) and dicoumarol in chicks and rats.
Topics: 4-Hydroxycoumarins; Animals; Anticoagulants; Chickens; Coumarins; Dicumarol; Rats | 1953 |
[Clinical experiences with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1953 |
[A new anticoagulant, tromexan; its action in health and disease and the interference of other medicinals].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Health | 1953 |
[Dicumarol therapy in pregnancy; an animal-experimental contribution].
Topics: Animals; Child; Coumarins; Dicumarol; Female; Fetus; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Pregnancy; Pregnancy Complications; Thrombophlebitis | 1953 |
[Coumarin in practice].
Topics: Coumarins | 1953 |
Hemorrhage due to self-medication with bishydroxycoumarin.
Topics: Coumarins; Dicumarol; Hemorrhage; Self Medication | 1953 |
[The hazards of dicumarin therapy during lactation].
Topics: Breast Feeding; Coumarins; Female; Humans; Lactation | 1953 |
[The dicoumarin problem].
Topics: Coumarins; Dicumarol | 1953 |
[Puerperal thrombosis, treatment with tromexan, control of prothrombin activity according to Pedrazzini, Salvidio and F. Koller].
Topics: Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Female; Humans; Postpartum Period; Prothrombin; Prothrombin Time; Thrombosis; Vascular Diseases | 1953 |
[Anticoagulant therapy with tromexan].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate | 1953 |
Experience with a new intravenous coumarin anticoagulant (warfarin, sodium derivative).
Topics: Anticoagulants; Coumarins; Sodium; Sodium, Dietary; Thromboembolism; Warfarin | 1953 |
Experiences with the long range use of anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Myocardial Infarction; Thromboembolism | 1953 |
Dilution curves and accuracy in prothrombin estimations during hepatitis and dicumarol therapy.
Topics: Coumarins; Dicumarol; Hemostatics; Hepatitis; Prothrombin; Prothrombin Time | 1953 |
[Dicoumarin therapy of myocardial infarct].
Topics: Coumarins; Dicumarol; Myocardial Infarction | 1953 |
[Pelentan therapy of thrombophlebitis].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombophlebitis | 1953 |
Coumarin in chromosome analysis.
Topics: Chromosomes; Coumarins; Humans | 1953 |
[A case of chronically recurrent myocarditis in periphlebitic focal infection and its treatment with anticoagulants].
Topics: Anticoagulants; Coumarins; Focal Infection; Humans; Myocarditis; Thrombophlebitis | 1953 |
Acute abdominal condition due to bishydroxycoumarin (dicumarol) poisoning.
Topics: Abdomen; Acute Disease; Coumarins; Dicumarol; Gastrointestinal Diseases; Hemorrhage | 1953 |
Long term dicumarol therapy in thromboembolic conditions, especially coronary thrombosis.
Topics: Coronary Disease; Coronary Thrombosis; Coumarins; Dicumarol; Embolism; Thromboembolism | 1953 |
[Marcumar, 3-1-phenylpropyl-4-oxy-coumarin, a new superdicumarol].
Topics: Coumarins; Phenprocoumon | 1953 |
[Toxicological data on anticoagulant rat poisons].
Topics: Animals; Anticoagulants; Coumarins; Poisons; Rats | 1953 |
[Clinical experiences with a new and very effective dicumarol derivative].
Topics: Coumarins; Dicumarol | 1953 |
[Possibilities of rectal dicumarol therapy].
Topics: Coumarins; Dicumarol; Sulfanilamide; Sulfanilamides | 1953 |
[New data in the treatment of chronic cor pulmonae].
Topics: Citrates; Coumarins; Heparin; Pulmonary Heart Disease | 1953 |
[Deratization by fixed or semi-fixed posts with anticoagulant derivatives of coumarin].
Topics: Anticoagulants; Coumarins; Rats | 1953 |
[A strange accident due to anticoagulant medication].
Topics: Accidents; Anticoagulants; Coumarins; Hematoma; Hemorrhage; Humans; Myocardial Infarction; Thigh | 1953 |
[Treatment of venous thrombosis].
Topics: Coumarins; Heparin; Thrombophlebitis; Venous Thrombosis | 1953 |
[Experimental contribution on the toxicity of the ethyl ester of 4,4'-dihydroxycoumarinylacetic acid].
Topics: Coumarins; Esters | 1953 |
[Experimental contribution on the effect of massive doses of the ethyl ester on the humoral factors of blood coagulation of 4,4'-dihydroxycoumarinylacetic acid].
Topics: Blood Coagulation; Coumarins; Esters | 1953 |
[Experimental studies on the effect of massive doses of the ethyl ester of 4,4'-dihydroxycoumarinylacetic acid on the thromboplastic activity of various organs].
Topics: Brain; Coumarins; Esters; Lung | 1953 |
[Blood coagulation and liver function. II. Tromexan as liver function test].
Topics: Blood Coagulation; Coumarins; Digestion; Ethyl Biscoumacetate; Liver; Liver Function Tests | 1953 |
Dicumarol therapy in the treatment of status angina and impending coronary thrombosis.
Topics: Angina Pectoris; Coronary Disease; Coronary Thrombosis; Coumarins; Dicumarol | 1953 |
[Clinical contribution to the prophylaxis and therapy of thrombophlebitis by the use of an new anticoagulant].
Topics: Anticoagulants; Coumarins; Female; Humans; Thrombophlebitis | 1953 |
[The antagonistic effect of K-vitamins in poisoning with rodenticides of the 4-hydroxycoumarin type].
Topics: 4-Hydroxycoumarins; Antifibrinolytic Agents; Coumarins; Heparin Antagonists; Humans; Naphthoquinones; Retinoids; Rodenticides; Vitamin K; Vitamins | 1953 |
Anticoagulant activity of a series of 2,2-bis(4-hydroxycoumarinyl-3)-ethanol ethers.
Topics: Anesthetics, General; Anticoagulants; Coumarins; Ethanol; Ethers | 1953 |
[Relation of pelentan to vitamin K].
Topics: Coumarins; Ethyl Biscoumacetate; Vitamin K | 1953 |
Acute mesenteric venous occlusion, etiology unknown; case report.
Topics: Coumarins; Heparin; Humans; Mesentery; Thrombosis; Vascular Diseases; Veins | 1954 |
Pulmonary embolus following tonsillectomy; report of a case.
Topics: Coumarins; Femoral Vein; Heparin; Humans; Pulmonary Embolism; Thrombosis; Tonsillectomy | 1953 |
[Physiological principles of heparin and dicoumarin].
Topics: Coumarins; Dicumarol; Heparin | 1953 |
[Therapy of venous thromboses of the lower extremities; some aspects of a new method].
Topics: Coumarins; Humans; Lower Extremity; Thrombosis; Venous Thrombosis | 1953 |
[Extermination of rats by anticoagulant substances].
Topics: Anticoagulants; Coumarins; Rats | 1953 |
[Death following ambulant dicumarol therapy].
Topics: Cerebral Hemorrhage; Coumarins; Death; Dicumarol; Exercise Therapy; Humans; Jurisprudence | 1953 |
[Vitamin E versus coumarin and heparin therapy of thrombosis].
Topics: Anticoagulants; Coumarins; Heparin; Thrombosis; Vitamin E | 1953 |
[Note on the condensation product between 4-hydroxycoumarin and thionylchloride].
Topics: 4-Hydroxycoumarins; Chlorides; Coumarins; Humans | 1953 |
[Optimum accomplishment of anticoagulant measures].
Topics: Anticoagulants; Coumarins; Humans | 1953 |
[Effect of significance of combination of a rare element with dicoumarins].
Topics: Coumarins; Dicumarol; Elements; Isomerism; Niacin; Nicotinic Acids | 1953 |
[Relation of chemical structure to anticholinesterasic activity of a group of selective inhibiting substances of globular acetylcholinesterase in dog].
Topics: Acetylcholinesterase; Animals; Biphenyl Compounds; Cholinesterase Inhibitors; Coumarins; Dogs | 1953 |
[Biological and clinical characteristics of a new anticoagulant of the dicumarol tupe: 3-(1-phenylpropyl)-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Dicumarol | 1953 |
[Effects of anticoagulants in blood proteins].
Topics: Anticoagulants; Blood Proteins; Coumarins; Heparin; Humans | 1953 |
[Constitutional specific effect of vitamin K1 and its analogs against coumarin compounds].
Topics: Coumarins; Fibrinolytic Agents; Humans; Vitamin K; Vitamin K 1 | 1953 |
[The antithrombotic significance of a new coumaria derivative, marcoumar].
Topics: Coumarins; Phenprocoumon | 1953 |
[Vitamin K1 as an antidote of dicumarol drugs; clinical observations].
Topics: Antidotes; Coumarins; Dicumarol; Female; Hemostatics; Humans; Vitamin K; Vitamin K 1 | 1953 |
[Treatment of myocardial infarct with anticoagulants].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Myocardial Infarction | 1953 |
[Anticoagulant therapy and its indications in cardiovascular diseases].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin | 1953 |
[Studies on the effect of phenyl-indandione and of ethyl ester of dicoumarin on the blood with special reference to modifications of proconvertinemia and to utilization of prothrombin].
Topics: Blood Coagulation; Coumarins; Dicumarol; Esters; Hemostatics; Humans; Phenindione; Prothrombin | 1953 |
[Therapy of myocardial infarct with dicumarin].
Topics: Coumarins; Myocardial Infarction | 1953 |
[Observations on the therapeutic use of pelentan in cardiovascular diseases].
Topics: Cardiovascular Diseases; Coumarins; Ethyl Biscoumacetate | 1953 |
Long term dicumarol therapy in cardio-vascular diseases.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Heart; Vascular Diseases | 1953 |
Hemorrhage following excessive dosage of dicumarol.
Topics: Coumarins; Dicumarol; Hematoma; Hemorrhage; Humans; Mouth; Oral Hemorrhage | 1953 |
Ultraviolet absorption spectra of coumarin derivatives.
Topics: Coumarins; Spectrum Analysis | 1954 |
[Thrombophlebitis prophylaxis].
Topics: Biomedical Research; Coumarins; Plants; Thrombophlebitis | 1953 |
[A new synthetic anticoagulant: 3-(l'fenyl-propyl)-4-idroxycoumarin].
Topics: Anticoagulants; Coumarins | 1953 |
[The secretion of drugs, especially 3,3' carboxymethylene bis (4-hydroxycoumarin) ethyl ester, tromexan, in human milk].
Topics: 4-Hydroxycoumarins; Coumarins; Esters; Ethyl Biscoumacetate; Hemostatics; Humans; Infant; Infant Nutritional Physiological Phenomena; Milk, Human; Prothrombin | 1954 |
[First results in the treatment of vitiligo with meladinin].
Topics: Coumarins; Vitiligo | 1953 |
Hedulin (phenindione), a new anticoagulant; a comparison of the anticoagulant action of Hedulin and combinations of Hedulin and Dicumarol.
Topics: Anticoagulants; Coumarins; Dicumarol; Phenindione | 1954 |
Vitamin K as antagonist to anticoagulants; the effect of synthetic vitamin K (menadione) and vitamin K1 in hypoprothrombinemia induced by dicoumarol, tromexan and phenylindanedione.
Topics: Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hemostatics; Humans; Hypoprothrombinemias; Phenindione; Prothrombin; Vitamin K; Vitamin K 1; Vitamin K 3 | 1953 |
A ten year analysis of thromboembolism and dicumarol prophylaxis.
Topics: Coumarins; Dicumarol; Thromboembolism | 1954 |
[Recently introduced anticoagulants].
Topics: Anticoagulants; Coumarins; Humans; Phenindione | 1954 |
[Antagonistic effect of vitamin K on anticoagulants].
Topics: Anticoagulants; Antifibrinolytic Agents; Coumarins; Humans; Phenindione; Vitamin K | 1954 |
Heparin and ethyl biscoum-acetate in prevention of experimental venous thrombosis.
Topics: Acetates; Coumarins; Heparin; Humans; Thrombosis; Venous Thrombosis | 1954 |
[Treatment with coumarin preparations].
Topics: Coumarins; Humans | 1954 |
[Prophylaxis and therapy of thrombosis with dicumarol].
Topics: Coumarins; Dicumarol; Thrombosis | 1953 |
[Anticoagulant therapy with preparations having prolonged dicoumarin action such as 3-(1 phenylpropyl)-4-hydroxycoumarin; antidote effect of synthetic vitamin K1].
Topics: 4-Hydroxycoumarins; Anticoagulants; Antidotes; Antifibrinolytic Agents; Coumarins; Dicumarol; Hemostatics; Vitamin K; Vitamin K 1 | 1954 |
The growth inhibiting properties of lactones.
Topics: Acids; Coumarins; Growth; Lactones | 1954 |
[Clinical study of the anticoagulant 3-(1-phenylpropyl)-4-hydroxycoumarin or marcoumar and of its antidote, vitamin K1].
Topics: 4-Hydroxycoumarins; Anticoagulants; Antidotes; Coumarins; Female; Hemostatics; Humans; Phenprocoumon; Prothrombin Time; Thrombophlebitis; Vitamin K; Vitamin K 1 | 1954 |
[Reports on clinical experiments with a new coumarin derivative (marcoumar)].
Topics: Coumarins; Humans; Phenprocoumon | 1954 |
Studies on the constituents of orange oil. I. On the structure of auraptene.
Topics: Citrus; Coumarins; Fruit; Oils; Plant Oils | 1953 |
[Tromexan; its effect on normal subjects and in certain pathological states].
Topics: Coumarins; Ethyl Biscoumacetate | 1954 |
[Arteritis nodosa; findings in a case].
Topics: Coumarins; Disease; Humans; Muscles; Muscular Diseases; Myocardial Infarction; Polyarteritis Nodosa | 1954 |
[Determination of the coagulation valence for control of dicumarol therapy].
Topics: Blood Coagulation; Coumarins; Dicumarol; Humans | 1954 |
The anticoagulants: heparin and dicumarol.
Topics: Anticoagulants; Blood Coagulation; Coumarins; Dicumarol; Heparin; Humans | 1954 |
[The therapeutic use of a new anticoagulant, marcoumar].
Topics: Anticoagulants; Coumarins; Myocardial Infarction; Phenprocoumon; Thromboembolism; Thrombophlebitis | 1954 |
Studies on the effectiveness of bare ground barriers and warfarin poison against field rodents in Korea (grid trapping method).
Topics: Animals; Anticoagulants; Coumarins; Humans; Poisons; Republic of Korea; Rodentia; Warfarin | 1954 |
Complications of anticoagulant therapy: review of the literature and report of a case.
Topics: Anticoagulants; Coumarins; Hemorrhage; Humans; Thrombophlebitis | 1954 |
Antibacterial properties of compounds containing the tricarbonylmethane group. IX. Effects of nitrogenous radicals in the side-chains of 3-acyl-4-hydroxycoumarins and its derivatives.
Topics: 4-Hydroxycoumarins; Anti-Bacterial Agents; Coumarins; Inorganic Chemicals; Nitrogen; Quinolines; Resorcinols; Uricosuric Agents | 1953 |
[Antibacterial activity of compounds possessing a tricarbonylmethane group. X. Observations on the acetylation of 4-hydroxycoumarin and synthesis of 3-(alpha-aminophenylacetyl)-4-hydroxycoumarins].
Topics: 4-Hydroxycoumarins; Acetylation; Anti-Bacterial Agents; Coumarins | 1953 |
Dicumarol and plasma antithrombin activity.
Topics: Blood Coagulation; Blood Coagulation Tests; Coumarins; Dicumarol | 1954 |
[Comparison of Owen's technic with a modified Quick's method for control of the treatment with coumarin preparations].
Topics: Coumarins; Prothrombin Time | 1953 |
[Thrombosis prophylaxis with marcoumar in puerperium and the state of health of the infant].
Topics: Anticoagulants; Coumarins; Female; Health; Humans; Phenprocoumon; Postpartum Period; Thrombosis | 1954 |
The control of tromexan therapy.
Topics: Coumarins; Ethyl Biscoumacetate | 1954 |
Warfarin poisoning; report of fourteen cases.
Topics: Coumarins; Humans; Poisoning; Warfarin | 1954 |
Local haemorrhage and necrosis of the skin and underlying tissues, during anti-coagulant therapy with dicumarol or dicumacyl.
Topics: Coagulants; Coumarins; Dicumarol; Gangrene; Hemorrhage; Humans; Necrosis; Skin | 1954 |
[The hemolytic complement activity in thrombophlebitis and thrombosis].
Topics: Complement System Proteins; Coumarins; Plants; Thiamine; Thrombophlebitis; Thrombosis | 1954 |
[Suitability of capillary protection during anticoagulant therapy with coumarin].
Topics: Anticoagulants; Capillaries; Coumarins; Flavonoids; Humans; Vitamin E; Vitamins | 1954 |
[Marcoumar in specific prevention of thrombosis].
Topics: Anticoagulants; Coumarins; Female; Genitalia; Genitalia, Female; Humans; Phenprocoumon; Postpartum Period; Thrombosis | 1954 |
[Tromexan in selective prevention of thrombo-embolic diseases in puerperium].
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Female; Humans; Postpartum Period; Thromboembolism | 1954 |
[Marcoumar in general prevention of puerperal thrombosis].
Topics: Anticoagulants; Coumarins; Female; Humans; Phenprocoumon; Postpartum Period; Puerperal Disorders; Thromboembolism | 1954 |
[The tromexan liver function test].
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Liver Function Tests | 1954 |
Action of coumarin anticoagulants on a possible new serum clotting factor.
Topics: Anticoagulants; Blood Coagulation; Coumarins; Humans | 1954 |
[Natural coumarins].
Topics: Coumarins; Plants | 1954 |
[Clinical observations in the use of ethyl bis-coumacetate in venous thrombosis in obstetrics and gynecology].
Topics: Ascorbic Acid; Coumarins; Female; Flavonoids; Genitalia; Genitalia, Female; Gynecology; Humans; Obstetrics; Postpartum Period; Thrombosis; Venous Thrombosis; Vitamin E; Vitamins | 1954 |
[Clinical experience with the new anticoagulant marcoumar].
Topics: Anticoagulants; Coumarins; Phenprocoumon | 1954 |
[Prevention of vascular injury by dicoumarin, coumarin and the rare earths].
Topics: Biomedical Research; Capillary Permeability; Coumarins; Dicumarol; Flavonoids; Vascular System Injuries; Vitamins | 1954 |
Treatment of alopecia areata with ammoidin-ammidin solution; preliminary report.
Topics: Alopecia; Alopecia Areata; Coumarins; Humans; Methoxsalen; Pharmaceutical Solutions; Solutions | 1954 |
Clinical experience with coumarin anticoagulants warfarin and warfarin sodium.
Topics: Anticoagulants; Coumarins; Humans; Prothrombin Time; Warfarin | 1954 |
Hemorrhagic fever. II. Prevention.
Topics: Animals; Biomedical Research; Coumarins; Hemorrhagic Fever with Renal Syndrome; Hexachlorocyclohexane; Mites; Rats | 1954 |
[Anticoagulant therapy of chronic obliterating peripheral arteriopathy].
Topics: Anticoagulants; Coumarins; Heparin; Peripheral Arterial Disease; Peripheral Vascular Diseases; Vascular Diseases | 1954 |
[Studies on anticoagulants. XXVI. New method of synthesis of 3-(o-hydroxybenzoyl ethyl)-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins | 1954 |
Anticoagulant therapy with dicumarol maintained during major surgery.
Topics: Anticoagulants; Coumarins; Dicumarol; Thrombosis | 1954 |
[Marcoumar and intermittent attack therapy].
Topics: Animals; Antifibrinolytic Agents; Behavior, Animal; Coumarins; Humans; Naphthoquinones; Phenprocoumon; Vitamin K | 1954 |
[Clinical aspects of three cases of phlebothrombosis in pregnancy treated with anticoagulating substances (heparin, tromexan)].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Thrombophlebitis; Venous Thrombosis | 1954 |
[Clinical action of the new anticoagulants, 2-2-bis-(4-hydroxy-3-coumarinyl)-ethanol ethers].
Topics: Anesthetics, General; Anticoagulants; Coumarins; Ethanol; Ethers | 1954 |
Dicumarol toxicity.
Topics: Coumarins; Dicumarol | 1954 |
[Experience with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Thromboembolism | 1954 |
Paraplegia following or associated with excessive dicumarol therapy.
Topics: Coumarins; Dicumarol; Hemorrhage; Humans; Paraplegia; Spinal Cord; Spinal Cord Vascular Diseases | 1954 |
[Therapy of thrombophlebitis of the extremities with dicoumarin].
Topics: Coumarins; Dicumarol; Extremities; Thrombophlebitis | 1954 |
[Critical remarks on the problem of dicumarol prophylaxis].
Topics: Climacteric; Coumarins; Dicumarol; Female; Humans; Leiomyoma; Menopause; Menorrhagia; Metrorrhagia; Thrombophlebitis; Uterine Neoplasms | 1954 |
[Action of anticoagulants and of lipocaic on body fluid balance in atherosclerosis patients].
Topics: Anticoagulants; Arteriosclerosis; Atherosclerosis; Body Fluids; Coumarins; Heparin; Humans; Lipotropic Agents; Water-Electrolyte Balance | 1954 |
[The modern anticoagulant therapy].
Topics: Anticoagulants; Coumarins; Humans | 1954 |
[Antibiotic element isolated from the mouse-eared hawkweed, Hieracium pilosella L].
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Asteraceae; Brucella; Coumarins; Dermatologic Agents; Mice | 1953 |
Anticoagulants.
Topics: Anticoagulants; Coumarins; Heparin | 1954 |
Late results of treatment in myocardial infarction; effect of short-term anticoagulant therapy on the mortality at one year.
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Humans; Myocardial Infarction | 1954 |
[Three cases of phlebothrombosis in pregnancy treated with anticoagulant substances].
Topics: Anticoagulants; Coumarins; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Thrombophlebitis; Venous Thrombosis; Vitamins | 1954 |
Standardized estimation of prothrombin activity and the accurate control of dicumarol therapy.
Topics: Blood Coagulation Tests; Coumarins; Dicumarol; Hematologic Tests; Prothrombin; Prothrombin Time; Reference Standards; Thrombosis | 1954 |
A comparative study of marcumar, tromexan and dicumarol, determination of plasma levels and prothrombin times after intravenous injection.
Topics: Blood; Coumarins; Dicumarol; Ethyl Biscoumacetate; Injections, Intravenous; Phenprocoumon; Plasma; Prothrombin Time | 1954 |
Long term anticoagulant therapy in coronary artery disease.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Coumarins; Humans | 1954 |
Observations on the rapidity of initial response to orally administered anticoagulants.
Topics: Anticoagulants; Coumarins; Humans; Phenindione | 1954 |
[Thrombosis prophylaxis after gallbladder surgery].
Topics: Anticoagulants; Biliary Tract Surgical Procedures; Coumarins; Gallbladder; Humans; Thrombosis | 1954 |
[Indications and contraindications for anticoagulant therapy in the light of coagulation physiology].
Topics: Adrenocorticotropic Hormone; Anticoagulants; Blood Coagulation; Cortisone; Coumarins; Heparin; Humans; Light | 1954 |
Bishydroxycoumarin (dicumarol) therapy in myocardial infarction; results of bishydroxycoumarin therapy as it is practiced in a private hospital.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Hospitals, Private; Myocardial Infarction | 1954 |
Comparison of two methods for determining prothrombin during dicumarol therapy.
Topics: Coumarins; Dicumarol; Hemostatics; Prothrombin; Prothrombin Time | 1954 |
[Observations on poisoning manifestations in the preparation of 4-hydroxycoumarin in laboratory].
Topics: 4-Hydroxycoumarins; Coumarins; Humans; Laboratories; Occupational Diseases; Poisoning | 1954 |
[The test of tromexan hypoprothrombinemia in the study of hepatic function].
Topics: Coumarins; Digestion; Ethyl Biscoumacetate; Hemostatics; Hypoprothrombinemias; Liver Function Tests; Prothrombin | 1954 |
Antagonistic effect of A.C.T.H. and cortisone on the anticoagulant activity of ethyl biscoumacetate.
Topics: Adrenocorticotropic Hormone; Anticoagulants; Cortisone; Coumarins; Ethyl Biscoumacetate; Hostility | 1954 |
Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.
Topics: Antifibrinolytic Agents; Coumarins; Ethyl Biscoumacetate; Heparin Antagonists; Naphthoquinones; Phenindione; Thromboembolism; Vitamin K; Vitamin K 1 | 1954 |
Prothrombin and haemorrhage.
Topics: Blood Coagulation; Coumarins; Hemorrhage; Hemostatics; Humans; Liver Diseases; Prothrombin; Prothrombin Time | 1954 |
New rat killers.
Topics: Coumarins; Rats | 1954 |
Polyphenol oxidases of lettuce seeds and their inhibition.
Topics: Catechol Oxidase; Coumarins; Humans; Lactuca; Oxidoreductases; Seeds; Thiourea; Vegetables | 1954 |
[Individual postoperative thrombosis control in prevention of early embolism].
Topics: Coumarins; Embolism; Humans; Postoperative Period; Procaine; Surgical Procedures, Operative; Thromboembolism; Thrombosis | 1954 |
[Tromexan excretion in human milk].
Topics: Biological Transport; Body Fluids; Coumarins; Ethyl Biscoumacetate; Milk, Human | 1954 |
[Experiences in prevention of thromboembolism].
Topics: Anticoagulants; Biomedical Research; Coumarins; Humans; Thromboembolism | 1954 |
Accidental ingestion of bishydroxycoumarin: use of vitamin K1 emulsion in two cases.
Topics: Antifibrinolytic Agents; Coumarins; Dicumarol; Hemorrhage; Naphthoquinones; Poisoning; Retinoids; Vitamin K; Vitamin K 1 | 1954 |
The influence of anticoagulants on the formation and regression of experimental atherosclerosis.
Topics: Anticoagulants; Arteriosclerosis; Atherosclerosis; Cholesterol; Coumarins; Heparin | 1954 |
Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
Topics: Anticoagulants; Antidotes; Blood Coagulation; Coumarins; Dicumarol; Hemostatics; Humans; Prothrombin Time; Vitamin K; Vitamin K 1 | 1954 |
Dicumarol sensibility as a test of liver function.
Topics: Coumarins; Dicumarol; Digestion; Liver; Liver Function Tests; Prothrombin Time | 1954 |
[The method for separation of heparin and coumarin effect].
Topics: Blood Coagulation; Coumarins; Heparin; Humans; Retinal Degeneration | 1954 |
Ammoidin (xanthotoxin) in the treatment of vitiligo.
Topics: Adult; Ammi; Coumarins; Dermatitis; Female; Furocoumarins; Humans; Methoxsalen; Recurrence; Research Personnel; Ultraviolet Rays; Vitiligo | 1954 |
Prevention of systemic arterial embolism in chronic rheumatic heart disease by means of protracted anticoagulant therapy.
Topics: Anticoagulants; Chronic Disease; Coumarins; Embolism; Humans; Myocarditis; Rheumatic Heart Disease | 1954 |
Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Phenprocoumon | 1954 |
The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Hemostatics; Myocardial Infarction; Prothrombin; Prothrombin Time | 1954 |
[Clinical studies on the new anticoagulant, marcoumar, and its antagonist, konakion (vitamin K1)].
Topics: Anticoagulants; Antifibrinolytic Agents; Coumarins; Female; Genitalia; Genitalia, Female; Humans; Hypoprothrombinemias; Phenprocoumon; Postpartum Period; Prothrombin; Thrombophlebitis; Vitamin K; Vitamin K 1 | 1954 |
Anticoagulant therapy of thrombophlebitis.
Topics: Anticoagulants; Coumarins; Heparin; Humans; Thrombophlebitis | 1954 |
Treatment of venous thrombosis with anticoagulants; review of 1135 cases.
Topics: Anticoagulants; Coumarins; Heparin; Humans; Phenindione; Pulmonary Embolism; Thrombosis; Venous Thrombosis | 1954 |
[Modifications of factor VII and prothrombin in plasma and serum following administration of pelentan].
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate; Factor VII; Hemostatics; Humans; Pharmaceutical Preparations; Plasma; Prothrombin; Prothrombin Time | 1954 |
[A new coumarin derivative in therapy of venous thrombosis: 3-(1'-phenylpropyl)-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Coumarins; Thrombosis; Venous Thrombosis | 1954 |
A further report on the effect of dicumarol on the visual fields in glaucoma.
Topics: Coumarins; Dicumarol; Glaucoma; Humans; Vision, Ocular; Visual Fields | 1953 |
[Comparison of two methods of prothrombin determination during dicumarol treatment].
Topics: Coumarins; Dicumarol; Prothrombin; Prothrombin Time | 1954 |
Treatment of vitiligo with psoralen derivatives.
Topics: Coumarins; Ficusin; Humans; Vitiligo | 1955 |
Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
Topics: Blood Coagulation; Blood Coagulation Tests; Coumarins; Dicumarol; Factor VII; Hemostatics; Plasma; Prothrombin | 1954 |
Investigations on the physiology of dicumarol.
Topics: Coumarins; Dicumarol | 1954 |
Dicumarol in retinitis pigmentosa; resulting changes in visual acuity and visual fields; a preliminary report.
Topics: Coumarins; Dicumarol; Humans; Retinitis Pigmentosa; Visual Acuity; Visual Fields | 1955 |
[Derivative of 4-hydroxycoumarin as a new anticoagulant].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins | 1954 |
[Considerations on control of thrombosan therapy].
Topics: Coumarins; Humans | 1954 |
Effect of dicumarol on localized Shwartzman reaction.
Topics: Coumarins; Dicumarol; Hypersensitivity; Immune System Diseases; Shwartzman Phenomenon | 1954 |
[Studies on benzopyrones; synthesis and properties of some 3-methylcoumarins].
Topics: Coumarins | 1954 |
[Coagulatory and histomorphological modifications induced by 3-(1-phenyl-propyl)-4-hydroxycoumarin; experimental study].
Topics: 4-Hydroxycoumarins; Blood Coagulation; Coumarins | 1954 |
Liver function studies after prolonged coumarin therapy.
Topics: Coumarins; Humans; Liver | 1955 |
[Action of lability factor on the effects of sodium salicylate and tromexan on prothrombin time].
Topics: Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Factor V; Prothrombin Time; Salicylates; Sodium Salicylate | 1954 |
[Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Pentosan Sulfuric Polyester; Thrombosis | 1954 |
Effect of sodium bicarbonate on the anticoagulant action of dicoumarol.
Topics: Anticoagulants; Bicarbonates; Coumarins; Dicumarol; Humans; Prothrombin Time; Sodium Bicarbonate | 1954 |
Mode of action of coumarin drugs.
Topics: Blood Coagulation; Coumarins; Humans; Phenindione | 1955 |
Chemistry of coumarin anticoagulant drugs.
Topics: Anticoagulants; Coumarins; Humans | 1955 |
[Photodynamic activity of natural coumarin derivatives].
Topics: Coumarins | 1954 |
[Important drugs].
Topics: Antifibrinolytic Agents; Cardiovascular Agents; Coumarins; Hexylresorcinol; Humans; Muscle Relaxants, Central; Naphthoquinones; Rosaniline Dyes; Vitamin K | 1954 |
[Vitiligo and its treatment with meladinin].
Topics: Coumarins; Vitiligo | 1954 |
[Antagonism between K1 and drugs of coumarin effects: experimental study].
Topics: Coumarins; Hemostatics; Humans; Vitamin K | 1954 |
Melanin formation in vitiliginous skin under the influence of external applications of 8-methoxypsoralen.
Topics: Coumarins; Humans; Leadership; Melanins; Methoxsalen; Skin; Ultraviolet Rays; Ultraviolet Therapy; Vitiligo | 1955 |
The hypoprothrombinemia-inducing activity of warfarin sodium (coumadin sodium).
Topics: Anions; Coumarins; Hypoprothrombinemias; Ions; Prothrombin; Sodium; Sodium, Dietary; Warfarin | 1954 |
[Effect of Melilotus officinalis tea and its comparison with pelentan].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Melilotus; Plants; Tea | 1954 |
[Anticoagulants in myocardial infarct after coronary thrombosis].
Topics: Anticoagulants; Coronary Disease; Coronary Thrombosis; Coumarins; Humans; Myocardial Infarction | 1954 |
[Prevention and therapy of thrombotic complications at a medium sized gynecological clinic in the course of 5 years].
Topics: Coumarins; Embolism; Humans; Thrombosis | 1954 |
[Rat extermination campaign in the city of Iquique by the use of warfarin (WARF 42)].
Topics: Coumarins; Rats; Warfarin | 1953 |
[Dosage of prothrombopenic agents in blood; comparison with prothrombinic complex rate].
Topics: Coumarins; Prothrombin Time | 1954 |
[Histochemical findings after treatment with 3-(1-phenylpropyl)4-hydroxycoumarin; experimental study].
Topics: 4-Hydroxycoumarins; Coumarins; Kidney; Liver | 1954 |
Prothrombin time longer than recalcification time; a paradoxical phenomenon in dicoumarol hypersensitivity.
Topics: Coumarins; Dicumarol; Hypersensitivity; Prothrombin Time | 1954 |
The effect of thromboplastin concentration on the one-stage prothrombin test in the control of anticoagulant.
Topics: Anticoagulants; Coumarins; Humans; Jaundice; Prothrombin; Prothrombin Time; Thromboplastin | 1954 |
Pulmonary infarction with incoercible hemoptysis and anticoagulant treatment.
Topics: Coumarins; Hemoptysis; Heparin; Humans; Infarction; Lung; Pulmonary Infarction | 1955 |
[Dicumacyl in prevention of thromboembolic complications after gynecologic and obstetric operations].
Topics: Biomedical Research; Coumarins; Female; Obstetric Surgical Procedures; Pregnancy; Thromboembolism | 1955 |
[Structure of calycanthoside].
Topics: Coumarins; Glycosides | 1955 |
For Thromboembolism Prophylaxis with Anticoagulants, Especially Marcumar.
Topics: Anticoagulants; Coumarins; Humans; Thromboembolism | 1955 |
[Anticoagulant treatment in myocardial infarction].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Myocardial Infarction | 1955 |
Potentiation of suntanning through ingestion of 8-methoxypsoralen.
Topics: Coumarins; Methoxsalen; Sunbathing; Sunlight | 1955 |
[Active principles of Ammi majus, a new therapeutic agent for leukoderma].
Topics: Ammi; Coumarins; Hypopigmentation; Skin Diseases | 1955 |
[Anticoagulant therapy with marcumar].
Topics: Anticoagulants; Coumarins; Phenprocoumon; Thromboembolism | 1954 |
Spontaneous intraspinal hemorrhage and paraplegia complicating dicumarol therapy.
Topics: Coumarins; Dicumarol; Hemorrhage; Humans; Myocardial Infarction; Paraplegia; Spinal Cord | 1955 |
[Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type].
Topics: Combined Modality Therapy; Coumarins; Dicumarol; Hemostatics; Heparin; Manipulation, Osteopathic; Prothrombin; Prothrombin Time | 1955 |
[Prolonged treatment with tromexan in arteriosclerosis obliterans and in nonacute aorto-iliac obstructions].
Topics: Aorta; Aortic Diseases; Arteriosclerosis; Arteriosclerosis Obliterans; Coumarins; Disease; Ethyl Biscoumacetate; Humans | 1955 |
[Meladinine in therapy of vitiligo].
Topics: Coumarins; Humans; Methoxsalen; Vitiligo | 1955 |
[The reaction of factor V in the serum under normal and pathological conditions].
Topics: Blood Coagulation; Blood Coagulation Tests; Coumarins; Factor V; Hemophilia A; Prothrombin Time; von Willebrand Diseases | 1955 |
Liver respiration, succinoxidase and DPN-cytochrome c reductase activity in vitamin K-deficiency and after treatment with long-acting anticoagulants.
Topics: Anticoagulants; Cell Respiration; Coumarins; Cytochromes c; Liver; NAD; Oxidoreductases; Vitamin K; Vitamin K Deficiency | 1955 |
[Combination of dicumarol with organic bases].
Topics: Coumarins; Dicumarol; Organic Chemicals | 1955 |
On the nature of the blood coagulation mechanisms in certain clinical states.
Topics: Blood Coagulation; Coumarins | 1955 |
The role of flavonoids in coumarin anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Flavones; Flavonoids; Humans | 1955 |
Some experience with the anticoagulant cyclocumarol.
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Myocardial Infarction; Thrombosis | 1955 |
[Antithrombic coagulation factors in thromboembolism].
Topics: Blood Coagulation; Blood Coagulation Factors; Coumarins; Humans; Thrombin; Thromboembolism | 1955 |
Inhibition of the local Shwartzman reaction by dicumarol.
Topics: Coumarins; Dicumarol; Hypersensitivity; Immune System Diseases; Shwartzman Phenomenon | 1955 |
[Effects on mother and infant of dicumacyl administration in pregnancy].
Topics: Coumarins; Female; Fetus; Humans; Infant; Leg; Mothers; Pharmaceutical Preparations; Pregnancy; Pregnancy Complications; Thrombosis | 1955 |
[Investigations on utilization of warfarin as raticide].
Topics: Coumarins; Poland; Rats; Warfarin | 1955 |
Phenyl-indane-dione and nitro-phenyl-acetyl-ethyl-4-oxycoumarin.
Topics: Coumarins; Humans; Phenindione | 1955 |
Marcumar, a new anticoagulant.
Topics: Anticoagulants; Coumarins; Phenprocoumon | 1955 |
Observations on the coagulation disturbance in human plasma following the ingestion of dicumarol.
Topics: Blood Coagulation; Coumarins; Dicumarol; Eating; Thromboplastin | 1954 |
[Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Coumarins; Ethyl Biscoumacetate; Factor VII; Humans; Phenprocoumon; Prothrombin; Thrombosis | 1955 |
[Specific treatment of thromboembolism in obstetrics and gynecology].
Topics: Anticoagulants; Coumarins; Female; Genital Diseases, Female; Gynecology; Heparin; Humans; Obstetrics; Postpartum Period; Pregnancy; Thromboembolism | 1955 |
Hydrocortisone ointment in psoralen-treated vitiligo; effect in preventing dermatitis.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Coumarins; Dermatitis; Ficusin; Humans; Hydrocortisone; Vitiligo | 1955 |
[Behavior of hematic fibrinogen during treatment with marcoumar and with marcoumar and vitamin K; clinical and experimental aspects].
Topics: Antifibrinolytic Agents; Coagulants; Coumarins; Fibrinogen; Hemostatics; Heparin Antagonists; Humans; Phenprocoumon; Vitamin K | 1955 |
[Mechanism of action of vitamin K].
Topics: Antifibrinolytic Agents; Coumarins; Heparin Antagonists; Humans; Phosphorus; Vitamin K | 1955 |
Anticoagulant studies with marcoumar, a new coumarin derivative.
Topics: Anticoagulants; Coumarins; Phenprocoumon; Research | 1955 |
Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis.
Topics: Blood Coagulation; Coumarins; Dicumarol; Heparin; Thrombosis; Venous Thrombosis | 1955 |
[Reduction on the frequency of thromboembolism by general prophylaxis with anticoagulants].
Topics: Anticoagulants; Coumarins; Surgical Procedures, Operative; Thromboembolism | 1955 |
[Effect of 3-(1-phenylpropyl)-4-hydroxycoumarin (marcumar) on the functional, morphological and histochemical characteristics of blood platelets and megakaryocytes; experimental research].
Topics: 4-Hydroxycoumarins; Blood Platelets; Cell Count; Coumarins; Humans; Megakaryocytes; Phenprocoumon | 1955 |
Clinical experience with warfarin (coumadin) sodium, a new anticoagulant.
Topics: Anions; Anticoagulants; Coumarins; Ions; Sodium; Sodium, Dietary; Warfarin | 1955 |
The effects of drugs on the protein-bound -SH and S-S groups of human serum.
Topics: 4-Aminobenzoic Acid; Blood; Coumarins; Humans; Quinacrine; Sulfanilamide; Sulfanilamides; Sulfhydryl Compounds; Sulfides; Sulfonamides | 1955 |
Augmented pigmentation and other responses of normal human skin to solar radiation following oral adminstration of 8-methoxypsoralen.
Topics: Coumarins; Humans; Methoxsalen; Pigmentation; Skin; Sunlight | 1955 |
[Remarks on P. Bockel and K. D. Schmidt's paper Accident in anticoagulant therapy].
Topics: Accidents; Anticoagulants; Coumarins; Humans; Paper; Thrombophlebitis | 1955 |
[Further experience with prolonged dicumarol therapy of coronary thrombosis].
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Coronary Disease; Coronary Thrombosis; Coumarins; Dicumarol; Enzyme Inhibitors | 1955 |
[Local necroses after dicoumarin therapy].
Topics: Coumarins; Dicumarol; Humans; Necrosis; Skin Diseases | 1955 |
Present status of anticoagulant therapy in the treatment of myocardial infarction; the use and misuse of anticoagulants; an evaluation of new anticoagulants, their indications and dosage.
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Humans; Myocardial Infarction; Phenindione | 1955 |
The control of excessive effect by anticoagulants.
Topics: Anticoagulants; Coumarins; Hemostatics; Humans; Phenindione; Protamines; Thrombosis; Vitamin K | 1955 |
Paroxysmal nocturnal hemoglobinuria: report of four cases, with observations on treatment with 3, 3'-methylenebis (4-hydroxycoumarin) (dicumarol).
Topics: 4-Hydroxycoumarins; Coumarins; Dicumarol; Hemoglobinuria; Hemoglobinuria, Paroxysmal; Humans | 1955 |
Anticoagulant therapy in cardiac infarction.
Topics: Anticoagulants; Coumarins; Heparin; Humans; Infarction; Myocardial Infarction | 1956 |
Phenylpropyl-hydroxycoumarin as an anticoagulant.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Coronary Disease; Coumarins; Thrombosis | 1956 |
Mitral commissurotomy performed during anticoagulant prophylaxis with dicumarol.
Topics: Anticoagulants; Cardiac Surgical Procedures; Coumarins; Dicumarol; Heart Valves; Humans; Mitral Valve | 1955 |
The coagulation defect caused by tromexan therapy.
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate | 1955 |
NEW AND nonofficial remedies.
Topics: Anesthetics; Anesthetics, Local; Anticonvulsants; Cardiovascular Agents; Contrast Media; Coumarins; Gold Radioisotopes; Muscle Relaxants, Central; Parasympatholytics; Scopolamine Derivatives; Steroids; Sulfones; Sympathomimetics; Trypsin | 1955 |
[Toxicity of pelentan in chronic circulatory insufficiency].
Topics: Coumarins; Ethyl Biscoumacetate; Heart Failure; Humans | 1954 |
[Practice of anticoagulant therapy; observations on therapy with coumarin preparations].
Topics: Anticoagulants; Coumarins; Humans | 1955 |
[The control of dangerous effects of coumarin with vitamin K1 (konakion)].
Topics: Antifibrinolytic Agents; Coumarins; Humans; Thromboplastin; Vitamin K; Vitamin K 1 | 1955 |
[Intravenous administration of dicumarinic anticoagulants].
Topics: Administration, Intravenous; Anticoagulants; Coumarins; Humans | 1955 |
Surgery in the presence of the therapeutic effect of dicumarol.
Topics: Coumarins; Dicumarol; Health Services; Thrombosis | 1955 |
The regulation of dicumarol dosage by special venous clotting technics.
Topics: Blood Coagulation; Coumarins; Dicumarol; Veins | 1956 |
Long-term treatment of some arteriopathies with tromexan.
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Long-Term Care; Peripheral Vascular Diseases; Vascular Diseases | 1955 |
Studies in detoxication. 67. The biosynthesis of the glucuronides of umbelliferone and 4-methylumbelliferone and their use in fluorimetric determination of beta-glucuronidase.
Topics: Coumarins; Fluorometry; Glucuronidase; Glucuronides; Glycoside Hydrolases; Hymecromone; Umbelliferones | 1955 |
Dental extraction during dicumarol therapy.
Topics: Coumarins; Dicumarol; Humans; Molar; Tooth Extraction | 1956 |
[Chemical characteristics of the main product of anticoagulant pelentan in human urine].
Topics: Anticoagulants; Body Fluids; Coumarins; Ethyl Biscoumacetate; Humans; Urine | 1955 |
[Application of Baeyer-Villiger reaction in synthesis of dihydrocoumarin].
Topics: Coumarins | 1955 |
[Anticoagulant therapy; tromexan and G-23350].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate | 1955 |
[Phenylpropyl hydroxycoumarin as anticoagulant in obstetric and gynecological thrombophlebitis and its antidote, vitamin K1].
Topics: Anticoagulants; Antidotes; Coumarins; Female; Genital Diseases, Female; Hemorrhage; Humans; Thrombophlebitis; Vitamin K; Vitamin K 1 | 1955 |
[Prolonged treatment with coumarinic anticoagulants; try-out of a new derivative, 3-(1'-phenyl-propyl)-4-hydroxycoumarine].
Topics: Anticoagulants; Coumarins; Humans | 1955 |
[Interesting properties of natural furocoumarin derivatives].
Topics: Coumarins; Furans; Furocoumarins | 1955 |
Local application of 8-methoxypsoralen in vitiligo.
Topics: Coumarins; Methoxsalen; Vitiligo | 1955 |
[Anticoagulants. II. Indirect anticoagulants with prothrombinopenic action; dicumarol derivatives and synthetic anticoagulants].
Topics: Anticoagulants; Coumarins; Dicumarol | 1956 |
[Symptom complex of acute abdomen after administration of dicoumarin].
Topics: Abdomen; Abdomen, Acute; Coumarins; Diagnosis, Differential; Dicumarol; Humans | 1955 |
[Pelentan therapy in puerperal thrombosis].
Topics: Coumarins; Ethyl Biscoumacetate; Female; Humans; Infant, Newborn; Postpartum Period; Puerperal Disorders; Thrombosis; Vascular Diseases | 1955 |
[Anticoagulant therapy of myocardial infarct].
Topics: Anticoagulants; Coumarins; Humans; Myocardial Infarction | 1955 |
[The thromboembolism-preventing properties of a new coumarin derivative, sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1955 |
[Value of total blood coagulability in control of dicumarol therapy of thrombophlebitis].
Topics: Blood Coagulation; Coumarins; Dicumarol; Female; Humans; Postpartum Period; Thrombophlebitis | 1955 |
[Indications for thrombosis prophylaxis with anticoagulants].
Topics: Anticoagulants; Coumarins; Humans; Thrombosis | 1956 |
Handling human chromosomes by a coumarin technic.
Topics: Chromosomes; Chromosomes, Human; Coumarins; Humans; Neoplasms | 1956 |
[Dicumarin therapy in pregnant and non-pregnant women].
Topics: Coumarins; Female; Humans; Pregnancy; Pregnancy Complications | 1955 |
The reduction of autoprothrombin. II. Activity with dicumarol.
Topics: Coumarins; Dicumarol; Prothrombin | 1956 |
[Bergaptol ethers].
Topics: Anesthetics, General; Coumarins; Ethers; Furocoumarins; Humans; Skin | 1955 |
[Synthesis of isobergaptene].
Topics: Coumarins | 1955 |
[Control of various pharmaceutical products. I. Disulfuric esters of 4-methylesculetol and of 2-methyl-1, 4-naphthohydroquinone].
Topics: Coumarins; Esters; Naphthoquinones | 1955 |
[Experience in using neodecumarin for prevention of thromboembolic complications in hypertension].
Topics: Biomedical Research; Coumarins; Humans; Hypertension; Thromboembolism; Vascular Diseases | 1956 |
Plasma thromboplastin component: influence of coumarin compounds and vitamin K on its activity in serum.
Topics: Antifibrinolytic Agents; Blood Coagulation; Coumarins; Factor IX; Humans; Vitamin K | 1956 |
[Anticoagulants of the coumarin type; historical outline].
Topics: Anticoagulants; Coumarins | 1955 |
[Clinical results with the anticoagulant sintrom (G 23350)].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Results of specific treatment of thromboembolism with anticoagulants cumid and athrombon].
Topics: Anticoagulants; Coumarins; Thromboembolism | 1955 |
Long-term treatment with dicumarol in myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Humans; Long-Term Care; Myocardial Infarction | 1956 |
[Research on a new short-acting coumarin, sintrom].
Topics: Acenocoumarol; Coumarins; Research | 1956 |
[Acute angina and anticoagulants].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Cardiotonic Agents; Coronary Disease; Coumarins; Heparin; Humans | 1955 |
[Pharmacodynamic properties of 4-methyl-7-hydroxy-coumarin (beta-methyl-umbelliferone)].
Topics: Coumarins | 1955 |
[Simple method for the preparation of ketones of 4-hydroxycoumarin with the aid of phosphorus oxychloride].
Topics: 4-Hydroxycoumarins; Coumarins; Ketones; Phosphorus; Phosphorus Compounds; Phosphorus, Dietary | 1955 |
[Dicumarol: its properties and mode of action. II. Fibroblast culture in the course of a myocardial infarct].
Topics: Coumarins; Dicumarol; Fibroblasts; Immunologic Tests; Myocardial Infarction; Research Design; Tissue Culture Techniques | 1956 |
[Clinical data on anticoagulant treatment with 3-(1-phenylpropy1)-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Humans | 1955 |
[Hyaluronidase-like effect of marcumar in vivo].
Topics: Coumarins; Hyaluronoglucosaminidase; Phenprocoumon | 1956 |
Over-all coagulability in patients receiving dicumarol therapy with emphasis on acute myocardial infarction.
Topics: Blood Coagulation; Cardiovascular Diseases; Coagulants; Coumarins; Dicumarol; Humans; Myocardial Infarction; Rheumatic Heart Disease | 1956 |
[Tromexan load-test in lead poisoning].
Topics: Coumarins; Ethyl Biscoumacetate; Lead Poisoning | 1955 |
[Clinical studies on sintrom (G 23350), a new anticoagulant].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Humans; Thromboembolism | 1956 |
[Inhibiting effect of heparin on hyaluronidase-like effect of marcumar].
Topics: Coumarins; Heparin; Humans; Hyaluronoglucosaminidase; Phenprocoumon | 1956 |
[Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins | 1956 |
[Sintrom in surgery].
Topics: Acenocoumarol; Coumarins | 1956 |
[Research on benzopyrones; coumarin derivatives of o-vanillin].
Topics: Acetates; Aldehydes; Benzaldehydes; Coumarins; Humans; Nitriles | 1955 |
[Research on benzopyrones; ultraviolet spectra of 3-methylcoumarin and 4-methylcoumarin].
Topics: Coumarins; Research | 1955 |
[Thrombotic diseases, especially treatment with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Thromboembolism; Thrombosis | 1956 |
[Marcoumar treatment of thromboembolic conditions].
Topics: Coumarins; Phenprocoumon; Thromboembolism | 1956 |
Further observations on use of warfarin sodium in anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Warfarin | 1956 |
[Protective action of vitamin E on lesions caused by marcoumar].
Topics: Coumarins; Phenprocoumon; Poisoning; Vitamin E | 1956 |
Clinical evaluation of acenocoumarin, a new 4-hydroxycoumarin anticoagulant.
Topics: 4-Hydroxycoumarins; Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[The anticoagulant Sintrom].
Topics: Acenocoumarol; Coumarins | 1956 |
[Use of a new coumarin derivative in venous thrombosis of retina].
Topics: Coumarins; Retina; Thrombosis; Venous Thrombosis | 1955 |
The effect of dicumarol on the transvascular exchange of T-1824-labeled protein in rabbits.
Topics: Animals; Blood Proteins; Coloring Agents; Coumarins; Dicumarol; Fetal Proteins; Rabbits; T-Box Domain Proteins | 1956 |
[Effect of weak concentrations of coumarin and maleic hydrazide on development of new shoots on corn].
Topics: Coumarins; Maleates; Maleic Hydrazide; Zea mays | 1955 |
[Cure of tonsillogenic jugularis and cavernosus sinus thrombosis, meningitis and general sepsis by chemotherapeutic treatment alone].
Topics: Abscess; Ascorbic Acid; Coumarins; Humans; Meningitis; Palatine Tonsil; Penicillins; Peritonsillar Abscess; Sepsis; Sinus Thrombosis, Intracranial; Streptomycin; Sulfonamides; Vitamin B Complex | 1956 |
Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.
Topics: Blood Coagulation; Blood Coagulation Tests; Cardiovascular Diseases; Coumarins; Dicumarol; Hematologic Diseases; Humans; Prothrombin Time | 1956 |
A note on the isolation of bergapten and imperatorin from the fruits of Pastinaca sativa L.
Topics: 5-Methoxypsoralen; Coumarins; Fruit; Furocoumarins; Methoxsalen; Pastinaca; Plants | 1956 |
[Excessive dosage of dicumarol and management of clinical manifestations and therapy of resulting hemorrhage].
Topics: Coumarins; Dicumarol; Disease Management; Hemorrhage | 1956 |
[Research on the effect of 4-hydroxycoumarin derivative G 23350 on Shwartzman-Sanarelli phenomenon].
Topics: 4-Hydroxycoumarins; Coumarins; Hypersensitivity; Immune System Diseases; Research; Shwartzman Phenomenon | 1956 |
[The effect of various coumarins and coumarin-like substances on blood coagulation and capillary permeability].
Topics: Blood Coagulation; Capillary Permeability; Coumarins; Humans | 1956 |
Clinical experience with a new antithrombotic substance.
Topics: Coumarins; Humans | 1956 |
[Neodicoumarin therapy of patients with coronary insufficiency].
Topics: Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Coumarins; Glycosides | 1956 |
Results in the treatment of vitiligo with 8-methoxypsoralen.
Topics: Coumarins; Humans; Methoxsalen; Vitiligo | 1956 |
[Condensation of heterocyclic and unsaturated aldehydes and ketones by 4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Aldehydes; Coumarins; Ketones | 1955 |
[The Fries reaction in the 4-hydroxycoumarin series].
Topics: 4-Hydroxycoumarins; Coumarins; Halogens | 1956 |
[Isolation of a new coumarin and paper chromatography of coumarin substances in Angelica Archangelica L].
Topics: Angelica archangelica; Chromatography, Paper; Coumarins; Plants | 1956 |
[Preparation of 4-hydroxycoumarin ketones with the help of phosphoroxychloride].
Topics: 4-Hydroxycoumarins; Coumarins; Humans; Ketones; Phosphorus; Phosphorus, Dietary | 1956 |
[Anticoagulant therapy in cardiovascular diseases].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins | 1956 |
Influence of ethyl-dicoumarol on the evolution of metastases from the epitheloma T8 in rats; introductory note.
Topics: Animals; Coumarins; Neoplasms, Experimental | 1955 |
Chemical characterization of the main metabolic product of the anticoagulant drug, pelentan, in human urine.
Topics: Anticoagulants; Biochemical Phenomena; Body Fluids; Coumarins; Ethyl Biscoumacetate; Humans; Urine | 1955 |
Vitamin K1 in treatment of bishydroxycoumarin-induced hypoprothrombinemia; comparison of intravenous and intramuscular administration.
Topics: Antifibrinolytic Agents; Coumarins; Dicumarol; Heparin Antagonists; Humans; Hypoprothrombinemias; Naphthoquinones; Prothrombin; Retinoids; Vitamin K; Vitamin K 1 | 1956 |
The effect of large doses of 1, 3-indandiones and 4-hydroxycoumarins on oxygen consumption of anesthetized cats and rabbits.
Topics: 4-Hydroxycoumarins; Animals; Cats; Coumarins; Ketones; Metabolism; Oxygen Consumption; Rabbits | 1956 |
[Effects of certain anticoagulants on uric metabolism].
Topics: Anticoagulants; Coumarins; Uric Acid | 1956 |
Anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Heparin; Thrombosis | 1956 |
[A new coumarin derivative in the treatment of myocardial infarct].
Topics: Coumarins; Humans; Myocardial Infarction | 1956 |
[Control of dicumarol therapy; relation between Quick's method and the P and P method of Owren and Aas].
Topics: Coumarins; Dicumarol; Humans; Prothrombin Time | 1956 |
[Decrease of hemorrhagic accidents in anticoagulant therapy with coumarin derivatives by administration of vitamin K1].
Topics: Accidents; Anticoagulants; Antifibrinolytic Agents; Coumarins; Hemorrhage; Humans; Thrombosis; Vitamin K; Vitamin K 1 | 1956 |
[Effect of flavones and coumarin derivatives on erythrocytes].
Topics: Coumarins; Erythrocytes; Flavones; Humans | 1956 |
[A new synthetic anticoagulant: warfarin].
Topics: Anticoagulants; Coumarins; Humans; Warfarin | 1956 |
Rectal administration of warfarin (coumadin) sodium (sodium [3(2-acetonyl-benzyl)-4 hydroxycoumarin)]).
Topics: 4-Hydroxycoumarins; Administration, Rectal; Coumarins; Ions; Sodium; Sodium, Dietary; Warfarin | 1956 |
[A case of ingestion of ethyl ester of bis-4-oxycoumarinyl acetic acid (tromexan) in suicide attempt].
Topics: Acetates; Acetic Acid; Coumarins; Esters; Ethyl Biscoumacetate; Poisoning; Suicide; Suicide, Attempted | 1956 |
The treatment of vitiligo with 8-methoxypsoralen.
Topics: Coumarins; Methoxsalen; Vitiligo | 1956 |
[Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Humans; Nitrophenols | 1956 |
[Antivitamins K and blood coagulation: a new synthetic anticoagulant, alpha-naphthyl-3-hydroxy-4-coumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Blood Coagulation; Coumarins; Humans; Indenes; Vitamin K | 1956 |
[New anticoagulants useful in therapy].
Topics: Anticoagulants; Coumarins; Humans | 1956 |
Necrosing cutaneous haemorrhages as a complication in dicumarol treatment.
Topics: Administration, Cutaneous; Coumarins; Dicumarol; Gangrene; Hemorrhage; Necrosis; Skin | 1956 |
[Synthesis of 4-hydroxy-6-chloro coumarin derivatives].
Topics: Coumarins | 1956 |
[Synthesis of 4-hydroxy-6-methyl-coumarin derivatives].
Topics: Coumarins | 1956 |
Synthesis of derivatives of 4-oxy-6-chloro-7-methyl-coumarin.
Topics: Coumarins | 1956 |
[Data on vitiligo therapy].
Topics: Coumarins; Humans; Vitiligo | 1956 |
[Quantitative determination of chromones].
Topics: Chromones; Coumarins | 1956 |
[Postoperative phlebitis and pulmonary embolism caused by early ambulation and anticoagulants].
Topics: Anticoagulants; Coumarins; Early Ambulation; Female; Humans; Phlebitis; Postoperative Care; Postpartum Period; Pulmonary Embolism; Thrombosis | 1954 |
[Action of phenyl-acetyl-ethyl-hydroxycoumarin on electrolyte level in tissues of Rattus decumanus].
Topics: Animals; Coumarins; Electrolytes; Rats | 1956 |
Toxicity of coumarin.
Topics: Coumarins; Humans | 1956 |
A clinical trial of a new anticoagulant for oral use.
Topics: Administration, Oral; Anticoagulants; Coumarins; Humans | 1956 |
[Anticoagulant 3-(1-phenyl-propyl)-4-hydroxycoumarin in the treatment of phlebothrombosis and thrombophlebitis].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Humans; Thrombophlebitis | 1956 |
[Experience with marcumar, a new prothrombopenic agent similar to coumarin].
Topics: Coumarins; Phenprocoumon | 1956 |
Acquired hypoprothrombinemia.
Topics: Coumarins; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Infant; Infant, Newborn; Infant, Newborn, Diseases; Liver Diseases; Vitamin K Deficiency | 1957 |
[Corrective dermatology. VI. Treatment of vitiligo with meladinine].
Topics: Coumarins; Dermatology; Methoxsalen; Vitiligo | 1956 |
The effect of the administration of the anticoagulant marcumar on the blood coagulation mechanisms.
Topics: Anticoagulants; Blood Coagulation; Coumarins; Phenprocoumon | 1956 |
A new coumarin derivative (G23350): a preliminary study.
Topics: Coumarins; Myocardial Infarction | 1956 |
[Use of coumarin derivatives].
Topics: Coumarins | 1956 |
[Comparative studies and recent results in the action of preparations of coumarin and indandion].
Topics: Anticoagulants; Coumarins; Humans | 1956 |
[Clinical experiences with the anticoagulant sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1956 |
[Experiments in the 4-hydroxy-coumarin series; chemistry of halogen cations].
Topics: Bromides; Cations; Coumarins; Halogens | 1956 |
Studies on the enhancement of the mutation rate by carcinogens.
Topics: Carcinogens; Coumarins; Genetics; Humans; Mutation Rate; Ultraviolet Rays; Urethane | 1956 |
[Prevention of thromboembolism after gynecological surgery with marcumar, a coumarin derivative].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Gynecologic Surgical Procedures; Humans; Phenprocoumon; Thromboembolism | 1956 |
[Hemorrhage due to coumarin derivatives].
Topics: Coumarins; Hemorrhage | 1956 |
The anticoagulant effect of a new coumarin derivative-sintrom (geigy)- and its control by standardized clotting time.
Topics: Acenocoumarol; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Coumarins; Humans | 1957 |
Experience with sintrom (G. 23350) as an anticoagulant.
Topics: Acenocoumarol; Anticoagulants; Coumarins | 1957 |
[Management of vitiligo with meladinin].
Topics: Coumarins; Disease Management; Vitiligo | 1956 |
Clinical evaluation of sintrom (G-23350); a new oral anticoagulant.
Topics: Acenocoumarol; Anticoagulants; Coumarins | 1957 |
Alopecia from coumarin.
Topics: Alopecia; Child; Coumarins; Humans; Infant | 1957 |
[Treatment of coronary insufficiency with dicoumarin].
Topics: Coronary Artery Disease; Coronary Disease; Coumarins; Dicumarol | 1956 |
[Sintrom, a new short-term anticoagulant monocoumarin derivative].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Myocardial Infarction; Thrombosis | 1957 |
Recurrent hypoprothrombinaemia due to poisoning with a dicumarol-containing rat-killer.
Topics: Animals; Coumarins; Dicumarol; Hypoprothrombinemias; Prothrombin; Rats | 1957 |
Prothrombinopenic action of G-23350, a new anticoagulant.
Topics: Anticoagulants; Coumarins; Prothrombin | 1957 |
The effect of coumarin drugs upon plasma thromboplastin component.
Topics: Blood Coagulation; Coumarins; Dicumarol; Ethyl Biscoumacetate; Factor IX | 1957 |
[Anticoagulant therapy with marcumar].
Topics: Anticoagulants; Coumarins; Phenprocoumon | 1957 |
[Studies of benzopyrones; ultraviolet spectra of several natural coumarins].
Topics: Coumarins | 1956 |
Influence of coumarin derivatives on the Christmas factor.
Topics: Blood Coagulation; Coumarins; Humans | 1957 |
Biochemistry of the wood-rotting fungi. IX. Volatile metabolic products of Stereum subpileatum Berk. & Curt.
Topics: Acids; Aldehydes; Coumarins; Fungi; Wood | 1957 |
Clinical evaluation of three anticoagulants in thrombo-embolic disease.
Topics: Anticoagulants; Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Phenindione; Prothrombin Time; Thromboembolism | 1957 |
Clinical evaluation of a new oral anticoagulant sintrom.
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1957 |
Effect of oral anticoagulant (marcumar) on prothrombin and related components in blood coagulation.
Topics: Anticoagulants; Blood Coagulation; Coumarins; Humans; Phenprocoumon; Prothrombin | 1957 |
[Auxin composition of healthy or virus infected tobacco: presence & role of scopoletin].
Topics: Coumarins; Indoleacetic Acids; Nicotiana; Plant Growth Regulators; Scopoletin; Viruses | 1957 |
[Anticoagulant treatment of cardiovascular diseases; experiences with a new oxycoumarin derivative].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins | 1957 |
[Experimental histopathological studies of the toxicity of indirect anticoagulants].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans; Phenindione | 1957 |
[Interpretation of the hemophilia-like findings caused by indirect anticoagulants (coumarinic, indandionic) on the basis of thromboelastographic and histological data].
Topics: Anticoagulants; Blood Coagulation; Coumarins; Hemophilia A; Humans; Niacin; Nicotinic Acids; Thrombelastography | 1957 |
A preliminary report on sodium warfarin (coumadin).
Topics: Coumarins; Sodium; Warfarin | 1957 |
[Our clinical experience with G-23350 (sintrom)].
Topics: Acenocoumarol; Coumarins | 1957 |
[A new coumarin derivative anticoagulant: sintrom (G 23350); clinical & experimental researches].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Humans | 1957 |
[Our experience with anticoagulant therapy].
Topics: Anticoagulants; Coumarins; Humans | 1957 |
Clinical experience with 3-(1-phenylpropyl)-4-hydroxycoumarin.
Topics: 4-Hydroxycoumarins; Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Thromboembolism | 1957 |
[Effect of marcoumar therapy on completely breast-fed children].
Topics: Breast Feeding; Coumarins; Phenprocoumon | 1957 |
[Prevention of complications during therapy of thromboses and myocardial infarct with anticoagulants (heparin, coumarin) by successful administration of butazolidin].
Topics: Anticoagulants; Coumarins; Embolism; Heparin; Humans; Myocardial Infarction; Phenylbutazone; Thrombosis | 1957 |
[Treatment of phlebitis].
Topics: Coumarins; Heparin; Humans; Phlebitis | 1957 |
[Choice & dosage of preparation in anticoagulant therapy of thrombosis].
Topics: Anticoagulants; Coumarins; Heparin; Thrombosis | 1957 |
[Optic examination of coumarin. I. Ultraviolet absorption of coumarin, coumaric acid, coumarinic acid & their derivatives].
Topics: Coumaric Acids; Coumarins; Eye | 1957 |
Use of different tissue thromboplastins in the control of anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Humans; Thromboplastin | 1957 |
The effect of thyroid function on the prothrombin time response to warfarin in rats.
Topics: Animals; Coumarins; Hyperthyroidism; Hypothyroidism; Prothrombin; Prothrombin Time; Rats; Warfarin | 1957 |
[Protective effect of heparin during acute poisoning with marcumar].
Topics: Coumarins; Heparin; Phenprocoumon | 1957 |
[Effects of marcumar therapy in breast-fed children].
Topics: Breast Feeding; Child; Coumarins; Humans; Infant; Infant, Newborn; Phenprocoumon | 1957 |
[Clinical experience with the anticoagulant sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins | 1957 |
[Postoperative thromboses & embolisms; causes, prophylaxis & treatment].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Surgical Procedures, Operative; Thromboembolism | 1957 |
Clinical experience with the anticoagulant acenocoumarin (sintrom).
Topics: Acenocoumarol; Anticoagulants; Coumarins; Thromboembolism | 1957 |
An effect of drugs derived from 4-hydroxycoumarins not depending on hypoprothrombinaemia.
Topics: 4-Hydroxycoumarins; Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Hypoprothrombinemias; Psoriasis | 1957 |
Anticoagulants in reconstructive vascular surgery.
Topics: Anticoagulants; Coumarins; Heparin; Humans; Peripheral Vascular Diseases; Vascular Diseases | 1957 |
[A new anticoagulant: acenocoumarin (G 23350) & its antagonism by phytylmenadione].
Topics: Acenocoumarol; Anticoagulants; Antifibrinolytic Agents; Coumarins; Humans; Vitamin K | 1957 |
[Limitations of prophylaxis of thrombosis & embolism].
Topics: Aminobenzoates; Anticoagulants; Coumarins; Embolism; Humans; Thromboembolism | 1957 |
Experience with the anticoagulant, marcumar.
Topics: Anticoagulants; Coumarins; Phenprocoumon | 1957 |
[Optical experiments on coumarin. III. Ultraviolet absorption by monomethoxycoumarin & its derivatives].
Topics: Coumarins; Ultraviolet Rays | 1957 |
[Optical experiments on coumarin. IV. Ultraviolet absorption of various coumarins of plant origin].
Topics: Coumarins; Plants; Ultraviolet Rays | 1957 |
Coumarins and phenolic acids in the uredospores of wheat stem rust.
Topics: Coumarins; Fungi; Hydroxybenzoates; Phenols; Plant Stems; Triticum | 1957 |
Clinical experience with G-23350 (sintrom).
Topics: Acenocoumarol; Coumarins | 1957 |
The effect of oxypsoralen upon ultraviolet carcinogenesis in albino mice.
Topics: Animals; Carcinogenesis; Coumarins; Mice; Neoplasms, Experimental; Ultraviolet Rays | 1957 |
[Experience in postoperative prevention and therapy of thromboembolism with special reference to the double test; Quick test and heparin tolerance test].
Topics: Coumarins; Female; Genitalia; Genitalia, Female; Heparin; Humans; Prothrombin Time; Thromboembolism | 1957 |
[Experience with specific medical thromboembolism prevention in St. Gallen Women's Clinic].
Topics: Anticoagulants; Coumarins; Humans; Thromboembolism | 1957 |
Intramuscular administration of the anticoagulant warfarin (coumadin) sodium.
Topics: Anticoagulants; Coumarins; Sodium; Sodium, Dietary; Warfarin | 1957 |
Clinical observations on use of warfarin (coumadin) sodium, a new anticoagulant.
Topics: Anticoagulants; Coumarins; Sodium; Sodium, Dietary; Warfarin | 1957 |
Clinical experiences with anticoagulants; a comparison of coumadin (warfarin) sodium and dicumarol (bishydroxycoumarin).
Topics: Anticoagulants; Coumarins; Dicumarol; Sodium; Thromboembolism; Warfarin | 1957 |
The transformation of gallates into ellagate.
Topics: Coumarins; Gallic Acid | 1957 |
[alpha-Pyrone derivatives with action on capillary fragility. I].
Topics: Capillaries; Capillary Fragility; Cardiovascular System; Coumarins; Pyrones | 1957 |
[Further study on alpha-pyrone derivatives. II].
Topics: Capillaries; Cardiovascular System; Coumarins; Pyrones | 1957 |
Prothrombin depressants and sodium fluoracetate in rat control.
Topics: Coumarins; Fluoroacetates; Prothrombin; Rats; Sodium; Sodium, Dietary | 1957 |
Anticoagulant studies with dicoumarol and marcoumar; control achieved and applications.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Phenprocoumon; Thromboembolism | 1957 |
[Effect of drugs with coumarin action on fragility of micro-vessels; protective action of ascorbic acid, a methyl-esculetol derivative and mesinositol].
Topics: Ascorbic Acid; Capillaries; Cardiovascular System; Coumarins; Ethyl Biscoumacetate; Inositol; Vitamins | 1957 |
Coumestrol, a new estrogen isolated from forage crops.
Topics: Coumarins; Coumestrol; Estrogens | 1957 |
[Three years of experience with medicinal postoperative thrombosis prevention].
Topics: Anticoagulants; Coumarins; Heparin; Humans; Thromboembolism | 1957 |
A new coumarin, 3-(1'-phenylpropyl)-4-hydroxycoumarin (marcumar).
Topics: 4-Hydroxycoumarins; Coumarins; Phenprocoumon | 1958 |
[Contributions to our knowledge on coumarins. I. Paper chromatographic determination of some simple coumarins and hydroxy acids].
Topics: Coumarins; Humans; Hydroxy Acids | 1957 |
[Use of dicumarol derivatives in diseases of the blood vessels].
Topics: Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Thromboembolism | 1957 |
Bronchodilator action of the anticoagulant warfarin sodium.
Topics: Anticoagulants; Bronchi; Bronchodilator Agents; Coumarins; Warfarin | 1958 |
[The anticoagulant sintrom in obstetrics & gynecology].
Topics: Acenocoumarol; Analgesia; Anesthesia; Anesthesia and Analgesia; Anticoagulants; Coumarins; Female; Genital Diseases, Female; Gynecology; Humans; Labor, Obstetric; Obstetrics; Pain Management; Pregnancy | 1957 |
[Anticoagulant treatment of cerebral thrombosis].
Topics: Anticoagulants; Coumarins; Intracranial Embolism; Intracranial Embolism and Thrombosis; Intracranial Thrombosis | 1957 |
[Prevention & treatment of anginose attacks of coronary origin with 3-methylchromone].
Topics: Angina Pectoris; Chromones; Coumarins; Humans | 1957 |
Early clue to visceral carcinoma-hemorrhage after intravenously given warfarin.
Topics: Coumarins; Hemorrhage; Humans; Neoplasms; Warfarin | 1958 |
[Prolonged treatment with anticoagulants].
Topics: Anticoagulants; Coumarins; Humans | 1957 |
[Anticoagulant therapy in daily practice].
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins | 1957 |
[Coumarins from the fruit of Heracleum panaces & Heracleum sibiricum].
Topics: Coumarins; Flavoring Agents; Fruit; Heracleum; Panax | 1957 |
Clinical experiences with the anticoagulant coumadin (warfarin) sodium.
Topics: Anticoagulants; Coumarins; Sodium; Warfarin | 1957 |
[Action of chromone derivatives on the isolated gallbladder of guinea pigs].
Topics: Animals; Chromones; Coumarins; Gallbladder; Guinea Pigs | 1957 |
The prevention of the generalized Shwartzman reaction with sodium warfarin.
Topics: Animals; Coumarins; Disseminated Intravascular Coagulation; Endotoxins; Hypersensitivity; Kidney; Necrosis; Rabbits; Shwartzman Phenomenon; Sodium; Thrombosis; Warfarin | 1958 |
[Khellins & chromones in the non-cardiological fields].
Topics: Cardiotonic Agents; Chromones; Coumarins; Heart Diseases; Humans; Khellin | 1957 |
Photosensitization of bacteria by furocoumarins and related compounds.
Topics: Bacteria; Coumarins; Furocoumarins; Humans; Photosensitivity Disorders | 1958 |
[Anticoagulant action of a dicoumarol derivative: sintrom].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Dicumarol | 1957 |
Effects of oral methoxsalen (8-methoxypsoralen) on sunburn and suntan; a blind clinical trial.
Topics: Blindness; Coumarins; Humans; Methoxsalen; Sunburn; Suntan; Visually Impaired Persons | 1958 |
Comparative clinical study of coumadin sodium and dicumarol in patients with thromboembolic diseases.
Topics: Coumarins; Dicumarol; Humans; Sodium; Sodium, Dietary; Thromboembolism; Warfarin | 1958 |
Studies in detoxication. 71. The metabolism of hydroxycoumarins.
Topics: Coumarins; Humans | 1958 |
Studies in detoxication. 72. The metabolism of coumarin and of o-coumaric acid.
Topics: Acids; Coumaric Acids; Coumarins | 1958 |
[Experiences with a general thrombosis preventative with a report of results of more than 3000 treatments with marcumar].
Topics: Anticoagulants; Coumarins; Humans; Phenprocoumon; Thromboembolism; Thrombosis | 1958 |
[Control of coumarin effects by clinical procedures].
Topics: Anticoagulants; Coumarins; Humans; Thromboembolism | 1957 |
[Analgesic & antipyretic effects of vitamin K & dicumarol with special reference to 4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Coumarins; Dicumarol; Vitamin K | 1957 |
[Contribution to general thrombosis prophylaxis after gynecological operations].
Topics: Anticoagulants; Coumarins; Genitalia; Genitalia, Female; Thromboembolism; Thrombosis | 1957 |
[Effect of microorganismal culture filtrate on production of scopoletin by germinal roots of oat (Avena sativa L. )].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antineoplastic Agents; Avena; Coumarins; Edible Grain; Humans; Penicillins; Plant Roots; Scopoletin | 1958 |
Preliminary classification of some naturally occurring hydroxycinnamic acids through their ultraviolet spectra.
Topics: Coumaric Acids; Coumarins; Plants | 1958 |
Formation of scopoletin from esculin and esculetin in the rat.
Topics: Animals; Coumarins; Esculin; Flavonoids; Rats; Scopoletin; Umbelliferones; Vitamins | 1958 |
ACENOCOUMAROL.
Topics: Acenocoumarol; Coumarins | 1958 |
Clinical experiences with warfarin (coumadin) sodium as an anticoagulant.
Topics: Anticoagulants; Coronary Disease; Coumarins; Dicumarol; Humans; Myocardial Infarction; Sodium; Warfarin | 1958 |
[Prophylaxis and therapy with the anticoagulant sintrom in gynecology and obstetrics].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Female; Genitalia; Genitalia, Female; Gynecology; Humans; Obstetric Labor Complications; Obstetrics; Pregnancy; Thromboembolism | 1958 |
Effects of 8-methoxypsoralen and ultraviolet light in human skin.
Topics: Coumarins; Humans; Methoxsalen; Skin; Ultraviolet Rays | 1958 |
Phenoprocoumon (marcumar). I. An agent for short-term anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Humans; Phenprocoumon | 1958 |
[Is 3-methyl-4-hydroxycoumarin the active principal to which we attribute the hypoprothrombinizing action of Ferula communis].
Topics: 4-Hydroxycoumarins; Coumarins; Ferula; Plants; Prothrombin Time | 1958 |
[Further research on the report of the structure & photodynamic properties of furocoumarin].
Topics: Coumarins; Furans; Furocoumarins; Light | 1958 |
[Synthesis of various furocoumarin derivatives].
Topics: Coumarins; Furans; Furocoumarins | 1958 |
[Research on the photo-oxidation of alpha-terpinene & ascaridol in the presence of furo [2,3-g] coumarin & other photodynamic drugs].
Topics: Coumarins; Cyclohexane Monoterpenes; Furans; Humans; Light; Monoterpenes; Peroxides; Terpenes | 1958 |
[Furocoumarin & photodynamic hemolysis].
Topics: Coumarins; Furans; Furocoumarins; Hemolysis; Light | 1958 |
[Polarographic research on the photo-oxidation of blood proteins in the presence of furocoumarin & other photodynamic substances].
Topics: Blood Proteins; Coumarins; Furans; Furocoumarins; Humans; Light; Polarography | 1958 |
[Extensive tissue necrosis after postoperative prophylaxis of an embolism by marcoumar].
Topics: Coumarins; Disease; Embolism; Humans; Phenprocoumon; Thigh | 1958 |
[Microscopic studies on the effect of the anticoagulant marcumar on vascular permeability].
Topics: Anticoagulants; Capillary Permeability; Coumarins; Humans; Phenprocoumon | 1958 |
[Experimental and clinical use of disodium salt of 4-methylesculetin disulfuric ester in treatment of traumatic shock in 400 cases].
Topics: Convulsive Therapy; Coumarins; Hospital Administration; Humans; Shock, Traumatic; Umbelliferones | 1958 |
Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants.
Topics: Anticoagulants; Coumarins; Hemorrhage; Humans; Prothrombin; Prothrombin Time; Thrombosis | 1958 |
[A new anticoagulant of the coumarin series: sinthrome, 3-(2-acetyl-1-p-nitrophenyl-ethyl)-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Acenocoumarol; Anticoagulants; Coumarins; Humans | 1958 |
[In vitro anticholinesterase effect of coumarin dialkylphosphoric & dialkylthiophosphoric acid esters].
Topics: Acids; Cholinesterase Inhibitors; Coumarins; Esters; In Vitro Techniques | 1957 |
Current therapeutics. 127. Warfarin; a new coumarin anticoagulant.
Topics: Anticoagulants; Coumarins; Humans; Warfarin | 1958 |
[Clinical tests of a new anticoagulant substance: 3-alpha-(4'nitrophenyl)-beta-acetyl-ethyl-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Humans; Thrombosis | 1958 |
[Inadequate thrombokinase control & the quality of long-acting coumarin therapy].
Topics: Coumarins; Factor Xa; Humans | 1958 |
Clinical experience with warfarin sodium.
Topics: Coumarins; Thromboembolism; Warfarin | 1958 |
[Hematoma in thrombosis prevention with sintrom after cesarean section].
Topics: Acenocoumarol; Anticoagulants; Cesarean Section; Coumarins; Diagnosis, Differential; Female; Hematoma; Humans; Pregnancy; Thrombosis | 1958 |
Clinical evaluation of acenocoumarol (sintrom), an anticoagulant of intermediate range.
Topics: Acenocoumarol; Anticoagulants; Coumarins; Humans | 1958 |
[Behavior of prothrombin factors during treatment with anticoagulants of the coumarin & indandione series].
Topics: Anticoagulants; Blood Coagulation; Coumarins; Hemostatics; Humans; Ketones; Prothrombin | 1958 |
Use of anticoagulants in the treatment of coronary artery disease.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Coronary Artery Disease; Coronary Disease; Coumarins; Humans | 1958 |
[Observations on a new anticoagulant].
Topics: Anticoagulants; Coumarins; Humans | 1958 |
Clinical experience with intramuscular warfarin sodium (coumadin sodium).
Topics: Coumarins; Ions; Sodium; Sodium, Dietary; Warfarin | 1958 |
The reduction of platelet cofactor II (autoprothrombin II) activity with anticoagulants.
Topics: Anticoagulants; Blood Coagulation; Blood Platelets; Coumarins; Factor IX; Humans; Phenindione | 1957 |
[The Stuart factor during coumarin therapy].
Topics: Blood Coagulation; Coumarins; Factor X; Humans | 1958 |
Clinical experiences with the anticoagulant warfarin sodium (coumadin sodium).
Topics: Anticoagulants; Coumarins; Sodium; Thromboembolism; Warfarin | 1958 |
The treatment of vitiligo with psoralen derivatives.
Topics: Coumarins; Ficusin; Furans; Humans; Vitiligo | 1958 |
[Intravenous anticoagulant therapy with marcumar].
Topics: Anticoagulants; Coumarins; Phenprocoumon | 1958 |
The Christmas factor deficiency in coumarin therapy.
Topics: Coumarins; Factor IX; Humans; Leukemia | 1958 |
Metabolism of coumarin and related compounds in cultures of Penicillium species.
Topics: Coumarins; Penicillium | 1958 |
Occurrence of coumarin analogues in lemon juice.
Topics: Citrus; Coumarins; Fruit; Organic Chemicals | 1958 |
Identification of methyl-p-coumarate as a metabolic product of Lentinus lepideus.
Topics: Cinnamates; Coumarins; Fungi; Lentinula | 1958 |
Peripheral arterial diseases.
Topics: Coumarins; Peripheral Arterial Disease; Peripheral Vascular Diseases; Vascular Diseases | 1958 |
Sintrom long-term therapy in angina pectoris.
Topics: Acenocoumarol; Angina Pectoris; Coumarins; Humans | 1958 |
[Effect of 3-methylchromone on the central nervous system].
Topics: Central Nervous System; Chromones; Coumarins | 1958 |
[Research & clinical evaluation of the coumarinic anticoagulant, 3 alpha-4'-nitrophenyl-beta-acetylethyl-4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Thrombosis | 1958 |
Clinical experience with orally administered warfarin sodium.
Topics: Coumarins; Humans; Warfarin | 1958 |
[Effect of 3-methylchromone on deficient coronary flow].
Topics: Chromones; Coronary Vessels; Coumarins; Humans | 1958 |
The significance of haemorrhage during the treatment of patients with the coumarin anticoagulants.
Topics: Anticoagulants; Coumarins; Hemorrhage; Humans | 1958 |
Urticaria after administration of warfarin sodium.
Topics: Coumarins; Humans; Peripheral Vascular Diseases; Urticaria; Vascular Diseases; Warfarin | 1959 |
[Synthesis of some derivatives of 3-aminocoumarin and first report on their antibacterial properties].
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacteria; Coumarins | 1958 |
[Coagulation disorders caused by abuse in the use of marcoumar].
Topics: Blood Coagulation Disorders; Coumarins; Hemorrhagic Disorders; Phenprocoumon | 1958 |
[The photodynamic properties of thiacoumarin compounds; lethal effects on paramecia and polarographic measurement of photo-oxidation in blood serum].
Topics: Ciliophora; Coumarins; Oxidation-Reduction; Paramecium; Serum | 1958 |
Historical data regarding the experiences with coumarin anticoagulants at the University of Wisconsin Medical School.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Schools, Medical; Universities | 1959 |
On the synthesis and structure of 4-hydroxy-3-phenyl-coumarins and related 2-imides.
Topics: Coumarins; Imides | 1958 |
[The indirect action anticoagulant marcumar in the control of thrombosis].
Topics: Anticoagulants; Coumarins; Phenprocoumon; Thrombosis | 1958 |
[Control of administration of coumarin preparations in a center for thrombosis treatment].
Topics: Coumarins; Thrombosis | 1958 |
[Ultraviolet spectra of various furocoumarins].
Topics: Coumarins; Furans; Furocoumarins | 1958 |
[Experience with butazolidin-sintrom combined prevention & butazolidine prevention Of thromboembolic disease].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Phenylbutazone; Thromboembolism | 1958 |
SPEEDING the tan.
Topics: Animals; Coumarins; Furans; Pigmentation | 1958 |
[Influence of Senecio on coagulation factors].
Topics: Blood Coagulation; Blood Coagulation Factors; Coumarins; Humans; Senecio | 1959 |
Anticoagulant therapy; clinical experience with acenocoumarin (Sintrom) and other coumarin derivatives.
Topics: Acenocoumarol; Anticoagulants; Coronary Disease; Coumarins; Humans | 1959 |
[The coumarins in the roots of Heracleum panaces L].
Topics: Coumarins; Heracleum; Panax; Plant Roots; Plants | 1959 |
[Prophylaxis & treatment of an apoplectic stroke with anticoagulants].
Topics: Anticoagulants; Cerebral Hemorrhage; Coumarins; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Stroke | 1959 |
The effects of heparin and coumarin derivatives on a standardized intravenous thrombosis.
Topics: Coumarins; Electricity; Heparin; Humans; Thrombosis | 1958 |
[Methods of controlling the effect of anticoagulants].
Topics: Anticoagulants; Coumarins | 1958 |
Use of different tissue thromboplastins in the control of anticoagulant-therapy.
Topics: Anticoagulants; Coumarins; Humans; Thromboplastin | 1958 |
[Problems of anticoagulant treatment].
Topics: Anticoagulants; Coumarins; Heparin; Myocardial Infarction | 1958 |
Influence of spectral composition of light on cis-trans interconversion of o-hydroxycinnamic acid.
Topics: Coumaric Acids; Coumarins; Light | 1959 |
A congenital blood-clotting anomaly resembling coumarin-induced defect.
Topics: Blood Coagulation Disorders; Coumarins; Hemorrhagic Disorders; Humans | 1959 |
[Determination of umbelliferone in mouse-ear hawkweed].
Topics: Animals; Coumarins; Mice; Plants; Umbelliferones | 1959 |
Historical aspects of methoxsalen and other furocoumarins.
Topics: Coumarins; Furans; Furocoumarins; Methoxsalen | 1959 |
Relationship of molecular configuration to the activity of furocoumarins which increase the cutaneous responses following long wave ultraviolet radiation.
Topics: Coumarins; Furans; Furocoumarins; Humans; Molecular Conformation; Ultraviolet Rays | 1959 |
Psoralen prophylaxis against skin cancer: progress of field trials.
Topics: Coumarins; Ficusin; Furans; Humans; Skin Neoplasms | 1959 |
The anticoagulant sintrom (acenocoumarin) in coronary artery disease; clinical experience.
Topics: Acenocoumarol; Anticoagulants; Coronary Artery Disease; Coronary Disease; Coumarins; Humans | 1959 |
[Two cases of central venous thrombosis cured by dicumarin].
Topics: Coumarins; Humans; Retina; Thrombophlebitis; Thrombosis | 1959 |
Cerebellar ischemia as a complication of myocardial infarction during treatment with acenocoumarin.
Topics: Acenocoumarol; Cardiovascular Diseases; Cerebellum; Coumarins; Myocardial Infarction | 1959 |
Ultra-violet carcinogenesis in albino and pigmented mice receiving furocoumarins: psoralen and 8-methoxypsoralen.
Topics: Animals; Carcinogenesis; Coumarins; Ficusin; Furans; Furocoumarins; Methoxsalen; Mice; Neoplasms; Neoplasms, Experimental; Ultraviolet Rays; Viola | 1959 |
Some observations on the coagulation defect during treatment with the anticoagulant sintrom.
Topics: Acenocoumarol; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Coumarins; Humans; Prothrombin | 1959 |
[Experimental and statistical data on the analgesic action of 4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Coumarins | 1959 |
Nicoumalone: a new anticoagulant.
Topics: Acenocoumarol; Anticoagulants; Coumarins; Humans | 1959 |
Urinary metabolites of coumarin and omicron-coumaric acid.
Topics: Acids; Coumaric Acids; Coumarins; Humans | 1959 |
Bioassay of natural and synthetic furocoumarins (psoralens).
Topics: Biological Assay; Coumarins; Furans; Furocoumarins | 1959 |
Investigations on the effect of psoralen derivatives on blood sugar and glutathione.
Topics: Alloxan; Blood Glucose; Coumarins; Ficusin; Furans; Glutathione; Humans | 1959 |
Investigations on lignins and lignification. XXI. Identification of phenolic esters in the culture medium of Lentinus lepideus and the O-methylation of methyl P-coumarate to methyl P-methoxycinnamate in vivo.
Topics: Cinnamates; Coumarins; Esters; Fungi; Lentinula; Lignin; Methylation | 1959 |
[Warfarin and coronary and peripheral circulation].
Topics: Blood Circulation; Coronary Vessels; Coumarins; Heart; Papaverine; Warfarin | 1959 |
New anticoagulant for oral use-3-(1'-phenylpropyl)-4 hydroxycoumarin (liquamar); its evaluation for short-term therapy.
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Phenprocoumon | 1959 |
Studies on the mode of action of psoralen derivatives. I. Their effect on copper and glutathione levels in blood and liver.
Topics: Copper; Coumarins; Ficusin; Furans; Glutathione; Liver | 1959 |
Studies on the mode of action of psoralen derivatives. II. The pituitary adrenal axis control of copper metabolism and its response to psoralens.
Topics: Adrenal Cortex; Copper; Coumarins; Ficusin; Furans; Furocoumarins; Pituitary Gland | 1959 |
An auxin-like action of coumarin.
Topics: Coumarins; Helianthus; Hypocotyl; Indoleacetic Acids; Plant Growth Regulators; Plants | 1959 |
[Coumarin derivatives in human urine in normal & pathological conditions].
Topics: Coumarins; Humans | 1959 |
Sintrom; a newer oral anticoagulant; preliminary report.
Topics: Acenocoumarol; Anticoagulants; Coumarins | 1959 |
The metabolism of aromatic compounds in higher plants. I. Coumarin and o-coumaric acid.
Topics: Acids; Coumaric Acids; Coumarins; Plants | 1959 |
Christman-factor (factor IX) deficiency produced by concurrent administration of heparin with coumarin drugs.
Topics: Coumarins; Factor IX; Hemophilia A; Heparin; Humans; Pharmaceutical Preparations | 1959 |
[Clinical experiences with sintrom].
Topics: Acenocoumarol; Coumarins | 1959 |
Coumarin anticoagulant therapy of patients with T-tube drainage of the common bile duct.
Topics: Anticoagulants; Cholelithiasis; Common Bile Duct; Coumarins; Drainage; Hemorrhage; Humans; Thromboembolism | 1961 |
The antithrombotic properties of coumarin drugs.
Topics: Blood Coagulation; Coumarins; Humans | 1961 |
[Anticoagulant medication. IV. Antivitamin K agents. 2. Coumarin related derivatives and analogs].
Topics: Anticoagulants; Coumarins; Humans; Inorganic Chemicals; Organic Chemicals | 1960 |
Genetic control of coumarin biosynthesis and beta-glucosidase activity in Melilotus alba.
Topics: Cellulases; Coumarins; Gene Expression Regulation; Glycoside Hydrolases; Melilotus; Plants | 1960 |
[The treatment of thromboembolic processes with a combination of heparin and coumarin preparations].
Topics: Anticoagulants; Coumarins; Heparin; Thromboembolism | 1961 |
The metabolism of aromatic compounds in higher plants. III. The beta-glucosides of o-coumaric, coumarinic, and melilotic acids.
Topics: Coumarins; Glucosides; Glycosides; Phenols; Plants | 1961 |
[The effect of a Melilotus extract and pure coumarin on the blood supply of the head, the coronary region and the posterior extremity of the dog].
Topics: Animals; Coronary Vessels; Coumarins; Dogs; Head; Heart; Leg; Melilotus; Plant Extracts | 1960 |
The inhibition of the antidotal activity of vitamin K1 against coumarin anticoagulant drugs by its chloro analogue.
Topics: Anticoagulants; Coumarins; Humans; Inorganic Chemicals; Vitamin K 1 | 1960 |
Lack of effect of coenzyme Q10 on coumarin-induced hypoprothrombinaemia.
Topics: Coenzymes; Coumarins; Humans; Hypoprothrombinemias; Prothrombin; Quinones; Ubiquinone | 1961 |
Duodenal hematoma induced by coumarin.
Topics: Coumarins; Disease; Duodenal Diseases; Duodenum; Gastrointestinal Hemorrhage; Hematoma; Humans; Radiography | 1961 |
Anti-veratrinic activity of coumarin and its derivative compounds.
Topics: Coumarins; Humans; Veratrum; Veratrum Alkaloids | 1960 |
Biosynthesis of the coumarins. Tracer studies on coumarin formation in Hierochloe odorata and Melilotus officinalis.
Topics: Coumarins; Melilotus; Poaceae; Research | 1960 |
[Comparison of coagulation time obtained with the one-stage method according to Quick (prothrombin time) and according to Owren (prothrombin-proconvertin time) in the control of coumarin treatment].
Topics: Blood Coagulation Tests; Coumarins; Factor VII; Humans; Prothrombin; Prothrombin Time | 1959 |
[On the biosynthesis of coumarin].
Topics: Coumarins | 1959 |
The FIRST recognition of cumarin.
Topics: Coumarins; Humans | 1960 |
Calophyllolide, a complex coumarin anticoagulant from Calophyllum inophyllum Linn.
Topics: Anticoagulants; Calophyllum; Coumarins | 1962 |
Biosynthesis of coumarin and herniarin in lavender.
Topics: Acids; Cinnamates; Coumaric Acids; Coumarins; Hydroxylation; Lavandula; Propionates; Umbelliferones | 1962 |
Biosynthesis of the coumarins. III. The role of glycosides in the formation of coumarin by Hierochloe odorata.
Topics: Biochemical Phenomena; Coumarins; Glycosides; Plants; Poaceae | 1962 |
The influence of barbiturates on coumarin plasma levels and prothrombin response.
Topics: Barbiturates; Coumarins; Humans; Plasma; Prothrombin; Prothrombin Time | 1961 |
"Purple toes": an uncommon sequela of oral coumarin drug therapy.
Topics: Coumarins; Humans; Skin Diseases; Toes | 1961 |
The complex pattern of response to coumarin drug therapy. The inadequacy of the prothrombin test as a guide to hypocoagulability.
Topics: Coumarins; Humans; Prothrombin; Prothrombin Time | 1962 |
[Factors which can influence coumarin therapy].
Topics: Coumarins; Humans | 1962 |
Influence of coumarin treatment on plasma thromboplastin formation and heparin tolerance.
Topics: Coumarins; Drug Tolerance; Heparin; Humans; Immune Tolerance; Plasma; Thromboplastin | 1962 |
[Research on a pyramidon derivative without delayed action on a simultaneously administered anticoagulant coumarin derivative].
Topics: Aminopyrine; Anticoagulants; Blood Coagulation; Coumarins; Delayed-Action Preparations; Research | 1962 |
[Germination in vitro of spores of Gymnogramma calomelanos (Filicineae) in the presence of coumarin].
Topics: Coumarins; Germination; In Vitro Techniques; Plants; Spores | 1961 |
The biosynthesis of coumarin in Melilotus alba.
Topics: Coumarins; Melilotus; Plants | 1962 |
Levels of equivalence for various measurements of coumarin activity.
Topics: Coumarins | 1962 |
[Study of a new coumarin anticoagulant, compound G-23350 (Sintrom)].
Topics: Acenocoumarol; Anticoagulants; Coronary Disease; Coumarins; Peripheral Vascular Diseases; Thromboembolism; Vascular Diseases | 1960 |
Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
Topics: Acenocoumarol; Blood Coagulation Tests; Coumarins; Dicumarol; Factor IX; Factor VII; Factor X; Hematologic Tests; Hemostatics; Humans; Prothrombin; Warfarin | 1963 |
[Study of the anticoagulant action of a new derivative of coumarin: Dicoumoxyl (Methoxy-1-bis-hydroxy-4-coumarinyl 3)-2,2 ethane)].
Topics: Anticoagulants; Coumarins; Dicumarol; Ethane | 1962 |
Glucosides of coumarinic and o-coumaric acids in the tonka bean.
Topics: Cellulases; Coumaric Acids; Coumarins; Dipteryx; Glucosides; Glycosides; Vegetables | 1963 |
[Studies on the content of coumarin in the herbs of the woodruff (Herba Asperulae odoratae) throughout the vegetative period of the plant].
Topics: Asteraceae; Coumarins; Plants, Medicinal | 1963 |
[Skin necroses due to coumarin medication].
Topics: Coumarins; Hematoma; Humans; Necrosis; Skin Diseases | 1962 |
The isolation and identification of bound coumarin from Melilotus alba.
Topics: Biophysical Phenomena; Coumarins; Melilotus; Seeds | 1962 |
Laboratory control of coumarin therapy: the clinician's dilemma.
Topics: Coumarins; Prothrombin Time | 1962 |
Anticoagulant therapy with coumarin congeners. Action and guidelines.
Topics: Anticoagulants; Coumarins; Humans | 1962 |
Thrombelastographic study of 76 patients on long-term anticoagulant therapy with coumarin-type drugs.
Topics: Anticoagulants; Coumarins; Humans; Thrombelastography | 1962 |
[Clinical trial of a new anticoagulant derived from coumarin: 1-methoxy-2, 2-bis(4-hydroxy-3-coumarinyl)-ethane].
Topics: Anticoagulants; Coumarins; Ethane | 1963 |
[Critical study of the use of a new anticoagulant, derived from coumarin: dicoumoxyl, 1-methoxy-2,2-bis (4-hydroxy-3-coumarinyl)-ethane].
Topics: Anticoagulants; Coumarins; Ethane | 1963 |
[Intravenous administration of coumarin derivates. Experiences with warfarin sodium].
Topics: Administration, Intravenous; Coumarins; Humans; Sodium; Vascular Surgical Procedures; Warfarin | 1963 |
COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
Topics: Anticoagulants; Blood Coagulation Tests; Coumarins; Dicumarol; Factor VII; Geriatrics; Hemostatics; Humans; Hypoprothrombinemias; Myocardial Infarction; Prothrombin; Thrombosis | 1963 |
ON THE CONCEPT OF SLOWLY AND RAPIDLY ACTING COUMARIN DRUGS.
Topics: Blood Coagulation; Coumarins; Dogs; Ethyl Biscoumacetate; Pharmacology; Research | 1963 |
CHEMICAL BASIS OF THE ACTION OF NATURAL COUMARIN AND ITS DERIVATIVES ON CHROMOSOME BREAKAGE.
Topics: Chromosome Breakage; Chromosomes; Coumarins; Humans; Plants, Medicinal | 1963 |
STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: THE PHARMACODYNAMICS OF WARFARIN IN MAN.
Topics: Anticoagulants; Coumarins; Humans; Male; Metabolism; Pharmacology; Prothrombin Time; Vitamin K 1; Warfarin | 1963 |
A FUNGISTATIC ACTION OF COUMARIN.
Topics: Antifungal Agents; Aspergillus; Coumarins; Penicillium; Pharmacology; Research; Triazoles | 1963 |
[CRITICAL STUDY, BASED ON 43 CASES, OF A COUMARIN ANTICOAGULANT: DICOUMOXYL (1-METHOXY-2,2-BIS-(4-HYDROXY-3-COU- MARINYL)-ETHANE)].
Topics: Anticoagulants; Arrhythmias, Cardiac; Coronary Disease; Coumarins; Ethane; Mitral Valve Stenosis; Myocardial Infarction; Pulmonary Embolism | 1963 |
COMPARISON OF RAT LIVER RESPONSE TO COUMARIN ADMINISTERED IN VIVO VERSUS IN VITRO.
Topics: Amino Acids; Aminoisobutyric Acids; Antimetabolites; Carbon Isotopes; Coumarins; Factor VII; Glycine; In Vitro Techniques; Liver; Metabolism; Naphthoquinones; Pharmacology; Proteins; Rats; Research; Ubiquinone; Vitamin K; Warfarin | 1964 |
BEHAVIOUR OF FACTORS II, VII, IX AND X IN BLEEDING COMPLICATIONS DURING LONG-TERM TREATMENT WITH COUMARIN.
Topics: Cerebral Hemorrhage; Coumarins; Epistaxis; Factor VII Deficiency; Hemophilia B; Hemorrhage; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Melena; Prothrombin; Splenic Rupture; Toxicology | 1964 |
STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: A COMPARISON OF THE PHARMACODYNAMICS OF DICUMAROL AND WARFARIN IN MAN.
Topics: Anticoagulants; Blood Proteins; Coumarins; Dicumarol; Feces; Humans; Hypoprothrombinemias; Male; Pharmacology; Prothrombin Time; Research; Warfarin | 1964 |
[DERIVATIVES OF BENZOFURAN AND COUMARIN. III. BETA-ALANINAMIDES OF THE 2-ETHYL-3-METHYLBENZOFURAN AND 2-ETHYL-3-METHYLCOUMARIN SERIES].
Topics: Antihypertensive Agents; Benzofurans; Chemistry, Pharmaceutical; Coumarins; Furans; Mice; Pharmacology; Research | 1964 |
[ON THE ANTIBIOTIC EFFECT OF NATURAL COUMARINS. V. MODIFICATION OF THE EFFECT OF THE TERPENE COUMARIN OSTRUTHIN BY SURFACE-ACTIVE AGENTS].
Topics: Anti-Bacterial Agents; Coumarins; Pharmacology; Research; Staphylococcus; Surface-Active Agents; Terpenes; Umbelliferones | 1964 |
[CAPILLARY-PROTECTIVE ACTION OF 4-METHYL-6,7-(BIS-BETA-DIETHYLAMINOETHOXY)-COUMARIN HYROCHLORIDE IN PARENTERAL AND ORAL ADMINISTRATION. STUDY OF BLEEDING TIME AND INTENSITY AND PETECHIOMETRY].
Topics: Administration, Oral; Bleeding Time; Capillaries; Coumarins; Hepatitis; Humans; Pharmacology; Purpura; Purpura, Thrombocytopenic; Thrombocytopenia | 1963 |
HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.
Topics: Anticoagulants; Blood; Blood Coagulation Factors; Blood Coagulation Tests; Child; Coumarins; Dicumarol; Diseases in Twins; Drug Tolerance; Genetics, Medical; Geriatrics; Heparin; Humans; Intestinal Absorption; Pharmacology; Phenindione; Vitamin K; Warfarin | 1964 |
METABOLISM OF COUMARIN BY A MICRO-ORGANISM.
Topics: Arthrobacter; Chromatography; Cinnamates; Coumarins; Metabolism; Research; Soil Microbiology; Tyrosine | 1964 |
7-METHOXY-8-ISO-PENTENYL COUMARIN (OSTHOL) -- TOXICITY AND ITS MECHANISM OF RESPIRATORY STIMULANT ACTION.
Topics: Aorta; Blood Pressure; Carotid Body; Coumarins; Decerebrate State; Denervation; Dogs; Pharmacology; Research; Respiration; Respiratory System Agents; Sensory Receptor Cells; Toxicology; Vagotomy | 1964 |
AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
Topics: Acenocoumarol; Anticoagulants; Blood Coagulation Tests; Coumarins; Dicumarol; Drug Therapy; Geriatrics; Hemorrhagic Disorders; Humans; Hypoprothrombinemias; Indans; Phenindione; Prothrombin Time; Warfarin | 1965 |
STRUCTURE OF LOMATIN, A NEW COUMARIN.
Topics: Chemistry, Pharmaceutical; Coumarins; Pharmacy; Plants, Medicinal; Research | 1964 |
[HYDROXYLATION OF COUMARIN WITH RABBIT LIVER MICROSOMES. 1. DIRECT SPECTRAL FLUROMETRIC MEASUREMENT OF ENZYME ACTIVITY].
Topics: Animals; Coumarins; Hydrolases; Hydroxylation; Liver; Metabolism; Microsomes; Microsomes, Liver; NADP; Rabbits; Research; Spectrum Analysis | 1964 |
METABOLISM OF COUMARIN BY A MICRO-ORGANISM: O-COUMARIC ACID AS AN INTERMEDIATE BETWEEN COUMARIN AND MELILOTIC ACID.
Topics: Arthrobacter; Chromatography; Cinnamates; Coumaric Acids; Coumarins; Metabolism; Phenols; Radioisotope Dilution Technique; Research; Spectrum Analysis; Tritium | 1964 |
[CHARACTERIZATION OF THE DIURETIC EFFECT OF COUMARIN-3-GLYOXYLIC ALDEHYDE].
Topics: Aldehydes; Aldosterone; Body Fluids; Carbon Tetrachloride; Chlorothiazide; Coumarins; Diuretics; Electrolytes; Pharmacology; Rats; Research; Spironolactone; Urine | 1963 |
THE METABOLISM OF COUMARIN BY A MICROORGANISM. II. THE REDUCTION OF O-COUMARIC ACID TO MELILOTIC ACID.
Topics: Arthrobacter; Benzoates; Catalysis; Centrifugation; Chemical Phenomena; Chemical Precipitation; Chemistry; Chromatography; Coumaric Acids; Coumarins; Dialysis; Enzyme Inhibitors; NAD; Oxidoreductases; Phenols; Propionates; Renal Dialysis; Research; Spectrophotometry | 1964 |
PETECHIAE, ECCHYMOSES, AND NECROSIS OF SKIN INDUCED BY COUMARIN CONGENERS: RARE, OCCASIONALLY LETHAL COMPLICATION OF ANTICOAGULANT THERAPY.
Topics: Acenocoumarol; Anticoagulants; Coumarins; Dicumarol; Drug Therapy; Ecchymosis; Ethyl Biscoumacetate; Gangrene; Necrosis; Phenindione; Pulmonary Embolism; Purpura; Skin Diseases; Thrombophlebitis; Toxicology; Warfarin | 1965 |
[ACTIVATION OF BLOOD COAGULATION BY A BACTERIAL ENDOTOXIN IN PERSONS UNDER COUMARIN THERAPY].
Topics: Blood Coagulation; Coumarins; Endotoxins; Factor V; Factor VII; Factor VIII; Factor X; Fibrinogen; Humans; Lipopolysaccharides; Pharmacology | 1965 |
CONSTITUENTS OF UMBELLIFEROUS PLANTS. VI. THE STRUCTURE OF PEULUSTRIN, A NEW COUMARIN FROM PEUCEDANUM PALUSTRE L.
Topics: Apiaceae; Chemistry Techniques, Analytical; Coumarins; Plants; Research | 1965 |
A RARE COMPLICATION OF COUMARIN-CONGENER ANTICOAGULANT THERAPY.
Topics: Anticoagulants; Coumarins; Drug Therapy; Hemorrhage; Humans; Necrosis; Skin Diseases; Toxicology | 1965 |
[ON SOME NEW DERIVATIVES OF 2-IMINOCOUMARIN AND COUMARIN WITH ANTIMICROBIAL ACTIVITY].
Topics: Anti-Infective Agents; Chemistry, Pharmaceutical; Coumarins; Pharmacy; Research | 1965 |
[ELEVATION OF THE ANTITHROMBIN CONTENT OF THE BLOOD DURING COUMARIN THERAPY].
Topics: Antithrombins; Coumarins; Enzyme Inhibitors; Humans; Thrombin | 1965 |
[Animal experiments on the effect of the anticoagulant tromexan on coronary blood flow and oxygen consumption of the heart].
Topics: Animal Experimentation; Animals; Anticoagulants; Coronary Vessels; Coumarins; Ethyl Biscoumacetate; Heart; Humans; Metabolism; Myocardium; Oxygen Consumption | 1955 |
[Local heparinization and pelentane diaphragm in arterial surgery].
Topics: Arteries; Coumarins; Diaphragm; Heparin; Humans | 1955 |
[Experiences with thrombosis prophylaxis with marcoumar].
Topics: Anticoagulants; Coumarins; Humans; Phenprocoumon; Thrombosis | 1954 |
[Hepatic function in infants in relation to alimentation: tromexan tolerance test and electrophoresis of blood proteins].
Topics: Blood Proteins; Coumarins; Digestion; Electrophoresis; Ethyl Biscoumacetate; Liver Function Tests | 1954 |
[Progress and simplification in the supervision of thrombosis therapy with coumarin derivatives].
Topics: Coumarins; Thrombosis | 1955 |
[Anticoagulant therapy with marcoumar; with criticism of ambulant use].
Topics: Anticoagulants; Coumarins; Phenprocoumon; Social Behavior | 1955 |
[Acute abdominal syndrome of intestinal occlusion type in dicumarol poisoning].
Topics: Abdomen; Abdomen, Acute; Coumarins; Diagnosis, Differential; Dicumarol; Humans; Intestinal Obstruction; Poisoning | 1954 |
[Effects on mother and infant of dicumarol therapy in pregnancy].
Topics: Blood Coagulation; Coumarins; Dicumarol; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Mothers; Pregnancy; Pregnancy Complications; Prothrombin Time | 1955 |
[Case of acute dicumarol poisoning].
Topics: Aged; Coumarins; Dicumarol; Disease; Humans; Kidney; Poisoning | 1954 |
[Intravenous administration of vitamin K1 (konakion) as antidote to the anticoagulants of the dicumarol type].
Topics: Administration, Intravenous; Anticoagulants; Antidotes; Coumarins; Dicumarol; Hemorrhagic Disorders; Hypoprothrombinemias; Prothrombin; Vitamin K 1 | 1955 |
[A new medicamentous incompatibility; thiomerin and marcoumar].
Topics: Coumarins; Diuretics; Drug Incompatibility; Organomercury Compounds; Phenprocoumon | 1955 |
The effect of meladinin in the treatment of vitiligo.
Topics: Ammi; Coumarins; Vitiligo | 1955 |
[Experiences with a new anticoagulant (marcoumar)].
Topics: Anticoagulants; Blood Coagulation; Coumarins; Phenprocoumon; Prothrombin Time | 1955 |
[Pelada and ammoidins].
Topics: Alopecia; Alopecia Areata; Coumarins; Humans; Methoxsalen | 1954 |
The current status of anticoagulants in the treatment of myocardial infarction.
Topics: Anticoagulants; Cardiovascular Diseases; Coumarins; Heparin; Humans; Myocardial Infarction | 1955 |
Haemorrhagic diathesis attributed to warfarin poisoning.
Topics: Coumarins; Hemorrhagic Disorders; Insecticides; Warfarin | 1955 |
[Ambulant treatment of thrombophlebitic processes with "marcoumar" Roche].
Topics: Coumarins; Humans; Phenprocoumon; Thrombophlebitis | 1955 |
[The Quick test in determining the effects of dicumarin therapy and its relationship to the coagulation factors].
Topics: Blood Coagulation; Blood Coagulation Factors; Coumarins; Prothrombin Time | 1955 |
Six years experience with dicumarol prophylaxis against postoperative thromboembolic complications in private practice.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Postoperative Care; Postoperative Complications; Private Practice; Thromboembolism | 1955 |
[Pelentan treatment of thromboembolism following a gynecological operation].
Topics: Coumarins; Ethyl Biscoumacetate; Female; Genital Diseases, Female; Gynecologic Surgical Procedures; Humans; Thromboembolism | 1954 |
[Vitamin K1, elective antidote of coumarin derivatives].
Topics: Antidotes; Antifibrinolytic Agents; Coumarins; Heparin Antagonists; Naphthoquinones; Retinoids; Vitamin K; Vitamin K 1 | 1954 |
Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system.
Topics: Anticoagulants; Basilar Artery; Brain; Cerebrovascular Disorders; Coumarins; Heparin; Humans; Thrombosis | 1955 |
[Dicumarol poisoning with severe hematuria].
Topics: Coumarins; Dicumarol; Hematuria; Humans; Poisoning | 1955 |
[Comparative studies of blood coagulation in the treatment of thrombophlebitis with marcoumar and panthesin hydergin].
Topics: Aminobenzoates; Blood Coagulation; Coumarins; Ergot Alkaloids; Leucine; para-Aminobenzoates; Phenprocoumon; Thrombophlebitis | 1955 |
[Experience with the anticoagulants marcumar and liquemin in gynecology].
Topics: Anticoagulants; Coumarins; Female; Genital Diseases, Female; Gynecology; Heparin; Humans; Phenprocoumon | 1955 |
[Vitamin K1-therapy in marcoumar hemorrhages].
Topics: Antifibrinolytic Agents; Coumarins; Hemorrhage; Humans; Naphthoquinones; Phenprocoumon; Retinoids; Vitamin K; Vitamin K 1 | 1955 |
[Parenteral and rectal use of 3-(1-phenylpropyl)-4-oxy-coumarin (marcunar) at the start of thrombosis prophylaxis].
Topics: Anticoagulants; Coumarins; Humans; Thrombosis | 1955 |
[Anticoagulant effects of 3,3'-ethylidenebis(4-hydroxycoumarin); importance of the calcium sensitivity index for the evaluation of hypocoagulation prompted by bishydroxycomarin derivatives].
Topics: 4-Hydroxycoumarins; Anticoagulants; Calcium; Calcium, Dietary; Coumarins; Water-Electrolyte Balance | 1954 |
[Tuberculostatic effect of some aromatic acids and coumarins in vitro].
Topics: Acids; Coumarins; In Vitro Techniques; Mycobacterium tuberculosis | 1955 |
[Photocolorimetric determination of di-(4-hydroxycumarinyl-3) acetic acid (pelentan)].
Topics: Acetates; Acetic Acid; Colorimetry; Coumarins; Ethyl Biscoumacetate | 1954 |
[Hemorrhage due to tromexan in eruption caused by penicillin].
Topics: Coumarins; Drug Eruptions; Ethyl Biscoumacetate; Exanthema; Hemorrhage; Humans; Penicillins; Tooth Eruption | 1955 |
The uricosuric action of ethyl biscoumacetate.
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Uric Acid; Urine | 1955 |
Ethyl biscoumacetate as an inhibitor of sickling.
Topics: Anemia; Anemia, Sickle Cell; Coumarins; Ethyl Biscoumacetate; Humans | 1955 |
[Practical application of anticoagulant therapy].
Topics: Anticoagulants; Coumarins; Humans | 1955 |
Marcumar.
Topics: Coumarins | 1955 |
[Dicumarol-like anticoagulants; clinical experience with various preparations].
Topics: Anticoagulants; Coumarins; Dicumarol; Humans | 1955 |
Plasma thromboplastin component (PTC) deficiency produced by prolonged administration or prothrombopenic anticoagulants.
Topics: Anticoagulants; Blood Coagulation; Coumarins; Factor IX; Hemophilia B; Hemorrhagic Disorders; Humans; Phenindione | 1955 |
[Vitamin K antagonists used as raticides].
Topics: Coumarins; Fibrinolytic Agents; Rats; Vitamin K | 1955 |
[Study of cyclocumarol, its clinical aspects and its depressive action on prothrombin and on proconvertin].
Topics: 4-Hydroxycoumarins; Blood Coagulation; Blood Coagulation Tests; Coumarins; Factor VII; Hemostatics; Prothrombin | 1955 |
[Observations in the antithrombotic treatment of a female patient with varico-thrombophlebitis].
Topics: Breast; Breast Diseases; Coumarins; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intestines; Thrombophlebitis | 1955 |
[Intravenous application of dicoumarins].
Topics: Coumarins; Dicumarol | 1955 |
The hydroxylation of coumarin and the cyclization of o-coumaric acid in vivo.
Topics: Acids; Coumaric Acids; Coumarins; Cyclization; Hydroxylation | 1955 |
[Study on anticoagulant substances. XVII. Anticoagulant effects of the new palentan derivatives].
Topics: Anticoagulants; Coumarins; Humans | 1952 |
[Development and prevention with pelentan of alimentary atheromatosis in rabbits].
Topics: Animals; Arteriosclerosis; Atherosclerosis; Biomedical Research; Coumarins; Ethyl Biscoumacetate; Rabbits | 1952 |
[Anticoagulant therapy of priapism with pelentan in chronic myeloid leukemia].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Priapism | 1952 |
[Hazards in pelentan therapy].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
[Pelentan therapy of arterial thrombosis and embolism].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Thrombosis | 1952 |
[Hazards and indications for pelentan therapy of myocardial infarction].
Topics: Cardiovascular Diseases; Coumarins; Ethyl Biscoumacetate; Myocardial Infarction | 1952 |
[Comparative results of prolonged administration in rats of pelentan and of 1,1-bis(4-hydroxy-3-coumarinyl)-propanone].
Topics: Animals; Coumarins; Ethyl Biscoumacetate; Propane; Rats | 1952 |
[Studies on anticoagulants. XXVIII. A new highly active anticoagulant analogue pelentan].
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans; Inorganic Chemicals; Organic Chemicals | 1955 |
[New aspects of treatment with anticoagulants].
Topics: Anticoagulants; Coumarins; Humans | 1955 |
[Anticoagulant prophylaxis by marcumar in gynecology and obstetrics].
Topics: Anticoagulants; Coumarins; Female; Genital Diseases, Female; Gynecologic Surgical Procedures; Gynecology; Humans; Obstetric Surgical Procedures; Obstetrics; Phenprocoumon; Pregnancy | 1955 |
[Endothelial permeability in the pathogenesis of experimental atherosclerosis. I. Protective effect of 4-Methylesculetin, disulfuric ester].
Topics: Arteriosclerosis; Atherosclerosis; Coumarins; Esters; Permeability; Umbelliferones | 1955 |
Leucoderma and its treatment with Ammi majus.
Topics: Ammi; Coumarins; Humans; Vitiligo | 1955 |
Treatment of vitiligo with extracts of Ammi majus Linn.
Topics: Ammi; Coumarins; Humans; Vitiligo | 1955 |
[Interference of barbiturates in the action of tromexan].
Topics: Barbiturates; Coumarins; Ethyl Biscoumacetate | 1955 |
[Anticoagulant prophylaxis with marcoumar in the puerperium].
Topics: Anticoagulants; Coumarins; Female; Humans; Phenprocoumon; Postpartum Period; Thromboembolism | 1955 |
[Clinical tests in pediatrics of the effect of a new compound with antirheumatic and antipyretic action].
Topics: Aminopyrine; Antipyretics; Child; Coumarins; Humans; Pediatrics; Respiratory System; Respiratory Tract Diseases; Tonsillitis | 1955 |
[Animal experimental studies with a new highly potent 4-hydroxycoumarin derivative with short action: sintrom (G 23350)].
Topics: 4-Hydroxycoumarins; Acenocoumarol; Animal Experimentation; Animals; Coumarins | 1955 |
[Clinical experience with a new 4-hydroxycoumarin derivative: sintrom (Geigy 23350)].
Topics: 4-Hydroxycoumarins; Acenocoumarol; Coumarins | 1955 |
[Acute abdominal syndromes in the course of dicoumarol intoxication].
Topics: Abdomen; Abdomen, Acute; Abdominal Cavity; Coumarins; Diagnosis, Differential; Dicumarol; Humans; Poisoning; Syndrome | 1955 |
[Thrombosis and embolism after major gynecological operations].
Topics: Coumarins; Embolism; Female; Genitalia; Genitalia, Female; Gynecologic Surgical Procedures; Humans; Thrombosis | 1955 |
[Thromboembolism prophylaxis in surgical gynecology with a coumarin derivative and its antagonist vitamin K1].
Topics: Anticoagulants; Coumarins; Female; Genitalia; Genitalia, Female; Gynecology; Humans; Thromboembolism; Vitamin K; Vitamin K 1 | 1955 |
[Results of prolonged coumarin therapy after heart infarct].
Topics: Coumarins; Humans; Myocardial Infarction | 1959 |
Effect of coumarin on the growth of Rhodotorula rosea cultures.
Topics: Coumarins; Fungi; Physiological Phenomena; Rhodotorula | 1960 |
[Therapeutic experiences with the new synthetic coumarin derivative, syncumar].
Topics: Acenocoumarol; Coumarins | 1960 |
Studies on the identity of bound coumarin in sweet clover.
Topics: Coumarins; Drug Combinations; Melilotus; Plants, Medicinal; Resins, Plant; Rutin | 1961 |
[Apropos of the anticoagulant effects of a new coumarin derivative].
Topics: Anticoagulants; Coumarins | 1961 |
Plasma thromboplastin antecedent levels in patients receiving coumarin anticoagulants and in patients with Laennec's cirrhosis.
Topics: Anticoagulants; Coumarins; Factor XI; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Thromboplastin | 1961 |
A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique.
Topics: Anticoagulants; Blood Coagulation Tests; Chromogenic Compounds; Coumarins; Drug Monitoring; Heparin; Humans; Indicators and Reagents; Reproducibility of Results; Thrombin | 2003 |
By the way, doctor. Can you help me out? I've been taking warfarin (Coumadin) for two years now because of a deep-vein thrombus that broke off and went to my lungs. I'd like to get off it. I've also had a hard time managing my vitamin K levels and have be
Topics: Anticoagulants; Coumarins; Humans; International Normalized Ratio; Patient Compliance | 2003 |
Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Biological Assay; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Mixed Function Oxygenases; Spectrometry, Fluorescence | 1998 |
Cloning and characterization of a glucosyltransferase that reacts on 7-hydroxyl group of flavonol and 3-hydroxyl group of coumarin from tobacco cells.
Topics: Amino Acid Sequence; Cells, Cultured; Cloning, Molecular; Coumarins; Enzyme Activation; Flavonoids; Gene Expression Regulation, Enzymologic; Glucosyltransferases; Hydroxyl Radical; Molecular Sequence Data; Nicotiana; Plant Growth Regulators; Plant Leaves; Protein Binding; Recombinant Proteins; Sequence Analysis, Protein | 2003 |
A comparison of US and Norwegian regulation of coumarin in tobacco products.
Topics: Coumarins; Health Policy; Humans; Nicotiana; Norway; Smoking; Tobacco Industry; United States | 2003 |
Photoacoustic investigations on the photostability of Coumarin 540-doped PMMA.
Topics: Acoustics; Coumarins; Lasers; Light; Models, Chemical; Polymers; Polymethyl Methacrylate; Spectrophotometry; Time Factors | 2004 |
Late onset of clinical symptoms and recurrent ecchymotic skin lesions in a 12-year-old girl with a severe double heterozygous protein C deficiency.
Topics: Age of Onset; Anticoagulants; Child; Coumarins; DNA Mutational Analysis; Ecchymosis; Family Health; Female; Heterozygote; Humans; Mutation, Missense; Nadroparin; Necrosis; Protein C Deficiency; Recurrence; Skin Diseases | 2004 |
[Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Coumarins; Cross-Sectional Studies; Germany; Humans; Hypertension; Intracranial Embolism; Risk Factors; Ventricular Remodeling | 2003 |
Probing protein-surfactant interaction by steady state and time-resolved fluorescence spectroscopy.
Topics: Anilino Naphthalenesulfonates; Animals; Cattle; Coumarins; Dose-Response Relationship, Drug; Fluorescent Dyes; Micelles; Models, Chemical; Protein Binding; Serum Albumin; Spectrometry, Fluorescence; Surface-Active Agents; Temperature; Time Factors | 2004 |
Identification of the human cytochrome P450s responsible for the in vitro metabolism of a leukotriene B4 receptor antagonist, CP-195,543.
Topics: Adolescent; Adult; Aged; Chromans; Coumarins; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Humans; Ketoconazole; Kinetics; Male; Mephenytoin; Microsomes, Liver; Middle Aged; NADP; Oxidation-Reduction; Quinidine; Receptors, Leukotriene B4; Recombinant Proteins; Sulfaphenazole; Theophylline | 2003 |
[Heightening of the hypoprothrombinemic action of some vitamin K antagonists by simultaneous ingestion of esculoside].
Topics: Coumarins; Esculin; Humans; Hypoprothrombinemias; Phenindione; Vitamin K | 1950 |
[Prophylaxis of thrombosis with tromexan in closed fractures of the leg].
Topics: Blood Coagulation; Coumarins; Ethyl Biscoumacetate; Fractures, Bone; Fractures, Closed; Humans; Leg; Thrombosis | 1950 |
[Relation of chemical substituents and biological comparison of esculin and quinine].
Topics: Coumarins; Esculin; Humans; Quinine | 1950 |
The nuclear oxidation of coumarins.
Topics: Coumarins; Oxidation-Reduction | 1950 |
Clinical evaluation of 4-hydroxycoumarin anticoagulant no. 63.
Topics: 4-Hydroxycoumarins; Anticoagulants; Blood; Coumarins; Hemostatics; Prothrombin | 1950 |
Experiences with a new anticoagulant.
Topics: Anticoagulants; Blood Coagulation; Coumarins | 1951 |
[Factors of growth and metamorphosis of tadpoles. IV. Action of nicotinamide and coumarin].
Topics: Animals; Coumarins; Growth; Humans; Larva; Metamorphosis, Biological; Niacin; Niacinamide | 1950 |
[Crisis and lysis in thrombosis].
Topics: Cell Death; Coumarins; Heparin; Humans; Thrombosis | 1950 |
[Advantages of a new coumarin derivative in recent phlebitis therapy of the deep vessels].
Topics: Coumarins; Humans; Phlebitis | 1951 |
[Advantages of a new coumarin derivative].
Topics: Coumarins; Ethyl Biscoumacetate | 1951 |
The interrelationship of vitamin K and dicoumarin.
Topics: Coumarins; Dicumarol; Humans; Vitamin K | 1951 |
[Investigation of hemorrhagic risk in synergistic sulfonamide and dicoumarin therapy].
Topics: Coumarins; Dicumarol; Humans; Risk; Sulfanilamide; Sulfanilamides; Sulfonamides | 1951 |
Clinical evaluation of 4-hydroxycoumarin anticoagulant No. 63.
Topics: 4-Hydroxycoumarins; Anticoagulants; Blood Coagulation; Coumarins | 1951 |
[Stimulation of the initial growth of barley by treatment of the seeds with coumarin].
Topics: Coumarins; Growth; Hordeum; Humans; Seeds | 1951 |
[Investigations on a new rodenticide with cumulative action, based upon coumarin derivatives].
Topics: Animals; Coumarins; Humans; Rodentia; Rodenticides | 1951 |
The hematologic aspects of disseminated (systemic) lupus erythematosus.
Topics: Coumarins; Lupus Erythematosus, Systemic | 1951 |
Tromexan and dicoumarol.
Topics: Coumarins; Dicumarol; Ethyl Biscoumacetate | 1951 |
[Dicoumarin in course of certain forms of hypertension; coagulant and anticoagulant therapy].
Topics: Anticoagulants; Blood Coagulation; Coagulants; Coumarins; Dicumarol; Humans; Hypertension | 1951 |
Control of anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Humans | 1951 |
Effect of oral cortisone on water diuresis in Addison's disease and hypopituitarism.
Topics: Addison Disease; Adrenal Insufficiency; Cortisone; Coumarins; Diuresis; Hypoadrenocorticism, Familial; Hypopituitarism; Metabolic Diseases; Pituitary Diseases; Pituitary Gland; Water | 1951 |
[Method of prothrombin time test in the control of pelentan therapy].
Topics: Coumarins; Ethyl Biscoumacetate; Hemostatics; Humans; Prothrombin; Prothrombin Time | 1951 |
[Possibility of tromexan therapy of anterior chamber inflammations of the eye].
Topics: Anterior Chamber; Coumarins; Ethyl Biscoumacetate; Eye Diseases; Humans; Inflammation | 1951 |
Anticoagulants in the treatment of coronary thrombosis.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Coronary Disease; Coronary Thrombosis; Coumarins; Heparin; Humans | 1951 |
Platelets and the coagulation defect caused by dicumarol.
Topics: Blood Coagulation Disorders; Blood Platelets; Coumarins; Dicumarol; Hemostatics; Prothrombin | 1951 |
The effect of anticoagulants on the clotting in the plasmoid fluid and its significance for the intraocular pressure.
Topics: Anticoagulants; Aqueous Humor; Body Fluids; Coumarins; Intraocular Pressure; Tonometry, Ocular | 1951 |
Hypoprothrombinemia due to dicumarol in a malingerer: a case report.
Topics: Coumarins; Dicumarol; Hypoprothrombinemias; Mental Disorders | 1951 |
[Effect of pelentan on blood cholinesterase in certain animals and men].
Topics: Animals; Cholinesterases; Coumarins; Ethyl Biscoumacetate; Humans; Male | 1951 |
[Effect of pelentan on blood coagulation in rabbits].
Topics: Animals; Blood Coagulation; Coumarins; Ethyl Biscoumacetate; Lagomorpha; Rabbits | 1951 |
[Reaction determining blood prothrombin activity and control of pelentan therapy from the practical viewpoint].
Topics: Coumarins; Ethyl Biscoumacetate; Humans; Prothrombin | 1951 |
Clinical experiences with 4-hydroxycoumarin anticoagulant No. 63 and the antagonistic effect of menadione and vitamin K.
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Hemostatics; Humans; Prothrombin; Vitamin K; Vitamin K 3 | 1951 |
Bleeding from unsupervised use of dicumarol.
Topics: Coumarins; Dicumarol; Hemorrhage; Humans | 1951 |
Vitamin K1 emulsions in bishydroxycoumarin emergencies; results of intravenous administration.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Coumarins; Dicumarol; Emergencies; Emulsions; Naphthoquinones; Prothrombin; Vitamin K; Vitamin K 1 | 1951 |
Tromexan therapy; dosage and indications.
Topics: Coumarins; Ethyl Biscoumacetate; Humans | 1951 |
Severe hemorrhage due to tromexan; report of three cases.
Topics: Coumarins; Ethyl Biscoumacetate; Hemorrhage; Humans | 1951 |
The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
Topics: Coumarins; Dalteparin; Dicumarol; Hemostatics; Heparin; Humans; Prothrombin; Prothrombin Time | 1952 |
Tromexan in the treatment of coronary thrombosis.
Topics: Cardiotonic Agents; Coronary Disease; Coronary Thrombosis; Coumarins; Ethyl Biscoumacetate; Humans | 1951 |
Clinical experience with the anticoagulant, tromexan.
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate | 1951 |
The prevention of impending cardiac infarction by anticoagulant treatment.
Topics: Angina, Unstable; Anticoagulants; Coronary Disease; Coumarins; Heparin; Humans; Infarction; Myocardial Infarction | 1951 |
[Modification of prothrombin time during storage of normal rabbit plasma and with added pelentan].
Topics: Animals; Coumarins; Ethyl Biscoumacetate; Plasma; Prothrombin; Prothrombin Time; Rabbits | 1951 |
Oral anticoagulant therapy in myocardial infarction.
Topics: Anticoagulants; Coronary Disease; Coumarins; Myocardial Infarction | 1951 |
Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
Topics: 4-Hydroxycoumarins; Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate | 1952 |
Unusual hemorrhagic complications in dicumarol therapy.
Topics: Abdominal Wall; Coumarins; Dicumarol; Hemorrhage; Humans | 1951 |
Spectrophotometric determination of Tromexan in plasma and serum.
Topics: Coumarins; Ethyl Biscoumacetate; Plasma; Spectrophotometry | 1951 |
Is hypoprothrombinemia caused by deficiency of vitamin K different from that of dicumarol?
Topics: Antifibrinolytic Agents; Coumarins; Dicumarol; Humans; Hypoprothrombinemias; Vitamin K; Vitamin K Deficiency | 1952 |
[Dicumarol prophylaxis of postoperative thrombosis; dosage and toxic reactions].
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Thrombosis | 1951 |
[Tromexan prophylaxis and therapy of thrombosis].
Topics: Coumarins; Ethyl Biscoumacetate; Thrombosis | 1951 |
A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin.
Topics: Anticoagulants; Coumarins; Ethyl Biscoumacetate; Humans | 1951 |
Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.
Topics: Antifibrinolytic Agents; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hypoprothrombinemias; Naphthoquinones; Prothrombin; Vitamin K | 1952 |
DICUMAROL.
Topics: Coumarins; Dicumarol | 1952 |
[Prevention of thrombosis].
Topics: Anticoagulants; Coumarins; Humans; Thrombosis | 1951 |
Use of bishydroxycoumarin (dicumarol) in the presence of impaired renal function.
Topics: Coumarins; Dicumarol; Kidney Diseases; Renal Insufficiency | 1952 |
Suicide attempt with warfarin, a bishydroxycoumarin-like rodenticide.
Topics: Coumarins; Dicumarol; Humans; Rodenticides; Suicide, Attempted; Warfarin | 1952 |
NEW and nonofficial remedies: cyclocumarol.
Topics: 4-Hydroxycoumarins; Coumarins | 1952 |
[Treatment with dicoumarin of myocardial infarction; preliminary communication].
Topics: Coronary Disease; Coumarins; Dicumarol; Humans; Myocardial Infarction | 1952 |
Dicoumarol in general practice.
Topics: Coronary Disease; Coumarins; Dicumarol; Family Practice; Humans | 1952 |
[Therapeutic and diuretic effects of dicumarin in hydrops gravidarum].
Topics: Coumarins; Diuretics; Edema; Female; Humans; Pregnancy | 1951 |
[Dicumarol therapy in multiple sclerosis].
Topics: Coumarins; Dicumarol; Humans; Multiple Sclerosis | 1951 |
[Early therapy or prevention of thromboembolism].
Topics: Biomedical Research; Coumarins; Heparin; Humans; Secondary Prevention; Thromboembolism | 1951 |
[Venous thrombosis and its anticoagulant therapy; in vitro tolerance test of heparin].
Topics: Anticoagulants; Coumarins; Hemostatics; Heparin; In Vitro Techniques; Prothrombin; Thrombophlebitis; Venous Thrombosis | 1951 |
The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
Topics: Coumarins; Dicumarol; Factor VII; Hemostatics; Prothrombin | 1951 |
Hypoprothrombinemia in biliary fistula dogs induced by minute doses of dicumarol.
Topics: Animals; Biliary Fistula; Biliary Tract; Coumarins; Dicumarol; Dogs; Fistula; Hemostatics; Hypoprothrombinemias; Prothrombin | 1952 |
[Therapeutic effectiveness of dicumarol suppositories].
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Suppositories; Thromboembolism | 1951 |
[Acute intoxication with dicumarol; histopathologic study in rat].
Topics: Animals; Coumarins; Dicumarol; Drug-Related Side Effects and Adverse Reactions; Rats | 1951 |
Ambulatory outpatient dicumarol therapy.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Outpatients | 1952 |
Observations on ethylidene dicoumarin as an anticoagulant, with special reference to puerperal patients.
Topics: Anticoagulants; Blood Coagulation; Coumarins; Dicumarol; Female; Humans; Postpartum Period | 1951 |
[Experimental and clinical results with Tromexan].
Topics: Coumarins; Ethyl Biscoumacetate; Hemostatics; Prothrombin | 1951 |
Toxic results of anticoagulant therapy.
Topics: Anticoagulants; Coumarins; Humans | 1952 |
[Pulmonary embolism as a cause of hemorrhage in two phlebitis cases treated with tromexane].
Topics: Coumarins; Phlebitis; Pulmonary Embolism | 1952 |
[Significance of coagulation time in dicumarol therapy].
Topics: Blood Coagulation Tests; Coumarins; Dicumarol; Prothrombin | 1951 |
The response of dicumarol-induced hypoprothrombinemia to vitamin K.
Topics: Coumarins; Dicumarol; Hemostatics; Humans; Hypoprothrombinemias; Prothrombin; Vitamin K | 1952 |
[Anticoagulants in the treatment of myocardial infarction].
Topics: Anticoagulants; Coronary Disease; Coumarins; Myocardial Infarction | 1951 |
[Experimental review of control methods in anticoagulant therapy with dicoumarin derivatives].
Topics: Anticoagulants; Coumarins; Dicumarol; Humans | 1952 |
The secretion of 3,3'-ethylidene bis (4-hydroxycoumarin) in milk.
Topics: 4-Hydroxycoumarins; Animals; Coumarins; Milk | 1952 |
[Cutaneous hemorrhage and necrosis in thrombosis treated with dicumarol].
Topics: Coumarins; Dicumarol; Purpura; Thrombosis | 1952 |
[Vitamin K therapy and blood transfusion in a case of dicumarol (synparin) poisoning].
Topics: Antifibrinolytic Agents; Blood Transfusion; Coumarins; Dicumarol; Humans; Vitamin K | 1952 |
Effects of hyperpyrexia on the heart in situ; studies with dicumarol, dinitrophenol and external heat.
Topics: Coumarins; Dicumarol; Dinitrophenols; Heart; Hot Temperature; Nitrophenols | 1952 |
[Effect of dicumarol on the visual field in glaucoma].
Topics: Coumarins; Dicumarol; Glaucoma; Humans; Visual Fields | 1952 |
[Diseases of children with increased capillary fragility treated with a disulfuric ester of 4-methyl-esculetin].
Topics: Capillary Fragility; Coumarins; Esters; Humans; Umbelliferones | 1951 |
Treatment and prophylaxis of thrombosis and embolism with dicumacyl; problems and results.
Topics: Coumarins; Embolism; Humans; Thromboembolism; Thrombosis | 1952 |
Indications for bishydroxycoumarin (dicumarol) in acute myocardial infarction.
Topics: Anterior Wall Myocardial Infarction; Coumarins; Dicumarol; Myocardial Infarction | 1952 |
[Treatment and prevention of hemorrhage during dicumarol therapy, with special reference to the effect of amino acids on clotting].
Topics: Amino Acids; Antifibrinolytic Agents; Blood Coagulation; Coumarins; Dicumarol; Humans; Methionine; Vitamin K | 1951 |
[The therapeutic and diuretic effect of dicoumarin in pregnancy dropsy].
Topics: Coumarins; Dicumarol; Diuretics; Edema; Female; Pregnancy; Pregnancy Complications | 1952 |
NEW and nonofficial remedies; ethyl biscoumacetate.
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
Increased prothrombin synthesis during aureomycin therapy illustrating antibiotic-anticoagulant antagonism.
Topics: Anti-Bacterial Agents; Anticoagulants; Chlortetracycline; Coumarins; Prothrombin; Thrombosis | 1952 |
An evaluation of the dicumarol therapy in 300 cases of myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Dicumarol; Myocardial Infarction | 1952 |
[Prevention of thrombosis with tromexan in puerperium].
Topics: Coumarins; Ethyl Biscoumacetate; Female; Humans; Postpartum Period; Thrombosis | 1952 |
The development of circulation in autogenous and homologous grafts of skin and observations upon the effects of ACTH and anticoagulants.
Topics: Adrenocorticotropic Hormone; Anticoagulants; Coumarins; Humans; Skin; Skin Transplantation | 1951 |
Extensive pericarditis complicating myocardial infarction.
Topics: Cardiovascular Diseases; Coumarins; Humans; Myocardial Infarction; Pericarditis | 1952 |
[Focal therapy in thrombophlebitis].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Coumarins; Humans; Thrombophlebitis | 1952 |
The action of dicumarol in the human being on plasma prothrombin time and total prothrombin time.
Topics: Coumarins; Dicumarol; Humans; Prothrombin; Prothrombin Time | 1952 |
Intravenous emulsified vitamin K in the treatment of coumarin-induced hypoprothrombinemia.
Topics: Coumarins; Humans; Hypoprothrombinemias; Prothrombin; Vitamin K | 1952 |
Antepartum dicumarol therapy.
Topics: Coumarins; Dicumarol; Female; Pregnancy; Pregnancy Complications; Thrombosis | 1952 |
[Mechanism of action of tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1951 |
[Modifications of heparin activity in the blood after tromexan administration].
Topics: Coumarins; Ethyl Biscoumacetate; Heparin; Humans | 1951 |
[Study of the relations between tryptophan and nicotinic acid: action of indol-acrylic acid, of coumarin, of 2-methylnaphthoquinone, and of beta-hydroxy-phenylalanine on Escherichia coli].
Topics: Acrylates; Coumarins; Escherichia coli; Niacin; Nicotinic Acids; Phenylalanine; Tryptophan; Vitamin K 3 | 1951 |
[Action of certain compounds with a lactone function derived from coumarin on the germination of chicory seeds; study of the spectra of these derivatives].
Topics: Cichorium intybus; Coumarins; Germination; Lactones; Seeds | 1951 |
[Properties and action of dicumarol. 1. The fibroblast test].
Topics: Connective Tissue; Coumarins; Dicumarol; Fibroblasts; Tissue Culture Techniques | 1951 |
Acceleration of blood coagulation in acute myocardial infarction as demonstrated by the heparin clotting time; effect of dicumarol therapy.
Topics: Blood Coagulation; Coumarins; Dicumarol; Heparin; Humans; Myocardial Infarction | 1952 |
[A new coagulation factor (factor 7) and its clinical significance].
Topics: Blood Coagulation; Blood Coagulation Factors; Coumarins; Humans | 1952 |
[Comparative studies on the effect of dicumarol and tromexan on prothrombin level, capillary resistance and capillary permeability].
Topics: Capillaries; Capillary Permeability; Capillary Resistance; Coumarins; Dicumarol; Ethyl Biscoumacetate; Humans; Prothrombin | 1952 |
[Problems of prothrombin determination; comparative studies with the one- and two-phase method in the control of the dicoumarin medication].
Topics: Coumarins; Dicumarol; Hemostatics; Prothrombin | 1952 |
[Tromexan in the treatment of thrombosis and embolism in urology].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Thrombosis; Urology | 1952 |
[Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
Topics: Anticoagulants; Coumarins; Dicumarol; Ethyl Biscoumacetate; Hemostatics; Prothrombin | 1952 |
Hemorrhage due to dicumarol and its analogues.
Topics: Coumarins; Dicumarol; Hemorrhage; Humans; Inorganic Chemicals | 1952 |
The fluorescence of coumarin derivatives as a function of pH. II.
Topics: Coumarins; Fluorescence | 1952 |
[Studies on acute intoxication with dicumarol].
Topics: Coumarins; Dicumarol; Drug-Related Side Effects and Adverse Reactions; Psychoses, Substance-Induced | 1952 |
Anticoagulant therapy in myocardial infarction.
Topics: Anticoagulants; Coumarins; Myocardial Infarction | 1952 |
[Resorption of arterial embolus by tromexan].
Topics: Coumarins; Embolism; Ethyl Biscoumacetate; Humans; Physiological Phenomena | 1952 |
[Paperchromatographic demonstration of natural cumarins in plants; cumarins of pimpinella magna and pimpinella saxifraga. IV. Communication of paperchromatography in phytochemical analysis].
Topics: Coumarins; Pimpinella; Plants; Saxifragaceae | 1952 |
[Treatment of cerebral embolism in heart diseases by anticoagulants; heparin and derivatives of coumarin].
Topics: Anticoagulants; Coumarins; Heart Diseases; Heparin; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Thrombosis | 1952 |
[Experience with tromexan].
Topics: Coumarins; Ethyl Biscoumacetate | 1952 |
[Effect of dicumarol in standard doses on prolonged sub-febrile temperature].
Topics: Coumarins; Dicumarol; Fever; Temperature | 1952 |
The prothrombin level in patients on dicoumarol therapy; a simplified capillary technique.
Topics: Capillaries; Coumarins; Dicumarol; Hematologic Tests; Humans; Prothrombin | 1952 |
[Effects of vitamine K 1 on hypoprothrombinemia caused by dicumarol and on the acceleration factors in the rabbit with liver damage and the hepatectomized cat].
Topics: Animals; Antifibrinolytic Agents; Blood Coagulation; Cats; Coumarins; Dicumarol; Hypoprothrombinemias; Liver; Rabbits; Vitamin K; Vitamin K 1 | 1952 |
[Raticidal effects of tomorin, an oxycoumarin derivative].
Topics: Coumarins; Rats | 1952 |
[Identification and purification of dicumarol by production of some of its salts].
Topics: Coumarins; Dicumarol; Salts | 1952 |
Studies on blood coagulation in acute myocardial infarction.
Topics: Blood Coagulation; Coumarins; Humans; Myocardial Infarction | 1952 |
[Theory and practice of blood coagulation. III. Therapeutic use of heparine and dicumarol].
Topics: Blood Coagulation; Coumarins; Dicumarol; Heparin; Humans | 1952 |
A comparative study of effects of coumarines by the use of a microprothrombin method.
Topics: Coumarins; Hemostatics; Humans; Prothrombin | 1952 |
Effect of scopoletin on indolacetic acid metabolism.
Topics: Coumarins; Indoleacetic Acids; Scopoletin | 1952 |
[Prolonged dicumarol therapy of severe angina pectoris and recurrent heart infarct].
Topics: Angina Pectoris; Coumarins; Dicumarol; Humans; Myocardial Infarction | 1952 |
[Biological survey of anticoagulant therapy].
Topics: Anticoagulants; Coumarins; Data Collection; Heparin | 1952 |
[Anticoagulants].
Topics: Anticoagulants; Coumarins; Heparin; Humans | 1952 |
[Sweet clover disease].
Topics: Animals; Cattle; Cattle Diseases; Coumarins; Drug Combinations; Medicago; Melilotus; Resins, Plant; Rutin; Trifolium | 1952 |
The effect of substitution patterns on the release rates of opioid peptides DADLE and [Leu(5)]-enkephalin from coumarin prodrug moieties.
Topics: Coumarins; Enkephalin, Leucine-2-Alanine; Enkephalins; Esterases; Kinetics; Molecular Structure; Prodrugs | 2004 |
[What is your diagnosis? Coumarin necrosis].
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Coumarins; Diagnosis, Differential; Female; Humans; Jugular Veins; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Necrosis; Skin; Skin Diseases; Venous Thrombosis | 2004 |
Vibrational analysis of structure activity relationships (SAR) in molecular binding.
Topics: Benzoxazoles; Coumarins; Estrogen Receptor beta; Feasibility Studies; Humans; Isoflavones; Molecular Structure; Protein Binding; Receptors, Estrogen; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Structure-Activity Relationship; Vibration | 2004 |
Attenuation of potassium bromate-induced nephrotoxicity by coumarin (1,2-benzopyrone) in Wistar rats: chemoprevention against free radical-mediated renal oxidative stress and tumor promotion response.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Bromates; Catalase; Chemoprevention; Coumarins; Creatinine; DNA; Female; Free Radicals; gamma-Glutamyltransferase; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Hydrogen Peroxide; Kidney; Kidney Neoplasms; Lipid Peroxidation; NAD(P)H Dehydrogenase (Quinone); Ornithine Decarboxylase; Oxidative Stress; Rats; Rats, Wistar; Xanthine Oxidase | 2004 |
Establishing an optimal therapeutic range for coumarins: filling in the gaps.
Topics: Anticoagulants; Coumarins; Hemorrhage; Humans; International Normalized Ratio; Thromboembolism; Warfarin | 2004 |
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Coumarins; Female; Heart Valve Prosthesis; Hemorrhage; Humans; International Normalized Ratio; Male; Prospective Studies; Risk Assessment; Thromboembolism | 2004 |
Effects of chronic exposure to low-level cadmium on renal tubular function and CYP2A6-mediated coumarin metabolism in healthy human subjects.
Topics: Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Cadmium; Cadmium Poisoning; Coumarins; Cytochrome P-450 CYP2A6; Dose-Response Relationship, Drug; Female; Humans; Kidney Tubules; Male; Mass Spectrometry; Middle Aged; Mixed Function Oxygenases; Umbelliferones | 2004 |
Biscoumarin: new class of urease inhibitors; economical synthesis and activity.
Topics: Coumarins; Enzyme Inhibitors; Urease | 2004 |
Efficient green coumarin dopants for organic light-emitting devices.
Topics: Anticoagulants; Coumarins; Dose-Response Relationship, Drug; Drug Stability; Fluorescent Dyes; Light; Models, Chemical; Photic Stimulation; Thermal Conductivity; Time Factors | 2004 |
[Use of anticoagulant therapy in non-valvular atrial fibrillation. Analysis of a Hungarian cohort].
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Coumarins; Drug Utilization; Emergency Medical Services; Female; Humans; Hungary; Male; Middle Aged; Risk Factors; Stroke | 2004 |
[A cerebral watershed infarction after general anaesthesia in a patient with increased anti-cardiolipin antibody level].
Topics: Anesthesia, General; Anticoagulants; Arthroplasty; Autoantibodies; Blood Coagulation Tests; Cardiolipins; Coumarins; Electrocardiography; Hemodynamics; Humans; Humeral Fractures; Infarction, Middle Cerebral Artery; Intraoperative Complications; Magnetic Resonance Imaging; Male; Middle Aged; Shoulder | 2004 |
Discovery and structure-activity relationship of coumarin derivatives as TNF-alpha inhibitors.
Topics: Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Leukocytes, Mononuclear; Lipopolysaccharides; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2004 |
Effect of lesions on the dynamics of DNA on the picosecond and nanosecond timescales using a polarity sensitive probe.
Topics: Base Pairing; Circular Dichroism; Coumarins; DNA; DNA Damage; Kinetics; Pliability; Spectrometry, Fluorescence; Time Factors | 2004 |
The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers.
Topics: Animals; Conjunctiva; Coumarins; Dose-Response Relationship, Drug; Epithelial Cells; Lactic Acid; Male; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits | 2004 |
Validated assays for human cytochrome P450 activities.
Topics: Amodiaquine; Bupropion; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diclofenac; Drug Design; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Mass Spectrometry; Microsomes, Liver; Phenacetin; Recombinant Proteins; Reproducibility of Results | 2004 |
Molecular cloning, functional expression in Escherichia coli and enzymatic characterisation of a cysteine protease from white clover (Trifolium repens).
Topics: Amino Acid Sequence; Base Sequence; Cloning, Molecular; Coumarins; Cysteine Endopeptidases; Enzyme Stability; Escherichia coli; Hydrogen-Ion Concentration; Molecular Sequence Data; Plant Roots; Sequence Homology, Amino Acid; Trifolium | 2004 |
Effects of betaine, coumarin and flavonoids on mucin release from cultured hamster tracheal surface epithelial cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Betaine; Cells, Cultured; Coumarins; Cricetinae; Dose-Response Relationship, Drug; Epithelial Cells; Flavonoids; Hesperidin; Kaempferols; Male; Mesocricetus; Mucins; Phytotherapy; Plants, Medicinal; Trachea | 2004 |
Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle; Coumarins; Humans; Lung Neoplasms; Phytohemagglutinins; Tumor Cells, Cultured; Umbelliferones | 2004 |
Photophysical aspects of single-molecule detection by two-photon excitation with consideration of sequential pulsed illumination.
Topics: Chemistry, Physical; Computer Simulation; Coumarins; Kinetics; Lasers; Light; Models, Statistical; Photons; Spectrometry, Fluorescence; Time Factors | 2004 |
Larvicidal and mosquitocidal extracts, a coumarin, isoflavonoids and pterocarpans from Neorautanenia mitis.
Topics: Animals; Anopheles; Coumarins; Culex; Culicidae; Drug Evaluation; Filariasis; Flavonoids; Insecticides; Larva; Malaria; Mosquito Control; Plant Extracts; Pterocarpans | 2004 |
The topography of transmembrane segment six is altered during the catalytic cycle of P-glycoprotein.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Boron Compounds; Catalysis; Cell Line; Cell Membrane; Codon; Coumarins; Cysteine; Electrophoresis, Polyacrylamide Gel; Hydrolysis; Insecta; Kinetics; Maleimides; Models, Chemical; Models, Molecular; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Recombinant Proteins; Sequence Analysis, DNA | 2004 |
Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
Topics: Amino Acid Sequence; Amino Acid Substitution; Arginine; Aryl Hydrocarbon Hydroxylases; Binding Sites; Computer Simulation; Coumarins; Cytochrome P-450 CYP2A6; Enzyme Activation; Hydroxylation; Mixed Function Oxygenases; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Binding; Protein Conformation; Sequence Homology, Amino Acid; Structure-Activity Relationship; Umbelliferones; Valine | 2004 |
A very short route to enantiomerically pure coumarin-bearing fluorescent amino acids.
Topics: Amino Acid Sequence; Amino Acids; Chromatography, High Pressure Liquid; Coumarins; Fluorescent Dyes; Models, Chemical; Molecular Sequence Data; Peptides; Stereoisomerism | 2004 |
Stability of the complexes of some lanthanides with coumarin derivatives. II. Neodymium(III)-acenocoumarol.
Topics: Acenocoumarol; Coumarins; Drug Stability; Lanthanoid Series Elements; Neodymium | 2004 |
Roles for epoxidation and detoxification of coumarin in determining species differences in clara cell toxicity.
Topics: Animals; Anticoagulants; Coumarins; Epithelial Cells; Female; Inactivation, Metabolic; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred F344; Respiratory Mucosa; Species Specificity | 2004 |
Coumarin tags for improved analysis of peptides by MALDI-TOF MS and MS/MS. 1. Enhancement in MALDI MS signal intensities.
Topics: Amino Acid Sequence; Coumarins; Mass Spectrometry; Molecular Sequence Data; Peptides; Protein Binding; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2004 |
Acute mechanical mitral valve thrombosis early after neurosurgery: is factor V Leiden mutation contributing?
Topics: Acute Disease; Anticoagulants; Coronary Thrombosis; Coumarins; Factor V; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Mutation; Neurosurgical Procedures | 2004 |
Functionality maps of the ATP binding site of DNA gyrase B: generation of a consensus model of ligand binding.
Topics: Adenosine Triphosphate; Binding Sites; Computer Simulation; Coumarins; DNA Gyrase; Escherichia coli Proteins; Ligands; Models, Molecular; Pliability; Protein Binding; Pyrroles; Solvents; Structure-Activity Relationship | 2004 |
Single molecule acid-base kinetics and thermodynamics.
Topics: Acids; Coumarins; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Light; Models, Statistical; Monte Carlo Method; Photons; Protons; Temperature; Thermodynamics | 2004 |
Suicidal oxidative stress induced by certain antioxidants.
Topics: Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Division; Coumarins; Female; Glioma; Humans; Oxidative Stress; Ploidies; Quercetin; Reactive Oxygen Species; Tumor Cells, Cultured | 2003 |
Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile.
Topics: Acetylation; Acids; Caspase Inhibitors; Copper; Coumarins; Enzyme Inhibitors; Matrix Metalloproteinase Inhibitors; Molecular Structure; Montana; Sesquiterpenes; Waste Products; Water | 2004 |
Incremental cost-effectiveness of cyclooxygenase 2-selective versus nonselective nonsteroidal anti-inflammatory drugs in a cohort of coumarin users: a pharmacoeconomic analysis linked to a case-control study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cost-Benefit Analysis; Coumarins; Cyclooxygenase Inhibitors; Economics, Pharmaceutical; Female; Health Care Costs; Hemorrhage; Humans; Male; Netherlands; Surveys and Questionnaires | 2004 |
Biochemical and biological characterization of a novel anti-aromatase coumarin derivative.
Topics: Androgens; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Coumarins; Estrogens; Female; Humans; Microsomes; Molecular Structure; Protein Isoforms; Receptors, Estrogen; Structure-Activity Relationship | 2004 |
Influence of membrane components in the binding of proteins to membrane surfaces.
Topics: Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Protein beta Subunits; GTP-Binding Protein gamma Subunits; Guanosine Diphosphate; Isoenzymes; Membrane Microdomains; Models, Molecular; Phospholipase C beta; Protein Binding; Protein Structure, Tertiary; Signal Transduction; Thermodynamics; Type C Phospholipases | 2004 |
Polyamine depletion inhibits etoposide-induced NF-kappaB activation in transformed mouse fibroblasts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspases; Cell Line, Transformed; Cell Nucleus; Coumarins; DNA; Eflornithine; Enzyme Inhibitors; Etoposide; Fibroblasts; Flavonoids; In Situ Nick-End Labeling; MAP Kinase Signaling System; Mice; NF-kappa B; Phosphorylation; Polyamines; Protein Binding; Time Factors | 2004 |
Legioliulin, a new isocoumarin compound responsible for blue-white autofluorescence in Legionella (Fluoribacter) dumoffii under long-wavelength UV light.
Topics: Coumarins; Legionella; Luminescent Measurements; Luminescent Proteins; Magnetic Resonance Imaging; Molecular Conformation; Molecular Weight; Protein Engineering; Species Specificity; Ultraviolet Rays | 2004 |
A coumarin from Mallotus resinosus that mediates DNA cleavage.
Topics: Coumarins; DNA; DNA Damage; Mallotus Plant; Philippines; Plant Roots; Plants, Medicinal; Scopoletin | 2004 |
Clinical tests of a new coumarin substance; a report to the Medical Research Council.
Topics: Biomedical Research; Coumarins; Humans | 1949 |
Coumarins as new indicators in acidimetry and alkalimetry.
Topics: Acids; Alkalies; Coumarins; Humans | 1949 |
The effects of 4 hydroxycoumarin anticoagulant No. 63 upon the prothrombin time in dogs and human beings.
Topics: 4-Hydroxycoumarins; Animals; Anticoagulants; Blood; Coumarins; Dogs; Prothrombin Time | 1950 |
Identification of osthole in Hseh Tsuang seed.
Topics: Coumarins; Humans; Pharmaceutical Preparations; Seeds | 1950 |
Inhibition of human serum cholinesterase by some 4-hydroxy-coumarin derivatives.
Topics: Blood; Cholinesterases; Coumarins; Humans; Proteins | 1950 |
[Inhibition of serum cholinesterase by certain derivatives of 4-hydroxycoumarin].
Topics: 4-Hydroxycoumarins; Blood; Cholinesterases; Coumarins; Humans | 1950 |
[Arterial thromboses treated by a new coagulant of the coumarin group].
Topics: Arteries; Blood; Coagulants; Coumarins; Humans; Thrombosis | 1950 |
Fluorescence of coumarin derivatives as a function of pH.
Topics: Coumarins; Fluorescence; Hydrogen-Ion Concentration | 1950 |
[Action of substances with antipermeabilizing activity on acute experimental pulmonary edema].
Topics: Capillaries; Cardiovascular System; Coumarins; Lung; Pulmonary Edema | 1950 |
The diuretic action of a coumarin-mercurial compound.
Topics: Coumarins; Diuresis; Diuretics; Heterocyclic Compounds; Humans | 1950 |
[Prevention of postoperative thromboembolic complications].
Topics: Biomedical Research; Coumarins; Humans; Postoperative Complications; Thromboembolism | 1952 |
Solid phase synthesis of 3-(4-hydroxyphenyl)coumarin: preliminary experiments for combinatorial synthesis of substituted 3-phenylcoumarin derivatives.
Topics: Combinatorial Chemistry Techniques; Coumarins | 2004 |
Functional diversity of cytochrome P450s of the white-rot fungus Phanerochaete chrysosporium.
Topics: Alkanes; Anti-Infective Agents; Anticoagulants; Antifungal Agents; Benzene Derivatives; Benzoic Acid; Camphor; Cinnamates; Coumaric Acids; Coumarins; Cyclohexanols; Cytochrome P-450 Enzyme System; Eucalyptol; Fungal Proteins; Monoterpenes; Parabens; Phanerochaete; Propionates | 2004 |
New types of soluble polymer-supported bisphosphine ligands with a cyclobutane backbone for Pd-catalyzed enantioselective allylic substitution reactions.
Topics: Allyl Compounds; Anticoagulants; Catalysis; Coumarins; Cyclobutanes; Dimerization; Ligands; Organometallic Compounds; Palladium; Phosphines; Polymers; Solubility; Stereoisomerism | 2004 |
Doxycycline-regulated over-expression of hsp22 has negative effects on stress resistance and life span in adult Drosophila melanogaster.
Topics: Aging; Animals; Coumarins; Disease Susceptibility; Doxycycline; Drosophila melanogaster; Drosophila Proteins; Drug Resistance; Gene Expression Regulation; Genes, Reporter; Heat Stress Disorders; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Longevity; Male; Oxidative Stress; Paraquat; Transcription, Genetic | 2004 |
Glucosylation of phenolic compounds by Pharbitis nil hairy roots: I. Glucosylation of coumarin and flavone derivatives.
Topics: Coumarins; Flavonols; Glycosylation; Ipomoea; Plant Roots; Plants, Medicinal | 2004 |
Cytotoxic and antimicrobial coumarins from Mammea africana.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Cell Division; Chemistry, Pharmaceutical; Chromatography, Gel; Coumarins; Humans; Mammea; Plant Bark; Plant Extracts; Staphylococcus aureus; Tumor Cells, Cultured; Xanthones | 2004 |
A series of related nucleotide analogues that aids optimization of fluorescence signals in probing the mechanism of P-loop ATPases, such as actomyosin.
Topics: Actomyosin; Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Azides; Coumarins; Deoxyadenine Nucleotides; Deoxyadenosines; Dideoxynucleotides; Fluorescent Dyes; Fluorometry; Myosin Subfragments; Rabbits; Spectrometry, Fluorescence; Spectrophotometry | 2004 |
Genomic transcriptional response to loss of chromosomal supercoiling in Escherichia coli.
Topics: Base Composition; Chromosomes, Bacterial; Codon, Initiator; Coumarins; DNA Topoisomerases; DNA, Bacterial; DNA, Superhelical; Enzyme Inhibitors; Escherichia coli K12; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Kinetics; Mutation; Norfloxacin; Oligonucleotide Array Sequence Analysis; Topoisomerase Inhibitors; Transcription, Genetic | 2004 |
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.
Topics: Antifungal Agents; Boric Acids; Candida; Candidiasis, Vulvovaginal; Coumarins; Drug Interactions; Female; Humans; Microbial Sensitivity Tests; Plant Extracts; Plant Oils; Vagina | 2005 |
Coumarin differentially affects the morphology of different root types of maize seedlings.
Topics: Coumarins; Culture Media; Hydroponics; Models, Biological; Plant Roots; Regression Analysis; Seedlings; Zea mays | 2004 |
Spinal hematoma unrelated to previous surgery: analysis of 15 consecutive cases treated in a single institution within a 10-year period.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Coumarins; Female; Hematoma, Epidural, Spinal; Humans; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Neurologic Examination; Pain; Postoperative Complications; Prognosis; Recovery of Function; Retrospective Studies; Spinal Cord; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Hydrogen bonding in human p450-substrate interactions: a major contribution to binding affinity.
Topics: Aryl Hydrocarbon Hydroxylases; Binding Sites; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Hydrogen Bonding; Mixed Function Oxygenases; Protein Binding | 2004 |
Antidiabetic coumarin and cyclitol compounds from Peucedanum japonicum.
Topics: Animals; Apiaceae; Blood Glucose; Coumarins; Hypoglycemic Agents; Mice; Mice, Inbred ICR; Plant Extracts; Plant Roots | 2004 |
[Study on coumarin compounds from Exocarpium Citri Grandis].
Topics: 5-Methoxypsoralen; Citrus; Coumarins; Fruit; Furocoumarins; Methoxsalen; Molecular Structure; Plants, Medicinal | 2004 |
Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6.
Topics: 7-Alkoxycoumarin O-Dealkylase; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Binding Sites; Binding, Competitive; Carbon; Catalysis; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP2A6; Cytochromes b5; Electron Transport; Electrons; Humans; Hydrogen; Hydrogen Bonding; Hydroxylation; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mixed Function Oxygenases; Models, Chemical; Oxygen; Protein Binding; Protein Structure, Tertiary; Spectrophotometry; Substrate Specificity; Time Factors; Ultraviolet Rays | 2005 |
Oxidative stress responses during cassava post-harvest physiological deterioration.
Topics: Antioxidants; Blotting, Northern; Catalase; Chromatography, High Pressure Liquid; Coumarins; Crops, Agricultural; Gene Expression Regulation, Developmental; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Plant; Hydrogen Peroxide; Isoenzymes; Manihot; Models, Biological; Oxidative Stress; Peroxidase; Plant Leaves; Plant Roots; Reactive Oxygen Species; Scopoletin; Superoxide Dismutase; Superoxides; Time Factors | 2004 |
Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin.
Topics: Alanine Transaminase; Animals; Anticoagulants; Bile; Chemical and Drug Induced Liver Injury; Coumarins; Glutamate Dehydrogenase; Hydroxyethylrutoside; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Melilotus; Phytotherapy; Plant Extracts; Protective Agents; Rats; Rats, Wistar | 2005 |
Antiulcerogenic activity of a crude hydroalcoholic extract and coumarin isolated from Mikania laevigata Schultz Bip.
Topics: Animals; Anti-Ulcer Agents; Anticoagulants; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenal Ulcer; Ethanol; Indomethacin; Male; Mikania; Phytotherapy; Plant Extracts; Plant Leaves; Rats; Rats, Wistar; Reserpine; Stress, Physiological | 2005 |
(Coumarin-4-yl)methyl esters as highly efficient, ultrafast phototriggers for protons and their application to acidifying membrane surfaces.
Topics: Coumarins; Esters; Lipid Bilayers; Membranes, Artificial; Photochemistry; Protons; Spectrum Analysis | 2005 |
High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays.
Topics: Amino Acid Sequence; Coumarins; Fluorescent Dyes; Humans; Molecular Sequence Data; Peptide Fragments; Peptide Library; Serine Endopeptidases; Solutions; Substrate Specificity | 2005 |
Approach to the patient with gastrointestinal bleeding and anticoagulation.
Topics: Anticoagulants; Coumarins; Gastrointestinal Hemorrhage; Humans; Practice Guidelines as Topic | 2005 |
Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays.
Topics: Amino Acid Motifs; Animals; Cattle; Coumarins; Factor Xa; Fibrinolysin; Fluorescent Dyes; Humans; Molecular Structure; Protein Array Analysis; Salmon; Serine Endopeptidases; Substrate Specificity; Thrombin; Urokinase-Type Plasminogen Activator | 2005 |
Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison.
Topics: Amiodarone; Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Chlorzoxazone; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dextromethorphan; Diclofenac; DNA, Complementary; Ethanolamines; Female; Humans; Kinetics; Lauric Acids; Male; Mephenytoin; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Microsomes, Liver; Mixed Function Oxygenases; NADP; Nitrophenols; Oxidoreductases, N-Demethylating; Oxygen; Paclitaxel; Phenacetin; Rats; Sex Factors; Species Specificity; Substrate Specificity; Testosterone | 2004 |
Mechanism of human SIRT1 activation by resveratrol.
Topics: Antioxidants; Binding Sites; Binding, Competitive; Cell Cycle; Chromatography, High Pressure Liquid; Coloring Agents; Coumarins; Crystallography, X-Ray; Gene Silencing; Histidine; Histone Deacetylases; Humans; Immunoprecipitation; Kinetics; Models, Chemical; Models, Molecular; Peptides; Protein Binding; Protein Conformation; Resveratrol; Rhodamines; Sirtuin 1; Sirtuin 2; Sirtuins; Stilbenes; Substrate Specificity; Time Factors; Tumor Suppressor Protein p53 | 2005 |
Cavernous sinus thrombosis elicited by a central retinal vein venous stasis retinopathy.
Topics: Aged; Angiography; Anticoagulants; Blood Volume; Cavernous Sinus Thrombosis; Coumarins; Drug Therapy, Combination; Fluorescein Angiography; Hemodilution; Heparin; Humans; Male; Retinal Vein; Retinal Vein Occlusion; Visual Acuity | 2005 |
Authentication and quantitative analysis on the chemical profile of cassia bark (cortex cinnamomi) by high-pressure liquid chromatography.
Topics: Acrolein; Chromatography, High Pressure Liquid; Cinnamates; Cinnamomum aromaticum; Coumarins; Food Contamination; Methanol; Plant Bark; Propanols; Quality Control; Species Specificity | 2005 |
Coumarin tags for analysis of peptides by MALDI-TOF MS and MS/MS. 2. Alexa Fluor 350 tag for increased peptide and protein Identification by LC-MALDI-TOF/TOF MS.
Topics: Acetates; Cations; Chromatography, Liquid; Chromones; Coumarins; Escherichia coli Proteins; Mass Spectrometry; Peptides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2005 |
Selective detection of saxitoxin over tetrodotoxin using acridinylmethyl crown ether chemosensor.
Topics: Biosensing Techniques; Chemistry Techniques, Analytical; Chromatography, Gel; Coumarins; Crown Ethers; Hydrogen-Ion Concentration; Protein Binding; Saxitoxin; Tetrodotoxin | 2005 |
Esterase-activated two-fluorophore system for ratiometric sensing of biological zinc(II).
Topics: Animals; Biosensing Techniques; Coumarins; Esterases; Fluoresceins; Fluorescent Dyes; HeLa Cells; Humans; Hydrolysis; Kinetics; Liver; Molecular Structure; Spectrometry, Fluorescence; Swine; Thermodynamics; Zinc | 2005 |
Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Arginine; Binding Sites; Binding, Competitive; Chromatography, Affinity; Coumarins; DNA Gyrase; Drug Design; Escherichia coli Proteins; Magnesium; Molecular Sequence Data; Novobiocin; Peptide Fragments | 2005 |
Patch testing with a new fragrance mix detects additional patients sensitive to perfumes and missed by the current fragrance mix.
Topics: Acrolein; Acyclic Monoterpenes; Adolescent; Adult; Aged; Aged, 80 and over; Aldehydes; Allergens; Coumarins; Cyclohexenes; Dermatitis, Allergic Contact; Dose-Response Relationship, Drug; Farnesol; Female; Humans; Male; Maximum Allowable Concentration; Middle Aged; Monoterpenes; Patch Tests; Perfume; Sensitivity and Specificity | 2005 |
Patch testing with a new fragrance mix - reactivity to the individual constituents and chemical detection in relevant cosmetic products.
Topics: Acrolein; Acyclic Monoterpenes; Adolescent; Adult; Aged; Aged, 80 and over; Aldehydes; Allergens; Cosmetics; Coumarins; Cyclohexenes; Dermatitis, Allergic Contact; Dose-Response Relationship, Drug; Farnesol; Female; Humans; Male; Maximum Allowable Concentration; Middle Aged; Monoterpenes; Patch Tests; Perfume; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants.
Topics: Acenocoumarol; Aged; Alleles; Anticoagulants; Apolipoproteins E; Blood Coagulation; Cohort Studies; Coumarins; Female; Genotype; Homozygote; Humans; International Normalized Ratio; Male; Middle Aged; Phenprocoumon; Time Factors; Vitamin K | 2005 |
Coumarins are competitive inhibitors of cytochrome P450 1B1, with equal potency for allelic variants.
Topics: Alleles; Amino Acids; Anticarcinogenic Agents; Aryl Hydrocarbon Hydroxylases; Base Sequence; Binding, Competitive; Coumarins; Cytochrome P-450 CYP1B1; Dihydroxydihydrobenzopyrenes; DNA, Complementary; Dose-Response Relationship, Drug; Furocoumarins; Genetic Variation; Haplotypes; Humans; Kinetics; Microsomes; Models, Chemical; Molecular Sequence Data; Oxygen; Polymorphism, Genetic | 2005 |
Ability of thrombin to act as molecular chaperone, inducing formation of quadruplex structure of thrombin-binding aptamer.
Topics: Aptamers, Nucleotide; Coumarins; DNA; G-Quadruplexes; HEPES; Molecular Chaperones; Potassium Chloride; Thrombin | 2005 |
Secondary metabolites from endophytic Streptomyces aureofaciens CMUAc130 and their antifungal activity.
Topics: Antibiosis; Antifungal Agents; Colletotrichum; Coumarins; Fusarium; Microbial Sensitivity Tests; Musa; Plant Diseases; Plant Roots; Streptomyces aureofaciens; Triticum; Zingiber officinale | 2005 |
Mechanism of biochemical action of substituted 4-methylcoumarins. Part 11: Comparison of the specificities of acetoxy derivatives of 4-methylcoumarin and 4-phenylcoumarin to acetoxycoumarins: protein transacetylase.
Topics: Acetylation; Acetyltransferases; Aflatoxin B1; Animals; Coumarins; Cytosol; DNA; Flavonoids; Glutathione Transferase; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Oxygen; Phenols; Polyphenols; Rats; Structure-Activity Relationship; Substrate Specificity | 2005 |
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Topics: Administration, Oral; Antineoplastic Agents; Bentonite; Biocompatible Materials; Caco-2 Cells; Coumarins; Drug Carriers; Drug Delivery Systems; Fluorescent Dyes; Gastrointestinal Tract; HT29 Cells; Humans; In Vitro Techniques; Lactic Acid; Microscopy, Atomic Force; Microscopy, Confocal; Nanotechnology; Paclitaxel; Particle Size; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Solvents; Temperature; Time Factors; X-Ray Diffraction | 2005 |
Power-law solvation dynamics in DNA over six decades in time.
Topics: Coumarins; DNA; Kinetics; Solubility; Spectrometry, Fluorescence | 2005 |
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
Topics: Aged; Ancrod; Canada; Chondroitin Sulfates; Cohort Studies; Coumarins; Dermatan Sulfate; Female; Germany; Heparin; Heparitin Sulfate; Humans; Male; Outcome Assessment, Health Care; Platelet Count; Practice Patterns, Physicians'; Retrospective Studies; Survival Analysis; Thrombocytopenia | 2006 |
Characterization of the C2 subdomain of yeast mitochondrial initiation factor 2.
Topics: Coumarins; Escherichia coli; Mitochondria; Peptide Initiation Factors; Protein Structure, Tertiary; Ribosomes; RNA, Transfer, Met; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2005 |
Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
Topics: Adenoma; Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Carcinogens; Chemoprevention; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Escherichia coli Proteins; Female; Humans; Lung Neoplasms; Methoxsalen; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microsomes; Mixed Function Oxygenases; Mutation; Nitrosamines; Pentosyltransferases; Proteins; Salmonella typhimurium; Steroid Hydroxylases | 2005 |
Regulation by allergens of chemokine receptor expression on in vitro-generated dendritic cells.
Topics: Allergens; Antigens, CD; B7-1 Antigen; B7-2 Antigen; CD83 Antigen; Coumarins; Dendritic Cells; Dimethyl Sulfoxide; Dinitrochlorobenzene; Humans; Immunoglobulins; In Vitro Techniques; Irritants; Leukocytes, Mononuclear; Membrane Glycoproteins; Phenylenediamines; Receptors, Chemokine; Sodium Dodecyl Sulfate | 2005 |
Effects of coumarin and 7OH-coumarin on bcl-2 and Bax expression in two human lung cancer cell lines in vitro.
Topics: Adenocarcinoma; Antineoplastic Agents; bcl-2-Associated X Protein; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; Coumarins; Formazans; Humans; In Vitro Techniques; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts; Tumor Cells, Cultured; Umbelliferones | 2005 |
Synthesis and biological evaluation of novel angularly fused polycyclic coumarins.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Benzofurans; Colony Count, Microbial; Coumarins; Heterocyclic Compounds, 4 or More Rings; Pain Measurement; Pyridines; Structure-Activity Relationship | 2005 |
Isolation and purification of coumarin compounds from the root of Peucedanum decursivum (Miq.) Maxim by high-speed counter-current chromatography.
Topics: Apiaceae; Chromatography, High Pressure Liquid; Coumarins; Countercurrent Distribution; Magnetic Resonance Spectroscopy; Plant Roots; Spectrophotometry, Ultraviolet | 2005 |
The coupling mechanism of P-glycoprotein involves residue L339 in the sixth membrane spanning segment.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Baculoviridae; Binding Sites; Catalysis; Cell Line; Cell Membrane; Coumarins; Cysteine; Hydrolysis; Insecta; Kinetics; Linear Models; Mutagenesis, Site-Directed; Nicardipine; Paclitaxel; Protein Binding; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Protein Transport; Quinolines; Recombinant Proteins; Sulfhydryl Compounds; Time Factors; Vinblastine | 2005 |
A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Biological Assay; Carbamates; CHO Cells; Coumarins; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescence; Fluorescent Dyes; Humans; Microsomes | 2005 |
Photo-induced intermolecular electron transfer from electron donating solvents to Coumarin dyes in bile salt aggregates: role of diffusion in electron transfer reaction.
Topics: Absorption; Anisotropy; Bile Acids and Salts; Coloring Agents; Coumarins; Diffusion; Electron Transport; Electrons; Kinetics; Light; Micelles; Models, Chemical; Oxidation-Reduction; Solvents; Spectrophotometry; Thermodynamics; Time Factors | 2006 |
Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
Topics: Caffeine; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Humans; Hydroxylation; Ketoconazole; Kinetics; Microsomes, Liver; Omeprazole; Quinidine; Substrate Specificity; Sulfuric Acid Esters; Theophylline; Triamterene | 2005 |
Three haplotypes associated with CYP2A6 phenotypes in Caucasians.
Topics: Alleles; Apolipoproteins; Aryl Hydrocarbon Hydroxylases; Base Sequence; Blotting, Western; Cloning, Molecular; Coumarins; Cytochrome P-450 CYP2A6; DNA; DNA Primers; DNA, Complementary; Exons; Gene Deletion; Genetic Variation; Genotype; Haplotypes; Humans; Liver; Mixed Function Oxygenases; Models, Genetic; Molecular Sequence Data; Phenotype; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid; White People; Xenobiotics | 2005 |
Efficient synthesis of tyrosine-derived marine sponge metabolites via acylation of amines with a coumarin.
Topics: Acylation; Amines; Animals; Coumarins; Cyclization; Histamine; Methyl Ethers; Molecular Structure; Porifera; Tyrosine | 2005 |
Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening.
Topics: Blood Platelets; Coumarins; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyridazines; Recombinant Proteins | 2005 |
Chemical defenses of Trifolium glanduliferum against redlegged earth mite Halotydeus destructor.
Topics: Animals; Coumarins; Flowers; Insecticides; Methylene Chloride; Mites; Norisoprenoids; Phytol; Plant Extracts; Plant Leaves; Trifolium | 2005 |
Bronchodilator activity of Phymatodes scolopendria (Burm.) Ching and its bioactive constituent.
Topics: Animals; Bronchodilator Agents; Calcium Chloride; Coumarins; Female; Guinea Pigs; Histamine Antagonists; Male; Plant Extracts; Polypodiaceae; Potassium Chloride; Propranolol; Theophylline; Trachea | 2005 |
Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen.
Topics: Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Humans; Methoxsalen; Microsomes; Mixed Function Oxygenases; Models, Molecular; Protein Structure, Tertiary | 2005 |
Generation and characterization of a transgenic mouse model with hepatic expression of human CYP2A6.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Female; Humans; Kinetics; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mixed Function Oxygenases; Models, Animal; Umbelliferones | 2005 |
Oral surgery procedures in patients on anticoagulants. Preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Coumarins; Female; Humans; International Normalized Ratio; Male; Middle Aged; Oral Surgical Procedures; Partial Thromboplastin Time; Platelet Aggregation Inhibitors; Treatment Outcome | 2005 |
Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol.
Topics: Animals; Biological Availability; Coumarins; Drug Design; Meptazinol; Molecular Structure; Prodrugs; Rats | 2005 |
Metabolism of coumarin by human P450s: a molecular modelling study.
Topics: Amino Acid Sequence; Coumarins; Cytochrome P-450 Enzyme System; Humans; Models, Molecular; Sequence Alignment; Sequence Homology, Amino Acid | 2006 |
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery.
Topics: Albumins; Animals; Brain; Capillaries; Cations; Cell Survival; Coumarins; Drug Carriers; Drug Delivery Systems; Electrochemistry; Endothelial Cells; Immunohistochemistry; Maleimides; Mice; Microscopy, Electron; Microscopy, Fluorescence; Nanostructures; Nephelometry and Turbidimetry; Particle Size; Polyethylene Glycols; Rats; Serum Albumin, Bovine; X-Ray Diffraction | 2005 |
Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis.
Topics: Caffeic Acids; Coumarins; Dimerization; HIV Integrase; HIV Integrase Inhibitors; Inhibitory Concentration 50; Molecular Structure; Salvia officinalis | 2005 |
In-vitro antibacterial, antifungal and cytotoxic activities of some coumarins and their metal complexes.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Artemia; Bacteria; Biological Assay; Cell Survival; Coumarins; Fungi; In Vitro Techniques; Lethal Dose 50; Microbial Sensitivity Tests; Transition Elements | 2005 |
Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis.
Topics: Amino Acid Sequence; Aryl Hydrocarbon Hydroxylases; Catalysis; Coumarins; Cytochrome P-450 CYP2A6; Gene Library; Humans; Kinetics; Mixed Function Oxygenases; Models, Molecular; Molecular Sequence Data; Mutagenesis; Mutagenesis, Site-Directed; Mutation; NADP; Oxygen; Protein Binding; Structure-Activity Relationship; Substrate Specificity; Time Factors | 2005 |
Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesis.
Topics: Aryl Hydrocarbon Hydroxylases; Benzyl Compounds; Binding Sites; Coumarins; Crystallization; Cytochrome P-450 CYP2A6; Gene Library; Humans; Hydrogen Bonding; Indoles; Kinetics; Magnetic Resonance Spectroscopy; Mixed Function Oxygenases; Models, Molecular; Mutagenesis, Site-Directed; Oxidation-Reduction; Polymerase Chain Reaction; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2005 |
Novel peptides bearing pyrene and coumarin units with or without beta-cyclodextrin in their side chains exhibit intramolecular fluorescence resonance energy transfer.
Topics: beta-Cyclodextrins; Circular Dichroism; Coumarins; Fluorescence Resonance Energy Transfer; Peptides; Pyrenes | 2003 |
CYP2A5-mediated activation and early ultrastructural changes in the olfactory mucosa: studies on 2,6-dichlorophenyl methylsulfone.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzene Derivatives; Chlorzoxazone; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Female; Injections, Intraperitoneal; Liver; Metyrapone; Mice; Microscopy, Electron, Transmission; Microsomes, Liver; Mixed Function Oxygenases; Nitriles; Olfactory Mucosa; Pyrazoles; Sulfhydryl Compounds; Sulfones | 2006 |
Pharmacogenetics in the management of coumarin anticoagulant therapy: the way forward or an expensive diversion?
Topics: Anticoagulants; Cost-Benefit Analysis; Coumarins; Dose-Response Relationship, Drug; Drug Resistance; Humans; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Genetic; Thromboembolism; Vitamin K Epoxide Reductases | 2005 |
Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
Topics: Amino Acid Sequence; Anticoagulants; Binding Sites; Cell Line; Coumarins; Disulfides; Drug Resistance; Humans; Hydrophobic and Hydrophilic Interactions; Kidney; Mixed Function Oxygenases; Molecular Sequence Data; Mutagenesis, Site-Directed; Vitamin K 1; Vitamin K Epoxide Reductases | 2005 |
Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids.
Topics: Animals; Aorta, Thoracic; Blood Platelets; Coumarins; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Structure; Muscle, Smooth, Vascular; Norepinephrine; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Resveratrol; Stilbenes; Thrombin; Time Factors; Vasodilator Agents; Vasomotor System | 2006 |
[Cholesterol emboli during coumarin therapy].
Topics: Aged; Anticoagulants; Coumarins; Diagnosis, Differential; Drug Eruptions; Embolism, Cholesterol; Erythema; Female; Foot Dermatoses; Humans | 2003 |
Hematoma of the rectus abdominis muscle simulating the distorsion of the ovarian cyst in the course of anticoagulant therapy.
Topics: Anticoagulants; Arm; Coumarins; Diagnosis, Differential; Female; Hematoma; Humans; Middle Aged; Ovarian Cysts; Rectus Abdominis; Thrombophlebitis | 1967 |
Stable isotope characterization of the ortho-oxygenated phenylpropanoids: coumarin and melilotol.
Topics: Coumarins; Deuterium; Magnetic Resonance Spectroscopy; Molecular Structure; Oxidation-Reduction | 2005 |
Separation and quantitative analysis of coumarin compounds from Angelica dahurica (Fisch. ex Hoffm) Benth. et Hook. f by pressurized capillary electrochromatography.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Coumarins; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Ions; Medicine, Chinese Traditional; Methanol; Models, Chemical; Phosphates; Technology, Pharmaceutical | 2006 |
A new coumarin and triterpenes from Malaysian Micromelum minutum.
Topics: Coumarins; Magnetic Resonance Spectroscopy; Malaysia; Molecular Structure; Rutaceae; Triterpenes | 2006 |
[Comparative studies on pharmacological effects of the main chemical constituents of Peucedanum praeruptorum from He'nan and Jiangxi].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antitussive Agents; Apiaceae; China; Coumarins; Drugs, Chinese Herbal; Female; Male; Mice | 2005 |
Ultrafast dynamics of the azobenzene-coumarin complex: investigation of cooling dynamics measured by an integrated molecular thermometer.
Topics: Azo Compounds; Cold Temperature; Coumarins; Kinetics; Models, Molecular; Molecular Conformation; Spectrum Analysis; Thermodynamics; Thermometers; Time Factors | 2005 |
Naturally occurring coumarins inhibit 7,12-dimethylbenz[a]anthracene DNA adduct formation in mouse mammary gland.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Chromatography, High Pressure Liquid; Coumarins; DNA Adducts; Female; Glutathione Transferase; Inhibitory Concentration 50; Liver; Mammary Glands, Animal; Mice; Models, Chemical; Mutagens | 2006 |
Yb(OTf)3-catalyzed reactions of 5-alkylidene Meldrum's acids with phenols: one-pot assembly of 3,4-dihydrocoumarins, 4-chromanones, coumarins, and chromones.
Topics: Acids; Alkenes; Anthraquinones; Catalysis; Chromones; Coumarins; Hydrogen; Molecular Structure; Organometallic Compounds; Phenols; Ytterbium | 2006 |
BACE-1 inhibitory activities of new substituted phenyl-piperazine coupled to various heterocycles: chromene, coumarin and quinoline.
Topics: Amyloid Precursor Protein Secretases; Benzopyrans; Coumarins; Endopeptidases; Enzyme Inhibitors; Piperazines; Quinolines | 2006 |
Investigation of mechanism-based thrombin inhibitors: Implications of a highly conserved water molecule for the binding of coumarins within the S pocket.
Topics: Antithrombins; Binding Sites; Coumarins; Models, Molecular; Water | 2006 |
Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization.
Topics: Alanine; Amino Acid Sequence; Aminocoumarins; Anti-Bacterial Agents; Binding Sites; Coumarins; Dimerization; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glutathione Transferase; HeLa Cells; HSP90 Heat-Shock Proteins; Humans; Immunophilins; Molecular Chaperones; Molecular Conformation; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Novobiocin; Plasmids; Point Mutation; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Steroids; Substrate Specificity; Tacrolimus Binding Proteins; Time Factors | 2006 |
A new bicoumarin from the leaves and stems of Triphasia trifolia.
Topics: Coumarins; Magnetic Resonance Spectroscopy; Plant Extracts; Plant Leaves; Plant Stems; Rutaceae | 2006 |
Hydrogen bonding properties of Coumarin 151, 500, and 35: the effect of substitution at the 7-amino position.
Topics: Chloroform; Coumarins; Hydrogen Bonding; Solvents; Spectrum Analysis | 2006 |
Mechanisms underlying the relaxation induced by isokaempferide from Amburana cearensis in the guinea-pig isolated trachea.
Topics: Adrenergic beta-Antagonists; Animals; Capsaicin; Carbachol; Coumarins; Enzyme Inhibitors; Flavonoids; Guanylate Cyclase; Guinea Pigs; Histamine; In Vitro Techniques; Muscarinic Agonists; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Plant Bark; Plant Extracts; Plants; Potassium Channel Blockers; Potassium Chloride; Trachea | 2006 |
Building addressable libraries: site selective coumarin synthesis and the "real-time" signaling of antibody-coumarin binding.
Topics: Antibodies; Combinatorial Chemistry Techniques; Coumarins; Electrochemistry; Electrodes; Molecular Structure; Oxidation-Reduction; Palladium | 2006 |
Widespread skin necrosis associated with unfractionated heparin therapy in a patient under chronic coumarin anticoagulation.
Topics: Aged; Anticoagulants; Arm; Cardiomyopathies; Colonic Neoplasms; Coumarins; Diagnosis, Differential; Drug Administration Schedule; Heparin; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Necrosis; Postoperative Complications; Skin | 2006 |
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities.
Topics: Animals; Binding, Competitive; Cathepsin K; Cathepsins; Coumarins; Cysteine; Humans; Ketones; Kinetics; Models, Chemical; Peptides; Phylogeny; Substrate Specificity | 2006 |
Successful treatment of methimazole-induced severe aplastic anemia with recombinant human granulocyte colony-stimulating factor and high-dosage steroids.
Topics: Aged; Anemia, Aplastic; Coumarins; Drug Overdose; Female; Granulocyte Colony-Stimulating Factor; Humans; Hypertension; Hyperthyroidism; Methimazole; Methylprednisolone; Platelet Transfusion; Recombinant Proteins | 2006 |
Resonance energy transfer in new fullerene-coumarin diads.
Topics: Coumarins; Fluorescence; Fluorescence Resonance Energy Transfer; Fullerenes | 2006 |
Inhibition of Plant Growth by Protoanemonin and Coumarin, and Its Prevention by Bal.
Topics: Coumarins; Furans; Plant Development; Plant Physiological Phenomena; Pulsatilla | 1949 |
The inhibitory effects of coumarin on the germination of durum wheat (Triticum turgidum ssp. durum, cv. Simeto) seeds.
Topics: Antioxidants; Coumarins; Germination; Oxygen; Seeds; Triticum; Water | 2006 |
Comparison of "high throughput" micromethods for determination of cytochrome P450 activities with classical methods using HPLC for product identification.
Topics: Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diclofenac; Humans; Male; Mixed Function Oxygenases; Testosterone | 2005 |
Antiphospholipid syndrome accompanied by a silent splenic infarct in a patient with juvenile SLE.
Topics: Antibodies, Anticardiolipin; Anticoagulants; Antiphospholipid Syndrome; Child; Coumarins; Female; Glycoproteins; Heparin; Humans; Immunoglobulin M; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Reference Values; Splenic Infarction; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2006 |
Pregnane, coumarin and lupane derivatives and cytotoxic constituents from Helicteres angustifolia.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coumarins; Humans; Malvaceae; Molecular Conformation; Nuclear Magnetic Resonance, Biomolecular; Plant Components, Aerial; Plant Roots; Pregnanes; Triterpenes | 2006 |
Should vitamin K be administered when HIT is diagnosed after administration of coumarin?
Topics: Aged, 80 and over; Anticoagulants; Cardiac Surgical Procedures; Coumarins; Extremities; Gangrene; Heparin; Humans; International Normalized Ratio; Male; Middle Aged; Necrosis; Thrombocytopenia; Vitamin K; Warfarin | 2006 |
The skin allergenic properties of chemicals may depend on contaminants--evidence from studies on coumarin.
Topics: Adult; Aged; Animals; Coumarins; Dermatitis, Allergic Contact; Drug Contamination; Female; Humans; Irritants; Local Lymph Node Assay; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Middle Aged; Patch Tests; Perfume | 2006 |
Detecting Hg2+ ions with an ICT fluorescent sensor molecule: remarkable emission spectra shift and unique selectivity.
Topics: Cations, Divalent; Coumarins; Mercury; Models, Molecular; Molecular Structure; Spectrophotometry | 2006 |
INR comparison between the CoaguChek S and a standard laboratory method among patients with self-management of oral anticoagulation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Clinical Laboratory Techniques; Coumarins; Drug Monitoring; Female; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Prothrombin Time; Retrospective Studies; Thrombosis | 2007 |
Microwave-assisted extraction of coumarin and related compounds from Melilotus officinalis (L.) Pallas as an alternative to Soxhlet and ultrasound-assisted extraction.
Topics: Chromatography, High Pressure Liquid; Coumarins; Flowers; Melilotus; Microwaves; Plant Extracts; Ultrasonics | 2006 |
Coumarin Schiff-bases: as antioxidant and possibly anti-inflammatory agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antioxidants; Biphenyl Compounds; Catechol Oxidase; Coumarins; Free Radical Scavengers; Glucuronidase; Hydroxyl Radical; Oxidation-Reduction; Picrates; Schiff Bases; Trypsin | 2006 |
Synthesis and anti-angiogenesis activity of coumarin derivatives.
Topics: Angiogenesis Inhibitors; Cell Proliferation; Cells, Cultured; Coumarins; Humans; Molecular Structure | 2006 |
Fluorescence quenching of 3-methyl 7-hydroxyl Coumarin in presence of acetone.
Topics: Acetone; Coumarins; Fluorescence; Spectrometry, Fluorescence | 2007 |
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
Topics: Adolescent; Adult; Aged; Antibodies, Catalytic; Arginine; Binding Sites, Antibody; Blood Coagulation; Child; Coumarins; Factor VIII; Hemophilia A; Humans; Hydrolysis; Immunoglobulin G; Middle Aged; Oligopeptides; Phenylalanine; Proline | 2006 |
Fluorescence anisotropy decay and solvation dynamics in a nanocavity: coumarin 153 in methyl beta-cyclodextrins.
Topics: beta-Cyclodextrins; Coumarins; Fluorescence Polarization; Fluorescent Dyes; Nanotechnology; Solubility | 2005 |
Photophysical and (photo)electrochemical properties of a coumarin dye.
Topics: Coloring Agents; Coumarins; Electrochemistry; Photochemistry; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2005 |
Solvation of coumarin 314 at water/air interfaces containing anionic surfactants. I. Low coverage.
Topics: Air; Anions; Chemistry, Physical; Computer Simulation; Coumarins; Ions; Models, Chemical; Models, Molecular; Models, Statistical; Probability; Solvents; Surface-Active Agents; Thermodynamics; Time Factors; Water | 2005 |
Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Calorimetry; Cell Cycle; Cell Line, Tumor; Coumarins; Humans; Microtubules; Models, Molecular; Protein Binding; Spectrometry, Fluorescence; Stilbenes; Structure-Activity Relationship; Thermodynamics; Tubulin | 2006 |
Microchannel device using self-spreading lipid bilayer as molecule carrier.
Topics: Coumarins; Fluorescein; Fluorescence Resonance Energy Transfer; Lipid Bilayers; Microfluidic Analytical Techniques; Silicon Dioxide | 2006 |
The effect of radical trap moieties on electron capture dissociation spectra of substance P.
Topics: Chromatography, High Pressure Liquid; Coumarins; Electrochemistry; Free Radicals; Indicators and Reagents; Lysine; Peptide Fragments; Substance P | 2006 |
3-Hydroxycoumarin as a new matrix for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of DNA.
Topics: Base Sequence; Coumarins; DNA; Molecular Sequence Data; Sensitivity and Specificity; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2006 |
Biocatalytic production of dihydrocoumarin from coumarin by Saccharomyces cerevisiae.
Topics: Bacillus cereus; Coumarins; Dipteryx; Flavoring Agents; Phenols; Pseudomonas; Saccharomyces cerevisiae | 2006 |
Huge intrathyroidal hematoma causing airway obstruction: a multidisciplinary challenge.
Topics: Administration, Oral; Aged, 80 and over; Airway Obstruction; Anticoagulants; Coumarins; Female; Goiter; Hematoma; Humans; International Normalized Ratio; Respiration Disorders; Thyroid Gland; Tomography, X-Ray Computed; Treatment Outcome; Vitamin K | 2006 |
Characterization of humanized liver from chimeric mice using coumarin as a human CYP2A6 and mouse CYP2A5 probe.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzaldehydes; Chimera; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Humans; Hydroxylation; Lactones; Liver; Male; Mice; Mice, Inbred DBA; Microsomes, Liver; Mixed Function Oxygenases; Molecular Probes; Serum Albumin | 2006 |
Factor V Leiden mutation and deep venous thrombosis in a patient with hypereosinophilic syndrome.
Topics: Adult; Anticoagulants; Coumarins; Enzyme Inhibitors; Factor V; Heparin, Low-Molecular-Weight; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Leg; Male; Mutation; Radionuclide Imaging; Venous Thrombosis | 2006 |
Surface-assisted transient displacement charge technique. I. Photoinduced charge transfer in self-assembled monolayers.
Topics: Coumarins; Electrochemistry; Fluorescence; Methods; Photochemistry; Solvents; Surface Properties | 2006 |
Surface-assisted transient displacement charge technique. II. Effect of gases on photoinduced charge transfer in self-assembled monolayers.
Topics: Coumarins; Electrochemistry; Fluorescence; Gases; Photochemistry; Surface Properties | 2006 |
Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Binding Sites; Computer Simulation; Coumarins; Enzyme Inhibitors; Estradiol Congeners; Estrogen Receptor Modulators; Flavanones; Flavones; Humans; Hydroxyprostaglandin Dehydrogenases; Isoflavones; Models, Biological; Models, Molecular; Phenanthrenes; Phytoestrogens; Progesterone; Progesterone Reductase; Protein Binding; Recombinant Proteins; Stilbenes; Zearalenone | 2006 |
Comparison of coumarin-induced toxicity between sandwich-cultured primary rat hepatocytes and rats in vivo: a toxicogenomics approach.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cell Culture Techniques; Cells, Cultured; Cholesterol; Coumarins; gamma-Glutamyltransferase; Gene Expression Profiling; Hepatocytes; Liver; Male; Oligonucleotide Array Sequence Analysis; Rats; Rats, Wistar; Toxicogenetics | 2006 |
Boronic acids as inhibitors of steroid sulfatase.
Topics: Boronic Acids; Chromones; Coumarins; Enzyme Inhibitors; Estrone; Humans; Molecular Structure; Steryl-Sulfatase; Structure-Activity Relationship | 2006 |
Reactivity trends of the base hydrolysis of coumarin and thiocoumarin in binary aqueous-methanol mixtures at different temperatures.
Topics: Coumarins; Hydrogen-Ion Concentration; Hydrolysis; Methanol; Temperature; Water | 2007 |
Synthesis, cytotoxic effect, and structure-activity relationship of Pd(II) complexes with coumarin derivatives.
Topics: Antineoplastic Agents; Cells, Cultured; Coumarins; Crystallography, X-Ray; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Magnetic Resonance Spectroscopy; Models, Chemical; Models, Molecular; Molecular Structure; Nitrogen; Organoplatinum Compounds; Quantum Theory; Structure-Activity Relationship | 2006 |
Ab initio calculations of absorption spectra of large molecules in solution: coumarin C153.
Topics: Computational Biology; Coumarins; Cyclohexanes; Dimethyl Sulfoxide; Heterocyclic Compounds, 4 or More Rings; Molecular Structure; Solutions; Spectrum Analysis | 2007 |
Mikania laevigata syrup does not induce side effects on reproductive system of male Wistar rats.
Topics: Administration, Oral; Animals; Brazil; Coumarins; Dose-Response Relationship, Drug; Epididymis; Fertility; Genitalia, Male; Intubation, Gastrointestinal; Male; Mikania; Parasympatholytics; Plant Extracts; Prostate; Rats; Rats, Wistar; Respiratory System Agents; Seminal Vesicles; Sperm Count; Spermatogenesis; Spermatozoa; Testis; Time Factors | 2007 |
Phenylpropanoid glycosyltransferases from osage orange (Maclura pomifera) fruit.
Topics: Chromatography, High Pressure Liquid; Coumarins; Flavonoids; Fruit; Glucose; Glycosyltransferases; Kinetics; Maclura; Molecular Sequence Data; Molecular Structure; Phenylpropionates; Phylogeny; Substrate Specificity | 2006 |
Toxicity and synergism in the feeding deterrence of some coumarins on Spodoptera frugiperda Smith (Lepidoptera: Noctuidae).
Topics: Animals; Choice Behavior; Coumarins; Drug Synergism; Feeding Behavior; Flowers; Larva; Plant Extracts; Plant Leaves; Plant Preparations; Spodoptera | 2006 |
Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
Topics: Animals; Blood-Brain Barrier; Corpus Striatum; Coumarins; Dose-Response Relationship, Drug; Lipids; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar | 2006 |
Enhanced resistance to Salmonella enterica serovar Typhimurium infection in mice after coumarin treatment.
Topics: Animals; Coumarins; Interferon-gamma; Interleukin-12; Liver; Macrophages; Mice; Mice, Inbred BALB C; Monocytes; Neutrophils; Phagocytosis; Reactive Nitrogen Species; Salmonella typhi; Spleen; Th1 Cells; Tumor Necrosis Factor-alpha; Typhoid Fever; Umbelliferones | 2007 |
[Inhibitory effects of 11 coumarin compounds against growth of human bladder carcinoma cell line E-J in vitro].
Topics: Antineoplastic Agents, Phytogenic; Benzopyrans; Butyrates; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esculin; Humans; Molecular Structure; Umbelliferones; Urinary Bladder Neoplasms | 2007 |
A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition.
Topics: Animals; Antineoplastic Agents, Alkylating; Coumarins; Cyclophosphamide; Gene Deletion; Hydroxylation; Immunohistochemistry; Liver; Male; Mice; Mice, Knockout; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Tissue Distribution | 2007 |
Inhibitory effects of neurotransmitters and steroids on human CYP2A6.
Topics: Aldehyde Oxidase; Androgens; Animals; Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Cell Line; Corticosterone; Coumarins; Cytochrome P-450 CYP2A6; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epinephrine; Estrogens; Histamine; Hormones; Humans; Hydroxylation; In Vitro Techniques; Insecta; Liver; Microsomes, Liver; Mixed Function Oxygenases; Molecular Structure; Neurotransmitter Agents; Nicotine; Norepinephrine; Phenotype; Recombinant Proteins; Serotonin; Tryptamines | 2007 |
Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
Topics: Animals; Area Under Curve; Biological Transport; Blood-Brain Barrier; Brain; Capillaries; Cations; Cattle; Coculture Techniques; Coumarins; Drug Carriers; Endothelial Cells; Endothelium, Vascular; Fluorescent Dyes; Immunohistochemistry; Male; Maleimides; Mice; Mice, Inbred BALB C; Molecular Weight; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polymers; Serum Albumin, Bovine | 2007 |
Novel coumarin-based fluorescent pH indicators, probes and membranes covering a broad pH range.
Topics: Coumarins; Hydrogen-Ion Concentration; Molecular Structure; Photochemistry; Sensitivity and Specificity; Solutions; Spectrometry, Fluorescence; Titrimetry | 2007 |
Determination of coumarin, vanillin, and ethyl vanillin in vanilla extract products: liquid chromatography mass spectrometry method development and validation studies.
Topics: Benzaldehydes; Chromatography, Liquid; Coumarins; Mass Spectrometry; Molecular Structure; Plant Extracts; Reproducibility of Results; Vanilla | 2007 |
Simultaneous concentration and separation of coumarins using a molecular micelle in micellar affinity gradient focusing.
Topics: Chromatography, Micellar Electrokinetic Capillary; Coumarins; Isoelectric Focusing; Micelles | 2007 |
A chemiluminescence nanosensor to monitor lipid peroxidation.
Topics: Coloring Agents; Coumarins; Humans; Lipid Peroxidation; Luminescent Measurements; Microscopy, Electron, Scanning; Nanoparticles; Silicon Dioxide | 2007 |
Synthesis of a coumarin-based europium complex for bioanalyte labeling.
Topics: Azides; Chelating Agents; Coumarins; Europium; Indicators and Reagents; Spectrometry, Fluorescence; Ultraviolet Rays | 2007 |
A simple strategy for mitigating the effect of data variability on the identification of active chemotypes from high-throughput screening data.
Topics: Adenosine Triphosphate; Biocompatible Materials; Biotinylation; Cluster Analysis; Computer Simulation; Coumarins; Drug Evaluation, Preclinical; Fluorescein; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Inhibitory Concentration 50; Monte Carlo Method; Polystyrenes; Protein Kinases; Receptor Protein-Tyrosine Kinases; Receptors, G-Protein-Coupled; Sampling Studies; Scintillation Counting; Software Design; Spectrophotometry; Wheat Germ Agglutinins | 2007 |
Prenyloxyphenylpropanoids as novel lead compounds for the selective inhibition of geranylgeranyl transferase I.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Chemistry, Pharmaceutical; Cinnamates; Coumarins; Drug Design; Enzyme Inhibitors; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Plant Extracts | 2007 |
Regio- and stereoselective intermolecular oxidative phenol coupling in kotanin biosynthesis by Aspergillus niger.
Topics: Aspergillus niger; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Circular Dichroism; Coumarins; Magnetic Resonance Spectroscopy; Methylation; Models, Chemical; Oxygen; Phenol; Stereoisomerism; Umbelliferones | 2007 |
Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction.
Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Coumarins; Data Collection; Dose-Response Relationship, Drug; Drug Interactions; Female; Follow-Up Studies; Humans; International Normalized Ratio; Male; Multicenter Studies as Topic; Netherlands; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
A library of noviosylated coumarin analogues.
Topics: Boronic Acids; Coumarins; Databases, Factual; Esterification; HSP90 Heat-Shock Proteins; Iodobenzoates; Molecular Structure; Novobiocin; Structure-Activity Relationship | 2007 |
Images in vascular medicine. Coumarin skin necrosis: a severe complication of oral anticoagulation.
Topics: Administration, Oral; Adult; Anticoagulants; Coumarins; Drug Eruptions; Female; Humans; Necrosis; Severity of Illness Index | 2006 |
Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Anti-Bacterial Agents; Bacterial Proteins; Cloning, Molecular; Coumarins; DNA Gyrase; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Novobiocin; Recombinant Proteins; Streptococcus pneumoniae; Topoisomerase II Inhibitors | 2007 |
Antitumor and immunomodulatory effect of coumarin and 7-hydroxycoumarin against Sarcoma 180 in mice.
Topics: Animals; Antineoplastic Agents; Cell Movement; Coumarins; Immunologic Factors; Interleukin-12; Lipopolysaccharides; Macrophage Activation; Mice; Mice, Inbred DBA; Mice, Inbred ICR; Nitric Oxide; Sarcoma 180; Umbelliferones | 2007 |
Quantity and quality of potential drug interactions with coumarin anticoagulants in the Netherlands.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Cohort Studies; Coumarins; Drug Interactions; Female; Humans; Male; Middle Aged | 2007 |
Compounds from Ageratum conyzoides: isolation, structural elucidation and insecticidal activity.
Topics: Ageratum; Animals; Chemical Fractionation; Coleoptera; Coumarins; Flavones; Houseflies; Insecta; Insecticides; Moths; Nuclear Magnetic Resonance, Biomolecular; Plant Extracts; Toxicity Tests | 2007 |
Nitric oxide release from coumarin-7-azomethine derivatives in the presence of thiol.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Azo Compounds; Coumarins; Cysteine; Dimethyl Sulfoxide; Nitric Oxide; Nitric Oxide Donors; Nitrites; Sulfhydryl Compounds; Thiosemicarbazones | 2007 |
Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Calophyllum; Cell Line; Coumarins; Leishmania; Macrophages; Mice; Microscopy, Electron, Transmission; Parasitic Sensitivity Tests; Plant Extracts; Plant Leaves | 2007 |
Solvent effect on absorption and fluorescence spectra of coumarin laser dyes: evaluation of ground and excited state dipole moments.
Topics: Absorption; Coumarins; Fluorescent Dyes; Lasers; Molecular Structure; Solvents; Spectrometry, Fluorescence | 2008 |
In vivo assessment of safety and mechanisms underlying in vitro relaxation induced by Mikania laevigata Schultz Bip. ex Baker in the rat trachea.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Brazil; Coumarins; Dose-Response Relationship, Drug; Female; Gas Chromatography-Mass Spectrometry; Glyburide; In Vitro Techniques; Male; Mice; Mikania; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Oxadiazoles; Plant Extracts; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Wistar; Tetraethylammonium; Toxicity Tests, Acute; Toxicity Tests, Chronic; Trachea | 2007 |
A new coumarin glycoside from the husks of Xanthoceras sorbifolia.
Topics: Coumarins; Glycosides; Humans; Phytotherapy; Sapindaceae | 2007 |
Novel gold(I) 7-azacoumarin complex: synthesis, structure, optical properties, and cytotoxic effects.
Topics: Chemistry, Inorganic; Coumarins; Gold; Inhibitory Concentration 50; Ligands; Methanol; Models, Chemical; Molecular Conformation; Organogold Compounds; Temperature; Thermodynamics | 2007 |
Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism.
Topics: Aged; Coumarins; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Recurrence; Registries; Venous Thrombosis; Vitamin K | 2007 |
Enantioselective synthesis of (s)- and (R)-tolterodine by asymmetric hydrogenation of a coumarin derivative obtained by a Heck reaction.
Topics: Benzhydryl Compounds; Catalysis; Chemistry, Organic; Coumarins; Cresols; Ligands; Models, Chemical; Phenylpropanolamine; Stereoisomerism; Temperature; Tolterodine Tartrate; Water | 2007 |
Metal-free triazole formation as a tool for bioconjugation.
Topics: Alkynes; Azides; Coumarins; Cyclization; Magnetic Resonance Spectroscopy; Metals; Molecular Structure; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles | 2007 |
Lipid constituents of Trifolium resupinatum var. microcephalum.
Topics: Coumarins; Lipids; Magnetic Resonance Spectroscopy; Molecular Structure; Pentacyclic Triterpenes; Steroids; Trifolium; Triterpenes | 2007 |
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.
Topics: Benzamides; Benzoflavones; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Survival; Coumarins; DNA Breaks; Environmental Pollutants; Estrogen Receptor alpha; Glutathione; Humans; NAD; NADP; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Polychlorinated Dibenzodioxins; Reactive Oxygen Species; Receptors, Aryl Hydrocarbon; Tamoxifen | 2007 |
Coumarin-derived discodermolide analogues possessing equivalent antiproliferative activity to the natural product--a further simplification of the lactone region.
Topics: Alkanes; Biological Products; Carbamates; Cell Line, Tumor; Cell Proliferation; Coumarins; Humans; Lactones; Molecular Structure; Pyrones | 2007 |
Inner anti-inflammatory mechanisms of petroleum ether extract from Melilotus suaveolens Ledeb.
Topics: Alkanes; Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Coumarins; Cyclooxygenase 2; Dexamethasone; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Interleukin-10; Interleukin-6; Lipopolysaccharides; Macrophages; Melilotus; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Extracts; RNA, Messenger; Solvents; Time Factors; Tumor Necrosis Factor-alpha | 2007 |
Determination of nateglinide in human plasma by high-performance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent.
Topics: Acetamides; Chromatography, High Pressure Liquid; Coumarins; Cyclohexanes; Fluorescent Dyes; Humans; Hypoglycemic Agents; Indicators and Reagents; Nateglinide; Phenylalanine; Reproducibility of Results | 2007 |
Effect of Flavonols on the Bacteriostatic Action of Dicoumarol.
Topics: Bacteria; Coumarins; Dicumarol; Flavonols | 1947 |
Virtual screening for selective allosteric mGluR1 antagonists and structure-activity relationship investigations for coumarine derivatives.
Topics: Allosteric Regulation; Animals; Coumarins; Excitatory Amino Acid Antagonists; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Structure-Activity Relationship | 2007 |
Amelioration of L-thyroxine-induced hyperthyroidism by coumarin (1,2-benzopyrone) in female rats.
Topics: Animals; Antithyroid Agents; Body Weight; Catalase; Cholesterol; Coumarins; Disease Models, Animal; Eating; Female; Glucose-6-Phosphatase; Glutathione; Glycogen; Hyperthyroidism; Iodide Peroxidase; Lipid Peroxidation; Liver; Rats; Rats, Wistar; Superoxide Dismutase; Thyroid Gland; Thyroid Hormones; Thyroxine; Time Factors | 2007 |
The increase in melanoma: are dietary furocoumarins responsible?
Topics: Animals; Coumarins; Diet; Family Health; Furocoumarins; Humans; Light; Melanoma; Models, Biological; Models, Theoretical; Risk; Skin Neoplasms; Time Factors; Ultraviolet Rays | 2008 |
Coumarin derivatives protection against ROS production in cellular models of Abeta toxicities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Coumarins; Free Radicals; Humans; Hydrogen Peroxide; Mice; Mice, Transgenic; Models, Chemical; Mutation; Oxidative Stress; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2007 |
Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
Topics: Administration, Oral; Anticoagulants; Aortic Valve; Coumarins; Heart Valve Prosthesis; Humans; International Normalized Ratio; Postoperative Hemorrhage; Risk Factors; Thromboembolism | 2007 |
Design and synthesis of a coumarin-based acidichromic colorant.
Topics: Color; Coloring Agents; Coumarins; Hydrogen-Ion Concentration; Spectrophotometry, Ultraviolet; Titrimetry | 2007 |
Laser-driven acoustic desorption of organic molecules from back-irradiated solid foils.
Topics: Anthracenes; Coumarins; Fluorescein; Fluorescent Dyes; Lasers; Metals; Molecular Structure; Photons; Reproducibility of Results; Rhodamines; Sensitivity and Specificity; Surface Properties; Tandem Mass Spectrometry; Volatilization | 2007 |
Functional characterization of CYP2A13 polymorphisms.
Topics: Amino Acid Sequence; Amino Acid Substitution; Aryl Hydrocarbon Hydroxylases; Carcinogens; Coumarins; Humans; Hydroxylation; Nitrosamines; Polymorphism, Genetic; Sequence Deletion | 2007 |
Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Coumarins; Female; Humans; International Normalized Ratio; Middle Aged; Thyroid Gland; Thyrotoxicosis; Thyrotropin; Thyroxine; Triiodothyronine; Ventricular Premature Complexes | 2007 |
The omlA gene is involved in multidrug resistance and its expression is inhibited by coumarins in Xanthomonas campestris pv. phaseoli.
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Base Sequence; Chloramphenicol; Coumarins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression; Lipoproteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Insertional; Novobiocin; Promoter Regions, Genetic; Sodium Dodecyl Sulfate; Transcription Initiation Site; Transcription, Genetic; Vitamin K 3; Xanthomonas campestris | 2008 |
Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins.
Topics: Analgesics; Animals; Aza Compounds; Bacteria; Coumarins; Drug Design; Fluorine; Fungi; Inflammation; Mice | 2008 |
Orthogonal protein purification--expanding the repertoire of GST fusion systems.
Topics: Acylation; Aldehydes; Base Sequence; Binding Sites; Catalysis; Chromatography, Affinity; Codon; Coumarins; Crystallization; Dimerization; Enzyme Stability; Escherichia coli; Esters; Fluorescent Dyes; Glutathione Transferase; Humans; Hydrogen-Ion Concentration; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Isoenzymes; Kinetics; Lysine; Models, Chemical; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Mutation; Peptide Hydrolases; Peptide Library; Protein Binding; Protein Folding; Proteins; Recombinant Fusion Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temperature; Time Factors | 2008 |
Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents.
Topics: Animals; Antiviral Agents; Benzimidazoles; Cell Line; Coumarins; Dose-Response Relationship, Drug; Genome, Viral; Hepacivirus; Humans; Molecular Structure; RNA, Viral; Structure-Activity Relationship; Viruses | 2008 |
Lack of evidence for allergenic properties of coumarin in a fragrance allergy mouse model.
Topics: Animals; CD4 Antigens; Coumarins; Dermatitis, Allergic Contact; Ear; Enzyme-Linked Immunosorbent Assay; Interferon-gamma; Local Lymph Node Assay; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Perfume; T-Lymphocytes | 2007 |
3-Formylchromones IV. The rearrangement of 3-formylchromone enamines as a simple, facile route to novel pyrazolo[3,4-b]pyridines and the synthetic utility of the latter.
Topics: Amines; Chromogranins; Chromones; Coumarins; Microbial Sensitivity Tests; Pyrazoles; Pyridines; Pyrimidines | 2005 |
Intermolecular dynamics, interactions, and solvation in ionic liquids.
Topics: Calorimetry; Cations; Coumarins; Ionic Liquids; Models, Chemical; Models, Molecular; Molecular Structure; Solubility; Temperature; Time Factors; Viscosity | 2007 |
Modification of DNA with octadiynyl side chains: synthesis, base pairing, and formation of fluorescent coumarin dye conjugates of four nucleobases by the alkyne--azide "click" reaction.
Topics: Alkynes; Animals; Azides; Base Pairing; Coumarins; Deoxyribonucleosides; DNA; Fluorescent Dyes; Nucleic Acid Denaturation; Oligonucleotides; Organophosphorus Compounds; Phosphoric Diester Hydrolases; Snake Venoms | 2008 |
Two-photon absorption cross-sections of reference dyes: a critical examination.
Topics: Chemistry, Physical; Coumarins; Electrons; Fluorescein; Fluorescent Dyes; Models, Statistical; Models, Theoretical; Photons; Reproducibility of Results; Rhodamines; Software; Solvents; Spectrometry, Fluorescence; Spectrophotometry; Styrenes | 2008 |
The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Female; Flavonoids; Humans; Lipopolysaccharides; Monocytes; Nitric Oxide; Ovarian Neoplasms; Tumor Necrosis Factor-alpha; Xanthones | 2008 |
On the constitution of the active principles isolated from the mature bark of Aegle marmelos, Correâ.
Topics: Aegle; Alkaloids; Coumarins; Humans; Lactones | 1949 |
New research on the migration of halogen in certain bromo-coumarins.
Topics: Coumarins | 1949 |
About the detectability of the ethyl ester of 3,3'-dicumarinylacetic acid and dicumarol in human blood.
Topics: Coumarins | 1949 |
Methyl coumarins.
Topics: Coumarins | 1949 |
Novel coumarin glycoside and phenethyl vanillate from Notopterygium forbesii and their binding affinities for opioid and dopamine receptors.
Topics: Animals; Coumarins; Diynes; Fatty Alcohols; Glycosides; Humans; Protein Binding; Receptors, Dopamine; Receptors, Opioid; Spectrum Analysis; Vanillic Acid | 2008 |
New coumarin glycosides from Rhododendron lepidotum.
Topics: Coumarins; Glycosides; Humans; Magnetic Resonance Spectroscopy; Phytotherapy; Plant Components, Aerial; Plant Extracts; Rhododendron | 2008 |
Quantification of free coumarin and its liberation from glucosylated precursors by stable isotope dilution assays based on liquid chromatography-tandem mass spectrometric detection.
Topics: Carbon Isotopes; Cassia; Chromatography, Liquid; Coumarins; Glycosylation; Indicator Dilution Techniques; Tandem Mass Spectrometry | 2008 |
Rapid probing of photocatalytic activity on titania-based self-cleaning materials using 7-hydroxycoumarin fluorescent probe.
Topics: Catalysis; Chemistry Techniques, Analytical; Coloring Agents; Coumarins; Fluorescent Dyes; Photochemistry; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Surface Properties; Time Factors; Titanium; Umbelliferones | 2008 |
Inhibition of 7,12-dimethylbenz[a]anthracene induced mouse skin carcinogenesis by Artemisia capillaris.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Artemisia; Camphanes; Camphor; Carcinogenicity Tests; Carcinogens; Chloroform; Coumarins; Disease Models, Animal; Female; Gas Chromatography-Mass Spectrometry; Mice; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Random Allocation; Sesquiterpenes; Skin Neoplasms | 2008 |
Inhibition of plant growth by protoanemonin and coumarin and its prevention by BAL.
Topics: Coumarins; Furans; Growth; Plant Development | 1949 |
Solubility enhancement of gluten and organic compounds by arginine.
Topics: Arginine; Coumarins; Gallic Acid; Glutens; Nephelometry and Turbidimetry; Organic Chemicals; Sodium Chloride; Solubility | 2008 |
Development of sensitive cathepsin G fluorogenic substrate using combinatorial chemistry methods.
Topics: Absorption; Acetic Acid; Amino Acid Sequence; Cathepsin G; Cathepsins; Combinatorial Chemistry Techniques; Coumarins; Drug Design; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Humans; Hydrolysis; Leukocyte Elastase; Myeloblastin; Peptides; Sensitivity and Specificity; Serine Endopeptidases | 2008 |
Phospholipid-linked coumarin: a fluorescent probe for sensing hydroxyl radicals in lipid membranes.
Topics: Coumarins; Ethanolamines; Fluorescent Dyes; Glycerol; Hydroxyl Radical; Liposomes; Membranes, Artificial; Molecular Structure; Phospholipids; Reproducibility of Results; Time Factors | 2008 |
Congenital hypersensitivity to vitamin K antagonists due to FIX propeptide mutation at locus -10: a (not so) rare cause of bleeding under oral anticoagulant therapy in Switzerland.
Topics: Aged; Alanine; Amino Acid Substitution; Anticoagulants; Coumarins; Drug Hypersensitivity; Factor IX; Heart Valve Prosthesis Implantation; Hemorrhage; Heterozygote; Humans; International Normalized Ratio; Male; Mutation; Partial Thromboplastin Time; Pedigree; Protein Precursors; Switzerland; Threonine; Vitamin K | 2008 |
Wheat germ agglutinin-conjugated nanoparticles for sustained cellular and lung delivery of budesonide.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Budesonide; Cell Cycle; Cell Proliferation; Cells, Cultured; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coumarins; Drug Delivery Systems; Excipients; Intubation, Intratracheal; Lactic Acid; Lung; Male; Microscopy, Confocal; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Wheat Germ Agglutinins | 2008 |
Fusarielin A as an anti-angiogenic and anti-proliferative agent: basic biological characterization.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Aspergillus oryzae; Cell Proliferation; Cells, Cultured; Coumarins; Epoxy Compounds; Fluorescent Dyes; HL-60 Cells; Humans; Indicators and Reagents; Isotope Labeling; Magnetic Resonance Spectroscopy; Naphthalenes; Photoaffinity Labels; Spores, Fungal; Structure-Activity Relationship | 2008 |
Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides.
Topics: Acetic Acid; Antitubercular Agents; Benzaldehydes; Coumarins; Hydrazines; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship | 2008 |
A coumarin-derived fluorescence probe selective for magnesium.
Topics: Coumarins; Crystallography, X-Ray; Fluorescent Dyes; Magnesium; Models, Molecular; Molecular Structure | 2008 |
Bidens pilosa L. exhibits high sensitivity to coumarin in comparison with three other weed species.
Topics: Bidens; Coumarins; Germination; Species Specificity | 2008 |
A new method for the HPLC determination of gamma-hydroxybutyric acid (GHB) following derivatization with a coumarin analogue and fluorescence detection: application in the analysis of biological fluids.
Topics: Chromatography, High Pressure Liquid; Coumarins; Humans; Hydroxybutyrates; Saliva; Sensitivity and Specificity; Spectrometry, Fluorescence | 2008 |
Nano-patterned layers of a grafted coumarinic chromophore.
Topics: Coumarins; Microscopy, Atomic Force; Microscopy, Electron; Molecular Structure; Nanostructures; Silicon; Spectrum Analysis | 2008 |
Evaluation of coumarin derivatives as anti-fungal agents against soil-borne fungal pathogens.
Topics: Benzodioxoles; Colony Count, Microbial; Coumarins; Dose-Response Relationship, Drug; Fungi; Fungicides, Industrial; Halogens; Microbial Sensitivity Tests; Pest Control, Biological; Phenols; Plant Extracts; Soil Microbiology | 2007 |
[Impending Coumarin-necrosis in a patient with heterozygous protein C deficiency type I].
Topics: Adult; Anticoagulants; Coumarins; Female; Humans; Necrosis; Protein C; Protein C Deficiency | 2008 |
Overanticoagulation with coumarin and cutaneous azole therapy.
Topics: Administration, Topical; Aged, 80 and over; Anticoagulants; Antifungal Agents; Azoles; Coumarins; Drug Synergism; Emollients; Humans; International Normalized Ratio | 2008 |
Engineering disulfide cross-links in RNA via air oxidation.
Topics: Air; Biochemistry; Coumarins; Cross-Linking Reagents; Disulfides; Glass; Nucleosides; Oxidation-Reduction; Porosity; RNA; Sulfhydryl Compounds; Uridine | 2001 |
Development of novel water-soluble photocleavable protective group and its application for design of photoresponsive paclitaxel prodrugs.
Topics: Chromatography, High Pressure Liquid; Coumarins; Drug Design; Lasers; Molecular Conformation; Paclitaxel; Photochemistry; Photolysis; Photosensitizing Agents; Prodrugs; Solubility; Stereoisomerism; Ultraviolet Rays; Water | 2008 |
Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans.
Topics: Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Chemical and Drug Induced Liver Injury; Coumarins; Data Interpretation, Statistical; Diclofenac; Gene Expression; Hepatocytes; Humans; Male; Microscopy, Electron, Scanning; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Risk Assessment; Species Specificity; Toxicogenetics | 2008 |
In vitro study of mutagenic potential of Bidens pilosa Linné and Mikania glomerata Sprengel using the comet and micronucleus assays.
Topics: Animals; Bidens; Cell Line, Tumor; Chromatography, High Pressure Liquid; Comet Assay; Coumarins; Dose-Response Relationship, Drug; Liver Neoplasms; Micronucleus Tests; Mikania; Mutagens; Rats; Tea | 2008 |
Quantitative distinction between competing intramolecular bond twisting and solvent relaxation dynamics: an ultrafast study.
Topics: Coumarins; Methods; Models, Molecular; Motion; Solvents; Time | 2008 |
[Dental surgery in patients receiving anticoagulant therapy].
Topics: Anticoagulants; Coumarins; Hemostasis, Surgical; Heparin; Humans; International Normalized Ratio; Oral Hemorrhage; Oral Surgical Procedures; Postoperative Hemorrhage; Risk Factors | 2008 |
Development of a long-wavelength fluorescent probe based on quinone-methide-type reaction to detect physiologically significant thiols.
Topics: Amino Acids; Chromatography, High Pressure Liquid; Coumarins; Fluorescent Dyes; Indolequinones; Kinetics; Molecular Structure; Photochemistry; Sulfhydryl Compounds | 2008 |
Monosaccharide-based water-soluble fluorescent tags.
Topics: Acylation; Alkenes; Coumarins; Fluorescent Dyes; Monosaccharides; Peptides; Solubility; Triazines; Water | 2008 |
Time-dependent density functional theory study on electronically excited States of coumarin 102 chromophore in aniline solvent: reconsideration of the electronic excited-state hydrogen-bonding dynamics.
Topics: Aniline Compounds; Coumarins; Electrons; Hydrogen Bonding; Models, Chemical; Solvents; Spectroscopy, Fourier Transform Infrared; Time | 2008 |
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Coumarins; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Platelet Count; Thrombocytopenia | 2008 |
Arginine increases the solubility of coumarin: comparison with salting-in and salting-out additives.
Topics: Arginine; Benzyl Alcohols; Biochemistry; Caffeine; Coumarins; Dose-Response Relationship, Drug; Guanidine; Hydrogen-Ion Concentration; Models, Biological; Salts; Solubility; Surface Properties; Urea; Water | 2008 |
Intestinal anti-inflammatory activity of coumarin and 4-hydroxycoumarin in the trinitrobenzenesulphonic acid model of rat colitis.
Topics: 4-Hydroxycoumarins; Acute Disease; Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Chronic Disease; Colitis; Colon; Coumarins; Diarrhea; Gastrointestinal Agents; Glutathione; Male; Organ Size; Peroxidase; Rats; Rats, Wistar; Secondary Prevention; Sulfasalazine; Trinitrobenzenesulfonic Acid | 2008 |
Nano- and microparticles of organic fluorescent dyes: self-organization and optical properties.
Topics: Chemistry, Organic; Coumarins; Crystallization; Fluorescent Dyes; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Models, Chemical; Nanoparticles; Nanotechnology; Oxadiazoles; Solvents; Spectrometry, Fluorescence | 2008 |
The structure-activity relationship between oxycoumarin derivatives showing inhibitory effects on iNOS in mouse macrophage RAW264.7 cells.
Topics: Animals; Blotting, Western; Cell Line; Coumarins; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship | 2009 |
Aflatoxin B1 detoxification by CYP321A1 in Helicoverpa zea.
Topics: Aflatoxin B1; Aflatoxins; Animals; Binding Sites; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 Enzyme System; Gene Expression; Glutathione; Indoles; Insect Proteins; Kinetics; Larva; Mass Spectrometry; Methoxsalen; Mice; Models, Molecular; Moths; Rats; RNA, Messenger | 2008 |
Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Colloids; Coumarins; Drug Carriers; Hematologic Neoplasms; Humans; Lactic Acid; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Neoplasms; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2008 |
Pharmacogenomics of coumarin anticoagulants: are we underestimating the role of CYP2C9?
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C9; Drug Resistance; Hemorrhage; Humans; Pharmacogenetics; Risk Factors | 2008 |
Separation and analysis of dynamic Stokes shift with multiple fluorescence environments: coumarin 153 in bovine beta-lactoglobulin A.
Topics: Animals; Cattle; Coumarins; Fluorescence; Lactoglobulins; Protein Conformation | 2008 |
Direct and nondestructive verification of PNA immobilization using click chemistry.
Topics: Acetylene; Azides; Breast Neoplasms; Coumarins; DNA Mutational Analysis; Fluorescent Dyes; Genes, BRCA1; Glass; Humans; Oligonucleotide Array Sequence Analysis; Oligonucleotide Probes; Peptide Nucleic Acids; Spectrometry, Fluorescence | 2008 |
Design, synthesis, and docking studies of novel benzopyrone derivatives as H(1)-antihistaminic agents.
Topics: Algorithms; Animals; Binding Sites; Coumarins; Drug Design; Guinea Pigs; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Histamine N-Methyltransferase; Male; Structure-Activity Relationship | 2008 |
Synthesis and biological evaluation of alkoxycoumarins as novel nematicidal constituents.
Topics: Animals; Antinematodal Agents; Artemia; Biological Assay; Chemistry, Pharmaceutical; Coumarins; Drug Design; Hydrolysis; Models, Chemical; Nematoda; Oryzias; Structure-Activity Relationship | 2008 |
Characterization of an LED based photoreactor to degrade 4-chlorophenol in an aqueous medium using coumarin (C-343) sensitized TiO2.
Topics: Catalysis; Chlorophenols; Coloring Agents; Coumarins; Electron Spin Resonance Spectroscopy; Hydroxyl Radical; Kinetics; Lighting; Photochemistry; Sensitivity and Specificity; Titanium; Water | 2008 |
[Haplogroup analysis of vitamin-K epoxide reductase (VKORC1) gene: novel element in the optimization of anticoagulant therapy].
Topics: Adult; Anticoagulants; Coumarins; Female; Haplotypes; Hemorrhage; Humans; Hungary; Male; Middle Aged; Mixed Function Oxygenases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Vitamin K Epoxide Reductases; Warfarin; White People | 2008 |
Synthesis and characterization of coumarin-based spiropyran photochromic colorants.
Topics: Benzopyrans; Color; Coumarins; Indoles; Models, Molecular; Molecular Structure; Nitro Compounds; Photochemistry; Spectrophotometry; X-Ray Diffraction | 2008 |
Differences in simulated liver concentrations of toxic coumarin metabolites in rats and different human populations evaluated through physiologically based biokinetic (PBBK) modeling.
Topics: Acetaldehyde; Animals; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Humans; Hydroxylation; Microsomes, Liver; Models, Biological; Rats; Species Specificity; Time Factors; Umbelliferones | 2008 |
Thio-urea and germination; antagonism between thiourea and coumarin.
Topics: Coumarins; Thiourea | 1948 |
Clinical experience with a new preparation from the coumarin range.
Topics: Coumarins | 1948 |
Contribution to the study of the anticoagulant action of synthetic dicumarin.
Topics: Blood Coagulation; Coumarins | 1947 |
An instructive case of dicumarol hemorrhage.
Topics: Coumarins; Dicumarol; Hemorrhage | 1947 |
The chemistry of the insoluble red woods; a new synthesis of 4-hydroxycoumarins.
Topics: 4-Hydroxycoumarins; Coumarins | 1948 |
Dicumarol poisoning.
Topics: Coumarins; Dicumarol | 1948 |
Dicoumarol.
Topics: Coumarins; Dicumarol | 1948 |
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.
Topics: Binding Sites; Binding, Competitive; Chromatography, High Pressure Liquid; Coumarins; Drug Stability; Humans; Kinetics; Magnetic Resonance Spectroscopy; Molecular Probes; Serum Albumin; Umbelliferones; Warfarin | 2009 |
Concentration-dependent energy transfer studies in ternary dye mixture of Stilbene-420, Coumarin-540 and Nile Blue.
Topics: Absorptiometry, Photon; Coumarins; Dose-Response Relationship, Drug; Drug Combinations; Energy Transfer; Fluorescent Dyes; Lasers, Gas; Models, Biological; Osmolar Concentration; Oxazines; Stilbenes | 2009 |
Transfer from Melilotus dentata to M. alba of the genes for reduction in coumarin content.
Topics: Coumarins; Genetic Phenomena; Heredity; Humans; Melilotus | 1948 |
The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity.
Topics: Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Design; Humans; Naphthalenes; Novobiocin; Quinolines | 2008 |
No oral-cavity-only discrimination of purely olfactory odorants.
Topics: Adolescent; Adult; Benzaldehydes; Caprylates; Coumarins; Discrimination, Psychological; Female; Humans; Male; Mentha piperita; Middle Aged; Mouth; Nasal Cavity; Odorants; Olfactory Perception; Phenylethyl Alcohol; Smell; Young Adult | 2009 |
Multi-catalysis reactions: direct organocatalytic sequential one-pot synthesis of highly functionalized cyclopenta[b]chromen-1-ones.
Topics: Aldehydes; Alkylation; Catalysis; Coumarins; Esters; Oxidation-Reduction | 2008 |
Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process.
Topics: Acetylcholinesterase; Amyloid; Animals; Anticoagulants; Cattle; Coumarins; Gerstmann-Straussler-Scheinker Disease; Glycoproteins; Humans; Microscopy, Atomic Force; Particle Size; Peptide Fragments; Plaque, Amyloid; Prions | 2009 |
Fluorescent labeling of peptides on solid phase.
Topics: Acetic Acid; Acylation; Carboxylic Acids; Coumarins; Fluorescent Dyes; Lysine; Peptides; Staining and Labeling; Triazoles | 2008 |
Effect of donor orientation on ultrafast intermolecular electron transfer in coumarin-amine systems.
Topics: Amines; Coumarins; Electron Transport; Fluorescence; Fluorescent Dyes; Time Factors | 2008 |
Nickel-catalyzed decarbonylative addition of anhydrides to alkynes.
Topics: Alkynes; Anhydrides; Carbon; Catalysis; Chemistry; Chlorides; Coumarins; Models, Chemical; Molecular Structure; Nickel; Oxygen; Phthalic Anhydrides; Zinc Compounds | 2008 |
A fluorescence sensor for detection of geranyl pyrophosphate by the chemo-ensemble method.
Topics: Amides; Calibration; Coumarins; Fluorescence; Fluorescent Dyes; Magnetic Resonance Spectroscopy; Polyisoprenyl Phosphates; Titrimetry | 2009 |
PEG-immobilization of cardol and soluble polymer-supported synthesis of some cardol-coumarin derivatives: preliminary evaluation of their inhibitory activity on mushroom tyrosinase.
Topics: Agaricales; Coumarins; Fungal Proteins; Monophenol Monooxygenase; Polyethylene Glycols; Polymers; Resorcinols; Solubility | 2009 |
Identification and physiological evaluation of the components from citrus fruits as potential drugs for anti-corpulence and anticancer.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Anti-Obesity Agents; Antineoplastic Agents; Cell Line, Tumor; Citrus; Coumarins; Drug Evaluation, Preclinical; Flavones; Humans; Mice | 2009 |
Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines.
Topics: Aryl Hydrocarbon Hydroxylases; Catalytic Domain; Chromatography, High Pressure Liquid; Coumarins; Models, Molecular; Mutagenesis, Site-Directed; Nicotiana; Nitrosamines; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry | 2009 |
Coumarin-based ratiometric fluorescent indicators with high specificity for lead ions.
Topics: Alkenes; Amines; Catalysis; Coumarins; Fluorescent Dyes; Gold; Hydrogen; Ions; Lead; Molecular Structure; Sensitivity and Specificity | 2008 |
CYP2A6 genotypes and coumarin-oxidation phenotypes in a Thai population and their relationship to tobacco smoking.
Topics: Adult; Alleles; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Asian People; Coumarins; Cytochrome P-450 CYP2A6; Female; Genotype; Humans; Male; Middle Aged; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Smoking; Thailand; Young Adult | 2009 |
[Study on fluorescent properties of coumarin derivatives and determination of trace iron].
Topics: Coumarins; Ethanol; Hydrogen-Ion Concentration; Iron; Models, Chemical; Solvents; Spectrometry, Fluorescence; Trace Elements; Water | 2008 |
Development and validation of an RP-HPLC method for quantification of cinnamic acid derivatives and kaurane-type diterpenes in Mikania laevigata and Mikania glomerata.
Topics: Chromatography, High Pressure Liquid; Cinnamates; Coumarins; Diterpenes; Diterpenes, Kaurane; Mikania; Plant Extracts; Plant Leaves | 2009 |
Solid-phase synthesis of peptide libraries combining alpha-amino acids with inorganic and organic chromophores.
Topics: Amino Acids; Anthracenes; Coloring Agents; Coumarins; Electrochemistry; Fluorenes; Naphthalenes; Peptide Library; Peptides; Photochemistry; Ruthenium; Spectrum Analysis | 2009 |
Assaying dynamic cell-cell junctional communication using noninvasive and quantitative fluorescence imaging techniques: LAMP and infrared-LAMP.
Topics: Cell Communication; Coumarins; Fluorescent Dyes; Infrared Rays; Intercellular Junctions; Molecular Probe Techniques | 2009 |
[Anticoagulation by oral treatment with vitamin K antagonists].
Topics: Administration, Oral; Anticoagulants; Arrhythmias, Cardiac; Coumarins; Drug Interactions; Humans; International Normalized Ratio; Myocardial Infarction; Thromboembolism; Vitamin K | 2008 |
Synthesis, characterization, DNA cleavage and in vitro antimicrobial studies of La(III), Th(IV) and VO(IV) complexes with Schiff bases of coumarin derivatives.
Topics: Anti-Infective Agents; Bacteria; Coumarins; DNA; Electrochemistry; Electron Spin Resonance Spectroscopy; Electron Transport; Electrophoresis; Fungi; Lanthanum; Magnetic Resonance Spectroscopy; Magnetics; Mass Spectrometry; Organometallic Compounds; Spectrophotometry, Infrared; Temperature; Thorium; Vanadium | 2009 |
Determination of hydroxyl rate constants by a high-throughput fluorimetric assay: towards a unified reactivity scale for antioxidants.
Topics: Antioxidants; Calibration; Coloring Agents; Coumarins; Fluorometry; Hydroxyl Radical; Pulse Radiolysis; Thiocyanates; Umbelliferones | 2009 |
Comparison of a nucleosidic vs non-nucleosidic postsynthetic "click" modification of DNA with base-labile fluorescent probes.
Topics: Alkynes; Azides; Coumarins; DNA; Fluorescent Dyes; Oligonucleotides; Oxazines | 2009 |
A new O-terpenoidal coumarin from Clausena anisum-olens Merr.
Topics: Clausena; Coumarins; Drugs, Chinese Herbal; Medicine, Chinese Traditional; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Extracts; Terpenes | 2009 |
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Coumarins; Edema; Female; Glycine max; Lipoxygenase; Lipoxygenase Inhibitors; Male; Rats; Thioctic Acid | 2009 |
Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey.
Topics: Anterior Cruciate Ligament; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Coumarins; Follow-Up Studies; Fondaparinux; Fracture Fixation, Internal; Guideline Adherence; Heparin, Low-Molecular-Weight; Humans; Netherlands; Polysaccharides; Practice Patterns, Physicians'; Stockings, Compression; Surveys and Questionnaires; Thrombosis | 2009 |
A p38 mitogen-activated protein kinase inhibitor screening method using growth recovery of Escherichia coli as an index.
Topics: Blotting, Western; Coumarins; Drug Evaluation, Preclinical; Escherichia coli; HeLa Cells; Humans; Kinetics; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors | 2009 |
Hydrogensquarates of 3-nicotinoyl and 3-isonicotinoyl coumarin--crystal structures and spectroscopic elucidation.
Topics: Coumarins; Crystallography, X-Ray; Hydrogen; Isonicotinic Acids; Models, Molecular; Molecular Structure; Spectrophotometry | 2009 |
Precision and accuracy of CoaguChek S and XS monitors: the need for external quality assessment.
Topics: Anticoagulants; Calibration; Coumarins; Drug Monitoring; Evaluation Studies as Topic; Humans; International Normalized Ratio; Quality Control; Sensitivity and Specificity | 2009 |
International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy.
Topics: Aged; Anticoagulants; Coumarins; Drug Monitoring; Female; Humans; International Normalized Ratio; Male; Middle Aged; Point-of-Care Systems; Self Administration; Sensitivity and Specificity | 2009 |
Investigating unexpected INRs: in search of the culprit--adherence, interactions, genetics, and superwarfarin.
Topics: 4-Hydroxycoumarins; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C9; Drug Interactions; Female; Genetic Variation; Humans; International Normalized Ratio; Male; Medication Adherence; Middle Aged; Mixed Function Oxygenases; Risk Factors; Vitamin K Epoxide Reductases; Young Adult | 2009 |
A new two-photon-sensitive block copolymer nanocarrier.
Topics: Coumarins; Light; Micelles; Nanoparticles; Photolysis; Photons; Polymers | 2009 |
Lympidem (a coumarin derivative) induced reversible hepatotoxicity in an adult Sri Lankan.
Topics: Chemical and Drug Induced Liver Injury; Coumarins; Female; Humans; Lower Extremity; Lymphedema; Middle Aged | 2009 |
A simple fluorescent probe for the determination of dissolved oxygen based on the catalytic activation of oxygen by iron(II) chelates.
Topics: Calibration; Catalysis; Chelating Agents; Coumarins; Fluorescence; Fluorescent Dyes; Hydrogen-Ion Concentration; Iron; Oxalates; Oxidation-Reduction; Oxygen; Solubility; Spectrometry, Fluorescence; Umbelliferones | 2009 |
Microtubule involvement in the deposition of radial fibrillar callose arrays in stomata of the fern Asplenium nidus L.
Topics: Actin Cytoskeleton; Coumarins; Cytochalasin B; Deoxyglucose; Dinitrobenzenes; Ferns; Glucans; Herbicides; Microfibrils; Microtubules; Nitriles; Plant Stomata; Sulfanilamides; Tubulin Modulators; Tunicamycin | 2009 |
Reduction-triggered fluorescent amplification probe for the detection of endogenous RNAs in living human cells.
Topics: Azides; Cell Survival; Coumarins; DNA; Drug Design; Flow Cytometry; Fluorescein; Fluorescent Dyes; HL-60 Cells; Humans; Kinetics; Microscopy, Fluorescence; Molecular Imaging; Oxidation-Reduction; RNA; RNA, Messenger; RNA, Ribosomal, 28S; Spectrometry, Fluorescence | 2009 |
Photodimerization of chromone.
Topics: Chromones; Coumarins; Dimerization; Models, Molecular; Molecular Structure; Photochemical Processes | 2009 |
Time course and strain dependence of ADP release during contraction of permeabilized skeletal muscle fibers.
Topics: Adenosine Diphosphate; Animals; Calcium; Computer Simulation; Coumarins; Female; Fluorescence; Kinetics; Linear Models; Muscle Contraction; Muscle Fibers, Skeletal; Muscle Strength; Mutation, Missense; Nucleoside-Diphosphate Kinase; Phosphorylation; Protein Isoforms; Psoas Muscles; Rabbits | 2009 |
Comparison of urinary scents of two related mouse species, Mus spicilegus and Mus domesticus.
Topics: Animals; Coumarins; Gas Chromatography-Mass Spectrometry; Lactones; Male; Mice; Pheromones; Smell; Species Specificity; Thiazoles | 2009 |
Quantum control experiment reveals solvation-induced decoherence.
Topics: Algorithms; Biophysics; Coloring Agents; Coumarins; Lasers; Pharmaceutical Solutions; Quantum Theory; Solutions; Solvents; Viscosity | 2009 |
Coumarin effects on amino acid levels in mice prefrontal cortex and hippocampus.
Topics: Amino Acids; Analysis of Variance; Animals; Central Nervous System Agents; Chromatography, High Pressure Liquid; Coumarins; Diazepam; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Hippocampus; Male; Mice; Prefrontal Cortex; Taurine | 2009 |
Enhancing nucleic acid detection sensitivity of propidium iodide by a three nanometer interaction inside cells and in solutions.
Topics: Cell Membrane Permeability; Coumarins; Drug Delivery Systems; Fluorescence Resonance Energy Transfer; HeLa Cells; Humans; Lactic Acid; Nanoparticles; Nucleic Acids; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Propidium; Sensitivity and Specificity; Spectrometry, Fluorescence | 2009 |
Fluorescence dynamics of coumarin C522 on reduced-charge montmorillonite in aqueous dispersion.
Topics: Bentonite; Coumarins; Solubility; Spectrometry, Fluorescence; Water | 2009 |
Monitoring protein-polymer conjugation by a fluorogenic Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition.
Topics: Alkynes; Animals; Azides; Catalysis; Cattle; Copper; Coumarins; Fluorescent Dyes; Models, Molecular; Polyethylene Glycols; Polymers; Protein Binding; Proteins; Serum Albumin, Bovine | 2009 |
Hg2+ -selective chromogenic and fluorogenic chemodosimeter based on thiocoumarins.
Topics: Cations, Divalent; Chromogenic Compounds; Coumarins; Fluorescent Dyes; Magnetic Resonance Spectroscopy; Mercury; Molecular Structure; Sulfhydryl Compounds | 2009 |
A toxicogenomics-based parallelogram approach to evaluate the relevance of coumarin-induced responses in primary human hepatocytes in vitro for humans in vivo.
Topics: Adult; Aged; Animals; Anticoagulants; Blood Coagulation; Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Gene Expression Regulation; Hepatocytes; Humans; In Vitro Techniques; Male; Mitochondria, Liver; Rats; Species Specificity; Toxicogenetics | 2009 |
Bioactivation of coumarin in rat olfactory mucosal microsomes: Detection of protein covalent binding and identification of reactive intermediates through analysis of glutathione adducts.
Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Coumarins; Glutathione; Humans; In Vitro Techniques; Male; Microsomes; Nasal Mucosa; Oxidation-Reduction; Protein Binding; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2009 |
A macrocyclic coumarin-containing tripeptide via CuAAC chemistry.
Topics: Coumarins; Macrocyclic Compounds; Oligopeptides | 2009 |
Separation and determination of coumarins in Fructus cnidii extracts by pressurized capillary electrochromatography using a packed column with a monolithic outlet frit.
Topics: Acetates; Acetonitriles; Apiaceae; Capillary Electrochromatography; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; China; Coumarins; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Medicine, Chinese Traditional; Models, Chemical; Plant Extracts; Time Factors | 2009 |
Energetics of coumarin and chromone.
Topics: Calorimetry, Differential Scanning; Chromones; Coumarins; Thermodynamics | 2009 |
Chirality transfer effects in proline-substituted coumarin compounds.
Topics: Circular Dichroism; Coumarins; Molecular Conformation; Proline; Proteins; Stereoisomerism | 2009 |
Coumarin use in dialysis patients with atrial fibrillation--more harm than benefit?
Topics: Animals; Anticoagulants; Atrial Fibrillation; Calcinosis; Coumarins; Humans; Mice; Quality-Adjusted Life Years; Renal Dialysis; Vitamin K | 2009 |
Tyrosinase inhibitor activity of coumarin-resveratrol hybrids.
Topics: Coumarins; Enzyme Inhibitors; Inhibitory Concentration 50; Monophenol Monooxygenase; Resveratrol; Stilbenes; Structure-Activity Relationship | 2009 |
Responsive polymer nanoparticles formed by poly(ether amine) containing coumarin units and a poly(ethylene oxide) short chain.
Topics: Amines; Coumarins; Ether; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Electron, Transmission; Models, Chemical; Nanoparticles; Nanotechnology; Polyethylene Glycols; Polymers; Spectrophotometry; Surface Properties; Temperature | 2009 |
Fluorescence enhancement of coumarin thiourea derivatives by Hg2+, Ag+, and silver nanoparticles.
Topics: Coumarins; Fluorescence; Mercury; Metal Nanoparticles; Molecular Structure; Silver; Thermodynamics; Thiourea | 2009 |
Lymphatic research: a global concern.
Topics: Anticoagulants; Coumarins; Humans; Lymphatic Diseases; Lymphatic System; Lymphedema | 2005 |
Antioxidant and antibacterial studies of arylazopyrazoles and arylhydrazonopyrazolones containing coumarin moiety.
Topics: Anti-Bacterial Agents; Antioxidants; Bacillus subtilis; Coumarins; Free Radical Scavengers; Pyrazoles; Pyrazolones; Staphylococcus aureus; Structure-Activity Relationship | 2009 |
Efficacy of coumarin on hepatic key enzymes of glucose metabolism in chemical induced type 2 diabetic rats.
Topics: Animals; Blood Glucose; Coumarins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose-Bisphosphatase; Glucose-6-Phosphatase; Hexokinase; Insulin; Liver; Male; Rats; Rats, Wistar; Streptozocin | 2009 |
Coumarin-derivative-based off-on catalytic chemodosimeter for Cu2+ ions.
Topics: Catalysis; Copper; Coumarins; Fluorescent Dyes; Hydrazones; Molecular Structure; Spectrometry, Fluorescence | 2009 |
Coumarin use in dialysis patients with atrial [corrected] fibrillation: yes, after individual risk stratification.
Topics: Anticoagulants; Atrial Fibrillation; Coumarins; Humans; Kidney Failure, Chronic; Renal Dialysis; Stroke | 2009 |
Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides.
Topics: Antibodies; Coumarins; Disulfides; Maleimides; Molecular Probes; Oxidation-Reduction; Proteins; Solubility; Sulfhydryl Compounds; Water | 2009 |
Coumarin and cinnamaldehyde in cinnamon marketed in Italy: a natural chemical hazard?
Topics: Acrolein; Chromatography, High Pressure Liquid; Cinnamomum aromaticum; Cinnamomum zeylanicum; Coumarins; Food Analysis; Hazardous Substances; Italy; Reproducibility of Results | 2008 |
[Simultaneous determination of three coumarin constituents in roots of Peucedanum praeruptorum by RP-HPLC].
Topics: Apiaceae; Chromatography, High Pressure Liquid; Coumarins; Linear Models; Plant Roots; Reproducibility of Results; Time Factors | 2009 |
Relative quantum yield measurements of coumarin encapsulated in core-shell silica nanoparticles.
Topics: Absorption; Coumarins; Fluorescent Dyes; Light; Nanoparticles; Scattering, Radiation; Silicon Dioxide; Spectrometry, Fluorescence | 2010 |
Anti-inflammatory activity and possible mechanism of extract from Mikania laevigata in carrageenan-induced peritonitis.
Topics: Animals; Anti-Inflammatory Agents; Brazil; Carrageenan; Cell Movement; Coumarins; Disease Models, Animal; Leukocyte Rolling; Male; Medicine, Traditional; Mice; Mikania; Neutrophils; Nitric Oxide; Peritonitis; Plant Extracts; Plant Leaves; Seasons | 2009 |
A comparison of several nanoscale photocatalysts in the degradation of a common pollutant using LEDs and conventional UV light.
Topics: Catalysis; Chlorophenols; Coumarins; Hydrogen-Ion Concentration; Light; Microscopy, Electron, Scanning; Molecular Structure; Nanofibers; Photochemical Processes; Photochemistry; Spectrophotometry; Tin Compounds; Ultraviolet Rays; Water Pollutants, Chemical | 2009 |
Mechanisms of low-power noncoherent photon upconversion in metalloporphyrin-organic blue emitter systems in solution.
Topics: Color; Coumarins; Fluorescence; Kinetics; Metalloporphyrins; Molecular Structure; Perylene; Photons; Solutions; Zinc | 2009 |
Determination of alkenylbenzenes and related flavour compounds in food samples by on-column preconcentration-capillary liquid chromatography.
Topics: Allylbenzene Derivatives; Anisoles; Benzene Derivatives; Benzyl Compounds; Chromatography, Liquid; Coumarins; Cyclohexane Monoterpenes; Dioxolanes; Eugenol; Flavoring Agents; Food Analysis; Linear Models; Monoterpenes; Pyrogallol; Sensitivity and Specificity | 2009 |
Nonlinear fluorescence quenching of newly synthesized coumarin derivative by aniline in binary mixtures.
Topics: Aniline Compounds; Coumarins; Energy Transfer; Fluorescence | 2009 |
Site-specific covalent labeling of His-tag fused proteins with a reactive Ni(II)-NTA probe.
Topics: Binding Sites; Coumarins; Fluorescent Dyes; Green Fluorescent Proteins; Histidine; Nickel; Nitrilotriacetic Acid; Organometallic Compounds; Staining and Labeling | 2009 |
Lavender as a source of novel plant compounds for the development of a natural herbicide.
Topics: Coumarins; Herbicides; Lavandula; Lolium; Plant Extracts; Plant Leaves; Plant Roots; Plant Stems | 2009 |
[Influence of combination of extractum Angelicae Dahuricae Siccum and total alkaloids of Rhizoma Corydalis on pharmacokinetics of tetrahydropalmatine in rats].
Topics: Alkaloids; Angelica; Animals; Berberine Alkaloids; Corydalis; Coumarins; Drugs, Chinese Herbal; Oils, Volatile; Rats; Rats, Sprague-Dawley; Rhizome | 2009 |
Influence of confined water on the photophysics of dissolved solutes in reverse micelles.
Topics: Coumarins; Deuterium Exchange Measurement; Fluorescence; Fluorescence Polarization; Hydrophobic and Hydrophilic Interactions; Micelles; Molecular Probes; Solvents; Water | 2009 |
Antibacterial activity of phenolic compounds against the phytopathogen Xylella fastidiosa.
Topics: Anti-Bacterial Agents; Coumarins; Crops, Agricultural; Flavonoids; Hydroxybenzoates; Microbial Sensitivity Tests; Plant Diseases; Stilbenes; Xylella | 2010 |
2-Azetidinone derivatives: design, synthesis, in vitro anti-microbial, cytotoxic activities and DNA cleavage study.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Artemia; Azetidines; Coumarins; DNA Cleavage; Drug Design; Electrophoresis, Agar Gel; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure | 2009 |
Insect monitoring with fluorescence lidar techniques: feasibility study.
Topics: Animal Migration; Animals; Coumarins; Environmental Monitoring; Equipment Design; Feasibility Studies; Female; Fluorescence; Fluorescent Dyes; Imaging, Three-Dimensional; Insecta; Light; Male; Optics and Photonics; Rhodamines | 2009 |
[Resistance to coumarin derivatives due to mutated vitamin-K enzyme].
Topics: Anticoagulants; Coumarins; Drug Resistance; Humans; Mixed Function Oxygenases; Mutation, Missense; Vitamin K; Vitamin K Epoxide Reductases | 2009 |
A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Survival; Coumarins; Cyclic S-Oxides; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Membrane Potential, Mitochondrial; Ovarian Neoplasms; Platinum; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2011 |
Photo-solid-phase microextraction of selected indoor air pollutants from office buildings. Identification of their photolysis intermediates.
Topics: Air Pollutants; Air Pollution, Indoor; Butylated Hydroxytoluene; Coumarins; Kinetics; Light; Mass Spectrometry; Naphthalenes; Photolysis; Solid Phase Microextraction; Time Factors | 2009 |
The coumarin-->indole transformation--a method for preparing 4-halo-5-hydroxyindoles from coumarins.
Topics: Coumarins; Cyclization; Indoles; Molecular Structure; Stereoisomerism | 2009 |
FRET enabled real time detection of RNA-small molecule binding.
Topics: Aminoglycosides; Base Sequence; Coumarins; Drug Design; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Ligands; RNA; Time Factors; Uridine | 2009 |
Pyrophosphate selective fluorescent chemosensors based on coumarin-DPA-Cu(II) complexes.
Topics: Amines; Clinical Laboratory Techniques; Copper; Coumarins; Crystallography, X-Ray; Diphosphates; Fluorescence; Phosphates; Picolinic Acids | 2009 |
Chemical constituents from Clematis delavayi var. spinescens.
Topics: Angiogenesis Inhibitors; Animals; Clematis; Coumarins; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phthalazines; Pyridines; Zebrafish | 2009 |
A micellar multitasking device: sensing pH windows and gauging the lipophilicity of drugs with fluorescent signals.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Coumarins; Fluorescence; Hydrogen-Ion Concentration; Kinetics; Micelles; Octoxynol; Spectrometry, Fluorescence; Water | 2010 |
Synthesis, crystal structure and photoluminescence of 3-(4-(anthracen-10-yl)phenyl)-benzo[5,6]coumarin.
Topics: Coumarins; Crystallography, X-Ray; Luminescence; Models, Molecular; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2010 |
Synthesis and characterization of coumarin-based europium complexes and luminescence measurements in aqueous media.
Topics: Coumarins; Cross-Linking Reagents; Europium; Ligands; Luminescent Measurements; Organometallic Compounds; Solutions; Spectrophotometry, Ultraviolet; Water | 2009 |
The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
Topics: Acetamides; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Crystallography, X-Ray; Humans; Lacosamide; Structure-Activity Relationship | 2010 |
Synthesis and study of novel coumarin derivatives potentially utilizable as memory media.
Topics: Catalysis; Coumarins; Spectrometry, Fluorescence | 2009 |
[Influence of anticoagulants on the appearance of chronic subdural hematoma].
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Chronic Disease; Coumarins; Female; Hematoma, Subdural; Heparin, Low-Molecular-Weight; Humans; Incidence; Male; Middle Aged; Poland; Surveys and Questionnaires | 2009 |
Real-time monitoring of drug release.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Survival; Coumarins; Drug Delivery Systems; Humans; Melphalan; Molecular Structure; Prodrugs | 2010 |
Coumarin-based, electron-trapping iridium complexes as highly efficient and stable phosphorescent emitters for organic light-emitting diodes.
Topics: Coumarins; Electrons; Iodopyracet; Iridium; Light; Luminescent Measurements; Molecular Structure; Photochemistry; Spectrometry, Fluorescence; Thermodynamics | 2010 |
Dietary exposure to flavouring substances: from screening methods to detailed assessments using food consumption data collected with EPIC-Soft software.
Topics: Aged; Butanones; Caffeine; Coumarins; Diet; Diet Records; Female; Flavoring Agents; Food; Glycyrrhizic Acid; Humans; Male; Middle Aged; Netherlands; Software; Surveys and Questionnaires | 2010 |
Use of folded micromachined pillar array column with low-dispersion turns for pressure-driven liquid chromatography.
Topics: Chromatography, Liquid; Coumarins; Fluorescent Dyes; Injections; Microarray Analysis; Pressure | 2010 |
Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Topics: Amino Acid Substitution; Bacterial Proteins; Biocatalysis; Carbon; Chlorzoxazone; Coumarins; Cytochrome P-450 Enzyme System; Enzyme Stability; Escherichia coli; Heme; Humans; Indigo Carmine; Indoles; Kinetics; Molecular Dynamics Simulation; NADPH-Ferrihemoprotein Reductase; Nitrophenols; Oxazines; Oxidation-Reduction; Phenacetin; Protein Engineering; Recombinant Proteins; Transformation, Genetic; Umbelliferones | 2010 |
A novel 3-arylcoumarin and three new 2-arylbenzofurans from Mucuna birdwoodiana.
Topics: Benzofurans; Coumarins; Molecular Structure; Mucuna; Plant Stems | 2010 |
Functional characterization of cytochrome P450 2A6 allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22.
Topics: Amino Acid Substitution; Aryl Hydrocarbon Hydroxylases; Base Sequence; Biocatalysis; Cell Membrane; Coumarins; Cytochrome P-450 CYP2A6; Escherichia coli; Humans; Kinetics; Mutagenesis, Site-Directed; Polymorphism, Single Nucleotide; Spectrophotometry; Transformation, Genetic; Umbelliferones | 2010 |
A note on variance estimation of the Aalen-Johansen estimator of the cumulative incidence function in competing risks, with a view towards left-truncated data.
Topics: Abortion, Spontaneous; Analysis of Variance; Computer Simulation; Coumarins; Data Interpretation, Statistical; Female; Humans; Kaplan-Meier Estimate; Models, Biological; Models, Statistical; Pregnancy; Risk Factors; Stochastic Processes | 2010 |
Light-sensitive intelligent drug delivery systems of coumarin-modified mesoporous bioactive glass.
Topics: Adsorption; Coumarins; Delayed-Action Preparations; Dimerization; Drug Delivery Systems; Glass; Light; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Nitrogen; Porosity; Spectrophotometry, Ultraviolet; Temperature; X-Ray Diffraction | 2010 |
A highly selective fluorescent probe for Hg(2+) based on a rhodamine-coumarin conjugate.
Topics: Coumarins; Fluorescent Dyes; Hydrogen-Ion Concentration; Mercury; Organometallic Compounds; Rhodamines; Water Pollutants, Chemical | 2010 |
A coumarin-based fluorescent chemosensor for Zn2+ in aqueous ethanol media.
Topics: Chemistry Techniques, Analytical; Coumarins; Electron Transport; Ethanol; Hydrogen-Ion Concentration; Photochemical Processes; Spectrometry, Fluorescence; Water; Zinc | 2010 |
Novel coumarin and furan from the roots of Angelica pubescens f. biserrata.
Topics: Angelica; Coumarins; Drugs, Chinese Herbal; Furans; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Roots | 2009 |
A novel coumarin fluorescent sensor to probe polarity around biomolecules.
Topics: Biopolymers; Biosensing Techniques; Coumarins; Electrochemistry; Equipment Design; Equipment Failure Analysis; Molecular Probe Techniques; Spectrometry, Fluorescence; Static Electricity | 2009 |
Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats.
Topics: Animals; Antioxidants; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Coumarins; Hymecromone; Male; Rats; Rats, Sprague-Dawley; Umbelliferones | 2011 |
Coumarin-caged rosamine probes based on a unique intramolecular carbon-carbon spirocyclization.
Topics: Coloring Agents; Coumarins; Crystallography, X-Ray; Cyclization; Fluorescent Dyes; Molecular Structure; Photolysis; Rhodamines; Spiro Compounds | 2010 |
The clinical use of anticoagulants; report of treatment with dicumarol in 1,686 postoperative cases.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Postoperative Period | 1947 |
Treatment of coronary artery disease; dicumarol therapy.
Topics: Coronary Artery Disease; Coronary Disease; Coronary Vessels; Coumarins; Dicumarol; Disease | 1947 |
The use of dicumarol in acute coronary thrombosis.
Topics: Coronary Thrombosis; Coumarins; Dicumarol; Humans | 1947 |
The use of anticoagulants in the management of acute myocardial infarction; a preliminary report.
Topics: Anticoagulants; Blood Coagulation; Coronary Vessels; Coumarins; Heart; Heparin; Humans; Infarction; Myocardial Infarction | 1947 |
Dicumarol and rutin in retinal vascular disorders.
Topics: Cardiovascular System; Coumarins; Dicumarol; Flavones; Retina; Rutin | 1946 |
Thrombophlebitis and phlebothrombosis; with special reference to dicumarol and heparin treatment.
Topics: Anticoagulants; Coumarins; Dicumarol; Heparin; Humans; Thrombophlebitis; Thrombosis; Venous Thrombosis | 1947 |
How Anticoagulants work, especially Dicumarin.
Topics: Blood Coagulation; Coumarins | 1947 |
Dicumarol.
Topics: Coumarins; Dicumarol | 1947 |
Action of N-bromosuccinimide on sea neck counterparts.
Topics: Coumarins; Succinimides | 1947 |
Coagulation time of the blood in lusteroid tubes; a study of patients receiving dicumarol.
Topics: Blood Coagulation; Blood Coagulation Tests; Coumarins; Dicumarol; Humans | 1947 |
Cytogenetics and breeding of forage crops; studies of coumarin.
Topics: Breeding; Coumarins; Crops, Agricultural; Cytogenetic Analysis | 1947 |
The hypoprothrombinaemic effect of 3,3'ethylidene-bis-4-hydroxycoumarin (E.D.C.) an experimental and clinical study.
Topics: 4-Hydroxycoumarins; Blood; Coumarins; Humans; Prothrombin | 1947 |
On the use of dicumarin as a means of preventing blood clotting in some animal experiences.
Topics: Coumarins | 1947 |
Dicumarol and rutin in retinal vascular disorders.
Topics: Coumarins; Dicumarol; Disease; Humans; Retina; Retinal Diseases; Rutin | 1947 |
Trials for the prevention of experimental thrombosis in rabbits with dicoumarol.
Topics: Coumarins; Humans; Thrombosis | 1947 |
The use of dicumarol as an anticoagulant; experience in 2,307 cases.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans | 1947 |
Dicoumarol poisoning with relapse: report of a case.
Topics: Aged; Chronic Disease; Coumarins; Dicumarol; Humans; Recurrence | 1947 |
Recent advances in the treatment of thromboembolic conditions with heparin and dicoumarin.
Topics: Coumarins; Embolism; Heparin; Humans; Thrombosis | 1947 |
Experiences with dicumarol in the treatment of coronary thrombosis.
Topics: Coronary Thrombosis; Coumarins; Dicumarol; Humans | 1945 |
The use of Russell viper venom as a means of following the anticoagulant action of 3,3'-methylenebis(4-hydroxycoumarin) in the dog.
Topics: 4-Hydroxycoumarins; Animals; Anticoagulants; Blood Coagulation; Coumarins; Daboia; Dogs; Venoms; Viper Venoms | 1947 |
Gross hematuria following the use of dicoumarol.
Topics: Coumarins; Dicumarol; Hematuria; Humans | 1947 |
Results of treatment of multiple sclerosis with dicoumarin.
Topics: Coumarins; Dicumarol; Humans; Multiple Sclerosis; Sclerosis | 1947 |
Action of 3,3' methylenebis (4-hydroxycoumarin) (dicumarol) on thromboplastic activity of rabbit brain.
Topics: 4-Hydroxycoumarins; Animals; Blood Coagulation; Brain; Coumarins; Dicumarol; Rabbits; Thromboplastin | 1947 |
The responses of onion and lily mitosis to coumarin and parasorbic acid.
Topics: Cell Division; Coumarins; Lactones; Lilium; Mitosis; Onions; Poisoning; Poisons | 1947 |
Coumarins from 2-hydroxy-3-methoxybenzaldehyde.
Topics: Benzaldehydes; Coumarins | 1947 |
Coumarin as a selective phytocidal agent.
Topics: Coumarins; Herbicides; Humans | 1947 |
The effect of perfusion through the isolated liver on the prothrombin activity of blood from normal and dicumarol treated rats.
Topics: Animals; Blood; Coumarins; Dicumarol; Liver; Perfusion; Prothrombin; Rats | 1947 |
Effect of 3,3' methylenebis (4-hydroxycoumarin) on vitamin A deficient ducks.
Topics: 4-Hydroxycoumarins; Animals; Coumarins; Ducks; Humans; Vitamin A; Vitamin A Deficiency; Vitamins | 1947 |
Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers.
Topics: Acetylcholinesterase; Animals; Antidotes; Aryldialkylphosphatase; Biocatalysis; Chemical Warfare Agents; Cholinesterase Inhibitors; Coumarins; Directed Molecular Evolution; Flow Cytometry; Fluorescent Dyes; Fluorides; Genetic Variation; High-Throughput Screening Assays; Humans; Hydrolysis; Optical Phenomena; Stereoisomerism; Substrate Specificity | 2010 |
The production of coumarin derivatives by condensation of o-hydroxy-aldehydes with delta beta gamma-angelicalactone.
Topics: Aldehydes; Coumarins; Gamma Rays; Humans; Lactones | 1946 |
The influence of 3,3'-methylene-bis-(4-hydroxycoumarin) upon streptococcus infection in rabbits.
Topics: 4-Hydroxycoumarins; Animals; Coumarins; Infections; Rabbits; Streptococcal Infections; Streptococcus | 1947 |
Gamma-glutamyl transpeptidase null mice fail to develop tolerance to coumarin-induced Clara cell toxicity.
Topics: Adaptation, Physiological; Animals; Bronchioles; Coumarins; Female; gamma-Glutamyltransferase; Glutathione; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout | 2010 |
Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans.
Topics: Adult; Anticoagulants; Calcinosis; Calcium-Binding Proteins; Cardiovascular Diseases; Coumarins; Databases, Factual; Extracellular Matrix Proteins; Female; Femoral Artery; Humans; Male; Matrix Gla Protein; Middle Aged; Radiography; Regression Analysis; Risk Factors; Thrombosis | 2010 |
Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Coumarins; DNA; Drug Evaluation, Preclinical; Electrophoresis; Female; Male; Mice; Pyrimidines; Rats; Structure-Activity Relationship | 2010 |
An iminocoumarin-based fluorescent probe for the selective detection of dual-specific protein tyrosine phosphatases.
Topics: Coumarins; Cyclization; Dual-Specificity Phosphatases; Fluorescent Dyes; Humans; Molecular Structure; Protein Tyrosine Phosphatases | 2010 |
Expression and characterization of dog cytochrome P450 2A13 and 2A25 in baculovirus-infected insect cells.
Topics: Animals; Baculoviridae; Cells, Cultured; Coumarins; Cytochrome P-450 Enzyme System; Dogs; Gene Expression Regulation, Enzymologic; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Phenacetin; Spodoptera; Substrate Specificity | 2010 |
A Hg2+-selective chemodosimeter based on desulfurization of coumarin thiosemicarbazide in aqueous media.
Topics: Coumarins; Mercury; Semicarbazides; Sensitivity and Specificity; Spectrometry, Fluorescence | 2010 |
Synthesis of novel benzocoumarin derivatives as lipid lowering agents.
Topics: Animals; Coumarins; Hyperlipidemias; Hypolipidemic Agents; Rats; Structure-Activity Relationship | 2010 |
Fast determination of five components of coumarin, alkaloids and bibenzyls in Dendrobium spp. using pressurized liquid extraction and ultra-performance liquid chromatography.
Topics: Alkaloids; Bibenzyls; Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coumarins; Dendrobium; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Chemical; Phytotherapy; Plant Extracts; Reproducibility of Results; Temperature | 2010 |
Hemorrhagic complications after intravitreal injections of ranibizumab in patients under coumarin-type anticoagulation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Coumarins; Drug Combinations; Eye Hemorrhage; Female; Humans; Male; Middle Aged; Ranibizumab; Retrospective Studies; Vitreous Body | 2010 |
Boronate derivatives of functionally diverse catechols: stability studies.
Topics: Boronic Acids; Coumarins; Crystallization; Dopamine; Drug Stability; Estrogens, Catechol | 2010 |
Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
Topics: 4-Hydroxycoumarins; Administration, Oral; Anticoagulants; Biomarkers; Coumarins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Lethal Dose 50; Molecular Structure; Platelet Aggregation Inhibitors; Protein Precursors; Prothrombin; Structure-Activity Relationship; Warfarin | 2010 |
A severe renal bleeding as a complication of coumarin therapy in Behçet's disease.
Topics: Adult; Behcet Syndrome; Coumarins; Humans; Male; Renal Insufficiency | 2010 |
A "turn-on" coumarin-based fluorescent sensor with high selectivity for mercury ions in aqueous media.
Topics: Computer Simulation; Coumarins; Fluorescent Dyes; Ions; Mercury; Models, Chemical; Water | 2010 |
Highly sensitive and selective "turn-on" fluorescent chemodosimeter for Cu2+ in water via Cu2+-promoted hydrolysis of lactone moiety in coumarin.
Topics: Copper; Coumarins; Fluorescent Dyes; Hydrolysis; Lactones; Organometallic Compounds; Temperature; Time Factors; Water | 2010 |
Aminocatalytic asymmetric inverse-electron-demand aza-Diels-Alder reaction of N-Ts-1-aza-1,3-butadienes based on coumarin cores.
Topics: Acetaldehyde; Aza Compounds; Butadienes; Catalysis; Coumarins; Crystallography, X-Ray; Electrons; Molecular Conformation; Stereoisomerism | 2010 |
dsDNA-triggered energy transfer and lanthanide sensitization processes. Luminescent probing of specific A/T sequences.
Topics: AT Rich Sequence; Base Sequence; Benzamidines; Coumarins; DNA; Energy Transfer; Fluorescent Dyes; Heterocyclic Compounds, 1-Ring; Lanthanoid Series Elements; Luminescence | 2010 |
Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitors.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; Chromones; Coumarins; DNA-Activated Protein Kinase; Humans; Inhibitory Concentration 50; Isocoumarins; Structure-Activity Relationship | 2010 |
[Guiding principles for anticoagulant therapy in cardiology].
Topics: Anticoagulants; Atrial Fibrillation; Cardiology; Cardiovascular Diseases; Coumarins; Heart Valve Prosthesis; Heparin; Humans; Platelet Aggregation Inhibitors; Stroke | 2010 |
Ketocoumarin dyes as electron mediators for visible light induced carboxylate photorelease.
Topics: Carboxylic Acids; Coloring Agents; Coumarins; Electron Transport; Electrons; Esters; Light; Photolysis; Picolines; Quantum Theory | 2010 |
Synthesis, structure and DNA cleavage studies of coumarin analogues of tetrahydroisoquinoline and protoberberine alkaloids.
Topics: Aspergillus niger; Berberine Alkaloids; Coumarins; DNA, Bacterial; DNA, Fungal; Escherichia coli; Staphylococcus aureus; Tetrahydroisoquinolines | 2010 |
Novel coumarin derivatives as potential antidyslipidemic agents.
Topics: Coumarins; Dyslipidemias; Humans | 2010 |
N6-(2-(R)-propargylglycyl)lysine as a clickable pyrrolysine mimic.
Topics: Alkynes; Azides; Calmodulin; Catalysis; Copper; Coumarins; Dipeptides; Fluorescent Dyes; Lysine; Stereoisomerism | 2010 |
Antitermite activities of coumarin derivatives and scopoletin from Protium javanicum Burm. f.
Topics: Animals; Burseraceae; Coumarins; Insecticides; Isoptera; Plant Extracts; Quercetin; Scopoletin; Stigmasterol; Structure-Activity Relationship; Umbelliferones | 2010 |
Radical scavenging and angiotensin converting enzyme inhibitory activities of standardized extracts of Ficus racemosa stem bark.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzopyrans; Biphenyl Compounds; Coumaric Acids; Coumarins; Ficus; Free Radical Scavengers; Kaempferols; Lung; Picrates; Plant Bark; Plant Extracts; Rabbits; Swine | 2010 |
Pressurized liquid extraction and GC-MS analysis for simultaneous determination of seven components in Cinnamomum cassia and the effect of sample preparation.
Topics: Acrolein; Analytic Sample Preparation Methods; Chemical Fractionation; Cinnamates; Cinnamomum aromaticum; Coumarins; Gas Chromatography-Mass Spectrometry; Molecular Structure; Pressure; Safrole; Sesquiterpenes; Stereoisomerism | 2010 |
A direct probe of the interplay between bilayer morphology and surface reactivity in polymersomes.
Topics: Coumarins; Diffusion; Electric Conductivity; Iodides; Lipid Bilayers; Membranes, Artificial; Polyethylene Glycols; Polymers; Spectrometry, Fluorescence; Surface Properties; Viscosity; Water | 2010 |
A simple scanless two-photon fluorescence microscope using selective plane illumination.
Topics: Animals; Caenorhabditis elegans; Coumarins; Lighting; Luminescent Proteins; Microscopy, Fluorescence; Muscles; Pharynx; Photons | 2010 |
New far-red and near-infrared fluorescent probes with large Stokes shifts for dual covalent labeling of DNA.
Topics: Base Sequence; Coumarins; DNA; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Oligonucleotides; Spectrometry, Fluorescence; Transition Temperature | 2010 |
Pharmacophores modeling in terms of prediction of theoretical physico-chemical properties and verification by experimental correlations of novel coumarin derivatives produced via Betti's protocol.
Topics: Aldehydes; Anti-Bacterial Agents; Chemical Phenomena; Coumarins; Drug Evaluation, Preclinical; Imines; Spectrum Analysis; Structure-Activity Relationship; User-Computer Interface | 2010 |
Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Line; Coumarins; Drug Resistance, Bacterial; Helicobacter pylori; Humans; Interleukin-8; Metronidazole; Microbial Sensitivity Tests; Structure-Activity Relationship | 2010 |
Design of novel 4-hydroxy-chromene-2-one derivatives as antimicrobial agents.
Topics: Anti-Infective Agents; Candida albicans; Coumarins; Escherichia coli; Microbial Sensitivity Tests; Mucor; Quantitative Structure-Activity Relationship; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
A novel dimeric coumarin analog and antimycobacterial constituents from Fatoua pilosa.
Topics: Antitubercular Agents; Coumarins; Humans; Microbial Sensitivity Tests; Models, Molecular; Moraceae; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Development of luciferin analogues bearing an amino group and their application as BRET donors.
Topics: Bacterial Proteins; Benzothiazoles; Coumarins; Firefly Luciferin; Fluorescence Resonance Energy Transfer; Luciferases; Luminescent Agents; Luminescent Measurements; Luminescent Proteins; Naphthalenes; Quinolines | 2010 |
Coumarin derivatives from Gerbera saxatilis.
Topics: Antineoplastic Agents, Phytogenic; Asteraceae; Cell Line, Tumor; Cell Survival; Coumarins; Drug Screening Assays, Antitumor; HeLa Cells; HL-60 Cells; Humans; Molecular Structure; X-Rays | 2011 |
Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Coumarins; Drug Delivery Systems; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Nanoparticles; Photons; Porosity; Silicon Dioxide; Surface Properties | 2010 |
A coumarin based ICT probe for fluoride in aqueous medium with its real application.
Topics: Coumarins; Electron Transport; Fluorides; Hydrogen; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Quantum Theory; Spectrophotometry, Ultraviolet; Water | 2010 |
Conformationally constrained (coumarin-triazolyl-bipyridyl) click fluoroionophore as a selective Al3+ sensor.
Topics: 2,2'-Dipyridyl; Aluminum; Chemistry Techniques, Analytical; Coumarins; Electron Transport; Molecular Conformation; Spectrometry, Fluorescence; Triazoles | 2010 |
Design and synthesis of a long-wavelength latent fluorogenic substrate for salicylate hydroxylase: a useful fluorimetric indicator for analyte determination by dehydrogenase-coupled biosensors.
Topics: 3-Hydroxybutyric Acid; Biosensing Techniques; Cholesterol; Coumarins; Electrodes; Fluorescent Dyes; Fluorometry; Mixed Function Oxygenases; NAD; Oxygen; Salicylic Acid | 2010 |
Platinized WO3 as an environmental photocatalyst that generates OH radicals under visible light.
Topics: Carbon; Catalysis; Coumarins; Environment; Hydroxyl Radical; Light; Oxidation-Reduction; Oxides; Platinum; Spectrophotometry, Ultraviolet; tert-Butyl Alcohol; Time Factors; Titanium; Tungsten | 2010 |
Anisotropic media effect on the dipole moment of some coumarin dyes.
Topics: Anisotropy; Coloring Agents; Coumarins; Lasers; Liquid Crystals; Solvents; Static Electricity | 2010 |
Anti-hypoxia activity and related components of Rhodobryum giganteum par.
Topics: Animals; Bryophyta; Cinnamates; Coumarins; Disease Models, Animal; Hypoxia; Isoproterenol; Male; Mice; Myocardial Reperfusion Injury; Phytotherapy; Pituitary Hormones, Posterior; Plant Extracts; Rats; Rats, Sprague-Dawley | 2011 |
Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy.
Topics: Antigens, Neoplasm; Blotting, Western; Cell Adhesion Molecules; Cell Cycle; Cell Death; Cell Line, Tumor; Chemical Phenomena; Coumarins; Epithelial Cell Adhesion Molecule; Humans; Imidazoles; Inhibitory Concentration 50; Intracellular Space; Membrane Potential, Mitochondrial; Microscopy, Confocal; Nanoparticles; Neoplasms; Particle Size; Piperazines; Polyglactin 910; Receptors, Cell Surface; Solutions | 2011 |
Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
Topics: Antineoplastic Agents; Binding Sites; Catalytic Domain; Cell Line, Tumor; Computer Simulation; Coumarins; Humans; Protein Structure, Tertiary; Pyrazoles; Stomach Neoplasms; Telomerase | 2010 |
Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases.
Topics: Antineoplastic Agents; cdc25 Phosphatases; Coumarins; Enzyme Inhibitors; Humans; Neoplasms | 2010 |
Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database.
Topics: Algorithms; Computer Simulation; Computer-Aided Design; Coumarins; Databases, Factual; Drug Design; Drug Discovery; Enzyme Inhibitors; Ligands; Models, Theoretical; Monophenol Monooxygenase; Quantitative Structure-Activity Relationship; Reproducibility of Results; Research Design | 2011 |
Coumarin-suberoylanilide hydroxamic acid as a fluorescent probe for determining binding affinities and off-rates of histone deacetylase inhibitors.
Topics: Coumarins; Depsipeptides; Fluorescent Dyes; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Kinetics; Protein Binding; Recombinant Proteins; Repressor Proteins; Spectrometry, Fluorescence; Vorinostat | 2011 |
Determination of aqueous stability and degradation products of series of coumarin dimers.
Topics: Animals; Carbon; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Coumarins; Hydrogen-Ion Concentration; Kinetics; Male; Mass Spectrometry; Mice; Microsomes, Liver; Models, Chemical; Oxygen; Solvents; Water | 2011 |
Expedient synthesis of coumarin-coupled triazoles via 'click chemistry' leading to the formation of coumarin-triazole-sugar hybrids.
Topics: Carbohydrates; Click Chemistry; Coumarins; Crystallography, X-Ray; Models, Molecular; Molecular Structure; Stereoisomerism; Triazoles | 2010 |
A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices.
Topics: Animals; Coumarins; Equipment Design; Equipment Failure Analysis; Flow Injection Analysis; Intestinal Mucosa; Lidocaine; Liver; Male; Microfluidic Analytical Techniques; Organ Culture Techniques; Rats; Rats, Wistar | 2010 |
Live-cell imaging of cellular proteins by a strain-promoted azide-alkyne cycloaddition.
Topics: Alkynes; Animals; Azides; Cell Line, Tumor; Cell Membrane Permeability; Coumarins; Fibroblasts; Fluorescent Dyes; Humans; Microscopy, Confocal; Proteins; Rats | 2010 |
Polymeric nanoparticle encapsulation of a naturally occurring plant scopoletin and its effects on human melanoma cell A375.
Topics: Apoptosis; Caspase 3; Coumarins; Down-Regulation; Humans; Imidazoles; Lactic Acid; Melanoma; Nanoparticles; Particle Size; Polyesters; Polymers; Scopoletin; Skin Neoplasms; Up-Regulation | 2010 |
Poly(ε-caprolactone)-block-poly(ethyl ethylene phosphate) micelles for brain-targeting drug delivery: in vitro and in vivo valuation.
Topics: Animals; Blood-Brain Barrier; Brain; Coumarins; Drug Delivery Systems; In Vitro Techniques; Mice; Mice, Inbred ICR; Micelles; Polyesters; Rats; Rats, Sprague-Dawley | 2010 |
Quantification of flavoring constituents in cinnamon: high variation of coumarin in cassia bark from the German retail market and in authentic samples from indonesia.
Topics: Acrolein; Chromatography, High Pressure Liquid; Cinnamates; Cinnamomum aromaticum; Cinnamomum zeylanicum; Coumarins; Eugenol; Germany; Indonesia; Plant Bark; Propanols; Reproducibility of Results | 2010 |
Ratiometric fluorescent detection of intracellular hydroxyl radicals based on a hybrid coumarin-cyanine platform.
Topics: Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hydroxyl Radical; Magnetic Resonance Spectroscopy; Spectrometry, Fluorescence; Spectrometry, Mass, Electrospray Ionization | 2010 |
Förster's resonance energy transfer between Fullerene C60 and Coumarin C440.
Topics: Coumarins; Dimerization; Fluorescence Resonance Energy Transfer; Fullerenes; Models, Biological; Models, Molecular; Spectrometry, Fluorescence | 2010 |
Screening for in vitro antimycobacterial activity and three-dimensional quantitative structure-activity relationship (3D-QSAR) study of 4-(arylamino)coumarin derivatives.
Topics: Antitubercular Agents; Coumarins; Models, Molecular; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Rifampin | 2010 |
Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.
Topics: Animals; Cholesterol; Coumarins; Cricetinae; Hypolipidemic Agents; Structure-Activity Relationship; Triglycerides | 2010 |
Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment.
Topics: Administration, Oral; Adult; Aged; Amino Acid Sequence; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Blood Coagulation; Computational Biology; Coumarins; Cytochrome P-450 CYP2C9; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Resistance; Female; Genotype; Haplotypes; Heterozygote; Humans; International Normalized Ratio; Male; Middle Aged; Mixed Function Oxygenases; Molecular Sequence Data; Mutation, Missense; Phenotype; Polymorphism, Genetic; Retrospective Studies; Vitamin K Epoxide Reductases | 2011 |
Biological activity and coordination modes of copper(II) complexes of Schiff base-derived coumarin ligands.
Topics: Amines; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Candida; Cell Line, Tumor; Copper; Coumarins; Electron Spin Resonance Spectroscopy; Humans; Hydrogen-Ion Concentration; Ligands; Organometallic Compounds; Potentiometry; Schiff Bases; Solubility | 2010 |
Multicolor protein labeling in living cells using mutant β-lactamase-tag technology.
Topics: Bacterial Proteins; beta-Lactamases; Cell Line; Cell Membrane; Coumarins; Escherichia coli; Fluorescein; Fluorescence; Fluorescent Dyes; Gene Expression; Green Fluorescent Proteins; Humans; Microscopy, Fluorescence; Molecular Imaging; Mutation; Phosphorylation; Plasmids; Recombinant Fusion Proteins; Rhodamines; Staining and Labeling; Transfection | 2010 |
Fluorescent caged compounds of 2,4-dichlorophenoxyacetic acid (2,4-d): photorelease technology for controlled release of 2,4-D.
Topics: 2,4-Dichlorophenoxyacetic Acid; Chemistry, Pharmaceutical; Coumarins; Delayed-Action Preparations; Fluorescence; Herbicides; Molecular Structure; Photolysis; Ultraviolet Rays | 2010 |
Artificial estrogens derived from coumarin.
Topics: Coumarins; Estradiol Congeners; Estrogens | 1945 |
Experimentally induced changes in the prothrombin level of the blood; prothrombin concentration of new-born pups of a mother given dicumarol before parturition.
Topics: Blood; Blood Coagulation; Coumarins; Dicumarol; Female; Humans; Mothers; Parturition; Prothrombin | 1946 |
Experiences with dicumarol (3,3' methylene-bis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction; preliminary report.
Topics: 4-Hydroxycoumarins; Coronary Thrombosis; Coumarins; Dicumarol; Heart; Humans; Infarction; Myocardial Infarction | 1946 |
Heparin and dicoumarin.
Topics: Anticoagulants; Coumarins; Heparin; Humans | 1946 |
Coumarin plants (sweet clover, asparagus, sweetleaf melit).
Topics: Coumarins | 1946 |
Dicumarol therapy.
Topics: Coumarins; Dicumarol | 1946 |
Use of the anti-coagulants, heparin and dicumarol.
Topics: Anticoagulants; Blood Coagulation; Coagulants; Coumarins; Dicumarol; Heparin; Humans; Thrombosis | 1946 |
Dicoumarol prophylaxis in thoracic surgery.
Topics: Anticoagulants; Coumarins; Dicumarol; Humans; Thoracic Surgery; Thorax; Thrombosis | 1946 |
Dicumarol; its use in acute coronary thrombosis.
Topics: Coronary Thrombosis; Coumarins; Dicumarol | 1946 |
On a new class of coumarins derived from the thiophene nucleus.
Topics: Coumarins | 1945 |
The use of dicoumarol and vitamin K in urological cases.
Topics: Coumarins; Dicumarol; Humans; Vitamin K | 1945 |
Experimentally induced changes in the prothrombin level of the blood; quantitative studies in dogs given dicumarol; the effect of methylxanthines on prothrombin per se and when administered with dicumarol.
Topics: Animals; Blood; Coumarins; Dicumarol; Dogs; Hemostatics; Prothrombin; Xanthines | 1945 |
Action of dicoumarin (3-3'-methylene-bis-4-hydroxycoumarin) on prothrombinemia and plasma coagulation in normal adults.
Topics: Coumarins; Humans | 1945 |
Trial to prevent experimental venous thrombosis in rabbits with dicoumarin.
Topics: Anticoagulants; Coumarins; Humans; Thrombosis | 1945 |
Dicumarol therapy in acute coronary thombosis; results in fifty attacks; with review of data on embolic complications and immediate mortality in myocardial infarction.
Topics: Coronary Thrombosis; Coumarins; Dicumarol; Embolism; Heart; Humans; Infarction; Myocardial Infarction | 1946 |
FAILURE OF vitamin K as an antidote in dicumarol poisoning.
Topics: Antidotes; Antifibrinolytic Agents; Coumarins; Dicumarol; Humans; Naphthoquinones; Vitamin K; Vitamins | 1945 |
On dicoumarin-synthetic anti-coagulant.
Topics: Coagulants; Coumarins; Dicumarol; Humans | 1945 |
On a new method of preparation of hydroxy-methyl-2-coumaranne and its derivatives.
Topics: Coumarins | 1945 |
Heparin and dicumarol, anticoagulants; their prophylactic and therapeutic uses.
Topics: Anticoagulants; Blood Coagulation; Coumarins; Dicumarol; Heparin; Humans | 1946 |
The effect of phthalic acid on the prothrombin time of dicumarol-treated dogs.
Topics: Animals; Blood Coagulation; Coumarins; Dicumarol; Dogs; Phthalic Acids; Prothrombin Time | 1945 |
Thrombosis and embolism; a preliminary report on the comparative results of femoral vein interruption and dicumarol therapy.
Topics: Coumarins; Dicumarol; Embolism; Femoral Vein; Humans; Thrombosis | 1946 |
Anticoagulant medication with dicoumarin.
Topics: Coumarins | 1946 |
Penicillin and dicumarol, and penicillin in the treatment of subacute bacterial endocarditis.
Topics: Coumarins; Dicumarol; Endocarditis; Endocarditis, Subacute Bacterial; Penicillins | 1945 |
Penicillin and dicumarol, and penicillin in the treatment of subacute bacterial endocarditis.
Topics: Coumarins; Dicumarol; Endocarditis; Endocarditis, Subacute Bacterial; Penicillins | 1946 |
Experimental and clinical study of the action of dicoumarol on venous thrombosis.
Topics: Coumarins; Thrombosis | 1946 |
On the mode of action of dicoúmarin.
Topics: Coumarins; Dicumarol; Humans | 1945 |
Serial prothrombin estimations in cardiac patients; diagnostic and therapeutic implications; use of dicumarol.
Topics: Coumarins; Dicumarol; Heart Diseases; Humans; Prothrombin | 1946 |
Thromboembolism and coumarin overdosage in a 19-year-old female: impact of pharmacogenetics.
Topics: Coumarins; Drug Overdose; Female; Humans; Iliac Vein; International Normalized Ratio; Pharmacogenetics; Phenprocoumon; Prothrombin; Thromboembolism; Vena Cava, Inferior; Young Adult | 2010 |
Short-term effects of coumarin along the maize primary root axis.
Topics: Coumarins; Dose-Response Relationship, Drug; Membrane Potentials; Plant Roots; Signal Transduction; Zea mays | 2010 |
Spectrofluorimetric determination of coumarin in commercial tablets.
Topics: Coumarins; Hydrogen-Ion Concentration; Limit of Detection; Solvents; Spectrometry, Fluorescence; Tablets | 2011 |
Discovery of novel osthole derivatives as potential anti-breast cancer treatment.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cnidium; Coumarins; Female; Humans | 2010 |
Exploring coumarin egress channels in human cytochrome P450 2A6 by random acceleration and steered molecular dynamics simulations.
Topics: Algorithms; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Humans; Molecular Dynamics Simulation; Oxidation-Reduction; Protein Binding; Protein Structure, Tertiary | 2011 |
Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large histopathological study in carotid and femoral plaques.
Topics: Age Factors; Aged; Anticoagulants; Carotid Arteries; Coumarins; Endarterectomy; Endarterectomy, Carotid; Female; Femoral Artery; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Plaque, Atherosclerotic; Treatment Outcome | 2011 |
Engineered biosynthesis of gilvocarcin analogues with altered deoxyhexopyranose moieties.
Topics: Aminoglycosides; Animals; Antineoplastic Agents; Biosynthetic Pathways; Cell Line, Tumor; Cell Survival; Coumarins; Deoxy Sugars; Humans; Mice; Streptomyces lividans | 2011 |
Effect of centrally active drugs on the action of coumarin anticoagulants.
Topics: Animals; Anticoagulants; Antidepressive Agents; Coumarins; Drug Interactions; Guinea Pigs; Tranquilizing Agents | 1966 |
Cellular uptake and elimination of lipophilic drug delivered by nanocarriers.
Topics: Algorithms; Anticoagulants; Chemistry, Pharmaceutical; Coumarins; Drug Carriers; Emulsions; Fluorescent Dyes; HeLa Cells; Humans; Indoles; Liposomes; Microscopy, Confocal; Particle Size | 2010 |
Coumarin-malonitrile conjugate as a fluorescence turn-on probe for biothiols and its cellular expression.
Topics: Coumarins; Cysteine; Fluorescence; Fluorescent Dyes; Glutathione; Homocysteine; Molecular Probes; Nitriles; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfhydryl Compounds; Time Factors | 2011 |
Highly sensitive and selective fluorescent chemosensor for Ag+ based on a coumarin-Se2N chelating conjugate.
Topics: Chelating Agents; Coumarins; Electron Transport; Organoselenium Compounds; Selenium; Silver; Spectrometry, Fluorescence | 2011 |
Novel synthesis of hydrazide-hydrazone derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thiophene derivatives with antitumor activity.
Topics: Antineoplastic Agents; Azides; Cell Division; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Pyridines; Thiazoles; Thiophenes | 2010 |
Excited-state intramolecular proton transfer in hydroxyoxime-based chemical sensors.
Topics: Coumarins; Fluorescence; Isoxazoles; Models, Chemical; Molecular Structure; Naphthalenes; Organophosphorus Compounds; Oximes; Protons; Pyrenes; Pyridines; Quantum Theory; Spectrometry, Fluorescence | 2011 |
Ultrafast forward and backward electron transfer dynamics of coumarin 337 in hydrogen-bonded anilines as studied with femtosecond UV-pump/IR-probe spectroscopy.
Topics: Absorption; Algorithms; Aniline Compounds; Coumarins; Electron Transport; Electrons; Free Radicals; Hydrogen; Hydrogen Bonding; Solvents; Spectrophotometry, Infrared; Spectrum Analysis; Vibration | 2011 |
Synthesis and evaluation of a class of new coumarin triazole derivatives as potential antimicrobial agents.
Topics: Anti-Infective Agents; Coumarins; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Triazoles | 2011 |
Synthesis of 4H-chromene, coumarin, 12H-chromeno[2,3-d]pyrimidine derivatives and some of their antimicrobial and cytotoxicity activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Biochemical and biological evaluation of novel potent coumarin inhibitor of 17β-HSD type 1.
Topics: 17-Hydroxysteroid Dehydrogenases; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Estrogens; Humans; Solubility | 2011 |
Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal?
Topics: Animals; Anticoagulants; Blood Coagulation; Coumarins; Hemorrhage; Humans; Prothrombin | 2011 |
Cinnamic acid, coumarin and vanillin: Alternative phenolic compounds for efficient Agrobacterium-mediated transformation of the unicellular green alga, Nannochloropsis sp.
Topics: Acetophenones; Benzaldehydes; Cinnamates; Coumarins; Genes, Reporter; Glucuronidase; Rhizobium; Stramenopiles; Transcriptional Activation; Transformation, Genetic | 2011 |
Tuning of intermolecular electron transfer reaction by modulating the microenvironment inside copolymer-surfactant supramolecular assemblies.
Topics: Aniline Compounds; Coumarins; Electron Transport; Macromolecular Substances; Micelles; Models, Molecular; Molecular Structure; Poloxalene; Surface-Active Agents | 2011 |
Rationally designed fluorescence 'turn-on' sensor for Cu2+.
Topics: Animals; Cell Line; Copper; Coumarins; Electron Transport; Fluorescent Dyes; Ions; Macaca mulatta; Mice; Microscopy, Fluorescence; Quantum Theory; Spectrometry, Fluorescence | 2011 |
Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation--the case of coumarin.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Area Under Curve; Computer Simulation; Coumarins; Humans; Liver; Models, Animal; Rats; Risk Assessment | 2011 |
Simplification of the tetracyclic SIRT1-selective inhibitor MC2141: coumarin- and pyrimidine-based SIRT1/2 inhibitors with different selectivity profile.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coumarins; Enzyme Activation; Humans; Inhibitory Concentration 50; Molecular Structure; Pyrimidines; Quinazolinones; Sirtuin 1; Sirtuin 2 | 2011 |
Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Topics: Coumarins; Humans; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Conformation | 2011 |
Visualization of nitroxyl in living cells by a chelated copper(II) coumarin complex.
Topics: Cell Line, Tumor; Copper; Coumarins; Fluorescent Dyes; Humans; Nitrites; Nitrogen Oxides; Organometallic Compounds | 2011 |
Coumarin-based thiol chemosensor: synthesis, turn-on mechanism, and its biological application.
Topics: Coumarins; Cysteine; Fluorescent Dyes; Hep G2 Cells; Humans; Microscopy, Confocal; Molecular Structure; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2011 |
Chemical differences in volatiles between Melittis melissophyllum L. subsp. melissophyllum and subsp. albida (Guss) P. W. Ball (Lamiaceae) determined by solid-phase microextraction (SPME) coupled with GC/FID and GC/MS.
Topics: Bicyclic Monoterpenes; Complex Mixtures; Coumarins; Gas Chromatography-Mass Spectrometry; Italy; Lamiaceae; Monoterpenes; Octanols; Oils, Volatile; Phylogeography; Plant Leaves; Polycyclic Sesquiterpenes; Principal Component Analysis; Sesquiterpenes; Solid Phase Microextraction | 2011 |
Photochemical construction of coumarin fluorophore on affinity-anchored protein.
Topics: Animals; Antibodies; Coumarins; Fluorescent Dyes; Mice; Muramidase; Photochemical Processes; Proteins; Spectrometry, Fluorescence | 2011 |
Coumarin metabolic routes in Aspergillus spp.
Topics: Aspergillus; Aspergillus flavus; Aspergillus niger; Coumarins; Gas Chromatography-Mass Spectrometry; Hydroxylation; Magnetic Resonance Spectroscopy; Species Specificity | 2011 |
Synthesis of coumarin/phenanthridine-fused heterocycles and their photochemical and thermochromic properties.
Topics: Coumarins; Heterocyclic Compounds; Models, Molecular; Molecular Structure; Phenanthridines; Photochemical Processes; Thermodynamics | 2011 |
Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.
Topics: Anti-HIV Agents; Binding Sites; Binding, Competitive; Carbamates; Coumarins; Dose-Response Relationship, Drug; Drug Design; Glutamic Acid; Glutamine; Humans; Macrophages; Mutation; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship; vpr Gene Products, Human Immunodeficiency Virus | 2011 |
Development and validation of two methods based on high-performance liquid chromatography-tandem mass spectrometry for determining 1,2-benzopyrone, dihydrocoumarin, o-coumaric acid, syringaldehyde and kaurenoic acid in guaco extracts and pharmaceutical pr
Topics: Benzaldehydes; Chromatography, High Pressure Liquid; Coumaric Acids; Coumarins; Diterpenes; Mikania; Pharmaceutical Preparations; Plant Extracts; Tandem Mass Spectrometry | 2011 |
Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virus.
Topics: Animals; Antiviral Agents; Cell Line; Coumarins; Drug Discovery; Furans; Hepacivirus; Humans; Hydroxides; Models, Molecular; Molecular Conformation; Purine Nucleosides; Ribonucleosides; Solubility; Virus Replication | 2011 |
Polymer nanofibre junctions of attolitre volume serve as zeptomole-scale chemical reactors.
Topics: Coumarins; Diffusion; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Nanofibers; Polymers; Rhodamines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2009 |
Ratiometric coumarin-neutral red (CONER) nanoprobe for detection of hydroxyl radicals.
Topics: Cell Line, Tumor; Coated Materials, Biocompatible; Coumarins; Fluorescent Dyes; Humans; Hydroxyl Radical; Microscopy, Fluorescence; Nanoparticles; Neutral Red | 2011 |
Multifunctional trackable dendritic scaffolds and delivery agents.
Topics: Coumarins; Dendrimers; Drug Delivery Systems; Molecular Structure; Spectrometry, Fluorescence | 2011 |
Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.
Topics: Animals; Central Nervous System; Coumarins; Drug Design; Drug Evaluation, Preclinical; Mice; Molecular Imaging; Molecular Probes; Myelin Sheath; Staining and Labeling; Structure-Activity Relationship | 2011 |
Protective role of a coumarin-derived schiff base scaffold against tertiary butyl hydroperoxide (TBHP)-induced oxidative impairment and cell death via MAPKs, NF-κB and mitochondria-dependent pathways.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Cell Death; Cell Survival; Coumarins; Cytoprotection; DNA Fragmentation; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Free Radicals; Hepatocytes; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mice; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Schiff Bases; tert-Butylhydroperoxide | 2011 |
Synthesis and biological evaluation of 4-styrylcoumarin derivatives as inhibitors of TNF-α and IL-6 with anti-tubercular activity.
Topics: Anti-Inflammatory Agents; Antitubercular Agents; Coumarins; Interleukin-6; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tumor Necrosis Factor-alpha | 2011 |
Screening of natural organic volatiles from Prunus mahaleb L. honey: coumarin and vomifoliol as nonspecific biomarkers.
Topics: Biomarkers; Butanols; Coumarins; Cyclohexanones; Gas Chromatography-Mass Spectrometry; Honey; Prunus; Volatile Organic Compounds | 2011 |
High Na+ and K+ -induced fluorescence enhancement of a π-conjugated phenylaza-18-crown-6-triazol-substituted coumarin fluoroionophore.
Topics: Aza Compounds; Copper; Coumarins; Cyclization; Fluorescence; Molecular Structure; Potassium; Sodium; Spectrometry, Fluorescence; Stereoisomerism; Triazoles | 2011 |
Sequential ordering among multicolor fluorophores for protein labeling facility via aggregation-elimination based β-lactam probes.
Topics: beta-Lactamases; Coumarins; Electrophoresis, Polyacrylamide Gel; Fluorescence; Fluorescent Dyes; Kinetics; Models, Chemical; Molecular Structure; Protein Binding; Proteins; Reproducibility of Results; Rhodamines; Spectrophotometry; Staining and Labeling; Substrate Specificity | 2011 |
Highly sensitive cyanide anion detection with a coumarin-spiropyran conjugate as a fluorescent receptor.
Topics: Anions; Benzopyrans; Chemistry Techniques, Analytical; Coumarins; Cyanides; Fluorescence; Indoles; Molecular Probes; Molecular Structure; Nitro Compounds; Photochemical Processes; Sensitivity and Specificity; Solutions; Spectrometry, Fluorescence; Thermodynamics; Ultraviolet Rays; Water | 2011 |
A coumarin-based fluorescent probe for Hg2+ and Ag+ with an N'-acetylthioureido group as a fluorescence switch.
Topics: Acetylation; Acids; Buffers; Coumarins; Fluorescence; Fluorescent Dyes; Hydrogen Bonding; Hydrogen-Ion Concentration; Limit of Detection; Mercury; Sensitivity and Specificity; Silver; Spectrometry, Fluorescence; Sulfur; Thiourea; Water Pollutants, Chemical | 2011 |
Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center.
Topics: Amyloid beta-Peptides; Coumarins; Drug Design; Humans; Protein Binding; Protein Multimerization; Structure-Activity Relationship | 2011 |
Marcus-like inversion in electron transfer in neat ionic liquid and ionic liquid-mixed micelles.
Topics: Aniline Compounds; Coumarins; Diffusion; Electron Transport; Fluorescent Dyes; Ionic Liquids; Micelles; Poloxalene; Spectrophotometry, Ultraviolet; Time Factors; Viscosity | 2011 |
Na+ triggered fluorescence sensors for Mg2+ detection based on a coumarin salen moiety.
Topics: Cations; Coumarins; Fluorescent Dyes; Ligands; Magnesium; Molecular Structure; Sodium | 2011 |
Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.
Topics: Administration, Intranasal; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell-Penetrating Peptides; Coumarins; Drug Carriers; Glioma; Injections, Intravenous; Micelles; Neoplasm Transplantation; Particle Size; Peptide Fragments; Polyesters; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; tat Gene Products, Human Immunodeficiency Virus; Tissue Distribution | 2011 |
Self-assembled phenylethynylene bis-urea macrocycles facilitate the selective photodimerization of coumarin.
Topics: Alkynes; Coumarins; Dimerization; Macrocyclic Compounds; Phenethylamines; Photochemical Processes; Urea | 2011 |
Membrane topology of the colicin E1 channel using genetically encoded fluorescence.
Topics: Amino Acyl-tRNA Synthetases; Colicins; Coumarins; Cysteine; Escherichia coli; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Lipid Bilayers; Models, Molecular; Mutagenesis, Site-Directed; Mutation; p-Dimethylaminoazobenzene; Protein Structure, Secondary | 2011 |
Photophysical, photochemical and BSA binding/BQ quenching properties of quaternizable coumarin containing water soluble zinc phthalocyanine complexes.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Cattle; Coumarins; Fluorescence; Indoles; Isoindoles; Organometallic Compounds; Photolysis; Protein Binding; Serum Albumin, Bovine; Singlet Oxygen; Solubility; Water; Zinc Compounds | 2011 |
Concerted electron-proton transfer in the optical excitation of hydrogen-bonded dyes.
Topics: Biphenyl Compounds; Coloring Agents; Coumarins; Electrons; Hydrogen Bonding; Nitrophenols; Photochemical Processes; Protons; Spectrum Analysis | 2011 |
Synthesis, DNA binding, and cleavage studies of novel PNA binding cyclen complexes.
Topics: Binding Sites; Copper; Coumarins; Cyclams; DNA; DNA Cleavage; Heterocyclic Compounds; Nucleic Acid Denaturation; Peptide Nucleic Acids | 2011 |
Selective colorimetric and fluorometric sensing of Cu(II) by iminocoumarin derivative in aqueous buffer.
Topics: Colorimetry; Copper; Coumarins; Crystallography, X-Ray; Fluorescent Dyes; Hydrogen-Ion Concentration; Imines; Molecular Conformation; Spectrophotometry, Ultraviolet; Water | 2011 |
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Chemistry, Pharmaceutical; Chlamydia Infections; Chlamydia trachomatis; Coumarins; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Synergism; Humans; Intracellular Space; Lactic Acid; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rifampin; Time Factors | 2011 |
Co(II), Ni(II) and Cu(II) complexes with coumarin-8-yl Schiff-bases: spectroscopic, in vitro antimicrobial, DNA cleavage and fluorescence studies.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cobalt; Coordination Complexes; Copper; Coumarins; DNA Cleavage; DNA, Fungal; Electron Spin Resonance Spectroscopy; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Nickel; Schiff Bases; Spectrophotometry, Infrared | 2011 |
Five new diarylpropan-1-ols from Combretum yunnanense.
Topics: China; Combretum; Coumarins; Drugs, Chinese Herbal; Magnetic Resonance Spectroscopy; Medicine, Chinese Traditional; Molecular Structure; Plant Components, Aerial; Triterpenes | 2011 |
Rational design, synthesis, biological evaluation, homology and docking studies of coumarin derivatives as α1 -adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Binding Sites; Computer Simulation; Coumarins; Drug Design; Humans; Receptors, Adrenergic, alpha-1 | 2011 |
Subcellular protein localization by using a genetically encoded fluorescent amino acid.
Topics: Amino Acyl-tRNA Synthetases; Archaea; Bacterial Proteins; Coumarins; Cytoskeletal Proteins; Fluorescent Dyes; Microscopy, Fluorescence; Molecular Biology; Protein Biosynthesis; RNA, Transfer, Amino Acyl; Staining and Labeling | 2011 |
MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Topics: Coumarins; Humans; Iproniazid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline | 2011 |
A novel fluoride ion colorimetric chemosensor based on coumarin.
Topics: Anions; Colorimetry; Coumarins; Fluorides; Magnetic Resonance Spectroscopy; Protons; Schiff Bases; Spectrophotometry, Ultraviolet | 2011 |
Reversible fluorescent probe for highly selective and sensitive detection of mercapto biomolecules.
Topics: Cells, Cultured; Coumarins; Crystallography, X-Ray; Cysteine; Fluorescent Dyes; Glutathione; HEK293 Cells; Homocysteine; Humans; Mercury; Models, Molecular; Molecular Structure; Organomercury Compounds; Particle Size; Stereoisomerism; Surface Properties | 2011 |
Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway.
Topics: Anti-HIV Agents; Cell Line; Coumarins; HIV-1; Humans; Microbial Sensitivity Tests; Oncogene Protein v-akt; p300-CBP Transcription Factors; Phosphorylation; tat Gene Products, Human Immunodeficiency Virus; Transcription, Genetic | 2011 |
Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin-loaded cubic phase nanoparticles for cancer therapy.
Topics: Animals; Apoptosis; Biocompatible Materials; Blotting, Western; Cell Line, Tumor; Chemical Phenomena; Coloring Agents; Coumarins; Flow Cytometry; Humans; Inhibitory Concentration 50; Membrane Potential, Mitochondrial; Mice; Microscopy, Confocal; Mitogens; Nanoparticles; Neoplasms; Particle Size; Proto-Oncogene Proteins c-akt; Sirolimus; Spectroscopy, Fourier Transform Infrared; Subcellular Fractions; Time Factors; TOR Serine-Threonine Kinases | 2011 |
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
Topics: Anti-Infective Agents; Candida albicans; Coumarins; Crystallography, X-Ray; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Spectrophotometry, Infrared; Thiazoles | 2011 |
A desulfatation-oxidation cascade activates coumarin-based cross-linkers in the wound reaction of the giant unicellular alga Dasycladus vermicularis.
Topics: Chlorophyta; Coumarins; Cross-Linking Reagents; Molecular Structure; Oxidation-Reduction; Stereoisomerism | 2011 |
Synthesis and anti-inflammatory activity of novel biscoumarin-chalcone hybrids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chalcone; Coumarins; Edema; Microsomes; Rats | 2011 |
Use of a coumarin-labeled hexa-arginine peptide as a fluorescent hydroxyl radical probe in a nanoparticulate plasmid DNA condensate.
Topics: Arginine; Coumarins; DNA; Fluorescent Dyes; Hydroxyl Radical; Ligands; Molecular Structure; Nanoparticles; Particle Size; Peptides; Plasmids; Staining and Labeling; Stereoisomerism; Surface Properties | 2011 |
Coumarin-based bioactive compounds: facile synthesis and biological evaluation of coumarin-fused 1,4-thiazepines.
Topics: Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Coumarins; Humans; Neoplasms; Thiazepines | 2011 |
Humanized mice with ectopic artificial liver tissues.
Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Coumarins; Fluorescence; Hepatocytes; Humans; Liver; Liver Transplantation; Mice; Tissue Engineering; X-Ray Microtomography | 2011 |
One-pot dual-labeling of a protein by two chemoselective reactions.
Topics: Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Oximes; Protein Folding; Protein Interaction Maps; rab GTP-Binding Proteins | 2011 |
Enantioselective synthesis of polycyclic coumarin derivatives catalyzed by an in situ formed primary amine-imine catalyst.
Topics: Amines; Catalysis; Coumarins; Crystallography, X-Ray; Imines; Models, Molecular; Molecular Structure; Stereoisomerism | 2011 |
Benzylidene-bis-(4-hydroxycoumarin) and benzopyrano-coumarin derivatives: synthesis, ¹H/¹³C-NMR conformational and X-ray crystal structure studies and in vitro antiviral activity evaluations.
Topics: 4-Hydroxycoumarins; Animals; Antiviral Agents; Cats; Cell Line; Cell Line, Tumor; Coumarins; Dogs; Herpesvirus 1, Human; Herpesvirus 2, Human; Magnetic Resonance Spectroscopy; Molecular Structure; X-Ray Diffraction | 2011 |
Enzymatic activation of a peptide functionalised gold nanoparticle system for prodrug delivery.
Topics: Animals; Cattle; Coumarins; Gold; Humans; Materials Testing; Nanocapsules; Peptides; Prodrugs | 2011 |
Study on the anticancer activity of coumarin derivatives by molecular modeling.
Topics: Antineoplastic Agents; Casein Kinase II; Coumarins; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Neoplasms; Protein Binding; Quantitative Structure-Activity Relationship | 2011 |
Reconsideration on hydrogen bond strengthening or cleavage of photoexcited coumarin 102 in aqueous solvent: a DFT/TDDFT study.
Topics: Coumarins; Hydrogen Bonding; Models, Molecular; Photochemical Processes; Quantum Theory; Solutions; Solvents; Time Factors; Water | 2011 |
Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish (Danio rerio) embryos.
Topics: Animals; Anticoagulants; Coumarins; Embryo, Nonmammalian; Teratogens; Warfarin; Zebrafish | 2012 |
Vanillin-coumarin hybrid molecule as an efficient fluorescent probe for trace level determination of Hg(II) and its application in cell imaging.
Topics: Algorithms; Benzaldehydes; Candida albicans; Chelating Agents; Copper; Coumarins; Edetic Acid; Fluorescent Dyes; Iron; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mercury; Microscopy, Fluorescence; Nickel; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Temperature; Zinc | 2011 |
A molecular probe for the optical detection of biogenic amines.
Topics: Biogenic Amines; Coumarins; Molecular Probes; Optical Phenomena; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Water | 2011 |
Evaluation of fluorescent phosphatidylserine substrates for the aminophospholipid flippase in mammalian cells.
Topics: Animals; Azoles; Biological Transport; Cell Line; Coumarins; Fluoresceins; Fluorescent Dyes; Nitrobenzenes; Phosphatidylserines; Phospholipid Transfer Proteins | 2012 |
Synthesis, pharmacological evaluation and docking studies of coumarin derivatives.
Topics: Animals; Coumarins; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Rats; Rats, Wistar; Spectrophotometry, Infrared | 2011 |
Novel small stable gold nanoparticles bearing fluorescent cysteine-coumarin probes as new metal-modulated chemosensors.
Topics: Coumarins; Crystallography, X-Ray; Cysteine; Fluorescent Dyes; Gold; Mercury; Metals; Models, Molecular; Nanoparticles; Sensitivity and Specificity; Spectrometry, Fluorescence | 2011 |
Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys.
Topics: Animals; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Assays; Female; Humans; Hydroxylation; Immunoblotting; Inactivation, Metabolic; Macaca fascicularis; Male; Microsomes, Liver; Oxazines; Sensitivity and Specificity; Steroid Hydroxylases | 2011 |
Coagulation: cascade!
Topics: Aged; Anticoagulants; Coumarins; Enoxaparin; Gangrene; Heparin; Humans; International Normalized Ratio; Male; Necrosis; Thrombocytopenia; Venous Thrombosis | 2011 |
Coumarin-Cu(II) ensemble-based cyanide sensing chemodosimeter.
Topics: Copper; Coumarins; Cyanides; Fluorescent Dyes; Hep G2 Cells; Humans; Models, Molecular; Molecular Conformation | 2011 |
Chemical tags for labeling proteins inside living cells.
Topics: Animals; Connexin 43; Coumarins; Fluorescein; Fluorescent Dyes; Histones; Mice; NIH 3T3 Cells; Peptides; Proteins; Rhodamines | 2011 |
HPLC quantification of coumarin in bastard balm (Melittis melissophyllum L., Lamiaceae).
Topics: Beverages; Chromatography, High Pressure Liquid; Coumarins; Italy; Lamiaceae; Plant Leaves; Species Specificity | 2011 |
Nitroolefin-based coumarin as a colorimetric and fluorescent dual probe for biothiols.
Topics: Alkenes; Colorimetry; Coumarins; Fluorescent Dyes; Hydrogen-Ion Concentration; Nitro Compounds; Sulfhydryl Compounds; Water | 2011 |
Cu(2+)-selective fluorescent chemosensor based on coumarin and its application in bioimaging.
Topics: Coordination Complexes; Copper; Coumarins; Crystallography, X-Ray; Fluorescent Dyes; Hep G2 Cells; Humans; Hydrazones; Microscopy, Confocal; Molecular Conformation | 2011 |
Acute and chronic nephropathy induced by fluindione must be addressed.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anticoagulants; Coumarins; Drug Hypersensitivity; Female; Follow-Up Studies; France; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nephritis, Interstitial; Phenindione; Prognosis; Retrospective Studies; Vitamin K | 2012 |
Cytochrome p450 assays.
Topics: Animals; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Dextromethorphan; Enzyme Inhibitors; Humans; Mephenytoin; Paclitaxel; Phenacetin; Testosterone | 2002 |
Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors.
Topics: Apoptosis; Binding Sites; Casein Kinase II; Catalytic Domain; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Drug Design; Ellagic Acid; Humans; Protein Kinase Inhibitors | 2011 |
Three dye energy transfer cascade within DNA thin films.
Topics: Cetrimonium; Cetrimonium Compounds; Coloring Agents; Coumarins; DNA; Fluorescence Resonance Energy Transfer; Porphobilinogen; Rhodamines | 2011 |
Highly selective colorimetric chemosensor for Co2+.
Topics: Biosensing Techniques; Cations, Divalent; Cobalt; Colorimetry; Coloring Agents; Coumarins; Escherichia coli; Sensitivity and Specificity | 2011 |
[Synthesis and antimicrobial evaluation of coumarin-based benzotriazoles and their synergistic effects with chloromycin and fluconazole].
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Chloramphenicol; Coumarins; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Triazoles | 2011 |
Protonation sites and dissociation mechanisms of t-butylcarbamates in tandem mass spectrometric assays for newborn screening.
Topics: Alkenes; Aminophenols; Carbamates; Carbon Dioxide; Coumarins; Humans; Infant, Newborn; Lysosomal Storage Diseases; Models, Molecular; Protons; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
Thermoresponsive copolymer containing a coumarin-spiropyran conjugate: reusable fluorescent sensor for cyanide anion detection in water.
Topics: Anions; Benzopyrans; Biosensing Techniques; Coumarins; Cyanides; Fluorescence; Indoles; Nitro Compounds; Polymers; Water Pollutants, Chemical | 2011 |
Ratiometric fluorescence detection of cyanide based on a hybrid coumarin-hemicyanine dye: the large emission shift and the high selectivity.
Topics: Coumarins; Cyanides; Fluorescent Dyes; Spectrometry, Fluorescence | 2011 |
Anti-UVC irradiation and metal chelation properties of 6-benzoyl-5,7-dihydroxy-4-phenyl-chromen-2-one: an implications for anti-cataract agent.
Topics: Animals; Cataract; Chelating Agents; Coumarins; DNA; Hydroxyl Radical; Lens, Crystalline; Metals; Nephelometry and Turbidimetry; Oxidative Stress; Photolysis; Plasmids; Protective Agents; Swine; Ultraviolet Rays | 2011 |
Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Chemistry, Pharmaceutical; Coumarins; Drug Delivery Systems; Drug Resistance, Neoplasm; Excipients; Freeze Drying; Humans; Lactic Acid; Nanoparticles; Neoplasms; Particle Size; Poloxamer; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface-Active Agents | 2011 |
Imaging protein-protein interactions inside living cells via interaction-dependent fluorophore ligation.
Topics: Animals; Cell Line; Coumarins; Escherichia coli; Escherichia coli Proteins; Fluorescent Dyes; Humans; Ligases; Microscopy, Fluorescence; Models, Molecular; Mutation; Protein Interaction Mapping; Proteins | 2011 |
Suppression of TNBS-induced colitis in rats by 4-methylesculetin, a natural coumarin: comparison with prednisolone and sulphasalazine.
Topics: Alkaline Phosphatase; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Colitis; Coumarins; Cytokines; Gene Expression Regulation; Glutathione; Humans; Male; Malondialdehyde; Matrix Metalloproteinase 9; Mice; Peroxidase; Prednisolone; Rats; Rats, Wistar; Recurrence; Sulfasalazine; Trinitrobenzenesulfonic Acid; Umbelliferones | 2012 |
Lignans from the heartwood of Streblus asper and their inhibiting activities to hepatitis B virus.
Topics: Antiviral Agents; Biological Assay; Biphenyl Compounds; Cell Line; Cell Survival; Coumarins; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Inhibitory Concentration 50; Lignans; Moraceae; Plant Extracts; Triterpenes; Ursolic Acid; Wood | 2012 |
The role of conformational changes in the signal enhancement of a selective chemosensor of Pb2+.
Topics: Calcium; Coordination Complexes; Coumarins; Crown Compounds; Fluorine; Ions; Lead; Mercury; Thermodynamics | 2012 |
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors.
Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Chemistry, Pharmaceutical; Coumarins; Drug Design; Enzyme Inhibitors; Humans; Kinetics; Lactones; Models, Chemical; Neoplasms; Prodrugs; Protein Isoforms | 2012 |
A differentially selective sensor with fluorescence turn-on response to Zn2+ and dual-mode ratiometric response to Al3+ in aqueous media.
Topics: Aluminum; Cations; Coumarins; Fluorescent Dyes; Quinolines; Sensitivity and Specificity; Spectrometry, Fluorescence; Water; Zinc | 2012 |
Increased catalytic activity of surface-immobilized palladium complexes in the fluorogenic deprotection of an alloc-derivatized coumarin.
Topics: Catalysis; Coordination Complexes; Coumarins; Molecular Structure; Palladium; Silicon | 2012 |
Risk assessment of coumarin using the bench mark dose (BMD) approach: children in Norway which regularly eat oatmeal porridge with cinnamon may exceed the TDI for coumarin with several folds.
Topics: Adolescent; Adult; Aged; Avena; Child; Cinnamomum zeylanicum; Coumarins; Dose-Response Relationship, Drug; Environmental Exposure; Female; Humans; Infant; Male; Middle Aged; Norway; Risk Assessment; Young Adult | 2012 |
Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines.
Topics: Annexin A5; beta-Galactosidase; Cell Death; Cell Line, Tumor; Chemistry, Pharmaceutical; Coumarins; Deoxyribonucleases; Docetaxel; Electrophoresis, Agar Gel; Electrophoretic Mobility Shift Assay; Etoposide; Flow Cytometry; Fluorescein-5-isothiocyanate; Freeze Drying; Humans; Intracellular Space; Liposomes; Lung Neoplasms; Microscopy, Electron, Transmission; Particle Size; Static Electricity; Taxoids; Transfection; Tumor Suppressor Protein p53 | 2012 |
Styryl conjugated coumarin caged alcohol: efficient photorelease by either one-photon long wavelength or two-photon NIR excitation.
Topics: Alcohols; Coumarins; Photolysis; Photons | 2012 |
Synthesis, photoluminescent behaviors, and theoretical studies of two novel ketocoumarin derivatives.
Topics: Coumarins; Electrons; Luminescence; Models, Chemical; Models, Molecular; Quantum Theory; Spectrometry, Fluorescence; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Temperature; Thermogravimetry | 2012 |
Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
Topics: Adult; Anticoagulants; Cardiac Catheterization; Cardiovascular Diseases; Case-Control Studies; Coumarins; Embolism; Embolism, Paradoxical; Female; Follow-Up Studies; Foramen Ovale, Patent; Humans; Intracranial Embolism; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Propensity Score; Proportional Hazards Models; Prosthesis Implantation; Radiography, Interventional; Retrospective Studies; Septal Occluder Device; Stroke; Switzerland | 2012 |
Fluorescent coumarin thiols measure biological redox couples.
Topics: Coumarins; Fluorescent Dyes; Humans; Jurkat Cells; Molecular Structure; Oxidation-Reduction; Sulfhydryl Compounds | 2012 |
The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Cell Death; Cell Line, Tumor; Coumarins; Endocytosis; Half-Life; HEK293 Cells; Humans; Intracellular Space; Liver; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Membrane Glycoproteins; Microscopy, Confocal; Models, Animal; Paclitaxel; Particle Size; Rats; Rats, Wistar; Solutions; Surface-Active Agents; Tissue Distribution | 2012 |
Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants.
Topics: Adult; Aged; Anticoagulants; Argentina; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2C9; Drug Administration Schedule; Female; Gene Frequency; Genetic Variation; Genotype; Humans; Male; Middle Aged; Mixed Function Oxygenases; Pharmacogenetics; Polymorphism, Single Nucleotide; Vitamin K 1; Vitamin K Epoxide Reductases; Warfarin; Young Adult | 2012 |
Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors.
Topics: Biocatalysis; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Metronidazole; Molecular Structure; Protein Isoforms; Structure-Activity Relationship | 2013 |
A novel coumarin Schiff-base as a Ni(II) ion colorimetric sensor.
Topics: Biosensing Techniques; Cations; Colorimetry; Coumarins; Fluorescence; Molecular Structure; Nickel; Schiff Bases; Solutions; Spectrophotometry, Ultraviolet | 2012 |
An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population.
Topics: Adult; Animals; Aryl Hydrocarbon Hydroxylases; Asian People; Binding Sites; Blotting, Western; Catalysis; Cell Line; Computer Simulation; Coumarins; DNA; Gene Frequency; Heme; Humans; Hydroxylation; Insecta; Models, Molecular; Mutagenesis, Site-Directed; Mutation, Missense; Polymerase Chain Reaction; Polymorphism, Single Nucleotide | 2012 |
Synthesis, photophysical, photochemical, and computational studies of coumarin-labeled nicotinamide derivatives.
Topics: Coumarins; Crystallography, X-Ray; Molecular Structure; Niacinamide; Photochemistry; Quantum Theory | 2012 |
Thiophene anchored coumarin derivative as a turn-on fluorescent probe for Cr3+: cell imaging and speciation studies.
Topics: Cells; Chromium; Coumarins; Crystallography, X-Ray; Cytological Techniques; Diagnostic Imaging; Fluorescent Dyes; Molecular Structure; Thiophenes | 2012 |
F420H2-dependent degradation of aflatoxin and other furanocoumarins is widespread throughout the actinomycetales.
Topics: Aflatoxins; Anti-Bacterial Agents; Bacterial Proteins; Coumarins; Flavins; Furocoumarins; Gene Expression Regulation; Hydrolysis; Khellin; Mass Spectrometry; Methoxsalen; Mycobacterium smegmatis; Oxidoreductases; Phylogeny; Species Specificity; Xenobiotics | 2012 |
[UPLC simultaneous determination of five active components in Cinnamomi Ramulus].
Topics: Acrolein; Chromatography, Liquid; Cinnamates; Cinnamomum; Coumarins; Drugs, Chinese Herbal; Hydroxybenzoates; Propanols | 2011 |
Ruthenium(II)-polyimine-coumarin light-harvesting molecular arrays: design rationale and application for triplet-triplet-annihilation-based upconversion.
Topics: Absorption; Coumarins; Imines; Light; Luminescent Measurements; Molecular Structure; Organometallic Compounds; Photochemistry; Quantum Theory; Ruthenium | 2012 |
Optimizing the charge balance of fluorescent organic light-emitting devices to achieve high external quantum efficiency beyond the conventional upper limit.
Topics: Benzidines; Coumarins; Electrons; Equipment Design; Fluorescence; Lighting; Naphthalenes | 2012 |
Novel emissive bio-inspired non-proteinogenic coumarin-alanine amino acid: fluorescent probe for polyfunctional systems.
Topics: Acridines; Alanine; Aluminum; Amino Acids; Cadmium; Cations; Coumarins; Drug Design; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Hydrogen-Ion Concentration; Lanthanoid Series Elements; Liposomes; Magnetic Resonance Spectroscopy; Molecular Probes; Quantum Theory; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Zinc | 2012 |
Transport of the coumarin metabolite 7-hydroxycoumarin glucuronide is mediated via multidrug resistance-associated proteins 3 and 4.
Topics: Biological Transport, Active; Coumarins; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Umbelliferones | 2012 |
Design and synthesis of fluorescent pilicides and curlicides: bioactive tools to study bacterial virulence mechanisms.
Topics: Anti-Bacterial Agents; Boron Compounds; Coumarins; Crystallography, X-Ray; Escherichia coli; Escherichia coli Proteins; Fluorescent Dyes; Models, Molecular; Structure-Activity Relationship; Virulence | 2012 |
In vitro evaluation of the interaction potential of irosustat with drug-metabolizing enzymes.
Topics: Aromatase Inhibitors; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Glucuronosyltransferase; Hepatocytes; Humans; Isoenzymes; Microsomes, Liver; Sulfonic Acids | 2012 |
Photoresponsive coumarin-stabilized polymeric nanoparticles as a detectable drug carrier.
Topics: Coumarins; Drug Carriers; Fluorescence; Nanoparticles; Photochemistry; Polymers | 2012 |
Coumarin-derived transformable fluorescent sensor for Zn2+.
Topics: Amides; Chelating Agents; Coumarins; Fluorescent Dyes; Imides; Molecular Structure; Stereoisomerism; Zinc | 2012 |
Rational design of fluorescent phosgene sensors.
Topics: Cinnamates; Coumarins; Cyclization; Fluorescent Dyes; Gases; Phosgene; Quantum Theory; Spectrometry, Fluorescence | 2012 |
Evanescent wave cavity ring-down spectroscopy (EW-CRDS) as a probe of macromolecule adsorption kinetics at functionalized interfaces.
Topics: Adsorption; Carboxylic Acids; Cellulose; Coumarins; Hydrogen-Ion Concentration; Kinetics; Macromolecular Substances; Polyglutamic Acid; Silicon Dioxide; Spectrum Analysis; Surface Properties | 2012 |
Coumarin-based chiral fluorescence sensor incorporating a thiourea unit for highly enantioselective recognition of N-Boc-protected proline.
Topics: Coumarins; Fluorescent Dyes; Molecular Structure; Proline; Stereoisomerism; Thiourea | 2012 |
Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives.
Topics: Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Dose-Response Relationship, Drug; Erythrocytes; Humans; Molecular Structure; Protein Isoforms; Structure-Activity Relationship | 2013 |
Application of photoremovable protecting group for controlled release of plant growth regulators by sunlight.
Topics: Coumarins; Ethanol; Glycolates; Indoleacetic Acids; Molecular Structure; Plant Growth Regulators; Plant Roots; Plant Stems; Sunlight; Water | 2012 |
Collagenase inhibitors from Viola yedoensis.
Topics: Anti-Inflammatory Agents; Collagenases; Coumarins; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase Inhibitors; Molecular Structure; Viola | 2013 |
Isolation of the minor and rare constituents from fruits of Peucedanum alsaticum L. using high-performance counter-current chromatography.
Topics: Apiaceae; Chromatography, High Pressure Liquid; Coumarins; Countercurrent Distribution; Fruit; Plant Extracts | 2012 |
[Coumarin-induced necrotic purpura of the skin -- case report and review of the literature].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Blood Coagulation Tests; Coumarins; Diagnosis, Differential; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Leg Dermatoses; Long-Term Care; Necrosis; Phenprocoumon; Skin; Venous Thrombosis; Vitamin K Deficiency | 2012 |
[A man with a skin lesion on his abdomen].
Topics: Abscess; Anticoagulants; Anus Diseases; Coumarins; Humans; Male; Middle Aged; Necrosis; Skin Diseases | 2012 |
Nonparametric inference for the cumulative incidence function of a competing risk, with an emphasis on confidence bands in the presence of left-truncation.
Topics: Abortion, Spontaneous; Analysis of Variance; Anticoagulants; Biometry; Coumarins; Female; Humans; Models, Statistical; Pregnancy; Pregnancy Outcome; Probability; Risk; Statistics, Nonparametric | 2012 |
A new ratiometric and colorimetric chemosensor for cyanide anion based on coumarin-hemicyanine hybrid.
Topics: Anions; Colorimetry; Coloring Agents; Coumarins; Cyanides; Models, Molecular; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry | 2012 |
Investigation the interaction of Daphnin with human serum albumin using optical spectroscopy and molecular modeling methods.
Topics: Binding Sites; Circular Dichroism; Coumarins; Humans; Hydrogen-Ion Concentration; Models, Molecular; Optical Phenomena; Protein Binding; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Thermodynamics | 2012 |
A novel fluorescent cell membrane-permeable caged cyclic ADP-ribose analogue.
Topics: Alkenes; Blotting, Western; Calcium; Cell Line; Cell Membrane; Coumarins; Cyclic ADP-Ribose; Fluorescence; HEK293 Cells; Humans; Jurkat Cells; Membrane Proteins; Neoplasm Proteins; Real-Time Polymerase Chain Reaction; Ryanodine Receptor Calcium Release Channel; Stromal Interaction Molecule 1; TRPM Cation Channels | 2012 |
Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats.
Topics: Animals; Coumarins; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hypoglycemic Agents; Kidney; Male; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; RNA, Messenger; Transforming Growth Factor beta1 | 2012 |
Coumarin-based octopamine phototriggers and their effects on an insect octopamine receptor.
Topics: Animals; Bees; Calcium Signaling; Carbon Dioxide; Coumarins; HEK293 Cells; Humans; Infrared Rays; Octopamine; Photolysis; Receptors, Biogenic Amine; Solubility; Ultraviolet Rays | 2012 |
[Determination of five coumarins in toys by high performance liquid chromatography-tandem mass spectrometry].
Topics: Chromatography, High Pressure Liquid; Coumarins; Play and Playthings; Tandem Mass Spectrometry | 2012 |
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
Topics: Aryl Hydrocarbon Hydroxylases; Binding, Competitive; Catalysis; Coumarins; Cytochrome P-450 CYP2A6; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Hydroxylation; Ligands; Models, Biological; Molecular Structure; Monoterpenes; Nitrophenols; Protein Binding; Recombinant Proteins; Substrate Specificity; Tranylcypromine | 2012 |
Self-calibrating viscosity probes: design and subcellular localization.
Topics: Calibration; Cell Line, Tumor; Cell Membrane; Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Microscopy, Confocal; Thiophenes; Viscosity | 2012 |
Modulation of copper uptake and toxicity by abiotic stresses in Matricaria chamomilla plants.
Topics: Cadmium; Copper; Coumarins; Hydroxybenzoates; Matricaria; Nitrogen; Plant Roots; Sodium Chloride | 2012 |
Photo-responsive interpenetrating network beads of alginate/polyvinyl alcohol-coumarin conjugate.
Topics: Alginates; Calcium Chloride; Coumarins; Dextrans; Dimerization; Drug Compounding; Fluorescein-5-isothiocyanate; Glucuronic Acid; Hexuronic Acids; Polyvinyl Alcohol; Time Factors; Ultraviolet Rays; Viscosity | 2013 |
Multifunctional polypeptide-PEO nanoreactors via the hydrophobic switch.
Topics: Alkynes; Antineoplastic Agents; Cell Survival; Click Chemistry; Coumarins; Doxorubicin; Drug Carriers; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Micelles; Nanotechnology; Peptides; Polyethylene Glycols | 2012 |
Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
Topics: Animals; Benzaldehydes; Computer Simulation; Coumarins; Diabetes Mellitus, Experimental; Esters; Hydantoins; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Models, Molecular; Oxazoles; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Streptozocin; Thiazolidinediones | 2012 |
Assessment of coumarin levels in ground cinnamon available in the Czech retail market.
Topics: Cinnamomum zeylanicum; Coumarins; Czech Republic; Food Analysis; Food Contamination; Marketing; Plant Bark; Spices | 2012 |
Evaluation of the cytotoxic activity of some Brazilian medicinal plants.
Topics: Annonaceae; Antineoplastic Agents, Phytogenic; Apocynaceae; Bicyclic Monoterpenes; Brazil; Bridged Bicyclo Compounds; Cell Line, Tumor; Cell Survival; Clusiaceae; Coumarins; Humans; Hyptis; Jatropha; Latex; Lippia; Magnoliopsida; Monoterpenes; Oils, Volatile; Plant Components, Aerial; Plant Extracts; Plants, Medicinal | 2012 |
CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.
Topics: Aryl Hydrocarbon Hydroxylases; Catalysis; Chromatography, High Pressure Liquid; Cotinine; Coumarins; Cytochrome P-450 CYP2A6; Enzyme Inhibitors; Humans; Kinetics; NADP; Nicotiana; Nicotine; Nicotinic Agonists; Oxidation-Reduction; Tritium | 2012 |
Coumarin-conjugated multiwalled carbon nanotubes for potential biological applications: development and characterization.
Topics: Adsorption; Cells, Cultured; Coumarins; Feasibility Studies; Humans; Keratinocytes; Materials Testing; Nanotubes, Carbon; Particle Size; Reactive Oxygen Species | 2012 |
Molecular modulated cysteine-selective fluorescent probe.
Topics: Buthionine Sulfoximine; Coumarins; Cysteine; Fluorescence; Glutamate-Cysteine Ligase; Glutathione; Hep G2 Cells; Humans; Microscopy, Confocal; Molecular Probes; Spectrometry, Fluorescence | 2012 |
Hybrid microparticles for drug delivery and magnetic resonance imaging.
Topics: Animals; Biocompatible Materials; Coumarins; Drug Delivery Systems; Ferric Compounds; Light; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Microscopy, Electron, Transmission; Nanotechnology; Polyesters; Polymers; Rats; Rats, Wistar; Scattering, Radiation; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Temperature | 2013 |
Development of a fluorogenic probe with a transesterification switch for detection of histone deacetylase activity.
Topics: Amino Acid Sequence; Coumarins; Drug Design; Enzyme Assays; Esterification; Fluorescent Dyes; Histone Deacetylases; Oligopeptides | 2012 |
Silica cross-linked nanoparticles encapsulating fluorescent conjugated dyes for energy transfer-based white light emission and porphyrin sensing.
Topics: Coumarins; Energy Transfer; Fluorescent Dyes; Hydrogen-Ion Concentration; Light; Micelles; Nanoparticles; Porphyrins; Silicon Dioxide; Spectrometry, Fluorescence | 2012 |
"Self-immolative" spacer for uncaging with fluorescence reporting.
Topics: Coumarins; Dimethylamines; Fluorescent Dyes; HEK293 Cells; Humans; Kinetics; Microscopy, Confocal; Nitrobenzenes | 2012 |
Preparation of dry extract of Mikania glomerata Sprengel (Guaco) and determination of its coumarin levels by spectrophotometry and HPLC-UV.
Topics: Chromatography, High Pressure Liquid; Coumarins; Freeze Drying; Mikania; Plant Extracts; Plant Leaves; Spectrophotometry | 2012 |
Amplified spontaneous emission spectra from the superexciplex of coumarin 138.
Topics: Absorption; Acetates; Coloring Agents; Coumarins; Electrons; Molecular Conformation; Solvents; Spectrometry, Fluorescence | 2012 |
Synthesis and biological evaluation of coumarin derivatives as inhibitors of Mycobacterium bovis (BCG).
Topics: Antitubercular Agents; Coumarins; Cyanides; Microbial Sensitivity Tests; Mycobacterium bovis | 2012 |
Genetic encoding of a bicyclo[6.1.0]nonyne-charged amino acid enables fast cellular protein imaging by metal-free ligation.
Topics: Alkynes; Azides; Bridged Bicyclo Compounds; Carbocyanines; Click Chemistry; Coumarins; Cycloaddition Reaction; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; HeLa Cells; Humans; Lysine; Microscopy, Fluorescence; Protein Engineering; Proteins; RNA, Transfer | 2012 |
Elution behavior of short dsDNA strands in silicon micropillar array columns in ion pair reversed-phase chromatography mode.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Coumarins; DNA; Microfluidic Analytical Techniques; Molecular Weight; Silicon | 2012 |
A versatile fluorescence approach to kinetic studies of hydrocarbon autoxidations and their inhibition by radical-trapping antioxidants.
Topics: Alkanes; Coumarins; Dehydrocholesterols; Fluorescence; Fluorescent Dyes; Free Radical Scavengers; Hydrogen Peroxide; Kinetics; Oxidation-Reduction; Phosphines | 2012 |
Enantioselective synthesis of coumarin derivatives by PYBOX-DIPH-Zn(II) complex catalyzed Michael reaction.
Topics: Benzopyrans; Catalysis; Coumarins; Lewis Acids; Molecular Structure; Oxazoles; Stereoisomerism; Zinc Compounds | 2012 |
Synthesis and antibacterial activities of novel 4-hydroxy-7-hydroxy- and 3-carboxycoumarin derivatives.
Topics: 4-Hydroxycoumarins; Anti-Bacterial Agents; Bacillus subtilis; Bacteria; Coumarins; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Umbelliferones | 2012 |
Self-cleaning functional molecular materials.
Topics: Coumarins; Crystallization; Imides; Microarray Analysis; Naphthalenes; Rhodamines; Surface Properties | 2012 |
Biological evaluation of coumarin derivatives as mushroom tyrosinase inhibitors.
Topics: Agaricales; Coumarins; Enzyme Inhibitors; Fungal Proteins; Molecular Structure; Monophenol Monooxygenase | 2012 |
Design and evaluation of matrix diffusion controlled transdermal patches of coumarin.
Topics: Administration, Cutaneous; Animals; Anticoagulants; Coumarins; Diffusion; Drug Design; Drug Evaluation, Preclinical; In Vitro Techniques; Male; Rats; Rats, Wistar | 2013 |
Coumarin-based fluorescent probes for H2S detection.
Topics: Amines; Animals; Azides; Cell Line; Cell Survival; Coumarins; Fluorescent Dyes; Hydrogen Sulfide; Molecular Imaging; Rabbits | 2013 |
PEG-labeled nucleotides and nanopore detection for single molecule DNA sequencing by synthesis.
Topics: Coumarins; Deoxyguanine Nucleotides; DNA; Electricity; Electrochemical Techniques; Fluorescent Dyes; Molecular Weight; Nanopores; Nucleotides; Polyethylene Glycols; Polymerase Chain Reaction; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staining and Labeling | 2012 |
Non-cytotoxic antibacterial silver-coumarin complex doped sol-gel coatings.
Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Coumarins; Enterobacter cloacae; Gels; Humans; Methicillin-Resistant Staphylococcus aureus; Models, Theoretical; Silver | 2013 |
Synthesis and pharmacological evaluation of N-substituted 2-(2-oxo-2H-chromen-4-yloxy)propanamide as cyclooxygenase inhibitors.
Topics: Amides; Benzopyrans; Coumarins; Crystallography, X-Ray; Cyclooxygenase Inhibitors; Enzyme Activation; Molecular Structure; Propane; Protein Binding | 2012 |
Self-healing microencapsulation of biomacromolecules without organic solvents.
Topics: Animals; Cattle; Coumarins; Drug Compounding; Kinetics; Lactic Acid; Macromolecular Substances; Muramidase; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Serum Albumin, Bovine; Solvents; Temperature; Trehalose | 2012 |
Coumarin glycosides and iridoid glucosides with neuroprotective effects from Hydrangea paniculata.
Topics: Animals; Coumarins; Drug Evaluation, Preclinical; Hydrangea; Iridoid Glucosides; Molecular Structure; Neuroprotective Agents; PC12 Cells; Plant Stems; Rats | 2012 |
In Situ probing of newly synthesized peptidoglycan in live bacteria with fluorescent D-amino acids.
Topics: Agrobacterium tumefaciens; Amino Acids; Bacillus subtilis; Bacteria; Benzoxazoles; Biosensing Techniques; Cell Wall; Coumarins; Escherichia coli; Fluorescent Dyes; Microscopy; Peptidoglycan | 2012 |
Coumarin-based benzopyranone derivatives induced apoptosis in human lung (A549) cancer cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Coumarins; Down-Regulation; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-bcl-2; Up-Regulation | 2012 |
Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Coumarins; Endocytosis; Fluorescent Antibody Technique; Glioma; Humans; Imaging, Three-Dimensional; In Situ Nick-End Labeling; Lapatinib; Lipoproteins; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Nanoparticles; Osteonectin; Quinazolines; Receptor, ErbB-2; Subcellular Fractions; Xenograft Model Antitumor Assays | 2012 |
Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Topics: Binding Sites; Catalytic Domain; Chromones; Coumarins; Humans; Kinetics; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Recombinant Proteins; Structure-Activity Relationship | 2012 |
PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Coumarins; Diagnostic Imaging; Drug Delivery Systems; Endocytosis; Ethylene Oxide; Glioblastoma; Kaplan-Meier Estimate; Lactones; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Weight; Nanoparticles; Paclitaxel; Protamines; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Tissue Distribution | 2013 |
Design, synthesis and pharmacological characterization of coumarin-based fluorescent analogs of excitatory amino acid transporter subtype 1 selective inhibitors, UCPH-101 and UCPH-102.
Topics: Benzopyrans; Coumarins; Drug Design; Excitatory Amino Acid Transporter 1; Fluorescent Dyes; HEK293 Cells; Humans; Inhibitory Concentration 50; Structure-Activity Relationship | 2012 |
Analysis of flavonoids by graphene-based surface-assisted laser desorption/ionization time-of-flight mass spectrometry.
Topics: Coumarins; Flavonoids; Graphite; Nanoparticles; Oxidation-Reduction; Oxides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Surface Properties | 2012 |
A coumarin-Meldrum's acid conjugate based chemodosimetric probe for cyanide.
Topics: Coumarins; Cyanides; Dioxanes; Kinetics; Molecular Probes; Quantum Theory; Spectrometry, Fluorescence | 2012 |
Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Anti-HIV Agents; Biological Availability; Chemistry, Pharmaceutical; Cholesterol; Coumarins; Drug Carriers; Drug Delivery Systems; Gels; Liposomes; Lopinavir; Male; Particle Size; Permeability; Rats; Rats, Wistar; Skin; Skin Absorption; Suspensions | 2012 |
Outcome of coumarin-therapy in an outpatient setting over a 10-year period: coumarin-therapy in clinical practice.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Austria; Comorbidity; Coumarins; Drug-Related Side Effects and Adverse Reactions; Female; Hemorrhage; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Practice Patterns, Physicians'; Retrospective Studies; Risk Factors; Thromboembolism; Treatment Outcome | 2012 |
Development of a novel fluorophore for real-time biomonitoring system.
Topics: Animals; Antibodies; Antibodies, Monoclonal; Biosensing Techniques; Chromatography, Affinity; Computer Systems; Coumarins; Dendrimers; Disease Outbreaks; Esters; Fluorescent Dyes; Hepatitis C; HIV Infections; Humans; Hydrogen-Ion Concentration; Light; Malaria; Models, Chemical; Plasmodium vivax; Quantum Dots; Spectrophotometry; Succinimides | 2012 |
Photo-controlled hierarchical assembly and fusion of coumarin-containing polydiacetylene vesicles.
Topics: Coumarins; Dimerization; Polyacetylene Polymer; Polymerization; Polymers; Polyynes | 2013 |
Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Coumarins; Female; Hemorrhage; Humans; Lung Diseases; Lung Diseases, Interstitial; Male; Middle Aged; Myocardial Infarction; Oxidative Stress; Pulmonary Alveoli; Pulmonary Fibrosis; Retrospective Studies; Risk Factors; Venous Thrombosis | 2013 |
Pyridocoumarin, aristolactam and aporphine alkaloids from the Australian rainforest plant Goniothalamus australis.
Topics: Aporphines; Coumarins; Goniothalamus; Indole Alkaloids; Molecular Structure | 2013 |
Experimental and database-transferred electron-density analysis and evaluation of electrostatic forces in coumarin-102 dye.
Topics: Coumarins; Crystallography, X-Ray; Electrons; Molecular Structure; Quantum Theory; Static Electricity | 2012 |
Monoamine oxidase A and B inhibiting effect and molecular modeling of some synthesized coumarin derivatives.
Topics: Coumarins; Models, Molecular; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 2013 |
New convenient approach for the synthesis of benzyl 2H-chromenones and their α-amylase Inhibitory, ABTS.+ scavenging activities.
Topics: alpha-Amylases; Benzothiazoles; Coumarins; Crystallography, X-Ray; Free Radical Scavengers; Humans; Molecular Structure; Pancreas; Sulfonic Acids | 2013 |
Isolation, identification and antimicrobial activities of two secondary metabolites of Talaromyces verruculosus.
Topics: Acrylates; Anti-Infective Agents; Bacteria; Coumarins; Fungi; Isocoumarins; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidines; Talaromyces | 2012 |
Alkaline earth metal ion induced coil-helix-coil transition of lysine-coumarin-azacrown hybrid foldamers with OFF-OFF-ON fluorescence switching.
Topics: Amino Acid Sequence; Circular Dichroism; Coumarins; Fluorescence; Ions; Lysine; Metals; Metals, Alkaline Earth; Molecular Structure | 2013 |
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Coumarins; Horses; Humans | 2013 |
Antiproliferative and apoptotic effects of compounds from the flower of Mammea siamensis (Miq.) T. Anders. on human cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Coumarins; DNA; DNA Fragmentation; Drug Screening Assays, Antitumor; Flowers; HL-60 Cells; Humans; Magnetic Resonance Spectroscopy; Mammea; Molecular Conformation; Poly(ADP-ribose) Polymerases | 2013 |
A highly selective fluorescent probe for BO3(-) based on acetate derivatives of coumarin in aqueous solution and thimerosal.
Topics: Acetates; Borates; Coumarins; Fluorescent Dyes; Hydrogen-Ion Concentration; Ions; Spectrometry, Fluorescence; Thimerosal; Water | 2013 |
Density functional theory based quantitative structure-property relationship studies on coumarin-based prodrugs.
Topics: Coumarins; Models, Theoretical; Molecular Structure; Prodrugs; Quantitative Structure-Activity Relationship | 2012 |
Fabrication of novel coumarin derivative functionalized polypseudorotaxane micelles for drug delivery.
Topics: alpha-Cyclodextrins; Animals; Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Coumarins; Doxorubicin; Drug Delivery Systems; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Micelles; Microscopy, Confocal; Models, Chemical; Polyethylene Glycols; Rotaxanes; Time Factors | 2013 |
Coumarin-DPA-Cu(II) as a chemosensing ensemble towards histidine determination in urine and serum.
Topics: Amines; Animals; Copper; Coumarins; Fluorescent Dyes; Histidine; Humans; Picolinic Acids; Sensitivity and Specificity; Spectrometry, Fluorescence | 2013 |
Nanoconfinement of water layers in lamellar structures prepared in the presence and absence of organic solvent.
Topics: Coumarins; Dioctyl Sulfosuccinic Acid; Heptanes; Hydrophobic and Hydrophilic Interactions; Nanotechnology; Scattering, Small Angle; Solvents; Water; X-Ray Diffraction | 2013 |
Chemopreventive potential of coumarin in 7, 12-dimethylbenz[a] anthracene induced hamster buccal pouch carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticoagulants; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Neoplastic; Coumarins; Cricetinae; Lipid Peroxidation; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Thiobarbituric Acid Reactive Substances | 2012 |
Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; MCF-7 Cells; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Thiones; Tumor Cells, Cultured | 2013 |
A ratiometric fluorescent probe for rapid detection of hydrogen sulfide in mitochondria.
Topics: Benzopyrans; Coumarins; Fluorescent Dyes; Humans; Hydrogen Sulfide; Hydrogen-Ion Concentration; Indoles; MCF-7 Cells; Microscopy, Confocal; Mitochondria | 2013 |
Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents.
Topics: Antineoplastic Agents; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; MCF-7 Cells; Molecular Structure; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship | 2013 |
Gravitropic response induced by coumarin: evidences of ROS distribution involvement.
Topics: Arabidopsis; Arabidopsis Proteins; Coumarins; Gravitropism; Reactive Oxygen Species; Triiodobenzoic Acids | 2013 |
A versatile long-wavelength-absorbing scaffold for Eu-based responsive probes.
Topics: Absorption; Chelating Agents; Coumarins; Europium; Lanthanoid Series Elements; Luminescence; Luminescent Measurements; Molecular Structure; Spectrophotometry, Ultraviolet; Umbelliferones | 2013 |
Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors.
Topics: Anticoagulants; Antiviral Agents; Binding Sites; Coumarins; Drug Evaluation, Preclinical; Enzyme Inhibitors; Flavones; Hepacivirus; RNA-Dependent RNA Polymerase; Viral Nonstructural Proteins | 2013 |
3-Phenylcoumarin derivatives selectively modulate different steps of reactive oxygen species production by immune complex-stimulated human neutrophils.
Topics: Antigen-Antibody Complex; Cells, Cultured; Coumarins; Drug Discovery; Free Radical Scavengers; Humans; Immune Complex Diseases; Immunomodulation; Luminescent Measurements; Molecular Targeted Therapy; Neutrophils; Oxidation-Reduction; Peroxidase; Reactive Oxygen Species; Structure-Activity Relationship | 2013 |
Coumarin: an alternative candidate for the treatment of non-alcoholic steatohepatitis?
Topics: Animals; Coumarins; Dietary Fats; Down-Regulation; Fatty Liver; Gene Expression; Male | 2013 |
Mechanism for different fluorescence response of a coumarin-amide-dipicolylamine linkage to Zn(II) and Cd(II) in water.
Topics: Amides; Amines; Cadmium; Computer Simulation; Coordination Complexes; Coumarins; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Naphthalimides; Picolinic Acids; Quantum Theory; Spectrophotometry, Infrared; Water; Zinc | 2013 |
[Drug interactions between coumarin derivatives and antimycotics: also with topical antifungal agents].
Topics: Aged; Aged, 80 and over; Anticoagulants; Antifungal Agents; Coumarins; Drug Interactions; Female; Humans; Male; Miconazole; Middle Aged | 2013 |
Photoaffinity casting of a coumarin flag for rapid identification of ligand-binding sites within protein.
Topics: Binding Sites; Coumarins; Glycine max; Ligands; Molecular Structure; Peptides; Photoaffinity Labels; Vesicular Transport Proteins | 2013 |
Benzene, coumarin and quinolinone derivatives from roots of Citrus hystrix.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antioxidants; Bacteria; Benzene; Cells, Cultured; Citrus; Coumarins; HIV; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Plant Roots; Quinolones | 2013 |
α-Glucosidase inhibitors via green pathway: biotransformation for bicoumarins catalyzed by Momordica charantia peroxidase.
Topics: alpha-Glucosidases; Biotransformation; Catalysis; Chromatography, High Pressure Liquid; Coumarins; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Hydrogen Peroxide; Magnetic Resonance Spectroscopy; Momordica charantia; Peroxidase; Plant Extracts | 2013 |
Molecular insight into affinities of drugs and their metabolites to lipid bilayers.
Topics: Caffeine; Cell Membrane; Chlorzoxazone; Coumarins; Cytochrome P-450 Enzyme System; Debrisoquin; Humans; Ibuprofen; Lipid Bilayers; Molecular Dynamics Simulation; Pharmaceutical Preparations; Phosphatidylcholines; Phosphatidylglycerols; Thermodynamics; Xenobiotics | 2013 |
Production of dosage forms for oral drug delivery by laminar extrusion of wet masses.
Topics: Administration, Oral; Cellulose; Chemistry, Pharmaceutical; Coumarins; Drug Delivery Systems; Elasticity; Hypromellose Derivatives; Lactose; Methylcellulose; Propranolol; Solubility; Stress, Mechanical; Technology, Pharmaceutical; Tensile Strength; Time Factors; Water | 2013 |
Seasonal variation on the contents of coumarin and kaurane-type diterpenes in Mikania laevigata and M. glomerata leaves under different shade levels.
Topics: Coumarins; Diterpenes, Kaurane; Mikania; Plant Leaves; Seasons; Sunlight | 2013 |
Synthesis and properties of arsenic(III)-reactive coumarin-appended benzothiazolines: a new approach for inorganic arsenic detection.
Topics: Arsenic; Benzothiazoles; Coumarins; Molecular Structure | 2013 |
Synthesis and photochemical behavior of coumarin-caged cholesterol.
Topics: Cholesterol; Coumarins; Molecular Structure; Photochemical Processes; Quantum Theory | 2013 |
Development and validation of a simple LC method for the determination of phenacetin, coumarin, tolbutamide, chlorzoxazone, testosterone and their metabolites as markers of cytochromes 1A2, 2A6, 2C11, 2E1 and 3A2 in rat microsomal medium.
Topics: Analgesics, Non-Narcotic; Animals; Anticoagulants; Calibration; Chlorzoxazone; Chromatography, High Pressure Liquid; Coumarins; Culture Media; Cytochrome P-450 Enzyme System; Hypoglycemic Agents; In Vitro Techniques; Liquid-Liquid Extraction; Microsomes, Liver; Muscle Relaxants, Central; Phenacetin; Quality Control; Rats; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Testosterone; Tolbutamide | 2013 |
Cell uptake of paclitaxel solid lipid nanoparticles modified by cell-penetrating peptides in A549 cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Coumarins; Dialysis; Dose-Response Relationship, Drug; Humans; Lipids; Microscopy, Atomic Force; Microscopy, Fluorescence; Nanoparticles; Paclitaxel; Particle Size; Peptides | 2013 |
Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Computer Systems; Coumarins; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Monitoring; Fluorescein-5-isothiocyanate; Fluorescence Resonance Energy Transfer; Glutathione; HeLa Cells; Humans; Nanoparticles; Nanotechnology; Oxidation-Reduction; Silicon Dioxide | 2013 |
Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
Topics: Antineoplastic Agents; Biotin; Cell Line, Tumor; Cell Survival; Coumarins; Deoxycytidine; Drug Delivery Systems; Fluorescent Dyes; Gemcitabine; Humans; Neoplasms; Prodrugs; Sulfhydryl Compounds | 2013 |
Investigation of coumarin functionality on the formation of polymeric nanoparticles.
Topics: Chemical Precipitation; Coumarins; Nanoparticles; Particle Size; Polymethyl Methacrylate | 2013 |
Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.
Topics: Animals; Biocatalysis; Carbamates; Coumarins; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Mice; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Protein Binding; Protein Structure, Tertiary; Selegiline; Substrate Specificity; Tyramine | 2013 |
High-throughput fluorescence assay of cytochrome P450 3A4.
Topics: Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Assays; Humans; Inhibitory Concentration 50; Ketoconazole; Spectrometry, Fluorescence | 2013 |
Nicotine kinetics in zebra finches in vivo and in vitro.
Topics: Animals; Brain; Coumarins; Finches; Humans; Male; Microsomes, Liver; Nicotine | 2013 |
Artificial photosynthetic reaction center with a coumarin-based antenna system.
Topics: Biocompatible Materials; Coumarins; Electron Transport; Energy Transfer; Photosynthetic Reaction Center Complex Proteins; Porphyrins; Quantum Theory; Spectrometry, Fluorescence; Time Factors | 2013 |
Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Binding Sites; Catalytic Domain; Chalcones; Cholinesterase Inhibitors; Coumarins; Drug Design; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2013 |
Photophysics of novel coumarin-labeled depsipeptides in solution: sensing interactions with SDS micelle via TICT model.
Topics: Coumarins; Depsipeptides; Fluorescent Dyes; Micelles; Sodium Dodecyl Sulfate; Spectrometry, Fluorescence; Staining and Labeling | 2013 |
Odorant metabolism catalyzed by olfactory mucosal enzymes influences peripheral olfactory responses in rats.
Topics: Animals; Biocatalysis; Coumarins; Enzyme Inhibitors; Male; Odorants; Olfactory Mucosa; Olfactory Perception; Pentanols; Protein Transport; Quinolones; Rats; Rats, Wistar; Xenobiotics | 2013 |
Thermochromism and supramolecular chirality of the coumarin-substituted polydiacetylene LB films.
Topics: Coumarins; Dimerization; Isomerism; Polyacetylene Polymer; Polymerization; Polymers; Polyynes; Surface Properties; Temperature; Ultraviolet Rays | 2013 |
O-tert-butyldiphenylsilyl coumarin and dicoumarol: a case toward selective sensing of F- ions in organic and aqueous environments.
Topics: Chloroform; Coumarins; Dicumarol; Fluorides; Ions; Organosilicon Compounds; Water | 2013 |
Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity.
Topics: Acenocoumarol; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Base Sequence; Binding Sites; Coumarins; Cytochrome P-450 CYP2C9; Female; Flurbiprofen; Genotype; Hemorrhage; Humans; International Normalized Ratio; Middle Aged; Molecular Docking Simulation; Mutation, Missense; Protein Binding; Warfarin | 2013 |
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Topics: Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell-Penetrating Peptides; Coumarins; Diagnostic Imaging; Endocytosis; Glioma; Male; Matrix Metalloproteinase 14; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligopeptides; Paclitaxel; Rats; Spheroids, Cellular; Survival Analysis; Tissue Distribution | 2013 |
Thiol-chromene click chemistry: a coumarin-based derivative and its use as regenerable thiol probe and in bioimaging applications.
Topics: Benzopyrans; Click Chemistry; Coumarins; Cysteine; Fluorescent Dyes; Glutathione; Hep G2 Cells; Humans; Molecular Imaging; Molecular Structure; Sulfhydryl Reagents | 2013 |
A sensitive and selective fluorescent probe for cysteine based on a new response-assisted electrostatic attraction strategy: the role of spatial charge configuration.
Topics: Cell Membrane Permeability; Coumarins; Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Humans; Kinetics; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Sulfhydryl Compounds | 2013 |
Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet.
Topics: Adiposity; Animals; Base Sequence; Blotting, Western; Body Weight; Coumarins; Dietary Fats; DNA Primers; Down-Regulation; Fatty Liver; Gene Expression; Male; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Thiobarbituric Acid Reactive Substances | 2013 |
Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
Topics: Animals; Binding, Competitive; Chalcone; CHO Cells; Coumarins; Cricetinae; Cricetulus; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Structure-Activity Relationship; Thiophenes | 2013 |
Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States.
Topics: Acrolein; Cassia; China; Chromatography, High Pressure Liquid; Cinnamates; Cinnamomum zeylanicum; Coumarins; Dietary Supplements; Eugenol; Food Analysis; Food Handling; Indonesia; Limit of Detection; Propanols; Reproducibility of Results; Sri Lanka; United States; Vietnam | 2013 |
Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cell-Penetrating Peptides; Coumarins; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats; Spectroscopy, Near-Infrared; Spheroids, Cellular; Tissue Distribution | 2013 |
Terpenes and polyacetylenes from cultivated Artemisia granatensis boiss (Royal chamomile) and their defensive properties.
Topics: Animals; Aphids; Artemisia; Coumarins; Feeding Behavior; Molecular Structure; Monoterpenes; Plant Components, Aerial; Plants, Genetically Modified; Polyynes; Sesquiterpenes; Spodoptera; Terpenes | 2013 |
Anticoagulant guidelines.
Topics: Anticoagulants; Benzimidazoles; Coumarins; Dabigatran; Dental Care for Chronically Ill; Hemostatic Techniques; Humans; Interprofessional Relations; Morpholines; Oral Hemorrhage; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyridines; Rivaroxaban; Thiophenes | 2013 |
[Optimization of preparation of salt-processed psoraleae fructus medicines with multi-index orthogonal method].
Topics: Chromatography, High Pressure Liquid; Coumarins; Drugs, Chinese Herbal; Flavones; Fruit; Hot Temperature; Phenols; Psoralea; Reproducibility of Results; Sodium Chloride; Technology, Pharmaceutical | 2013 |
Extraction and quantitation of coumarin from cinnamon and its effect on enzymatic browning in fresh apple juice: a bioinformatics approach to illuminate its antibrowning activity.
Topics: Beverages; Catechol Oxidase; Cinnamomum zeylanicum; Color; Coumarins; Enzyme Inhibitors; Food Preservatives; Food Quality; Fruit; Malus; Molecular Conformation; Molecular Docking Simulation; Peroxidase; Plant Bark; Plant Extracts; Plant Proteins; Spices | 2013 |
Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Dose-Response Relationship, Drug; Drug Design; Electrophorus; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tacrine | 2013 |
Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Topics: Absorption; Animals; Caco-2 Cells; Calorimetry, Differential Scanning; Camptothecin; Cell Death; Chitosan; Coated Materials, Biocompatible; Coumarins; Enterocytes; HT29 Cells; Humans; Intestines; Irinotecan; Kinetics; Lactic Acid; Male; Nanoparticles; Particle Size; Perfusion; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Rhodamine 123; Spectroscopy, Fourier Transform Infrared; Static Electricity; X-Ray Diffraction | 2013 |
A highly efficient and selective turn-on fluorescent sensor for Hg2+, Ag+ and Ag nanoparticles based on a coumarin dithioate derivative.
Topics: Coumarins; Fluorescence; Fluorescent Dyes; Mercury; Metal Nanoparticles; Molecular Structure; Silver; Sulfhydryl Compounds; Temperature | 2014 |
A self-calibrating bipartite viscosity sensor for mitochondria.
Topics: Biosensing Techniques; Boron; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Mitochondria; Porphobilinogen; Spectrometry, Fluorescence; Viscosity | 2013 |
Synthesis of coumarin/pyrrole-fused heterocycles and their photochemical and redox-switching properties.
Topics: Coumarins; Heterocyclic Compounds; Hydrogenation; Oxidation-Reduction; Photochemical Processes; Pyrroles | 2013 |
Medicinal flowers. XXXX . Structures of dihydroisocoumarin glycosides and inhibitory effects on aldose reducatase from the flowers of Hydrangea macrophylla var.thunbergii.
Topics: Aldehyde Reductase; Animals; Circular Dichroism; Coumarins; Flowers; Glycosides; Hydrangea; Lens, Crystalline; Magnetic Resonance Spectroscopy; Molecular Conformation; Protein Binding; Rats; Structure-Activity Relationship | 2013 |
Antinociceptive profiles and mechanisms of orally administered coumarin in mice.
Topics: Acetic Acid; Administration, Oral; Analgesics; Animals; Behavior, Animal; Coumarins; Formaldehyde; Glutamic Acid; Male; Mice; Mice, Inbred ICR; Naloxone; Narcotic Antagonists; Pain; Receptors, Opioid; Substance P | 2013 |
Polarization effects on the solvation dynamics of coumarin C153 in ionic liquids: components and their cross-correlations.
Topics: Coumarins; Ionic Liquids; Molecular Dynamics Simulation; Solubility | 2013 |
Time resolved spectroscopy and gain studies of Fullerenes C60 and C70.
Topics: Absorption; Coumarins; Energy Transfer; Fullerenes; Spectrometry, Fluorescence; Time Factors | 2013 |
Multilayer laminar co-extrudate as a novel controlled release dosage form.
Topics: Administration, Oral; Calcium Phosphates; Cellulose; Coumarins; Delayed-Action Preparations; Dosage Forms; Excipients; Hypromellose Derivatives; Lactose; Methylcellulose; Propranolol; Technology, Pharmaceutical; Water | 2013 |
Synthesis and in vitro photocytotoxicity of coumarin derivatives for one- and two-photon excited photodynamic therapy.
Topics: Cell Survival; Coumarins; Hep G2 Cells; Humans; Models, Chemical; Molecular Structure; Neoplasms; Photochemotherapy; Photons; Photosensitizing Agents; Reactive Oxygen Species; Singlet Oxygen | 2013 |
Studies on the structure of coumarin-modified dextran nanoparticles by fluorescence spectroscopy.
Topics: Coumarins; Cycloaddition Reaction; Dextrans; Nanoparticles; Spectrometry, Fluorescence | 2013 |
Novel synthesis of substituted furo[3,2-c]chromen-4-ones via four-component reaction from substituted nitrostyrenes, aromatic aldehydes, coumarins, and ammonium acetate.
Topics: Acetates; Aldehydes; Benzopyrans; Coumarins; Cyclization; Styrenes | 2013 |
Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
Topics: Antineoplastic Agents; Apoptosis; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Chemistry Techniques, Synthetic; Coumarins; Drug Design; Humans; Isoenzymes; MCF-7 Cells; Melanoma, Experimental; Molecular Docking Simulation; Protein Conformation; Quantitative Structure-Activity Relationship; Substrate Specificity; Sulfonamides | 2013 |
Are time-dependent fluorescence shifts at the tunnel mouth of haloalkane dehalogenase enzymes dependent on the choice of the chromophore?
Topics: Bradyrhizobium; Coumarins; Fluorescence; Fluorescence Polarization; Fluorescent Dyes; Hydrolases; Naphthalenes; Rhodococcus | 2013 |
Pattern-based sensing of peptides and aminoglycosides with a single molecular probe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Coumarins; Molecular Probes; Peptides; Photoelectron Spectroscopy | 2013 |
[Allelopathy effects of ferulic acid and coumarin on Microcystis aeruginosa].
Topics: Coumaric Acids; Coumarins; Microcystis; Pheromones; Plant Extracts | 2013 |
Coumarin derivatives protect against ischemic brain injury in rats.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Coumarins; Male; Molecular Structure; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2013 |
Design, synthesis and cellular dynamics studies in membranes of a new coumarin-based "turn-off" fluorescent probe selective for Fe2+.
Topics: Cell Line, Tumor; Cell Membrane; Coumarins; Drug Design; Ferrous Compounds; Fluorescent Dyes; Humans; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Spectrometry, Fluorescence; Tissue Distribution | 2013 |
Colorimetric and ratiometric fluorescent detection of sulfite in water via cationic surfactant-promoted addition of sulfite to α,β-unsaturated ketone.
Topics: Cations; Cetrimonium; Cetrimonium Compounds; Colorimetry; Coloring Agents; Coumarins; Dietary Sucrose; Fluorescence; Fluorescent Dyes; Hydrogen-Ion Concentration; Ketones; Micelles; Mineral Waters; Sulfhydryl Compounds; Sulfites; Surface-Active Agents; Wine | 2013 |
Characterization of laminar extrudates manufactured at room temperature in the absence of solvents for the delivery of drugs.
Topics: Coumarins; Diffusion; Drug Carriers; Elasticity; Excipients; Kinetics; Lipids; Particle Size; Porosity; Solubility; Solvents; Technology, Pharmaceutical; Temperature | 2013 |
Synthesis and luminescence properties of iridium complexes chelated with coumarin ligands.
Topics: Chelating Agents; Coumarins; Iridium; Luminescent Measurements; Materials Testing; Nanostructures; Particle Size | 2013 |
Cyclohexyl iodide promoted approach for coumarin analog synthesis using small scaffold.
Topics: Coumarins; Cyclization; Iodides | 2013 |
Time-resolved and mechanistic study of the photochemical uncaging reaction of the o-hydroxycinnamic caged compound.
Topics: Coumaric Acids; Coumarins; Ethanol; Molecular Structure; Photochemical Processes; Spectrophotometry, Infrared; Time Factors; Ultraviolet Rays | 2013 |
Photo responsive monoolein cubic phase containing coumarin-Tween 20 conjugates.
Topics: Anticoagulants; Coumarins; Dimerization; Drug Delivery Systems; Drug Stability; Fluoresceins; Fluorescent Dyes; Glycerides; Hot Temperature; Hymecromone; Kinetics; Magnetic Resonance Spectroscopy; Pharmaceutical Vehicles; Phase Transition; Photochemical Processes; Polysorbates; Solubility; Surface-Active Agents; Ultraviolet Rays; Umbelliferones | 2013 |
Design, synthesis, and anti-tumor activities of novel triphenylethylene-coumarin hybrids, and their interactions with Ct-DNA.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Proliferation; Coumarins; DNA; Drug Design; Drug Screening Assays, Antitumor; Humans; Intercalating Agents; Neoplasms; Stilbenes | 2013 |
Synthetic models related to methoxalen and menthofuran-cytochrome P450 (CYP) 2A6 interactions. benzofuran and coumarin derivatives as potent and selective inhibitors of CYP2A6.
Topics: Aryl Hydrocarbon Hydroxylases; Benzofurans; Coumarins; Cytochrome P-450 CYP2A6; Enzyme Inhibitors; Humans; Models, Chemical; Monoterpenes; Protein Binding | 2013 |
Mechanism-based inactivation of cytochrome P450 2A6 and 2A13 by Rhinacanthus nasutus constituents.
Topics: Acanthaceae; Animals; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; Humans; Hydroxylation; Kinetics; NADPH-Ferrihemoprotein Reductase; Naphthoquinones; Plant Extracts; Rats; Recombinant Proteins | 2014 |
Ultrasound accelerated gelation of novel L-lysine based hydrogelators.
Topics: Animals; Coumarins; Hydrazines; Hydrogels; Hydrophobic and Hydrophilic Interactions; Lysine; Magnetic Resonance Spectroscopy; Mice; Microscopy, Electron, Scanning; NIH 3T3 Cells; Sound | 2013 |
Quantification of coumarin in cinnamon and woodruff beverages using DIP-APCI-MS and LC-MS.
Topics: Beverages; Chromatography, Liquid; Cinnamomum zeylanicum; Coumarins; Isotope Labeling; Mass Spectrometry; Reproducibility of Results | 2013 |
[Dynamic accumulation of dry substance and active components in root of Peucedanum praeruptorum].
Topics: Apiaceae; Chromatography, High Pressure Liquid; Coumarins; Plant Extracts; Plant Roots | 2013 |
Supersaturated polymeric micelles for oral cyclosporine A delivery.
Topics: Absorption; Administration, Oral; Animals; Biological Availability; Biological Transport; Caco-2 Cells; Chemistry, Pharmaceutical; Coumarins; Cyclosporine; Drug Delivery Systems; Flow Cytometry; Fluorescent Dyes; Humans; Intestinal Absorption; Male; Micelles; Microscopy, Confocal; Particle Size; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Water | 2013 |
Photocatalytic surface patterning of cellulose using diazonium salts and visible light.
Topics: Catalysis; Cellulose; Coumarins; Diazonium Compounds; Light; Molecular Structure; Photochemical Processes; Salts; Surface Properties | 2013 |
Total syntheses of the coumarin-containing natural products pimpinellin and fraxetin using Au(I)-catalyzed intramolecular hydroarylation (IMHA) chemistry.
Topics: Biological Products; Catalysis; Coumarins; Gold; Hydroxylation; Methoxsalen; Molecular Structure; Organic Chemistry Phenomena | 2013 |
A coumarin-indole-based near-infrared ratiometric pH probe for intracellular fluorescence imaging.
Topics: Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen-Ion Concentration; Indoles; Intracellular Fluid; KB Cells; Microscopy, Fluorescence, Multiphoton | 2013 |
Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase.
Topics: Acetylcholinesterase; Benzopyrans; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Drug Design; Enzyme Activation; Inhibitory Concentration 50; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Tacrine | 2013 |
Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors.
Topics: Amyloid; Coumarins; Escherichia coli; Humans; Prealbumin; Protein Binding; Protein Folding; Protein Structure, Quaternary; Spectrometry, Fluorescence | 2013 |
Study on the interaction between gliadins and a coumarin as molecular model system of the gliadins-anthocyanidins complexes.
Topics: Anthocyanins; Coumarins; Gliadin; Models, Molecular; Protein Binding; Protein Structure, Secondary; Spectrum Analysis, Raman | 2013 |
Antioxidant effectiveness generated by one or two phenolic hydroxyl groups in coumarin-substituted dihydropyrazoles.
Topics: Antioxidants; Coumarins; Free Radicals; Oxidation-Reduction; Phenols; Pyrazoles | 2013 |
Affinity-based fluorogenic labeling of ATP-binding proteins with sequential photoactivatable cross-linkers.
Topics: Adenosine Triphosphate; Affinity Labels; Coumarins; Diazomethane; Fluorescent Dyes; Glutamate Dehydrogenase; Photolysis; ras Proteins; Stereoisomerism; Ultraviolet Rays | 2013 |
Highly effective discrimination of catecholamine derivatives via FRET-on/off processes induced by the intermolecular assembly with two fluorescence sensors.
Topics: Aldehydes; Boronic Acids; Catecholamines; Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Pyrenes | 2013 |
Multimodal use of new coumarin-based fluorescent chemosensors: towards highly selective optical sensors for Hg(2+) probing.
Topics: Animals; Chlorocebus aethiops; COS Cells; Coumarins; Fluorescent Dyes; Ions; Mercury; Microscopy, Confocal; Nanoparticles; Polyethylene Glycols; Polyvinyl Chloride; Quantum Theory; Spectrometry, Fluorescence; Water | 2013 |
Sol-gel conversion based on photoswitching between noncovalently and covalently linked netlike supramolecular polymers.
Topics: Coumarins; Gels; Macromolecular Substances; Models, Molecular; Molecular Structure; Particle Size; Photochemical Processes; Polymers; Surface Properties | 2013 |
Ultrafast branching in the excited state of coumarin and umbelliferone.
Topics: Coumarins; Electrons; Models, Molecular; Quantum Theory; Solvents; Spectrophotometry, Ultraviolet; Umbelliferones | 2013 |
Microwave assisted synthesis of dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones; synthesis, in vitro antimicrobial and anticancer activities of novel coumarin substituted dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Fungi; Humans; Microbial Sensitivity Tests; Microwaves; Models, Molecular; Molecular Structure; Pyrimidinones | 2013 |
Nano composite system based on coumarin derivative-titanium dioxide nanoparticles and ionic liquid: determination of levodopa and carbidopa in human serum and pharmaceutical formulations.
Topics: Carbidopa; Carbon; Catalysis; Chemistry, Pharmaceutical; Coumarins; Electrochemical Techniques; Electrodes; Humans; Hydrogen-Ion Concentration; Ionic Liquids; Levodopa; Metal Nanoparticles; Nanocomposites; Oxidation-Reduction; Titanium | 2013 |
Tyrosine specific sequential labeling of proteins.
Topics: Alkynes; Azides; Catalysis; Click Chemistry; Coumarins; Fluorescent Dyes; Humans; Palladium; Serum Albumin; Tyrosine | 2013 |
Elucidation of the transport mechanism of baicalin and the influence of a Radix Angelicae Dahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model.
Topics: Absorption; Angelica; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Coumarins; Drugs, Chinese Herbal; Flavonoids; Humans; Multidrug Resistance-Associated Proteins; Oils, Volatile; Plant Extracts; Scutellaria baicalensis | 2013 |
The effect of the coumarin-like derivative osthole on the osteogenic properties of human periodontal ligament and jaw bone marrow mesenchymal stem cell sheets.
Topics: Adolescent; Adult; Bone Marrow Cells; Cell Proliferation; Cell Survival; Cells, Cultured; Coumarins; Flow Cytometry; Humans; Jaw; Mesenchymal Stem Cells; Osteogenesis; Periodontal Ligament; Young Adult | 2013 |
'PET' vs. 'push-pull' induced ICT: a remarkable coumarinyl-appended pyrimidine based naked eye colorimetric and fluorimetric sensor for the detection of Hg2+ ions in aqueous media with test trips.
Topics: Chemistry Techniques, Analytical; Coumarins; Fluorescent Dyes; Fluorometry; Ions; Mercury; Pyrimidines; Spectrophotometry; Water; Water Pollutants, Chemical | 2013 |
Coumarin and furanocoumarin quantitation in citrus peel via ultraperformance liquid chromatography coupled with mass spectrometry (UPLC-MS).
Topics: Chromatography, High Pressure Liquid; Citrus; Coumarins; Fruit; Furocoumarins; Mass Spectrometry; Plant Extracts | 2013 |
Synthesis and biological evaluation of novel formyl-pyrazoles bearing coumarin moiety as potent antimicrobial and antioxidant agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Coumarins; Molecular Structure; Pyrazoles; Structure-Activity Relationship | 2013 |
The genome of Mesobuthus martensii reveals a unique adaptation model of arthropods.
Topics: Adaptation, Biological; Animals; Arthropod Proteins; Biological Evolution; Chromosome Mapping; Coumarins; Defensins; Fluorescence; Gene Expression Profiling; Genome; Neurotoxins; Phylogeny; Scorpions; Transcriptome | 2013 |
New continuous fluorometric assay for bacterial transglycosylase using Förster resonance energy transfer.
Topics: Bacteria; Coumarins; Enzyme Assays; Enzyme Inhibitors; Fluorescence Resonance Energy Transfer; Peptidoglycan Glycosyltransferase; Uridine Diphosphate N-Acetylmuramic Acid | 2013 |
General and practical carboxyl-group-directed remote C-H oxygenation reactions of arenes.
Topics: Carbon; Carboxylic Acids; Catalysis; Copper; Coumarins; Cyclization; Electrons; Hydrogen; Oxygen; Sodium Compounds; Sulfates | 2013 |
Synthesis and evaluation of two coumarin-type derivatization reagents for fluorescence detection of chiral amines and chiral carboxylic acids.
Topics: Amines; Carboxylic Acids; Chemistry Techniques, Analytical; Chromatography, High Pressure Liquid; Coumarins; Fluorescent Dyes; Molecular Structure; Propionates; Stereoisomerism | 2013 |
A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death.
Topics: Apoptosis; Benzoquinones; Breast Neoplasms; cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Coumarins; Cyclin-Dependent Kinases; DNA Cleavage; Female; Humans; MCF-7 Cells; Naphthoquinones; Protein Isoforms; Reactive Oxygen Species; Viral Proteins | 2015 |
A coumarin-based fluorescent probe for biological thiols and its application for living cell imaging.
Topics: Cell Survival; Coumarins; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Molecular Structure; Pancreatic Neoplasms; Quantum Theory; Sulfhydryl Compounds | 2013 |
Design, synthesis, and anticancer properties of novel benzophenone-conjugated coumarin analogs.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzophenones; Carcinoma, Ehrlich Tumor; Caspase Inhibitors; Caspases; Cell Proliferation; Chick Embryo; Coumarins; Drug Design; Humans; Inhibitory Concentration 50; MCF-7 Cells; Mice; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Neovascularization, Physiologic; Phosphatidylinositol 3-Kinase; Protein Conformation; Signal Transduction; Structure-Activity Relationship | 2013 |
Discovery of coumarin derivatives as fluorescence acceptors for intrinsic fluorescence resonance energy transfer of proteins.
Topics: Biotin; Coumarins; Fluorescence; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Proteins; Streptavidin; Tryptophan | 2014 |
Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Coumarins; Mice; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
[Study on transport mechanism of baicalin in Scutellariae radix extracts and effect of Angelica dahurica extracts on transport of baicalin by Caco-2 cell monolayer model].
Topics: Angelica; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cell Line, Tumor; Coumarins; Drug Interactions; Drugs, Chinese Herbal; Flavonoids; Humans; Intestinal Absorption; Oils, Volatile; Plant Extracts; Plant Roots; Probenecid; Scutellaria baicalensis; Verapamil | 2013 |
A water-soluble near-infrared probe for colorimetric and ratiometric sensing of SO2 derivatives in living cells.
Topics: Cell Line; Cell Survival; Colorimetry; Coumarins; Fluorescent Dyes; Humans; Limit of Detection; Optical Imaging; Solubility; Sulfur Dioxide; Time Factors; Water | 2014 |
Synthesis and evaluation of new coumarin-pyridine hybrids with promising anti-osteoporotic activities.
Topics: Animals; Bone Density Conservation Agents; Cell Differentiation; Coumarins; Dose-Response Relationship, Drug; Female; Male; Mice; Molecular Structure; Osteoblasts; Osteogenesis; Osteoporosis; Pyridines; Structure-Activity Relationship | 2013 |
Exploring the metric of excited state proton transfer reactions.
Topics: Coumarins; Imidazoles; Protons | 2013 |
Simultaneous determination of 14 phenolic compounds in grape canes by HPLC-DAD-UV using wavelength switching detection.
Topics: Catechin; Chromatography, High Pressure Liquid; Coumarins; Flavonoids; Phenols; Quercetin; Resveratrol; Stilbenes; Ultraviolet Rays; Vitis | 2013 |
A prodrug approach to the use of coumarins as potential therapeutics for superficial mycoses.
Topics: Antifungal Agents; Arthrodermataceae; Bacteria; beta-Glucosidase; Coumarins; Dermatomycoses; Drosophila Proteins; Esculin; Humans; Hydrolysis; Microbial Sensitivity Tests; Microbiota; Prodrugs; Skin; Umbelliferones | 2013 |
FeCl3-catalysed ultrasonic-assisted, solvent-free synthesis of 4-substituted coumarins. A useful complement to the Pechmann reaction.
Topics: Catalysis; Chemistry Techniques, Synthetic; Chlorides; Coumarins; Ferric Compounds; Green Chemistry Technology; Ultrasonics | 2014 |
A coumarin derivative as a fluorogenic glycoproteomic probe for biological imaging.
Topics: Coumarins; Flow Cytometry; Fluorescent Dyes; Glycoproteins; HeLa Cells; Humans; Models, Biological; Molecular Imaging | 2014 |
4-Trifluoromethyl-substituted coumarins with large Stokes shifts: synthesis, bioconjugates, and their use in super-resolution fluorescence microscopy.
Topics: Coumarins; Fluorescent Dyes; Halogenation; HeLa Cells; Humans; Methylation; Microscopy, Fluorescence | 2013 |
Non-native N-aroyl L-homoserine lactones are potent modulators of the quorum sensing receptor RpaR in Rhodopseudomonas palustris.
Topics: 4-Butyrolactone; Bacterial Proteins; Coumarins; Ligands; Protein Binding; Quorum Sensing; Repressor Proteins; Rhodopseudomonas; Signal Transduction; Structure-Activity Relationship; Trans-Activators | 2014 |
Effect of polymer porosity on aqueous self-healing encapsulation of proteins in PLGA microspheres.
Topics: Animals; Biocompatible Materials; Cattle; Coumarins; Drug Compounding; Enzyme Assays; Kinetics; Lactic Acid; Magnesium; Microscopy, Electron, Scanning; Microspheres; Molecular Weight; Muramidase; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Serum Albumin, Bovine; Water | 2013 |
Interaction of anticancer reduced Schiff base coumarin derivatives with human serum albumin investigated by fluorescence quenching and molecular modeling.
Topics: Antineoplastic Agents; Binding Sites; Coumarins; Humans; Molecular Dynamics Simulation; Molecular Structure; Protons; Schiff Bases; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2014 |
Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Luminescence; Models, Molecular; Neoplasms; Organogold Compounds; Phosphines; Solubility; Thioredoxin-Disulfide Reductase; Water | 2014 |
New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: synthesis, in vivo antithrombotic evaluation and molecular docking.
Topics: Animals; Anticoagulants; Binding Sites; Coumarins; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Male; Mice; Molecular Docking Simulation; Molecular Structure; Prothrombin Time; Structure-Activity Relationship; Warfarin | 2014 |
Study of possible mechanisms involved in the inhibitory effects of coumarin derivatives on neutrophil activity.
Topics: Adenosine Triphosphate; Adult; Cell Death; Cell-Free System; Coumarins; Extracellular Space; Humans; Inhibitory Concentration 50; Intracellular Space; Isoenzymes; Kinetics; Luminescent Measurements; Male; Middle Aged; Neutrophil Activation; Neutrophils; Phosphoproteins; Phosphorylation; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Young Adult | 2013 |
Total synthesis of six 3,4-unsubstituted coumarins.
Topics: Combinatorial Chemistry Techniques; Coumarins; Molecular Structure | 2013 |
A new fluorescent turn-on chemodosimeter for mercury ions in solution and its application in cells and organisms.
Topics: Cell Survival; Coumarins; Escherichia coli; Fluorescent Dyes; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydrazines; Hydrogen-Ion Concentration; Ions; Mercury; Metals; Microscopy, Confocal; Solutions; Spectrometry, Fluorescence | 2014 |
Determination of vanillin, ethyl vanillin, and coumarin in infant formula by liquid chromatography-quadrupole linear ion trap mass spectrometry.
Topics: Benzaldehydes; Carcinogens; Chromatography, Liquid; Coumarins; Flavoring Agents; Food Contamination; Humans; Infant; Infant Formula; Infant, Newborn; Mass Spectrometry | 2014 |
Synthesis of tricyclic fused coumarin sulfonates and their inhibitory effects on LPS-induced nitric oxide and PGE2 productions in RAW 264.7 macrophages.
Topics: Animals; Cell Line; Coumarins; Dinoprostone; Dose-Response Relationship, Drug; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Sulfonic Acids | 2014 |
Determination of ground and excited state dipole moments of dipolar laser dyes by solvatochromic shift method.
Topics: Coloring Agents; Coumarins; Lasers; Models, Molecular; Solvents; Spectrometry, Fluorescence | 2014 |
Design, synthesis and evaluation of 9-hydroxy-7H-furo[3,2-g]chromen-7-one derivatives as new potential vasodilatory agents.
Topics: Animals; Benzopyrans; Coumarins; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Furocoumarins; Hypertension; Male; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Vasodilator Agents | 2014 |
Interaction of fluorescently labeled triethyleneglycol and peptide derivatives with β-cyclodextrin.
Topics: beta-Cyclodextrins; Coumarins; Ethylene Glycol; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Models, Molecular; Peptides | 2014 |
Cytotoxicity and DNA binding property of triphenylethylene-coumarin hybrids with two amino side chains.
Topics: Amino Acids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Circular Dichroism; Coumarins; DNA; Drug Design; Humans; Stilbenes; Structure-Activity Relationship | 2014 |
Photoresponsive polyesters by incorporation of alkoxyphenacyl or coumarin chromophores along the backbone.
Topics: Amines; Coumarins; Decanoic Acids; Dicarboxylic Acids; Ketones; Nanoparticles; Photochemical Processes; Polyesters | 2014 |
Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coumarins; Flow Cytometry; Humans; Inhibitory Concentration 50; MCF-7 Cells; Triazoles | 2014 |
Inhibition of reverse transcriptase and Taq DNA polymerase by compounds possessing the coumarin framework.
Topics: Animals; Asteraceae; Cell Line, Tumor; Coumarins; Enzyme Activation; Inhibitory Concentration 50; Mice; Models, Biological; Molecular Structure; Moloney murine leukemia virus; Plant Preparations; Reverse Transcriptase Inhibitors; Taq Polymerase | 2014 |
Coumarin-based fluorescent probes for dual recognition of copper(II) and iron(III) ions and their application in bio-imaging.
Topics: Cell Line, Tumor; Cell Tracking; Copper; Coumarins; Fluorescence; Fluorescent Dyes; Humans; Hydrogen Peroxide; Ions; Iron; Molecular Imaging | 2014 |
The reduction of anti-cancer drug antagonism by the spatial protection of drugs with PLA-TPGS nanoparticles.
Topics: Antineoplastic Agents; Cell Death; Colloids; Coumarins; Drug Antagonism; Endocytosis; Humans; MCF-7 Cells; Nanoparticles; Polyesters; Polyethylene Glycols; Vitamin E | 2014 |
The role of cytochrome P450 2B6 and 2B4 substrate access channel residues predicted based on crystal structures of the amlodipine complexes.
Topics: Amlodipine; Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Calcium Channel Blockers; Catalytic Domain; Coumarins; Crystallography, X-Ray; Cytochrome P-450 CYP2B6; Cytochrome P450 Family 2; Humans; Models, Molecular; Point Mutation; Protein Conformation; Rabbits | 2014 |
Protein and enzyme gated supramolecular disassembly.
Topics: Binding Sites; Coumarins; Enzymes; Indicators and Reagents; Models, Biological; Molecular Structure; Protein Transport; Proteins; Substrate Specificity | 2014 |
Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; HSP90 Heat-Shock Proteins; Humans; MCF-7 Cells; Naphthalenes; Novobiocin; Protein Binding; Quinolines | 2014 |
A potential low-coumarin cinnamon substitute: Cinnamomum osmophloeum leaves.
Topics: Cinnamomum; Cinnamomum zeylanicum; Coumarins; Oils, Volatile; Plant Extracts; Plant Leaves; Taiwan | 2014 |
Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Coumarins; Disease Models, Animal; Enzyme Activation; Male; Memory; Memory Disorders; Mice; Mice, Inbred ICR; Protein Binding; Pyrrolidines; Scopoletin; Structure-Activity Relationship | 2014 |
A botryane metabolite with a new hexacyclic skeleton from an entomogenous fungus Hypocrea sp.
Topics: Antineoplastic Agents; Coumarins; Crystallography, X-Ray; HeLa Cells; Humans; Hypocrea; MCF-7 Cells; Molecular Conformation; Molecular Structure; Sesquiterpenes | 2013 |
Synthesis, characterization and cytotoxicity of a new palladium(II) complex with a coumarine-derived ligand.
Topics: Animals; Caspases; Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Ligands; Magnetic Resonance Spectroscopy; Membrane Potential, Mitochondrial; Mice; Palladium; Reactive Oxygen Species | 2014 |
The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrin.
Topics: Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain Diseases; Cattle; Coumarins; Lactoferrin; Liposomes; Memory, Short-Term; Mice; Nanomedicine; Neuropeptides; Neuroprotective Agents; Peptide Fragments; Peptides; Polyethylene Glycols; Polyglactin 910; Protons; Rats; Serum Albumin, Bovine; Tissue Distribution | 2014 |
In vitro inhibition effects of some coumarin derivatives on human erythrocytes glucose-6-phosphate dehydrogenase activities.
Topics: Coumarins; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Erythrocytes; Glucosephosphate Dehydrogenase; Humans; Kinetics; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2014 |
A coumarin-based fluorescent probe for selective and sensitive detection of thiophenols and its application.
Topics: Coumarins; Fluorescent Dyes; Magnetic Resonance Spectroscopy; Mass Spectrometry; Phenols; Sulfhydryl Compounds | 2014 |
Rational design of biotin-disulfide-coumarin conjugates: a cancer targeted thiol probe and bioimaging.
Topics: Biotin; Cell Line, Tumor; Coumarins; Disulfides; Endocytosis; Fluorescent Dyes; Humans; Molecular Probes; Neoplasms; Optical Imaging; Receptors, Growth Factor | 2014 |
Extensive coumarin-induced necrosis - a vasculopathy following oral anticoagulation.
Topics: Administration, Oral; Adult; Anticoagulants; Buttocks; Coumarins; Diagnosis, Differential; Female; Humans; Necrosis; Skin Diseases, Vascular | 2014 |
Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzophenones; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Coumarins; Female; Humans; Lymphoma; Mice; Neovascularization, Pathologic | 2014 |
ANTICOAGULANT therapy in congestive heart failure.
Topics: Anticoagulants; Coumarins; Heart Failure; Heparin; Humans; Thromboembolism | 1952 |
Alkynyl-coumarinyl ethers as MAO-B inhibitors.
Topics: Alkynes; Coumarins; Dose-Response Relationship, Drug; Ethers; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Recombinant Proteins; Structure-Activity Relationship | 2014 |
Coumarinoids from the fruits of Micromelum falcatum.
Topics: Antifungal Agents; Coumarins; Dose-Response Relationship, Drug; Fruit; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Plant Extracts; Pythium; Rutaceae | 2014 |
Coumarin derivatives, but not coumarin itself, cause skin irritation via topical delivery.
Topics: Administration, Cutaneous; Animals; Biomarkers; Cell Line; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Female; Hair Follicle; Humans; Irritants; Keratinocytes; Mice; Mice, Nude; Molecular Structure; Permeability; Reproducibility of Results; Skin; Skin Absorption; Skin Irritancy Tests; Structure-Activity Relationship; Swine; Water Loss, Insensible | 2014 |
Faster photoinduced electron transfer in a diluted mixture than in a neat donor solvent: effect of excited-state H-bonding.
Topics: Aniline Compounds; Coumarins; Cyclohexanes; Electron Transport; Electrons; Hydrogen Bonding; Solvents; Spectrometry, Fluorescence; Thermodynamics; Toluene | 2014 |
New cytotoxic compounds from flowers of Lawsonia inermis L.
Topics: Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Line, Tumor; Cell Survival; Coumarins; Crystallography, X-Ray; Flavonoids; Flowers; Humans; Lawsonia Plant; Molecular Structure; Plant Extracts; Plants, Medicinal; X-Ray Diffraction | 2014 |
Synthesis of coumarin derivatives as fluorescent probes for membrane and cell dynamics studies.
Topics: Cell Line, Tumor; Coumarins; Crystallography, X-Ray; Fluorescent Dyes; Humans; Molecular Dynamics Simulation; Neuroblastoma | 2014 |
Synthesis, characterization, and evaluation of a novel amphiphilic polymer RGD-PEG-Chol for target drug delivery system.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line; Cholesterol; Coumarins; Drug Delivery Systems; Drug Evaluation, Preclinical; Human Umbilical Vein Endothelial Cells; Humans; Liposomes; Mice; Oligopeptides; Paclitaxel; Polyethylene Glycols | 2014 |
A coumarin-based fluorescent probe for recognition of Cu(2+) and fast detection of histidine in hard-to-transfect cells by a sensing ensemble approach.
Topics: Cell Line, Tumor; Copper; Coumarins; Fluorescent Dyes; Histidine; Humans; Molecular Structure; Transfection | 2014 |
Substitution pattern reverses the fluorescence response of coumarin glycoligands upon coordination with silver (I).
Topics: Contrast Media; Coumarins; Glycogen; Hep G2 Cells; Humans; Ligands; Microscopy, Fluorescence; Silver; Subcellular Fractions | 2014 |
A highly selective turn-on fluorescent probe for Al(III) based on coumarin and its application in vivo.
Topics: Aluminum; Animals; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Spectrometry, Fluorescence; Spectrometry, Mass, Electrospray Ionization; Zebrafish | 2014 |
Assembly and manipulation of Fe(3)O(4)/coumarin bifunctionalized submicrometer Janus particles.
Topics: Coumarins; Magnetite Nanoparticles; Particle Size; Polymers; Surface Properties | 2014 |
Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives.
Topics: Antineoplastic Agents; Caspase 3; Caspase 7; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; Humans; Hydrazones; Magnetic Resonance Spectroscopy; Mass Spectrometry | 2014 |
Plant chemical ecology finally gets to its root(s).
Topics: Alkaloids; Coumarins; Cyclopentanes; Ecology; Nicotine; Oxylipins; Pheromones; Plant Roots; Plants; Signal Transduction | 2014 |
Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Neuroprotective Agents; Protein Binding; Structure-Activity Relationship | 2014 |
8-Alkylcoumarins from the fruits of Cnidium monnieri protect against hydrogen peroxide induced oxidative stress damage.
Topics: Animals; Apiaceae; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coumarins; Fruit; Hydrogen Peroxide; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Neuroblastoma; Oxidants; Oxidative Stress; Protective Agents | 2014 |
A coumarin-labeled vinyl sulfone as tripeptidomimetic activity-based probe for cysteine cathepsins.
Topics: Binding Sites; Catalytic Domain; Cathepsins; Coumarins; Dipeptides; Electrophoresis, Polyacrylamide Gel; Fluorescent Dyes; Humans; Isoenzymes; Molecular Docking Simulation; Quinolines; Sulfones | 2014 |
Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux.
Topics: Animals; Breast Neoplasms; Colorectal Neoplasms; Coumarins; Female; HCT116 Cells; Humans; Lactic Acid; MCF-7 Cells; Mice; Neoplasm Recurrence, Local; Prognosis; Thiophenes; Uracil | 2014 |
Intermolecular proton shuttling in excited state proton transfer reactions: insights from theory.
Topics: Coumarins; Imidazoles; Models, Molecular; Protons; Quantum Theory; Toluene | 2014 |
Benzopyrone coumarin leads to an inhibition of ochratoxin biosynthesis in representatives of Aspergillus and Penicillium spp. via a type of feedback response mechanism.
Topics: Antifungal Agents; Aspergillus; Coumarins; Dose-Response Relationship, Drug; Food Microbiology; Food Preservation; Ochratoxins; Penicillium | 2014 |
Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs.
Topics: Animals; Anti-Asthmatic Agents; Coumarins; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Models, Molecular; Molecular Structure; Rats; Rats, Wistar; Structure-Activity Relationship; Trachea | 2014 |
A simple and effective coumarin-based fluorescent probe for cysteine.
Topics: Animals; Biosensing Techniques; Cattle; Coumarins; Cysteine; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Limit of Detection; Optical Imaging; Spectrometry, Fluorescence | 2014 |
Plasmonic liquid marbles: a miniature substrate-less SERS platform for quantitative and multiplex ultratrace molecular detection.
Topics: Coumarins; Limit of Detection; Methylene Blue | 2014 |
Experimental designs characterizing seasonal variations and solvent effects on the quantities of coumarin and related metabolites from Mikania laevigata.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Coumarins; Mass Spectrometry; Mikania; Plant Extracts; Plant Leaves; Seasons; Solvents | 2014 |
Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition.
Topics: Binding Sites; Coumarins; Humans; Hydrophobic and Hydrophilic Interactions; Isoenzymes; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship | 2014 |
A new fluorescent probe for Zn²⁺ with red emission and its application in bioimaging.
Topics: Cations, Divalent; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Models, Molecular; Optical Imaging; Pyridines; Spectrometry, Fluorescence; Zinc | 2014 |
Synthesis and cellular characterization of novel isoxazolo- and thiazolohydrazinylidene-chroman-2,4-diones on cancer and non-cancer cell growth and death.
Topics: 4-Hydroxycoumarins; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Coumarins; Humans; Isoxazoles; MCF-7 Cells; Poly(ADP-ribose) Polymerases; Thiazoles; U937 Cells | 2014 |
Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients.
Topics: Administration, Cutaneous; Administration, Oral; Algorithms; Animals; Antioxidants; Caffeine; Calibration; Central Nervous System Stimulants; Cosmetics; Coumarins; Data Interpretation, Statistical; Humans; Hydroquinones; Liver; Models, Statistical; No-Observed-Adverse-Effect Level; Pharmacokinetics; Quantitative Structure-Activity Relationship; Rats; Skin; Skin Absorption; Species Specificity | 2014 |
Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; HEK293 Cells; HeLa Cells; Humans; MCF-7 Cells; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2014 |
Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis.
Topics: Animals; Brain; Brain Neoplasms; Cell Line; Coumarins; Cysteamine; Drug Delivery Systems; Glioma; Interleukin-13 Receptor alpha2 Subunit; Male; Mice; Nanoparticles; Peptides | 2014 |
A new fluorescent pH probe for extremely acidic conditions.
Topics: Coumarins; Drug Design; Escherichia coli; Fluorescent Dyes; Hydrogen-Ion Concentration; Imidazoles; Models, Molecular; Molecular Conformation; Optical Imaging | 2014 |
UV-triggerable alginate beads decorated with basic proteinoid-coumarin conjugates.
Topics: Alginates; Coumarins; Dextrans; Dimerization; Drug Carriers; Drug Liberation; Fluorescein-5-isothiocyanate; Glucuronic Acid; Hexuronic Acids; Microspheres; Proteins; Ultraviolet Rays | 2014 |
[Design, synthesis and anti-proliferative activity of novel coumarin derivatives linking Schiff base and aryl nitrogen mustard].
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Design; Drug Screening Assays, Antitumor; Humans; Nitrogen Mustard Compounds; Schiff Bases; Structure-Activity Relationship | 2014 |
Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Topics: Binding Sites; Coumarins; Hydrogen Bonding; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship | 2014 |
Inhibitory effects of phytochemicals on metabolic capabilities of CYP2D6(*)1 and CYP2D6(*)10 using cell-based models in vitro.
Topics: Berberine; Cell Line, Tumor; Chromatography, High Pressure Liquid; Coumarins; Cyclooctanes; Cyclopentanes; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Furans; Ginkgolides; Hep G2 Cells; Humans; Isoflavones; Kinetics; Lignans; Luteolin; Phytochemicals; Polycyclic Compounds | 2014 |
Immunosuppressive activity of daphnetin, one of coumarin derivatives, is mediated through suppression of NF-κB and NFAT signaling pathways in mouse T cells.
Topics: Animals; Cell Proliferation; Concanavalin A; Coumarins; Down-Regulation; G1 Phase; Hypersensitivity, Delayed; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; NF-kappa B; NFATC Transcription Factors; Resting Phase, Cell Cycle; Signal Transduction; T-Lymphocytes; Umbelliferones | 2014 |
Hepatoprotective coumarins and secoiridoids from Hydrangea paniculata.
Topics: Cell Line; Cell Survival; Coumarins; Galactosamine; Glucosides; Humans; Hydrangea; Hydrolysis; Iridoids; Liver; Magnetic Resonance Spectroscopy; Molecular Structure; Plant Stems | 2014 |
Induction of ROS-independent JNK-activation-mediated apoptosis by a novel coumarin-derivative, DMAC, in human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Blotting, Western; Cell Line, Tumor; Colonic Neoplasms; Coumarins; Cysteine; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Molecular Structure; Reactive Oxygen Species | 2014 |
Spectroscopic and quantum chemical electronic structure investigations of 3,4-dihydrocoumarin and 3-methylcoumarin.
Topics: Algorithms; Carbon; Coumarins; Electrons; Molecular Conformation; Oxygen; Software; Spectrophotometry; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Static Electricity; Vibration | 2014 |
Multiple dual mode counter-current chromatography with variable duration of alternating phase elution steps.
Topics: Aspirin; Caffeine; Coumarins; Countercurrent Distribution; Models, Theoretical; Salicylic Acid | 2014 |
A coumarin-based fluorescent probe for differential identification of sulfide and sulfite in CTAB micelle solution.
Topics: Cetrimonium; Cetrimonium Compounds; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Micelles; Optical Imaging; Spectrometry, Fluorescence; Sulfides; Sulfites | 2014 |
Cytotoxicity and DNA binding property of the dimers of triphenylethylene-coumarin hybrid with one amino side chain.
Topics: Amines; Animals; Antineoplastic Agents; Binding Sites; Cattle; Cell Line, Tumor; Cell Proliferation; Coumarins; Dimerization; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; K562 Cells; MCF-7 Cells; Molecular Structure; Osteoblasts; Stilbenes; Structure-Activity Relationship | 2014 |
A hybrid coumarin-thiazole fluorescent sensor for selective detection of bisulfite anions in vivo and in real samples.
Topics: Anions; Biosensing Techniques; Color; Coumarins; Female; Fluorescent Dyes; Humans; MCF-7 Cells; Molecular Structure; Sensitivity and Specificity; Sulfites; Thiazoles | 2014 |
Photoswitchable formation of a DNA interstrand cross-link by a coumarin-modified nucleotide.
Topics: Base Sequence; Click Chemistry; Coumarins; Cycloaddition Reaction; Deoxyadenosines; Deoxycytidine; DNA; Oligodeoxyribonucleotides; Pyrimidine Nucleosides; Thymidine; Ultraviolet Rays | 2014 |
A coumarin-quinolinium-based fluorescent probe for ratiometric sensing of sulfite in living cells.
Topics: Animals; Biosensing Techniques; Cell Survival; Coumarins; Fluorescent Dyes; Macrophages; Mice; Models, Molecular; Proton Magnetic Resonance Spectroscopy; Quantum Theory; Quinolinium Compounds; Spectrometry, Fluorescence; Sulfites; Time Factors | 2014 |
New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
Topics: Coumarins; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2014 |
Coumestan inhibits radical-induced oxidation of DNA: is hydroxyl a necessary functional group?
Topics: Amidines; Antioxidants; Benzofurans; Biphenyl Compounds; Coumarins; DNA; Glutathione; Hydroxyl Radical; Oxidation-Reduction; Picrates | 2014 |
Ultrafluorogenic coumarin-tetrazine probes for real-time biological imaging.
Topics: Cell Line; Coumarins; Fluorescent Dyes; Heterocyclic Compounds | 2014 |
Fluorescent sensor for selective detection of Al(3+) based on quinoline-coumarin conjugate.
Topics: Aluminum; Cations; Coumarins; Fluorescent Dyes; Limit of Detection; Quinolines; Spectrometry, Fluorescence | 2014 |
Preparation and mechanism insight of nuclear envelope-like polymer vesicles for facile loading of biomacromolecules and enhanced biocatalytic activity.
Topics: Biocatalysis; Biomimetic Materials; Coumarins; Drug Carriers; Drug Design; Fluorescent Dyes; Glucose Oxidase; Hemoglobins; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Macromolecular Substances; Membranes, Artificial; Nuclear Envelope; Photochemical Processes; Polymers; RNA, Small Interfering | 2014 |
Ratiometric measurement of hydrogen sulfide and cysteine/homocysteine ratios using a dual-fluorophore fragmentation strategy.
Topics: 4-Chloro-7-nitrobenzofurazan; Chemistry Techniques, Analytical; Coumarins; Cysteine; Fluorescent Dyes; Homocysteine; Hydrogen Sulfide; Hymecromone; Oxadiazoles; Oxidation-Reduction; Spectrometry, Fluorescence | 2014 |
Metabolites identification of glycycoumarin, a major bioactive coumarin from licorice in rats.
Topics: Animals; Chromatography, Liquid; Coumarins; Glucuronidase; Glucuronides; Glycyrrhiza; Glycyrrhiza uralensis; Hydroxylation; Male; Mass Spectrometry; Microsomes, Liver; Rats; Rats, Sprague-Dawley | 2014 |
Quality assessment of Cinnamomi Ramulus by the simultaneous analysis of multiple active components using high-performance thin-layer chromatography and high-performance liquid chromatography.
Topics: Acrolein; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Cinnamates; Cinnamomum; Coumarins; Propanols; Quality Control | 2014 |
Studies on non-covalent interaction of coumarin attached pyrimidine and 1-methyl indole 1,2,3 triazole analogues with intermolecular telomeric G-quadruplex DNA using ESI-MS and spectroscopy.
Topics: Coumarins; DNA; G-Quadruplexes; Humans; Indoles; Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Spectrum Analysis; Telomere; Triazoles | 2014 |
Pteryxin: a coumarin in Peucedanum japonicum Thunb leaves exerts antiobesity activity through modulation of adipogenic gene network.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiponectin; Animals; Apiaceae; Coumarins; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Lipid Metabolism; Mice; Obesity; Phytotherapy; Plant Extracts; Plant Leaves; PPAR gamma; Sterol Esterase; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2014 |
Temperature insensitive fluorescence intensity in a coumarin monomer-aggregate coupled system.
Topics: Coumarins; Fluorescent Dyes; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2014 |
Effect of CYP2A6 genetic polymorphism on the metabolic conversion of tegafur to 5-fluorouracil and its enantioselectivity.
Topics: Cell Line; Coumarins; Cytochrome P-450 CYP2A6; DNA, Complementary; Escherichia coli; Fluorouracil; Humans; Microsomes, Liver; Nicotine; Polymorphism, Genetic; Sf9 Cells; Tegafur | 2014 |
A time-dependent density-functional theory and complete active space self-consistent field method study of vibronic absorption and emission spectra of coumarin.
Topics: Coumarins; Electrons; Quantum Theory; Specific Gravity; Vibration | 2014 |
[Study on extraction process of coumarin in a Mongolian drug Chagan-sorlo (Radix Glehniae)].
Topics: Apiaceae; Chromatography, High Pressure Liquid; Coumarins; Drugs, Chinese Herbal; Plant Roots; Solvents; Temperature; Ultrasonics | 2014 |
Performance of coumarin-derived dendrimer-based fluorescence-linked immunosorbent assay (FLISA) to detect malaria antigen.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Antibodies, Protozoan; Antigens, Protozoan; Coumarins; Dendrimers; Enzyme-Linked Immunosorbent Assay; Epitopes; Erythrocytes; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; Fluorometry; Humans; Immunoenzyme Techniques; Immunosorbent Techniques; L-Lactate Dehydrogenase; Malaria, Falciparum; Malaria, Vivax; Molecular Sequence Data; Parasitemia; Plasmodium; Plasmodium falciparum; Plasmodium vivax; Protozoan Proteins; Sensitivity and Specificity; Sequence Alignment; Sequence Homology, Amino Acid | 2014 |
Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolonged in vivo glucose-lowering ability.
Topics: Animals; Coumarins; Diabetes Mellitus, Type 2; Disease Models, Animal; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Tolerance Test; HEK293 Cells; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Liraglutide; Male; Mice, Inbred C57BL; Peptides; Rats, Sprague-Dawley; Receptors, Glucagon; Serum Albumin; Venoms | 2014 |
Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.
Topics: Coumarins; Humans; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Receptor, Adenosine A3; Spectrometry, Mass, Electrospray Ionization | 2014 |
Vertically π-expanded coumarin--synthesis via the Scholl reaction and photophysical properties.
Topics: Computer Simulation; Coumarins; Light; Materials Testing; Models, Chemical; Models, Molecular; Naphthalenes | 2014 |
Inorganic-organic hybrid nanoprobe for NIR-excited imaging of hydrogen sulfide in cell cultures and inflammation in a mouse model.
Topics: Animals; Carbocyanines; Coumarins; Disease Models, Animal; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Inflammation; Lipopolysaccharides; Luminescence; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Nanostructures; Nanotechnology; Shock, Septic; Signal Transduction; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared | 2014 |
Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents.
Topics: Antimalarials; Antineoplastic Agents; Cell Line, Tumor; Chalcone; Chemistry Techniques, Synthetic; Coumarins; Cysteine Endopeptidases; Humans; Molecular Docking Simulation; Plasmodium falciparum; Protein Conformation; Triazoles; Tubulin | 2014 |
Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Tacrine | 2014 |
Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Coumarins; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Structure-Activity Relationship; Tacrine | 2014 |
New limonoids from Hortia oreadica and unexpected coumarin from H. superba using chromatography over cleaning Sephadex with sodium hypochlorite.
Topics: Chromatography; Coumarins; Limonins; Plant Extracts; Rutaceae; Sodium Hypochlorite | 2014 |
Coumarins as turn on/off fluorescent probes for detection of residual acetone in cosmetics following headspace single-drop microextraction.
Topics: Acetone; Alcohols; Chromatography, Gas; Cosmetics; Coumarins; Ethanol; Fluorescent Dyes; Limit of Detection; Liquid Phase Microextraction; Microscopy, Fluorescence; Solvents; Spectrometry, Fluorescence; Temperature | 2014 |
Rapid, selective, and sensitive fluorometric detection of cyanide anions in aqueous media by cyanine dyes with indolium-coumarin linkages.
Topics: Anions; Carbocyanines; Coumarins; Fluorescent Dyes; Indoles; Nitriles; Quantum Theory; Spectrometry, Fluorescence; Water | 2014 |
Anticancer activity and DNA-binding investigations of the Cu(II) and Ni(II) complexes with coumarin derivative.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cattle; Cell Line, Tumor; Circular Dichroism; Coordination Complexes; Copper; Coumarins; DNA; DNA Cleavage; Hep G2 Cells; HL-60 Cells; Humans; Nickel | 2015 |
A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy.
Topics: Antineoplastic Agents; Cell Survival; Coumarins; Doxorubicin; Drug Delivery Systems; HeLa Cells; Humans; Hydrogen-Ion Concentration; Neoplasms; Prodrugs | 2014 |
Earthworm is a versatile and sustainable biocatalyst for organic synthesis.
Topics: Aldehydes; Animals; Catalysis; Chemistry Techniques, Synthetic; Complex Mixtures; Coumarins; Oligochaeta | 2014 |
Natural product polyamines that inhibit human carbonic anhydrases.
Topics: Antineoplastic Agents; Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Proliferation; Coumarins; Humans; Spermidine; Spermine; Structure-Activity Relationship | 2014 |
Synthesis and fluorescence study of naphthalimide-coumarin, naphthalimide-luminol conjugates.
Topics: Coumarins; Fluorescence; Fluorescent Dyes; Luminol; Magnetic Resonance Spectroscopy; Naphthalimides; Solvents; Spectrometry, Fluorescence | 2014 |
The coumarin-pterocarpan conjugate--a natural product inspired hybrid molecular probe for DNA recognition.
Topics: Biological Products; Coumarins; DNA; Models, Molecular; Molecular Probes; Molecular Structure; Pterocarpans; Temperature | 2014 |
Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Topics: Apoproteins; Chromatography, Gel; Coumarins; Cross-Linking Reagents; Crystallography, X-Ray; Deuterium; Fluorescence; Heme; Heme Oxygenase (Decyclizing); Humans; Kinetics; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Weight; Mutagenesis; Mutant Proteins; NADPH-Ferrihemoprotein Reductase; Oxidoreductases Acting on CH-CH Group Donors; Protein Binding; Surface Plasmon Resonance; Ultracentrifugation | 2014 |
Delivery of drugs from laminar co-extrudates manufactured by a solvent-free process at room temperature.
Topics: Administration, Cutaneous; Administration, Oral; Chemistry, Pharmaceutical; Coumarins; Dosage Forms; Drug Carriers; Drug Stability; Elastic Modulus; Kinetics; Microscopy, Electron, Scanning; Porosity; Solubility; Surface Properties; Technology, Pharmaceutical; Temperature | 2014 |
Photodegradable and size-tunable single-chain nanoparticles prepared from a single main-chain coumarin-containing polymer precursor.
Topics: Carbodiimides; Catalysis; Coumarins; Nanoparticles; Photolysis; Polyesters; Polymers; Propylene Glycols; Thiones; Ultraviolet Rays | 2014 |
A ratiometric fluorescent probe based on a coumarin-hemicyanine scaffold for sensitive and selective detection of endogenous peroxynitrite.
Topics: Biosensing Techniques; Colorimetry; Coumarins; Fluorescent Dyes; Peroxynitrous Acid; Spectrometry, Fluorescence | 2015 |
DNA cleavage, antibacterial, antifungal and anthelmintic studies of Co(II), Ni(II) and Cu(II) complexes of coumarin Schiff bases: synthesis and spectral approach.
Topics: Amines; Anthelmintics; Anti-Infective Agents; Carbon; Cobalt; Copper; Coumarins; DNA; DNA Cleavage; Hydrogen; Ligands; Microbial Sensitivity Tests; Models, Chemical; Nickel; Nitrogen; Schiff Bases; Spectrometry, Fluorescence; Spectrophotometry; Spectrophotometry, Infrared; Temperature | 2015 |
Total burden of intraplaque hemorrhage in coronary arteries relates to the use of coumarin-type anticoagulants but not platelet aggregation inhibitors.
Topics: Aged; Anticoagulants; Autopsy; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Coumarins; Female; Hemorrhage; Humans; Immunohistochemistry; Male; Middle Aged; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors | 2014 |
A thiazole coumarin (TC) turn-on fluorescence probe for AT-base pair detection and multipurpose applications in different biological systems.
Topics: Base Pairing; Carbocyanines; Cell Cycle; Coumarins; DNA; Flow Cytometry; Fluorescence; Fluorescent Dyes; HEK293 Cells; HeLa Cells; Humans; Molecular Imaging; Thiazoles | 2014 |
Microwave assisted convenient one-pot synthesis of coumarin derivatives via Pechmann condensation catalyzed by FeF3 under solvent-free conditions and antimicrobial activities of the products.
Topics: Anti-Infective Agents; Coumarins; Ferric Compounds; Fluorides; Microbial Sensitivity Tests; Microwaves; Solvents; Spectrum Analysis | 2014 |
Novel benzopsoralen analogues: synthesis, biological activity and molecular docking studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Coumarins; Cytochrome P-450 Enzyme System; Ficusin; Humans; Molecular Docking Simulation | 2014 |
[Analysis of variation of coumarin and volatile compounds in Angelica Dahuricae radix in different drying methods and conditions].
Topics: Angelica; Coumarins; Desiccation; Gas Chromatography-Mass Spectrometry; Hot Temperature; Principal Component Analysis; Volatile Organic Compounds | 2014 |
A ratiometric fluorescent probe for sensing HOCl based on a coumarin-rhodamine dyad.
Topics: Animals; Cell Line; Coumarins; Fluorescent Dyes; Hypochlorous Acid; Mice; Molecular Structure; Rhodamines; Spectrometry, Fluorescence | 2014 |
Selective catalytic behavior of a phosphine-tagged metal-organic framework organocatalyst.
Topics: Catalysis; Coumarins; Cycloaddition Reaction; Magnetic Resonance Spectroscopy; Organometallic Compounds; Phosphines; Thermodynamics | 2014 |
Rapid and quantitative detection of zoonotic influenza A virus infection utilizing coumarin-derived dendrimer-based fluorescent immunochromatographic strip test (FICT).
Topics: Animals; Birds; Chromatography, Affinity; Coumarins; Dendrimers; Fluorescence; Humans; Influenza A virus; Influenza in Birds; Influenza, Human; Nucleoproteins; Zoonoses | 2014 |
A coumarin-based two-photon probe for hydrogen peroxide.
Topics: Cell Line, Tumor; Coumarins; Fluorescent Dyes; Humans; Hydrogen Peroxide; Microscopy, Fluorescence, Multiphoton; Molecular Imaging; Neoplasms, Experimental | 2015 |
Computational design of a red fluorophore ligase for site-specific protein labeling in living cells.
Topics: Animals; Biocatalysis; Cell Survival; Chlorocebus aethiops; Computational Biology; COS Cells; Coumarins; Crystallography, X-Ray; Fluorescent Dyes; Green Fluorescent Proteins; HEK293 Cells; HeLa Cells; Humans; Imaging, Three-Dimensional; Ligases; Microscopy, Electron; Models, Molecular; Mutagenesis; Oxazines; Rats; Staining and Labeling | 2014 |
Coumarin-based fluorogenic probes for no-wash protein labeling.
Topics: Coumarins; Fluorescent Dyes; Proteins | 2014 |
Use of coumarin anticoagulants and cerebral microbleeds in the general population.
Topics: Anticoagulants; Cerebral Hemorrhage; Coumarins; Cross-Sectional Studies; Female; Humans; Male; Microcirculation; Middle Aged; Netherlands; Population Surveillance | 2014 |
Arsenite oxidation-enhanced photocatalytic degradation of phenolic pollutants on platinized TiO2.
Topics: Adsorption; Arsenites; Benzhydryl Compounds; Catalysis; Chlorophenols; Coumarins; Environment; Hydrogen-Ion Concentration; Hydroxyl Radical; Kinetics; Oxidation-Reduction; Phenols; Photoelectron Spectroscopy; Photolysis; Platinum; Time Factors; Titanium; Water Pollutants, Chemical | 2014 |
Determination of four flavorings in infant formula by solid-phase extraction and gas chromatography-tandem mass spectrometry.
Topics: Benzaldehydes; Coumarins; Flavoring Agents; Gas Chromatography-Mass Spectrometry; Humans; Infant Formula; Molecular Structure; Solid Phase Extraction | 2014 |
Coumarin-3-aldehyde as a scaffold for the design of tunable PET-modulated fluorescent sensors for neurotransmitters.
Topics: Aldehydes; Chromaffin Cells; Coloring Agents; Coumarins; Electron Transport; Fluorescent Dyes; Neurotransmitter Agents; Norepinephrine; Oxidation-Reduction; Positron-Emission Tomography; Quantum Theory; Spectrometry, Fluorescence | 2014 |
Micropatterned coumarin polyester thin films direct neurite orientation.
Topics: Animals; Astrocytes; Coumarins; Nerve Regeneration; Neurites; Polyesters; Polymers; Rats; Surface Properties; Wound Healing | 2014 |
Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Combinations; Drug Screening Assays, Antitumor; Female; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; MAP Kinase Kinase 1; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 3; Neoplasms; Nitric Oxide; Oxadiazoles; Signal Transduction | 2014 |
Rational design of coumarin-based supramolecular hydrogelators for cell imaging.
Topics: Animals; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hydrogels; Mice; Models, Molecular; Nanofibers; NIH 3T3 Cells; Optical Imaging | 2014 |
An iminocoumarin sulfonamide based turn-on fluorescent probe for the detection of biothiols in aqueous solution.
Topics: Coumarins; Crystallography, X-Ray; Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Humans; Microscopy, Fluorescence; Molecular Conformation; Quantum Theory; Spectrometry, Fluorescence; Sulfhydryl Compounds; Sulfonamides | 2015 |
Stabilization of AuNPs by monofunctional triazole linked to ferrocene, ferricenium, or coumarin and applications to synthesis, sensing, and catalysis.
Topics: Catalysis; Coumarins; Ferrous Compounds; Gold; Metal Nanoparticles; Metallocenes; Molecular Structure; Organogold Compounds; Particle Size; Surface Properties; Triazoles | 2014 |
Characterization of mixtures of compounds produced in chlorpromazine aqueous solutions by ultraviolet laser irradiation: their applications in antimicrobial assays.
Topics: Anti-Infective Agents; Biological Assay; Chlorpromazine; Chromatography, Liquid; Coumarins; Dimethyl Sulfoxide; Ethanol; Indoles; Isoindoles; Lasers; Mass Spectrometry; Microbial Sensitivity Tests; Oxygen; Singlet Oxygen; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Ultraviolet Rays; Zinc | 2015 |
Solvent effect on the fluorescence response of hydroxycoumarin bearing a dipicolylamine binding site to metal ions.
Topics: Acetonitriles; Amines; Binding Sites; Coumarins; Fluorescent Dyes; Metals; Picolinic Acids; Solvents; Spectrometry, Fluorescence; Water | 2014 |
A new turn-on chemosensor for bio-thiols based on the nanoaggregates of a tetraphenylethene-coumarin fluorophore.
Topics: Coumarins; Ethylenes; Fluorescent Dyes; Models, Chemical; Models, Molecular; Nanoconjugates; Particle Size; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2014 |
A coumarin-based fluorescent probe as a central nervous system disease biomarker.
Topics: Biomarkers; Biosensing Techniques; Coumarins; Fluorescent Dyes; Homocysteine; Humans; Methylmalonic Acid; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2014 |
Screening a strain of Aspergillus niger and optimization of fermentation conditions for degradation of aflatoxin B₁.
Topics: Aflatoxin B1; Aspergillus niger; Carcinogens, Environmental; Cell-Free System; China; Coumarins; Edible Grain; Fermentation; Food Contamination; Fungal Proteins; Hot Temperature; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Metals; Molecular Typing; Phylogeny; Species Specificity; Starch; Substrate Specificity | 2014 |
Polymeric microbubbles as delivery vehicles for sensitizers in sonodynamic therapy.
Topics: Animals; Cell Line; Cell Survival; Coumarins; Drug Delivery Systems; Female; HeLa Cells; Humans; Mice; Microbubbles; Molecular Structure; Ultrasonic Therapy; Ultrasonics; Uterine Neoplasms | 2014 |
Synthesis of fluorescent dye-doped silica nanoparticles for target-cell-specific delivery and intracellular microRNA imaging.
Topics: Aptamers, Nucleotide; Cell Line, Tumor; Coumarins; Diagnostic Imaging; Fluorescent Dyes; Humans; MCF-7 Cells; MicroRNAs; Nanoparticles; Neoplasms; Nucleolin; Oligodeoxyribonucleotides; Phosphoproteins; RNA-Binding Proteins; Silanes | 2015 |
Chemical composition and antioxidant activity of a polar extract of Thymelaea microphylla Coss. et Dur.
Topics: Coumarins; Flavonoids; Free Radical Scavengers; Glucosides; Molecular Structure; Phenols; Plant Components, Aerial; Plant Extracts; Plants, Medicinal; Thymelaeaceae | 2015 |
A new ester coumarin from Ferula Persica wild, indigenous to Iran.
Topics: Chemical Fractionation; Coumarins; Ferula; Iran; Molecular Structure; Plant Components, Aerial; Plant Extracts; Plant Roots | 2015 |
Interaction of coumarin with calf thymus DNA: deciphering the mode of binding by in vitro studies.
Topics: Animals; Cattle; Circular Dichroism; Coumarins; DNA; Models, Molecular; Nucleic Acid Conformation; Nucleic Acid Denaturation; Osmolar Concentration; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Viscosity | 2015 |
Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.
Topics: Antioxidants; Coumarins; Dose-Response Relationship, Drug; Glycine max; Lipoxygenase; Lipoxygenase Inhibitors; Molecular Structure; Structure-Activity Relationship | 2014 |
Extension of Drosophila lifespan by cinnamon through a sex-specific dependence on the insulin receptor substrate chico.
Topics: Acrolein; Animals; Cinnamomum zeylanicum; Coumarins; Drosophila melanogaster; Drosophila Proteins; Female; Fertility; HSP70 Heat-Shock Proteins; Insulin; Insulin Receptor Substrate Proteins; Longevity; Male; Mitochondria; Motor Activity; Sex Characteristics; Signal Transduction; Spices; Stress, Physiological | 2014 |
Visible light-induced nitric oxide release from a novel nitrobenzene derivative cross-conjugated with a coumarin fluorophore.
Topics: Cell Proliferation; Coumarins; Fluorescent Dyes; Free Radicals; HCT116 Cells; Humans; Light; Molecular Structure; Nitric Oxide; Nitrobenzenes; Photochemistry | 2014 |
A coumarin-indole based colorimetric and "turn on" fluorescent probe for cyanide.
Topics: Colorimetry; Coumarins; Cyanides; Drinking Water; Fluorescent Dyes; Indoles; Limit of Detection; Spectrometry, Fluorescence; Water Pollutants, Chemical | 2015 |
A new strategy to construct a FRET platform for ratiometric sensing of hydrogen sulfide.
Topics: Coumarins; Fluorescence Resonance Energy Transfer; Hydrogen Sulfide; Naphthalimides | 2015 |
Bifunctional Zn(II) complexes for recognition of non-canonical thymines in DNA bulges and G-quadruplexes.
Topics: Binding Sites; Calorimetry; Coordination Complexes; Coumarins; Cyclams; DNA; G-Quadruplexes; Heterocyclic Compounds; Nucleic Acid Conformation; Quinolines; Spectrometry, Fluorescence; Surface Plasmon Resonance; Thymine; Zinc | 2015 |
Oviposition deterrent activities of Pachyrhizus erosus seed extract and other natural products on Plutella xylostella (Lepidoptera: Plutellidae).
Topics: Animals; Brassica; Coumarins; Derris; Female; Insect Repellents; Moths; Oviposition; Pachyrhizus; Plant Extracts; Plant Leaves; Rotenone; Rutin | 2014 |
Characterization of typical potent odorants in cola-flavored carbonated beverages by aroma extract dilution analysis.
Topics: Acyclic Monoterpenes; Carbonated Beverages; Coumarins; Cyclohexanols; Eucalyptol; Eugenol; Gas Chromatography-Mass Spectrometry; Guaiacol; Humans; Indicator Dilution Techniques; Monoterpenes; Odorants; Olfactometry; Smell; Stereoisomerism | 2015 |
A straightforward method to determine flavouring substances in food by GC-MS.
Topics: Allylbenzene Derivatives; Anisoles; Benzyl Compounds; Beverages; Bicyclic Monoterpenes; Coumarins; Cyclohexane Monoterpenes; Dioxolanes; Eugenol; Flavoring Agents; Food Analysis; Gas Chromatography-Mass Spectrometry; Limit of Detection; Monoterpenes; Pyrogallol; Quality Control; Reproducibility of Results | 2015 |
Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats.
Topics: Animals; Biomarkers; Blood Glucose; Coumarins; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fasting; Glucose Tolerance Test; Glycation End Products, Advanced; Glycogen; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Liver; Male; Niacinamide; Oxidative Stress; Pancreas; Rats, Wistar; Streptozocin | 2014 |
Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.
Topics: Coumarins; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Drug Dosage Calculations; Ethnicity; Gene Frequency; Genotype; Humans; Inactivation, Metabolic; Mexico; Pharmacogenetics; Polymorphism, Single Nucleotide; Vitamin K Epoxide Reductases | 2015 |
Silver-mediated radical cyclization of alkynoates and α-keto acids leading to coumarins via cascade double C-C bond formation.
Topics: Catalysis; Coumarins; Cyclization; Keto Acids; Molecular Structure; Silver Compounds; Stereoisomerism | 2015 |
Coumarin 545: an emission reference dye with a record-low temperature coefficient for ratiometric fluorescence based temperature measurements.
Topics: Cold Temperature; Coumarins; Fluorescent Dyes; Spectrometry, Fluorescence; Temperature; Thermometers | 2015 |
Fluorescence spectroscopy as a tool for determination of coumarins by multivariate calibration.
Topics: Calibration; Coumarins; Hydrogen-Ion Concentration; Least-Squares Analysis; Linear Models; Multivariate Analysis; Solvents; Spectrometry, Fluorescence; Teas, Herbal | 2015 |
A general method to improve fluorophores for live-cell and single-molecule microscopy.
Topics: Azetidines; Chemistry Techniques, Synthetic; Coumarins; Fluorescein; Fluorescent Dyes; HeLa Cells; Humans; Microscopy, Ultraviolet; Models, Molecular; Molecular Imaging; Quantum Theory; Rhodamines; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2015 |
Cytotoxic activity and composition of petroleum ether extract from Magydaris tomentosa (Desf.) W. D. J. Koch (Apiaceae).
Topics: Alkanes; Animals; Apiaceae; Cell Death; Cell Line, Tumor; Cell Proliferation; Coumarins; Flowers; Gas Chromatography-Mass Spectrometry; Humans; Mice; Plant Extracts | 2015 |
New coumarin derivative from Euphorbia wallichii.
Topics: Coumarins; Euphorbia; Glyceraldehyde; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Quercetin | 2015 |
Untangling interactions of a zinc(II) complex containing a coumarin-porphyrin unit with alkaloids in water solutions: a photophysical study.
Topics: Caffeine; Cotinine; Coumarins; Ethanol; Fresh Water; Molecular Structure; Nicotine; Photochemical Processes; Porphyrins; Portugal; Solutions; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrum Analysis; Ultraviolet Rays; Zinc | 2015 |
A ratiometric fluorescent probe for gasotransmitter hydrogen sulfide based on a coumarin-benzopyrylium platform.
Topics: Benzopyrans; Cell Line; Cell Survival; Coumarins; Fluorescent Dyes; Gasotransmitters; Hepatic Stellate Cells; Humans; Hydrogen Sulfide; Optical Imaging | 2015 |
Real-time ratiometric fluorescent assay for alkaline phosphatase activity with stimulus responsive infinite coordination polymer nanoparticles.
Topics: Alkaline Phosphatase; Biological Assay; Coumarins; Enzyme Inhibitors; Fluorescent Dyes; Humans; Limit of Detection; Nanoparticles; Polymers; Spectrometry, Fluorescence; Terbium | 2015 |
Coumarin pretreatment alleviates salinity stress in wheat seedlings.
Topics: Antioxidants; Catalase; Chlorophyll; Coumarins; Flavonoids; Hydrogen Peroxide; Peroxidases; Phenols; Plant Leaves; Plant Proteins; Plant Roots; Potassium; Proline; Salinity; Salt Tolerance; Scopoletin; Seedlings; Sodium; Sodium Chloride; Stress, Physiological; Triticum | 2015 |
Long circulating micelles of an amphiphilic random copolymer bearing cell outer membrane phosphorylcholine zwitterions.
Topics: Animals; Cell Death; Cell Line; Cell Membrane; Coumarins; Fluorescence; Half-Life; Hydrodynamics; Ions; Male; Mice, Inbred BALB C; Micelles; Particle Size; Phagocytosis; Phosphorylcholine; Polymers; Rabbits; Scattering, Radiation; Static Electricity; Surface-Active Agents; Time Factors; Tissue Distribution | 2015 |
Evaluation of luminol chemiluminescence based on simultaneous introducing of coumarin derivatives as green fluorophores and chitosan-induced Au/Ag alloy nanoparticle as catalyst for the sensitive determination of glucose.
Topics: Alloys; Catalysis; Chitosan; Coumarins; Glucose; Gold; Hydrogen Peroxide; Hydrogen-Ion Concentration; Limit of Detection; Luminescent Measurements; Luminol; Metal Nanoparticles; Silver; Succinic Acid | 2015 |
A new turn on Pd(2+)-specific fluorescence probe and its use as an imaging reagent for cellular uptake in Hct116 cells.
Topics: Coumarins; Fluorescent Dyes; HCT116 Cells; Humans; Lead; Rhodamines | 2015 |
Bioactivity-guided fast screen and identification of cancer metastasis chemopreventive components from raw extracts of Murraya exotica.
Topics: Cell Line, Tumor; Chemoprevention; Chromatography, High Pressure Liquid; Coumarins; HT29 Cells; Humans; Liquid-Liquid Extraction; Murraya; Neoplasm Metastasis; Neoplasms; Plant Extracts; Plant Leaves; Plant Roots; Spectrometry, Mass, Electrospray Ionization | 2015 |
Bacterial autoinducer-2 detection via an engineered quorum sensing protein.
Topics: Bacterial Proteins; Biosensing Techniques; Coumarins; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Healthy Volunteers; Homoserine; Humans; Lactones; Protein Conformation; Protein Engineering; Quorum Sensing; Recombinant Fusion Proteins; Saliva | 2015 |
Enhanced NIR radiation-triggered hyperthermia by mitochondrial targeting.
Topics: Animals; Biological Transport; Cell Transformation, Neoplastic; Coumarins; Ferric Compounds; HeLa Cells; Humans; Hyperthermia, Induced; Infrared Rays; Intracellular Space; Mice; Mice, Inbred BALB C; Mitochondria; Nanomedicine; Nanoparticles | 2015 |
Deciphering the role of coumarin as a novel quorum sensing inhibitor suppressing virulence phenotypes in bacterial pathogens.
Topics: Acyl-Butyrolactones; Anti-Bacterial Agents; Biofilms; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Phenotype; Pseudomonas aeruginosa; Quorum Sensing | 2015 |
Bichromophoric dyes for wavelength shifting of dye-protein fluoromodules.
Topics: Benzothiazoles; Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Light; Microscopy, Confocal; Proteins; Quinolines; Saccharomyces cerevisiae; Spectrophotometry, Ultraviolet | 2015 |
A new fluorogenic probe for the selective detection of carbon monoxide in aqueous medium based on Pd(0) mediated reaction.
Topics: Carbon Monoxide; Cell Line, Tumor; Coumarins; Cyclization; Fluorescent Dyes; Humans; Lead; Microscopy, Fluorescence; Reactive Nitrogen Species; Reactive Oxygen Species; Spectrometry, Fluorescence; Sulfur Compounds; Water | 2015 |
Purine homo-N-nucleoside+coumarin hybrids as pleiotropic agents for the potential treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Coumarins; Glycine max; Humans; Hypolipidemic Agents; Lipoxygenase; Lipoxygenase Inhibitors; Molecular Structure; Nucleosides; Purines; Structure-Activity Relationship | 2015 |
Restriction of molecular twisting on a gold nanoparticle surface.
Topics: Coumarins; Gold; Luminescent Agents; Metal Nanoparticles; Surface Properties | 2015 |
Cyclic adenosine 5'-diphosphoribose (cADPR) mimics used as molecular probes in cell signaling.
Topics: Animals; Calcium; Calcium Signaling; Coumarins; Cyclic ADP-Ribose; HeLa Cells; Humans; Inosine Monophosphate; Jurkat Cells; Mice; Molecular Mimicry; Molecular Probes; Myocytes, Cardiac; PC12 Cells; Rats; Structure-Activity Relationship | 2015 |
Coumarin-BODIPY hybrids by heteroatom linkage: versatile, tunable and photostable dye lasers for UV irradiation.
Topics: Boron Compounds; Coumarins; Electrochemical Techniques; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Ultraviolet Rays | 2015 |
[Intracranial hypertension and jugular vein thrombosis].
Topics: Acetazolamide; Adult; Anticoagulants; Carbonic Anhydrase Inhibitors; Coumarins; Diagnosis, Differential; Diplopia; Humans; Jugular Veins; Male; Optic Nerve Diseases; Pseudotumor Cerebri; Treatment Outcome; Venous Thrombosis | 2015 |
A kinetic study of the main guaco metabolites using syrup formulation and the identification of an alternative route of coumarin metabolism in humans.
Topics: Administration, Oral; Adult; Coumarins; Drug Combinations; Drug Evaluation, Preclinical; Female; Humans; Male; Mikania; Plant Extracts; Respiratory System Agents; Umbelliferones; Young Adult | 2015 |
Synthesis of bifunctional molecules containing [12]aneN3 and coumarin moieties as effective DNA condensation agents and new non-viral gene vectors.
Topics: Cell Line, Tumor; Click Chemistry; Coumarins; DNA; Green Fluorescent Proteins; Humans; Macrocyclic Compounds; Plasmids; Polyamines; Transfection | 2015 |
DAW22, a natural sesquiterpene coumarin isolated from Ferula ferulaeoides (Steud.) Korov. that induces C6 glioma cell apoptosis and endoplasmic reticulum (ER) stress.
Topics: Animals; Apoptosis; Cell Line, Tumor; Coumarins; Endoplasmic Reticulum Stress; Ferula; Glioma; Mice; Molecular Docking Simulation; Plant Roots; Sesquiterpenes; Unfolded Protein Response | 2015 |
A novel cytochrome P450 CYP6AB14 gene in Spodoptera litura (Lepidoptera: Noctuidae) and its potential role in plant allelochemical detoxification.
Topics: Amino Acid Sequence; Animals; Coumarins; Cytochrome P-450 Enzyme System; Digestive System; Enzyme Induction; Flavones; Insect Proteins; Larva; Methoxsalen; Molecular Sequence Data; Pheromones; RNA Interference; RNA, Double-Stranded; Spodoptera | 2015 |
A ratiometric fluorescent probe for in situ quantification of basal mitochondrial hypochlorite in cancer cells.
Topics: Animals; Cell Line; Coumarins; Fluorescent Dyes; Humans; Hypochlorous Acid; Mice; Mitochondria; Rhodamines | 2015 |
Investigation of (E)-3-[4-(2-Oxo-3-aryl-chromen-4-yl)oxyphenyl]acrylic Acids as Oral Selective Estrogen Receptor Down-Regulators.
Topics: Administration, Oral; Animals; Cell Line, Tumor; Coumarins; Down-Regulation; Estrogen Receptor alpha; Humans; Molecular Docking Simulation; Rats; Umbelliferones | 2015 |
Biology-oriented synthesis of benzopyrano[3,4-c]pyrrolidines.
Topics: Azo Compounds; Benzopyrans; Coumarins; Cycloaddition Reaction; Pyrrolidines; Silver; Thiosemicarbazones | 2015 |
Photoprotective effect of coumarin and 3-hydroxycoumarin in sea urchin gametes and embryonic cells.
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Female; Male; Ovum; Protective Agents; Radiation-Protective Agents; Sea Urchins; Spermatozoa; Ultraviolet Rays; Umbelliferones; Zygote | 2015 |
Structure-assisted ligand-binding analysis using fluorogenic photoaffinity labeling.
Topics: Allosteric Regulation; Chromatography, High Pressure Liquid; Coumarins; Glutamate Dehydrogenase; Ligands; Photoaffinity Labels; Substrate Specificity; Tandem Mass Spectrometry; Ultraviolet Rays | 2015 |
Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cell Survival; Coumarins; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase 1; Dose-Response Relationship, Drug; Fibrinolytic Agents; Guinea Pigs; Humans; Male; Molecular Docking Simulation; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Quantitative Structure-Activity Relationship; Rats; Rats, Wistar | 2015 |
Zinc complexes containing coumarin-derived anilido-aldimine ligands as catalysts for ring opening polymerization of L-lactide.
Topics: Aniline Compounds; Catalysis; Coordination Complexes; Coumarins; Dioxanes; Ligands; Magnetic Resonance Spectroscopy; Molecular Structure; Polymerization; Zinc | 2015 |
Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Benzopyrans; Blood-Brain Barrier; Brain; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Coumarins; Drug Design; Erythrocytes; Humans; Kinetics; Models, Molecular; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Piperazines; Tacrine | 2015 |
Sesquiterpene coumarins from seeds of Ferula sinkiangensis.
Topics: Antineoplastic Agents, Phytogenic; Coumarins; Ferula; HeLa Cells; Humans; K562 Cells; Molecular Structure; Seeds; Sesquiterpenes | 2015 |
An organophosphorus hydrolase-based biosensor for direct detection of paraoxon using silica-coated magnetic nanoparticles.
Topics: Aryldialkylphosphatase; Bacterial Proteins; Biosensing Techniques; Coumarins; Magnetite Nanoparticles; Paraoxon; Pseudomonas; Silicon Dioxide | 2015 |
Coumarin-fused coumarin: antioxidant story from N,N-dimethylamino and hydroxyl groups.
Topics: Amidines; Antioxidants; Copper; Coumarins; DNA; Free Radical Scavengers; Free Radicals; Glutathione; Hydroxyl Radical; Oxidants; Oxidation-Reduction | 2015 |
BK/TD models for analyzing in vitro impedance data on cytotoxicity.
Topics: Animal Testing Alternatives; Animals; Benzophenones; Cell Survival; Chemical and Drug Induced Liver Injury; Cosmetics; Coumarins; Dose-Response Relationship, Drug; Electric Impedance; Eugenol; Hep G2 Cells; Humans; Kinetics; Linear Models; Models, Biological; Reproducibility of Results; Risk Assessment; Toxicity Tests; Toxicokinetics | 2015 |
Visible-light initiated oxidative cyclization of phenyl propiolates with sulfinic acids to coumarin derivatives under metal-free conditions.
Topics: Catalysis; Coumarins; Cyclization; Eosine Yellowish-(YS); Light; Oxidation-Reduction; Palladium; Phenylpropionates; Sulfinic Acids; Temperature | 2015 |
Coumarin sharing the benzene ring with quinoline for quenching radicals and inhibiting DNA oxidation.
Topics: Benzene; Coumarins; DNA; Free Radical Scavengers; Oxidation-Reduction; Quinolines | 2015 |
Water-soluble phosphorescent ruthenium complex with a fluorescent coumarin unit for ratiometric sensing of oxygen levels in living cells.
Topics: Cell Hypoxia; Cell Line, Tumor; Coordination Complexes; Coumarins; Epithelial Cells; Fluorescent Dyes; Humans; Luminescent Measurements; Molecular Probe Techniques; Molecular Probes; Molecular Structure; Oxygen; Ruthenium; Solubility; Water | 2015 |
Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence.
Topics: Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Humans; Kinetics; Kynuramine; Models, Biological; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phytotherapy; Plant Components, Aerial; Plant Extracts; Plants, Medicinal; Recombinant Proteins; Tobacco Use Disorder; Vernonia | 2015 |
A highly selective fluorescent sensor for glucosamine.
Topics: Aldehydes; Boronic Acids; Coumarins; Fluorescent Dyes; Glucosamine; Molecular Structure | 2015 |
A ratiometric fluorescence sensor for Fe(3+) based on FRET and PET processes.
Topics: Coumarins; Ferric Compounds; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Molecular Structure; Positron-Emission Tomography; Rhodamines | 2016 |
A colorimetric and fluorescent probe for detecting intracellular GSH.
Topics: Biosensing Techniques; Cell Survival; Colorimetry; Coumarins; Fluorescent Dyes; Glutathione; HEK293 Cells; HeLa Cells; Humans; Optical Imaging; Spectrometry, Fluorescence | 2015 |
Synthesis of a new class of furo[3,2-c]coumarins and its anticancer activity.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Coumarins; DNA; Humans; Kinetics; MCF-7 Cells; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Serum Albumin, Bovine | 2015 |
Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Coumarins; Dendrimers; Drug Carriers; Humans; Irinotecan; Molecular Dynamics Simulation; Nanostructures | 2015 |
Stereoselective construction of functionalized tetracyclic and pentacyclic coumarinopyranpyrazole/pyrimidinedione/coumarin scaffolds using a solid-state melt reaction.
Topics: Catalysis; Coumarins; Hot Temperature; Molecular Structure; Polycyclic Compounds; Pyrazoles; Pyrimidinones; Stereoisomerism | 2015 |
A coumarin-based fluorescent turn-on probe for detection of biothiols in vitro.
Topics: Cell Line; Cells; Coumarins; Fluorescent Dyes; Humans; Limit of Detection; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2015 |
Study on DNA binding behavior and light switch effect of new coumarin-derived Ru(II) complexes.
Topics: 2,2'-Dipyridyl; Animals; Cattle; Coumarins; DNA; DNA Cleavage; Intercalating Agents; Light; Organometallic Compounds; Phenanthrolines; Photolysis; Ruthenium | 2015 |
Heavy atom quenched coumarin probes for sensitive and selective detection of biothiols in living cells.
Topics: Bromine; Cell Survival; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Iodine; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2015 |
Fluorescence labeling of carbonylated lipids and proteins in cells using coumarin-hydrazide.
Topics: Animals; Cells, Cultured; Chromatography, Thin Layer; Coumarins; Fluorescent Dyes; Humans; Hydrazines; Immunohistochemistry; Mice; Microscopy, Fluorescence; Oxidative Stress; Paraquat; Phospholipids; Protein Carbonylation; Proteins; Rats; Tandem Mass Spectrometry | 2015 |
Discrimination between streptavidin and avidin with fluorescent affinity-based probes.
Topics: Animals; Avidin; Cattle; Coumarins; Electron Transport; Fluorescent Dyes; HeLa Cells; Humans; Streptavidin | 2015 |
A colorimetric and ratiometric fluorescent probe for selective detection and cellular imaging of glutathione.
Topics: Colorimetry; Coumarins; Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Homocysteine; Humans; Microscopy, Fluorescence; Optical Imaging; Spectrometry, Fluorescence | 2015 |
Structural Insights into Substrate Specificity of Feruloyl-CoA 6'-Hydroxylase from Arabidopsis thaliana.
Topics: Arabidopsis; Arabidopsis Proteins; Binding Sites; Biocatalysis; Coumarins; Crystallography, X-Ray; Dioxygenases; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Oxygenases; Protein Structure, Tertiary; Substrate Specificity | 2015 |
Light up ClO(-) in live cells using an aza-coumarin based fluorescent probe with fast response and high sensitivity.
Topics: Animals; Aza Compounds; Cell Survival; Color; Coumarins; Drug Design; Fluorescent Dyes; Humans; Hypochlorous Acid; Limit of Detection; MCF-7 Cells; Mice; Microscopy, Fluorescence; RAW 264.7 Cells; Time Factors | 2015 |
Synthesis, spectral, thermal, fluorescence, antimicrobial, anthelmintic and DNA cleavage studies of mononuclear metal chelates of bi-dentate 2H-chromene-2-one Schiff base.
Topics: Animals; Anthelmintics; Anti-Infective Agents; Antifungal Agents; Cattle; Cobalt; Coordination Complexes; Copper; Coumarins; DNA; DNA Cleavage; Electron Spin Resonance Spectroscopy; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetics; Nickel; Oligochaeta; Schiff Bases; Spectrometry, Fluorescence | 2015 |
Potential antibacterial activity of coumarin and coumarin-3-acetic acid derivatives.
Topics: Acetates; Anti-Bacterial Agents; Bacillus subtilis; Coumarins; Escherichia coli; Microbial Sensitivity Tests; Shigella sonnei; Staphylococcus aureus | 2015 |
Coumarin-Based Turn-On Fluorescence Probe for Specific Detection of Glutathione over Cysteine and Homocysteine.
Topics: Coumarins; Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Homocysteine; Humans; Hydrogen-Ion Concentration; Optical Imaging | 2015 |
[Chemical constituents from stems of Clausena excavata].
Topics: Carbazoles; Clausena; Coumarins; Glucosides; Phytochemicals; Plant Stems; Umbelliferones | 2014 |
Anticoagulant activity of some Artemisia dracunculus leaf extracts.
Topics: Anticoagulants; Artemisia; Blood; Blood Physiological Phenomena; Coumarins; Humans; In Vitro Techniques; International Normalized Ratio; Plant Extracts; Plant Leaves; Prothrombin Time; Whole Blood Coagulation Time | 2015 |
Exploring carbonic anhydrase inhibition with multimeric coumarins displayed on a fullerene scaffold.
Topics: Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Coumarins; Fullerenes; Humans | 2015 |
Hydrogen sulfide mediated cascade reaction forming an iminocoumarin: applications in fluorescent probe development and live-cell imaging.
Topics: Cell Survival; Chromatography, High Pressure Liquid; Coumarins; Crystallography, X-Ray; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; Imaging, Three-Dimensional; Kinetics; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared | 2015 |
External and Intraparticle Diffusion of Coumarin 102 with Surfactant in the ODS-silica Gel/water System by Single Microparticle Injection and Confocal Fluorescence Microspectroscopy.
Topics: Absorption, Physicochemical; Coumarins; Diffusion; Injections; Kinetics; Microscopy, Confocal; Microscopy, Fluorescence; Microspheres; Silica Gel; Surface-Active Agents; Water | 2015 |
Coumarin-containing-star-shaped 4-arm-polyethylene glycol: targeted fluorescent organic nanoparticles for dual treatment of photodynamic therapy and chemotherapy.
Topics: Antineoplastic Agents; Chlorambucil; Coumarins; Drug Delivery Systems; HeLa Cells; Humans; Molecular Structure; Nanoparticles; Photochemotherapy; Polyethylene Glycols | 2015 |
Ratiometric Molecular Probes Based on Dual Emission of a Blue Fluorescent Coumarin and a Red Phosphorescent Cationic Iridium(III) Complex for Intracellular Oxygen Sensing.
Topics: Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Iridium; MCF-7 Cells; Microscopy, Fluorescence; Molecular Probes; Oxygen | 2015 |
Synthesis of 8-hydroxy-2-iminochromene derivatives as selective and potent inhibitors of human carbonyl reductase 1.
Topics: Alcohol Oxidoreductases; Animals; Aorta; Benzopyrans; Cattle; Cell Survival; Coumarins; Endothelial Cells; Enzyme Inhibitors; Humans; Imines; Molecular Dynamics Simulation; Mutation | 2015 |
Molecular Dynamics Guided Receptor Independent 4D QSAR Studies of Substituted Coumarins as Anticancer Agents.
Topics: Antineoplastic Agents; Coumarins; Drug Design; Humans; Least-Squares Analysis; Mitogen-Activated Protein Kinase 8; Molecular Docking Simulation; Molecular Dynamics Simulation; Neoplasms; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Static Electricity | 2015 |
A single-molecule digital enzyme assay using alkaline phosphatase with a cumarin-based fluorogenic substrate.
Topics: Alkaline Phosphatase; Coumarins; Enzyme Assays; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Fluorescent Dyes; Galactosides; Models, Molecular; Optical Imaging; Oxazines | 2015 |
Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.
Topics: Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Dogs; Drug Design; Humans; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Permeability; Protein Conformation; Rats; Structure-Activity Relationship | 2015 |
Uses of 3-(2-Bromoacetyl)-2H-chromen-2-one in the Synthesis of Heterocyclic Compounds Incorporating Coumarin: Synthesis, Characterization and Cytotoxicity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Screening Assays, Antitumor; Humans; Neoplasms; Pyrans; Structure-Activity Relationship; Thiazoles | 2015 |
Design of Environmentally Responsive Fluorescent Polymer Probes for Cellular Imaging.
Topics: Acrylamides; Acrylic Resins; Cell Tracking; Coumarins; Fluorescein; Fluorescent Dyes; Hydrogen-Ion Concentration; Molecular Imaging; Phase Transition; Phosphatidylcholines; Polymers; Rhodamines; Temperature | 2015 |
Novel macromolecules derived from coumarin: synthesis and antioxidant activity.
Topics: 4-Hydroxycoumarins; Antioxidants; Coumarins; Free Radical Scavengers; Hydrogen Peroxide; Magnetic Resonance Spectroscopy; Molecular Structure; Oxidation-Reduction; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2015 |
Tetrapeptide-coumarin conjugate 3D networks based on hydrogen-bonded charge transfer complexes: gel formation and dye release.
Topics: Coumarins; Fluorescent Dyes; Gels; Hydrogen; Hydrogen Bonding; Nanostructures; Peptides; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Broadband Light-Harvesting Molecular Triads with High FRET Efficiency Based on the Coumarin-Rhodamine-BODIPY Platform.
Topics: Boron Compounds; Coumarins; Fluorescence Resonance Energy Transfer; Light; Photochemistry; Pyrroles; Rhodamines | 2015 |
Cooperativity between various types of polar solute-solvent interactions in aqueous media.
Topics: Amino Acids; Benzaldehydes; Benzyl Alcohol; Coumarins; Dextrans; Glucosides; Linear Models; Phenol; Phenylethyl Alcohol; Polyethylene Glycols; Povidone; Solvents; Water | 2015 |
A highly selective and sensitive ON-OFF-ON fluorescence chemosensor for cysteine detection in endoplasmic reticulum.
Topics: Biosensing Techniques; Cell Line; Copper; Coumarins; Cysteine; Endoplasmic Reticulum; Equipment Design; Equipment Failure Analysis; Humans; Molecular Probe Techniques; Molecular Probes; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2015 |
Photodimerisation of a coumarin-dipeptide gelator.
Topics: Coumarins; Dimerization; Dipeptides; Gels; Photochemical Processes | 2015 |
Uncovering previously undetected metabolites using modern bioanalytical tools.
Topics: Chromatography, High Pressure Liquid; Coumarins; Data Mining; Mass Spectrometry; Pharmaceutical Preparations; Software | 2015 |
How does bile salt penetration affect the self-assembled architecture of pluronic P123 micelles?--light scattering and spectroscopic investigations.
Topics: Coumarins; Dynamic Light Scattering; Micelles; Microscopy, Electron, Transmission; Poloxalene; Rhodamines; Spectrometry, Fluorescence | 2015 |
Novel coumarin-based fluorescent probe for selective detection of Cu(II).
Topics: Cations, Divalent; Copper; Coumarins; Fluorescence; Fluorescent Dyes; Models, Molecular; Spectrometry, Fluorescence | 2016 |
Photolabile protection for amino acids: studies on the release from novel benzoquinolone cages.
Topics: Alanine; Amino Acids; Benzoquinones; Chromatography, High Pressure Liquid; Coumarins; Esters; Glutamic Acid; Light; Magnetic Resonance Spectroscopy; Molecular Structure; Phenylalanine; Photochemical Processes; Photolysis; Quinolones; Solvents; Spectrophotometry, Ultraviolet; Temperature | 2015 |
The influence of naphthaleneacetic acid (NAA) and coumarin on flavonoid production by fungus Phellinus sp.: modeling of production kinetic profiles.
Topics: Basidiomycota; Bioreactors; Coumarins; Flavonoids; Glucose; Kinetics; Models, Theoretical; Naphthaleneacetic Acids | 2015 |
Controlled intracellular generation of reactive oxygen species in human mesenchymal stem cells using porphyrin conjugated nanoparticles.
Topics: Apoptosis; Cell Line; Coumarins; Humans; Hydrogen Peroxide; Mesenchymal Stem Cells; Nanoparticles; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Zinc | 2015 |
Has endoscopic (TEP, TAPP) or open inguinal hernia repair a higher risk of bleeding in patients with coagulopathy or antithrombotic therapy? Data from the Herniamed Registry.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Austria; Blood Coagulation Disorders; Comorbidity; Coumarins; Dissection; Female; Germany; Hernia, Inguinal; Herniorrhaphy; Humans; International Normalized Ratio; Laparoscopy; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Recurrence; Registries; Reoperation; Risk; Risk Factors; Switzerland; Wound Healing | 2016 |
Retro-inverso bradykinin opens the door of blood-brain tumor barrier for nanocarriers in glioma treatment.
Topics: Actins; Animals; Antineoplastic Agents; Blood-Brain Barrier; Bradykinin; Brain Neoplasms; Capillary Permeability; Coumarins; Drug Carriers; Drug Synergism; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Micelles; Nanoparticles; Protein Transport; Xenograft Model Antitumor Assays; Zonula Occludens-1 Protein | 2015 |
Novel Coumarin-Containing Aminophosphonatesas Antitumor Agent: Synthesis, Cytotoxicity, DNA-Binding and Apoptosis Evaluation.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspases; Cattle; Cell Cycle; Cell Line, Tumor; Circular Dichroism; Coumarins; Cytochromes c; DNA; Humans; Kinetics; Organophosphonates; Spectrometry, Fluorescence | 2015 |
An Injectable PEG-BSA-Coumarin-GOx Hydrogel for Fluorescence Turn-on Glucose Detection.
Topics: Animals; Cattle; Coumarins; Enzymes, Immobilized; Glucose; Glucose Oxidase; Humans; Hydrogels; Polyethylene Glycols; Serum Albumin, Bovine | 2015 |
A Bio-Inspired, Catalytic E → Z Isomerization of Activated Olefins.
Topics: Alkenes; Biomimetics; Catalysis; Coumarins; Cyclization; Riboflavin; Stereoisomerism | 2015 |
An effective colorimetric and ratiometric fluorescent probe for bisulfite in aqueous solution.
Topics: Cell Line; Colorimetry; Coumarins; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Optical Imaging; Sulfites; Water | 2015 |
Biogas production from coumarin-rich plants--inhibition by coumarin and recovery by adaptation of the bacterial community.
Topics: Adaptation, Physiological; Anaerobiosis; Biofuels; Bioreactors; Coumarins; Euryarchaeota; Fermentation; Manure; Melilotus; Methanomicrobiaceae; Methanosarcina; Silage | 2015 |
A new coumarin isolated from Sarcandra glabra as potential anti-inflammatory agent.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Coumarins; Lipopolysaccharides; Macrophages; Magnoliopsida; Mice; Molecular Structure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; RAW 264.7 Cells | 2016 |
Effects of substituents on fluorometric detection of cyanide anions by indolium-coumarin dyads.
Topics: Anions; Coumarins; Cyanides; Fluorescent Dyes; Indoles; Kinetics; Magnetic Resonance Spectroscopy; Quantum Theory; Spectrometry, Fluorescence | 2015 |
Modulation of the aggregation properties of sodium deoxycholate in presence of hydrophilic imidazolium based ionic liquid: water dynamics study to probe the structural alteration of the aggregates.
Topics: Coumarins; Deoxycholic Acid; Hydrophobic and Hydrophilic Interactions; Imidazoles; Ionic Liquids; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Pyrenes; Water | 2015 |
Design of a novel coumarin-based multifunctional fluorescent probe for Zn²⁺/Cu²⁺/S²⁻ in aqueous solution.
Topics: Copper; Coumarins; Environmental Monitoring; Fluorescent Dyes; Molecular Probe Techniques; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Sulfur; Water; Water Pollutants, Chemical; Zinc | 2015 |
Colorimetric and fluorescence detection of G-quadruplex nucleic acids with a coumarin-benzothiazole probe.
Topics: Benzothiazoles; Cell Nucleolus; Chromatin Immunoprecipitation; Colorimetry; Coumarins; DNA, Ribosomal; Fluorescence; Fluorescent Dyes; G-Quadruplexes; HeLa Cells; Humans; Microscopy, Fluorescence; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Surface Plasmon Resonance | 2015 |
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization.
Topics: Coumarins; Dose-Response Relationship, Drug; Drug Design; Fluorescent Dyes; Humans; Ligands; Melatonin; Molecular Imaging; Molecular Structure; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Structure-Activity Relationship | 2015 |
Spectral Switching of Naphthalimide-Coumarin Induced by F-.
Topics: Coumarins; Fluorine; Naphthalimides; Spectrophotometry | 2015 |
A fast-responsive fluorescent probe for sulfite and its bioimaging.
Topics: Coumarins; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Molecular Structure; Solubility; Spectrometry, Fluorescence; Sulfites; Sulfur Dioxide; Time Factors; Tumor Cells, Cultured | 2016 |
Acenocoumarol Pharmacogenetic Dosing Algorithms and Their Application in Two Bulgarian Patients with Low Anticoagulant Requirements.
Topics: Acenocoumarol; Algorithms; Anticoagulants; Aortic Valve; Bulgaria; Coumarins; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Middle Aged; Mitral Valve; Pharmacogenetics; Polymorphism, Single Nucleotide; Thromboembolism | 2015 |
Study of Microheterogeneity in Acetonitrile-Water Binary Mixtures by using Polarity-Resolved Solvation Dynamics.
Topics: Acetonitriles; Coumarins; Dimethyl Sulfoxide; Models, Molecular; Solvents; Spectrometry, Fluorescence; Spectrophotometry, Infrared; Water | 2015 |
Site Covalent Modification of Methionyl Peptides for the Production of FRET Complexes.
Topics: Alkylation; Amino Acids; Biological Phenomena; Coumarins; Europium; Lanthanoid Series Elements; Magnetic Resonance Spectroscopy; Methionine; Peptides; Peptides, Cyclic; Photons | 2015 |
Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thiourea | 2015 |
Investigation of binding mechanism of novel 8-substituted coumarin derivatives with human serum albumin and α-1-glycoprotein.
Topics: Circular Dichroism; Coumarins; Humans; Ligands; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Orosomucoid; Protein Binding; Serum Albumin; Spectrometry, Fluorescence; Structure-Activity Relationship | 2016 |
Red/NIR G-Quadruplex Sensing, Harvesting Blue Light by a Coumarin-Naphthalene Diimide Dyad.
Topics: Coumarins; DNA; Fluorescent Dyes; G-Quadruplexes; Imides; Light; Naphthalenes; RNA; Spectrometry, Fluorescence | 2015 |
Utilization of the Heavy Atom Effect for the Development of a Photosensitive 8-Azacoumarin-Type Photolabile Protecting Group.
Topics: Aza Compounds; Coumarins; Molecular Structure; Photolysis; Sulfonamides | 2015 |
Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Topics: Antineoplastic Agents; Cell Cycle; Cell Death; Cell Line; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; MCF-7 Cells; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship | 2015 |
Synthesis, and Fluorescence Properties of Coumarin and Benzocoumarin Derivatives Conjugated Pyrimidine Scaffolds for Biological Imaging Applications.
Topics: Chemistry Techniques, Synthetic; Coumarins; Fluorescent Dyes; Optical Imaging; Pyrimidines; Rhodamines; Spectrometry, Fluorescence | 2015 |
3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Coumarins; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Protein Binding; Rats | 2015 |
Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients.
Topics: Adult; Carcinoma, Hepatocellular; Coumarins; Cytochrome P-450 Enzyme System; Female; Gene Expression Regulation, Neoplastic; Hepatitis B virus; Humans; Inactivation, Metabolic; Liver Neoplasms; Male; Microsomes, Liver; Middle Aged; Precision Medicine; RNA, Messenger | 2015 |
Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
Topics: Animals; Antioxidant Response Elements; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Luciferases; Male; Mice; Mice, Inbred C57BL; Models, Animal; Molecular Structure; NF-E2-Related Factor 2; Oxidative Stress; Oximes; Structure-Activity Relationship; Tumor Cells, Cultured | 2015 |
Paratrimerins A and B, Two New Dimeric Monoterpene-Linked Coumarin Glycosides from the Roots and Stems of Paramignya trimera.
Topics: Coumarins; Glycosides; Monoterpenes; Plant Roots; Plant Stems; Rutaceae | 2015 |
Estimation of ground and excited state dipole moment of laser dyes C504T and C521T using solvatochromic shifts of absorption and fluorescence spectra.
Topics: Coumarins; Electrons; Fluorescence; Hydrogen Bonding; Lasers, Dye; Models, Molecular; Spectrometry, Fluorescence | 2016 |
Development of surface immobilized 3-azidocoumarin-based fluorogenic probe via strain promoted click chemistry.
Topics: Click Chemistry; Coumarins; DNA; DNA Primers; Fluorescent Dyes; Microscopy, Fluorescence; Polystyrenes | 2015 |
Synthesis, biological activity evaluation and molecular docking studies of novel coumarin substituted thiazolyl-3-aryl-pyrazole-4-carbaldehydes.
Topics: Aldehydes; Anti-Bacterial Agents; Antineoplastic Agents; Binding Sites; Cell Line; Coumarins; Cytochrome P-450 CYP2A6; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Microsomes; Molecular Docking Simulation; Protein Structure, Tertiary; Pyrazoles | 2015 |
The Distribution of Coumarins and Furanocoumarins in Citrus Species Closely Matches Citrus Phylogeny and Reflects the Organization of Biosynthetic Pathways.
Topics: Chromatography, High Pressure Liquid; Citrus; Coumarins; Fruit; Furocoumarins; Mass Spectrometry; Phylogeny; Principal Component Analysis | 2015 |
Synthesis and carbonic anhydrase inhibitory properties of amino acid - coumarin/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties.
Topics: Alanine; Amino Acids; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Glycine; Phenylalanine; Quinolones | 2016 |
BODIPY-Coumarin Conjugate as an Endoplasmic Reticulum Membrane Fluidity Sensor and Its Application to ER Stress Models.
Topics: Boron Compounds; Coumarins; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Fluorescent Dyes; HeLa Cells; Humans; Membrane Fluidity; Microscopy, Fluorescence; Spectrometry, Fluorescence | 2015 |
A Sensitive and Selective Fluorescent Coumarin-Based Probe for Detection of Hypochlorite ion and its Application to Cellular Imaging.
Topics: Coumarins; Fluorescent Dyes; Humans; Hypochlorous Acid; Image Processing, Computer-Assisted; Lymphoma, B-Cell; Microscopy, Confocal; Tumor Cells, Cultured | 2016 |
Modeling Solvent Broadening on the Vibronic Spectra of a Series of Coumarin Dyes. From Implicit to Explicit Solvent Models.
Topics: Coloring Agents; Coumarins; Molecular Dynamics Simulation; Quantum Theory; Solvents; Static Electricity | 2015 |
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors.
Topics: Animals; Brain Ischemia; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Dose-Response Relationship, Drug; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides | 2016 |
Temperature Dependent Solvation and Partitioning of Coumarin 152 in Phospholipid Membranes.
Topics: Coumarins; Dimyristoylphosphatidylcholine; Fluorescent Dyes; Lipid Bilayers; Permeability; Solvents; Spectrometry, Fluorescence; Temperature | 2016 |
Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities.
Topics: Anti-Infective Agents; Antioxidants; Bacteria; Bacterial Infections; Coumarins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrazoles; Quantitative Structure-Activity Relationship | 2016 |
Synthesis and biological evaluation of novel phosphoramidate derivatives of coumarin as chitin synthase inhibitors and antifungal agents.
Topics: Amides; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Chitin Synthase; Coumarins; Cryptococcus neoformans; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Phosphoric Acids; Structure-Activity Relationship | 2016 |
Non-targeted profiling of semi-polar metabolites in Arabidopsis root exudates uncovers a role for coumarin secretion and lignification during the local response to phosphate limitation.
Topics: Arabidopsis; Arginine; Citric Acid; Cluster Analysis; Coumarins; Hydroponics; Lignin; Malates; Meristem; Metabolome; Metabolomics; Phloroglucinol; Phosphates; Plant Exudates; Plant Roots | 2016 |
Exclusive photorelease of signalling lipids at the plasma membrane.
Topics: Animals; Arachidonic Acid; Calcium; Calcium Signaling; Cell Membrane; Coumarins; HeLa Cells; Humans; Insulin-Secreting Cells; Light; Mice; Mice, Inbred C57BL; Neurons | 2015 |
Coumarin fluorometry to quantitatively detectable OH radicals in ultrasound aqueous medium.
Topics: Coumarins; Fluorescent Dyes; Hydrogen-Ion Concentration; Hydroxyl Radical; Spectrometry, Fluorescence; Ultrasonic Waves; Umbelliferones | 2016 |
Albumin's Influence on Carprofen Enantiomers-Hymecromone Interaction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocatalysis; Carbazoles; Coumarins; Glucuronosyltransferase; Hymecromone; Kinetics; Serum Albumin, Bovine; Stereoisomerism | 2016 |
One Photocatalyst, n Activation Modes Strategy for Cascade Catalysis: Emulating Coumarin Biosynthesis with (-)-Riboflavin.
Topics: Biocatalysis; Coumarins; Cyclization; Electron Transport; Energy Transfer; Molecular Conformation; Photochemical Processes; Riboflavin; Stereoisomerism | 2016 |
Development and Characterization of Ultrafiltration TiO2 Magnéli Phase Reactive Electrochemical Membranes.
Topics: Coumarins; Electrochemical Techniques; Kinetics; Membranes, Artificial; Nitrates; Oxalic Acid; Oxidation-Reduction; Phthalic Acids; Titanium; Ultrafiltration; Water Pollutants, Chemical; Water Purification | 2016 |
1-Phenylethynylpyrene (PEPy) as a novel blue-emitting dye for qPCR assay.
Topics: Alkynes; Azides; Catalysis; Click Chemistry; Color; Copper; Coumarins; Fluorescent Dyes; Oligonucleotides; Pyrenes; Real-Time Polymerase Chain Reaction | 2016 |
Synthesis, characterization and antimicrobial activities of novel silver(I) complexes with coumarin substituted N-heterocyclic carbene ligands.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candida tropicalis; Coumarins; Dose-Response Relationship, Drug; Escherichia coli; Heterocyclic Compounds; Ligands; Methane; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Pseudomonas aeruginosa; Silver; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Anti-inflammatory terpenylated coumarins from the leaves of Zanthoxylum schinifolium with α-glucosidase inhibitory activity.
Topics: Alkaloids; alpha-Glucosidases; Animals; Anti-Inflammatory Agents; Coumarins; Cyclooxygenase 2; Glycoside Hydrolase Inhibitors; Imidazoles; Inflammation; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Extracts; Plant Leaves; RAW 264.7 Cells; Zanthoxylum | 2016 |
Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.
Topics: Antioxidants; Antiprotozoal Agents; Binding Sites; Cell Survival; Coumarins; Drug Design; Enzyme Inhibitors; HeLa Cells; Humans; Inhibitory Concentration 50; Leishmania; Molecular Docking Simulation; Oxidoreductases; Protein Structure, Tertiary; Protozoan Proteins; Structure-Activity Relationship | 2016 |
Blue 'turn-on' fluorescent probes for the direct detection of free radicals and nitric oxide in Pseudomonas aeruginosa biofilms.
Topics: Biofilms; Cell Membrane Permeability; Copper; Coumarins; Fluorescent Dyes; Free Radicals; Microscopy, Confocal; Nitric Oxide; Oxidation-Reduction; Pseudomonas aeruginosa; Staining and Labeling | 2016 |
Relationship between coumarin-induced hepatocellular toxicity and mitochondrial function in rats.
Topics: Aconitate Hydratase; Animals; Chemical and Drug Induced Liver Injury; Coumarins; Dose-Response Relationship, Drug; Drug Administration Schedule; Glutathione; Male; Mitochondria, Liver; Necrosis; Rats; Rats, Sprague-Dawley | 2016 |
Prediction of the metabolic clearance of benzophenone-2, and its interaction with isoeugenol and coumarin using cryopreserved human hepatocytes in primary culture.
Topics: Benzophenones; Cells, Cultured; Coumarins; Drug Interactions; Eugenol; Hepatocytes; Humans; Molecular Structure | 2016 |
Influence of C-H···O Hydrogen Bonds on Macroscopic Properties of Supramolecular Assembly.
Topics: Coumarins; Crystallography, X-Ray; Hydrogels; Hydrogen Bonding; Molecular Structure; Nanofibers; Nitrogen; Pyridines; Water | 2016 |
Combined Treatment of Tyrosine Kinase Inhibitor-Labeled Gold Nanorod Encapsulated Albumin With Laser Thermal Ablation in a Renal Cell Carcinoma Model.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Coumarins; Drug Compounding; Gold; Humans; Kidney Neoplasms; Lasers; Nanotubes; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Serum Albumin; Solubility; Sorafenib | 2016 |
Impacts on Sirtuin Function and Bioavailability of the Dietary Bioactive Compound Dihydrocoumarin.
Topics: Animals; Biocatalysis; Biological Availability; Coumarins; Diet; Digestion; Extracellular Fluid; Gastrointestinal Tract; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Reporter; Genetic Loci; Mutation; Phenols; Phenotype; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Silent Information Regulator Proteins, Saccharomyces cerevisiae; Sirtuin 2; Spores, Fungal; Sus scrofa | 2016 |
Identification, Recombinant Expression, and Biochemical Analysis of Putative Secondary Product Glucosyltransferases from Citrus paradisi.
Topics: Amino Acid Sequence; Citrus paradisi; Coumarins; Escherichia coli; Flavonoids; Gene Expression; Genes, Plant; Glucosyltransferases; Limonins; Molecular Sequence Data; Phenols; Phylogeny; Pichia; Recombinant Proteins; Seeds; Sequence Alignment; Substrate Specificity | 2016 |
pH-Activatable MnO-Based Fluorescence and Magnetic Resonance Bimodal Nanoprobe for Cancer Imaging.
Topics: Cell Line, Tumor; Cell Survival; Contrast Media; Coumarins; HeLa Cells; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Manganese Compounds; Metal Nanoparticles; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Neoplasms; Oxides; Particle Size; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared | 2016 |
FALCON: A method for flexible adaptation of local coordinates of nuclei.
Topics: Algorithms; Conotoxins; Coumarins; Glycine; Models, Chemical; Molecular Structure; Oligopeptides; Vibration | 2016 |
Gustatory Receptors Required for Avoiding the Toxic Compound Coumarin in Drosophila melanogaster.
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Drosophila melanogaster; Drosophila Proteins; Feeding Behavior; Female; Mutation; Oviposition; Receptors, Cell Surface; Receptors, Odorant; Toxicity Tests | 2016 |
Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Donepezil; Dose-Response Relationship, Drug; Drug Design; Eels; Humans; Indans; Models, Molecular; Molecular Structure; Molecular Targeted Therapy; Piperidines; Structure-Activity Relationship | 2016 |
Phenotypic and biomarker evaluation of zebrafish larvae as an alternative model to predict mammalian hepatotoxicity.
Topics: Acetaminophen; Amiodarone; Animals; Apoptosis; Aryl Hydrocarbon Hydroxylases; Ceruloplasmin; Coumarins; Female; Gene Expression Regulation; Genetic Markers; Genome-Wide Association Study; Humans; In Situ Hybridization; Larva; Liver; Male; Methapyrilene; Nitriles; Oxidoreductases, N-Demethylating; Phenotype; Toxicity Tests; Transferrin; Triazoles; Zebrafish; Zebrafish Proteins | 2016 |
Dual-emissive fluorescence measurements of hydroxyl radicals using a coumarin-activated silica nanohybrid probe.
Topics: Coumarins; HeLa Cells; Humans; Hydroxyl Radical; Limit of Detection; Molecular Imaging; Nanoparticles; Permeability; Silicon Dioxide; Spectrometry, Fluorescence | 2016 |
Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors.
Topics: alpha-Glucosidases; Coumarins; Dose-Response Relationship, Drug; Drug Design; Glycoside Hydrolase Inhibitors; Molecular Docking Simulation; Molecular Structure; Saccharomyces cerevisiae; Structure-Activity Relationship; Thiazoles | 2016 |
A Peptoid-Based Fluorescent Sensor for Cyanide Detection.
Topics: Copper; Coumarins; Cyanides; Fluorescence; Fluorescent Dyes; Peptoids; Spectrum Analysis | 2016 |
[The Thiacalix [4] arene-Coumarin Fluorescence Probe Recognition for Fe³⁺ and Bovine Hemoglobin].
Topics: Animals; Cattle; Coumarins; Ferric Compounds; Fluorescent Dyes; Hemoglobins; Phenols; Sulfides; Water | 2015 |
[Effects of P and K fertilizer on content of coumarin and yield of Glehnia littoralis].
Topics: Agriculture; Apiaceae; Coumarins; Drugs, Chinese Herbal; Fertilizers; Phosphorus; Potassium | 2015 |
Coumarin-Chalcone Hybrids as Peroxyl Radical Scavengers: Kinetics and Mechanisms.
Topics: Chalcone; Coumarins; Free Radical Scavengers; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Molecular Conformation; Peroxides; Solvents; Water | 2016 |
Organophotocatalysis: Insights into the Mechanistic Aspects of Thiourea-Mediated Intermolecular [2+2] Photocycloadditions.
Topics: Alkenes; Catalysis; Coumarins; Cycloaddition Reaction; Light; Models, Molecular; Photochemical Processes; Thiourea | 2016 |
Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors.
Topics: Aminocoumarins; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Coumarins; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Molecular Structure; Novobiocin; Structure-Activity Relationship | 2016 |
An unusual sesquiterpene coumarin from the seeds of Ferula sinkiangensis.
Topics: Coumarins; Drugs, Chinese Herbal; Electron Spin Resonance Spectroscopy; Ferula; Humans; Influenza A Virus, H1N1 Subtype; Molecular Structure; Plant Roots; Seeds; Sesquiterpenes | 2016 |
Fluorescent Formazans and Tetrazolium Salts - Towards Fluorescent Cytotoxicity Assays.
Topics: Animals; Cell Survival; Cells, Cultured; Coumarins; Cytophotometry; Diagnostic Imaging; Fluorescein; Fluorescence; Formazans; Humans; Indicators and Reagents; Tetrazolium Salts; Xanthones | 2016 |
Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Complement C3a; Coumarins; Dexamethasone; Drug Delivery Systems; Drug Liberation; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; Joints; Lactones; Macrophages; Mice; Micelles; Polyethylene Glycols; Rats, Wistar; RAW 264.7 Cells; Tumor Necrosis Factor-alpha | 2016 |
Green Chromatographic Separation of Coumarin and Vanillins Using Subcritical Water as the Mobile Phase.
Topics: Benzaldehydes; Chromatography; Coumarins; Green Chemistry Technology; Humans; Skin Cream; Temperature; Time Factors; Water | 2016 |
Deep-red to near-infrared fluorescent dyes: Synthesis, photophysical properties, and application in cell imaging.
Topics: Coumarins; Esterification; Fluorescent Dyes; HeLa Cells; Humans; Lysosomes; Microscopy, Fluorescence; Optical Imaging; Photolysis; Pyronine; Spectrometry, Fluorescence | 2016 |
Microwave-assisted synthesis and antifungal activity of novel coumarin derivatives: Pyrano[3,2-c]chromene-2,5-diones.
Topics: Antifungal Agents; Benzopyrans; Chemistry Techniques, Synthetic; Coumarins; Fungi; Microwaves | 2016 |
A FeCl3-catalyzed highly regioselective 1,2-addition/substitution sequence for the construction of coumarin-substituted bis(indolyl)methanes.
Topics: Catalysis; Chlorides; Coumarins; Ferric Compounds; Indoles; Methane; Stereoisomerism | 2016 |
Synthesis, Antiproliferative, and Multidrug Resistance Reversal Activities of Heterocyclic α,β-Unsaturated Carbonyl Compounds.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Flavonoids; Heterocyclic Compounds; Humans; Inhibitory Concentration 50; Molecular Structure; Real-Time Polymerase Chain Reaction | 2016 |
Assessment of Binding Affinity between Drugs and Human Serum Albumin Using Nanoporous Anodic Alumina Photonic Crystals.
Topics: Aluminum Oxide; Biosensing Techniques; Coumarins; Crystallization; Electrodes; Humans; Indomethacin; Nanopores; Optical Phenomena; Photons; Salicylic Acid; Serum Albumin, Human; Sulfadimethoxine; Warfarin | 2016 |
Pulchrin A, a New Natural Coumarin Derivative of Enicosanthellum pulchrum, Induces Apoptosis in Ovarian Cancer Cells via Intrinsic Pathway.
Topics: Antineoplastic Agents; Apoptosis; Biological Products; Cell Cycle; Chromatography, Liquid; Cisplatin; Coumarins; Female; Humans; Magnetic Resonance Spectroscopy; Ovarian Neoplasms; Phosphatidylserines; Proto-Oncogene Proteins c-bcl-2 | 2016 |
Generation of Benzyne Species from Diphenylphosphoryl Derivatives: Simultaneous Exchange of Three Functional Groups.
Topics: Benzene Derivatives; Benzopyrans; Butyrates; Coumarins; Crystallography, X-Ray; Cycloaddition Reaction; Dimethylformamide; Furans; Molecular Conformation; Sodium Compounds | 2016 |
A quick response fluorescent probe based on coumarin and quinone for glutathione and its application in living cells.
Topics: Benzoquinones; Chromatography, Thin Layer; Coumarins; Fluorescent Dyes; Glutathione; HeLa Cells; Humans; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2016 |
A colorimetric and fluorescent probe for detecting intracellular biothiols.
Topics: Animals; Cattle; Chickens; Colorimetry; Coumarins; Cysteine; Fluorescent Dyes; Glutathione; Goats; HeLa Cells; Homocysteine; Horses; Humans; Mice; Optical Imaging; Sheep; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2016 |
A donor-acceptor triptycene-coumarin hybrid dye featuring a charge separated excited state and AIE properties.
Topics: Anthracenes; Cell Line; Coumarins; Electron Transport; Fluorescent Dyes; Models, Molecular; Molecular Conformation; Optical Imaging; Spectrometry, Fluorescence | 2016 |
Functional characterization of a Mg(2+)-dependent O-methyltransferase with coumarin as preferred substrate from the liverwort Plagiochasma appendiculatum.
Topics: Amino Acid Sequence; Biosynthetic Pathways; Cloning, Molecular; Coumarins; Electrophoresis, Polyacrylamide Gel; Hepatophyta; Kinetics; Magnesium; Methyltransferases; Phylogeny; Recombinant Proteins; Scopoletin; Sequence Alignment; Subcellular Fractions; Substrate Specificity; Umbelliferones | 2016 |
Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity-Based Probes of Matriptase-2.
Topics: Animals; Binding Sites; Catalytic Domain; Cattle; Coumarins; Factor Xa; Fluorescent Dyes; Guanidines; Humans; Kinetics; Membrane Proteins; Molecular Docking Simulation; Peptidomimetics; Phosphorus; Serine Endopeptidases; Serine Proteinase Inhibitors; Stereoisomerism; Trypsin | 2016 |
Nanoemulsions Containing a Coumarin-Rich Extract from Pterocaulon balansae (Asteraceae) for the Treatment of Ocular Acanthamoeba Keratitis.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Asteraceae; Benzodioxoles; Coumarins; Emulsions; Hexanes; Nanoparticles; Plant Extracts | 2017 |
On the role of a coumarin derivative for sensing applications: Nucleotide identification using a micellar system.
Topics: Coumarins; Fluorescence; Micelles; Molecular Structure; Nucleotides; Quaternary Ammonium Compounds | 2016 |
Design, Synthesis and Cytotoxicity of Novel Dihydroartemisinin-Coumarin Hybrids via Click Chemistry.
Topics: Antigens, Neoplasm; Artemisinins; Carbonic Anhydrase IX; Cell Proliferation; Click Chemistry; Coumarins; Drug Design; Enzyme Inhibitors; HCT116 Cells; Humans; Magnetic Resonance Spectroscopy; Neoplasms | 2016 |
Water-soluble Hantzsch ester as switch-on fluorescent probe for efficiently detecting nitric oxide.
Topics: Animals; Coumarins; Esters; Fluorescence; Fluorescent Dyes; Limit of Detection; Mice; Microscopy, Fluorescence; Models, Molecular; Nitric Oxide; Pyridines; RAW 264.7 Cells; Solubility; Spectrometry, Fluorescence; Water | 2016 |
Analysis of real-time mixture cytotoxicity data following repeated exposure using BK/TD models.
Topics: Benzophenones; Cell Line, Tumor; Cell Survival; Cosmetics; Coumarins; Drug Interactions; Eugenol; Humans; Models, Biological | 2016 |
Effect of Accessions and Environment Conditions on Coumarin, O-Coumaric and Kaurenoic Acids Levels of Mikania laevigata.
Topics: Coumaric Acids; Coumarins; Diterpenes; Environment; Mikania; Phenotype | 2016 |
Syntheses of new 3-thiazolyl coumarin derivatives, in vitro α-glucosidase inhibitory activity, and molecular modeling studies.
Topics: alpha-Glucosidases; Chemistry Techniques, Synthetic; Coumarins; Glycoside Hydrolase Inhibitors; Molecular Docking Simulation; Protein Conformation; Thiazoles | 2016 |
Light Harvesting and White-Light Generation in a Composite of Carbon Dots and Dye-Encapsulated BSA-Protein-Capped Gold Nanoclusters.
Topics: Color; Coumarins; Energy Transfer; Gold; Light; Light-Harvesting Protein Complexes; Metal Nanoparticles; Nanocomposites | 2016 |
Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Coumarins; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Hypoglycemic Agents; Insulin; Islets of Langerhans; Liver; Mutagenicity Tests; Oxidative Stress; Rats; Salmonella typhimurium; Streptozocin; Superoxide Dismutase | 2016 |
Hybrid Benzoxazole-Coumarin Compounds Induce Death Receptor-Mediated Switchable Apoptotic and Necroptotic Cell Death on HN-5 Head and Neck Cancer Cell Line.
Topics: Antineoplastic Agents; Apoptosis; Benzoxazoles; Caspase 3; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Head and Neck Neoplasms; Humans; Molecular Structure; Necrosis; Structure-Activity Relationship | 2017 |
Readily functionalizable phosphonium-tagged fluorescent coumarins for enhanced detection of conjugates by mass spectrometry.
Topics: Coumarins; Fluorescence; Mass Spectrometry; Molecular Structure; Organophosphorus Compounds | 2016 |
Gold catalyzed double condensation reaction: Synthesis, antimicrobial and cytotoxicity of spirooxindole derivatives.
Topics: Anti-Infective Agents; Bacteria; Binding Sites; Catalysis; Cell Line, Tumor; Cell Survival; Checkpoint Kinase 1; Colonic Neoplasms; Coumarins; Gold; Humans; Hydrogen Bonding; Indoles; Inhibitory Concentration 50; Microbial Sensitivity Tests; Microwaves; Molecular Docking Simulation; Molecular Structure; Oxindoles; Spiro Compounds | 2016 |
Theoretical study of closed-loop recycling liquid-liquid chromatography and experimental verification of the theory.
Topics: Acetates; Aspirin; Caffeine; Coumarins; Countercurrent Distribution; Ethanol; Hexanes; Models, Theoretical; Recycling; Reproducibility of Results; Solutions; Solvents; Water | 2016 |
Biophysical influence of coumarin 35 on bovine serum albumin: Spectroscopic study.
Topics: Animals; Binding Sites; Biophysical Phenomena; Cattle; Coumarins; Energy Transfer; Hydrogen-Ion Concentration; Kinetics; Protein Conformation; Serum Albumin, Bovine; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Temperature | 2017 |
Substrate Engineering Enabling Fluorescence Droplet Entrapment for IVC-FACS-Based Ultrahigh-Throughput Screening.
Topics: Coumarins; Flow Cytometry; Fluorescence; High-Throughput Screening Assays; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Particle Size; Protein Engineering; Proteins | 2016 |
A TPA-caged precursor of (imino)coumarin for "turn-on" fluorogenic detection of Cu(.).
Topics: Copper; Coumarins; Fluorescent Dyes; Imines; Molecular Structure; Pyridines | 2016 |
Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis.
Topics: Biomarkers; Biosensing Techniques; Circulating MicroRNA; Coumarins; Fluorescent Dyes; Humans; Male; Nucleic Acid Hybridization; Nucleic Acid Probes; Oligonucleotides; Peptide Nucleic Acids; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction | 2016 |
Phototriggered protein syntheses by using (7-diethylaminocoumarin-4-yl)methoxycarbonyl-caged aminoacyl tRNAs.
Topics: Acylation; Animals; CHO Cells; Codon; Coumarins; Cricetinae; Cricetulus; Frameshift Mutation; Green Fluorescent Proteins; Lasers; Light; Liposomes; Peptide Elongation Factor Tu; Photolysis; Protein Biosynthesis; RNA, Messenger; RNA, Transfer, Amino Acyl | 2016 |
Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Topics: Aldehyde Reductase; Animals; Cattle; Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Thiazoles | 2016 |
A highly selective fluorescent probe based on coumarin for the imaging of N
Topics: Anions; Coumarins; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Hydrazines; Hydrogen-Ion Concentration; Limit of Detection; Microscopy, Fluorescence; Molecular Imaging; Time Factors; Water | 2017 |
Simultaneous quantification and identification of flavonoids, lignans, coumarin and amides in leaves of Zanthoxylum armatum using UPLC-DAD-ESI-QTOF-MS/MS.
Topics: Amides; Apigenin; Benzodioxoles; Catechin; Chromatography, High Pressure Liquid; Coumarins; Dioxoles; Flavonoids; Furans; Hesperidin; Hydroxybenzoates; Lignans; Limit of Detection; Plant Leaves; Powders; Reproducibility of Results; Seasons; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Zanthoxylum | 2017 |
Ncm, a Photolabile Group for Preparation of Caged Molecules: Synthesis and Biological Application.
Topics: Amino Acids; Animals; Auditory Cortex; Cells, Cultured; Coumarins; Evoked Potentials; Glutamates; Hydrogen-Ion Concentration; Light; Mice; Photolysis; Pyramidal Cells | 2016 |
Optimized Tetrazine Derivatives for Rapid Bioorthogonal Decaging in Living Cells.
Topics: Coumarins; Fluorescent Dyes; Green Fluorescent Proteins; HEK293 Cells; Humans; Tetrazoles | 2016 |
Isolation and Identification of Mosquito (Aedes aegypti) Biting-Deterrent Compounds from the Native American Ethnobotanical Remedy Plant Hierochloë odorata (Sweetgrass).
Topics: Aedes; Animals; Coumarins; Drug Evaluation, Preclinical; Ethnobotany; Female; Guaiacol; Humans; Indians, North American; Insect Repellents; Oils, Volatile; Phytol; Plant Extracts; Poaceae; Vinyl Compounds | 2016 |
In silico identification and computational analysis of the nucleotide binding site in the C-terminal domain of Hsp90.
Topics: Amino Acid Sequence; Binding Sites; Computer Simulation; Conserved Sequence; Coumarins; HSP90 Heat-Shock Proteins; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Models, Molecular; Molecular Docking Simulation; Nucleotides; Protein Domains; Protein Multimerization; Protein Structure, Quaternary; Protein Structure, Secondary; Proteolysis | 2016 |
Phenolic compounds alone or in combination may be involved in propolis effects on human monocytes.
Topics: Anti-Bacterial Agents; Antifungal Agents; Apitherapy; Caffeic Acids; Coumarins; Drug Synergism; Humans; Hydrogen Peroxide; Immunologic Factors; Interleukin-10; Interleukin-6; Monocytes; Phenols; Phenylpropionates; Propolis; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2017 |
Organocatalytic Asymmetric Benzylation and Aldol-Hemiacetalization of α,β-Unsaturated Trifluoromethyl Ketones: Efficient Enantioselective Construction of 3,4-Dihydroisocoumarins.
Topics: Aldehydes; Amines; Carbon; Catalysis; Coumarins; Crystallography, X-Ray; Isocoumarins; Ketones; Molecular Conformation; Stereoisomerism; Thiourea; Toluene | 2017 |
A Self-Immobilizing and Fluorogenic Probe for β-Lactamase Detection.
Topics: beta-Lactamases; Chromatography, High Pressure Liquid; Coumarins; Electrophoresis, Polyacrylamide Gel; Enzymes, Immobilized; Escherichia coli; Fluorescent Dyes; Hydrolysis; Microscopy, Fluorescence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Effect of operating parameters on a centrifugal partition chromatography separation.
Topics: Algorithms; Centrifugation; Coumarins; Countercurrent Distribution; Cyclohexane Monoterpenes; Monoterpenes; Reproducibility of Results; Solvents | 2016 |
A multi-emissive fluorescent probe for the discrimination of glutathione and cysteine.
Topics: Biosensing Techniques; Boron Compounds; Coumarins; Cysteine; Fluorescent Dyes; Glutathione; HeLa Cells; Humans | 2017 |
Resveratrol and Coumarin: Novel Agricultural Antibacterial Agent against Ralstonia solanacearum In Vitro and In Vivo.
Topics: Anti-Bacterial Agents; Biofilms; Coumarins; Nicotiana; Plant Diseases; Ralstonia solanacearum; Resveratrol; Stilbenes | 2016 |
Simultaneous Determination of Coumarin and Its Derivatives in Tobacco Products by Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Coumarins; Flavoring Agents; Molecular Structure; Nicotiana; Reproducibility of Results; Sensitivity and Specificity; Solvents; Tandem Mass Spectrometry | 2016 |
Promising Compounds From Murraya exotica for Cancer Metastasis Chemoprevention.
Topics: Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Movement; Chemoprevention; Coumarins; Humans; Inflammation; Murraya; Neoplasm Metastasis; Plant Extracts; Plant Leaves; Plant Roots | 2017 |
A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging.
Topics: Benzaldehydes; Cell Line, Tumor; Cell Survival; Coumarins; Doxorubicin; Drug Carriers; Drug Liberation; Fluorescent Dyes; Humans; Kinetics; Paclitaxel; Photolysis; Ultraviolet Rays | 2017 |
Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold.
Topics: Anti-Bacterial Agents; Benzopyrans; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Hydrazines; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
Development of a coumarin-furan conjugate as Zn
Topics: Coumarins; Ethanol; Fluorescent Dyes; Furans; Hydrogen-Ion Concentration; Ions; Proton Magnetic Resonance Spectroscopy; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Time Factors; Water; Zinc | 2017 |
A Green Light-Triggerable RGD Peptide for Photocontrolled Targeted Drug Delivery: Synthesis and Photolysis Studies.
Topics: Chromatography, Liquid; Coumarins; Drug Delivery Systems; Light; Oligopeptides; Photolysis; Spectrum Analysis | 2016 |
Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C-Oxidation and Coumarin 7-Hydroxylation Activities.
Topics: Alleles; Cotinine; Coumarins; Cytochrome P-450 CYP2A6; HEK293 Cells; Humans; Hydroxylation; Kinetics; Microsomes; Models, Molecular; Nicotine; Oxidation-Reduction; Polymorphism, Genetic; Substrate Specificity; Transfection; Umbelliferones | 2017 |
pH-Dependent Fluorescent Probe That Can Be Tuned for Cysteine or Homocysteine.
Topics: Biosensing Techniques; Cell Tracking; Coumarins; Cyclization; Cysteine; Fluorescent Dyes; Hep G2 Cells; Homocysteine; Humans; Hydrogen-Ion Concentration; Kinetics; Solutions; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2017 |
Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors.
Topics: Coumarins; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Humans; Molecular Structure; Naphthoquinones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2017 |
Synthesis of bioactive and fluorescent pyridine-triazole-coumarin peptidomimetics through sequential click-multicomponent reactions.
Topics: Alkynes; Antineoplastic Agents; Azides; Catalysis; Cell Survival; Copper; Coumarins; Cycloaddition Reaction; Humans; MCF-7 Cells; Microscopy, Fluorescence; Peptidomimetics; Pyridines; Quantum Theory; Triazoles | 2017 |
Structural and Functional Basis of C-Methylation of Coumarin Scaffolds by NovO.
Topics: Catalysis; Coumarins; Crystallography, X-Ray; Methylation; Methyltransferases; Molecular Structure; Novobiocin; Streptomyces; Substrate Specificity | 2017 |
Highly sensitive detection of cysteine over glutathione and homo-cysteine: New insight into the Michael addition of mercapto group to maleimide.
Topics: Animals; Biosensing Techniques; Cattle; Cell Line; Coumarins; Cysteine; Fluorescent Dyes; Glutathione; Homocysteine; Limit of Detection; Maleimides; Mice; Models, Molecular; Optical Imaging; Serum Albumin, Bovine; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2017 |
Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans | 2017 |
Pathological and biochemical evaluation of coumarin and chlorophyllin against aflatoxicosis in rat.
Topics: Aflatoxin B1; Animal Feed; Animals; Chlorophyllides; Coumarins; Food Contamination; Male; Random Allocation; Rats; Rats, Sprague-Dawley | 2017 |
Control of an Unusual Photo-Claisen Rearrangement in Coumarin Caged Tamoxifen through an Extended Spacer.
Topics: Animals; Cells, Cultured; Chromatography, Liquid; Coumarins; Kinetics; Mice; Photochemistry; Selective Estrogen Receptor Modulators; Spectrum Analysis; Tamoxifen | 2017 |
A Cysteine-Specific Fluorescent Switch for Monitoring Oxidative Stress and Quantification of Aminoacylase-1 in Blood Serum.
Topics: Amidohydrolases; Cell Line, Tumor; Coumarins; Cysteine; Enzyme Assays; Fluorescent Dyes; HEK293 Cells; Humans; Hydrogen Peroxide; Optical Imaging; Oxidative Stress; Spectrometry, Fluorescence | 2016 |
Synthesis of 5α,8α-Ergosterol Peroxide 3-Carbamate Derivatives and a Fluorescent Mitochondria-Targeting Conjugate for Enhanced Anticancer Activities.
Topics: Antineoplastic Agents; Apoptosis; Carbamates; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coumarins; Crystallography, X-Ray; Ergosterol; Fluorescent Dyes; Hep G2 Cells; Humans; MCF-7 Cells; Microscopy, Confocal; Mitochondria; Molecular Conformation; Structure-Activity Relationship | 2017 |
Fluorescein-Based Chromogenic and Ratiometric Fluorescence Probe for Highly Selective Detection of Cysteine and Its Application in Bioimaging.
Topics: Carbon-13 Magnetic Resonance Spectroscopy; Coumarins; Cysteine; Fluorescein; Fluorescent Dyes; Hep G2 Cells; Humans; Limit of Detection; Molecular Imaging; Proton Magnetic Resonance Spectroscopy; Spectrometry, Fluorescence; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2017 |
Alkyne-Functionalized Coumarin Compound for Analytic and Preparative 4-Thiouridine Labeling.
Topics: Affinity Labels; Alkynes; Binding Sites; Click Chemistry; Coumarins; Protein Binding; RNA Processing, Post-Transcriptional; RNA, Bacterial; Staining and Labeling; Thiouridine | 2017 |
Coumarin-Based Boron Complexes with Aggregation-Induced Emission.
Topics: Boron Compounds; Coumarins; Fluorescence; Lysosomes; Molecular Structure; Particle Size | 2017 |
New polyacetylenes from Echinophora cinerea (Boiss.) Hedge et Lamond.
Topics: Antineoplastic Agents; Apiaceae; Cell Death; Cell Line, Tumor; Coumarins; Flavonoids; Glycosides; Humans; MCF-7 Cells; Medicine, Traditional; Molecular Structure; Plant Components, Aerial; Polyynes; Prenylation | 2017 |
Phototriggered release of tetrapeptide AAPV from coumarinyl and pyrenyl cages.
Topics: Coumarins; Oligopeptides; Photochemical Processes; Pyrenes | 2017 |
Photoreversibility and Biocompatibility of Polydimethylsiloxane-Coumarin as Adjustable Intraocular Lens Material.
Topics: Animals; Cell Line; Coumarins; Fibroblasts; Lenses, Intraocular; Materials Testing; Mice; Silicones | 2017 |
Highlighting the effects of coumarin on adult plants of Arabidopsis thaliana (L.) Heynh. by an integrated -omic approach.
Topics: Arabidopsis; Arabidopsis Proteins; Coumarins; Hydrogen Peroxide; Lipid Peroxidation; Metabolomics; Proteomics; Water | 2017 |
Application of bacterial reverse mutation assay for detection of non-genotoxic carcinogens.
Topics: Activation, Metabolic; Acyclic Monoterpenes; Allylbenzene Derivatives; Anisoles; Anthracenes; Benzo(a)pyrene; Carcinogens; Coumarins; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Synergism; Microsomes, Liver; Monoterpenes; Mutagenicity Tests; Mutagens; Salmonella typhimurium | 2017 |
Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Coumarins; Drug Design; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Molecular Dynamics Simulation; Structure-Activity Relationship | 2017 |
Temperature-Dependent Partitioning of Coumarin 152 in Phosphatidylcholine Lipid Bilayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Coumarins; Diffusion; Dimyristoylphosphatidylcholine; Entropy; Fluorescent Dyes; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Permeability; Phase Transition; Phosphatidylcholines; Temperature; Unilamellar Liposomes | 2017 |
Insights into the molecular interaction between two polyoxygenated cinnamoylcoumarin derivatives and human serum albumin.
Topics: Binding Sites; Calorimetry; Chalcone; Circular Dichroism; Coumarins; Fluorescence Resonance Energy Transfer; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Serum Albumin, Human; Spectrometry, Fluorescence; Static Electricity; Thermodynamics | 2017 |
Analysis of small biomolecules and xenobiotic metabolism using converted graphene-like monolayer plates and laser desorption/ionization time-of-flight mass spectrometry.
Topics: Amino Acids; Carbohydrates; Coumarins; Cytochrome P-450 CYP2A6; Fatty Acids; Flavonoids; Gold; Graphite; Humans; Hydroxylation; Metal Nanoparticles; Microsomes, Liver; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Surface Properties | 2017 |
Photo-controlled release of fipronil from a coumarin triggered precursor.
Topics: Aedes; Animals; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Insecticides; Larva; Light; Microscopy, Fluorescence; Pyrazoles; Spectrophotometry, Ultraviolet; Spodoptera | 2017 |
Inhibitory Effect of Coumarin on Syntrophic Fatty Acid-Oxidizing and Methanogenic Cultures and Biogas Reactor Microbiomes.
Topics: Acetates; Bacteria; Biofuels; Bioreactors; Coumarins; Fatty Acids; Methane; Microbiota; Oxidation-Reduction | 2017 |
Structural implications on the excitation dynamics of fluorescent 3H-indolium cations.
Topics: Cations; Coumarins; Fluorescent Dyes; Indoles; Molecular Structure | 2017 |
Fluorescent coumarin-based probe for cysteine and homocysteine with live cell application.
Topics: Animals; Coumarins; Cysteine; Cytological Techniques; Fluorescent Dyes; Homocysteine; Mice; Microscopy, Confocal; RAW 264.7 Cells | 2017 |
Synthesis and in vitro biological evaluation of novel coumarin derivatives containing isoxazole moieties on melanin synthesis in B16 cells and inhibition on bacteria.
Topics: Anti-Bacterial Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Escherichia coli; Humans; Isoxazoles; Melanins; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Anti-influenza activity of monoterpene-containing substituted coumarins.
Topics: Animals; Antiviral Agents; Cell Death; Cells, Cultured; Coumarins; Dogs; Dose-Response Relationship, Drug; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Monoterpenes; Structure-Activity Relationship; Virus Replication | 2017 |
Optimizing the Readout of Lanthanide-DOTA Complexes for the Detection of Ligand-Bound Copper(I).
Topics: Azides; Click Chemistry; Copper; Coumarins; Lanthanoid Series Elements; Luminescence | 2017 |
Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Topics: Aromatase; Aromatase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
A tri-functional vanadium(iv) complex to detect cysteine oxidation.
Topics: Coordination Complexes; Coumarins; Cysteine; Electron Spin Resonance Spectroscopy; HCT116 Cells; Humans; Microscopy, Fluorescence; Oxidation-Reduction; Phosphoric Monoester Hydrolases; Protein Binding; Vanadium | 2017 |
Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Humans; Indoles; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Thiadiazoles; Tumor Cells, Cultured | 2017 |
Discovery of Chromen-7-yl Furan-2-Carboxylate as a Potent and Selective Factor XIa Inhibitor.
Topics: Anticoagulants; Benzopyrans; Blood Coagulation; Coumarins; Drug Design; Factor XIa; Furans; Humans; Molecular Docking Simulation; Small Molecule Libraries; Thermodynamics | 2017 |
Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel.
Topics: Animals; Biological Transport; Cell Line, Tumor; Coumarins; Drug Carriers; Folic Acid; Humans; Intracellular Space; Male; Micelles; Paclitaxel; Poloxamer; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Succinates; Tissue Distribution | 2017 |
A bioorthogonal nanosystem for imaging and in vivo tumor inhibition.
Topics: Animals; Antineoplastic Agents; Coumarins; Ferrous Compounds; Fluorescent Dyes; HeLa Cells; Humans; Liposomes; Metallocenes; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Nanoparticles; Neoplasms; Optical Imaging; Palladium; Pargyline; Phosphines; Phospholipids; Photons; Prodrugs; Xenograft Model Antitumor Assays | 2017 |
Dual-Emission Channels for Simultaneous Sensing of Cysteine and Homocysteine in Living Cells.
Topics: Biosensing Techniques; Coumarins; Cysteine; Fluorescent Dyes; HeLa Cells; Homocysteine; Humans; Molecular Structure | 2017 |
A colorimetric and fluorogenic probe for bisulfite using benzopyrylium as the recognition unit.
Topics: Anions; Benzopyrans; Cell Line; Colorimetry; Coumarins; Fluorescent Dyes; Food Analysis; Humans; Hydrogen-Ion Concentration; Kinetics; Limit of Detection; Magnetic Resonance Spectroscopy; Spectrometry, Fluorescence; Sulfites | 2017 |
Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-Based Moieties.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Coumarins; Dimerization; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Molecular Docking Simulation; Protective Agents; Structure-Activity Relationship | 2017 |
Effects of Cinnamoyloxy-mammeisin from Geopropolis on Osteoclast Differentiation and Porphyromonas gingivalis-Induced Periodontitis.
Topics: Alveolar Bone Loss; Animals; Bone Resorption; Cell Differentiation; Coumarins; Macrophage Colony-Stimulating Factor; Mice; Molecular Structure; Osteoblasts; Osteoclasts; Periodontitis; Porphyromonas gingivalis; RANK Ligand | 2017 |
Toxicity of coumarins synthesized by Pechmann-Duisberg condensation against Drosophila melanogaster larvae and antibacterial effects.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Coumarins; Drosophila melanogaster; Insecticides; Larva; Microwaves; Molecular Structure | 2017 |
Fluorescence detection of serum albumin with a turnover-based sensor utilizing Kemp elimination reaction.
Topics: Animals; Cattle; Coumarins; Fluorescence; Fluorescent Dyes; Humans; Isoxazoles; Serum Albumin; Spectrometry, Fluorescence | 2017 |
Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids.
Topics: Acetylcholinesterase; Acridines; Catalytic Domain; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Coumarins; Humans; Inhibitory Concentration 50; Molecular Docking Simulation | 2017 |
Rapid fluorescence lifetime estimation with modified phasor approach and Laguerre deconvolution: a comparative study.
Topics: Adipose Tissue; Algorithms; Animals; Bone and Bones; Coumarins; Fluorescence; Fluorescent Dyes; Image Processing, Computer-Assisted; Muscles; Sheep; Spectrometry, Fluorescence | 2017 |
Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
Topics: Animals; Antiviral Agents; Cell Line; Cell Line, Tumor; Coumarins; Drug Discovery; Ebolavirus; Hemorrhagic Fever, Ebola; High-Throughput Screening Assays; Histamine Antagonists; Humans; Hydrophobic and Hydrophilic Interactions; Marburg Virus Disease; Marburgvirus; Small Molecule Libraries; Structure-Activity Relationship; Virus Internalization | 2017 |
Construction of Pentacyclic Lamellarin Skeleton via Grob Reaction: Application to Total Synthesis of Lamellarins H and D.
Topics: Coumarins; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Molecular Structure; Pyrroles; Stereoisomerism | 2017 |
Transcriptomic profiling of Melilotus albus near-isogenic lines contrasting for coumarin content.
Topics: beta-Glucosidase; Biosynthetic Pathways; Computational Biology; Coumarins; Gene Expression Profiling; Gene Expression Regulation, Plant; Genotype; High-Throughput Nucleotide Sequencing; Melilotus; Molecular Sequence Annotation; Sequence Analysis, RNA; Transcriptome | 2017 |
A Two-Photon-Photocleavable Linker for Triggering Light-Induced Strand Breaks in Oligonucleotides.
Topics: Chromatography, High Pressure Liquid; Coumarins; DNA; DNA Breaks; Drug Delivery Systems; Electrophoretic Mobility Shift Assay; Humans; Molecular Structure; NF-kappaB-Inducing Kinase; Oligonucleotides; Photons; Protein Serine-Threonine Kinases | 2017 |
Preparation and evaluation of mesoporous silica layers on radially elongated pillars.
Topics: Chemistry Techniques, Analytical; Chromatography, Reverse-Phase; Coumarins; Kinetics; Porosity; Silanes; Silicon Dioxide | 2017 |
Facile Synthesis of Novel Coumarin Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study, ADMET Prediction and Toxicity Study.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Candida albicans; Coumarins; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2017 |
Weak nanoscale chaos and anomalous relaxation in DNA.
Topics: Coumarins; DNA; Hydrogen Bonding; Models, Genetic; Molecular Dynamics Simulation; Motion; Nonlinear Dynamics; Spectrum Analysis; Water | 2017 |
Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo.
Topics: Animals; Benzylisoquinolines; Carcinogenesis; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coumarins; Humans; Inhibitory Concentration 50; Lipids; Melanoma, Experimental; Mice, Inbred C57BL; Mitochondria; Nanoparticles; Neoplasm Invasiveness; Neoplasm Metastasis | 2017 |
Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Male; Mice; Mice, Inbred Strains; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; PC12 Cells; Protein Aggregates; Rats; Structure-Activity Relationship | 2017 |
Isofraxidin, a coumarin component improves high-fat diet induced hepatic lipid homeostasis disorder and macrophage inflammation in mice.
Topics: Animals; Coumarins; Diet, High-Fat; Homeostasis; Humans; Interleukin-6; Liver; Macrophages; Male; Mice; NF-kappa B; Non-alcoholic Fatty Liver Disease; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2017 |
Coumarin impairs redox homeostasis in wheat aleurone layers.
Topics: Abscisic Acid; Coumarins; Gibberellins; Homeostasis; Oxidation-Reduction; Plant Growth Regulators; Plant Proteins; Triticum | 2018 |
Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
Topics: Amines; Animals; Antineoplastic Agents; Binding, Competitive; Cell Line, Tumor; Cell Nucleus; Chelating Agents; Circular Dichroism; Coordination Complexes; Copper; Coumarins; DNA; DNA Damage; Electrochemistry; Humans; Ligands; Magnetic Resonance Spectroscopy; Mice; Molecular Docking Simulation; Neoplasms; Oxidants; Oxygen; Potassium Iodide; Reactive Oxygen Species; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared | 2017 |
Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Isatin; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Triazoles | 2017 |
Highly selective on-off fluorescence recognition of Fe
Topics: Animals; Calibration; Cell Death; Cell Line; Cell Survival; Coumarins; Fluorescence; Fluorescent Dyes; Hydrogen-Ion Concentration; Imaging, Three-Dimensional; Ions; Iron; Limit of Detection; Solubility; Solvents; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2018 |
Changes in coumarin kinetics and subcellular localization of CYP2E1 contribute to bile duct damage and reduce hepatocellular damage after repeated administration of coumarin in rats.
Topics: Animals; Bile Ducts; Coumarins; Cytochrome P-450 CYP2E1; Gene Expression Regulation, Enzymologic; Hep G2 Cells; Hepatocytes; Humans; Male; Protein Transport; Random Allocation; Rats; Rats, Sprague-Dawley | 2017 |
Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
Topics: Agaricales; Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Molecular Docking Simulation; Molecular Structure; Monophenol Monooxygenase; Pyrazoles; Structure-Activity Relationship; Thiazoles | 2017 |
Electrostatic Modification for Promotion of Flavin-Mediated Oxidation of a Probe for Flavin Detection.
Topics: Amines; Coumarins; Electrochemical Techniques; Eosinophilia; Eosinophils; Flavins; Flow Cytometry; Humans; Kinetics; Microscopy, Fluorescence; Organometallic Compounds; Oxidation-Reduction; Picolinic Acids; Static Electricity; Thermodynamics; Zinc | 2017 |
Characterization of the Degradation Profile of Umbelliprenin, a Bioactive Prenylated Coumarin of a Ferulago Species.
Topics: Anti-Inflammatory Agents; Antioxidants; Apiaceae; Coumarins; Humans; Hydrolysis; Molecular Structure; Oxidation-Reduction; Prenylation; Umbelliferones | 2017 |
Cnidimonins A-C, Three Types of Hybrid Dimer from Cnidium monnieri: Structural Elucidation and Semisynthesis.
Topics: Chromones; Cnidium; Coumarins; Fruit; Molecular Structure; Plant Extracts | 2017 |
Extraction time and temperature affect the extraction efficiencies of coumarin and phenylpropanoids from Cinnamomum cassia bark using a microwave-assisted extraction method.
Topics: Acrolein; Chemical Fractionation; Chromatography, High Pressure Liquid; Cinnamates; Cinnamomum aromaticum; Coumarins; Linear Models; Microwaves; Plant Bark; Plant Extracts; Propanols; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Temperature; Time Factors | 2017 |
Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrimidines; Structure-Activity Relationship | 2017 |
An ortho C-methylation/O-glycosylation motif on a hydroxy-coumarin scaffold, selectively installed by biocatalysis.
Topics: Biocatalysis; Coumarins; Glycosylation; Glycosyltransferases; Hydroxides; Malus; Methylation; Methyltransferases; Molecular Structure; Streptomyces | 2017 |
A two-photon fluorescent probe for ratiometric imaging of endogenous hypochlorous acid in live cells and tissues.
Topics: Animals; Brain; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hypochlorous Acid; Mice; Microscopy, Fluorescence, Multiphoton; Photons; Rhodamines; Spectrometry, Fluorescence | 2017 |
A Fluorescent Coumarin-Based Probe for the Fast Detection of Cysteine with Live Cell Application.
Topics: Cell Line; Coumarins; Cysteine; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Microscopy, Fluorescence; Molecular Imaging; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 2017 |
Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Coumarins; Humans; MCF-7 Cells; Styrene | 2017 |
A copper-catalyzed tandem reaction for the construction of coumarin fused 9H-pyrrolo[1,2-a]indoles.
Topics: Catalysis; Copper; Coumarins; Indoles; Molecular Structure | 2017 |
A two-photon excitable and ratiometric fluorogenic nitric oxide photoreleaser and its biological applications.
Topics: Animals; Coumarins; Delayed-Action Preparations; Drug Liberation; Fluorescent Dyes; Gasotransmitters; HeLa Cells; Humans; Light; Mice; Naphthalimides; Nitric Oxide; Photons | 2017 |
Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking.
Topics: Binding Sites; Coumarins; Cycloaddition Reaction; Drug Design; HEK293 Cells; Humans; Hydrogen Bonding; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Structure, Tertiary; Pyrimidines; Receptors, G-Protein-Coupled | 2017 |
Identification of 7,8-Diacetoxy-3-Arylcoumarin Derivative as a Selective Cytotoxic and Apoptosis-inducing Agent in a Human Prostate Cancer Cell Line.
Topics: Apoptosis; Cell Proliferation; Coumarins; Humans; Male; Membrane Potential, Mitochondrial; Mitochondria; Prostatic Neoplasms; Reactive Oxygen Species; Tumor Cells, Cultured | 2017 |
The evaluation of potent antitumor activities of shikonin coumarin-carboxylic acid, PMMB232 through HIF-1α-mediated apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Carboxylic Acids; Coumarins; Drug Evaluation, Preclinical; Female; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Molecular Docking Simulation; Naphthoquinones; Uterine Cervical Neoplasms | 2018 |
Use of a small molecule as an initiator for interchain staudinger reaction: A new ATP sensing platform using product fluorescence.
Topics: Adenosine Triphosphate; Aptamers, Nucleotide; Azides; Base Sequence; Biosensing Techniques; Coumarins; Organoselenium Compounds | 2018 |
New Metabolites of Coumarin Detected in Human Urine Using Ultra Performance Liquid Chromatography/Quadrupole-Time-of-Flight Tandem Mass Spectrometry.
Topics: Chromatography, High Pressure Liquid; Coumarins; Humans; Molecular Structure; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2017 |
Coumarin enhances nitrate uptake in maize roots through modulation of plasma membrane H
Topics: Cell Membrane; Coumarins; Gene Expression Profiling; Gene Expression Regulation, Plant; Nitrates; Plant Roots; Proton-Translocating ATPases; Reverse Transcriptase Polymerase Chain Reaction; Zea mays | 2018 |
Conformational dynamics in TRPV1 channels reported by an encoded coumarin amino acid.
Topics: Capsaicin; Coumarins; HEK293 Cells; Humans; Intravital Microscopy; Microscopy, Fluorescence; Models, Molecular; Molecular Dynamics Simulation; Protein Conformation; Staining and Labeling; TRPV Cation Channels; Tyrosine | 2017 |
Synthesis and biological evaluation of coumarin derivatives containing imidazole skeleton as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Coumarins; Dose-Response Relationship, Drug; Escherichia coli; Flavobacterium; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptococcus agalactiae; Structure-Activity Relationship | 2018 |
Design, Synthesis and In Vitro Anti-microbial Evaluation of Ethylene/ Propylene-1H-1,2,3-Triazole-4-Methylene-tethered Isatin-coumarin Hybrids.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Chlorocebus aethiops; Coumarins; Drug Design; Ethylenes; Gram-Negative Bacteria; Gram-Positive Bacteria; Isatin; Microbial Sensitivity Tests; Triazoles; Vero Cells | 2017 |
The 3-phenylcoumarin derivative 6,7-dihydroxy-3-[3',4'-methylenedioxyphenyl]-coumarin downmodulates the FcγR- and CR-mediated oxidative metabolism and elastase release in human neutrophils: Possible mechanisms underlying inhibition of the formation and re
Topics: Anti-Inflammatory Agents; Cells, Cultured; Coumarins; Extracellular Traps; Humans; Immunomodulation; Neutrophils; Oxidation-Reduction; Oxidative Stress; Pancreatic Elastase; Peroxidase; Phagocytosis; Reactive Oxygen Species; Receptors, Complement; Receptors, IgG | 2018 |
Redesigning the Coumarin Scaffold into Small Bright Fluorophores with Far-Red to Near-Infrared Emission and Large Stokes Shifts Useful for Cell Imaging.
Topics: Coumarins; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Infrared Rays; Molecular Structure; Optical Imaging; Tumor Cells, Cultured | 2018 |
Drug likeness prediction of 5-hydroxy-substituted coumarins with high affinity to 5-HT
Topics: Binding Sites; Coumarins; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Protein Binding; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serum Albumin | 2018 |
An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells.
Topics: Biomarkers; Cell Line, Tumor; Cell Membrane; Cell Membrane Permeability; Coumarins; Fluorescent Dyes; Humans; Hymecromone; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Oxidative Stress; Up-Regulation | 2018 |
Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Coumarins; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Models, Molecular; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
In vitro antiplasmodial efficacy of synthetic coumarin-triazole analogs.
Topics: Antimalarials; Cell Line, Tumor; Cell Survival; Coumarins; DNA Gyrase; Dose-Response Relationship, Drug; Escherichia coli; Humans; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Topoisomerase II Inhibitors; Triazoles | 2018 |
Anticancer Activity Study of Chromone and Coumarin Hybrids using Electrical Impedance Spectroscopy.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Chromones; Coumarins; Dielectric Spectroscopy; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Electric Impedance; Humans; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Design and synthesis of coumarin-based organoselenium as a new hit for myeloprotection and synergistic therapeutic efficacy in adjuvant therapy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Proliferation; Chemotherapy, Adjuvant; Chromosome Aberrations; Coumarins; DNA Damage; Drug Design; Female; Lipid Peroxidation; Lymphoma; Mice; Myelopoiesis; Organoselenium Compounds; Oxidative Stress; Sarcoma, Experimental; Tumor Cells, Cultured | 2018 |
Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Kinetics; Male; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Structure; Peptide Fragments; Protein Aggregates; Range of Motion, Articular; Structure-Activity Relationship; Thiocarbamates | 2018 |
Synthesis of coumarin-theophylline hybrids as a new class of anti-tubercular and anti-microbial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Coumarins; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Salmonella typhi; Staphylococcus aureus; Structure-Activity Relationship; Theophylline | 2018 |
Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Drug Design; Electrophorus; Horses; Models, Molecular; Molecular Structure; Pyridinium Compounds; Structure-Activity Relationship | 2018 |
Two new compounds from the fruit of Ailanthus altissima.
Topics: Ailanthus; Antiviral Agents; Coumarins; Fruit; Phenols; Plant Leaves; Tobacco Mosaic Virus | 2019 |
A hybrid of coumarin and phenylsulfonylfuroxan induces caspase-dependent apoptosis and cytoprotective autophagy in lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein 5; Caspases; Cell Line, Tumor; Coumarins; Humans; Lung Neoplasms; Nitric Oxide; Oxadiazoles; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Determination of coumarin in seasonal bakery products using QuEChERS and GC-MS.
Topics: Bread; Cinnamomum aromaticum; Coumarins; Food Contamination; Gas Chromatography-Mass Spectrometry; Limit of Detection; Seasons | 2017 |
Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Topics: alpha-Glucosidases; Coumarins; Dose-Response Relationship, Drug; Glycoside Hydrolase Inhibitors; Molecular Docking Simulation; Molecular Structure; Saccharomyces cerevisiae; Structure-Activity Relationship | 2018 |
Probing binding specificity of the sucrose transporter AtSUC2 with fluorescent coumarin glucosides.
Topics: Arabidopsis; Arabidopsis Proteins; Biological Transport; Coumarins; Fluorescence; Glucosides; Membrane Transport Proteins; Phloem; Plant Proteins; Protein Binding; Solanum tuberosum | 2018 |
Capillary electrophoresis method for the discrimination between natural and artificial vanilla flavor for controlling food frauds.
Topics: Benzaldehydes; Chromatography, High Pressure Liquid; Coumarins; Electrophoresis, Capillary; Flavoring Agents; Food Quality; Parabens; Vanilla | 2018 |
Synthesis, molecular docking study and thymidine phosphorylase inhibitory activity of 3-formylcoumarin derivatives.
Topics: Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship; Thymidine Phosphorylase | 2018 |
Sterically modulated silver(I) complexes of coumarin substituted benzimidazol-2-ylidenes: Synthesis, crystal structures and evaluation of their antimicrobial and antilung cancer potentials.
Topics: A549 Cells; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Coumarins; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus | 2018 |
Synthesis of some novel orcinol based coumarin triazole hybrids with capabilities to inhibit RANKL-induced osteoclastogenesis through NF-κB signaling pathway.
Topics: Animals; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Humans; Mice; Molecular Structure; NF-kappa B; Osteogenesis; RAW 264.7 Cells; Receptor Activator of Nuclear Factor-kappa B; Resorcinols; Signal Transduction; Structure-Activity Relationship; Triazoles; U937 Cells | 2018 |
Lysozyme amyloid fibrillization in presence of tacrine/acridone-coumarin heterodimers.
Topics: Amyloid; Coumarins; Humans; Microscopy, Atomic Force; Muramidase; Tacrine | 2018 |
Chemical profiling and quantitation of bioactive compounds in Platycladi Cacumen by UPLC-Q-TOF-MS/MS and UPLC-DAD.
Topics: Acids; Chromatography, High Pressure Liquid; Coumarins; Drugs, Chinese Herbal; Flavonoids; Medicine, Chinese Traditional; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2018 |
Synthesis and Spectroscopic Properties of Fluorinated Coumarin Lysine Derivatives.
Topics: Chemistry Techniques, Synthetic; Coumarins; Halogenation; Hydrogen-Ion Concentration; Lysine; Spectrum Analysis | 2018 |
Synthesis and evaluation of novel coumarin-oxime ethers as potential anti-tubercular agents: Their DNA cleavage ability and BSA interaction study.
Topics: Animals; Antitubercular Agents; Cattle; Cell Survival; Chlorocebus aethiops; Coumarins; DNA Cleavage; Dose-Response Relationship, Drug; Ethers; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oximes; Serum Albumin, Bovine; Structure-Activity Relationship; Vero Cells | 2018 |
Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.
Topics: Animals; Antimalarials; Coumarins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Design; Malaria, Falciparum; Mice; Molecular Docking Simulation; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2018 |
Coumarin Content, Morphological Variation, and Molecular Phylogenetics of Melilotus.
Topics: Coumarins; DNA, Chloroplast; Genetic Variation; Haplotypes; Melilotus; Phylogeny; Sequence Analysis, DNA | 2018 |
Insect taste receptors relevant to host identification by recognition of secondary metabolite patterns of non-host plants.
Topics: Animals; Bombyx; Calcium; Coumarins; Feeding Behavior; Gene Expression Regulation; HEK293 Cells; Host-Parasite Interactions; Humans; Insect Proteins; Organ Specificity; Plants; Receptors, Cell Surface; Secondary Metabolism; Taste | 2018 |
A ratiometric iron probe enables investigation of iron distribution within tumour spheroids.
Topics: Colorectal Neoplasms; Coumarins; Fluoresceins; Fluorescent Dyes; Humans; Iron; Iron Chelating Agents; Spheroids, Cellular; Tumor Cells, Cultured | 2018 |
Development of coumarin-benzofuran hybrids as versatile multitargeted compounds for the treatment of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzofurans; Binding Sites; Cholinesterase Inhibitors; Coumarins; Donepezil; Drug Design; Humans; Molecular Docking Simulation; Peptide Fragments; Structure-Activity Relationship | 2018 |
A Self-Assembled Coumarin-Anchored Dendrimer for Efficient Gene Delivery and Light-Responsive Drug Delivery.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coumarins; Dendrimers; Drug Delivery Systems; Fluorouracil; Gene Transfer Techniques; HEK293 Cells; Humans; Nanostructures; Neoplasm Proteins; Neoplasms; Phototherapy; TNF-Related Apoptosis-Inducing Ligand | 2018 |
siRNA release from gold nanoparticles by nanosecond pulsed laser irradiation and analysis of the involved temperature increase.
Topics: Coumarins; Drug Carriers; Gold; Lasers; Metal Nanoparticles; Particle Size; RNA, Small Interfering; Temperature | 2018 |
Utility of Von Pechman synthesis of coumarin reaction for development of spectrofluorimetric method for quantitation of salmeterol xinafoate in pharmaceutical preparations and human plasma.
Topics: Acetoacetates; Coumarins; Fluorescent Dyes; Humans; Limit of Detection; Pharmaceutical Preparations; Reproducibility of Results; Salmeterol Xinafoate; Solvents; Spectrometry, Fluorescence; Sulfuric Acids; Temperature; Time Factors | 2018 |
Discovery of coumarin-dihydroquinazolinone analogs as niacin receptor 1 agonist with in-vivo anti-obesity efficacy.
Topics: Animals; Anti-Obesity Agents; Coumarins; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Discovery; Glucose Tolerance Test; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Obesity; Quinazolinones; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Structure-Activity Relationship | 2018 |
Safety evaluation of the temporary consolidant based on a zebrafish embryo model.
Topics: Animals; Coumarins; Cycloparaffins; Embryo, Nonmammalian; Menthol; Pyrones; Spine; Toxicity Tests; Zebrafish | 2018 |
Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Peroxide; Ligands; Molecular Docking Simulation; Molecular Structure; PC12 Cells; Protein Aggregates; Rats; Reactive Oxygen Species; Structure-Activity Relationship; Thioctic Acid | 2018 |
A new isoflavane-4-ol derivative from
Topics: Coumarins; Flavonoids; Fructose; Glucosides; Isoflavones; Melilotus; Plant Components, Aerial; Uridine | 2019 |
Molecular Characterization and Bioactivity of Coumarin Derivatives from the Fruits of Cucumis bisexualis.
Topics: Animals; Cell Line; Coumarins; Cucumis; Fruit; Liver; Mice; Molecular Structure; Plant Extracts; Protective Agents | 2018 |
Chemical study, antioxidant, anti-hypertensive, and cytotoxic/cytoprotective activities of Centaurea cyanus L. petals aqueous extract.
Topics: Anthocyanins; Antihypertensive Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Caffeic Acids; Cell Line, Tumor; Centaurea; Chlorogenic Acid; Chromatography, Liquid; Coumaric Acids; Coumarins; Drug Evaluation, Preclinical; Flowers; Hemolysis; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Lipid Peroxidation; Microbial Sensitivity Tests; Plant Extracts; Quercetin; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Water | 2018 |
Copper-redox cycling by coumarin-di(2-picolyl)amine hybrid molecule leads to ROS-mediated DNA damage and apoptosis: A mechanism for cancer chemoprevention.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cells, Cultured; Copper; Coumarins; DNA Damage; HCT116 Cells; Humans; Lipid Peroxidation; Lymphocytes; MCF-7 Cells; Membrane Potential, Mitochondrial; Microscopy, Electron, Scanning; Molecular Dynamics Simulation; Oxidation-Reduction; Protein Carbonylation; Reactive Oxygen Species; Thermodynamics | 2018 |
Simultaneous identification and quantification of polymethoxyflavones, coumarin and phenolic acids in Ageratum conyzoides by UPLC-ESI-QToF-MS and UPLC-PDA.
Topics: Ageratum; Chromatography, High Pressure Liquid; Coumarins; Flavones; Hydroxybenzoates; Plant Extracts; Plant Leaves; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2017 |
Enzyme-linked immunosorbent assays for therapeutic drug monitoring coumarin oral anticoagulants in plasma.
Topics: Anticoagulants; Blood Chemical Analysis; Coumarins; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Humans | 2018 |
Bimolecular fluorescence quenching reactions of the biologically active coumarin composite 2-acetyl-3H-benzo[f]chromen-3-one in different solvents.
Topics: Coumarins; Fluorescence; Molecular Structure; Solvents; Spectrometry, Fluorescence | 2018 |
Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
Topics: Alkynes; Antineoplastic Agents; Azides; Catalysis; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Copper; Coumarins; Cycloaddition Reaction; Drug Design; Humans; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Monophenol Monooxygenase; Pyrazoles; Structure-Activity Relationship; Triazoles | 2018 |
Multiple dye-doped silica cross-linked micellar nanoparticles for colour-tuneable sensing of cysteine in an aqueous media and living cells.
Topics: Coumarins; Cysteine; Fluorescein; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; HeLa Cells; Humans; Micelles; Nanoparticles; Optical Imaging; Rhodamines; Silicon Dioxide | 2018 |
Investigation of potential toxic components based on the identification of Genkwa Flos chemical constituents and their metabolites by high-performance liquid chromatography coupled with a Q Exactive high-resolution benchtop quadrupole Orbitrap mass spectr
Topics: Animals; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Coumarins; Diterpenes; Drugs, Chinese Herbal; Flavonoids; Glycosides; Humans; Lignans; Male; Mass Spectrometry; Medicine, Chinese Traditional; Molecular Structure; Rats; Rats, Sprague-Dawley | 2018 |
Coumarin/fluorescein-fused fluorescent dyes for rapidly monitoring mitochondrial pH changes in living cells.
Topics: Coumarins; Fluorescein; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen-Ion Concentration; Mitochondria; Spectrometry, Fluorescence | 2018 |
Tacrine-coumarin and Tacrine-7-chloroquinoline Hybrids with Thiourea Linkers: Cholinesterase Inhibition Properties, Kinetic Study, Molecular Docking and Permeability Assay for Blood-brain Barrier.
Topics: Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Coumarins; Humans; Kinetics; Models, Molecular; Molecular Docking Simulation; Permeability; Structure-Activity Relationship; Tacrine; Thiourea | 2018 |
A Click Cage: Organelle-Specific Uncaging of Lipid Messengers.
Topics: Arachidonic Acid; Calcium; Click Chemistry; Coumarins; Endoplasmic Reticulum; HeLa Cells; Humans; Lysosomes; Microscopy, Fluorescence; Mitochondria; Organelles; Sphingosine; Time-Lapse Imaging; Ultraviolet Rays | 2018 |
Osthole Protects against Acute Lung Injury by Suppressing NF-
Topics: Active Transport, Cell Nucleus; Acute Lung Injury; Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Coumarins; Enzyme-Linked Immunosorbent Assay; Inflammation; Lung Injury; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; NF-kappa B; Real-Time Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2018 |
Coumarin-based Fluorescent Probes for Selectively Targeting and Imaging the Endoplasmic Reticulum in Mammalian Cells.
Topics: Coumarins; Endoplasmic Reticulum; Fluorescent Dyes; HeLa Cells; Humans | 2019 |
Rational Design and Bioimaging Applications of Highly Specific "Turn-On" Fluorescent Probe for Hypochlorite.
Topics: Animals; Azides; Cell Line, Tumor; Coumarins; Fluorescent Dyes; Humans; Hypochlorous Acid; Mice; Microscopy, Confocal; Models, Biological; RAW 264.7 Cells; Reactive Oxygen Species; Spectrometry, Fluorescence | 2018 |
A Hybrid Coumarin-Semifluorescein-Based Fluorescent Probe for the Detection of Cysteine.
Topics: Coumarins; Cysteine; Fluorescein; Fluorescent Dyes; Humans; MCF-7 Cells; Spectrometry, Fluorescence | 2018 |
Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: Design, synthesis and antibacterial activity.
Topics: Anti-Bacterial Agents; Coumarins; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Humans; Listeria monocytogenes; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Salmonella; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2018 |
Assessment of the skin sensitizing potential of chemicals, contained in foods and/or cosmetic ingredients, using a modified local lymph node assay with an elicitation phase (LLNA:DAE) method.
Topics: Animals; Carmine; Cosmetics; Coumarins; Curcumin; Dose-Response Relationship, Drug; Female; Food Analysis; Local Lymph Node Assay; Mice, Inbred CBA; Naphthoquinones; Quercetin; Skin; Skin Irritancy Tests; Umbelliferones | 2018 |
Synthesis and antitumor mechanisms of two novel platinum(ii) complexes with 3-(2'-benzimidazolyl)-7-methoxycoumarin.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Coumarins; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Ligands; Mitochondria; Models, Molecular; Molecular Structure; Organoplatinum Compounds; Ovarian Neoplasms; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; Telomerase; Tumor Cells, Cultured | 2018 |
Design, Synthesis, and Antiproliferative Evaluation of Novel Coumarin/2-Cyanoacryloyl Hybrids as Apoptosis Inducing Agents by Activation of Caspase-Dependent Pathway.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Shape; Coumarins; Cyanoacrylates; Drug Design; Enzyme Activation; Humans; Signal Transduction | 2018 |
Antipruritic Effect of Natural Coumarin Osthole through Selective Inhibition of Thermosensitive TRPV3 Channel in the Skin.
Topics: Animals; Antipruritics; Calcium Channel Blockers; Cell Line; Coumarins; HEK293 Cells; Humans; Keratinocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pruritus; Signal Transduction; Skin; TRPV Cation Channels | 2018 |
Biological Degradation of Aflatoxin B₁ by Cell-Free Extracts of Bacillus velezensis DY3108 with Broad PH Stability and Excellent Thermostability.
Topics: Aflatoxin B1; Bacillus; Biodegradation, Environmental; Coumarins; Hot Temperature; Hydrogen-Ion Concentration | 2018 |
The Coumarin Glucoside, Esculin, Reveals Rapid Changes in Phloem-Transport Velocity in Response to Environmental Cues.
Topics: Arabidopsis; Biological Transport; Carbon; Coumarins; Environment; Esculin; Glucosides; Membrane Transport Proteins; Phloem; Plant Proteins | 2018 |
A latent green fluorescent styrylcoumarin probe for the selective growth and detection of Gram negative bacteria.
Topics: Anti-Infective Agents; CD13 Antigens; Coumarins; Fluorescent Dyes; Gram-Negative Bacteria; Gram-Positive Bacteria; Pseudomonas aeruginosa; Substrate Specificity; Yeasts | 2018 |
Cationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studies.
Topics: Arginine; Cations; Cholesterol; Circular Dichroism; Computer Simulation; Coumarins; DNA; Gene Transfer Techniques; Genetic Therapy; HEK293 Cells; Humans; Liposomes; Molecular Dynamics Simulation; Particle Size; Phosphatidylcholines | 2019 |
Industrial countercurrent chromatography separations based on a cascade of centrifugal mixer-settler extractors.
Topics: Caffeine; Centrifugation; Coumarins; Countercurrent Distribution; Metals, Rare Earth; Models, Theoretical; Solvents | 2018 |
Salivary Hydrogen Sulfide Measured with a New Highly Sensitive Self-Immolative Coumarin-Based Fluorescent Probe.
Topics: Adult; Biosensing Techniques; Coumarins; Female; Fluorescent Dyes; Humans; Hydrogen Sulfide; Male; Molecular Structure; Saliva; Valerates; Young Adult | 2018 |
Coumarin derivatives as promising xanthine oxidase inhibitors.
Topics: Allopurinol; Catalytic Domain; Coumarins; Enzyme Inhibitors; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Xanthine Oxidase | 2018 |
5-Phenylcoumarin Derivatives: Design, Synthesis, and Vasodilatory Activity.
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Drug Design; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Sprague-Dawley; Vasodilation | 2018 |
Naked-eye Detection of Hg
Topics: Colorimetry; Coumarins; Environmental Pollutants; Fluorescent Dyes; Limit of Detection; Mercury; Molecular Structure; Spectrometry, Fluorescence | 2018 |
Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
Topics: Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2018 |
Rapid and Visual Detection of Benzoyl Peroxide in Food by a Colorimetric and Ratiometric Fluorescent Probe.
Topics: Benzoyl Peroxide; Color; Colorimetry; Coumarins; Fluorescent Dyes; Food Analysis; Food Contamination; Humans; Limit of Detection; Spectrometry, Fluorescence | 2018 |
Synthesis and biological evaluation of substituted 3-(2'-benzimidazolyl)coumarin platinum(II) complexes as new telomerase inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coumarins; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Organoplatinum Compounds; Platinum; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Structure-Activity Relationship; Telomerase | 2018 |
The fluorescent biomarkers for lipid droplets with quinolone-coumarin unit.
Topics: Biomarkers; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen-Ion Concentration; Lipid Droplets; Microscopy, Fluorescence; Optical Imaging; Quinolines; Spectrometry, Fluorescence; Water | 2018 |
Seasonal changes and solvent effects on fractionated functional food component yields from Mikania laevigata leaves.
Topics: Chemical Fractionation; Coumarins; Functional Food; Mikania; Plant Extracts; Plant Leaves; Seasons; Secondary Metabolism; Solvents | 2019 |
A biological, fluorescence and computational examination of synthetic coumarin derivatives with antithrombotic potential.
Topics: Animals; Computer Simulation; Coumarins; Fibrinolytic Agents; Liver; Molecular Docking Simulation; Organ Culture Techniques; Protein Structure, Secondary; Spectrometry, Fluorescence; Swine | 2018 |
Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Coumarins; Disease Models, Animal; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis | 2018 |
Rewired Downregulation of DNA Gyrase Impacts Cell Division, Expression of Topology Modulators, and Transcription in Mycobacterium smegmatis.
Topics: Bacterial Proteins; Cell Division; Coumarins; DNA Gyrase; Gene Deletion; Gene Expression Regulation, Bacterial; Gene Knockdown Techniques; Mycobacterium smegmatis; Operon; Topoisomerase II Inhibitors; Transcription, Genetic | 2018 |
PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor.
Topics: Caco-2 Cells; Cell Line, Tumor; Coumarins; Drug Carriers; Humans; Inhibitory Concentration 50; Microscopy, Electron, Scanning; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nanoparticles; Parkinson Disease; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Surface-Active Agents | 2018 |
Osthole alleviates oxidized low-density lipoprotein-induced vascular endothelial injury through suppression of transforming growth factor-β1/Smad pathway.
Topics: Atherosclerosis; Cell Survival; Coumarins; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1 | 2018 |
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Cells, Cultured; Coumarins; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Madin Darby Canine Kidney Cells; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Tetrahydroisoquinolines | 2019 |
Turn-On Fluorescence Probe for Nitric Oxide Detection and Bioimaging in Live Cells and Zebrafish.
Topics: Animals; Cell Survival; Coumarins; Fluorescent Dyes; Humans; Limit of Detection; MCF-7 Cells; Molecular Imaging; Nitric Oxide; Zebrafish | 2019 |
Development of a mitochondrial-targeted ratiometric probe for the detection of SO
Topics: Animals; Coumarins; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Mitochondria; Molecular Imaging; Sulfur Dioxide; Zebrafish | 2019 |
Synthesis of new coumarin tethered isoxazolines as potential anticancer agents.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coumarins; Disease Models, Animal; Humans; Isoxazoles; Microvessels; Structure-Activity Relationship; Survival Rate | 2018 |
Single-Sided Competitive Axial Coordination of G-Quadruplex/Hemin as Molecular Switch for Imaging Intracellular Nitric Oxide.
Topics: Biosensing Techniques; Coumarins; Fluorescent Dyes; G-Quadruplexes; Gold; HeLa Cells; Hemin; Humans; Imidazoles; Ligands; Metal Nanoparticles; Microscopy, Confocal; Nitric Oxide; Spectrophotometry | 2019 |
Photoresponsive, Water-Soluble Supramolecular Dendronized Polymer with Specific Lysosome-Targetable Bioimaging Application in Living Cells.
Topics: Coumarins; Dendrimers; Fluorescence; gamma-Cyclodextrins; Humans; Lysosomes; Magnetic Resonance Spectroscopy; MCF-7 Cells; Microscopy, Confocal; Models, Chemical; Molecular Structure; Photochemical Processes; Polymers; Solubility; Water | 2019 |
Resonance Energy Transfer in a Genetically Engineered Polypeptide Results in Unanticipated Fluorescence Intensity.
Topics: Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Maleimides; Models, Molecular; Peptides; Protein Conformation, beta-Strand; Protein Folding; Tryptophan | 2019 |
Sensitization to fragrances in Spain: A 5-year multicentre study (2011-2015).
Topics: Acyclic Monoterpenes; Adult; Aged; Aged, 80 and over; Aldehydes; Anti-Infective Agents; Coumarins; Cyclohexenes; Dermatitis, Allergic Contact; Dermatitis, Occupational; Eugenol; Facial Dermatoses; Farnesol; Female; Hand Dermatoses; Humans; Leg Dermatoses; Longitudinal Studies; Male; Middle Aged; Monoterpenes; Myroxylon; Patch Tests; Perfume; Propanols; Retrospective Studies; Spain; Terpenes | 2019 |
A fluorescent probe for hypochlorite with colorimetric and fluorometric characteristics and imaging in living cells.
Topics: A549 Cells; Colorimetry; Coumarins; Fluorescent Dyes; Fluorometry; Humans; Hydroxylamine; Hypochlorous Acid | 2019 |
Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Cells, Cultured; Cerebral Cortex; Coumarins; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Lipopolysaccharides; Membrane Proteins; Microglia; Prostaglandin-E Synthases; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, G-Protein-Coupled | 2018 |
Suitability of MMGBSA for the selection of correct ligand binding modes from docking results.
Topics: Binding Sites; Coumarins; Cytochrome P-450 CYP2A6; Humans; Ligands; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Substrate Specificity; Thermodynamics | 2019 |
A coumarin-based fluorescent probe for ratiometric detection of hydrazine and its application in living cells.
Topics: Acetates; Buffers; Chlorides; Coumarins; Fluorescent Dyes; Fluorometry; HeLa Cells; Humans; Hydrazines; Hydrogen-Ion Concentration; Limit of Detection; Microscopy, Fluorescence; Molecular Imaging; Sensitivity and Specificity | 2019 |
Coumarin-Based Fluorescent Probes for Super-resolution and Dynamic Tracking of Lipid Droplets.
Topics: Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Lipid Droplets; Molecular Structure; Particle Size; Photons; Surface Properties | 2019 |
Simultaneous qualitative and quantitative evaluation of Toddalia asiatica root by using HPLC-DAD and UPLC-QTOF-MS/MS.
Topics: Alkaloids; Chromatography, High Pressure Liquid; Cluster Analysis; Coumarins; Discriminant Analysis; Flavonoids; Hydroxybenzoates; Limit of Detection; Plant Roots; Principal Component Analysis; Reference Standards; Reproducibility of Results; Rutaceae; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry | 2019 |
An On-Off-On Fluorescence Probe Based on Coumarin for Cu
Topics: A549 Cells; Biosensing Techniques; Copper; Coumarins; Cysteine; Fluorescence; Fluorescent Dyes; Histidine; Humans; Limit of Detection; Quantum Dots; Reproducibility of Results; Schiff Bases; Spectrometry, Fluorescence | 2019 |
A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Coumarins; Dexamethasone; Drug Liberation; Guinea Pigs; Hair Cells, Auditory, Outer; Hearing Loss; Nanoparticles; Peptides; Proteins | 2018 |
Insight into the Dynamics of Different Fluorophores in the Interior of Aerosol OT Lamellar Structures in the Presence of Sugars: From Picosecond-to-Femtosecond Study.
Topics: Aerosols; Coumarins; Fluorescent Dyes; Molecular Dynamics Simulation; Molecular Structure; Sucrose; Time Factors | 2019 |
A novel OFF-ON-OFF fluorescence probe based on coumarin for Al
Topics: Aluminum; Cell Line, Tumor; Coumarins; Density Functional Theory; Fluorescent Dyes; Fluorides; HEPES; Humans; Hydrogen-Ion Concentration; Limit of Detection; Molecular Imaging; Molecular Structure; Normal Distribution; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Tea; Toothpastes | 2019 |
Photodegradable coumarin-derived amphiphilic dendrons for DNA binding: Self-assembly and phototriggered disassembly in water and air-water interface.
Topics: Air; Coumarins; Dendrimers; DNA; Fluorescence; Hydrophobic and Hydrophilic Interactions; Micelles; Photolysis; Surface Properties; Water | 2019 |
Convenient Synthesis of Functionalized Cyclopropa[
Topics: Carboxylic Acids; Coumarins; Cyclopropanes; Esterification | 2018 |
Photoinduced Electron Transfer-Regulated Protein Labeling With a Coumarin-Based Multifunctional Photocrosslinker.
Topics: Coumarins; Cross-Linking Reagents; Electron Transport; Molecular Structure; Photochemical Processes; Proteins | 2019 |
Novel synthetic chalcone-coumarin hybrid for Aβ aggregation reduction, antioxidation, and neuroprotection.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Antioxidants; Cell Line, Tumor; Chalcone; Coumarins; Dose-Response Relationship, Drug; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Inhibitory Concentration 50; Neuroblastoma; Neuronal Outgrowth; Protein Aggregates; Reactive Oxygen Species; RNA Interference; RNA, Messenger; Transfection | 2018 |
End-product inhibition of skatole-metabolising enzymes CYP1A, CYP2A19 and CYP2E1 in porcine and piscine hepatic microsomes.
Topics: Acetophenones; Animals; Coumarins; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Cytochrome P-450 Enzyme System; Fishes; Liver; Male; Microsomes, Liver; Nitrophenols; Oxazines; Red Meat; Seafood; Skatole; Species Specificity; Swine | 2019 |
Photocrosslinked hydrogels from coumarin derivatives of hyaluronic acid for tissue engineering applications.
Topics: Animals; Cell Line; Coumarins; Cross-Linking Reagents; Humans; Hyaluronic Acid; Hydrogels; Materials Testing; Mice; Photochemical Processes; Tissue Engineering; Ultraviolet Rays | 2019 |
Activity of coumarin against Candida albicans biofilms.
Topics: Antifungal Agents; Biofilms; Candida albicans; Coumarins; Fungal Proteins; Gentian Violet; Hyphae; Membrane Glycoproteins | 2019 |
Synthesis, CYP 450 evaluation, and docking simulation of novel 4-aminopyridine and coumarin derivatives.
Topics: 4-Aminopyridine; Central Nervous System Diseases; Coumarins; Cytochrome P-450 Enzyme System; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Structure; Potassium Channels; Protein Binding | 2019 |
Fluorescence Quenching-Based Mechanism for Determination of Hypochlorite by Coumarin-Derived Sensors.
Topics: Biosensing Techniques; Coumarins; Fluorescence; Fluorescent Dyes; Hypochlorous Acid; Molecular Structure; Spectrometry, Fluorescence | 2019 |
A new coumarin from
Topics: Coumarins; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Murraya; Pain; Plant Leaves; Rutaceae; TRPV Cation Channels | 2020 |
A ratiometric fluorescent probe for the detection of endogenous hydroxyl radicals in living cells.
Topics: Cell Line, Tumor; Coumarins; Fluorescent Dyes; Humans; Hydroxyl Radical; Optical Imaging; Reactive Nitrogen Species; Spectrometry, Fluorescence | 2019 |
New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Coumarins; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2019 |
Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Non-Small-Cell Lung; Caspase 8; Caspase 9; Cell Line, Tumor; Coumarins; Humans; Lung Neoplasms; Poly(ADP-ribose) Polymerases; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; X-Linked Inhibitor of Apoptosis Protein | 2019 |
Chikungunya virus inhibition by synthetic coumarin-guanosine conjugates.
Topics: Animals; Antiviral Agents; Chikungunya virus; Chlorocebus aethiops; Coumarins; Guanosine; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Vero Cells | 2019 |
A dual-channel probe with green and near-infrared fluorescence changes for in vitro and in vivo detection of peroxynitrite.
Topics: Animals; Cell Survival; Color; Coumarins; Fluorescent Dyes; Infrared Rays; Mice; Molecular Imaging; Peroxynitrous Acid; RAW 264.7 Cells; Spectrometry, Fluorescence | 2019 |
Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coumarins; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Imines; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Thiazoles | 2019 |
Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Coumarins; Epithelial-Mesenchymal Transition; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Oximes; Pyrazoles; Structure-Activity Relationship; Transforming Growth Factor beta1 | 2019 |
A novel coumarin-based fluorescent probe for sensitive detection of copper(II) in wine.
Topics: Copper; Coumarins; Fluorescence; Fluorescent Dyes; Limit of Detection; Spectrometry, Fluorescence; Water; Wine | 2019 |
Identification of a cytochrome P450 CYP6AB60 gene associated with tolerance to multi-plant allelochemicals from a polyphagous caterpillar tobacco cutworm (Spodoptera litura).
Topics: Animals; Coumarins; Cytochrome P450 Family 6; Drug Tolerance; Gene Expression Regulation, Enzymologic; Insect Proteins; Larva; Methoxsalen; Pheromones; RNA Interference; Spodoptera; Tomatine | 2019 |
A coumarin-based colorimetric fluorescent probe for rapid response and highly sensitive detection of hydrogen sulfide in living cells.
Topics: Animals; Cell Line; Cell Survival; Colorimetry; Coumarins; Cricetinae; Dose-Response Relationship, Drug; Fluorescent Dyes; Hydrogen Sulfide; Molecular Structure; Optical Imaging; Structure-Activity Relationship | 2019 |
A Dual-Purpose Bromocoumarin Tag Enables Deep Profiling of the Cellular Cysteinome.
Topics: Coumarins; Cysteine; Fluorescence; Fluorescent Dyes; Halogenation; Humans; K562 Cells; Peptides; Proteomics; Tandem Mass Spectrometry | 2019 |
A parallel permeability assay of peptides across artificial membranes and cell monolayers using a fluorogenic reaction.
Topics: Alkynes; Animals; Caco-2 Cells; Cell Membrane Permeability; Coumarins; Dogs; Fluorescent Dyes; Humans; Madin Darby Canine Kidney Cells; Membranes, Artificial; Molecular Structure; Optical Imaging; Peptides | 2019 |
The in vitro and in vivo anti-inflammatory effect of osthole, the major natural coumarin from Cnidium monnieri (L.) Cuss, via the blocking of the activation of the NF-κB and MAPK/p38 pathways.
Topics: Animals; Anti-Inflammatory Agents; Cnidium; Colitis, Ulcerative; Coumarins; Dinoprostone; Disease Models, Animal; Mice; Mice, Inbred BALB C; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; RAW 264.7 Cells; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |
New coumarin- and phenoxazine-based fluorescent probes for live-cell STED nanoscopy.
Topics: Cell Line; Cell Survival; Coumarins; Epithelial Cells; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Nanotechnology; Oxazines; Photobleaching | 2019 |
Fluorogenic l-alanylaminopeptidase substrates derived from 6-amino-2-hetarylquinolines and 7-amino-3-hetarylcoumarins and their potential applications in diagnostic microbiology.
Topics: CD13 Antigens; Coumarins; Enzyme Assays; Fluorescent Dyes; Gram-Negative Bacteria; Quinolines; Spectrometry, Fluorescence; Substrate Specificity | 2019 |
Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Survival; Coordination Complexes; Coumarins; HeLa Cells; Humans; Iridium; Light; Neoplasms; Photochemotherapy; Superoxides | 2019 |
A new pyrano coumarin from
Topics: alpha-Glucosidases; Antioxidants; Carbazoles; Clausena; Coumarins; Free Radicals; Glycoside Hydrolase Inhibitors; Plant Extracts; Plant Roots; Pyrans | 2021 |
Anatolicin, a Highly Potent and Selective Cytotoxic Sesquiterpene Coumarin from the Root Extract of
Topics: Antineoplastic Agents, Phytogenic; Apiaceae; Cell Line, Tumor; Cell Proliferation; Coumarins; Humans; Kidney Neoplasms; Molecular Structure; Plant Extracts; Plant Roots; Sesquiterpenes | 2019 |
Use of Core-Cross-Linked Polymeric Micelles Induced by the Selective Detection of Cu(II) Ions for the Sustained Release of a Model Drug.
Topics: Acrylamides; Colorimetry; Coordination Complexes; Copper; Coumarins; Drug Carriers; Ions; Micelles; Pharmaceutical Preparations; Polymers | 2019 |
The Molecular and Structural Basis of
Topics: Amino Acid Sequence; Apiaceae; Biosynthetic Pathways; Coumarins; Data Mining; Evolution, Molecular; Furocoumarins; Gene Duplication; Heterozygote; Methylation; Methyltransferases; Molecular Docking Simulation; Phytochemicals; S-Adenosylhomocysteine; Sequence Analysis, RNA; Substrate Specificity; Transcriptome; Umbelliferones | 2019 |
General Strategy for in Situ Generation of a Coumarin-Cu
Topics: Copper; Coumarins; Deuterium; Fluorescent Dyes; Spectrometry, Fluorescence; Water | 2019 |
Effect of cattle-specific estrus molecules on libido and semen production of zebu bulls under tropical climate.
Topics: Acetic Acid; Animals; Butanones; Cattle; Coumarins; Estrus; India; Libido; Male; Oleic Acid; Propionates; Semen; Spermatogenesis; Squalene; Tropical Climate | 2019 |
Reactivity Modulation of Benzopyran-Coumarin Platform by Introducing Electron-Withdrawing Groups: Specific Detection of Biothiols and Peroxynitrite.
Topics: Animals; Benzopyrans; Coumarins; Electrons; Fluorescent Dyes; Hep G2 Cells; Humans; Mice; Mice, Inbred Strains; Molecular Structure; Optical Imaging; PC12 Cells; Peroxynitrous Acid; Rats; Sulfhydryl Compounds | 2019 |
Synthesis and biological evaluation of coumarin-1,3,4-oxadiazole hybrids as selective carbonic anhydrase IX and XII inhibitors.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Coumarins; Dose-Response Relationship, Drug; Humans; Isoenzymes; Molecular Structure; Oxadiazoles; Structure-Activity Relationship | 2019 |
Tissue-Specific Metabolite Profiling on the Different Parts of Bolting and Unbolting
Topics: Apiaceae; Chromatography, High Pressure Liquid; Coumarins; Humans; Mass Spectrometry; Medicine, Chinese Traditional; Organ Specificity; Plant Roots; Pyranocoumarins; Xylem | 2019 |
FRET Assay for Ligands Targeting the Bacterial A-Site RNA.
Topics: Aminoglycosides; Coumarins; Fluorescence; Fluorescence Resonance Energy Transfer; Ligands; RNA, Bacterial; Uridine | 2019 |
Soil carbonate drives local adaptation in Arabidopsis thaliana.
Topics: Adaptation, Physiological; Arabidopsis; Calcium; Carbonates; Chlorophyll; Coumarins; Iron; Phenols; Plant Extracts; Plant Leaves; Soil; Stress, Physiological | 2019 |
Enantioselective Total Synthesis of (+)-Monocerin, a Dihydroisocoumarin Derivative with Potent Antimalarial Properties.
Topics: Antimalarials; Chemistry Techniques, Synthetic; Coumarins; Lactones; Stereoisomerism | 2019 |
Design, Synthesis, and Mechanism of Dihydroartemisinin⁻Coumarin Hybrids as Potential Anti-Neuroinflammatory Agents.
Topics: Anti-Inflammatory Agents; Artemisinins; Cell Line, Tumor; Cell Survival; Coumarins; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2019 |
Trifunctional Fluorogenic Probes for Fluorescence Imaging and Isolation of Glycosidases in Cells.
Topics: Chromatography, Affinity; Coumarins; Fluorescent Dyes; Glycoside Hydrolases; HT29 Cells; Humans; Molecular Structure; Optical Imaging; Sugars | 2019 |
Multiphoton fluorescence lifetime imaging microscopy (FLIM) and super-resolution fluorescence imaging with a supramolecular biopolymer for the controlled tagging of polysaccharides.
Topics: Boronic Acids; Cell Line; Cell Survival; Coumarins; Drug Carriers; Fluorescent Dyes; Humans; Microscopy, Atomic Force; Microscopy, Fluorescence, Multiphoton; Nanostructures; Polysaccharides | 2019 |
Ratiometric fluorogenic determination of endogenous hypochlorous acid in living cells.
Topics: Animals; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hypochlorous Acid; Mice; Optical Imaging; RAW 264.7 Cells; Rhodamines; Spectrometry, Fluorescence; Water | 2019 |
A copper(ii)-dipicolylamine-coumarin sensor for maltosyltransferase assay.
Topics: Amines; Biocatalysis; Copper; Coumarins; Dimerization; Enzyme Assays; Glucosyltransferases; Organometallic Compounds; Picolinic Acids | 2019 |
Antiviral efficiency of a coumarin derivative on spring viremia of carp virus in vivo.
Topics: Animals; Antiviral Agents; Aquaculture; Coumarins; Fish Diseases; Rhabdoviridae; Rhabdoviridae Infections; Viral Load; Zebrafish | 2019 |
Genetic diversity of cytochrome P450 1A2 with different metabolic activities in domestic cats.
Topics: Animals; Cats; Coumarins; Cytochrome P-450 CYP1A2; Female; Genetic Variation; Hydroxylation; Liver; Male; Recombinant Proteins; Sequence Analysis, DNA | 2019 |
Genetic diversity of cytochrome P450 2A with different metabolic activities in domestic cats.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cats; Coumarins; Female; Genetic Variation; Hydroxylation; Liver; Male; Recombinant Proteins; Sequence Analysis, DNA; Steroid Hydroxylases | 2019 |
Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Coumarins; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Humans; Liposomes; Lung; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Particle Size; Peptides; Phosphatidylethanolamines; Polyethylene Glycols; Quercetin; Receptors, Transferrin; Spheroids, Cellular; Tissue Distribution | 2019 |
A dual electron-withdrawing enhanced selective/sensitive chemodosimeter for detection on bisulfate and its living cell imaging.
Topics: Acetates; Coumarins; Electrons; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen-Ion Concentration; Limit of Detection; Molecular Imaging; Sensitivity and Specificity; Solubility; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Sulfates; Sulfites; Sulfur Dioxide | 2019 |
The Arabidopsis non-host defence-associated coumarin scopoletin protects soybean from Asian soybean rust.
Topics: Arabidopsis; Coumarins; Disease Resistance; Gene Expression Profiling; Gene Expression Regulation, Plant; Glycine max; Host-Pathogen Interactions; Phakopsora pachyrhizi; Plant Diseases; Plant Leaves; Scopoletin | 2019 |
Structure-based design and synthesis of new 4-methylcoumarin-based lignans as pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) inhibitors.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Coumarins; Drug Design; Interleukin-1beta; Interleukin-6; Lignans; Lipopolysaccharides; Macrophages; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide; Protein Structure, Tertiary; RAW 264.7 Cells; Signal Transduction; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2019 |
Design, synthesis, in vivo, and in silico evaluation of new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant agents.
Topics: Animals; Anticonvulsants; Binding Sites; Coumarins; Drug Design; Male; Mice; Molecular Docking Simulation; Muscles; Oxadiazoles; Protein Structure, Tertiary; Receptors, GABA-A; Rotarod Performance Test; Seizures; Structure-Activity Relationship | 2019 |
A novel coumarin-based fluorescent probe with fine selectivity and sensitivity for hypochlorite and its application in cell imaging.
Topics: Cells, Cultured; Coumarins; Fluorescent Dyes; HEK293 Cells; Humans; Hypochlorous Acid; Molecular Structure; Optical Imaging; Quantum Theory | 2019 |
A coumarin-based fluorescent probe for hypochlorite ion detection in environmental water samples and living cells.
Topics: Cell Line, Tumor; Coumarins; Fluorescent Dyes; Humans; Hypochlorous Acid; Ions; Molecular Structure; Optical Imaging; Water Pollution, Chemical | 2019 |
Self-delivery of N-hydroxylethyl peptide assemblies to the cytosol inducing endoplasmic reticulum dilation in cancer cells.
Topics: Apoptosis; Carboxylesterase; Cell Line, Tumor; Cell Survival; Coumarins; Cytosol; Endoplasmic Reticulum Stress; Humans; Microscopy, Fluorescence; Peptides; Prodrugs | 2019 |
Influence of environmental factors on the volatile composition of two Brazilian medicinal plants: Mikania laevigata and Mikania glomerata.
Topics: Bicyclic Monoterpenes; Brazil; Coumarins; Droughts; Mikania; Plants, Medicinal; Sesquiterpenes, Germacrane; Stress, Physiological; Temperature; Volatile Organic Compounds | 2019 |
Fluorogenic 7-azidocoumarin and 3/4-azidophthalimide derivatives as indicators of reductase activity in microorganisms.
Topics: Coumarins; Fluorescent Dyes; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Nitroreductases; Phthalimides; Substrate Specificity | 2019 |
Antimicrobial secondary metabolites from the stem barks and leaves of Monotes kerstingii Gilg (Dipterocarpaceae).
Topics: Anthelmintics; Anti-Bacterial Agents; Antifungal Agents; Cameroon; Coumarins; Dipterocarpaceae; Glycosides; Molecular Structure; Phytochemicals; Plant Bark; Plant Leaves | 2019 |
Simultaneous determination of 19 constituents in Cimicifugae Rhizoma by HPLC-DAD and screening for antioxidants through DPPH free radical scavenging assay.
Topics: Alkaloids; Antioxidants; Biphenyl Compounds; Chromatography, High Pressure Liquid; Cimicifuga; Coumarins; Drugs, Chinese Herbal; Free Radicals; Hydroxybenzoates; Limit of Detection; Linear Models; Picrates; Reproducibility of Results | 2019 |
Cellular target identification of Withangulatin A using fluorescent analogues and subsequent chemical proteomics.
Topics: Cell Line, Tumor; Coumarins; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Pregnenes; Proteomics; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2019 |
Constitutive expression of GmF6'H1 from soybean improves salt tolerance in transgenic Arabidopsis.
Topics: Arabidopsis; Chlorophyll; Cloning, Molecular; Coumarins; Gene Expression Profiling; Gene Expression Regulation, Plant; Germination; Glycine max; Phenotype; Plant Leaves; Plants, Genetically Modified; Promoter Regions, Genetic; Salt Tolerance | 2019 |
Pressurized Hot Water Extraction and Capillary Electrophoresis for Green and Fast Analysis of Useful Metabolites in Plants.
Topics: Coumarins; Electrophoresis, Capillary; Liquid-Liquid Extraction; Plant Extracts; Plant Leaves; Plants; Sesquiterpenes | 2019 |
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship | 2019 |
Robust synthesis of sugar-coumarin based fluorescent 1,4-disubstituted-1,2,3-triazoles using highly efficient recyclable citrate grafted β-cyclodextrin@magnetite nano phase transfer catalyst in aqueous media.
Topics: beta-Cyclodextrins; Catalysis; Chemistry Techniques, Synthetic; Citric Acid; Coumarins; Fluorescent Dyes; Magnetite Nanoparticles; Recycling; Sugars; Triazoles; Water | 2019 |
Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Peroxide; Iron Chelating Agents; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyridines; Scopolamine; Structure-Activity Relationship | 2019 |
Insight into triphenylamine and coumarin serving as copper (II) sensors with "OFF" strategy and for bio-imaging in living cells.
Topics: Aniline Compounds; Cell Line, Tumor; Copper; Coumarins; Crystallography, X-Ray; Humans; Spectrometry, Fluorescence | 2020 |
One- and two-photon responsive injectable nano-bundle biomaterials from co-assembled lipopeptides for controlling molecular diffusion.
Topics: Animals; Biocompatible Materials; Cattle; Cell Survival; Coumarins; Diffusion; Doxorubicin; Drug Carriers; Drug Liberation; HeLa Cells; Humans; Infrared Rays; Lipopeptides; Nanotubes; Photons; Rheology; Serum Albumin, Bovine; Shear Strength; Ultraviolet Rays | 2019 |
pH-labile and photochemically cross-linkable polymer vesicles from coumarin based random copolymer for cancer therapy.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Coumarins; Cross-Linking Reagents; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Molecular Structure; Osteosarcoma; Particle Size; Photochemical Processes; Polymers; Surface Properties | 2019 |
Alcohol Participates in the Synthesis of Functionalized Coumarin-Fused Pyrazolo[3,4-
Topics: Chemistry Techniques, Synthetic; Coumarins; Ethanol; Microwaves; Molecular Conformation; Molecular Structure; Pyrazoles; Pyridines | 2019 |
Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties.
Topics: Antineoplastic Agents; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Quinolines; Steroids; Stomach Neoplasms; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2019 |
Synthesis, In silico and Biological Studies of Thiazolyl-2h-chromen-2-one Derivatives as Potent Antitubercular Agents.
Topics: Antitubercular Agents; Coumarins; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Mycobacterium tuberculosis | 2020 |
Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Topics: alpha-Glucosidases; Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Drug Design; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Infant; Kinetics; Molecular Docking Simulation; Molecular Structure; Saccharomyces cerevisiae; Structure-Activity Relationship; Triazoles | 2019 |
Coumarin tethered cyclic imides as efficacious glucose uptake agents and investigation of hit candidate to probe its binding mechanism with human serum albumin.
Topics: Binding Sites; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Hypoglycemic Agents; Imides; Models, Molecular; Molecular Structure; Serum Albumin; Structure-Activity Relationship | 2019 |
A click chemistry approach for the synthesis of cyclic ureido tethered coumarinyl and 1-aza coumarinyl 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis H37Rv and their in silico studies.
Topics: Algorithms; Antitubercular Agents; Click Chemistry; Coumarins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Uracil | 2019 |
Luciferase-Induced Photouncaging: Bioluminolysis.
Topics: Adenine; Coumarins; Fluorescence Resonance Energy Transfer; HeLa Cells; Humans; Luciferases; Luminescent Measurements; Luminescent Proteins; Piperidines; Protein Binding; Pyrazoles; Pyrimidines | 2019 |
Estimation of bisulfate in edible plant foods, dog urine, and drugs: picomolar level detection and bio-imaging in living organisms.
Topics: Alanine; Animals; Artemia; Bacteria; Coumarins; Dogs; Fluorescent Dyes; Food Analysis; Glycine; Humans; Hydrogen-Ion Concentration; Limit of Detection; Optical Imaging; Permeability; Plants, Edible; Sensitivity and Specificity; Sulfates; Water | 2019 |
Computational study on the antioxidant property of coumarin-fused coumarins.
Topics: Antioxidants; Computational Biology; Coumarins; Electron Transport; Oxidation-Reduction; Thermodynamics | 2020 |
Persistent Chemiluminescent Glow of Phenoxy-dioxetane Luminophore Enables Unique CRET-Based Detection of Proteases.
Topics: Cell Line, Tumor; Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Humans; Kinetics; Luminescent Measurements; Matrix Metalloproteinases; Peptide Hydrolases | 2019 |
Coumarin (2H-1-benzopyran-2-one): a novel and eco-friendly aphicide.
Topics: Animals; Aphids; Coumarins; Culex; Houseflies; Inhibitory Concentration 50; Insecticides; Larva; Moths; Plant Extracts; Seeds; Spodoptera; Toxicity Tests | 2021 |
Development of Fluorogenic Probes for Rapid High-Contrast Imaging of Transient Nuclear Localization of Sirtuin 3.
Topics: Bacterial Proteins; Biosensing Techniques; Cell Nucleus; Coumarins; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Mitochondria; Photoreceptors, Microbial; Single-Cell Analysis; Sirtuin 3 | 2020 |
Hydrogen-bonding-induced bathochromic effect of Si-coumarin and its use in monitoring adipogenic differentiation.
Topics: Adipogenesis; Animals; Cell Line; Coumarins; Density Functional Theory; Hydrogen Bonding; Mesenchymal Stem Cells; Mice; Microscopy, Confocal; Silicon | 2019 |
Dietary Supplementation with sodium bentonite and coumarin alleviates the toxicity of aflatoxin B
Topics: Aflatoxin B1; Animal Feed; Animals; Bentonite; Cecum; Chemical and Drug Induced Liver Injury; Coumarins; Diet; Food Contamination; Male; Rabbits | 2019 |
Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; HT29 Cells; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2019 |
Mitigation of radiation-induced gastro-intestinal injury by the polyphenolic acetate 7, 8-diacetoxy-4-methylthiocoumarin in mice.
Topics: Abnormalities, Radiation-Induced; Acute Radiation Syndrome; Animals; Cell Proliferation; Coumarins; Female; Gastrointestinal Tract; Inflammation; Lipid Peroxidation; Macrophages; Mice; Mice, Inbred C57BL; Signal Transduction; Stromal Cells; Whole-Body Irradiation | 2019 |
Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent
Topics: Animals; Antiparkinson Agents; Carbidopa; Catalepsy; Coumarins; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Locomotion; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Reserpine | 2019 |
Exploring biological efficacy of coumarin clubbed thiazolo[3,2-b][1,2,4]triazoles as efficient inhibitors of urease: A biochemical and in silico approach.
Topics: Binding Sites; Catalytic Domain; Coumarins; Enzyme Inhibitors; Models, Molecular; Molecular Structure; Protein Binding; Structure-Activity Relationship; Thiazoles; Triazoles; Urease | 2020 |
Ratiometric assay of CARM1 activity using a FRET-based fluorescent probe.
Topics: Arginine; Coumarins; Fluorescein; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Humans; Molecular Structure; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases | 2019 |
Discovery of coumarin-derived imino sulfonates as a novel class of potential cardioprotective agents.
Topics: Antioxidants; Cardiotonic Agents; Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imines; Molecular Structure; NF-E2-Related Factor 2; Reactive Oxygen Species; Signal Transduction; Structure-Activity Relationship; Sulfonic Acids | 2019 |
A coumarin-appended cyclometalated iridium(III) complex for visible light driven photoelectrochemical bioanalysis.
Topics: Biosensing Techniques; Coordination Complexes; Coumarins; Electrochemical Techniques; Gold; Humans; Light; Limit of Detection; Metal Nanoparticles; Thrombin | 2020 |
Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting Janus Kinas (JAK)-Signal Transducer and Activator of Transcription-3 (STAT3) Activation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coumarins; Gene Expression Regulation, Neoplastic; Humans; Janus Kinases; Laryngeal Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Umbelliferones; Xenograft Model Antitumor Assays | 2019 |
Visible-Light-Activated High-Density Materials for Controlled in Vivo Insulin Release.
Topics: Azides; Coumarins; Insulin; Light; Photolysis; Polymers; Solubility | 2019 |
Synthesis of Coumarin Derivatives as Versatile Scaffolds for GSK-3β Enzyme Inhibition.
Topics: Coumarins; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3 beta; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship | 2020 |
4-Methylesculetin, a natural coumarin with intestinal anti-inflammatory activity, elicits a glutathione antioxidant response by different mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Coumarins; Glutathione; Glutathione Reductase; Inflammation; Male; Oxidation-Reduction; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Umbelliferones | 2020 |
Coumarin and 3,4-dihydroquinolinone derivatives: Synthesis, antidepressant activity, and molecular docking studies.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Coumarins; Depression; Hindlimb Suspension; Mice; Molecular Docking Simulation; Structure-Activity Relationship; Swimming | 2019 |
Design, Synthesis, and Photochemical Properties of Clickable Caged Compounds.
Topics: Alcohols; Animals; Carboxylic Acids; CHO Cells; Coumarins; Cricetinae; Cricetulus; Optical Imaging; Photochemical Processes; Photolysis; Solubility | 2019 |
New approaches to old problems: Removal of phospholipase A
Topics: Abdomen; Animals; Bees; Coumarins; Hydroxylation; Microsomes; Neonicotinoids; Phospholipase A2 Inhibitors; Phospholipases A2; Substrate Specificity; Xenobiotics | 2019 |
Synthesis and discovery of new compounds bearing coumarin scaffold for the treatment of pulmonary fibrosis.
Topics: Animals; Bleomycin; Cell Movement; Cell Survival; Cells, Cultured; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Pulmonary Fibrosis; RAW 264.7 Cells; Structure-Activity Relationship | 2020 |
Bis(4-hydroxy-2H-chromen-2-one) Coumarin Induces Apoptosis in MCF-7 Human Breast Cancer Cells Through Aromatase Inhibition.
Topics: Apoptosis; Aromatase; Biomarkers, Tumor; Breast Neoplasms; Cell Cycle; Cell Proliferation; Chromones; Coumarins; Female; Gene Expression Regulation, Neoplastic; Humans; Tumor Cells, Cultured | 2019 |
Antimicrobial, anti-adherence and antibiofilm activity against Staphylococcus aureus of a 4-phenyl coumarin derivative isolated from Brazilian geopropolis.
Topics: Animals; Anti-Infective Agents; Bees; Biofilms; Brazil; Coumarins; Humans; Keratinocytes; Larva; Microbial Sensitivity Tests; Moths; Propolis; Staphylococcus aureus; Toxicity Tests | 2020 |
A coumarin-connected carboxylic indolinium sensor for cyanide detection in absolute aqueous medium and its application in biological cell imaging.
Topics: Animals; Anions; Cell Death; Coumarins; Cyanides; Indoles; Melanoma, Experimental; Mice; Models, Molecular; Molecular Imaging; Proton Magnetic Resonance Spectroscopy; Solutions; Spectrophotometry, Ultraviolet; Water | 2020 |
Real-time monitoring of etoposide prodrug activated by hydrogen peroxide with improved safety.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Coumarins; Drug Liberation; Etoposide; Humans; Hydrogen Peroxide; Mice; Mice, Nude; Microscopy, Confocal; Neoplasms; Prodrugs; Reactive Oxygen Species; Survival Rate; Transplantation, Heterologous; Zebrafish | 2019 |
Discovery and evaluation of inhibitory activity and mechanism of arylcoumarin derivatives on Theileria annulata enolase by in vitro and molecular docking studies.
Topics: Catalytic Domain; Coumarins; Drug Design; Kinetics; Molecular Docking Simulation; Phosphopyruvate Hydratase; Structure-Activity Relationship; Theileria annulata | 2020 |
A new "turn-on" fluorescence probe based on hydrazine-triggered tandem reaction.
Topics: Cell Line; Coumarins; Drinking Water; Fluorescence; Fluorescent Dyes; Humans; Hydrazines; Imines; Spectrometry, Fluorescence; Water Pollutants, Chemical | 2020 |
Identification of the Trail Pheromone of the Carpenter Ant Camponotus modoc.
Topics: Alkanes; Animals; Ants; Behavior, Animal; Biosensing Techniques; Caproates; Complex Mixtures; Coumarins; Exocrine Glands; Gas Chromatography-Mass Spectrometry; Intestines; Lauric Acids; Pheromones; Stereoisomerism | 2019 |
Isolation, structure elucidation, tyrosinase inhibitory, and antioxidant evaluation of the constituents from Angelica dahurica roots.
Topics: Angelica; Antioxidants; Coumarins; Monophenol Monooxygenase; Plant Roots | 2020 |
A Switch between Antioxidant and Prooxidant Properties of the Phenolic Compounds Myricetin, Morin, 3',4'-Dihydroxyflavone, Taxifolin and 4-Hydroxy-Coumarin in the Presence of Copper(II) Ions: A Spectroscopic, Absorption Titration and DNA Damage Study.
Topics: Antineoplastic Agents; Antioxidants; Chelating Agents; Copper; Coumarins; DNA Damage; Electron Spin Resonance Spectroscopy; Flavonoids; Humans; Hydroxyl Radical; Ions; Photoelectron Spectroscopy; Polyphenols; Quercetin; Reactive Oxygen Species | 2019 |
Modeling of two semi-continuous methods in liquid-liquid chromatography: Comparing conventional and closed-loop recycling modes.
Topics: Caffeine; Chemistry Techniques, Analytical; Coumarins; Hexanes; Models, Chemical; Solvents; Water | 2020 |
Ethylenic conjugated coumarin thiazolidinediones as new efficient antimicrobial modulators against clinical methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Coumarins; Dose-Response Relationship, Drug; Ethylenes; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiazolidinediones | 2020 |
Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.
Topics: Antineoplastic Agents; Binding Sites; Cell Line; Cell Survival; Coumarins; Drug Design; Drug Synergism; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Ligands; Molecular Docking Simulation; Mutation; Phosphoric Diester Hydrolases; Protein Structure, Tertiary; Topotecan | 2020 |
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2
Topics: Cholinesterase Inhibitors; Coumarins; Drug Evaluation, Preclinical; Enzyme Activation; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Monoamine Oxidase Inhibitors; para-Aminobenzoates; Structure-Activity Relationship | 2019 |
Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.
Topics: Administration, Cutaneous; Caffeine; Computer Simulation; Consumer Product Safety; Cosmetics; Coumarins; Detergents; Humans; Isothiocyanates; Models, Biological; Risk Assessment; Skin Absorption; Sulfoxides | 2020 |
Controllable Coumarin-Based NIR Fluorophores: Selective Subcellular Imaging, Cell Membrane Potential Indication, and Enhanced Photodynamic Therapy.
Topics: Animals; Cell Membrane; Coumarins; Escherichia coli; Female; Fluorescent Dyes; HeLa Cells; Humans; Membrane Potentials; Mice, Inbred BALB C; Optical Imaging; Photochemotherapy; Reactive Oxygen Species; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared; Staphylococcus aureus; Time Factors; Water | 2020 |
Benzazole Substituted Iminocoumarins as Potential Antioxidants with Antiproliferative Activity.
Topics: Antineoplastic Agents; Antioxidants; Benzothiazoles; Cell Cycle; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HeLa Cells; Humans | 2021 |
Synthesis and activity of a coumarin-based fluorescent probe for hydroxyl radical detection.
Topics: Coumarins; Fluorescence; Fluorescent Dyes; Humans; Hydroxyl Radical; Molecular Structure; Reactive Oxygen Species; Spectrophotometry | 2020 |
Design, Synthesis, and Biological Evaluation of 4-amino Substituted 2Hchromen- 2-one Derivatives as an NEDD8 Activating Enzyme Inhibitor in Pancreatic Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Coumarins; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; NEDD8 Protein; Pancreatic Neoplasms; Tumor Cells, Cultured | 2020 |
Synthesis and biological evaluation of novel 3-benzylcoumarin-imidazolium salts.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Coumarins; Drug Design; Drug Screening Assays, Antitumor; G1 Phase Cell Cycle Checkpoints; Humans; Imidazoles; Salts; Structure-Activity Relationship | 2020 |
Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Chalcone; Coumarins; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Fluorescent Dyes; HCT116 Cells; Humans; Inhibitory Concentration 50; Precision Medicine; Reactive Oxygen Species; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2020 |
Theoretical Study of the Wavelength Selection for the Photocleavage of Coumarin-caged D-luciferin.
Topics: Benzothiazoles; Coumarins; Models, Theoretical; Photochemical Processes; Spectrophotometry, Ultraviolet | 2020 |
UV-light cross-linked and pH de-cross-linked coumarin-decorated cationic copolymer grafted mesoporous silica nanoparticles for drug and gene co-delivery in vitro.
Topics: Animals; Biocompatible Materials; Cations; Chlorocebus aethiops; COS Cells; Coumarins; Cross-Linking Reagents; Drug Carriers; Drug Delivery Systems; Fluorouracil; Gene Transfer Techniques; Hemolysis; Humans; Hydrogen-Ion Concentration; Hydrolysis; MCF-7 Cells; Nanoparticles; Plasmids; Polymers; Silicon Dioxide; Tumor Suppressor Protein p53; Ultraviolet Rays | 2020 |
A Water-Soluble Fluorescent Probe for the Selective Sensing of Ag
Topics: Animals; Caenorhabditis elegans; Coumarins; Density Functional Theory; Fluorescent Dyes; HeLa Cells; Hep G2 Cells; Humans; Imidazoles; Molecular Structure; Optical Imaging; Silver; Solubility; Spectrometry, Fluorescence; Tumor Cells, Cultured; Water | 2020 |
Ultra-fast and visual detection of hydrazine hydrate based on a simple coumarin derivative.
Topics: A549 Cells; Colorimetry; Coumarins; Fluorescent Dyes; Humans; Hydrazines; Limit of Detection; Microscopy, Confocal; Microscopy, Fluorescence; Models, Molecular; Optical Imaging; Spectrometry, Fluorescence; Water | 2020 |
Cytosolic NQO1 Enzyme-Activated Near-Infrared Fluorescence Imaging and Photodynamic Therapy with Polymeric Vesicles.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coumarins; Cytosol; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Electron Transport; HeLa Cells; Humans; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Optical Imaging; Oxazines; Particle Size; Photochemical Processes; Photochemotherapy; Photosensitizing Agents; Polymers; Surface Properties | 2020 |
A Fluorescent False Neurotransmitter as a Dual Electrofluorescent Probe for Secretory Cell Models.
Topics: Animals; Cell Line; Coumarins; Electrochemical Techniques; Electrodes; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Models, Biological; Neurotransmitter Agents; PC12 Cells; Rats; Secretory Vesicles | 2019 |
Computational prediction methods to simulate structure and binding sites of coumarin with olfactory receptor 5P3.
Topics: Binding Sites; Coumarins; Humans; Receptors, Odorant | 2019 |
Synthesis, Antitrypanosomal and Antimycobacterial Activities of Coumarin N-acylhydrazonic Derivatives.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Chemistry Techniques, Synthetic; Coumarins; Drug Resistance, Bacterial; Hydrazones; Mycobacterium tuberculosis; Nitrogen; Trypanosoma | 2021 |
Synthesis, In vitro, and Docking Analysis of C-3 Substituted Coumarin Analogues as Anticancer Agents.
Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; MCF-7 Cells | 2021 |
Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition.
Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Chitosan; Coumarins; Drug Carriers; Drug Delivery Systems; Etoposide; Eye; Lipids; Mucins; Nanostructures; Oligosaccharides; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Distribution; Toxicity Tests | 2020 |
Interaction of coumarin triazole analogs to serum albumins: Spectroscopic analysis and molecular docking studies.
Topics: Circular Dichroism; Coumarins; Fluorescence; Molecular Docking Simulation; Serum Albumin; Ultraviolet Rays | 2020 |
Quercetin and Coumarin Inhibit Dipeptidyl Peptidase-IV and Exhibits Antioxidant Properties: In Silico, In Vitro, Ex Vivo.
Topics: Animals; Antioxidants; Computer Simulation; Coumarins; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Erythrocytes; Hemolysis; Hydrogen Bonding; In Vitro Techniques; Inhibitory Concentration 50; Ligands; Lipid Peroxidation; Liver; Male; Molecular Conformation; Molecular Docking Simulation; Oxidative Stress; Quercetin; Rats; Rats, Wistar | 2020 |
Coumarin-Rasagiline Hybrids as Potent and Selective hMAO-B Inhibitors, Antioxidants, and Neuroprotective Agents.
Topics: Animals; Antioxidants; Biphenyl Compounds; Cells, Cultured; Coumarins; Female; Humans; Hydrogen Peroxide; Indans; Inflammation; Lipopolysaccharides; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Oxidative Stress; Picrates; Rats; Rats, Wistar | 2020 |
Successful pregnancy in a liver transplant patient of Budd-Chiari syndrome.
Topics: Adult; Budd-Chiari Syndrome; Cesarean Section; Coumarins; Female; Humans; Liver Transplantation; Pregnancy; Pregnancy Outcome; Tacrolimus | 2020 |
Elimination pharmacokinetics of sphaeralcic acid, tomentin and scopoletin mixture from a standardized fraction of Sphaeralcea angustifolia (Cav.) G. Don orally administered.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Coumarins; Female; Malvaceae; Mice; Mice, Inbred ICR; Reference Standards; Scopoletin | 2020 |
Ready Access to Molecular Rotors Based on Boron Dipyrromethene Dyes-Coumarin Dyads Featuring Broadband Absorption.
Topics: Boron; Coumarins; Fluorescence; Fluorescent Dyes; Molecular Conformation; Porphobilinogen; Spectrometry, Fluorescence | 2020 |
Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.
Topics: Amides; Benzoflavones; Binding Sites; Catalytic Domain; Coumarins; Cyclopropanes; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P450 Family 1; Humans; Liver; Molecular Dynamics Simulation; Oxidation-Reduction | 2020 |
Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Proliferation; Cisplatin; Colorectal Neoplasms; Coumarins; Drug Design; Drug Screening Assays, Antitumor; Energy Metabolism; G1 Phase; Glucose; HCT116 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Reactive Oxygen Species; Thiazoles | 2020 |
Dextran-covered pH-sensitive oily core nanocapsules produced by interfacial Reversible Addition-Fragmentation chain transfer miniemulsion polymerization.
Topics: Albumins; Antineoplastic Agents; Cell Survival; Coumarins; Dextrans; Drug Compounding; Drug Liberation; Emulsions; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Kinetics; Methacrylates; Nanocapsules; Phase Transition; Polymerization; Polymethyl Methacrylate; Surface Properties; THP-1 Cells; Triglycerides | 2020 |
Umbelliprenin as a novel component of the phytochemical pool from Artemisia spp.
Topics: Artemisia; Chromatography, High Pressure Liquid; Coumaric Acids; Coumarins; Phytochemicals; Plant Extracts; Umbelliferones | 2020 |
Stability and Extraction of Vanillin and Coumarin under Subcritical Water Conditions.
Topics: Benzaldehydes; Chromatography, High Pressure Liquid; Coumarins; Hot Temperature; Plant Extracts; Sonication; Water | 2020 |
Visualization of Lipid Droplets in Living Cells and Fatty Livers of Mice Based on the Fluorescence of π-Extended Coumarin Using Fluorescence Lifetime Imaging Microscopy.
Topics: 3T3-L1 Cells; Animals; Cells, Cultured; Coumarins; Fatty Liver; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Lipid Droplets; Mice; Microscopy, Fluorescence; Molecular Structure; Optical Imaging | 2020 |
Interaction of Coumarin Phytoestrogens with ER
Topics: Binding Sites; Coumarins; Estrogen Receptor alpha; Estrogen Receptor beta; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Phytoestrogens; Protein Binding; Structure-Activity Relationship | 2020 |
Design, Synthesis and Evaluation of 3-Substituted Coumarin Derivatives as Anti-inflammatory Agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Coumarins; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Ear Diseases; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; RAW 264.7 Cells; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; Xylenes | 2020 |
A bioorthogonal system reveals antitumour immune function of pyroptosis.
Topics: Animals; Coumarins; Delayed-Action Preparations; Female; Green Fluorescent Proteins; HeLa Cells; Humans; Immunoconjugates; Inflammasomes; Inflammation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Oligopeptides; Programmed Cell Death 1 Receptor; Proteins; Pyroptosis; Silanes; T-Lymphocytes; Trastuzumab; Xenograft Model Antitumor Assays | 2020 |
Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance.
Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Cisplatin; Coumarins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mitochondria; Molecular Structure; Organoplatinum Compounds; Prodrugs; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2020 |
Development of biodegradable polyesters based on a hydroxylated coumarin initiator towards fluorescent visible paclitaxel-loaded microspheres.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Cell Line, Tumor; Coumarins; Drug Carriers; Materials Testing; Mice; Microspheres; Paclitaxel; Polyesters | 2019 |
A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products.
Topics: Animals; Computational Biology; Computer Simulation; Consumer Product Safety; Cosmetics; Coumarins; Family Characteristics; Humans; Risk Assessment; Toxicity Tests | 2020 |
Anxiolytic-Like Action of Selected 4-(Alkylamino)-3-nitrocoumarin Derivatives in BALB/c Mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Coumarins; Diazepam; Male; Mice; Mice, Inbred BALB C; Sleep | 2020 |
Fluorescent iridium(iii) coumarin-salicylaldehyde Schiff base compounds as lysosome-targeted antitumor agents.
Topics: A549 Cells; Aldehydes; Antineoplastic Agents; Apoptosis; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Iridium; Ligands; Models, Molecular; Molecular Structure; Schiff Bases; Structure-Activity Relationship; Wound Healing | 2020 |
Ultrasound-assisted hydrophobic deep eutectic solvent based solid-liquid microextraction of Sudan dyes in spice samples.
Topics: Capsicum; Centrifugation; Chromatography, High Pressure Liquid; Coloring Agents; Coumarins; Cuminum; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Liquid Phase Microextraction; Naphthols; Rhus; Solvents; Spectroscopy, Fourier Transform Infrared; Spices; Temperature; Thymol; Time Factors; Ultrasonics | 2020 |
Investigation of the cytotoxicity of bioinspired coumarin analogues towards human breast cancer cells.
Topics: Biomimetic Materials; Breast Neoplasms; Cell Death; Cell Line, Tumor; Coumarins; Drug Design; Female; Humans; Inhibitory Concentration 50; Models, Biological | 2021 |
Phytochemical composition profile and space-time accumulation of secondary metabolites for Dracocephalum moldavica Linn. via UPLC-Q/TOF-MS and HPLC-DAD method.
Topics: Chromatography, High Pressure Liquid; Coumarins; Hydroxybenzoates; Lamiaceae; Limit of Detection; Linear Models; Mass Spectrometry; Phytochemicals; Plant Extracts; Plant Structures; Reproducibility of Results | 2020 |
Coumarin-Tagged Dinuclear Trithiolato-Bridged Ruthenium(II)⋅Arene Complexes: Photophysical Properties and Antiparasitic Activity.
Topics: Animals; Antiparasitic Agents; Cell Proliferation; Cells, Cultured; Coordination Complexes; Coumarins; Crystallography, X-Ray; Female; Humans; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Photochemical Processes; Ruthenium; Sulfhydryl Compounds; Toxoplasma | 2020 |
New synthetic coumarinolignans as attenuators of pro-inflammatory cytokines in LPS-induced sepsis and carrageenan-induced paw oedema models.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Coumarins; Cytokines; Disease Models, Animal; Edema; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Plant Extracts; Sepsis; Tumor Necrosis Factor-alpha | 2020 |
Structural Studies on the Inhibitory Binding Mode of Aromatic Coumarinic Esters to Human Kallikrein-Related Peptidase 7.
Topics: Binding Sites; Catalytic Domain; Coumarins; Crystallography, X-Ray; Esters; Humans; Kallikreins; Molecular Dynamics Simulation; Protease Inhibitors; Recombinant Proteins; Tandem Mass Spectrometry | 2020 |
6-Acetyl-5-hydroxy-4,7-dimethylcoumarin derivatives: Design, synthesis, modeling studies, 5-HT
Topics: Acetylation; Animals; CHO Cells; Coumarins; Cricetulus; Drug Design; Drug Discovery; Humans; Male; Methylation; Mice, Inbred BALB C; Molecular Docking Simulation; Piperazine; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists | 2020 |
Morphogenesis Guided by 3D Patterning of Growth Factors in Biological Matrices.
Topics: Aminoacyltransferases; Animals; Axons; Bacterial Proteins; Coumarins; Cysteine Endopeptidases; Extracellular Matrix; Hyaluronic Acid; Hydrogels; Microscopy, Fluorescence, Multiphoton; Nerve Growth Factor; Photons | 2020 |
Coumarin-Caged Compounds of 1-Naphthaleneacetic Acid as Light-Responsive Controlled-Release Plant Root Stimulators.
Topics: Agrochemicals; Animals; Chlorocebus aethiops; Coumarins; Delayed-Action Preparations; Drug Liberation; Kinetics; Light; Molecular Structure; Naphthaleneacetic Acids; Photolysis; Plant Roots; Vero Cells; Vigna | 2020 |
Theoretical study of rhodium(III)-catalyzed synthesis of benzoxepine and coumarin.
Topics: Acetylene; Benzoxepins; Carbon Monoxide; Catalysis; Computational Chemistry; Coumarins; Models, Chemical; Rhodium | 2020 |
Interaction of amphiphilic coumarin with DPPC/DPPS lipid bilayer: effects of concentration and alkyl tail length.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Coumarins; Hydrophobic and Hydrophilic Interactions; Lipid Bilayers; Molecular Dynamics Simulation; Molecular Structure; Phosphatidylserines; Surface-Active Agents | 2020 |
A novel near-infrared turn-on and ratiometric fluorescent probe capable of copper(ii) ion determination in living cells.
Topics: Benzopyrans; Biosensing Techniques; Cell Line; Copper; Coumarins; Fluorescent Dyes; Humans | 2020 |
Anti-Inflammatory and Cytotoxic Potential of New Phenanthrenoids from
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Line, Tumor; Cell Proliferation; Coumarins; Cytotoxins; Humans; Magnoliopsida; Phenanthrenes; Plant Extracts; Seeds | 2020 |
Chemical Diversity of Bastard Balm (
Topics: Caffeic Acids; Chlorogenic Acid; Coumaric Acids; Coumarins; Flavones; Flavonoids; Glucosides; Lamiaceae; Phenols; Plant Development; Propionates; Succinates | 2020 |
Pretreatment with Warfarin Attenuates the Development of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats.
Topics: Acute Disease; Animals; Anticoagulants; Coumarins; Ischemia; Male; Pancreas; Pancreatitis; Rats; Rats, Wistar; Reperfusion Injury; Warfarin | 2020 |
Green analytical method for the simultaneous analysis of cytochrome P450 probe substrates by poly(N-isopropylacrylamide)-based temperature-responsive chromatography.
Topics: Acrylic Resins; Chlorzoxazone; Chromatography, Liquid; Coumarins; Cytochrome P-450 Enzyme System; Drug Development; Green Chemistry Technology; Mephenytoin; Molecular Structure; Phenacetin; Solvents; Substrate Specificity; Temperature; Testosterone; Tolbutamide; Water | 2020 |
Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Topics: Antitubercular Agents; Chalcones; Coumarins; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyrazoles; Quinolines; Software | 2020 |
Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Behavior, Animal; Binding Sites; Cell Survival; Coumarins; Disease Models, Animal; Drug Design; Humans; Iron Chelating Agents; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; PC12 Cells; Peptide Fragments; Rats; Structure-Activity Relationship | 2020 |
Real-Time Imaging of Intracellular Glutathione Levels Based on a Ratiometric Fluorescent Probe with Extremely Fast Response.
Topics: Coumarins; Density Functional Theory; Fluorescent Dyes; Glutathione; HeLa Cells; Humans; Molecular Structure; Optical Imaging; Time Factors; Tumor Cells, Cultured | 2020 |
LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Coordination Complexes; Coumarins; Drug Screening Assays, Antitumor; Ferric Compounds; Ferrous Compounds; HeLa Cells; Humans; Ligands; Light; Metallocenes; Molecular Structure; Optical Imaging; Photochemotherapy; Photosensitizing Agents | 2020 |
Insights into coumarin-mediated inhibition of biofilm formation in
Topics: Anti-Bacterial Agents; Biofilms; Coumarins; Salmonella typhimurium | 2020 |
Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Coumarins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrazoles; Staphylococcal Infections; Staphylococcus aureus | 2020 |
Synthesis and In Silico Studies of C-4 Substituted Coumarin Analogues as Anticancer Agents.
Topics: Antineoplastic Agents; Coumarins; Humans; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship | 2021 |
Water Soluble Coumarin Quaternary Ammonium Chlorides: Synthesis and Biological Evaluation.
Topics: Ammonium Chloride; Anti-Bacterial Agents; Antineoplastic Agents; Bacillus subtilis; Carbonic Anhydrases; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Structure; Solubility; Structure-Activity Relationship; Water; Xanthine Oxidase | 2020 |
The Grapefruit Effect: Interaction between Cytochrome P450 and Coumarin Food Components, Bergamottin, Fraxidin and Osthole. X-ray Crystal Structure and DFT Studies.
Topics: Catalytic Domain; Citrus paradisi; Coumarins; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Furocoumarins; Heme; Humans; Hydrogen Bonding | 2020 |
Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
Topics: Acetamides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship | 2021 |
Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Bone Remodeling; Cell Differentiation; Collagen Type I; Coumarins; Diabetes Mellitus; Glucose; Glycation End Products, Advanced; Humans; Mice; Models, Biological; Osteoblasts; Osteoclasts; RANK Ligand; RAW 264.7 Cells | 2020 |
Nodakenin alleviated obstructive nephropathy through blunting Snail1 induced fibrosis.
Topics: Angelica; Animals; Anti-Inflammatory Agents; Coumarins; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Kidney; Kidney Failure, Chronic; Macrophages; Mice; NF-kappa B; Phosphorylation; Plant Roots; Signal Transduction; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta1; Ureteral Obstruction | 2020 |
Apoptosis in Leukemic Cells Induced by Anti-proliferative Coumarin Isolated from the Stem Bark of
Topics: Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coumarins; Fraxinus; Humans; Jurkat Cells; Membrane Potential, Mitochondrial; Mitochondria; Plant Bark; Plant Extracts; Reactive Oxygen Species; Signal Transduction; Umbelliferones | 2020 |
Synthesis and Evaluation of New Coumarin Derivatives as Antioxidant, Antimicrobial, and Anti-Inflammatory Agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Coumarins; Edema; Formaldehyde; Humans; Molecular Structure; Rats; Structure-Activity Relationship | 2020 |
The novel HOCl fluorescent probe CAN induced A549 apoptosis by inhibiting chlorination activity of MPO.
Topics: A549 Cells; Animals; Apoptosis; Cations; Coumarins; Fluorescent Dyes; Halogenation; Humans; Hypochlorous Acid; Metals; Mice; Optical Imaging; Oxidation-Reduction; Peroxidase; RAW 264.7 Cells; Signal Transduction | 2020 |
Unusual absence of FRET in triazole bridged coumarin-hydroxyquinoline, an active sensor for Hg2+ detection.
Topics: Coumarins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Hydroxyquinolines; Mercury; Molecular Structure; Optical Imaging; Spectrometry, Fluorescence; Triazoles; Tumor Cells, Cultured | 2020 |
Design, synthesis and in vivo evaluation of 3-arylcoumarin derivatives of rhenium(I) tricarbonyl complexes as potent antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Animals; Chemistry Techniques, Synthetic; Coordination Complexes; Coumarins; Drug Design; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rhenium; Zebrafish | 2020 |
Dihydropyridine-coumarin-based fluorescent probe for imaging nitric oxide in living cells.
Topics: Animals; Cell Survival; Cells, Cultured; Coumarins; Dihydropyridines; Dose-Response Relationship, Drug; Fluorescent Dyes; Mice; Molecular Structure; Nitric Oxide; Optical Imaging; RAW 264.7 Cells | 2020 |
Two CYP71AJ enzymes function as psoralen synthase and angelicin synthase in the biosynthesis of furanocoumarins in Peucedanum praeruptorum Dunn.
Topics: Apiaceae; China; Chromatography, High Pressure Liquid; Coenzyme A Ligases; Coumarins; Cytochrome P-450 Enzyme System; Furocoumarins; Gene Expression Regulation, Plant; Kinetics; Medicine, Chinese Traditional; Phenylalanine Ammonia-Lyase; Phylogeny; Plant Proteins; Spectrometry, Mass, Electrospray Ionization; Transcriptome | 2020 |
New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Humans; Molecular Structure; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Structure-Activity Relationship; Triazoles | 2020 |
A systematic study on the discrepancy of fluorescence properties between in solutions and in cells: super-bright, environment-insensitive benzocoumarin dyes.
Topics: Cell Line, Tumor; Coumarins; Fluorescence; Fluorescent Dyes; Humans; Solutions | 2020 |
Synthesis and Evaluation of Cytotoxicity of Novel Coumarin Peptide Alcohol Derivatives.
Topics: Alcohols; Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Coumarins; Humans; Peptides | 2021 |
Anticounterfeiting and photoluminescent cellulosic papers based on fluorescent acrylic copolymer nanoparticles containing coumarin.
Topics: Acrylates; Cellulose; Coumarins; Counterfeit Drugs; Emulsions; Fluorescence; Fraud; Ink; Nanoparticles; Paper; Polymerization; Polymers | 2020 |
A new coumarin compound DCH combats methicillin-resistant
Topics: Anti-Bacterial Agents; Arginine; Biofilms; Coumarins; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation | 2020 |
Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Topics: alpha-Glucosidases; Computer Simulation; Coumarins; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Kinetics; Molecular Docking Simulation; Protein Conformation; Structure-Activity Relationship; Thiocarbamates | 2021 |
A Visible and Near-Infrared Light Activatable Diazocoumarin Probe for Fluorogenic Protein Labeling in Living Cells.
Topics: Amino Acid Sequence; Azo Compounds; Benzenesulfonamides; Carbonic Anhydrases; Coumarins; Escherichia coli; Fluorescent Dyes; HeLa Cells; Humans; Infrared Rays; Light; MCF-7 Cells; Molecular Structure; Optical Imaging; Photochemical Processes; Staining and Labeling; Sulfonamides; Tetrahydrofolate Dehydrogenase | 2020 |
Coumarin and Moracin Derivatives from Mulberry Leaves (
Topics: Benzofurans; Chemical Fractionation; Coumarins; Epoxide Hydrolases; Models, Molecular; Molecular Conformation; Molecular Structure; Morus; Plant Leaves | 2020 |
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy.
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Humans; Injections, Intraperitoneal; Male; Mice; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Pyridazines; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Dual DNA binding mode of a turn-on red fluorescent probe thiazole coumarin.
Topics: Benzothiazoles; Binding Sites; Carbocyanines; Coumarins; DNA; Fluorescent Dyes; Nucleic Acid Conformation; Thermodynamics | 2020 |
Coumarin-chalcone hybrids targeting insulin receptor: Design, synthesis, anti-diabetic activity, and molecular docking.
Topics: Administration, Oral; Animals; Antigens, CD; Chalcone; Coumarins; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Hypoglycemic Agents; Injections, Intraperitoneal; Male; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Wistar; Receptor, Insulin; Streptozocin; Structure-Activity Relationship | 2020 |
Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Coumarins; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2020 |
Synthesis and biological evaluation of radioiodinated 3-phenylcoumarin derivatives targeting myelin in multiple sclerosis.
Topics: Animals; Autoradiography; Brain; Coumarins; Encephalomyelitis, Autoimmune, Experimental; Iodine Radioisotopes; Mice; Multiple Sclerosis; Myelin Sheath; Radiopharmaceuticals; Tissue Distribution | 2020 |
Multi- and transgenerational effects following early-life exposure of zebrafish to permethrin and coumarin 47: Impact on growth, fertility, behavior and lipid metabolism.
Topics: Animals; Behavior, Animal; Coumarins; Ecosystem; Fertility; Insect Repellents; Larva; Lipid Metabolism; Permethrin; Zebrafish | 2020 |
Synergistic transport of a fluorescent coumarin probe marks coumarins as pharmacological modulators of Organic anion-transporting polypeptide, OATP3A1.
Topics: Coumarins; Fluorescent Dyes; HEK293 Cells; Humans; Organic Anion Transporters; Protein Structure, Secondary; Protein Transport | 2020 |
A Fluorescence-Based Assay System for the Determination of Haloperoxidase-Activity Using a Two-Dimensional Calibration Ap-proach.
Topics: Calibration; Coumarins; Enzyme Assays; Halogenation; Peroxidases; Spectrometry, Fluorescence | 2020 |
Sortase A-Inhibitory Coumarins from the Folk Medicinal Plant
Topics: Aminoacyltransferases; Bacterial Proteins; Coumarins; Cysteine Endopeptidases; Fibrinogen; Fibronectins; Gram-Positive Bacteria; Membrane Proteins; Molecular Structure; Plants, Medicinal; Poncirus; Staphylococcal Infections; Staphylococcus aureus | 2020 |
In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.
Topics: Antiviral Agents; Betacoronavirus; Binding Sites; China; Coronavirus Infections; Coumarins; COVID-19; Humans; Models, Molecular; Molecular Docking Simulation; Pandemics; Pneumonia, Viral; Protease Inhibitors; SARS-CoV-2 | 2020 |
Importance of oxidation products in coumarin-mediated Fe(hydr)oxide mineral dissolution.
Topics: Coumarins; Ferric Compounds; Hydrogen-Ion Concentration; Minerals; Oxidation-Reduction; Solubility | 2020 |
A novel near-infrared fluorescent sensor for zero background nitrite detection via the "covalent-assembly" principle.
Topics: Coumarins; Escherichia coli; Fluorescent Dyes; Fresh Water; Limit of Detection; Nitrites; Spectroscopy, Near-Infrared | 2021 |
A coumarin embedded highly sensitive nitric oxide fluorescent sensor: kinetic assay and bio-imaging applications.
Topics: Coumarins | 2020 |
An overview of carbohydrate-based carbonic anhydrase inhibitors.
Topics: Binding Sites; Carbohydrates; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Coumarins; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Protein Binding; Structure-Activity Relationship; Sulfamerazine; Sulfonamides; Sulfonic Acids; Triazoles | 2020 |
Coumarin-based fluorescent biosensor with large linear range for ratiometric measurement of intracellular pH.
Topics: Biosensing Techniques; Cells, Cultured; Coumarins; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Optical Imaging; Spectrometry, Fluorescence; Triazines | 2020 |
Metabolic profiles of coumarin in human plasma extrapolated from a rat data set with a simplified physiologically based pharmacokinetic model.
Topics: Animals; Computer Simulation; Coumarins; Datasets as Topic; Humans; In Vitro Techniques; Liver; Male; Models, Biological; Phenylacetates; Rats, Sprague-Dawley; Risk Assessment; Umbelliferones | 2020 |
Coumarin-Modified CQDs for Biomedical Applications-Two-Step Synthesis and Characterization.
Topics: Animals; Carbon; Cell Proliferation; Cells, Cultured; Coumarins; Fibroblasts; Fluorescent Dyes; Luminescence; Mice; Quantum Dots | 2020 |
A novel biscoumarin derivative dephosphorylates ERK and alleviates apoptosis induced by mitochondrial oxidative damage in ischemic stroke mice.
Topics: Animals; Apoptosis; Cells, Cultured; Coumarins; Dose-Response Relationship, Drug; Ischemic Stroke; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitochondria; Oxidative Stress; Phosphorylation | 2021 |
Synthesis and antioxidant activity of conjugates of hydroxytyrosol and coumarin.
Topics: Antioxidants; Apoptosis; Benzothiazoles; Biphenyl Compounds; Cell Line; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Humans; Hydrogen Peroxide; Molecular Structure; Phenylethyl Alcohol; Picrates; Reactive Oxygen Species; Structure-Activity Relationship; Sulfonic Acids | 2020 |
Antiglioma Potential of Coumarins Combined with Sorafenib.
Topics: 4-Hydroxycoumarins; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Beclin-1; Caspase 3; Cell Line, Tumor; Cell Proliferation; Coumarins; Esculin; Gene Expression Regulation; Glioblastoma; Humans; Magnoliopsida; Necrosis; Phosphatidylinositol 3-Kinases; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; raf Kinases; RNA, Small Interfering; Sorafenib; Umbelliferones | 2020 |
Novel complexes with ONNO tetradentate coumarin schiff-base donor ligands: x-ray structures, DFT calculations, molecular dynamics and potential anticarcinogenic activity.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Coumarins; Crystallography, X-Ray; Density Functional Theory; Drug Screening Assays, Antitumor; Humans; Ligands; Metals, Heavy; Molecular Dynamics Simulation; Molecular Structure; Schiff Bases | 2021 |
Lanthanide(III) Complexes of Cyclen Triacetates and Triamides Bearing Tertiary Amide-Linked Antennae.
Topics: Acetates; Amides; Binding Sites; Coumarins; Hydroxyquinolines; Lanthanoid Series Elements; Ligands; Luminescence; Magnetic Resonance Spectroscopy; Metals; Models, Molecular; Molecular Structure; Quinolones; Spectrophotometry, Ultraviolet; Temperature | 2020 |
Thiocoumarin Caged Nucleotides: Synthetic Access and Their Photophysical Properties.
Topics: Adenosine Triphosphate; Coumarins; Fluorescence; Light; Nucleotides; Photolysis; Physical Phenomena | 2020 |
Coumarin accumulation and trafficking in Arabidopsis thaliana: a complex and dynamic process.
Topics: Arabidopsis; Arabidopsis Proteins; Coumarins; Plant Roots | 2021 |
Coumarin functionalized molecular scaffolds for the effectual detection of hazardous fluoride and cyanide.
Topics: Coumarins; Cyanides; Drinking Water; Fluorides; Spectrophotometry, Ultraviolet; Water Pollutants, Chemical | 2021 |
Plant-Inspired Multifunctional Fluorescent Hydrogel: A Highly Stretchable and Recoverable Self-Healing Platform with Water-Controlled Adhesiveness for Highly Effective Antibacterial Application and Data Encryption-Decryption.
Topics: Acrylamide; Adhesiveness; Anti-Bacterial Agents; Biomimetics; Computer Security; Coumarins; Escherichia coli; Fluorescent Dyes; Hydrogels; Hydrogen Bonding; Plants; Surface Properties; Water | 2020 |
(+/-)-Dievodialetins A-G: Seven pairs of enantiomeric coumarin dimers with anti-acetylcholinesterase activity from the roots of Evodia lepta Merr.
Topics: Acetylcholinesterase; Cholinesterase Inhibitors; Coumarins; Evodia; Molecular Structure; Plant Roots; Rutaceae | 2021 |
Enzyme-Instructed Self-Assembly Enabled Monomer-Excimer Transition to Construct Higher Ordered Luminescent Supramolecular Assembly for Activity-based Bioimaging.
Topics: Alkaline Phosphatase; Coumarins; Enzyme-Linked Immunosorbent Assay; Fluorescent Dyes; HeLa Cells; Humans; Luminescence; Macromolecular Substances; Molecular Structure; Nanofibers; Optical Imaging | 2021 |
Synthesis and evaluation of sensitive coumarin-based fluorogenic substrates for discovery of α-N-acetyl galactosaminidases through droplet-based screening.
Topics: alpha-N-Acetylgalactosaminidase; Chemistry Techniques, Synthetic; Coumarins; Enzyme Assays; Fluorescent Dyes; Lab-On-A-Chip Devices; Substrate Specificity | 2021 |
A ratiometric fluorescent probe for monitoring pH fluctuations during autophagy in living cells.
Topics: Autophagy; Cell Line, Tumor; Coumarins; Down-Regulation; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Molecular Structure; Pyridines | 2021 |
In Vitro Macrophage Immunomodulation by Poly(ε-caprolactone) Based-Coated AZ31 Mg Alloy.
Topics: Alloys; Animals; Biodegradable Plastics; Coumarins; Gene Expression Regulation; Humans; Immunomodulation; Inflammation; Macrophages; Magnesium; Metal Nanoparticles; Mice; Osteogenesis; Polyesters; RANK Ligand; RAW 264.7 Cells; Spectroscopy, Fourier Transform Infrared; Zinc Oxide | 2021 |
Chiral Tertiary Amine Catalyzed Asymmetric [4 + 2] Cyclization of 3-Aroylcoumarines with 2,3-Butadienoate.
Topics: Amines; Catalysis; Coumarins; Cyclization; Diacetyl; Molecular Structure; Stereoisomerism | 2021 |
Automated Radiosynthesis and Molecular Docking Studies of Coumarin- Triazole Hybrid with fluorine-18: A feasibility study.
Topics: Coumarins; Feasibility Studies; Fluorine Radioisotopes; Molecular Docking Simulation; Positron-Emission Tomography; Radiopharmaceuticals; Solvents; Triazoles | 2022 |
Cell-Based Identification of New IDO1 Modulator Chemotypes.
Topics: Cell Line, Tumor; Coumarins; Enzyme Inhibitors; Fluorescent Dyes; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Molecular Structure | 2021 |
Chemical characterization and in vitro immunomodulatory effects of different extracts of moss Hedwigia ciliata (Hedw.) P. Beauv. from the Vršačke Planine Mts., Serbia.
Topics: Antioxidants; Bryophyta; Cell Line; Coumarins; Fibroblasts; Flavonoids; Humans; Hydroxybenzoates; Nitric Oxide; Plant Extracts; Serbia; Triterpenes | 2021 |
One-Pot Synthesis of Coumarin-Indomethacin Hybrids as COX-2 Targeting Probes for Cancer Imaging.
Topics: Antineoplastic Agents; Cell Survival; Coumarins; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Indomethacin; Molecular Docking Simulation; Molecular Structure; Optical Imaging; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Coumarins; Dose-Response Relationship, Drug; Ficusin; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2021 |
Ultrasensitive and selective fluorescent sensor for cysteine and application to drug analysis and bioimaging.
Topics: Coumarins; Cysteine; Fluorescent Dyes; HeLa Cells; Humans; Maleimides; Molecular Structure; Optical Imaging | 2021 |
Microwave and Conventional Study of Coumarin-Oxadiazole Adducts and their Anti-Microbial Evaluation.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Microwaves; Oxadiazoles; Pseudomonas aeruginosa; Structure-Activity Relationship | 2021 |
Coumarin (5,6-Benzo-2-pyrone) Trapping of an HDDA-Benzyne.
Topics: Benzene Derivatives; Coumarins; Cycloaddition Reaction; Naphthalenes; Pyrones | 2021 |
New Coumarin Dipicolinate Europium Complexes with a Rich Chemical Speciation and Tunable Luminescence.
Topics: Chelating Agents; Coordination Complexes; Coumarins; Europium; Lanthanoid Series Elements; Luminescence; Magnetic Resonance Spectroscopy; Molecular Probes | 2021 |
The application of amide units in the construction of neutral functional dyes for mitochondrial staining.
Topics: Amides; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Lipid Droplets; Mitochondria; Solvents; Staining and Labeling | 2021 |
One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Chromones; Computer Simulation; Coumarins; DNA Cleavage; DNA Topoisomerases, Type II; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Flavonoids; Humans; Imidazoles; Protein Binding; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2021 |
Screening the Q-markers of TCMs from RA rat plasma using UHPLC-QTOF/MS technique for the comprehensive evaluation of Wu-Wei-Wen-Tong Capsule.
Topics: Acrolein; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers, Pharmacological; Chromatography, High Pressure Liquid; Cinnamates; Coumarins; Drug Development; Drugs, Chinese Herbal; Flavanones; Humans; Medicine, Chinese Traditional; Propanols; Quality Control; Rats; Tandem Mass Spectrometry; Triterpenes | 2021 |
FFCASP: A Massively Parallel Crystal Structure Prediction Algorithm.
Topics: Algorithms; Coumarins; Crystallography, X-Ray; Cytosine; Density Functional Theory; Models, Molecular; Molecular Structure; Pyrazinamide | 2021 |
Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Behavior, Animal; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship | 2021 |
In vitro inhibition studies of coumarin derivatives on Bos taurus enolase and elucidating their interaction by molecular docking, molecular dynamics simulations and MMGB(PB)SA binding energy calculation.
Topics: Animals; Cattle; Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Models, Molecular; Molecular Structure; Phosphopyruvate Hydratase; Structure-Activity Relationship | 2021 |
Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations.
Topics: Antiprotozoal Agents; Coumarins; Dose-Response Relationship, Drug; Isatin; Leishmania tropica; Leishmaniasis; Models, Molecular; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2021 |
Coumarin-Annulated Ferrocenyl 1,3-Oxazine Derivatives Possessing In Vitro Antimalarial and Antitrypanosomal Potency.
Topics: Antimalarials; Antiprotozoal Agents; Cell Proliferation; Cell Survival; Coumarins; Female; Ferrous Compounds; Humans; In Vitro Techniques; Molecular Structure; Oxazines; Plasmodium falciparum; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Trypanosoma brucei brucei; Tumor Cells, Cultured | 2021 |
Synthesis and Biological Activity Evaluation of Coumarin-3-Carboxamide Derivatives.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Benzamides; Cell Line; Cell Line, Tumor; Coumarins; Doxorubicin; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation | 2021 |
Design, synthesis and molecular modeling studies of novel mesalamine linked coumarin for treatment of inflammatory bowel disease.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Female; Inflammatory Bowel Diseases; Male; Mesalamine; Models, Molecular; Molecular Structure; Rats; Rats, Wistar; Structure-Activity Relationship | 2021 |
A Coumarin-Porphyrin FRET Break-Apart Probe for Heme Oxygenase-1.
Topics: Coumarins; Escherichia coli; Fluorescence Resonance Energy Transfer; Heme Oxygenase-1; Humans; Photochemical Processes; Protoporphyrins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry, Ultraviolet | 2021 |
Mixed-Ligand Cobalt(III) Complexes of a Naturally Occurring Coumarin and Phenanthroline Bases as Mitochondria-Targeted Dual-Purpose Photochemotherapeutics.
Topics: Antineoplastic Agents; Cell Proliferation; Cobalt; Coordination Complexes; Coumarins; Crystallography, X-Ray; Density Functional Theory; Drug Screening Assays, Antitumor; Humans; Ligands; Mitochondria; Models, Molecular; Molecular Structure; Phenanthrolines; Photochemistry; Tumor Cells, Cultured | 2021 |
Photoactivated release of membrane impermeant sulfonates inside cells.
Topics: Anions; Cell Membrane Permeability; Coumarins; HeLa Cells; Humans; Phosphates; Photochemical Processes; Rhodamines; Sulfonic Acids | 2021 |
Synthesis of a Coumarin-Based PPARγ Fluorescence Probe for Competitive Binding Assay.
Topics: Animals; Binding, Competitive; Biological Assay; Chlorocebus aethiops; COS Cells; Coumarins; Crystallography, X-Ray; Fluorescent Dyes; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Ligands; PPAR gamma; Spectrometry, Fluorescence; Transcription, Genetic | 2021 |
Inhibitory Effects of Coumarin Derivatives on Tyrosinase.
Topics: Agaricales; Cosmetics; Coumarins; Enzyme Inhibitors; Humans; Monophenol Monooxygenase; Skin | 2021 |
Discovery of Potent Coumarin-Based Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains Using Structure-Based Design.
Topics: Amyloid; Coumarins; Crystallography, X-Ray; Drug Design; High-Throughput Screening Assays; Immunoglobulin Light Chains; Kinetics; Models, Molecular; Protein Domains; Protein Stability | 2021 |
Synthesis and Biological Activity of Triterpene-Coumarin Conjugates.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Coumarins; Hep G2 Cells; HT29 Cells; Humans; Melanoma, Experimental; Membrane Potential, Mitochondrial; Mice; Molecular Structure; Olive Oil; Triterpenes | 2021 |
De novo transcriptome assembly of Angelica dahurica and characterization of coumarin biosynthesis pathway genes.
Topics: Angelica; Biosynthetic Pathways; Coumarins; Gene Expression Profiling; Phylogeny; Plant Roots; Secondary Metabolism; Transcriptome | 2021 |
Ratiometric Detection of Glutathione Based on Disulfide Linkage Rupture between a FRET Coumarin Donor and a Rhodamine Acceptor.
Topics: Animals; Coumarins; Disulfides; Drosophila melanogaster; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Glutathione; HeLa Cells; Humans; Molecular Structure; Rhodamines; Tumor Cells, Cultured | 2021 |
Deciphering protein microenvironment by using a cysteine specific switch-ON fluorescent probe.
Topics: Coumarins; Cysteine; Fluorescent Dyes; Models, Molecular; Molecular Structure; Protein Unfolding; Proteins | 2021 |
Ultrasensitive detection by maxillary palp neurons allows non-host recognition without consumption of harmful allelochemicals.
Topics: Animals; Bombyx; Chemoreceptor Cells; Coumarins; Feeding Behavior; HEK293 Cells; Humans; Larva; Neurons; Pheromones; Plant Extracts; Plant Leaves; Receptors, Cell Surface; Taste; Taste Perception | 2021 |
A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Kallikreins; Male; Molecular Structure; Prostate-Specific Antigen; Prostatic Neoplasms | 2021 |
Enzyme Mimic Facilitated Artificial Cell to Mammalian Cell Signal Transfer.
Topics: Artificial Cells; Biocatalysis; Coumarins; Cytochrome P-450 Enzyme System; Hep G2 Cells; Humans; Oxazines; Signal Transduction | 2021 |
Preclinical safety assessment of the crude extract from Sida rhombifolia L. aerial parts in experimental models of acute and repeated-dose 28 days toxicity in rats.
Topics: Administration, Oral; Animals; Caffeic Acids; Coumarins; Female; Male; Malvaceae; Plant Components, Aerial; Plant Extracts; Rats; Rutin; Toxicity Tests, Acute; Toxicity Tests, Subacute | 2021 |
Novel chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids as potential antibacterial repressors against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Chalcones; Coumarins; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Thiazoles | 2021 |
Potency boost of a
Topics: Coumarins; Drug Resistance, Bacterial; Folic Acid; Folic Acid Antagonists; Genes, Bacterial; Loss of Function Mutation; Molecular Docking Simulation; Multienzyme Complexes; Mycobacterium tuberculosis; Oxidation-Reduction; Oxidoreductases; Tetrahydrofolate Dehydrogenase | 2021 |
Viscosity sensitive endoplasmic reticulum fluorescent probes based on oxazolopyridinium.
Topics: Cell Line, Tumor; Cell Survival; Coumarins; Endoplasmic Reticulum; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Molecular Structure; Optical Imaging; Oxazoles; Pyridones; Viscosity | 2021 |
A Novel Fluorescent Probe for Hydrogen Peroxide and Its Application in Bio-Imaging.
Topics: Animals; Cell Membrane; Coumarins; Fluorescent Dyes; Humans; Hydrogen Peroxide; MCF-7 Cells; Optical Imaging; Zebrafish | 2021 |
Coumarin-Based Triapine Derivatives and Their Copper(II) Complexes: Synthesis, Cytotoxicity and mR2 RNR Inhibition Activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Copper; Coumarins; Crystallography, X-Ray; Humans; Mice; Models, Molecular; Molecular Structure; Pyridines; Structure-Activity Relationship; Thiosemicarbazones | 2021 |
Development and validation of ultra-high performance supercritical fluid chromatography method for quantitative determination of six compounds in Guizhi Fuling capsule and tablet samples.
Topics: Acetophenones; Amygdalin; Capsules; Chromatography, Supercritical Fluid; Cinnamates; Coumarins; Drugs, Chinese Herbal; Glucosides; Monoterpenes; Propanols; Tablets | 2021 |
Candida albicans exhibit two classes of cell surface binding sites for serum albumin defined by their affinity, abundance and prospective role in interkingdom signalling.
Topics: Binding Sites; Candida albicans; Cell Adhesion; Cell Membrane; Coumarins; Fungal Proteins; Protein Binding; Serum Albumin; Signal Transduction | 2021 |
Synthesis and characterization of a new two photon excitable acid sphingomyelinase FRET probe.
Topics: Coumarins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescence Resonance Energy Transfer; Humans; Molecular Structure; Photons; Sphingomyelin Phosphodiesterase; Structure-Activity Relationship | 2021 |
Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.
Topics: Alzheimer Disease; Cell Line, Tumor; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Structure-Activity Relationship | 2021 |
Molecular cloning and biochemical characterization of a new coumarin glycosyltransferase CtUGT1 from Cistanche tubulosa.
Topics: China; Cistanche; Cloning, Molecular; Coumarins; Glycosylation; Glycosyltransferases; Molecular Docking Simulation; Molecular Structure; Phylogeny; Plant Proteins; Protein Structure, Secondary; Substrate Specificity | 2021 |
Coumarin Interferes with Polar Auxin Transport Altering Microtubule Cortical Array Organization in
Topics: Arabidopsis; Arabidopsis Proteins; Biological Transport; Coumarins; Gene Expression Regulation, Plant; Indoleacetic Acids; Meristem; Microtubules; Plant Roots | 2021 |
Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
Topics: Aldehyde Reductase; Binding Sites; Coumarins; Enzyme Inhibitors; Half-Life; Humans; Kinetics; Molecular Docking Simulation; Protein Isoforms; Protein Structure, Tertiary; Structure-Activity Relationship; Thiosemicarbazones | 2021 |
Identification of a new autophagy inhibitor targeting lipid droplets in vascular endothelial cells.
Topics: Autophagy; Cells, Cultured; Coumarins; Endothelial Cells; Humans; Lipid Droplets; Pyrazoles | 2021 |
Curcumin-Coumarin Hybrid Analogues as Multitarget Agents in Neurodegenerative Disorders.
Topics: Acetylcholinesterase; Animals; Antioxidants; Biphenyl Compounds; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Coumarins; Curcumin; GPI-Linked Proteins; Humans; Hydrogen Peroxide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Cortex; Nanoparticles; Neurons; Neuroprotective Agents; Picrates; Primary Cell Culture; Rats; Structure-Activity Relationship | 2021 |
8-Geranylumbelliferone isolated from Paramignya trimera triggers RIPK1/RIPK3-dependent programmed cell death upon TNFR1 ligation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Coumarins; HEK293 Cells; HeLa Cells; HT29 Cells; Humans; MCF-7 Cells; Mice; Mice, Knockout; Plant Extracts; RAW 264.7 Cells; Receptor-Interacting Protein Serine-Threonine Kinases; Receptors, Tumor Necrosis Factor, Type I; Umbelliferones | 2021 |
Fluorogenic
Topics: Antiviral Agents; Coronavirus 3C Proteases; Coumarins; COVID-19; COVID-19 Drug Treatment; Drug Discovery; Fluorescence Resonance Energy Transfer; High-Throughput Screening Assays; Humans; In Vitro Techniques; Protease Inhibitors; SARS-CoV-2; Viral Proteins | 2021 |
O-prenylated carbostyrils as a novel class of 15-lipoxygenase inhibitors: Synthesis, characterization, and inhibitory assessment.
Topics: Arachidonate 15-Lipoxygenase; Biphenyl Compounds; Coumarins; Glycine max; Humans; Hydroxyquinolines; Lipoxygenase Inhibitors; Picrates; Quinolones; Structure-Activity Relationship | 2021 |
A coumarin-based TICT fluorescent probe for real-time fluorescence lifetime imaging of mitochondrial viscosity and systemic inflammation
Topics: Animals; Cell Survival; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Indoles; Inflammation; Lipopolysaccharides; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Mitochondria; Viscosity; Zebrafish | 2021 |
A Novel Coumarin-based Fluorescent Probe with Aggregation Induced Emission for Detecting CN
Topics: Animals; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Ions; Molecular Structure; Nitriles; Optical Imaging; Spectrometry, Fluorescence; Tumor Cells, Cultured; Zebrafish | 2021 |
Novel Coumarin-Thiadiazole Hybrids and Their Cu(II) and Zn(II) Complexes as Potential Antimicrobial Agents and Acetylcholinesterase Inhibitors.
Topics: Acetylcholinesterase; Anti-Bacterial Agents; Anti-Infective Agents; Cholinesterase Inhibitors; Copper; Coumarins; Crystallography, X-Ray; Escherichia coli; Ligands; Magnetic Resonance Spectroscopy; Metals; Microbial Sensitivity Tests; Neurodegenerative Diseases; Pseudomonas aeruginosa; Schiff Bases; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Staphylococcus aureus; Staphylococcus epidermidis; Thiadiazoles; Thiazoles; Zinc | 2021 |
Influence of lactide vs glycolide composition of poly (lactic-co-glycolic acid) polymers on encapsulation of hydrophobic molecules: molecular dynamics and formulation studies.
Topics: Animals; CHO Cells; Coumarins; Cricetulus; Drug Carriers; Drug Compounding; Glycolates; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Materials Testing; Microscopy, Electron, Transmission; Molecular Dynamics Simulation; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Toxicity Tests | 2021 |
In silico bimolecular characterization of anticancer phytochemicals from Fagonia indica.
Topics: Antineoplastic Agents, Phytogenic; bcl-X Protein; Cell Survival; Computer Simulation; Coumarins; Epidermal Growth Factor; ErbB Receptors; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; In Vitro Techniques; Inhibitory Concentration 50; Kaempferols; Molecular Docking Simulation; Myeloid Cell Leukemia Sequence 1 Protein; Phytochemicals; Plant Extracts; Zygophyllaceae | 2021 |
Piperazine-Coumarin based fluorescence probe with enhanced brightness and solubility for bio-thiol detection and esophageal carcinoma diagnosis.
Topics: Coumarins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorescent Dyes; HEK293 Cells; Humans; Molecular Structure; Piperazine; Solubility; Spectrometry, Fluorescence | 2021 |
Synthesis and biological evaluation of N, N-dialkylcarboxy coumarin-NO donor conjugates as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Molecular Structure; Nitric Oxide; Structure-Activity Relationship | 2021 |
Novel Boronate Probe Based on 3-Benzothiazol-2-yl-7-hydroxy-chromen-2-one for the Detection of Peroxynitrite and Hypochlorite.
Topics: Boronic Acids; Cell Proliferation; Chromones; Colonic Neoplasms; Coumarins; Fluorescence; Fluorescent Dyes; HT29 Cells; Humans; Hydrogen Peroxide; Peroxynitrous Acid | 2021 |
Coumarin and Its Derivatives-Editorial.
Topics: Coumarins; Humans | 2021 |
Potential application of antiviral coumarin in aquaculture against IHNV infection by reducing viral adhesion to the epithelial cell surface.
Topics: Animals; Antiviral Agents; Aquaculture; Cell Line; Coumarins; Fish Diseases; Infectious hematopoietic necrosis virus; Oncorhynchus mykiss; Rhabdoviridae Infections; Survival Rate; Viral Load; Viral Proteins; Virus Attachment; Virus Replication | 2021 |
A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products.
Topics: Animal Testing Alternatives; Bayes Theorem; Cell Culture Techniques; Cosmetics; Coumarins; Cytochrome P-450 Enzyme System; Dermatitis, Contact; Liver; Models, Theoretical; Risk Assessment; Skin Irritancy Tests | 2021 |
Deciphering the AChE-binding mechanism with multifunctional tricyclic coumarin anti-Alzheimer's agents using biophysical and bioinformatics approaches and evaluation of their modulating effect on Amyloidogenic peptide assembly.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Computational Biology; Coumarins; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Peptide Fragments; Protein Binding; Protein Structure, Secondary; Structure-Activity Relationship | 2021 |
Physico-chemical investigations of human olfactory receptors OR10G4 and OR2B11 activated by vanillin, ethyl vanillin, coumarin and quinoline molecules using statistical physics method.
Topics: Benzaldehydes; Coumarins; Humans; Models, Chemical; Quinolines; Receptors, Odorant | 2021 |
Targeting Oxidative Stress: Novel Coumarin-Based Inverse Agonists of GPR55.
Topics: Cell Line; Coumarins; Drug Evaluation, Preclinical; Drug Inverse Agonism; Humans; Oxidative Stress; Primary Cell Culture; Receptors, Cannabinoid | 2021 |
Coumarin 1,4-enedione for selective detection of hydrazine in aqueous solution and fluorescence imaging in living cells.
Topics: Coumarins; Cyclization; Fluorescent Dyes; HeLa Cells; Humans; Hydrazines; Limit of Detection; Optical Imaging; Water | 2021 |
Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy.
Topics: Antineoplastic Agents; Antioxidants; Binding Sites; Coumarins; Flavones; Flavonoids; Humans; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Oxidation-Reduction; Oxidative Stress; Phytochemicals; Protein Binding; Triterpenes | 2021 |
An Activity-Based Ratiometric Fluorescent Probe for In Vivo Real-Time Imaging of Hydrogen Molecules.
Topics: Animals; Azides; Coumarins; Fluorescent Dyes; Humans; Hydrogen; Molecular Imaging; Palladium; Silicon Dioxide; Time Factors | 2022 |
A coumarin-based fluorescent probe for specific detection of cysteine in the lysosome of living cells.
Topics: Cell Survival; Coumarins; Cysteine; Dose-Response Relationship, Drug; Fluorescent Dyes; HeLa Cells; Humans; Lysosomes; Molecular Structure; Optical Imaging; Structure-Activity Relationship; Tumor Cells, Cultured | 2022 |
Crossing of the Cystic Barriers of
Topics: Coumarins; Fluorescent Dyes; Histone Deacetylase Inhibitors; Histone Deacetylases; Models, Molecular; Peptides, Cyclic; Toxoplasma | 2021 |
Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
Topics: Acetylcholinesterase; Alzheimer Disease; Cells, Cultured; Chalcone; Cholinesterase Inhibitors; Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Thiophenes | 2022 |
Growth modulation and metabolic responses of Ganoderma boninense to salicylic acid stress.
Topics: Alanine; Arecaceae; Carbohydrates; Carbon; Chromatography, Liquid; Cluster Analysis; Coumarins; Culture Media; Ganoderma; In Vitro Techniques; Ions; Lipids; Mass Spectrometry; Melanins; Phenols; Phenylalanine; Plant Diseases; Plant Roots; Salicylic Acid; Tryptophan | 2021 |
Evaluation of the Antiviral Activity against Infectious Pancreatic Necrosis Virus (IPNV) of a Copper (I) Homoleptic Complex with a Coumarin as Ligand.
Topics: Antiviral Agents; Coordination Complexes; Copper; Coumarins; Infectious pancreatic necrosis virus; Ligands; Models, Molecular; Structure-Activity Relationship; Virus Replication | 2021 |
Experimental mixture design as a tool to evaluate coumarin (1,2-benzopyrone) extraction from Dipteryx odorata seeds.
Topics: Chromatography, High Pressure Liquid; Coumarins; Dipteryx; Reproducibility of Results; Solvents | 2022 |
Amyloidogenic immunoglobulin light chain kinetic stabilizers comprising a simple urea linker module reveal a novel binding sub-site.
Topics: Binding Sites; Coumarins; Dose-Response Relationship, Drug; Humans; Immunoglobulin Light Chains; Kinetics; Molecular Structure; Protein Stability; Structure-Activity Relationship; Urea | 2022 |
Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin
Topics: Catalytic Domain; Coumarins; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Resveratrol; Styrenes | 2022 |
Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors.
Topics: Coumarins; Molecular Docking Simulation; Molecular Dynamics Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2023 |
A two-photon fluorogenic probe based on a coumarin schiff base for formaldehyde detection in living cells.
Topics: Coumarins; Fluorescent Dyes; Formaldehyde; HeLa Cells; Humans; Schiff Bases | 2022 |
Effects of Structural Manipulation on the Bioactivity of some Coumarin-Based Products.
Topics: Antifungal Agents; Coumarins; Fungi; Microbial Sensitivity Tests | 2021 |
Forming coumarin C-glycosides via biocatalysis: Characterization of a C-glycosyltransferase from Angelica decursiva.
Topics: Angelica; Biocatalysis; Coumarins; Glycosides; Glycosyltransferases | 2022 |
A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes
Topics: Animals; Antioxidants; Body Weight; Cardiotonic Agents; Catalase; Coumarins; Electrocardiography; Glutathione; Isoproterenol; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Rats, Wistar | 2022 |
A Coumarin-Donepezil Hybrid as a Blood-Brain Barrier Permeable Dual Cholinesterase Inhibitor: Isolation, Synthetic Modifications, and Biological Evaluation of Natural Coumarins.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Blood-Brain Barrier; Chalcones; Cholinesterase Inhibitors; Cholinesterases; Coumarins; Donepezil; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2022 |
3-Arylcoumarin inhibits vascular calcification by inhibiting the generation of AGEs and anti-oxidative stress.
Topics: Cells, Cultured; Coumarins; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Oxidative Stress; Vascular Calcification | 2022 |
Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Coumarins; Disease Models, Animal; Dopaminergic Neurons; Mice; Parkinson Disease; Rats; Synucleinopathies | 2022 |
5-Demethoxy-10'-ethoxyexotimarin F, a New Coumarin with MAO-B Inhibitory Potential from
Topics: Coumarins; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Murraya | 2022 |
Isolation, Identification and Characterization of Growth Parameters of
Topics: Biodegradation, Environmental; Coumarins; DNA, Ribosomal; Excipients; Pseudomonas putida; Soil; Soil Microbiology | 2022 |
Efficient Synthesis of Fluorescent Coumarins and Phosphorous-Containing Coumarin-Type Heterocycles via Palladium Catalyzed Cross-Coupling Reactions.
Topics: Catalysis; Coloring Agents; Coumarins; Molecular Structure; Palladium | 2022 |
Synthesis, Computational and Pharmacological Evaluation of 7-(2-(2- (3- (Substituted Phenyl) Acryloyl) Phenoxy) Ethoxy)-4-Methyl-2H-Chromen- 2-Ones as CNS Agents.
Topics: Animals; Central Nervous System Agents; Chalcone; Coumarins; Diazepam; Mice; Prospective Studies; Structure-Activity Relationship | 2023 |
Structural and Spectroscopic Study of New Copper(II) and Zinc(II) Complexes of Coumarin Oxyacetate Ligands and Determination of Their Antimicrobial Activity.
Topics: Anti-Infective Agents; Coordination Complexes; Copper; Coumarins; Ligands; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Zinc | 2023 |
Synthesis, Antioxidant and Antiproliferative Evaluation, Molecular Docking and DFT Studies of Some Novel Coumarin and Fused Coumarin Derivatives.
Topics: Antineoplastic Agents; Antioxidants; Cell Line; Coumarins; Humans; Molecular Docking Simulation; Structure-Activity Relationship | 2023 |
Synthesis and antimicrobial activity of new series of thiazoles, pyridines and pyrazoles based on coumarin moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Coumarins; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Pyridines; Thiazoles | 2023 |
Novel coumarin-chalcone derivatives: Synthesis, characterization, antioxidant, cyclic voltammetry, molecular modelling and biological evaluation studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors.
Topics: Acetylcholinesterase; Antioxidants; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Chalcone; Cholinesterase Inhibitors; Coumarins; Glycoside Hydrolases; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2023 |
Engineered coumarin accumulation reduces mycotoxin-induced oxidative stress and disease susceptibility.
Topics: Arabidopsis; Coumarins; Disease Susceptibility; Mycotoxins; Oxidative Stress; Plant Roots; Scopoletin | 2023 |
Application of urea-based magnetic covalent organic framework as sorbent for the determination of coumarin and its derivatives in food samples combined with liquid chromatography-mass spectrometry.
Topics: Chromatography, Liquid; Coumarins; Magnetic Phenomena; Mass Spectrometry; Metal-Organic Frameworks; Urea | 2024 |